{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "\nChevron’s outstanding loan to Petroboscan was $560 million (fully provisioned at year‑end 2021), and the company held a 39.2 % ownership interest in the joint‑stock Petroboscan entity as of the 2022 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-part question. (1) CORRECTNESS: Both key facts are accurate - the outstanding loan amount of $560 million and the 39.2% ownership interest are correctly stated. The LLM properly formatted the dollar amount as '$560 million' which is semantically equivalent to the ground truth '$560'. The percentage is exactly correct at 39.2%. (2) QUANTITATIVE ACCURACY: All numeric values are precise and match the ground truth. The loan amount ($560M), ownership percentage (39.2%), and time period (2022 reporting period) are all factually correct. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly identified both required entities (Chevron and Petroboscan) and synthesized the multi-hop information appropriately. The answer demonstrates understanding that these are two separate data points about the same relationship. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses the question asked. The additional contextual detail about the loan being 'fully provisioned at year-end 2021' and describing Petroboscan as a 'joint-stock' entity adds helpful context without detracting from accuracy. (5) MINOR CONSIDERATION: The LLM included a parenthetical note about 2021 provisioning which, while accurate and contextually relevant, goes slightly beyond what was explicitly asked. However, this is supplementary information that enhances rather than contradicts the answer. The core answer perfectly matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 422,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "\nThe February 2021 transaction generated **$356 million in cash proceeds** and produced a **$335 million pretax gain** that Target recorded in “Net Other (Income) / Expense.” This gain is reflected as a $335 million positive adjustment in the cash‑flow reconciliation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies both key financial figures: $356 million in cash proceeds and $335 million pretax gain from the Dermstore LLC sale. Both numbers match the ground truth exactly. The answer also correctly identifies the transaction timing (February 2021) and properly notes where the gain was recorded (Net Other Income/Expense). However, the answer has a notable weakness: it does NOT explicitly calculate or state the total financial impact of $691 million (the sum of cash received plus pretax gain), which was the core ask of the question. The original answer explicitly states 'resulting in a total financial impact of $691 million,' while the LLM answer provides the component figures but leaves the synthesis incomplete. The LLM does mention both figures are 'positive adjustments' which implies additive impact, but fails to explicitly synthesize them into the total figure requested. The answer is factually accurate on all numbers and provides good contextual detail about accounting treatment, but incompletely addresses the multi-hop synthesis requirement of the question (combining cash received + pretax gain into total impact). This is a case where individual facts are correct but the final synthesis step is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 351,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "\nAmgen recorded $125 million of product‑sales to BeiGene in 2023, $64 million in 2022 and $72 million in 2021. Summing these three years, the total product‑sales revenue from BeiGene for fiscal 2021‑2023 equals **approximately $261 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All numerical values are correct: $72 million (2021), $64 million (2022), and $125 million (2023). The calculation is accurate: $72M + $64M + $125M = $261M. The answer correctly identifies all entities (Amgen, BeiGene, collaboration agreement) and the correct time period (2021-2023). The multi-hop reasoning is sound - the model synthesized revenue data across three fiscal years and correctly summed them. The use of 'approximately $261 million' is a minor semantic choice (the ground truth states 'totaling $261 million'), but this is not a factual error since the sum is exact. The answer presents the information in a clear, logical order and addresses all parts of the question. The only minor distinction is the word 'approximately' which could suggest some rounding, though the actual sum is precise - this is a negligible semantic variation that does not affect the factual accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 278,
        "total_tokens": 1395
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan authorized roughly **127 million** shares of Danaher common stock, and **about 50 million** of those shares were still available for issuance as of December 31, 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth. Both key numeric values are accurate: (1) 127 million shares authorized under the 2007 Omnibus Incentive Plan - correctly stated as 'roughly 127 million' in the LLM answer, (2) approximately 50 million shares remaining available as of December 31, 2021 - correctly stated as 'about 50 million' in the LLM answer. The LLM appropriately used qualifiers like 'roughly' and 'about' which are semantically equivalent to 'approximately' in the ground truth, reflecting the nature of these figures. The answer addresses both parts of the multi-part question completely: authorization amount and available shares as of the specific date. Entity identification is correct (Danaher, 2007 Omnibus Incentive Plan, December 31, 2021). The reasoning is sound - the LLM correctly synthesized that the 50 million available shares are a subset of the 127 million authorized shares. Minor deduction (1 point) only because the LLM could have been slightly more explicit in clarifying that the 50 million represents the remaining/unallocated portion of the 127 million total, though this is clearly implied in the phrasing 'of those shares were still available.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 342,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "\nLLY received **$1.05 billion in cash in 2023** and **an additional $305 million in cash in 2024** from the sale of the olanzapine (Zyprexa) portfolio to Cheplapharm, for a total cash proceeds of **$1.355 billion** across those two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: $1.05 billion in 2023, $305 million in 2024, and $1.355 billion total. The answer correctly identifies all entities (LLY, Cheplapharm, olanzapine portfolio, Zyprexa). The multi-hop synthesis is sound - the model correctly combined information about the transaction across two fiscal years and calculated the total. The answer addresses all parts of the question: (1) total cash received ($1.355 billion), (2) 2023 distribution ($1.05 billion), and (3) 2024 distribution ($305 million). The presentation is clear and logical, with the specific year amounts provided first followed by the total, making the distribution across years explicit. No calculation errors, no missing information, and no entity confusion. The answer demonstrates proper understanding of the multi-year transaction structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 267,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "\nLockheed Martin recorded **$298 million of goodwill** as a result of its acquisition of Terran Orbital. Of the total **$314 million purchase consideration**, **$231 million was paid in cash** (the remainder being the $83 million of previously held investments).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers are correct: $298 million in goodwill, $314 million total purchase consideration, and $231 million paid in cash. The answer correctly addresses both parts of the multi-part question. The LLM goes beyond the ground truth by providing additional context about the $83 million of previously held investments that comprised the non-cash portion of the consideration, which demonstrates strong synthesis and understanding of the transaction structure. The calculation is implicit but correct: $231M cash + $83M investments = $314M total consideration. All entities are correctly identified (Lockheed Martin, Terran Orbital), and the temporal context is appropriate. The only minor consideration is that the ground truth answer is more concise, while the LLM provides additional explanatory detail about the composition of the non-cash consideration. This additional detail is accurate and enhances understanding rather than detracting from it. No factual errors, calculation errors, or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 307,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "\nChevron’s carrying value of its investment in GS Caltex Corporation was **$3.6 billion (approximately $3,616 million) at the end of 2021**. This carrying amount reflects Chevron’s **50 % equity ownership** in the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the carrying value of $3,616 million (presented as $3.6 billion, which is an acceptable format variation) and the 50% equity ownership percentage match the ground truth exactly. The conversion from millions to billions is mathematically accurate. (2) COMPLETENESS: The answer addresses both parts of the question - the carrying value amount and the equity ownership percentage comparison. (3) ENTITY ACCURACY: Chevron (CVX), GS Caltex Corporation, and the 2021 fiscal year are all correctly identified. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly identified and presented both the investment carrying value and the ownership percentage from what would be separate data points in the filing. The statement that the carrying amount 'reflects' the 50% ownership shows appropriate contextual understanding. (5) SEMANTIC EQUIVALENCE: The answer conveys identical information to the ground truth, with only minor wording differences ('was $3,616 million' vs 'was $3.6 billion (approximately $3,616 million)') that enhance clarity rather than detract from accuracy. The parenthetical approximation is helpful and accurate. Minor deduction from perfect score only due to the slightly verbose presentation with the approximation notation, though this is actually a strength in financial communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 405,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "\nThe Forest Products segment’s revenue rose by **$197 million** (from $1,160 million in 2020 to $1,357 million in 2021).  During the same period the **average revenue per car** increased by **$155** (from $5,269 to $5,424).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - the revenue increase of $197 million and the average revenue per car increase of $155 match the ground truth exactly. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct: 2020 revenue of $1,160 million, 2021 revenue of $1,357 million (difference = $197M ✓), 2020 average revenue per car of $5,269, 2021 average revenue per car of $5,424 (difference = $155 ✓). The calculations are accurate. (3) QUALITATIVE ACCURACY: The LLM correctly identified the Forest Products segment, properly synthesized the multi-hop information (combining revenue change with per-car metric change), and presented the data in a clear, logical manner with supporting detail. The answer goes beyond the minimum by providing the underlying figures, which adds transparency and verifiability. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses both parts of the multi-part question - the dollar change in total revenue AND the corresponding change in average revenue per car. The presentation is well-structured with bold formatting for key metrics, making it easy to identify the answer components. Minor note: The LLM provided additional context (the actual revenue figures and per-car amounts) which, while not required, enhances the answer's credibility and usefulness. No errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 388,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "\nIn 2024 Restasis generated **$224 million** in total net revenue.  Compared with $436 million in 2023, this represents a **48.7 % decline** when measured using actual currency rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: (1) 2024 Restasis net revenue of $224 million matches ground truth exactly, (2) 2023 comparison figure of $436 million is accurate, (3) the 48.7% decline calculation is mathematically correct (($436M - $224M) / $436M = $212M / $436M = 48.6%, which rounds to 48.7%). The answer properly addresses both parts of the multi-part question: the total net revenue contribution and the percentage decline. The specification of 'actual currency rates' is appropriately included, matching the ground truth's emphasis on this metric. The entity identification (Restasis) and time periods (2024 vs 2023) are correct. The multi-hop reasoning is sound - the model correctly synthesized the 2024 revenue figure, the 2023 comparison figure, and calculated the percentage decline. Minor formatting variation in the percentage display (48.7 % vs 48.7%) is inconsequential. The answer is well-structured, clear, and provides all necessary context for understanding the decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1085,
        "completion_tokens": 299,
        "total_tokens": 1384
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "\nAs of December 31, 2023, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**, while the regulatory minimum CET1 requirement under the Basel III standardized approach was **4.5 %**. Therefore, the Company’s CET1 ratio exceeded the minimum by **approximately 8.4 percentage points**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative elements are correct: (1) Capital One's CET1 ratio of 12.9% as of December 31, 2023 matches the ground truth, (2) the minimum regulatory requirement of 4.5% is correct, (3) the calculated difference of 8.4 percentage points is accurate (12.9% - 4.5% = 8.4%). The multi-hop reasoning is sound - the model correctly identified both the actual ratio and the minimum requirement, then performed the subtraction accurately. The entity identification is correct (Capital One Financial Corp, CET1 metric, December 31, 2023 date). The LLM answer provides slightly more context by referencing 'Basel III standardized approach' and uses the phrase 'exceeded the minimum by approximately 8.4 percentage points' which is semantically equivalent to the ground truth's 'difference of 8.4%'. The use of 'approximately' is a minor qualifier that doesn't detract from accuracy since the calculation is exact. The answer fully addresses all parts of the question and presents the information clearly with proper formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 308,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "\nThe pretax pension expense for Lockheed Martin’s nonqualified defined‑benefit pension plans was **$64 million in 2023**. This amount is **lower than the $81 million recorded in 2022** but **higher than the $56 million recorded in 2021**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: All three financial figures are correct - $64 million in 2023, $81 million in 2022, and $56 million in 2021. The comparisons are accurate: 2023 ($64M) is lower than 2022 ($81M) and higher than 2021 ($56M). (2) COMPLETENESS: The answer addresses all required components - the 2023 amount and explicit comparisons to both prior years (2022 and 2021). (3) ENTITY ACCURACY: Correctly identifies Lockheed Martin, the nonqualified defined benefit pension plans, and all three fiscal years (2023, 2022, 2021). The metric 'pretax pension expense' is correctly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly establishing the temporal relationships and comparative analysis. (5) SEMANTIC EQUIVALENCE: The LLM uses clear, professional language that conveys the same information as the ground truth. The phrasing 'lower than' and 'higher than' effectively communicates the year-over-year comparisons. Minor formatting note: The LLM uses 'defined‑benefit' with a special hyphen character, which is a stylistic variation but does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 343,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "\nThe net carrying amount of BlackRock’s finite‑lived “investor/customer relationships” fell from **$492 million at 12/31/2022 to $447 million at 12/31/2023**, a **$45 million decrease**.  \nThis decline reflects that the gross carrying amount rose only modestly (from $746 million to $785 million, + $39 million) while accumulated amortization jumped sharply (from $254 million to $338 million, + $84 million). Because the increase in accumulated amortization exceeded the increase in gross carrying amount, the net carrying amount was reduced by roughly $45 million over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is comprehensive and factually accurate across all dimensions. (1) QUANTITATIVE ACCURACY: All numbers are correct - net carrying amount decreased from $492M to $447M (verified), the $45M decline is accurate, gross carrying amount increased from $746M to $785M (+$39M correct), accumulated amortization increased from $254M to $338M (+$84M correct). All calculations are mathematically sound. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question: (a) the change in net carrying amount between the two dates, and (b) how accumulated amortization contributed to this change. (3) ENTITY ACCURACY: BlackRock is correctly identified, the specific metric (investor/customer relationships) is correctly specified as finite-lived, and both fiscal year-end dates (12/31/2022 and 12/31/2023) are accurate. (4) REASONING & MULTI-HOP SYNTHESIS: The LLM correctly synthesizes the relationship between three interconnected metrics: gross carrying amount, accumulated amortization, and net carrying amount. The logical explanation that accumulated amortization increase ($84M) exceeded gross carrying amount increase ($39M), resulting in a net decrease of approximately $45M, demonstrates sound financial reasoning and proper understanding of how these balance sheet components interact. (5) SEMANTIC EQUIVALENCE: The answer conveys identical information to the ground truth with clear, professional financial terminology. The presentation is well-structured and easy to follow. No errors, omissions, or misstatements detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 429,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "\nThe 2.200 % senior notes had a principal balance of **$400 million** outstanding as of December 31, 2023.  Although the notes mature in September 2024, UPS continues to report them as **long‑term debt** on its consolidated balance sheet, reflecting management’s intent and ability to refinance the obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - the principal amount of $400 million matches the ground truth exactly, and the maturity date of September 2024 is accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the principal amount outstanding as of December 31, 2023, and (b) how UPS classifies this debt on its balance sheet despite the 2024 maturity. (3) ENTITY ACCURACY: UPS is correctly identified, the debt instrument (2.200% senior notes) is correctly specified, and the fiscal year (2023) is accurate. (4) REASONING: The multi-hop synthesis is sound - the model correctly connects the principal amount to the classification rationale (management's intent and ability to refinance), which explains why debt maturing in 2024 is classified as long-term. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'continues to report them as long-term debt' and 'reflecting management's intent and ability to refinance the obligation' conveys the same meaning as the ground truth's 'classifies this debt as long-term...based on its intent and ability to refinance the debt.' The only minor difference is the LLM provides the specific maturity month (September 2024) which adds helpful detail not contradicting the ground truth. No calculation errors, no missing information, and all facts are correctly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 390,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments fell by **$5.727 billion** (down from $15.592 bn to $9.865 bn) in the fiscal year ended July 27 2024.  As a result of that decline—and the $2.615 bn drop in cash & cash equivalents—the combined total of cash and cash equivalents, available‑for‑sale debt investments and marketable equity securities declined by **$8.292 billion**, from $26.146 bn in fiscal 2023 to $17.854 bn in fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Available-for-sale debt investments decrease: $5,727 million = $5.727 billion ✓ (2) Cash and cash equivalents decrease: $2,615 million = $2.615 billion ✓ (3) Total combined decrease: $8,292 million = $8.292 billion ✓ (4) The LLM correctly identifies the fiscal year ending July 27, 2024 ✓ (5) Multi-hop synthesis is sound: the model correctly combines the three separate movements (debt investments down $5.727B, cash down $2.615B, equity securities up $50M) to arrive at the net total decrease of $8.292B ✓ (6) The LLM provides additional context by showing the before/after totals ($26.146B to $17.854B), which adds helpful detail. The only minor point is that the LLM uses billion notation ($5.727 bn) while the ground truth uses million notation ($5,727 million), but this is a formatting variation that is semantically equivalent and acceptable. The answer fully addresses both parts of the multi-part question: the specific decrease in available-for-sale debt investments AND the impact on the combined total. All calculations are accurate and the reasoning is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 331,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "\nAs of December 31 2023, 7,661,431 shares were still available for equity grants under the 2021 Linde plc Long‑Term Incentive Plan, and of that pool 2,452,443 shares could be used for awards other than options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and 2,452,443 shares could be granted as awards other than options or stock appreciation rights. The date (December 31, 2023) is also correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the total shares available and the subset that could be used for non-option/non-SAR awards. (3) ENTITY ACCURACY: All entities are correctly identified - Linde plc, the 2021 Long Term Incentive Plan, and the specific share categories. (4) REASONING: The multi-hop synthesis is sound, correctly connecting the total available shares to the subset available for specific award types. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording ('were still available' vs 'remained available', 'of that pool' vs 'of which', 'could be used for' vs 'could be granted as') but conveys identical factual information. Minor formatting differences in hyphenation (Long‑Term vs Long Term) are inconsequential. The answer is factually perfect and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 359,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "\nThe company received $247 million when it settled the forward interest‑rate swaps tied to the 2023 Notes, $143 million for the March 2022 Notes, and $136 million for the September 2022 Notes – a total cash receipt of **$526 million**.  \nBecause these swaps were accounted for as cash‑flow hedges, the $526 million appears as a cash inflow in the operating section of the cash‑flow statement, directly boosting cash flow and offsetting part of the cash outflows associated with issuing the notes, thereby improving the company’s overall liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: All numerical values are correct and properly summed ($247M + $143M + $136M = $526M total). The breakdown by note type is accurate. Number formatting is appropriate. WEAKNESSES: The LLM makes a significant factual error regarding cash flow statement classification. The ground truth states that 'cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items' - meaning the classification depends on the nature of what is being hedged, not that they automatically appear in operating activities. The LLM incorrectly asserts these appear 'in the operating section of the cash-flow statement,' which is a material mischaracterization of how derivative settlements are classified. The ground truth is more nuanced and accurate - it indicates the classification is contingent on the underlying hedged item's nature, not a fixed operating classification. This represents a fundamental error in explaining the financial impact and cash flow treatment. The LLM's explanation about 'offsetting part of the cash outflows associated with issuing the notes' and 'improving overall liquidity' adds interpretive language not present in the ground truth and could be misleading without proper context. The core quantitative answer is correct, but the qualitative explanation of the financial impact and cash flow classification contains a significant error that undermines the accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 415,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "\nNEE’s ownership in XPLR falls within the roughly 33 %–85 % interest range it holds in its other equity‑method investees. Those principal equity‑method investees—including XPLR—are chiefly invested in contracted renewable‑energy assets (wind, solar and battery‑storage projects) together with a contracted natural‑gas pipeline. (Based on the 2024 10‑K notes on equity‑method investments and the XPLR description.)",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The ownership percentage range of 33%-85% is correctly stated and matches the ground truth exactly. (2) The numeric values are accurate with proper formatting. (3) The answer correctly identifies XPLR as a principal equity method investee of NEE. WEAKNESSES: (1) CRITICAL SEMANTIC DIVERGENCE: The LLM describes the assets as 'contracted renewable-energy assets (wind, solar and battery-storage projects) together with a contracted natural-gas pipeline,' while the ground truth states 'electric generation facilities or natural gas pipelines.' The LLM's answer is MORE SPECIFIC than the ground truth, adding details about renewable energy types (wind, solar, battery storage) that may not be supported by the filing or may represent an over-specification of what was stated. (2) The phrase 'contracted renewable-energy assets' introduces a qualifier ('contracted') and specific technology types that diverge from the simpler 'electric generation facilities' language in the ground truth. (3) The multi-hop reasoning appears sound in connecting NEE's ownership percentage to the asset types of principal equity method investees, but the characterization of those assets differs materially. (4) The answer adds interpretive detail ('contracted') that wasn't in the ground truth, suggesting potential hallucination or over-inference from the source material. The core facts (ownership range and that they own generation/pipeline assets) are correct, but the specific characterization of asset types introduces uncertainty about accuracy relative to the actual filing language.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 435,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "\nThe fair‑value hierarchy table reports corporate notes and obligations with a **fair value of $2,978 million**, while their **amortized cost is $3,014 million**. This results in **unrealized losses of $45 million** relative to the amortized cost.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. (1) QUANTITATIVE ERRORS - All three critical numbers are wrong: Fair value reported as $2,978M (ground truth: $3,354M), amortized cost as $3,014M (ground truth: $3,442M), and unrealized losses as $45M (ground truth: $92M). These are not minor rounding differences but represent significant discrepancies of $376M in fair value, $428M in amortized cost, and $47M in unrealized losses. (2) CALCULATION VERIFICATION - The LLM's calculation of unrealized losses ($3,014M - $2,978M = $36M) doesn't even match their stated $45M figure, indicating internal inconsistency. The ground truth calculation is correct: $3,442M - $3,354M = $92M. (3) MULTI-HOP REASONING - While the LLM correctly identifies the structure of the answer (fair value, amortized cost, unrealized loss comparison), it has retrieved or synthesized completely incorrect data points. The reasoning framework is sound but applied to wrong numbers. (4) ENTITY ACCURACY - The LLM correctly identifies 'Corporate notes and obligations' and understands the fair value hierarchy context, but the actual data values are entirely incorrect. This suggests either retrieval from wrong filing sections, wrong company data, or wrong fiscal period. The answer addresses all parts of the question structurally but with fundamentally wrong data, making it misleading and unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 389,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "\nUnion Pacific operated **7,026 locomotives in 2024**. This total includes **6,106 owned locomotives** and **920 leased locomotives**, whose combined count makes up the full fleet figure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the question. All numeric values are correct: total locomotives (7,026), owned locomotives (6,106), and leased locomotives (920). The arithmetic is verified: 6,106 + 920 = 7,026. The answer correctly identifies Union Pacific (UNP) and the fiscal year 2024. The response properly synthesizes the multi-hop information by combining the owned and leased locomotive counts to derive the total fleet figure. The explanation clearly demonstrates how the two components (owned and leased) contribute to the overall total. The wording is clear and directly addresses both parts of the question: the total number and how the combination of owned and leased locomotives contributes to it. No omissions, errors, or ambiguities are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 236,
        "total_tokens": 1320
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "\nThe net book value of Linde’s Brands/Tradenames fell by **about $137 million** in 2024 (from roughly $2.38 billion to $2.24 billion).  Roughly **$112 million** of that decline stemmed from foreign‑currency translation adjustments (a $107 million reduction in the carrying cost offset by a $5 million increase in the accumulated amortization), and **approximately $36 million** was attributable to the additional amortization expense recorded during the year (with only minor offsetting effects from disposals and other adjustments).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. (1) STARTING VALUE ERROR: LLM states the value fell 'from roughly $2.38 billion to $2.24 billion' but ground truth shows it was $2,609 million ($2.609 billion) in 2023 to $2,239 million ($2.239 billion) in 2024. The starting value is off by ~$370 million. (2) NET CHANGE ERROR: LLM claims 'about $137 million' decline, but ground truth shows $370 million decline ($2,609M - $2,239M = $370M). This is a massive error - the LLM understated the decline by more than 60%. (3) FOREIGN CURRENCY TRANSLATION ERROR: LLM states '$112 million' with confusing breakdown ('$107 million reduction offset by $5 million increase'), but ground truth clearly states '$107 million' reduction from FX translation. The LLM's attempt to reconcile this with a $5M adjustment is not supported by the ground truth. (4) AMORTIZATION: LLM correctly identifies $36 million amortization expense, matching ground truth. (5) MISSING CONTEXT: Ground truth explains that FX ($107M) + amortization ($36M) = $143M in combined decline, which is more than total additions ($0M) and partially offset by $4M 'Other' adjustment. The LLM's explanation is muddled and doesn't clearly articulate this reconciliation. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the opening balance, closing balance, and the components of change. The fundamental starting point is wrong, which cascades through the entire analysis. The answer demonstrates poor attention to detail on critical financial figures and appears to have confused or misread the actual balance sheet values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 457,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "\nAt the end of 2021, the fair‑value of Coca‑Cola’s corporate bonds and debt‑security holdings was **$1,023 million**. This is **$19 million lower** than the $1,042 million reported at the end of 2020, indicating a net decrease of $19 million year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - $1,023 million for 2021, $1,042 million for 2020, and the $19 million decrease calculation is accurate (1,042 - 1,023 = 19). The number format variation ($1,023 million) is acceptable and matches the ground truth. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the total fair value at end of 2021 ($1,023 million), and (b) the year-over-year comparison showing a $19 million decrease. (3) ENTITY ACCURACY: Coca-Cola (KO) is correctly identified, the metric 'Corporate Bonds and Debt Securities' is correctly referenced, and both fiscal years (2021 and 2020) are properly identified. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted the 2021 value, the 2020 value, and calculated the difference to show the year-over-year change. The logic is clear and the conclusion is accurate. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('$19 million lower' and 'net decrease of $19 million') conveys the same information as the ground truth's 'decrease of $19 million.' The answer is well-structured, clear, and provides all necessary context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 342,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "\nThe performance‑based LTIP units granted under the 2023 LTI Program have a maximum grant‑date fair‑value of **$42.5 million**. They are not reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023 because the performance criteria have not yet been met – the units are not earned until a future measurement period, so no expense (and thus no dilution) is recognized in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question effectively. (1) QUANTITATIVE ACCURACY: The maximum potential fair value of $42.5 million is stated correctly and matches the ground truth exactly. The numeric value is precise and properly formatted. (2) COMPLETENESS: The answer addresses both sub-questions: (a) the maximum fair value amount, and (b) the reason why these units are not reflected as a material dilutive effect in 2023. (3) ENTITY ACCURACY: All entities are correctly identified - the 2023 LTI Program, performance-based LTIP units, and the year ended December 31, 2023 are all accurate. (4) REASONING: The multi-hop reasoning is sound. The LLM correctly synthesizes that: (a) the units have a specific grant-date fair value, and (b) they are not dilutive because performance conditions have not been met and the units are not yet earned. This logic aligns with the ground truth explanation that the units \"have not yet met the performance conditions necessary to be considered earned.\" (5) SEMANTIC EQUIVALENCE: The LLM's explanation that \"the performance criteria have not yet been met – the units are not earned until a future measurement period, so no expense (and thus no dilution) is recognized in 2023\" is semantically equivalent to the ground truth statement that units \"have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.\" The minor difference in wording (\"no expense recognized\" vs. \"no material dilutive effect\") conveys the same fundamental concept. The answer is clear, concise, and directly responsive to the question without unnecessary elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 472,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "\nThe covered‑bond position had an amortized cost of **$105 million** but a fair value of **$101 million**—a **$4 million** gap.  This gap is reflected as an **unrealized loss of $4 million** on those bonds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data matches the ground truth exactly: amortized cost of $105 million, fair value of $101 million, and unrealized loss of $4 million. The calculation of the difference ($105M - $101M = $4M) is correct. The answer properly addresses all three components of the multi-part question: (1) the amortized cost, (2) the fair value, and (3) the unrealized loss. The entity identification is correct (CRM and Covered Bonds in 2023). The reasoning is sound and clearly explains the relationship between the cost-to-fair-value gap and the unrealized loss. The only minor consideration is that the LLM uses slightly informal phrasing ('gap' instead of 'difference'), but this is semantically equivalent and does not detract from accuracy. The answer demonstrates proper multi-hop synthesis by connecting the two valuation metrics to derive the unrealized loss figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 269,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "\nAbout 13 % of Union Pacific’s Multiple‑Purpose locomotives are leased (920 ÷ 6,893 ≈ 13 %). By contrast, the combined “Switching” and “Other” locomotive categories have zero leased units (0 ÷ (122 + 11) = 0 %).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct but contains a minor precision issue. Ground truth states 13.35% for Multiple Purpose leased locomotives, while the LLM rounds this to 'About 13%'. The calculation shown (920 ÷ 6,893 ≈ 13%) is mathematically sound and yields approximately 13.35%, so the rounding is reasonable and acceptable for a percentage approximation. The LLM correctly identifies that 0% of locomotives in the 'Switching' and 'Other' categories are leased, and properly shows the calculation (0 ÷ (122 + 11) = 0%). The multi-hop reasoning is sound: the answer correctly synthesizes information about three locomotive categories and makes the required comparison between Multiple Purpose leased percentage versus the combined Switching/Other leased percentage. All entities are correctly identified (Union Pacific, locomotive categories). The answer fully addresses both parts of the question - the percentage of leased Multiple Purpose locomotives and the comparison to Switching/Other categories. The only minor deduction is for rounding 13.35% to 'About 13%' rather than stating the more precise 13.35%, though this is a reasonable approximation and doesn't constitute a factual error. The presentation is clear and the calculations are shown transparently.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 357,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "\nThe NGL volume in the Lower 48 rose from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, an increase of **567 million barrels**. The total depreciation, depletion, amortization and impairment expense for the Lower 48 segment in 2023 was **$5,729 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) CORRECTNESS: All factual information matches the ground truth exactly. The NGL volume increase of 567 million barrels (from 230 to 797 million barrels) is correct, and the depreciation, depletion, amortization, and impairments figure of $5,729 million is correct. (2) QUANTITATIVE ACCURACY: All numeric values are precise and correct - the starting volume (230 million barrels), ending volume (797 million barrels), calculated difference (567 million barrels), and the DD&A expense ($5,729 million) all match the ground truth. The calculation of the increase (797 - 230 = 567) is accurate. (3) ENTITY ACCURACY: The answer correctly identifies the Lower 48 segment, the proper time periods (end of 2020 vs. end of 2023, and 2023 for the expense), and the correct financial metrics (NGL volume and DD&A). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - combining historical NGL volumes from different years and matching them with 2023 expense data from the Lower 48 segment. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, using standard financial terminology ('depreciation, depletion, amortization and impairment expense' vs. 'depreciation, depletion, amortization, and impairments') which are semantically equivalent. The answer is well-structured, directly answering both parts of the question with appropriate emphasis on the key figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 415,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "\nWalmart spent roughly $0.4 billion of cash in fiscal 2023 to buy the remaining non‑controlling interest in Massmart and another $0.4 billion to acquire Alert Innovation, for a total of about $0.8 billion of cash outlay in that year. In fiscal 2025 the company sold Alert Innovation and de‑consolidated it, so the entity no longer appears in the consolidated financial statements—any gain or loss on the sale was recorded in that year’s results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $0.4 billion for Massmart, $0.4 billion for Alert Innovation, totaling $0.8 billion in fiscal 2023. The amounts match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) total cash spent in fiscal 2023 for both acquisitions, and (b) the subsequent financial treatment of Alert Innovation in fiscal 2025. (3) ENTITY ACCURACY: All entities are correctly identified - Walmart, Massmart, Alert Innovation, and the correct fiscal years (2023 and 2025). The LLM correctly specifies that the $0.4 billion for Massmart was for the 'remaining non-controlling interest,' which adds appropriate context. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two separate transactions, correctly linking the 2023 acquisitions to the 2025 deconsolidation. (5) SEMANTIC EQUIVALENCE: The language 'sold and de-consolidated' matches the ground truth's 'sold and deconsolidated.' The additional detail about recording a gain or loss on the sale is reasonable contextual information that doesn't contradict the ground truth. Minor note: The LLM uses 'roughly' and 'about' which are appropriate qualifiers for rounded figures, and the phrasing 'no longer appears in the consolidated financial statements' is semantically equivalent to the ground truth's treatment description. The answer is clear, well-structured, and provides all necessary information with accurate calculations and proper synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 444,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "\nIn 2021 the Metals & Minerals segment generated **$1,811 million** in freight revenue. This figure equals the 697 thousand carloads shipped that year multiplied by the $2,598 average revenue per car for that category.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct with only minor formatting differences. Ground truth: $1,810,806,000. LLM answer: $1,811 million ($1,811,000,000). The difference of $194,000 represents a rounding variation (0.01% difference), which is acceptable given the conversion from detailed figures to rounded millions. The LLM correctly identified: (1) the company (UNP), (2) the year (2021), (3) the segment (Metals & Minerals), (4) the carload count (697 thousand), (5) the average revenue per car ($2,598), and (6) the calculation methodology (carloads × average revenue per car). The multi-hop reasoning is sound - the model synthesized data from multiple fields (carload volume and per-unit revenue) to derive the total revenue figure. The semantic meaning is equivalent: both answers convey the same financial result in the same category for the same company and year. The minor rounding difference ($1,810.806M vs $1,811M) is a standard accounting practice and does not constitute a material error. All entities are correctly identified and the calculation logic is properly explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1064,
        "completion_tokens": 312,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "\nThe 2023 Securitization issued $1,284.4 million of Series 2023‑1A Securities (see page 108).  The Series 2013‑2A Securities that were fully repaid in March 2023 had an outstanding principal of $1,299.7 million immediately before repayment (also shown on page 108).  Thus, the 2023 issuance is about $15 million (roughly 1 %) lower than the amount of the 2013‑2A notes that were retired.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numbers and calculations, but these directly contradict the ground truth. Ground truth states: (1) Series 2023-1A Securities = $1.3 billion, (2) Series 2013-2A Securities repaid = $1.3 billion, and (3) these amounts match, indicating direct refinancing. LLM answer states: (1) Series 2023-1A = $1,284.4 million (~$1.284 billion), (2) Series 2013-2A = $1,299.7 million (~$1.300 billion), and (3) a $15 million difference (~1%). The LLM's numbers are more precise but fundamentally incorrect compared to ground truth. The LLM correctly identifies the entities (2023-1A and 2013-2A securities, March 2023 repayment) and addresses both parts of the multi-part question. The reasoning structure is sound - comparing the two amounts and calculating the difference. However, the core factual content is wrong: the ground truth indicates the amounts matched at $1.3 billion each, while the LLM reports different amounts ($1,284.4M vs $1,299.7M). This is a critical error for a financial question where precision matters. The LLM's calculation of the $15 million difference is mathematically correct given its stated numbers, but those numbers themselves are incorrect per the ground truth. The answer is contextually relevant and well-structured, but fails on the primary requirement of factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 371,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "\nDuring 2023 the Company borrowed **$3.0 billion** of revolving indebtedness under its 2021 Multicurrency Credit Facility and repaid **$6.1 billion** of that facility (including $842.6 million EUR). As of December 31 2023 the facility’s total borrowing capacity was **$6.0 billion**, so the amount borrowed represented roughly **50 %** of capacity, while the repayments exceeded the capacity by about **$0.1 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All core financial figures are correct: $3.0 billion borrowed, $6.1 billion repaid, and $6.0 billion total borrowing capacity as of December 31, 2023. The answer correctly addresses all parts of the multi-part question. The LLM provides additional valuable context by: (1) specifying that the repayment amount included $842.6 million EUR, (2) calculating that borrowings represented 50% of capacity ($3.0B / $6.0B = 50%), and (3) noting that repayments exceeded capacity by approximately $0.1 billion ($6.1B - $6.0B = $0.1B). All calculations are mathematically accurate. The multi-hop reasoning is sound - the model correctly synthesized information about the facility's activity during 2023 and compared it to the facility's total capacity. The only minor observation is that the percentage calculation (50%) and the comparison statement about repayments exceeding capacity by $0.1B, while mathematically correct, go slightly beyond what was explicitly asked but represent helpful analytical context. The answer is well-structured, clearly formatted with bold text for key figures, and directly addresses the question's requirements. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 343,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "\nIn 2021 Union Pacific’s Intermodal freight revenue rose from **$3,989 million in 2020 to $4,504 million in 2021**, an increase of **$515 million**.  Over the same period the **average revenue per Intermodal car grew from $1,267 to $1,403**, i.e., an **$136‑million (≈11 %) rise**.  Thus, the total Intermodal revenue grew by $515 million, which is far larger than the $136‑million increase in average revenue per car.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN UNIT INTERPRETATION: The LLM made a fundamental mistake in interpreting the average revenue per car metric. The ground truth states the average revenue per car increased by $136 (meaning $136 per car), but the LLM incorrectly stated this as a '$136-million' increase and then compared '$515 million' to '$136 million' as if they were in the same units. This is a major conceptual error. CORRECT FACTS: (1) Total Intermodal revenue increase of $515 million is correct (2020: $3,989M to 2021: $4,504M = $515M increase). (2) Average revenue per car figures are correct ($1,267 to $1,403 = $136 per car increase). ERRORS: (1) The LLM incorrectly labeled the $136 per-car increase as '$136-million,' confusing per-unit metrics with aggregate dollar amounts. (2) The comparison statement 'far larger than the $136-million increase' is nonsensical because $136 million and $136 per car are different units and cannot be directly compared in this manner. (3) The percentage calculation (≈11%) appears to reference the per-car metric ($136/$1,267 ≈ 10.7%), which is correct, but this doesn't justify calling it a '$136-million' increase. The answer demonstrates partial understanding of the underlying data but fails on the critical task of properly synthesizing and comparing metrics with different units. The question asks 'how did this growth compare' - the proper answer should acknowledge that total revenue grew by $515M while average revenue per car grew by $136 per car, and these are different metrics that cannot be directly compared in absolute dollar terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 433,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "\nIn 2021 ConocoPhillips invested **about $534 million** in capital projects in the Europe, Middle East and North Africa (EMENA) region.  That same year the EMENA segment posted a **net operating gain of roughly $24 million**, which is far smaller than the capital spending in the region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The original answer states the EMENA region reported a NET LOSS of $24 million from operations in 2021, but the LLM answer claims a NET OPERATING GAIN of roughly $24 million. This is a complete reversal of the financial result - loss vs. gain - which is a material factual error. The capital expenditure figure of $534 million is correct and properly formatted. The LLM correctly identifies the company (ConocoPhillips), region (EMENA), and year (2021). However, the sign of the operational result is inverted, which fundamentally misrepresents the financial performance of the region. The LLM's comparison statement ('far smaller than the capital spending') is logically sound in structure, but is based on incorrect data (gain instead of loss). The question is appropriately addressed in terms of structure and relevance, but the core factual content regarding the operational result is wrong. This is not a minor wording difference or interpretation issue - it's a factual error about whether operations were profitable or unprofitable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 326,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "\nMicrosoft describes Copilot Pro as a consumer‑focused subscription that delivers faster, more powerful AI assistance inside Microsoft 365 apps and on the web, embodying its “reinvent productivity and business processes” ambition by putting advanced AI tools directly into the everyday workflow. Financially, Copilot Pro is counted in the **Productivity and Business Processes** segment, specifically under the **Office Consumer products and cloud services** (Microsoft 365 Consumer) revenue category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies Copilot Pro as a consumer subscription service offering faster, more powerful AI assistance in Microsoft 365 apps and on the web, and accurately links this to Microsoft's strategic ambition to 'reinvent productivity and business processes.' The financial classification is correctly stated as 'Office Consumer products and cloud services revenue' under the Productivity and Business Processes segment. (2) QUANTITATIVE ACCURACY: No numeric values were required in this question, so this dimension is not applicable. The answer contains no calculations or financial figures that could be verified. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes: (a) the strategic positioning of Copilot Pro from strategic documents, (b) its specific features and target audience, and (c) its financial reporting classification. The connection between strategic ambition and product positioning is clearly articulated. (4) ENTITY ACCURACY: All entities are correctly identified - Microsoft, Copilot Pro, Microsoft 365 apps, Office Consumer products, and the Productivity and Business Processes segment. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly enhanced clarity. The ground truth states it's classified under 'Office Consumer products and cloud services revenue,' and the LLM answer provides the same classification while adding the segment context (Productivity and Business Processes), which is accurate and helpful. Minor note: The LLM adds parenthetical clarification '(Microsoft 365 Consumer)' which is consistent with the ground truth's mention of 'Microsoft 365 Consumer' subscriptions. The answer fully addresses both parts of the multi-part question: strategic positioning and financial classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 516,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "\nThe 2024 special dividend triggered a proportional adjustment to the 2019 Incentive Plan’s share reserve, adding **128,000 RSU shares** to the amount available for future grant. This increase was calculated by multiplying the plan’s existing share reserve by a factor of **1.018**, which reflects the ratio of the Nasdaq closing price on the last trading day before the ex‑dividend date ($674.62 on Dec 26 2023) to the Nasdaq opening price on the ex‑dividend date ($662.70 on Dec 27 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) The 128,000 RSU shares increase is accurate, (2) The adjustment factor of 1.018 is correct, (3) The Nasdaq closing price of $674.62 on December 26, 2023 is accurate, (4) The Nasdaq opening price of $662.70 on December 27, 2023 is accurate, (5) The date identification (Dec 26 as last trading day before ex-dividend date, Dec 27 as ex-dividend date) is correct. The multi-hop reasoning is sound: the answer correctly synthesizes that the special dividend triggered a proportional adjustment, explains the calculation methodology (ratio of prices), and identifies the specific adjustment factor. The explanation of how the adjustment was determined is clear and accurate. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing (\"last trading day before the ex‑dividend date\" vs \"the day before\"), but this is semantically equivalent and actually more precise. The answer fully addresses both parts of the question: (1) what was the total increase (128,000 shares), and (2) how was it determined (using the price ratio to calculate the 1.018 factor). No calculation errors are present, and all entities (2019 Incentive Plan, RSU shares, Nasdaq prices, dates) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 373,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "\nThe PFAS‑related special‑item reduced the Transportation & Electronics segment’s 2024 sales by about **$945 million**, turning a **+3.1 % non‑GAAP (adjusted) increase** into a **‑1.4 % reported decline**. In other words, once the PFAS headwinds are removed, the segment’s sales would have grown 3 % rather than fallen 1.4 % year‑over‑year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core quantitative relationship: PFAS headwinds caused a 4.5 percentage point difference between reported sales (-1.4%) and non-GAAP adjusted sales (+3.1%). The reasoning and synthesis are sound - the model correctly explains that PFAS-related items reduced growth by 4.5 percentage points. However, there is a significant quantitative accuracy issue: the LLM introduces a dollar amount of '$945 million' that is not present in the ground truth answer. The original answer focuses exclusively on percentage point differences (4.5 pp, -1.4%, +3.1%), not absolute dollar amounts. The LLM's statement 'reduced the Transportation & Electronics segment's 2024 sales by about $945 million' adds information not verified in the ground truth and could be incorrect or unsupported. Additionally, there is a minor wording inconsistency: the LLM states 'sales would have grown 3%' when the ground truth specifies '+3.1%' - this is a rounding that slightly understates the actual adjusted growth rate. The multi-hop reasoning is correct (comparing reported vs. adjusted sales, identifying PFAS impact), and the entity identification (3M, Transportation and Electronics segment, 2024) is accurate. The answer addresses the question's core requirement but introduces unverified financial data that reduces confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 378,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "\nThe company recognized a **$2 million gain** on its equity‑method investment contracts during 2021.  As of **December 31, 2021**, the fair value of those contracts was a **$(3) million** liability (i.e., a $3 million negative fair‑value position).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the $2 million gain on equity method investment contracts in 2021 and the $(3) million fair value as of December 31, 2021. The numbers match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the recognized gain and the fair value as of the specified date. (3) ENTITY ACCURACY: The answer correctly identifies the equity method investment contracts and the correct fiscal year (2021) and date (December 31, 2021). (4) SEMANTIC EQUIVALENCE: The LLM provides excellent clarification by explaining that the $(3) million represents a liability or negative fair-value position, which adds helpful context while maintaining factual accuracy. The parenthetical notation $(3) million is correctly interpreted as a negative value. (5) REASONING: The answer demonstrates sound understanding by connecting the gain recognition with the fair value position. Minor note: The LLM's additional explanatory text (clarifying that $(3) million is a liability) goes slightly beyond the ground truth answer but is semantically accurate and adds value without introducing errors. This is a minor enhancement rather than a deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 357,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "\nAbbott’s $2.2 billion of interest‑rate swaps are designated as fair‑value hedges of the variability in the fair value of a portion of its fixed‑rate debt. The swaps are marked‑to‑market and any gain or loss on the hedge directly offsets the change in the fair value of the underlying debt, so movements in benchmark rates do not materially affect the overall fair‑value exposure of the $13.7 billion of long‑term debt. In effect, the hedge neutralizes interest‑rate risk, keeping the net fair‑value impact of rate changes close to zero.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $2.2 billion notional value of interest rate hedges and $13.7 billion long-term debt as of December 31, 2024. The quantitative elements are entirely accurate with no calculation errors. The answer correctly identifies that these are fair-value hedges converting fixed-rate debt to variable-rate exposure, and accurately explains the mechanics of how the hedges offset fair value changes. The multi-hop reasoning is sound, synthesizing the relationship between the hedge contracts and their impact on debt fair value volatility. The explanation of mark-to-market accounting and the neutralization of interest-rate risk is technically precise and demonstrates understanding of derivative accounting. Minor differences from the ground truth: (1) The LLM uses more technical accounting language ('fair-value hedges,' 'marked-to-market,' 'designated') versus the ground truth's slightly more general explanation of 'reducing volatility.' (2) The LLM emphasizes that movements in benchmark rates do not 'materially affect' fair-value exposure, while the ground truth states they 'would fluctuate more significantly' without hedges - these are semantically equivalent but frame the concept slightly differently. (3) The LLM's statement that the hedge 'neutralizes interest-rate risk, keeping the net fair-value impact of rate changes close to zero' is more precise than the ground truth's 'reduces the volatility.' Both answers are correct; the LLM provides more technical detail about the accounting treatment. No factual errors detected. The answer fully addresses the question's core inquiry about how the hedges impact fair value of long-term debt.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 471,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "\nEquity‑company proved reserves in Asia total **1,276 million barrels (oil‑equivalent)**, while consolidated subsidiaries in Asia hold **2,286 million barrels** of oil‑equivalent proved reserves. Thus, the equity‑company figure represents roughly **56 % of**—or about **half of**—the reserves held by consolidated subsidiaries in the region. (Data from page 11 of the 2024 10‑K.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: equity companies in Asia = 1,276 million barrels, consolidated subsidiaries in Asia = 2,286 million barrels. The comparison calculation is accurate: 1,276/2,286 = 0.558 or approximately 56%, which the LLM correctly identifies. The LLM also provides the alternative framing ('about half'), which is semantically equivalent and helpful. The answer properly addresses all parts of the multi-hop question: (1) identifies the equity company reserves, (2) identifies the consolidated subsidiary reserves, (3) synthesizes a meaningful comparison. The citation to page 11 of the 2024 10-K adds credibility. Minor note: The original ground truth states the consolidated subsidiaries hold 'approximately 1.8 times more' reserves (2,286/1,276 = 1.79), while the LLM frames it as equity companies representing '56% of' consolidated subsidiaries. Both are mathematically equivalent and correct (if A is 56% of B, then B is 1.79x A), so this represents different but equally valid ways of expressing the same relationship. The LLM's percentage-based framing is arguably more precise and easier to verify. All entities are correctly identified (ExxonMobil, Asia region, equity companies vs. consolidated subsidiaries, 2024 10-K). The reasoning is sound and the answer is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 378,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "\nThe 2019 Swiss tax reform caused Mondelēz International’s effective tax rate to collapse to **0.1 %** (versus an adjusted 22.4 % without the reform).  As a result of the reform, the company recorded a **$767 million net tax benefit** in 2019—a $769 million reduction in deferred‑tax expense from the step‑up of intangible assets, net of a modest $2 million indirect tax charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides comprehensive detail beyond the ground truth. Verification of key claims: (1) The $767 million net financial benefit matches exactly with the ground truth. (2) The effective tax rate impact is correctly characterized - the ground truth states a 22.3 percentage point reduction, and the LLM provides the specific context that the effective tax rate fell to 0.1% from an adjusted 22.4%, which represents a 22.3 percentage point reduction (22.4% - 0.1% = 22.3%), confirming mathematical accuracy. (3) The LLM provides additional valuable detail about the composition of the benefit: $769 million reduction in deferred-tax expense from step-up of intangible assets, net of $2 million indirect tax charge ($769M - $2M = $767M), which demonstrates sound multi-hop reasoning and calculation verification. (4) All entities are correctly identified (Mondelēz International, 2019, Swiss Tax Reform). (5) The answer directly addresses both parts of the multi-part question: the impact on effective tax rate AND the net financial benefit. The only minor consideration is that the ground truth uses slightly different language ('reduced by 22.3 percentage points' vs. the LLM's specific rate calculation), but these are semantically equivalent and the LLM's approach is actually more precise and informative. The additional breakdown of the $767 million benefit into its components ($769M - $2M) adds credibility and demonstrates deeper understanding of the underlying financial mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 420,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "\nIn 2022 PepsiCo transferred $145 million of pension and retiree‑medical obligations to TBG as part of the Juice Transaction (Note 13, page 94), and it recorded a $520 million gain from remeasuring its 39 % ownership stake in TBG (Note 13, page 111).  Adding the two amounts, the total financial impact of these items was approximately **$665 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Quantitative verification: (1) Pension obligation transfer: $145 million - correct; (2) Gain from remeasurement of 39% ownership stake: $520 million - correct; (3) Sum calculation: $145M + $520M = $665M - correct. All numbers match the ground truth exactly. Entity accuracy: PepsiCo, TBG, and the 39% ownership stake are all correctly identified. The answer properly identifies this as part of the Juice Transaction and cites appropriate note references (Note 13). Multi-hop reasoning is sound: the model correctly synthesized two separate financial impacts (pension transfer and equity remeasurement) and combined them to arrive at the total impact. The answer demonstrates clear understanding that these are two distinct transactions that together comprise the total financial impact. Minor observation: The LLM uses 'approximately' before $665 million, which is slightly cautious language, but the actual calculation is precise ($145M + $520M = exactly $665M), so this is a very minor semantic choice that doesn't affect accuracy. The answer is complete, addresses all parts of the question, and provides proper documentation references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 337,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "\nIn 2021 Merck paid **$200 million** of sales‑based milestone payments to Eisai under the Lenvima collaboration. As of December 31 2021, **$600 million** of sales‑based milestones had been accrued but were still unpaid, meaning the accrued‑but‑unpaid amount is $400 million larger than the amount actually paid during the year. (Source: MRK_10k_2022.pdf, page 103)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper entity identification. Verification of key facts: (1) $200 million in sales-based milestone payments paid by Merck to Eisai for Lenvima in 2021 - CORRECT; (2) $600 million accrued but unpaid as of December 31, 2021 - CORRECT; (3) All entities correctly identified (Merck, Eisai, Lenvima, 2021) - CORRECT. The answer addresses both parts of the multi-part question comprehensively. However, there is a minor issue with the comparative analysis: The LLM states the accrued-but-unpaid amount is '$400 million larger than the amount actually paid during the year' ($600M - $200M = $400M difference), which is mathematically correct. However, the ground truth emphasizes the ratio comparison ('three times the amount paid in 2021'), which is also mathematically correct ($600M / $200M = 3x). The LLM chose to express the comparison as an absolute difference rather than a ratio. While both are valid ways to compare the figures, the ground truth's ratio-based comparison provides slightly more meaningful context about the relative magnitude. The LLM's calculation is accurate but represents a different analytical perspective. The source citation (MRK_10k_2022.pdf, page 103) is appropriately provided. Overall, the answer demonstrates sound multi-hop reasoning by correctly synthesizing information about both the 2021 payments and the year-end accrual balance, and properly comparing these two related metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 411,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "\nPepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other select juice brands to PAI Partners, and it retained a 39 percent non‑controlling ownership interest in the newly formed Tropicana Brands Group (TBG).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth - the $3.5 billion cash amount is correct, and the 39% noncontrolling ownership interest is correct. (2) QUANTITATIVE ACCURACY: Both numeric values are precisely accurate with no calculation errors. The percentage (39%) and dollar amount ($3.5 billion) match exactly. Number formatting is acceptable (39 percent vs 39%). (3) QUALITATIVE ACCURACY: The answer correctly identifies all entities (PepsiCo, PAI Partners, TBG/Tropicana Brands Group) and properly synthesizes the multi-hop information about the transaction. The terminology is accurate - 'non-controlling ownership interest' is the correct financial term. The answer adds helpful context by spelling out 'Tropicana Brands Group' which aids clarity. (4) MULTI-HOP REASONING: The answer successfully combines information about both parts of the transaction (cash received AND ownership retained), demonstrating proper synthesis. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical meaning to the ground truth with slightly enhanced clarity by explicitly naming TBG as 'Tropicana Brands Group' and using 'select juice brands' which is semantically equivalent to 'other juice brands.' Minor note: The hyphenation in 'non‑controlling' vs 'noncontrolling' is a formatting variation that does not affect accuracy. Overall, this is an excellent answer that fully addresses the multi-part question with complete accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 414,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "\nSouthern Company now measures the market‑related value of its liability‑hedging securities at fair value, so gains and losses in that portion of the plan assets are reflected **immediately** in the expected‑return component of net periodic pension cost. Under the prior calculated‑value method those changes would have been amortized over five years, smoothing the impact; the fair‑value approach therefore produces a more current, but more volatile, recognition of asset‑value changes in the pension‑cost calculation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key factual elements: (1) Southern Company adopted fair value approach for liability-hedging securities, (2) changes are recognized immediately rather than amortized, (3) the prior method amortized changes over five years, (4) the fair value approach produces more current but more volatile recognition. The answer adds valuable context by specifying that the immediate recognition occurs in the 'expected-return component of net periodic pension cost,' which is technically precise and enhances understanding. All numeric values are correct (5-year amortization period). The multi-hop reasoning is sound: the answer synthesizes the comparison between two valuation methods and explains the downstream effect on pension cost measurement. The semantic meaning matches the ground truth perfectly - both convey that fair value produces immediate recognition versus the smoothed amortization under calculated value. The LLM answer actually provides slightly more technical precision by identifying the specific component of pension cost affected (expected-return component) and explicitly noting the volatility trade-off, which represents a minor enhancement over the ground truth without introducing any inaccuracies. No calculation errors, no entity confusion, and the reasoning chain is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 385,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "\nThe company’s total content spending rose from **$9.22 billion in 2019 to $12.23 billion in 2021**, an absolute increase of roughly **$3.01 billion**.  \n\nOver the same period, **produced content grew by about $2.20 billion** (≈112 % growth), while **licensed content increased by only $0.81 billion** (≈11 % growth), meaning the rise in produced content was more than twice as large as the rise in licensed content.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Total increase of $3.01 billion matches ground truth of $3,014,120,000 (formatting variation acceptable); (2) Produced content increase of $2.20 billion matches ground truth of $2,201,108,000; (3) Licensed content increase of $0.81 billion matches ground truth of $813,012,000. The 2019-2021 base figures ($9.22B and $12.23B) are consistent with the stated increases. The percentage calculations are approximately correct (produced content ~112% growth is reasonable given the $2.2B increase on a ~$1.96B base; licensed content ~11% growth is reasonable given the $0.81B increase on a ~$7.26B base). The multi-hop reasoning is sound: the answer correctly synthesizes data across three years and two content categories, properly compares the growth rates, and accurately concludes that produced content growth was more than twice as large as licensed content growth. The answer directly addresses all parts of the question: total increase, produced content growth, licensed content growth, and the comparative analysis. Minor note: The percentage figures are approximations (shown with ≈ symbol), which is appropriate given rounding. The semantic equivalence is excellent - the answer conveys all ground truth information with clear, accessible language.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 374,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "\nIn 2023 PepsiCo recorded a **$321 million pre‑tax impairment charge** on its 39 % interest in TBG.  By contrast, in 2022 the company recognized a **$520 million gain** from remeasuring that same 39 % stake to fair value.  Thus, the 2023 charge is roughly **$840 million lower** (and opposite in sign) than the 2022 gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN CALCULATION: The LLM correctly identifies both the 2023 impairment charge ($321 million) and the 2022 gain ($520 million), and correctly notes they are opposite in sign. However, the comparison statement contains a fundamental mathematical error. The LLM states the 2023 charge is 'roughly $840 million lower' than the 2022 gain. This is incorrect. The proper comparison is: $520 million (2022 gain) - (-$321 million) (2023 charge) = $841 million difference, OR more simply: $520M + $321M = $841M net swing. The LLM's phrasing of '$840 million lower (and opposite in sign)' is confusing and mathematically imprecise. The ground truth answer correctly identifies the net pre-tax difference as -$199 million over the two-year period, which represents the net impact: $520M gain minus $321M charge = $199M net positive. The LLM failed to calculate or mention this key metric that was explicitly requested in the question ('how does this compare'). The LLM also uses awkward phrasing ('$840 million lower...and opposite in sign') that obscures rather than clarifies the comparison. While the individual numbers are correct and the entities/years are properly identified, the failure to provide the correct comparative analysis (the -$199M net difference) and the erroneous $840M statement represent significant analytical failures on a multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 383,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "\nIn 2021 Netflix spent significantly more on acquiring and producing original titles, which pushed the amortization of those content assets up by about $1.4 billion year‑over‑year.  As a result, the share of content amortization in total cost of revenues fell – cost of revenues dropped from roughly 61 % of revenue in 2020 to about 58 % of revenue in 2021, even though the absolute dollar amount of amortization grew.  The slower amortization growth relative to the rapid revenue increase (driven by a larger member base and higher subscription prices) is what reduced the cost‑of‑revenues‑as‑a‑percentage‑of‑revenue metric.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $1.4 billion increase in content amortization is accurate (ground truth states $1,423 million, LLM rounds to ~$1.4 billion - acceptable format variation). (2) The cost of revenues percentages are correct: 61% in 2020 to 58% in 2021. (3) The core insight that cost of revenues as a percentage decreased despite absolute amortization increasing is correct. (4) The reasoning about revenue growth outpacing amortization growth is sound. PROBLEMATIC ELEMENTS: (1) The LLM attributes the slower amortization growth to 'larger member base and higher subscription prices' but the ground truth specifically identifies 'delays in content releases caused by the COVID-19 pandemic' as the PRIMARY reason for the slower amortization growth relative to revenue growth. This is a significant omission of a key causal factor. (2) The LLM's explanation focuses on revenue growth drivers (member base, pricing) rather than the content release delays that actually explain why amortization didn't grow as fast as revenue. MULTI-HOP REASONING: The LLM correctly synthesized the relationship between increased investment, amortization changes, and the percentage metric. However, it failed to identify and explain the critical COVID-19 pandemic impact on content release timing, which is essential context for understanding why the percentage metric improved despite higher absolute amortization. The answer is partially correct on the mechanics but incomplete on the causal explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 428,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "\nIn 2024 Ozurdex generated total net revenue of **$494 million** ( $138 million in the United States and $356 million internationally). Its international sales grew **8.3 %** at actual currency rates compared with the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth exactly - total net revenue of $494 million in 2024, international revenue growth of 8.3% at actual currency rates. (2) QUANTITATIVE ACCURACY: All numbers are correct: $494M total revenue, $138M US revenue, $356M international revenue (which correctly sums to $494M), and 8.3% growth rate. The breakdown of US vs international revenue adds valuable detail not explicitly required but consistent with the ground truth. (3) MULTI-HOP REASONING: The answer correctly synthesizes the combined total revenue figure and compares it to the prior year's international growth rate at actual currency rates, demonstrating proper multi-hop synthesis across the required data points. (4) ENTITY ACCURACY: Ozurdex is correctly identified, 2024 is the correct fiscal year, and the metrics (net revenue, international revenue growth, actual currency rates) are all properly identified. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, using standard financial reporting terminology. The answer directly addresses both parts of the multi-part question: the combined total net revenue and the international revenue growth comparison. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 365,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "\nTarget recognized a **$335 million pretax gain** from the February 2021 sale of Dermstore LLC.  The gain was recorded in **Net Other (Income) / Expense** and disclosed in **Note 2 (Dermstore Sale)** of the consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The $335 million pretax gain figure is correct and matches the ground truth exactly. The treatment in Net Other Income is correctly identified. (2) QUANTITATIVE ACCURACY: The $335 million amount is precise and accurate with no calculation errors. The date reference (February 2021) adds helpful context and is consistent with typical Dermstore sale timing. (3) QUALITATIVE ACCURACY: The answer correctly identifies all key elements - the company (Target Corporation), the asset sold (Dermstore LLC), the gain amount, and the financial statement treatment. The reference to Note 2 and the specific line item 'Net Other (Income) / Expense' demonstrates proper understanding of how this transaction was disclosed. The multi-hop synthesis is sound: connecting the sale event to the financial gain to the statement presentation. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'Net Other (Income) / Expense' is semantically equivalent to the ground truth's 'Net Other Income' - both refer to the same financial statement line item. The additional detail about Note 2 disclosure enhances rather than detracts from the answer. Minor note: The ground truth states the gain was 'included in Net Other Income' while the LLM says it was 'recorded in Net Other (Income) / Expense' - these are equivalent statements describing the same accounting treatment. The LLM answer is slightly more detailed and precise in its presentation without introducing any factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 420,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "\nThe 2024 10‑K shows that Salesforce’s mortgage‑backed obligations had an amortized cost of **$244 million** but a fair value of **$236 million**, yielding an $8 million difference. This $8 million shortfall represents roughly **0.14 %** of the total marketable securities at fair value ($5.722 billion) reported in the same filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative values are correct: amortized cost of $244 million, fair value of $236 million, difference of $8 million, total marketable securities at fair value of $5,722 million (presented as $5.722 billion, which is a valid format variation), and the percentage calculation of 0.14%. The multi-hop reasoning is sound - the model correctly identified the mortgage-backed obligations data, calculated the difference, and then synthesized this with the total marketable securities figure to compute the percentage. The calculation verification: $8M / $5,722M = 0.001397 = 0.14% (rounded) is accurate. Entity identification is correct (Salesforce/CRM, 2024 10-K, mortgage-backed obligations, marketable securities). The only minor observation is that the LLM uses \"shortfall\" which adds slight interpretive language not in the ground truth, but this is semantically appropriate and doesn't detract from accuracy. The answer directly addresses all parts of the multi-part question: the difference amount, the fair value comparison, and the percentage representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 318,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "\nThe 2023 10‑K discloses that, upon adopting the LDTI guidance, MetLife retrospectively restated its **consolidated statements of comprehensive income, consolidated balance sheet, and consolidated statements of cash flows**.  The restatements cover the **comparative fiscal years 2021 and 2022** (i.e., the balances as of December 31 2022 and the results for 2021‑2022), with the transition date set at January 1 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) FINANCIAL STATEMENTS DISCREPANCY: The LLM claims MetLife retrospectively restated 'consolidated statements of comprehensive income, consolidated balance sheet, and consolidated statements of cash flows.' However, the ground truth explicitly states only the consolidated statements of comprehensive income and consolidated balance sheet were adjusted. The inclusion of cash flows statements is incorrect and not supported by the ground truth. (2) TIME PERIOD ERRORS: The LLM states adjustments cover 'comparative fiscal years 2021 and 2022' with a transition date of January 1, 2021. The ground truth indicates adjustments were applied 'as of December 31, 2022' for the balance sheet and 'as of December 31' for comprehensive income statements, with no mention of 2021 comparative periods or a January 1, 2021 transition date. The LLM appears to have fabricated specific transition dates and multi-year coverage not present in the ground truth. (3) SPECIFICITY ISSUES: While the LLM provides more detailed language about 'comparative fiscal years' and 'transition date,' this additional specificity is factually incorrect rather than helpful. The ground truth is more conservative and accurate about what was actually adjusted. (4) PARTIAL CREDIT: The LLM correctly identifies MetLife as the company and correctly references the 2023 10-K filing, and it does recognize that retrospective adjustments were made due to LDTI guidance adoption. However, the core factual errors regarding which statements were adjusted and the time periods covered are substantial enough to significantly undermine the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 468,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "\nDisney’s two cruise‑ship credit facilities together provide up to **$2.2 billion** of financing. The $1.1 billion facility used for the **Disney Treasure** carries a **fixed 3.80 % interest rate** (semi‑annual payments over 12 years), whereas the comparable facility that could be used for the **Disney Destiny** would carry a slightly lower **fixed 3.74 % interest rate**, also payable semi‑annually over the same 12‑year term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: (1) Total financing commitment of $2.2 billion is correct, (2) Disney Treasure fixed rate of 3.80% is correct, (3) Disney Destiny fixed rate of 3.74% is correct. The answer correctly identifies the two separate credit facilities and their respective interest rates, demonstrating proper multi-hop synthesis across the cruise ship financing information. The LLM provides additional contextual details (semi-annual payments, 12-year term) that enhance understanding without contradicting the ground truth. The comparison between the two rates is accurate (3.80% vs 3.74%, with Disney Destiny being slightly lower). The answer fully addresses both parts of the multi-part question: the total commitment amount and the interest rate structure differences. Minor deduction from perfect score only because the ground truth answer is more concise, though the LLM's additional details are accurate and helpful rather than erroneous. All entities (Disney, Disney Treasure, Disney Destiny) are correctly identified and properly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 322,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "\nChevron’s equity‑method earnings from Angola LNG Limited were **$405 million in 2024**.  That amount represented roughly **11 percent of the company’s total upstream equity earnings of $3.58 billion** for the year.  The sizeable share shows that Angola LNG is a key component of Chevron’s upstream portfolio, confirming an ongoing and material production presence in Angola through its equity investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: (1) Angola LNG earnings of $405 million - CORRECT, matches ground truth exactly. (2) Total upstream equity earnings of $3,580 million ($3.58 billion) - CORRECT, matches ground truth exactly. (3) Percentage calculation: $405M / $3,580M = 11.3%, which rounds to 'roughly 11 percent' - CORRECT and appropriately qualified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the contribution amount ($405M) and (2) what it indicates about Chevron's production involvement in Angola. ENTITY ACCURACY: All entities correctly identified - Chevron, Angola LNG Limited, 2024, upstream equity earnings. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the specific earnings contribution, (2) calculating the percentage relative to total upstream earnings, (3) drawing a logical conclusion about Angola's significance to Chevron's portfolio. The reasoning that Angola LNG represents a 'key component' and 'material production presence' is well-supported by the 11% contribution figure. SEMANTIC EQUIVALENCE: The LLM's characterization of Angola LNG as 'a key component of Chevron's upstream portfolio' and 'ongoing and material production presence' conveys the same meaning as the ground truth's 'significant production involvement.' Minor difference: The LLM adds the calculated percentage (11%), which provides additional useful context not explicitly in the ground truth but is mathematically sound and enhances the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 438,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "\nAs of September 28 2024 Disney had **CAD $2.6 billion** of senior notes denominated in Canadian dollars (equivalent to about **$1.9 billion USD**).  The company entered into pay‑floating interest‑rate and cross‑currency swaps that effectively converted essentially the entire CAD‑denominated exposure—roughly the $1.9 billion USD equivalent—into variable‑rate U.S.‑dollar borrowings indexed to SOFR.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core response. (1) TOTAL CAD AMOUNT - CORRECT: LLM correctly identifies CAD $2.6 billion total outstanding. (2) USD CONVERSION - INCORRECT: The LLM states the CAD $2.6 billion is equivalent to approximately $1.9 billion USD. However, the ground truth specifies that CAD $1.3 billion = $1.0 billion USD and CAD $1.3 billion = $0.9 billion USD, totaling $1.9 billion USD. While the final $1.9 billion USD figure happens to match, the LLM's reasoning is flawed because it treats the entire amount as a single conversion rate rather than recognizing two separate tranches with different conversion rates. (3) CROSS-CURRENCY SWAP AMOUNT - INCORRECT: The ground truth clearly states that only CAD $1.3 billion ($1.0 billion USD) was converted through cross-currency swaps and remained outstanding as of September 28, 2024. The LLM incorrectly states 'essentially the entire CAD-denominated exposure—roughly the $1.9 billion USD equivalent' was converted through swaps. This is a critical error - the LLM fails to distinguish that only half the Canadian notes (CAD $1.3 billion) were subject to cross-currency swaps, while the other half was paid off in October 2024. (4) MISSING CONTEXT: The LLM omits the important detail that CAD $1.3 billion was paid in October 2024, which is material context for understanding the September 28, 2024 position. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the multi-part structure of Disney's Canadian debt - two separate CAD $1.3 billion tranches with different fates (one swapped, one paid). The answer conflates the total amount with the swapped amount, which is a fundamental error in addressing the second part of the question. The LLM does correctly identify that swaps converted the exposure to SOFR-indexed USD borrowings, but this is undermined by the incorrect amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 524,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "\nThe combined fair‑value of private‑fund investments in Honeywell’s U.S. and non‑U.S. pension plans as of December 31 2023 is **$1,408 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect on the primary metric. The ground truth states the total fair value of private fund investments is $1,380 million ($1,265M from U.S. Plans + $115M from Non-U.S. Plans). The LLM provided $1,408 million, which is a $28 million discrepancy (approximately 2% error). This is a significant quantitative error for a financial question where precision is critical. The LLM correctly identified the company (Honeywell), the time period (December 31, 2023), the asset class (private funds), and the geographic segments (U.S. and Non-U.S. Plans), demonstrating good entity identification and contextual understanding. However, the core calculation or data retrieval is incorrect. The LLM did not show the component breakdown ($1,265M + $115M = $1,380M) that would have allowed verification of the calculation. The semantic framing is appropriate (combining U.S. and Non-U.S. plans), but the numerical answer is definitively wrong. For financial questions, accuracy of numbers is paramount, and a $28 million error on a $1.3+ billion figure represents a material mistake.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 313,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "\nOracle’s flexible deployment strategy creates a mix of performance‑obligation patterns that drive distinct revenue‑recognition rules.  Cloud‑based services and support contracts are recognized ratably over the contract term, while traditional on‑premise or “perpetual” licenses are recorded up‑front when the software is made available, with any usage‑based royalties recognized only when the customer actually consumes the service.  Because cloud licenses are rarely sold stand‑alone, Oracle typically allocates the transaction price using a residual method—first assigning value to other distinct obligations and then recognizing the remaining amount as cloud‑license revenue—whereas license‑support revenues are spread evenly over the support period.  This structure reflects how the company’s hybrid cloud‑and‑license model separates over‑time (service) revenue from point‑in‑time (license) revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The core distinction between ratable recognition for cloud services over the contract term versus point-in-time recognition for licenses is accurate and matches the ground truth. (2) The identification of cloud services as 'over-time' revenue and licenses as 'point-in-time' revenue is correct. (3) The mention of support contracts being recognized ratably is accurate. (4) The general framework of hybrid cloud-and-license models is appropriate. PROBLEMATIC ASPECTS: (1) The introduction of 'residual method' allocation and discussion of how cloud licenses are 'rarely sold stand-alone' introduces technical details not present in the ground truth and appears to conflate cloud services with cloud licenses in a way that may be misleading. (2) The statement about 'usage-based royalties recognized only when the customer actually consumes the service' adds specificity not confirmed in the ground truth. (3) The discussion of 'license-support revenues spread evenly over the support period' shifts focus away from the key distinction between cloud services and licenses that the original answer emphasizes. (4) The answer lacks the ground truth's key insight about cloud services providing 'more predictable and stable revenue streams' compared to the volatility of point-in-time license recognition. (5) The answer doesn't emphasize how timing of large license transactions can significantly affect overall revenue patterns, which is a critical aspect of the original answer. MULTI-HOP REASONING: The answer attempts to synthesize revenue recognition patterns across different deployment models, but introduces additional complexity (residual method, usage-based royalties) that goes beyond what the ground truth establishes. While not necessarily incorrect, these additions dilute the focus on the primary distinction. The answer is more technically elaborate but less focused on the strategic impact question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 540,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "\nERLEADA’s worldwide sales rose from $1.29 billion in 2021 to $2.39 billion in 2023 – an approximate 85 % cumulative increase (about 26.9 % growth from 2022 to 2023 and roughly 84.8 % growth over the two‑year span).  This strong expansion was a key driver of the Oncology segment’s overall performance, helping the segment post a 10.5 % rise in worldwide sales in 2023 versus 2022; ERLEADA’s robust growth therefore contributed a substantial share of that segment‑level growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures (approximately $1.29B in 2021 to $2.39B in 2023), the cumulative growth rate (~85%), the year-over-year growth from 2022 to 2023 (26.9%), and the Oncology segment's overall growth (10.5%). The format variations ($1.29B vs $1,291M) are acceptable. The LLM correctly synthesized that ERLEADA contributed to the Oncology segment's performance and identified it as a key driver. WEAKNESSES: (1) The LLM failed to provide the complete ranking context - the ground truth specifies ERLEADA was the THIRD-LARGEST contributor to Oncology segment growth, after DARZALEX (22.2% growth) and TREMFYA (17.9% growth). This is a significant omission that reduces completeness. (2) The LLM's statement that ERLEADA's growth \"contributed a substantial share\" is vague and lacks the specific comparative context provided in the ground truth. (3) While the LLM mentions the growth percentages, it doesn't explicitly state the 2022 sales figure ($1,879M implied from the 26.9% growth calculation), which would have strengthened the answer. CALCULATION VERIFICATION: 2021-2023 growth: ($2,387M - $1,291M) / $1,291M = 84.9% ✓ (LLM stated ~85%, acceptable rounding); 2022-2023 growth: 26.9% ✓ (matches ground truth). The multi-hop reasoning is sound but incomplete - the LLM synthesized ERLEADA's performance with the Oncology segment but failed to provide the full competitive context within that segment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 401,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "\nAs of December 31 2023, the combined notional amount of MDLZ’s net‑investment‑hedge derivative contracts ($7.456 bn) plus the non‑U.S.‑dollar debt designated for those hedges (€3.516 bn + CHF 0.386 bn + CA$0.453 bn ≈ $4.355 bn) totaled **approximately $11.8 bn**.  By contrast, the fair value of all derivative assets recorded in “other current assets” and “other assets” on the consolidated balance sheet at that date was **$1.597 bn**, meaning the notional hedge amount is roughly seven‑times larger than the recorded fair‑value of those derivative assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Net investment hedge derivative contracts notional amount: $7,456 million ($7.456 bn) - CORRECT; (2) Non-U.S. dollar denominated debt components: €3.516 bn, CHF 0.386 bn, CA$0.453 bn totaling $4.355 bn - CORRECT; (3) Combined total: $11.811 billion (presented as ~$11.8 bn) - CORRECT; (4) Fair value of derivative assets in other current assets: $1,347 million - CORRECT; (5) Fair value in other assets: $250 million - CORRECT; (6) Total fair value: $1,597 million ($1.597 bn) - CORRECT. The LLM correctly synthesized the multi-hop information by: identifying both components of the hedge (derivative contracts and debt), summing them appropriately, and comparing to the fair value figures from the balance sheet. The calculation of the ratio (notional amount being roughly 7-8 times larger than fair value) is mathematically sound ($11.8bn / $1.597bn ≈ 7.4x). The answer addresses all parts of the question comprehensively. Minor formatting variations (using 'bn' instead of 'million', rounding $11.811 to ~$11.8) are acceptable and do not detract from accuracy. The reasoning is clear and the synthesis across multiple data points is logical and well-presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 351,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "\nAs of December 31 2023, the U.S. pension plans held $676 million and the non‑U.S. pension plans held $10 million in mortgage/asset‑backed securities, giving a combined total of $686 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and directly addresses the question. All numeric values are correct: U.S. Plans $676 million, Non-U.S. Plans $10 million, and combined total $686 million. The calculation is accurate ($676M + $10M = $686M). The answer correctly identifies all entities (Honeywell's U.S. and Non-U.S. pension plans), the correct metric (Mortgage/Asset-backed securities investments), and the correct date (December 31, 2023). The multi-hop reasoning is sound - the model successfully synthesized information from both plan categories to arrive at the combined total. The wording is clear and concise, presenting the information in a logical flow that matches the ground truth answer semantically. No omissions, errors, or ambiguities are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 231,
        "total_tokens": 1345
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "\nAs of September 29 2024, Starbucks still has **about $5.98 billion** of prepaid royalty revenue from Nestlé that has not yet been recognized—comprised of the current $177 million and the long‑term $5.8 billion balances reported in Note 11. This amount represents the remaining portion of the roughly $7 billion upfront payment received for the Global Coffee Alliance arrangement, which is being amortized on a straight‑line basis over the agreement’s **40‑year economic life**. Consequently, the company will recognize this revenue gradually over the next four decades as it fulfills its ongoing performance obligations under the alliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $177 million (current), $5.8 billion (long-term), totaling $5.977 billion (LLM states 'about $5.98 billion' which is appropriate rounding), and the original $7 billion upfront payment. The date (September 29, 2024) is correct. The 40-year economic life is accurately stated. CALCULATION CHECK: $177M + $5,800M = $5,977M ≈ $5.98B - correctly calculated and presented. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple elements: (1) identifies the specific deferred revenue balances from the filing, (2) connects them to the Nestlé Global Coffee Alliance arrangement, (3) explains the 40-year amortization schedule, (4) clarifies the straight-line recognition basis. COMPLETENESS: The answer addresses all parts of the question - the total remaining amount, the breakdown between current and long-term, the relationship to the Global Coffee Alliance, and the 40-year arrangement context. ENTITY ACCURACY: Correctly identifies Starbucks, Nestlé, and the Global Coffee Alliance. MINOR OBSERVATION: The LLM uses 'about $5.98 billion' which is appropriate given the rounding of $177M + $5,800M = $5,977M. The phrasing 'roughly $7 billion' is also appropriately cautious. The explanation of straight-line recognition and performance obligations is accurate and adds helpful context. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 400,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "\nThe 2023 10‑K discloses a fair‑value amount of **$1.896 billion** for long‑term obligations to equity companies and a separate guarantee amount of **$1.862 billion** related to those equity‑company obligations. Combined, the total fair‑value exposure is roughly **$3.76 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the question. Verification of key elements: (1) Long-term obligations to equity companies: Ground truth states $1,896 million; LLM states $1.896 billion - these are equivalent (1,896 million = 1.896 billion). (2) Guarantees related to equity company obligations: Ground truth states $1,862 million; LLM states $1.862 billion - these are equivalent. (3) Combined total: Ground truth states $3,758 million; LLM states $3.76 billion - these are equivalent (3,758 million = 3.76 billion, with minor rounding in presentation). (4) Company and year: Correctly identified as XOM's 2023 10-K filing. (5) Multi-hop synthesis: The LLM correctly synthesized the two separate components and calculated the combined total. The only minor deviation is the use of 'roughly' before the combined figure ($3.76 billion vs. the precise $3.758 million), which is a reasonable characterization given the rounding but slightly less precise than stating the exact figure. The answer is complete, addresses all parts of the multi-part question, uses correct number formatting (billions vs. millions are equivalent), and demonstrates sound reasoning in combining the two separate obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 347,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "\nAs of December 31 2023, Honeywell’s U.S. plans held **$676 million** in mortgage/asset‑backed securities, whereas the non‑U.S. plans held only **$10 million**. Thus, the U.S. allocation is roughly 68 times larger and accounts for the vast majority of the combined mortgage/asset‑backed securities investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures: U.S. plans at $676 million and Non-U.S. plans at $10 million, with the correct date of December 31, 2023. The total of $686 million is implicitly correct (though not explicitly stated). However, there are notable differences from the ground truth: (1) The LLM states the U.S. allocation is 'roughly 68 times larger' - this is mathematically correct ($676M / $10M = 67.6x), but the ground truth provides the more precise percentage breakdown of 98.5% for U.S. plans, which is more informative for comparison purposes. (2) The LLM omits the explicit total value of $686 million, which was requested in the question ('What is the total value'). (3) The LLM uses the phrase 'accounts for the vast majority' which is semantically equivalent to the ground truth's emphasis on 'significantly larger allocation,' but lacks the specific percentage metric. The answer demonstrates sound multi-hop reasoning by correctly synthesizing data from both U.S. and Non-U.S. plans and making a valid comparative analysis. The quantitative accuracy is strong on individual figures but incomplete on the total and percentage calculations. The answer is contextually relevant and addresses the core comparison question, but falls short of fully answering the 'total value' component with explicit clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 375,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "\nThe “Medical device regulations” adjustment added $83 million to Medtronic’s Non‑GAAP income before income taxes in fiscal 2021 and $102 million in fiscal 2022. Combined, the pre‑tax impact of these adjustments over the two years is **$185 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the question. (1) QUANTITATIVE ACCURACY: All numbers are correct - $83 million for fiscal 2021, $102 million for fiscal 2022, and the total of $185 million. The arithmetic is accurate (83 + 102 = 185). (2) COMPLETENESS: The answer addresses all parts of the multi-part question by providing both individual year amounts and the combined total. (3) ENTITY ACCURACY: Correctly identifies Medtronic, the 'Medical device regulations' adjustment category, Non-GAAP income before income taxes metric, and both fiscal years 2021 and 2022. (4) REASONING: The multi-hop synthesis is sound - the model correctly combined the two separate fiscal year adjustments to arrive at the total pre-tax impact. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with clear presentation of both component years and the aggregate total. The wording is slightly different but semantically equivalent and arguably clearer in presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 293,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "\nIn 2020 the OpenTable and KAYAK reporting unit recorded a goodwill impairment of **$573 million** in the September 30 annual test (the charge recognized that year). The impairment persisted because the pandemic’s prolonged impact forced a **longer assumed recovery period to pre‑COVID profitability and a lower outlook for cash‑flow generation**, especially in restaurant‑reservation and airline‑travel monetization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially misrepresent the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM reports only $573 million as the total impairment for 2020, when the ground truth clearly states the total was $1.062 billion ($489M interim + $573M annual). The LLM appears to have reported only the September 30 annual test amount while omitting the $489 million interim impairment from March 2020. This is a major omission representing approximately 46% of the total impairment. The question explicitly asks for 'in total during 2020,' which requires summing both interim and annual tests. (2) COMPLETENESS FAILURE: The question has two parts: (a) total impairment amount and (b) key factor for continued impairment. While the LLM addresses the second part reasonably well (mentioning prolonged pandemic impact, recovery period, and lower monetization outlook for restaurants and airlines), it fundamentally fails on the first part by providing an incomplete number. (3) MULTI-HOP REASONING: The LLM failed to synthesize information across the two impairment tests (interim March 2020 and annual September 2020) that occurred during 2020. This is a critical multi-hop synthesis failure. (4) QUALITATIVE ASSESSMENT: The explanation of the key factors is reasonably accurate and semantically aligned with the ground truth (pandemic impact, recovery timeline, monetization challenges in restaurants and airlines), but this cannot compensate for the major quantitative error. The answer demonstrates partial understanding but incomplete execution of the multi-hop requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 443,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "\nWalmart’s Flipkart ownership rose from roughly 75 % at the end of fiscal 2023 to about 85 % at the end of fiscal 2024 – an increase of roughly 10 percentage points.  This jump was funded by a $3.5 billion cash transaction in which Walmart bought additional Flipkart shares from the prior non‑controlling interest holders (and settled related liabilities).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative facts are correct: (1) Ownership stake increased from approximately 75% to approximately 85% - a 10 percentage point increase; (2) The transaction amount of $3.5 billion is accurate; (3) The transaction involved acquiring shares from noncontrolling interest holders. The multi-hop reasoning is sound - the model correctly synthesized that the ownership increase was supported by the $3.5 billion transaction. The LLM answer uses slightly different wording than the ground truth ('roughly' vs 'approximately', 'prior non-controlling interest holders' vs 'certain Flipkart noncontrolling interest holders', and adds the parenthetical about 'settled related liabilities') but these are semantic variations that enhance clarity rather than detract from accuracy. All fiscal year references (fiscal 2023 ending January 31, 2023 and fiscal 2024 ending January 31, 2024) are implicit and correct. The answer fully addresses both parts of the multi-part question: (1) the magnitude of the ownership increase and (2) the financial transaction supporting it. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 333,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "\nThe Baby, Feminine & Family Care segment accounts for about **24 % of Procter & Gamble’s total net sales**. Within that segment, the **Bounty paper‑towel brand holds a North American market share of just over 40 %**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) CORRECTNESS: Both key facts are correct - the Baby, Feminine & Family Care segment represents 24% of P&G's total net sales, and Bounty holds over 40% North American market share in paper towels. (2) QUANTITATIVE ACCURACY: All numeric values are precise and match the ground truth exactly: 24% for segment representation and 40% for Bounty market share. The phrasing 'just over 40%' is semantically equivalent to 'over 40%' from the ground truth. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across two distinct data points - first identifying the segment's percentage of total sales, then identifying the brand's market share within that segment. The logical flow is clear and appropriate. (4) ENTITY ACCURACY: All entities are correctly identified (Procter & Gamble, Baby Feminine & Family Care segment, Bounty brand, paper towel category, North American market). (5) COMPLETENESS: The answer fully addresses both parts of the question without omissions. Minor formatting variation in spacing around the percentage symbol ('24 %' vs '24%') is inconsequential. The answer demonstrates sound multi-hop synthesis and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 352,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "\nRTX recorded a **$364 million pre‑tax charge in 2024** for the “Thales‑Raytheon Systems and Related Matters” resolution (see the $918 million combined charge broken out as $364 million for this matter).  This charge stems from the settlement that included the **SEC Administrative Order**, under which Raytheon and RTX resolved the SEC’s investigation, agreed to retain an independent compliance monitor, and meet specified cooperation and disclosure obligations; the order is a key component of the overall legal‑matter resolution that generated the accounting charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $364 million pre-tax charge is correctly stated and matches the ground truth exactly. The reference to the $918 million combined charge provides helpful context showing how this $364 million figure fits into the broader settlement. (2) ENTITY ACCURACY: RTX, Thales-Raytheon Systems, SEC Administrative Order, and Raytheon Company are all correctly identified. The year 2024 is correct. (3) MULTI-HOP REASONING: The answer successfully synthesizes the connection between the accounting charge and the SEC Administrative Order, explaining that the order was part of the settlement investigation into improper payments related to Middle East contracts since 2012. (4) COMPLETENESS: The answer addresses both parts of the question - the total pre-tax charge amount and how it connects to the SEC Administrative Order. The LLM correctly identifies that the SEC Administrative Order requires retention of an independent compliance monitor and specifies cooperation/disclosure obligations. (5) MINOR OBSERVATION: The ground truth mentions the three-year period from the monitor's engagement, while the LLM answer states 'specified cooperation and disclosure obligations' without explicitly mentioning the three-year timeframe. This is a very minor omission of contextual detail but does not affect the core accuracy of the answer. The wording differs slightly from ground truth but conveys equivalent meaning and all critical facts are present and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 422,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "\nAs of April 2021, Trodelvy had two FDA‑approved indications – full approval for unresectable locally advanced or metastatic triple‑negative breast cancer and accelerated approval for metastatic urothelial cancer. By September 2021, the drug was approved for metastatic triple‑negative breast cancer in the United States, Great Britain, Australia, Switzerland and Canada.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The number of approved indications (2) as of April 2021 is correct. The five countries listed for TNBC approval by September 2021 (United States, Great Britain, Australia, Switzerland, Canada) match the ground truth exactly. All dates are accurate. (2) COMPLETENESS: Both sub-questions are fully addressed - the total number of indications and the specific countries for TNBC approval. (3) ENTITY ACCURACY: All entities are correctly identified - Trodelvy, the specific indications (urothelial cancer and TNBC), and all five countries. (4) REASONING: The multi-hop synthesis is sound, correctly connecting the April 2021 approval status with the September 2021 geographic expansion. (5) SEMANTIC EQUIVALENCE: The LLM answer provides additional helpful context by specifying 'full approval' vs 'accelerated approval' for the two indications, which adds clarity beyond the ground truth without contradicting it. The country list is presented in a slightly different order (US first rather than Australia first) but this is a trivial formatting difference. The answer demonstrates accurate multi-hop reasoning across time periods and geographic jurisdictions. Minor deduction only because the ground truth lists Australia first while LLM lists US first, though this ordering difference is inconsequential to factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 399,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "\nAs of September 29 2024, the “Foreign currency – other” derivatives had a net gain of **$11.5 million** recorded in AOCI.  The company expects to **reclassify $9.5 million** of that amount into earnings within the next 12 months (leaving roughly $2 million still remaining in AOCI).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) The net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024 is correctly stated as $11.5 million, matching the ground truth exactly. (2) The expected reclassification amount of $9.5 million within 12 months is also correct. (3) The LLM correctly synthesized the multi-hop information by comparing the two amounts and providing the logical inference that approximately $2 million would remain in AOCI ($11.5M - $9.5M = $2M). This demonstrates sound reasoning across the required data points. The answer addresses all parts of the question: the total net gain, the reclassification amount, and the comparison between them. The date (September 29, 2024) is correctly identified. The only minor observation is that the LLM added interpretive commentary ('leaving roughly $2 million still remaining in AOCI') which, while mathematically sound and helpful, goes slightly beyond the ground truth answer's scope. However, this addition is accurate and enhances clarity rather than detracting from it. Number formatting is consistent and clear. The semantic meaning perfectly matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 343,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "\nThe two yen‑denominated credit facilities together provide a total of **$103.6 million** (¥5.0 billion ≈ $34.5 million plus ¥10.0 billion ≈ $69.1 million). One facility matures on **December 30, 2024** and bears interest at **TIBOR + 0.400%**, while the other matures on **March 27, 2025** and bears interest at **TIBOR + 0.300%**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: total value of $103.6 million, individual facility amounts (¥5.0 billion = $34.5 million and ¥10.0 billion = $69.1 million), maturity dates (December 30, 2024 and March 27, 2025), and interest rate margins (TIBOR + 0.400% and TIBOR + 0.300%). The calculation of the sum is accurate ($34.5M + $69.1M = $103.6M). The multi-hop synthesis is sound - the answer correctly identifies both facilities, their respective characteristics, and presents the comparison clearly. The wording differs slightly from the ground truth (e.g., 'bears interest at TIBOR + 0.400%' vs 'carries an interest rate margin of 0.400% over TIBOR'), but these are semantically equivalent and convey identical information. The answer directly addresses all parts of the multi-part question: total dollar value, individual facility amounts, maturity dates, and interest rate margins. The fiscal year context (September 29, 2024) is implicit in the answer through the use of current facility information. No factual errors, calculation errors, or omissions were identified. The presentation is clear and well-organized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 332,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "\nIn the fourth quarter of fiscal 2024 Accenture purchased **2,072,563** Class A ordinary shares in total—**2,000,308** of those were acquired under its publicly announced open‑market share‑purchase program and the remaining **72,255** were bought in transactions unrelated to that program (e.g., employee‑share‑withholding for tax obligations).  The average price paid for the shares purchased under the open‑market program was **$303.05 per share**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness despite addressing all parts of the question. SPECIFIC ERRORS: (1) Total shares purchased: LLM states 2,072,563 but ground truth is 2,072,263 - a discrepancy of 300 shares. This is a factual error in a key metric. (2) Average price per share: LLM states $303.05 but ground truth is $302.45 - a difference of $0.60 per share. This represents a calculation error. The ground truth calculation is verifiable: $605 million ÷ 2,000,308 shares = $302.45 per share. The LLM's figure of $303.05 does not align with the stated $605 million aggregate purchase price. (3) The breakdown of shares (2,000,308 open-market vs 72,255 unrelated transactions) is correct. STRENGTHS: The LLM correctly identifies all required components of the answer (total shares, breakdown by program type, average price), provides appropriate context about employee share withholding, and demonstrates understanding of the multi-part question structure. The reasoning and entity identification are sound. WEAKNESSES: The quantitative errors are material - the total share count is wrong by 300 shares, and the average price calculation is incorrect by $0.60 per share. These are not minor rounding differences but actual factual errors in the source data. For a financial question requiring precision, these errors are significant and would be problematic for decision-making or reporting purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 402,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "\nThe 6.375 % 2037 Notes were reported with a carrying value of **$478 million**. In the 2020 exchange offer, **$74 million** of principal of those notes was tendered and exchanged for the newly issued 2.77 % 2053 Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses both parts of the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the carrying value of $478 million matches the ground truth exactly, and the principal amount exchanged of $74 million is also correct. Number formats are consistent and appropriate. (2) COMPLETENESS: The answer addresses both required components: the total carrying value and the principal amount exchanged. (3) ENTITY ACCURACY: All entities are correctly identified - the 6.375% 2037 Notes are properly referenced, the exchange offer context is accurate (2020 timeframe), and the newly issued 2.77% 2053 Notes are correctly mentioned as the replacement security. (4) REASONING: The multi-hop synthesis is sound - the answer correctly connects the carrying value information with the exchange transaction details, demonstrating understanding that these are related but distinct pieces of information about the same security. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, conveying all necessary information without ambiguity. The only minor observation is that the LLM provides slightly more contextual detail (mentioning the 2.77% 2053 Notes and the 2020 exchange offer) than the ground truth answer, but this additional context is accurate and enhances rather than detracts from the response. No calculation errors, no missing information, and no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 402,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "\nNetflix expects that ≈ 90 % of each licensed or produced title will be amortized within about four years of its first availability, so the “average” amortization period for its content assets is roughly four years. Because the amortization is accelerated—front‑loading expense to reflect higher early viewing—the bulk of the cost is recognized in the first four years, with a sharply declining amortization charge thereafter.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. Strengths: (1) Correctly identifies the ~90% amortization threshold within four years (ground truth states 'over 90%', LLM states '≈90%' - semantically equivalent and acceptable); (2) Accurately characterizes the four-year period as the expected amortization timeframe; (3) Properly explains the accelerated amortization policy's impact, noting front-loading of expenses and higher early viewing recognition; (4) Correctly describes the declining amortization charge pattern after the initial four-year period. Minor weakness: The LLM answer states the 'average' amortization period is 'roughly four years,' which is slightly imprecise. The ground truth indicates that over 90% is amortized within four years, but this doesn't necessarily mean the average period is four years—it means the bulk is front-loaded within that window. The LLM's characterization is close enough for practical purposes but could be more technically precise. The answer successfully synthesizes the multi-hop information about: (1) the quantitative threshold (90%), (2) the time period (four years), and (3) the policy's distributional impact (accelerated/front-loaded). All factual claims are accurate, and the reasoning about why this matters (reflecting viewing patterns, especially for films) aligns with the ground truth explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 387,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "\nBased on the market‑risk tables in the filing, BlackRock’s foreign‑exchange‑linked investments amounted to **$1,125 million** of exposure at year‑end 2023. A hypothetical 10 % adverse movement in the relevant foreign‑exchange rates would therefore result in an estimated **$112 million** loss (the “Effect of –10% Change” figure disclosed). This $112 million represents the total potential financial impact on those foreign‑exchange rate risk investments for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Verification of key elements: (1) QUANTITATIVE ACCURACY: All numbers are correct - the $1,125 million exposure figure matches the ground truth, the -10% change percentage is correct, and the calculated $112 million impact is accurate. The calculation is straightforward: $1,125M × 10% = $112.5M, which rounds to $112M as disclosed. (2) COMPLETENESS: The answer fully addresses the multi-part question by identifying the exposure amount, the percentage change, and the resulting financial impact. (3) ENTITY ACCURACY: BLK (BlackRock) is correctly identified, the year 2023 is correct, and the metric (Foreign Exchange Rate Risk Investments) is properly characterized. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted the exposure figure from market-risk tables, applied the -10% change scenario, and arrived at the correct impact figure. The reasoning explicitly connects the exposure to the hypothetical adverse movement to the resulting loss. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, using slightly more detailed language ('market-risk tables,' 'hypothetical 10% adverse movement,' 'Effect of –10% Change' figure) which adds helpful context without contradicting the ground truth. Minor note: The answer uses 'loss' terminology which is semantically appropriate for a negative change scenario. The only reason this is not a perfect 10 is the minimal additional context provided (referencing 'market-risk tables' and 'Effect of –10% Change' figure) goes slightly beyond what was strictly necessary, though this actually enhances clarity rather than detracting from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 470,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "\nThere are three amendments to the Target Corporation Deferred Compensation Trust Agreement disclosed in the 2022 10‑K. Their effective dates are June 8 , 2011; October 25 , 2017; and December 18 , 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and matches the ground truth exactly. (1) CORRECTNESS: All factual information is correct - the answer identifies three amendments to the Target Corporation Deferred Compensation Trust Agreement with all three effective dates correctly stated. (2) QUANTITATIVE ACCURACY: All dates are precisely correct: June 8, 2011; October 25, 2017; and December 18, 2020. The count of three amendments is accurate. Minor formatting differences in date presentation (spacing around commas) are inconsequential and do not affect accuracy. (3) QUALITATIVE ACCURACY: The answer correctly identifies the entity (Target Corporation Deferred Compensation Trust Agreement), the document source (2022 10-K filing), and provides complete information addressing both parts of the multi-part question (number of amendments AND their effective dates). (4) CONTEXTUAL RELEVANCE: The answer is directly responsive to the question asked, providing exactly the information requested without extraneous details. The synthesis is straightforward and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 306,
        "total_tokens": 1410
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "\nThe 6.90 % 2038 Notes had a reported carrying value of **$254 million** (page 130), and **$37 million** of principal of those notes was tendered and exchanged in the 2020 private debt‑exchange transaction (page 131).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the carrying value of $254 million matches the ground truth exactly, and the principal amount exchanged of $37 million is also correct. Number formats are consistent and appropriate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) total carrying value of the 6.90% 2038 Notes, and (b) principal amount exchanged in debt exchange transactions. (3) ENTITY ACCURACY: All entities are correctly identified - the specific debt instrument (6.90% 2038 Notes), the transaction type (debt exchange), and the year (2020) are all accurate. (4) REASONING & SYNTHESIS: The answer correctly synthesizes information from multiple pages of the filing (pages 130-131), demonstrating proper multi-hop reasoning by connecting the carrying value disclosure with the exchange transaction details. (5) SEMANTIC EQUIVALENCE: The wording is clear and precise, with appropriate use of bold formatting for emphasis on key numbers. The phrase 'tendered and exchanged' accurately describes the nature of the transaction. Minor note: The answer includes helpful page references which add credibility but are not required by the question. Overall, this is a well-executed response with no material errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 371,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "\nThe FBM program accounted for roughly **$620 million of the $1.1 billion rise in Space‑segment product sales** (the sales boost tied to “higher volume in the Fleet Ballistic Missile (FBM) program”) and **about $815 million of the $849 million increase in Space product costs** (the cost rise attributed to “higher volume in the Fleet Ballistic Missile (FBM) program”).  \n\nThese favorable sales gains were largely offset by the higher costs, but they still produced an **increase of approximately $101 million in Space operating profit**, which helped lift Lockheed Martin’s consolidated operating profit by about **$159 million** in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its correctness. (1) PRODUCT SALES: Ground truth states FBM contributed $940M to product sales increase; LLM claims $620M. This is a $320M discrepancy (34% understatement). (2) PRODUCT COSTS: Ground truth states $815M increase in product costs; LLM correctly identifies $815M but contextualizes it differently within a larger $849M total increase, which is acceptable framing but the core number matches. (3) NET FINANCIAL IMPACT: Ground truth calculates net impact as $125M gross profit increase ($940M - $815M); LLM claims $101M increase in Space operating profit. This is a $24M discrepancy and represents a different metric (operating profit vs. gross profit contribution). (4) CONSOLIDATED IMPACT: LLM adds a claim about $159M consolidated operating profit increase, which is not addressed in the ground truth and appears to be unsupported synthesis. (5) MULTI-HOP REASONING: The LLM correctly identifies the FBM program as the driver and attempts to synthesize the sales, costs, and profit impact, but the numerical synthesis is flawed. The calculation logic (sales minus costs = profit impact) is sound in principle, but the input numbers are wrong. (6) COMPLETENESS: The LLM addresses all parts of the question (sales contribution, cost contribution, net impact) but with incorrect figures. The answer demonstrates understanding of the question structure but fails on factual accuracy. The $320M error on sales and $24M error on net profit are material discrepancies that would mislead stakeholders on the FBM program's actual financial contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 456,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "\nThe 5.375% 2043 Notes had a carrying value of about $185 million, which is roughly 0.56 % of AMGN’s total debt carrying value of $33.3 billion reported in the 2022 filing. In the 2020 exchange offer, $76 million of principal of these notes was tendered and exchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key facts: (1) Carrying value of 5.375% 2043 Notes: LLM states '$185 million' which matches ground truth exactly. (2) Total debt carrying value: LLM states '$33.3 billion' which is equivalent to the ground truth's '$33,309 million' (minor rounding/format difference, semantically identical). (3) Percentage calculation: LLM states 'roughly 0.56%' vs ground truth's 'approximately 0.555%' - both are correct representations of the same calculation (185/33,309 = 0.555%), with LLM's rounding to 0.56% being reasonable and acceptable. (4) Principal exchanged: LLM correctly identifies '$76 million' matching ground truth exactly. (5) Time period context: LLM adds helpful context by specifying '2020 exchange offer' which provides additional relevant detail not contradicting the ground truth. Multi-hop synthesis is sound: the answer correctly combines information about the specific note's carrying value, total debt, calculates the percentage relationship, and identifies the exchange activity. All entities are correctly identified (AMGN, 2022 filing, 5.375% 2043 Notes). The only minor deviation is the rounding of the percentage (0.56% vs 0.555%), which is a negligible difference and represents appropriate rounding practice. The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 386,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "\nThe Company had roughly **$259 billion** of securities on loan that are covered by indemnification, and it was holding about **$276 billion** of cash and securities as collateral for those indemnified loans as of December 31 2023.  If a large number of borrowers defaulted at the same time that the pledged collateral fell sharply in value, collateral shortfalls could trigger **material liabilities under the indemnities**, which would likely **depress the Company’s revenue and earnings**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All three key numbers are correct - $259 billion in securities on loan subject to indemnification, $276 billion in collateral held (cash and securities), and the date December 31, 2023. Number formats are acceptable variations. (2) COMPLETENESS: The answer addresses all three parts of the multi-part question: (a) total value of securities on loan subject to indemnification, (b) collateral held against these securities, and (c) potential financial impact of simultaneous borrower defaults and collateral value declines. (3) ENTITY ACCURACY: BlackRock is correctly identified as the company (referred to as 'the Company'), the fiscal year 2023 is correct, and all financial metrics are properly identified. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points - connecting the securities on loan to the collateral held to the potential risk scenario. The logical chain is sound: defaults + collateral decline = collateral shortfalls = material liabilities = revenue/earnings decline. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'material liabilities under the indemnities' and 'depress the Company's revenue and earnings' conveys the same meaning as the ground truth's 'material liabilities under these indemnities' and 'cause BlackRock's revenue and earnings to decline.' Minor wording variations are appropriate and maintain accuracy. The only negligible difference is the LLM uses 'depress' while ground truth uses 'decline,' but these are semantically equivalent in this context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 443,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "\nThe 2022 10‑K filing lists three related documents: the original Pharmacy Operating Agreement (dated December 16 2015) and two subsequent amendments— a First Amendment (dated November 30 2016) and a Second Amendment (dated January 9 2018). Therefore, **two amendments** have been made to the Pharmacy Operating Agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth. The answer correctly identifies that two amendments were made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. The quantitative answer (2 amendments) is accurate and matches the original answer exactly. The LLM provides additional supporting detail by listing the specific documents: the original agreement (December 16, 2015), First Amendment (November 30, 2016), and Second Amendment (January 9, 2018). These dates and amendment designations appear reasonable and add credibility to the response. The reasoning is sound - the LLM correctly synthesizes that while three documents are listed (original + 2 amendments), the question asks specifically for amendments, which totals two. The answer directly addresses the question asked and provides appropriate context from the 2022 10-K filing. Minor deduction from perfect score only because the specific dates provided cannot be independently verified from the question context alone, though they appear plausible and the core answer is definitively correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 318,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "\nThe net carrying amount of technology‑related finite‑lived intangible assets fell from **$180 million** at 12/31/22 to **$142 million** at 12/31/23, a **$38 million decrease**.  Over the same period the accumulated amortization rose from **$81 million** to **$118 million**, an **$37 million increase**.  Thus the decline in net carrying amount is essentially offset by the corresponding rise in accumulated amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: net carrying amount decreased from $180M to $142M (a $38M decrease), and accumulated amortization increased from $81M to $118M (a $37M increase). All calculations are accurate. The answer addresses all parts of the multi-hop question: (1) the change in net carrying amount, (2) the change in accumulated amortization, and (3) the comparison between these two changes. The reasoning is sound and correctly synthesizes the relationship between the two metrics. The only minor difference from the ground truth is the phrasing 'essentially offset by the corresponding rise' versus 'primarily due to the increase' - both convey the same semantic meaning that the accumulated amortization increase explains the net carrying amount decline. The LLM's phrasing is actually slightly more precise in noting that a $38M decrease is offset by a $37M increase (leaving a $1M difference), whereas the ground truth's 'primarily due to' is slightly less precise. The answer demonstrates proper multi-hop synthesis across the required financial metrics and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 324,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "\nThe Subscriptions‑and‑Services revenue in the Asia Pacific rose from $657 million in fiscal 2023 to $2,203 million in fiscal 2024, an increase of **$1,546 million**. By contrast, the same line item in the Americas grew from $5,678 million to $12,726 million, a **$7,048 million** rise. Thus, the YoY jump in the Americas was more than four times larger than the increase seen in the Asia Pacific region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: Asia Pacific increase of $1,546 million (from $657M to $2,203M) and Americas increase of $7,048 million (from $5,678M to $12,726M). The calculations are verified as accurate: $2,203M - $657M = $1,546M and $12,726M - $5,678M = $7,048M. The multi-hop reasoning is sound, correctly synthesizing data across two regions and comparing the year-over-year changes. The LLM properly identified the correct fiscal years (2023 to 2024) and the correct financial metric (Subscriptions and Services revenue). The comparative analysis is logical and accurate - the statement that Americas growth was 'more than four times larger' is mathematically correct ($7,048M ÷ $1,546M ≈ 4.56x). The answer directly addresses all parts of the question: the specific YoY increase in Asia Pacific, the specific YoY increase in the Americas, and a clear comparison between the two regions. The presentation is clear and well-structured, providing both the underlying data and the comparative insight requested. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 322,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "\nThe Company’s redeemable preferred securities had a total fair value of **$20 million** as of December 31, 2023, and the unrealized loss recorded on those securities was **$1 million** (i.e., the amount of loss recognized in fair value).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two key quantitative facts: (1) total fair value of $20 million as of December 31, 2023, and (2) unrealized loss of $1 million. Both numbers match the ground truth exactly. However, the answer is incomplete in its explanation of the unrealized loss composition. The ground truth provides important context that the $1 million unrealized loss is entirely in the 'Greater than 12 months' category with no losses in the 'Less than 12 months' category. The LLM answer states the unrealized loss was 'recognized in fair value' but doesn't explain the temporal breakdown of these losses, which is a material detail provided in the original answer. The LLM's parenthetical explanation '(i.e., the amount of loss recognized in fair value)' is somewhat unclear and doesn't fully capture the nuance that the entire $1 million loss falls into the longer-term category. The answer addresses the main question adequately but lacks the complete analytical detail present in the ground truth regarding the categorization of unrealized losses by time horizon. Quantitatively, all numbers are correct; qualitatively, the reasoning is incomplete as it doesn't synthesize the full picture of how the unrealized loss is distributed across time categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 357,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "\nAt January 30 2022, HD had **$1.0 billion of outstanding borrowings** under its commercial‑paper programs. This amount is **one‑third of the total $3.0 billion capacity** of the back‑up credit facilities that were available at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. QUANTITATIVE VERIFICATION: (1) Commercial paper borrowings at January 30, 2022: $1.0 billion - CORRECT. (2) Back-up credit facilities total capacity: $3.0 billion - CORRECT. (3) Calculation of ratio: $1.0B / $3.0B = one-third - CORRECT and properly expressed. All numbers match the ground truth exactly. COMPLETENESS: The answer addresses both parts of the question: (1) total borrowings amount, and (2) comparison to back-up credit facility capacity. ENTITY ACCURACY: Correctly identifies HD, the date (January 30, 2022), commercial paper programs, and back-up credit facilities. REASONING: The multi-hop synthesis is sound - the model correctly combined information about borrowings and available capacity to make a meaningful comparison. The characterization of $1.0B as 'one-third of $3.0B' demonstrates proper mathematical reasoning. MINOR OBSERVATION: The ground truth answer provides additional detail about the composition of the $3.0B capacity (five-year $2.0B facility + 364-day $1.0B facility), which the LLM answer omits. However, this compositional detail was not explicitly required by the question, which asked for 'combined capacity.' The LLM answer fully answers what was asked while being more concise. The semantic meaning is equivalent - both convey that borrowings were fully covered by available capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 394,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "\nAmgen generated **$125 million** of product sales to BeiGene in 2023.  The company recorded **$40 million** of profit‑and‑loss sharing expenses related to those products during the same year (reflected in SG&A expense).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key financial figures are correct - $125 million in product sales to BeiGene and $40 million in profit-and-loss sharing expenses in 2023. The answer directly addresses both parts of the multi-part question. (2) QUANTITATIVE ACCURACY: All numbers match the ground truth exactly. The dollar amounts ($125M and $40M) are presented clearly and correctly. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly identified all entities (Amgen, BeiGene, 2023) and synthesized the multi-hop information appropriately. The additional contextual detail that the P&L sharing expenses are reflected in SG&A expense adds helpful context without introducing errors. (4) MULTI-HOP REASONING: The answer successfully synthesizes information about both revenue and expense items related to the same business relationship, demonstrating proper multi-hop synthesis. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, with 'product sales' being semantically equivalent to 'revenue from sales,' and the phrasing matches the ground truth intent. Minor deduction (1 point) only because the ground truth uses 'sales' while LLM uses 'product sales' - a negligible semantic difference that adds specificity rather than detracting from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 370,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "\nThe Crypto Asset Safeguarding Liability grew from **$1,241 million** at 31 Dec 2023 to **$2,886 million** at 31 Dec 2024, an increase of **$1,645 million** year‑over‑year. This rise reflects the same fair‑value measurement used for the corresponding safeguarding asset—both are recorded at fair value using quoted prices on the principal exchange (Level 2), and as of 31 Dec 2023 the asset and liability were equal at $1,241 million, so the liability’s growth directly mirrors the increase in the asset’s fair‑value.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN VALUATION METHOD CLASSIFICATION: The LLM answer contains a fundamental factual error regarding the fair value measurement level. The LLM states the asset is valued using 'Level 2' (Significant Other Observable Inputs), but then incorrectly describes it as 'quoted prices on the principal exchange,' which is actually the definition of Level 1 (quoted prices in active markets). This is a major conceptual error that contradicts the ground truth. The ground truth correctly identifies the valuation as Level 2 (Significant Other Observable Inputs), which means the asset is NOT based on active market quotes but on other observable market data. QUANTITATIVE ACCURACY: All dollar amounts are correct ($1,241M in 2023, $2,886M in 2024, $1,645M increase). The calculation is accurate. QUALITATIVE ACCURACY: The LLM failed to correctly identify and explain the valuation methodology. It conflated Level 1 and Level 2 fair value measurement definitions, which is a serious error in financial reporting terminology. The statement 'quoted prices on the principal exchange' directly contradicts the Level 2 classification and the ground truth's explanation that the valuation is based on 'other observable market data' rather than active market quotes. MULTI-HOP REASONING: The LLM correctly synthesized that the liability mirrors the asset's valuation and that both were equal at $1,241M as of Dec 31, 2023. However, the failure to correctly characterize the valuation method undermines the answer's credibility. COMPLETENESS: The answer addresses all parts of the question (year-over-year increase, valuation method relationship) but provides incorrect information on the valuation method itself, which is a core component of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 476,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "\nAs of December 31 2024, 48 million shares remained available for future grants under UnitedHealth Group’s 2020 Stock Incentive Plan. The plan’s documentation explicitly references a variety of award types—including non‑qualified stock options, restricted stock units (both standard and performance‑based), restricted stock, performance awards and stock‑appreciation rights—that can be issued from this reserve.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies 48 million shares available for future grants as of December 31, 2024, matching the ground truth exactly. The date and numeric value are accurate. COMPLETENESS & ENTITY ACCURACY: The LLM correctly identifies UnitedHealth Group and the 2020 Stock Incentive Plan. However, there is a significant discrepancy in the types of awards referenced. GROUND TRUTH AWARDS: The original answer explicitly states three types: (1) Non-Qualified Stock Option Awards, (2) Restricted Stock Unit Awards, and (3) Performance-Based Restricted Stock Unit Awards. LLM AWARDS: The LLM lists five types: (1) non-qualified stock options, (2) restricted stock units (standard), (3) performance-based restricted stock units, (4) restricted stock, and (5) stock-appreciation rights. CRITICAL ISSUE: The LLM introduces two award types NOT mentioned in the ground truth: 'restricted stock' and 'stock-appreciation rights.' The ground truth explicitly states the plan documentation references specific types 'as evidenced by the various form agreements listed in the filing.' The LLM appears to have added award types beyond what was explicitly documented in the actual filing. Additionally, the LLM groups 'restricted stock units (both standard and performance-based)' which is a reasonable interpretation, but the addition of restricted stock and stock-appreciation rights represents a factual error—these were not explicitly referenced in the ground truth answer derived from the actual filing. REASONING: The multi-hop reasoning is partially sound (correctly synthesizing the share count and company/plan identification), but the expansion of award types beyond what was explicitly documented represents a failure to accurately reflect the filing contents. The LLM may have inferred or generalized beyond the actual documentation. SEMANTIC EQUIVALENCE: While the wording differs appropriately, the factual content diverges by including unreferenced award types, which violates the requirement for accuracy in multi-hop financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 555,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "\nThe company expects to recognize roughly **$1 billion** of contracted Paxlovid revenue from firm deliveries scheduled between 2025 and 2028. By comparison, only **$129 million** was recorded in 2024 from a one‑time sales true‑up settlement with a commercialization partner—about an eight‑fold difference. (Pages 103 and 109)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - the $1 billion in remaining contracted Paxlovid revenue for 2025-2028 deliveries matches the ground truth exactly, and the $129 million from the 2024 one-time sales true-up settlement is accurate. (2) QUANTITATIVE ACCURACY: Both dollar amounts are precisely correct with proper formatting. The LLM also correctly calculated the comparative ratio (approximately 8-fold difference: $1,000M ÷ $129M ≈ 7.75x, reasonably rounded to 'eight-fold'). (3) QUALITATIVE ACCURACY: The answer correctly identifies all entities (Pfizer/company, Paxlovid product, the commercialization partner settlement), properly distinguishes between the two revenue sources (firm contracted deliveries vs. one-time settlement), and accurately characterizes the time periods (2025-2028 vs. 2024). The multi-hop synthesis is sound - the answer successfully combines information about future contracted revenue with historical settlement revenue to make the comparison. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question: the forward-looking contracted revenue amount AND the comparison to 2024 settlement revenue. The inclusion of page references (103 and 109) adds credibility. Minor note: The phrasing 'roughly' and 'only' appropriately conveys the magnitude difference without overstating precision. The answer is well-structured and semantically equivalent to the ground truth while being slightly more detailed in its comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 428,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "\nAs of December 31 2023, the Berkshire Hathaway parental guarantee covers the full $12.8 billion (≈ $12,805 million) of ceded loss reserves under the 2017 adverse‑development reinsurance agreement with NICO. Thus, 100 % of those reserves are secured by the guarantee.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - WRONG DOLLAR AMOUNT: The LLM states $12.8 billion (≈$12,805 million) in ceded loss reserves, but the ground truth clearly states $12.4 billion. This is a significant factual error of $400 million difference. The LLM correctly identifies all entities (AIG, NICO, Berkshire Hathaway, 2017 agreement, December 31, 2023) and correctly states that 100% of reserves are covered by the parental guarantee. However, the core quantitative answer is materially incorrect. The LLM appears to have synthesized the multi-hop relationship correctly (identifying that Berkshire's guarantee covers the reserves), but the fundamental number is wrong. The question asks 'how much' was covered, making the dollar amount the primary focus of the answer. A $400 million discrepancy (3.2% error) is not a minor formatting difference and represents a significant factual error that would be material in financial contexts. The reasoning about the guarantee coverage is sound, but it is built on an incorrect foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 292,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "\nPayPal purchased roughly **$1.8 billion of credit receivables in each of the years ended December 31, 2021 and 2020** for its merchant‑finance offerings.  As of December 31, 2021, the outstanding balance of merchant loans, advances and interest/fees receivable was **about $1.4 billion (net of the $63 million participation interest sold to WebBank)**, reflecting the pool of receivables that remained on the books after purchases, repayments and the participation sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - $1.8 billion in credit receivables purchased for both 2021 and 2020, $1.4 billion outstanding balance as of December 31, 2021, and $63 million participation interest sold to WebBank. Number formats are appropriately varied (roughly, about) which is acceptable. (2) COMPLETENESS: The answer addresses all three components of the multi-part question: (a) total credit receivables purchased in 2021, (b) total credit receivables purchased in 2020, and (c) the relationship to outstanding balance as of December 31, 2021. (3) ENTITY ACCURACY: All entities are correctly identified - PayPal, merchant finance offerings, WebBank, and the correct fiscal year (December 31, 2021). (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points, explaining that the $1.4 billion outstanding balance represents the net position after purchases, repayments, and the participation sale to WebBank. The logical connection between the purchased receivables and the outstanding balance is clearly articulated. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical meaning. The phrase 'reflecting the pool of receivables that remained on the books after purchases, repayments and the participation sale' provides additional helpful context that enhances understanding. The only minor distinction is that the ground truth explicitly states 'PayPal maintains a significant portion of the credit risk' while the LLM answer implies this through the explanation of the net position, which is a reasonable interpretive choice. Overall, this is an excellent response that accurately answers the question with proper synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 493,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "\nThe Japanese subsidiary issued roughly $500 million of Guaranteed Senior Notes in November 2023, and by July 2024 it had repaid about $77 million of that debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) $500 million in Guaranteed Senior Notes issued in November 2023 - CORRECT, matches ground truth exactly; (2) $77 million repaid by July 2024 - CORRECT, matches ground truth exactly. The use of 'roughly' and 'about' in the LLM answer introduces appropriate hedging language that is semantically equivalent to the definitive ground truth statement, as both convey the same factual information. Entity identification is correct: Costco's Japanese subsidiary properly identified, correct financial instruments (Guaranteed Senior Notes), correct time periods (November 2023 issuance, July 2024 repayment status). Multi-hop reasoning is sound: the answer correctly synthesizes information about both the issuance event and the subsequent repayment activity. The only minor distinction is the use of qualifiers ('roughly,' 'about') which slightly soften the presentation but do not alter factual accuracy. All required information from the multi-part question is addressed: (1) total amount issued, (2) timing of issuance, (3) amount repaid, (4) timing of repayment. No calculations were required, but the numbers are presented with appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 356,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "\nThe available‑for‑sale debt‑investment portfolio fell in fair value from **$15.2 billion (July 31 2021)** to **$11.95 billion (July 30 2022)** – a decline of **≈ $3.26 billion**.  During the same period the company recorded only **$9 million of net realized gains** on those securities.  Consequently, the decline exceeded the realized gains by roughly **$3.25 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally misunderstand the question. (1) QUANTITATIVE ERRORS: The LLM states the decline in fair value was approximately $3.26 billion ($15.2B - $11.95B = $3.25B), which matches the ground truth's $3,259 million decline. However, the LLM then states 'the company recorded only $9 million of net realized gains' - this is INCORRECT. The ground truth indicates net gains DECREASED by $44 million, not that gains were $9 million. This is a fundamental misinterpretation of what the question asks. (2) CALCULATION ERROR: The LLM concludes 'the decline exceeded the realized gains by roughly $3.25 billion' ($3.26B - $9M ≈ $3.25B). However, the correct calculation per ground truth should be: the decrease in investment value ($3,259M) minus the change in net gains ($44M decrease) = $3,215 million. The LLM's approach of subtracting $9M from $3,260M is mathematically different from the ground truth's methodology. (3) SEMANTIC MISUNDERSTANDING: The question asks 'by how much did the decrease...exceed the net gains realized' - this is asking for a comparison between the magnitude of the value decrease and the magnitude of the gains change. The LLM interpreted this as comparing the value decrease to the absolute gains amount ($9M), rather than comparing the value decrease to the change in gains ($44M decrease). (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the relationship between the two metrics as presented in the ground truth. The correct answer is $3,215 million, not $3,250 million. The LLM's answer is off by approximately $35 million due to using the wrong baseline for the gains metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 466,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "\nAs of December 31, 2021, Amazon had $7.0 billion of unused capacity under its $7.0 billion unsecured revolving credit facility and $7.2 billion of unused letters of credit, giving a combined unused short‑term credit capacity of roughly $14.2 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the question. Quantitative verification: (1) $7.0 billion unsecured revolving credit facility - CORRECT, (2) $7.2 billion unused letters of credit - CORRECT, (3) Combined total of $14.2 billion - CORRECT (7.0 + 7.2 = 14.2). The date of December 31, 2021 is correctly identified. Multi-hop synthesis is sound: the answer correctly combines information from two separate credit sources (revolving facility and letters of credit) to arrive at the total. The LLM appropriately notes that the full $7.0 billion was available since there were no borrowings outstanding, which aligns with the ground truth explanation. Minor difference: The LLM uses the phrase 'roughly $14.2 billion' while the ground truth states it 'is $14.2 billion' - the word 'roughly' introduces slight imprecision in language, though the actual number stated is precise. This is a very minor semantic distinction that does not materially affect the accuracy of the answer. All entities (Amazon, credit facility, letters of credit) are correctly identified and the reasoning is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 323,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "\nThermo Fisher spent roughly $3.6 billion of cash on acquisitions in 2023, and $2.7 billion of that amount was earmarked for the purchase of The Binding Site Group. The remainder—about $0.9 billion—was used for the acquisition of CorEvitas, LLC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) Total acquisition cash outflow of $3.6 billion matches the ground truth of $3.61 billion (minor rounding difference acceptable), (2) The Binding Site Group allocation of $2.7 billion matches exactly, (3) The calculated remainder of $0.9 billion is correct ($3.6B - $2.7B = $0.9B). Entity accuracy: TMO (Thermo Fisher) correctly identified, The Binding Site Group correctly named, and CorEvitas, LLC correctly identified as the other acquisition. Multi-hop reasoning: The answer successfully synthesizes information across multiple acquisitions and correctly calculates the remainder. The LLM went beyond the ground truth by providing additional context about CorEvitas, which adds value without introducing errors. The only minor deviation is the rounding of $3.61B to $3.6B, which is a standard and acceptable formatting variation. All core facts are correct, calculations are accurate, and the answer fully addresses both parts of the multi-part question (total outflow and specific allocation to The Binding Site Group).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 316,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "\nAbout 36 % of Union Pacific’s chassis units are leased (17,705 of 48,340 total), whereas only roughly 1 % of its containers are leased (545 of 47,984 total). Thus, the leased share of chassis is dramatically higher than the much smaller leased proportion of containers in the highway revenue‑equipment fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) Chassis leased percentage: 17,705 / 48,340 = 0.3663 = 36.63%, correctly rounded to 36% in the LLM answer vs. 36.6% in ground truth - both are acceptable representations; (2) Container leased percentage: 545 / 47,984 = 0.01136 = 1.136%, correctly rounded to 1% in the LLM answer vs. 1.1% in ground truth - both are acceptable; (3) All absolute numbers (17,705 chassis leased, 48,340 total chassis, 545 containers leased, 47,984 total containers) are correct. The LLM correctly synthesized the multi-hop comparison across two different equipment types (chassis vs. containers) and accurately identified the dramatic difference in leasing proportions (36% vs. 1%). The reasoning is sound and the conclusion appropriately emphasizes the significantly higher reliance on leasing for chassis. Minor difference: Ground truth specifies 36.6% while LLM states 36%, but this is a reasonable rounding difference and both are factually correct. The answer is complete, addresses the comparison question directly, and maintains semantic equivalence with the ground truth while using slightly different wording ('roughly 1%' vs. '1.1%' and 'dramatically higher' vs. 'significantly higher').",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 363,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "\nTwo supplemental indentures that reference a 2035 Note are identified – the 2015 Fifth Supplemental Indenture and the 2024 Tenth Supplemental Indenture. The most recent of these, the 2024 Tenth Supplemental Indenture, was executed with **Computershare Trust Company, National Association** acting as the trustee.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the two supplemental indentures (Fifth Supplemental Indenture from 2015 and Tenth Supplemental Indenture from 2024) and accurately names the trustee (Computershare Trust Company, National Association) involved in the most recent agreement. All numeric values and dates are correct. The answer successfully synthesizes multi-hop information by identifying which indentures reference the 2035 Note and determining which is most recent. However, there is one minor omission: the ground truth specifies that Computershare Trust Company, National Association is acting as 'successor to Wells Fargo Bank,' which provides important historical context about the trustee succession. The LLM answer omits this successor relationship detail. This is a relatively minor contextual omission that doesn't affect the core factual accuracy of the answer, but it represents incomplete information relative to the ground truth. The answer is otherwise semantically equivalent and factually sound in all material respects.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 298,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "\nThe 2023 non‑employee director deferred‑stock‑unit awards no longer vest immediately; they now vest on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting (subject to possible acceleration), and the related compensation cost is recognized on a straight‑line basis over that service period. In contrast, awards granted before 2022 vested instantly and were expensed in full on the grant date. Thus, the 2023 awards will typically become vested after one year—or, if the next shareholder meeting occurs sooner, just before that meeting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key factual elements: (1) 2023 awards use straight-line expensing over the service period vs. full expensing on grant date for pre-2022 awards; (2) 2023 awards vest immediately upon grant vs. instant vesting for prior awards; (3) vesting timeline is correctly stated as the earlier of first anniversary of grant date or day immediately preceding next Annual Meeting of Shareholders; (4) acceleration provisions are mentioned. The answer demonstrates sound multi-hop reasoning by synthesizing the comparison between two time periods and explaining both the expensing methodology change and vesting timeline change. The wording differs slightly from the ground truth (e.g., 'no longer vest immediately' vs. 'vested immediately') but conveys identical semantic meaning. One minor note: the ground truth says pre-2022 awards 'vested immediately' while the LLM says they 'vested instantly'—these are semantically equivalent. The LLM's clarification that 2023 awards 'will typically become vested after one year—or, if the next shareholder meeting occurs sooner, just before that meeting' adds helpful context without introducing inaccuracy. All dates, time periods, and conditions are correctly stated. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 373,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "\nThe 2023 operating profit for the Oral, Personal and Home Care business in Africa/Eurasia was **$254 million**. This profit corresponded to roughly **36 %** of the region’s total identifiable assets of **$698 million** for that same business unit.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor discrepancies. Verification of key facts: (1) Operating profit of $254 million - CORRECT; (2) Identifiable assets of $698 million - CORRECT; (3) Year 2023 - CORRECT; (4) Business unit (Oral, Personal and Home Care) - CORRECT; (5) Region (Africa/Eurasia) - CORRECT. Calculation verification: $254M / $698M = 0.3638 or 36.38%, which rounds to approximately 36.4%. The LLM stated 'roughly 36%' which is a reasonable rounding but slightly less precise than the ground truth's 36.4%. The LLM answer correctly synthesized the multi-hop information by identifying the specific business unit and region, extracting both financial metrics, and performing the percentage calculation. The reasoning is sound and all entities are correctly identified. The only minor weakness is the rounding to 36% instead of 36.4%, which represents a small loss of precision (0.4 percentage points). The answer is semantically equivalent to the ground truth and addresses all parts of the multi-part question comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 301,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "\nIn fiscal 2024 AMD bought roughly **$1.7 billion** of inventory from the ATMP joint venture and sold about **$121 million** of inventory back to it.  By contrast, the loan AMD provided to the JV was a **$100 million** one‑year term loan—only about 5–6 % of the total purchase‑resale amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key facts: (1) Purchases from ATMP JV: $1.7 billion - CORRECT; (2) Resales to ATMP JV: $121 million - CORRECT; (3) Combined total: $1.821 billion (implied by $1.7B + $121M) - CORRECT; (4) Loan amount: $100 million - CORRECT; (5) Loan timing: October 2024 - CORRECT. The LLM's percentage calculation (5-6% of total) is accurate: $100M / $1.821B ≈ 5.49%, which rounds to 5-6%. The answer successfully synthesizes information across multiple data points (purchases, resales, and loan) and makes the appropriate comparison showing the loan is significantly smaller than the combined purchase-resale activity. The only minor difference from the ground truth is that the LLM uses slightly more casual phrasing ('roughly,' 'about,' 'one‑year term loan') rather than the formal structure of the original answer, but this is a stylistic choice that does not affect factual accuracy. The answer is complete, addresses all parts of the question, and the multi-hop reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 308,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "\nThe Analytical and physical instrumentation product line grew from $2.464 billion in 2019 to $2.620 billion in 2021, an increase of **$0.156 billion**. In contrast, the Research and medical products segment rose from $13.512 billion in 2019 to $24.802 billion in 2021, an increase of **$11.290 billion**—making the research‑and‑medical growth roughly 72 times larger than the increase in analytical instrumentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All numerical values are correct: (1) Analytical and physical instrumentation increased from $2.464 billion (2019) to $2.620 billion (2021), a $0.156 billion increase - correctly stated; (2) Research and medical products increased from $13.512 billion (2019) to $24.802 billion (2021), an $11.290 billion increase - correctly stated. The calculations are accurate: $2.620B - $2.464B = $0.156B ✓ and $24.802B - $13.512B = $11.290B ✓. The comparative analysis is sound: $11.290B ÷ $0.156B ≈ 72.4x, which the LLM correctly rounds to 'roughly 72 times larger.' The answer successfully synthesizes multi-hop information across two different product lines/segments and time periods. The format variation (using billions instead of millions) is acceptable and actually enhances readability. The LLM properly addresses all parts of the question: (1) total increase for Analytical and physical instrumentation, (2) total increase for Research and medical products, and (3) comparison between the two. The reasoning is clear and logical. Minor deduction (1 point) only because the original answer explicitly states the comparison is 'relatively modest' while the LLM uses a more quantitative '72 times larger' framing - both are correct but the original provides slightly more interpretive context about the relative scale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 381,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "\nMicrosoft’s SQL Server is embedded in the **Server products and cloud services** portion of the Intelligent Cloud segment.  That line‑item— which also covers Azure, Windows Server, CALs, Nuance and GitHub—generated **$67.3 billion of revenue in fiscal 2022**, up from $52.6 billion in 2021 and $41.4 billion in 2020.  The growth is driven by both on‑premises licensing (including SQL Server volume‑license, OEM and retail sales) and the consumption‑based cloud services that SQL Server enables, and it feeds directly into the segment’s broader “Microsoft Cloud” revenue of $91.2 billion.  Consequently, SQL Server’s licensing and related Enterprise Services are a primary contributor to the Intelligent Cloud segment’s rising revenue and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a strong response with accurate financial data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies SQL Server as part of the Server products and cloud services category within Intelligent Cloud segment; (2) Accurately cites specific revenue figures ($67.3B for FY2022, $52.6B for FY2021, $41.4B for FY2020) with proper year-over-year context; (3) Correctly identifies multiple revenue streams: volume licensing, OEM, retail, and CALs; (4) Properly synthesizes the connection between SQL Server and broader cloud services (Azure); (5) Mentions the $91.2B Microsoft Cloud revenue figure, showing understanding of segment hierarchy; (6) Explains both on-premises and consumption-based revenue drivers. MINOR WEAKNESSES: (1) The answer goes slightly beyond the ground truth by providing specific fiscal year revenue numbers and growth context, which while accurate and helpful, represents some elaboration beyond what the ground truth explicitly states about SQL Server's contribution mechanism; (2) The ground truth emphasizes SQL Server's role through licensing programs and CALs more directly, while the LLM answer frames it more broadly within the server products category; (3) The mention of 'Nuance and GitHub' as part of the same line-item is accurate but adds detail not in the ground truth. QUANTITATIVE VERIFICATION: The revenue figures cited ($67.3B, $52.6B, $41.4B) appear consistent with Microsoft's actual FY2022, FY2021, and FY2020 Intelligent Cloud segment reporting. The $91.2B Microsoft Cloud figure is also consistent with Microsoft's reported metrics. MULTI-HOP REASONING: The answer correctly synthesizes that SQL Server contributes through multiple mechanisms (licensing, CALs, cloud services) and connects this to the segment's overall financial performance. The logic linking on-premises licensing growth to cloud services consumption is sound. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth—that SQL Server is a key revenue driver for Intelligent Cloud through licensing and cloud services—while providing additional quantitative context that enhances understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 580,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "\nThe fair‑value of the insurance buy‑in contracts climbed from **$950 million at 31 Dec 2022** to **$1,605 million at 31 Dec 2023**, and then slipped to **$1,390 million at 31 Dec 2024**.  This two‑year movement represents a **net increase of $440 million**, with the 2023 year‑end balance of $1,605 million and the 2024 year‑end balance of $1,390 million reflecting that change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: $950 million (Dec 31, 2022), $1,605 million (Dec 31, 2023), and $1,390 million (Dec 31, 2024). The calculation of the net change is accurate: $1,390M - $950M = $440 million. The answer correctly addresses all parts of the multi-part question: (1) total change in value over the two-year period, (2) the 2023 year-end balance, and (3) the 2024 year-end balance. The multi-hop reasoning is sound, synthesizing the three data points across the two-year period to derive the net change. The terminology used ('fair-value of insurance buy-in contracts') is appropriate and matches the ground truth concept. The wording differs slightly from the original answer (e.g., 'climbed' and 'slipped' vs. 'increased' and 'decreased'), but this represents stylistic variation rather than factual error. The answer clearly explains the trajectory of the value changes and explicitly states both year-end balances as requested. Minor deduction from perfect score only due to slightly more elaborate wording that, while accurate, could be considered marginally less concise than necessary.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 329,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "\nAs of December 31 2024, TI’s defined‑contribution plans held $852 million of TI common stock in the U.S. plan and $34 million in the non‑U.S. plan, for a combined total of roughly **$886 million**.  Dividends paid on those shares during 2024 were **$26 million** (essentially all from the U.S. plan; dividends on the non‑U.S. holdings were not material).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: (1) Total value of TI common stock: LLM states $886 million, which matches the ground truth exactly. The breakdown provided ($852M U.S. + $34M non-U.S.) correctly sums to $886M. (2) Dividends paid during 2024: LLM states $26 million, which matches the ground truth exactly. COMPLETENESS: The answer addresses both parts of the multi-part question: (a) total value as of December 31, 2024, and (b) dividends paid during 2024. ENTITY ACCURACY: Correctly identifies TI (Texas Instruments), the correct fiscal year (2024), and the correct plan types (U.S. and non-U.S. defined contribution plans). MULTI-HOP REASONING: The LLM successfully synthesized information across multiple data points - combining U.S. and non-U.S. plan holdings, calculating the total, and separately identifying dividend payments. The additional context provided (that dividends were essentially all from the U.S. plan with non-U.S. dividends being immaterial) adds helpful detail without contradicting the ground truth. MINOR OBSERVATION: The LLM uses 'roughly' before $886 million, which is slightly informal but not incorrect given the component values sum exactly to this amount. The answer demonstrates sound multi-hop reasoning by correctly combining separate U.S. and non-U.S. figures and linking them to dividend information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 385,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "\nThe 5.300 % Senior Notes due 2050 were issued with a principal amount of **$1,250 million**. Together, the 3.900 %, 4.450 % and 5.200 % Senior Notes total **$2,250 million**, so the 5.300 % issue is **$1,000 million (about 44 %) lower** than the combined principal of those three series.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1,250 million and correctly calculates the combined principal of the three other notes as $2,250 million. However, there is a critical calculation error in the comparison. The LLM states the 5.300% issue is '$1,000 million (about 44%) lower' than the combined principal. This is incorrect: $2,250M - $1,250M = $1,000M difference is correct, but the percentage calculation is wrong. The LLM calculates 44% when the ground truth shows 55.6%. Specifically: $1,250M / $2,250M = 55.6%, not 44%. The LLM appears to have calculated the inverse (44.4% ≈ $1,000M / $2,250M), which represents what percentage the difference is of the combined total, not what percentage the 5.300% notes represent of the combined total. The ground truth asks for how the 5.300% notes compare to the combined principal of the other three notes, which should be expressed as a ratio of the 5.300% notes to the combined total (55.6%), not as a percentage difference. This is a significant calculation error that affects the core comparison requested in the question. The LLM correctly synthesized the multi-hop information by gathering all four note amounts and performing calculations, but the final percentage comparison is mathematically incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 368,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "\nThe Service‑Based RSUs that were outstanding at the start of the year and still held at the end of 2024 total 1,807 (thousand) shares, and their weighted‑average grant‑date fair value is **$183.41 per share** (representing an aggregate fair‑value of roughly **$331 million**).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FUNDAMENTAL MISINTERPRETATION OF THE METRIC: The ground truth states the answer is $183.41 million (total weighted-average grant-date fair value), but the LLM claims this is a per-share value ($183.41 per share). This is a categorical error that fundamentally misrepresents the answer. (2) CALCULATION ERROR: The LLM calculates 1,807 thousand shares × $183.41/share = ~$331 million. However, this calculation contradicts the ground truth answer of $183.41 million total. If the per-share value were truly $183.41, the aggregate would be much higher than $183.41 million, making the math internally inconsistent with the ground truth. (3) MISSING CLARITY ON METRIC: The question asks for 'total weighted-average grant-date fair value' which is a single aggregate metric, not a per-share metric. The LLM conflates these two different measures. (4) SHARE COUNT ACCURACY: While the LLM provides a share count (1,807 thousand), this detail was not requested and appears to be additional information that may or may not be accurate. (5) SEMANTIC FAILURE: The ground truth answer is straightforward: $183.41 million. The LLM's answer of '$183.41 per share' with an aggregate of '$331 million' directly contradicts the ground truth. The core numerical answer is wrong by a factor of approximately 1.8x. This is not a minor wording difference but a fundamental factual error in the primary metric being requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 398,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "\nUPS applies a two‑step test to each uncertain tax position: it first judges whether the position is more likely than not to be sustained on audit, and, if it meets that threshold, it measures the benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. Because this assessment is refreshed each quarter and relies on the weight of available evidence—including changes in facts, tax law, audit outcomes, and the probability of various outcomes—any revision can result in either the recognition of a tax benefit or an additional charge to the tax provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS's uncertain tax position estimation process. (1) CORRECTNESS: The LLM correctly identifies the two-step process (determining if position is more likely than not to be sustained, then measuring the largest amount more likely than not to be realized), which matches the ground truth exactly. The answer accurately describes how this process influences tax benefit recognition or additional charges to the tax provision. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are required in this question, and the LLM appropriately avoids introducing unsupported figures. The conceptual framework is presented without numerical errors. (3) QUALITATIVE ACCURACY: The LLM successfully synthesizes information across multiple sections (financial statement notes and management discussion) as required by the question. The reasoning is sound: it explains the two-step test, the measurement criteria (largest amount more likely than not to be realized), and the quarterly reevaluation process. The answer correctly identifies that changes in facts, tax law, audit outcomes, and probability assessments drive revisions. (4) MULTI-HOP SYNTHESIS: The answer effectively connects the estimation process to its consequences (recognition of benefits or additional charges), demonstrating proper multi-hop reasoning across the financial statements and MD&A sections. (5) MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but captures all essential elements. The phrase 'weight of available evidence' in the LLM answer is a reasonable elaboration that aligns with the ground truth's reference to 'available evidence.' The answer fully addresses the specific criteria for measurement (the largest amount more likely than not to be realized upon settlement) and the process drivers (quarterly reevaluations based on changes in facts, tax law, audit outcomes).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 538,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "\nThe total capital expenditure allocated to Africa/Eurasia in 2021 was **$33 million**, and **organic sales in that region rose 7.0%** during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) CORRECTNESS: Both key facts match the ground truth exactly - capital expenditure of $33 million and organic sales increase of 7.0% in Africa/Eurasia for 2021. (2) QUANTITATIVE ACCURACY: All numeric values are precise and correct: $33 million (capital expenditure) and 7.0% (organic sales growth rate). The formatting is clear and appropriate. (3) QUALITATIVE ACCURACY: The answer correctly synthesizes information across two different metrics (capex and organic sales growth) for the same region and year, demonstrating proper multi-hop reasoning. Entity identification is accurate (Africa/Eurasia region, 2021 fiscal year). (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses both parts of the question without extraneous information. The wording is clear and professional, using appropriate financial terminology. No calculation errors, omissions, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 287,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "\nContact Lenses/Other sales rose from **$2.994 billion in 2020 to $3.440 billion in 2021**, an increase of **$0.446 billion (≈ 15 %)**.  This growth was a key driver of the Vision franchise’s total sales, which climbed from **$3.919 billion to $4.688 billion**—an increase of **$0.769 billion (≈ 20 %)**—so the Contact Lenses/Other gain accounted for a substantial portion of the overall Vision‑segment sales rise.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. All key numbers are accurate: Contact Lenses/Other sales increased from $2.994 billion to $3.440 billion (increase of $0.446 billion), and Vision segment sales grew from $3.919 billion to $4.688 billion (increase of $0.769 billion). The percentage calculations are correct (15% for Contact Lenses/Other, 20% for Vision segment). The LLM correctly identifies that Contact Lenses/Other accounted for a 'substantial portion' of the overall Vision segment growth. However, the ground truth provides a specific quantitative contribution metric (approximately 58%), which the LLM answer does not explicitly calculate or state. The LLM uses qualitative language ('substantial portion') rather than the precise percentage contribution. The multi-hop reasoning is sound—the model correctly synthesizes information across the two metrics and time periods, establishing the relationship between the two growth figures. The format variations (billions vs millions in presentation) are acceptable and don't affect accuracy. The main minor weakness is the lack of the specific 58% contribution calculation, which would have made the answer more complete and precise, though the qualitative assessment of 'substantial' is semantically reasonable given that 58% is indeed substantial.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 381,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "\nIn 2023 the Control Systems & Software segment’s earnings rose to **$529 million**, up **21 %** from $437 million in 2022, but its profit margin fell sharply from **14.7 %** to **11.6 %** – a decline of **3.1 percentage points**. The margin compression was driven mainly by the **$249 million of incremental intangible‑amortization** associated with the Heritage AspenTech acquisition, which offset the benefit of higher sales and earnings from the consolidated AspenTech business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states earnings 'rose to $529 million, up 21% from $437 million in 2022' - this is mathematically incorrect. $529M is only 21% higher than $437M ($437M × 1.21 = $529M), but the ground truth explicitly states earnings 'remained flat at $529 million in 2023' compared to 2022. The LLM mischaracterizes a flat performance as growth. (2) The LLM completely omits the critical AspenTech earnings deterioration that is central to the question: $12M earnings in 2022 vs. $107M loss in 2023 (a $119M swing). This is the primary driver of the impact and should be explicitly stated. (3) The LLM attributes margin compression to '$249 million of incremental intangible-amortization' but the ground truth identifies AspenTech's poor performance as the 'largely driven by' factor. While intangible amortization may be a contributing factor, the ground truth emphasizes AspenTech's operational loss as the main driver. (4) The LLM correctly identifies the margin decline from 14.7% to 11.6% (3.1 percentage points) and the $529M earnings figure, but frames the earnings change incorrectly as growth rather than flat. MULTI-HOP REASONING: The LLM fails to properly synthesize the AspenTech consolidation impact across years. The ground truth requires understanding that AspenTech's contribution swung from +$12M to -$107M, which is the key insight about consolidation impact. The LLM's explanation focuses on intangible amortization rather than the operational performance deterioration. WHAT WAS CORRECT: Margin percentages (14.7% to 11.6%), margin decline (3.1 pp), and the $529M 2023 earnings figure. WHAT WAS INCORRECT: Characterization of earnings as 'rose' and 'up 21%' when they remained flat, omission of AspenTech's specific earnings swing, and misattribution of primary cause of margin compression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 516,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "\nVisa recorded a **$861 million accrual** for U.S.‑covered litigation during fiscal 2022 (the additional provision shown in the “Accrual Summary‑U.S. Covered Litigation” table).  \nUnder the **U.S. Retrospective Responsibility Plan**, that monetary liability is recovered not by cash outlay but by a **downward adjustment to the conversion rate of class B common stock into class A shares**, thereby shifting the cost to the holders of the class B stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $861 million figure is correct and matches the ground truth exactly. The number is properly formatted and sourced from the Accrual Summary table for U.S. Covered Litigation. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the total monetary liability amount ($861 million), and (b) how it is recovered under the U.S. Retrospective Responsibility Plan (downward adjustment to conversion rate of class B to class A stock). (3) ENTITY ACCURACY: All entities are correctly identified - Visa, fiscal 2022, U.S. Covered Litigation, U.S. Retrospective Responsibility Plan, class B common stock, and class A common stock. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across the litigation liability accrual and the recovery mechanism, demonstrating sound understanding of how the two are connected. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'downward adjustment to the conversion rate of class B common stock into class A shares' is semantically equivalent to the ground truth's 'downward adjustment to the conversion rate of class B common stock to class A common stock.' The additional detail about 'shifting the cost to the holders of the class B stock' provides helpful context without introducing inaccuracy. Minor note: The LLM uses 'accrual' terminology which is appropriate accounting language and adds clarity. No calculation errors, no missing information, and all facts are verifiable against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 429,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "\nIn 2021 Pfizer’s discontinued‑operations results reflected the remaining activity of its former Meridian business.  The company recorded a **$345 million pre‑tax charge in Q2** to resolve a Meridian‑related legal matter and, after the December 31 2021 sale of Meridian, it recognized a **$167 million after‑tax loss**.  These items together produced a **$435 million net loss in discontinued operations for the full year**, representing the total financial impact of Pfizer’s historical ownership of Meridian in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN CALCULATION: The LLM answer contains a significant mathematical error in the final total. The ground truth states the total financial impact was $512 million negative, comprised of: (1) $345 million pre-tax legal charge in Q2, and (2) $167 million after-tax loss from the sale in Q4. The LLM correctly identifies both component figures ($345M and $167M) and correctly attributes them to the right quarters and events. However, the LLM then states these items 'together produced a $435 million net loss in discontinued operations for the full year.' This is mathematically incorrect: $345M + $167M = $512M, not $435M. The LLM appears to have either miscalculated or misunderstood how to combine these figures. QUANTITATIVE ACCURACY: The individual numbers ($345M Q2 charge, $167M after-tax loss) are correct, but the final sum is wrong by $77 million ($512M - $435M = $77M discrepancy). This is a material error that directly contradicts the ground truth total. QUALITATIVE ACCURACY: The LLM correctly identifies the two components of the financial impact, correctly attributes them to the appropriate quarters and events (Q2 legal charge, Q4 sale loss), and properly characterizes them as discontinued operations. The reasoning structure is sound, but the execution fails at the final calculation step. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about total financial impact and includes both operational results and post-closing adjustments as requested. The multi-hop synthesis across quarters and event types is conceptually correct but undermined by the calculation error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 444,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "\nBank of America Corporation must hold a supplementary leverage ratio of **at least 5 percent** – the 3 percent SLR floor plus a 2 percent leverage buffer – to avoid restrictions on capital distributions. In contrast, its insured depository‑institution subsidiaries must maintain a **minimum 6 percent SLR** to be classified as “well‑capitalized” under the PCA framework, so they are subject to a higher static SLR requirement. (Pages 46 and 53)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-part question. QUANTITATIVE VERIFICATION: All numbers are correct - Bank of America Corporation's SLR requirement is stated as 3% floor plus 2% leverage buffer totaling 5%, and the insured depository institution subsidiaries' requirement is correctly stated as 6%. The calculation (3% + 2% = 5%) is accurate. COMPLETENESS: The answer addresses both parts of the question: (1) BofA Corporation's SLR requirement including the leverage buffer, and (2) the comparison to subsidiary requirements. ENTITY ACCURACY: Bank of America Corporation and its insured depository institution subsidiaries are correctly identified. The PCA (Prompt Corrective Action) framework is correctly referenced. REASONING: The multi-hop synthesis is sound - the answer correctly identifies that BofA Corporation has a lower combined requirement (5%) compared to its subsidiaries (6%), and properly explains the distinction between the parent company requirement and the subsidiary well-capitalized threshold. SEMANTIC EQUIVALENCE: The LLM's phrasing 'at least 5 percent' is semantically equivalent to the ground truth's 'totaling 5 percent' - both convey the same requirement. The explanation of the leverage buffer as a separate component (3% + 2%) matches the ground truth structure. MINOR OBSERVATION: The LLM includes page references (Pages 46 and 53) which adds helpful sourcing but is not part of the ground truth evaluation. The characterization of the 6% requirement as a 'higher static SLR requirement' is accurate and adds appropriate context. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 449,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "\nThe January 1 2020 credit‑loss guidance required MetLife to shift from an “incurred‑loss” model to an expected‑lifetime‑loss model for its mortgage‑loan portfolio. As a result, an allowance for credit losses is recorded at the time a loan is purchased (in net investment gains / losses) based on discounted cash‑flow estimates of the portion of the loan’s amortized cost that is not expected to be collected, and credit‑loss expense is recognized immediately rather than waiting for an actual default or later incurred loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key elements: (1) The adoption date of January 1, 2020 is correct; (2) The shift from 'incurred-loss' model to 'expected-lifetime-loss' model is accurately described and matches the ground truth; (3) The requirement to establish an allowance for credit losses (ACL) at time of purchase is correctly stated; (4) The basis for the allowance (expected lifetime credit losses/discounted cash-flow estimates) is accurate; (5) The timing change from waiting for probable/incurred losses to immediate recognition is correctly conveyed. The LLM answer adds helpful detail about the recording location (net investment gains/losses) and the methodology (discounted cash-flow estimates), which provides additional context without contradicting the ground truth. The semantic meaning is equivalent to the original answer - both convey the fundamental shift from incurred loss to expected loss model and the earlier recognition of credit losses. No quantitative errors are present. The multi-hop reasoning is sound, correctly synthesizing the accounting policy change and its specific impacts on mortgage loan treatment. Minor point: The LLM uses slightly different phrasing ('expected-lifetime-loss model' vs 'expected loss model') but this is semantically equivalent and actually more precise. The answer fully addresses all aspects of the question regarding impact on accounting treatment, allowance for credit losses, and timing of recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 418,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "\nThe January 1 2020 credit‑loss guidance replaced the prior “incurred‑loss” model with an **expected‑lifetime‑loss** model, so that an allowance for credit loss is recorded each reporting period rather than only when a loss is actually incurred.  Under the new guidance, **leveraged‑lease receivables are pooled by risk characteristics and evaluated with a probability‑of‑default / loss‑given‑default framework that uses third‑party lessee credit ratings and historical default data**, while **mortgage‑loan losses are estimated over the contractual term (adjusted for expected prepayments and extensions) using discounted‑cash‑flow analyses that incorporate past events and forward‑looking economic forecasts**.  The allowance is recognized in earnings within investment gains (losses) and the investment in leases is presented net of that allowance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All core facts are correct - the shift from incurred-loss to expected-lifetime-loss model on January 1, 2020 is accurately stated. The specific methodologies for both asset types are correctly identified. (2) QUANTITATIVE ACCURACY: The date (January 1, 2020) is correct. No calculations are required for this question, and all numeric/temporal references are accurate. (3) QUALITATIVE ACCURACY: The answer demonstrates strong multi-hop reasoning by synthesizing information across two asset types (leveraged lease receivables and mortgage loans) and correctly identifying the distinct models used for each: (a) leveraged leases use probability-of-default/loss-given-default framework with third-party credit ratings and historical default data - matches ground truth exactly; (b) mortgage loans use discounted-cash-flow analyses over contractual term adjusted for prepayments/extensions, incorporating past events and forward-looking economic conditions - matches ground truth. The answer adds valuable detail about the allowance being recognized in investment gains/losses and presented net of allowance, which is contextually relevant and accurate. (4) SEMANTIC EQUIVALENCE: The LLM uses 'expected-lifetime-loss' which is semantically equivalent to 'expected lifetime credit loss' in the ground truth. The description of 'discounted-cash-flow analyses' is a reasonable elaboration on 'applying significant judgment to estimate expected lifetime credit loss' and is consistent with standard mortgage loan valuation practices. (5) COMPLETENESS: The answer addresses all parts of the multi-part question: timing (January 1, 2020), methodology change (incurred to expected lifetime), specific models (PD/LGD for leases, DCF for mortgages), and inputs (credit ratings, historical data, economic conditions). Minor: The answer could have been slightly more explicit about 'significant judgment' being applied, but the DCF reference implicitly captures this.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 545,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "\nTexas Instruments’ investment in 300‑millimeter wafer fabrication gives it a structural cost advantage—producing an unpackaged chip on a 300‑mm wafer costs roughly 40 % less than on a 200‑mm wafer (page 8).  That lower‑cost manufacturing raises the gross margin of its analog products, which in turn drives the high free‑cash‑flow generation the company cites as a core pillar of its business model (pages 13, 20, 22).  The resulting cash surplus enables TI to fund continued capital spending, pay sizable dividends and repurchase shares, directly supporting its stated goal of returning significant cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: The key metric of '40% cost reduction per unpackaged chip' using 300-mm vs 200-mm wafers is correctly stated and matches the ground truth exactly. No calculation errors present. (2) ENTITY ACCURACY: Texas Instruments (TXN) correctly identified; 300-millimeter and 200-millimeter wafer specifications accurately referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes the causal chain: 300-mm wafer cost advantage (40% reduction) → higher gross margins → increased free cash flow generation → ability to return cash to shareholders through dividends and buybacks. This matches the ground truth's logic flow precisely. (4) COMPLETENESS: The answer addresses all key components of the question: the structural cost advantage, its contribution to manufacturing competitiveness, the impact on cash generation, and the connection to shareholder returns. The mention of specific page references (8, 13, 20, 22) adds credibility and demonstrates source grounding. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'roughly 40% less' is semantically equivalent to the ground truth's '40% cost reduction.' The explanation of how this enables 'sizable dividends and repurchase shares' aligns with 'returning substantial amounts of cash to shareholders.' Minor note: The LLM provides slightly more operational detail (mentioning capital spending alongside dividends and buybacks) which enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 425,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "\nAs of December 31 2021, the 1.5‑Year Floating Rate (SOFR + 0.35 %) Senior Notes had a reported carrying value of **$1,000 million**, whereas the Floating Rate (SOFR + 0.39 %) 2‑Year Senior Notes due on October 18 2023 were recorded at **$500 million**. Thus, the 1.5‑year issue was twice the size of the 2‑year issue at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. (1) CORRECTNESS: All factual information is correct. The 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes value of $1,000 million matches the ground truth exactly. The 2-Year Floating Rate (SOFR + 0.39%) Senior Notes due October 18, 2023 value of $500 million also matches precisely. The comparison statement that the 1.5-year issue was twice the size of the 2-year issue is mathematically accurate ($1,000M / $500M = 2x). (2) QUANTITATIVE ACCURACY: All numbers are correct - $1,000 million, $500 million, the interest rate spreads (0.35% and 0.39%), the maturity date (October 18, 2023), and the reference date (December 31, 2021). The calculation/comparison is sound. (3) ENTITY ACCURACY: TMO is correctly identified, the note types are correctly specified with their respective SOFR spreads, and the fiscal year (2021) is correct. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different debt instruments and correctly performs the comparative analysis. The logic is sound - identifying both values and then drawing the correct comparison. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'reported carrying value' vs. 'total value', 'issue' vs. 'Senior Notes') but conveys identical meaning. The minor stylistic differences (use of dashes, spacing in numbers) are acceptable formatting variations. The answer is complete, accurate, and well-reasoned with no material omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 430,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "\nAs of December 31 2023, 17 million shares were available for future issuance under the 1993 Employee Stock Purchase Plan and 53 million shares under the 2020 Stock Incentive Plan, for a combined total of 70 million shares; the 2020 Stock Incentive Plan had the greater remaining availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-part question. Verification of key elements: (1) QUANTITATIVE ACCURACY: All numbers are correct - 17 million shares for ESPP, 53 million shares for 2020 Stock Incentive Plan, and 70 million combined total. The date (December 31, 2023) is accurate. (2) COMPLETENESS: The answer addresses all three sub-questions: (a) shares available under 2020 Plan, (b) shares available under ESPP, (c) combined total, and (d) which plan had more shares. (3) ENTITY ACCURACY: Both plan names are correctly identified (1993 Employee Stock Purchase Plan and 2020 Stock Incentive Plan), and the company (UnitedHealth Group) is correctly implied. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified and combined information from two separate plans and made the correct comparison. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'greater remaining availability' vs 'had more shares available'), but the semantic meaning is identical. Minor note: The LLM answer omits the company name 'UnitedHealth Group' explicitly, though it's clearly implied by context. This is a very minor omission that does not affect the factual accuracy of the answer. Overall, this is a high-quality response that correctly synthesizes multi-hop information with accurate calculations and proper entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 393,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "\nIn 2023 Caterpillar reported a total post‑employment benefit liability of **$701 million (non‑current)** – comprised of $56 million for other post‑retirement benefits and $565 million for non‑qualified deferred compensation – with a current portion of $52 million, giving a combined liability of roughly **$753 million**.  \n\nThe 2019 freeze of all U.S. pension benefits eliminated any service‑cost component and the compensation‑increase assumption from the pension calculations; consequently, in the 2023 financial statements the pension expense no longer includes service cost or a salary‑growth assumption, leaving only the discount rate and other actuarial assumptions to measure the benefit obligation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM reports a total liability of $701 million (non-current) plus $52 million (current) for a combined ~$753 million. However, the ground truth states the total postemployment benefits liability was $621 million ($56M OPEB + $565M non-qualified deferred compensation). The LLM's figures are significantly inflated and do not match the ground truth. The breakdown of $56M for OPEB and $565M for non-qualified deferred compensation is correct, but the total of $621M is fundamentally misrepresented as $701M non-current plus $52M current. This is a critical error in the primary quantitative answer to the question. QUALITATIVE ASSESSMENT: The LLM correctly identifies that the 2019 pension benefits freeze eliminated service cost and affected actuarial assumptions. The explanation that service cost and compensation-increase assumptions were removed is accurate and well-articulated. The description of remaining assumptions (discount rate and other actuarial assumptions) is reasonable and demonstrates understanding of the impact. However, the ground truth more concisely states that certain actuarial assumptions became 'no longer applicable,' while the LLM provides more detail about which specific assumptions remain. MULTI-HOP REASONING: The LLM attempts to synthesize the liability components and the freeze impact, but the synthesis is undermined by the incorrect total liability figure. The connection between the freeze and the elimination of service cost is correctly made. CORE ISSUE: The answer fails on the primary factual requirement - the total liability amount. Reporting $701M/$753M instead of $621M represents a ~13-21% overstatement of the actual liability, which is a material error in financial reporting context. This is not a minor rounding or formatting difference but a fundamental misstatement of the key financial metric requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 511,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "\nThe combined fair value of Merck’s developed‑markets equity holdings in its U.S. pension plans was **$4.73 billion in 2024**. This is roughly **$0.14 billion (about 3 %) lower** than the $4.87 billion recorded for the same category in 2023. (Pages 120 & 121)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates sound multi-hop reasoning. Verification of key numbers: (1) 2024 total of $4.73 billion matches ground truth of $4,726 million (formatting variation acceptable); (2) 2023 total of $4.87 billion matches ground truth of $4,868 million; (3) Decrease of $0.14 billion matches ground truth of $142 million (formatting variation acceptable); (4) Percentage calculation of ~3% is accurate ($142M / $4,868M = 2.92%, reasonably rounded to 3%). The answer correctly synthesizes information across both investment funds and equity securities for U.S. Pension Plans, addressing all parts of the multi-part question. The LLM appropriately breaks down the comparison showing both absolute dollar change and percentage change. Minor note: The answer does not explicitly state the component breakdown ($2,555M investment funds + $2,171M equity securities for 2024, and $2,797M + $2,071M for 2023), which was included in the ground truth. However, the question asks for 'total fair value...across both' which the LLM correctly provides as the combined total. The omission of component details is a minor incompleteness but does not affect the core correctness of the answer to the question as asked. All numeric values are accurate, calculations are correct, and the reasoning properly synthesizes the multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 380,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan has authorized **approximately 135 million shares** of Danaher common stock since the plan’s inception, and **about 47 million shares** remain available for future issuance as of December 31, 2024 (including shares that can be used for stock options, RSUs and PSUs).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numbers match the ground truth exactly - 135 million shares authorized since inception and 47 million shares remaining available as of December 31, 2024. The use of 'approximately' and 'about' is appropriate given the nature of these figures and adds appropriate hedging language. (2) COMPLETENESS: The answer addresses all required components: total authorized shares, remaining available shares, the specific date (December 31, 2024), and the types of awards covered (stock options, RSUs, PSUs). (3) ENTITY ACCURACY: Correctly identifies Danaher common stock, the 2007 Omnibus Incentive Plan, and the relevant fiscal year-end date. (4) REASONING: The multi-hop synthesis is sound - the answer correctly connects the plan's authorization, its use for multiple award types, and the remaining availability calculation. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'approximately 135 million shares' and 'about 47 million shares' is semantically equivalent to the ground truth's 'A total of 135 million shares' and 'approximately 47 million shares.' The parenthetical clarification about award types adds helpful context without introducing errors. Minor note: The ground truth uses 'A total of 135 million' while LLM uses 'approximately 135 million' - both are acceptable phrasings for the same data point. No calculation errors detected. The answer demonstrates proper multi-hop reasoning by synthesizing information about plan authorization, usage, and remaining capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 436,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "\nThe rise of Google Play as a larger share of non‑advertising revenue can pressure Google’s overall profitability because non‑advertising streams—such as Google Play, hardware, and YouTube subscriptions—typically carry lower contribution margins than the high‑margin advertising business. As these lower‑margin revenues grow, they dilute the company’s average margin, potentially reducing overall profit margins unless offset by cost efficiencies or higher‑margin growth elsewhere.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core concept and provides accurate reasoning about Google Play's impact on overall profit margins. STRENGTHS: (1) Correctly identifies Google Play as part of non-advertising revenues; (2) Accurately characterizes the margin differential between advertising and non-advertising streams; (3) Properly explains the dilution effect on overall margins; (4) Correctly notes the potential offset through cost efficiencies or higher-margin growth; (5) Appropriately references the 2022 10-K context implicitly through the discussion framework. MINOR WEAKNESSES: (1) The LLM mentions 'YouTube subscriptions' as an example of non-advertising revenue, which while reasonable, is not explicitly mentioned in the ground truth answer (which focuses on Google Play, hardware, and Google Cloud); (2) The answer doesn't explicitly reference the 2022 10-K filing as the source, though this is a minor omission since the question doesn't require citation; (3) No quantitative data is provided (though the ground truth also lacks specific margin percentages, so this is not a deficiency). MULTI-HOP REASONING: The answer successfully synthesizes the relationship between (a) Google Play's growth, (b) its lower margins relative to advertising, and (c) the impact on overall profitability. The logic is sound and complete. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, using slightly different phrasing ('pressure Google's overall profitability' vs 'may adversely affect overall profit margins') but maintaining factual accuracy and conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 449,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "\nCVS hedges credit‑quality risk primarily through a suite of derivative instruments—including interest‑rate swaps, Treasury‑rate locks, forward and futures contracts, warrants, put options and credit‑default swaps—that are tied to credit spreads and ratings. Management expects these hedges to offset potential losses from deteriorating credit metrics, thereby limiting the volatility of earnings and protecting the company’s overall risk exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in identifying the specific financial instruments CVS uses for hedging. All instruments listed match the ground truth: interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps. No quantitative errors are present as the question does not require specific numbers or calculations. The answer correctly identifies that these are derivative instruments used for hedging purposes. However, there are minor differences in how the expected impact is characterized: (1) The ground truth states these instruments 'reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately' - emphasizing the trade-off nature of hedging. (2) The LLM answer frames the impact as 'offset potential losses from deteriorating credit metrics, thereby limiting the volatility of earnings and protecting the company's overall risk exposure' - which is semantically similar but adds interpretive language about 'deteriorating credit metrics' and 'earnings volatility' that goes slightly beyond what the ground truth explicitly states. The LLM answer adds reasonable context about how these hedges function (tied to credit spreads and ratings, offsetting losses), but this represents minor elaboration rather than error. The multi-hop reasoning is sound - the answer correctly synthesizes that CVS uses multiple types of derivatives specifically for credit quality risk hedging and understands the expected risk reduction outcome. The answer is well-structured and directly addresses both parts of the question (what instruments and expected impact).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 467,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "\nThe Company reported $682 million in hedge‑fund/limited‑partnership assets within its U.S. pension plans, $38 million in such assets within its non‑U.S. pension plans, and $9 million in hedge‑fund/limited‑partnership assets for its other postretirement benefit plans. Adding these amounts gives a total of **$729 million** invested in hedge funds/limited partnerships across both U.S. pension plans and other postretirement benefit plans in 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The question specifically asks for the total invested in hedge funds/limited partnerships across BOTH U.S. Pension Plans AND Other Postretirement Benefit Plans in 2021. The ground truth answer correctly identifies this as $691 million ($682M + $9M). However, the LLM answer: (1) Includes non-U.S. pension plans ($38M) which were NOT requested in the question - the question explicitly asks only for U.S. Pension Plans and Other Postretirement Benefit Plans; (2) Calculates an incorrect total of $729 million by summing $682M + $38M + $9M, which violates the scope of the question; (3) Misinterprets the multi-hop requirement by adding data from an unrelated category (non-U.S. pension plans) that was not part of the question. The LLM correctly identified the individual numbers ($682M for U.S. Pension Plans and $9M for Other Postretirement Benefit Plans), but failed to properly scope the answer to only those two categories as specified in the question. The calculation itself ($682M + $38M + $9M = $729M) is arithmetically correct, but it answers the wrong question. The correct answer should have been $691 million with only U.S. Pension Plans and Other Postretirement Benefit Plans included.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 349,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "\nUnion Pacific owned or leased **56,176 freight cars** in total as of December 31 2024.  In 2024 the company spent **approximately $788 million** on capital investments for locomotives and freight cars, which includes **$143 million of lease‑buyout costs**, representing the amount used to acquire freight cars that year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CORRECT ELEMENTS: (1) The total freight cars figure of 56,176 is accurate. (2) The $143 million lease-buyout cost is correctly identified. (3) The company is correctly identified as Union Pacific (UNP). (4) The date reference (December 31, 2024) is appropriate.\n\nINCORRECT/PROBLEMATIC ELEMENTS: (1) The question asks specifically 'how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?' The ground truth answer is $143 million. The LLM answer states they spent 'approximately $788 million on capital investments for locomotives and freight cars' with '$143 million of lease-buyout costs.' This is misleading because: (a) The $788 million includes locomotives AND freight cars combined, not just freight cars; (b) The question asks for the amount spent on acquiring freight cars specifically, which according to the ground truth is $143 million, not $788 million; (c) While the LLM correctly identifies the $143 million component, it introduces the $788 million figure which conflates the answer and doesn't directly address what was spent on freight cars acquisition.\n\nMULTI-HOP REASONING: The LLM correctly synthesized the freight car count from one source and identified the lease-buyout figure from another source. However, it failed to properly answer the second part of the question by introducing an additional $788 million figure that wasn't part of the ground truth answer and appears to conflate locomotives with freight cars.\n\nCALCULATION/SYNTHESIS: The core issue is that the question asks for spending on 'acquiring freight cars' and the ground truth specifies $143 million. The LLM's introduction of $788 million (which includes locomotives) represents a misinterpretation of what constitutes 'acquiring freight cars' spending. The $143 million lease-buyout figure is the correct answer to the second part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 513,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "\nThe unrealized gain on Google’s non‑marketable equity securities jumped from $3.0 billion in 2020 to $10.0 billion in 2021, an increase of about **$6.9 billion**. This rise in gains was the primary driver of the $5.2 billion increase in “Other income (expense), net,” with the remainder of the change offset by a $1.3 billion increase in accrued performance fees on those investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - the $6.9 billion increase in non-marketable equity securities (from $3.0B to $10.0B in 2021), the $5.2 billion net increase in other income (expense), and the $1.3 billion offset from accrued performance fees all match the ground truth exactly. The calculation is sound: $6.9B contribution minus $1.3B offset equals approximately $5.2B net increase. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple data points - identifying the unrealized gains on non-marketable equity securities as the primary driver, quantifying the contribution, and explaining how it relates to the overall change in other income (expense), net. The reasoning properly identifies the offsetting factor (accrued performance fees). ENTITY ACCURACY: Google is correctly identified, the fiscal years (2020 to 2021) are correct, and the financial metrics (non-marketable equity securities, other income/expense) are properly identified. MINOR OBSERVATION: The LLM provides slightly more detail by specifying the 2020 and 2021 values ($3.0B and $10.0B) which adds helpful context, though this wasn't explicitly required by the question. The answer is semantically equivalent to the ground truth and conveys all essential information accurately. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 390,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "\nThe forward contracts tied to the ASR programs executed in 2022 and 2023 had a combined notional amount of **$0.7 billion** ($0.3 billion in 2022 and $0.4 billion in 2023).  These contracts were treated as equity instruments and initially recorded in **capital surplus**; when the ASR settled, the forward contracts were **re‑classified from capital surplus into treasury stock**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct - $0.7 billion total ($0.3 billion in 2022 and $0.4 billion in 2023) matches the ground truth exactly. The arithmetic is sound. (2) COMPLETENESS: The answer addresses all parts of the multi-part question: (a) total value of forward contracts, (b) breakdown by year, (c) initial classification as equity instruments in capital surplus, and (d) reclassification to treasury stock upon settlement. (3) ENTITY ACCURACY: CVS is correctly identified, years 2022 and 2023 are correct, ASR transactions are properly referenced, and financial statement classifications (capital surplus, treasury stock) are accurate. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple dimensions - combining the temporal breakdown (2022/2023), the accounting treatment (initial classification and reclassification), and the financial statement impact. The logic flow is sound: forward contracts → equity instruments → capital surplus → reclassification to treasury stock upon settlement. (5) SEMANTIC EQUIVALENCE: The LLM uses 'notional amount' which is appropriate terminology for forward contracts and is semantically equivalent to 'value.' The phrase 're-classified from capital surplus into treasury stock' accurately conveys the accounting treatment. Minor stylistic differences (use of dashes, formatting) do not affect accuracy. The answer demonstrates clear understanding of ASR mechanics and accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 426,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "\nThe Lowe’s Companies **Benefit Restoration Plan** is a supplemental defined‑contribution arrangement that provides additional employer matching contributions to participants whose regular 401(k) benefits are limited by the Internal Revenue Code’s eligibility and compensation restrictions. By offering these extra matches, the plan ensures that eligible employees can receive the full Company match that would otherwise be curtailed under IRC 1986 provisions. (See NOTE 11 – Employee Retirement Plans and Exhibit 10.3, “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1, 2025.”)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the Benefit Restoration Plan as a supplemental arrangement that addresses IRC restrictions for eligible employees and provides matching contributions. The core relationship between the two plans is accurately described. However, there is a critical omission: the ground truth specifies that the Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan. The LLM answer mentions 'full Company match' but fails to include the specific 4.25% maximum percentage, which is a quantitative detail that should have been included. The LLM correctly references the appropriate SEC filing sections (NOTE 11 and Exhibit 10.3) and accurately describes the supplemental nature of the plan and its purpose. The reasoning about how the plan ensures eligible employees receive full matching contributions despite IRC restrictions is sound and well-articulated. The semantic understanding of the relationship between the two plans is correct. The main weakness is the incomplete quantitative information (missing the 4.25% figure), which prevents a higher correctness score despite the otherwise accurate qualitative explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 353,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "\nAt December 31 2023 the combined balance on the secured uncommitted lines of credit was **$1.65 billion** – $950 million outstanding under CS&Co’s secured uncommitted facility plus $700 million outstanding under TDAC’s secured uncommitted facility.  This amount is essentially equal to the total borrowing capacity of the uncommitted facilities (approximately $1.8 billion), indicating that nearly all of the available capacity was being used.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.65 billion total ($950M CS&Co + $700M TDAC = $1.65B), and the $1.8 billion total borrowing capacity is accurate. The date (December 31, 2023) is correct. CALCULATION VERIFICATION: The sum of $950M + $700M = $1.65B is correct. The utilization rate calculation is accurate: $1.65B / $1.8B = 91.67% (approximately 91.7%). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two entities (CS&Co and TDAC) and combines their outstanding balances while comparing to total capacity. MINOR WORDING DIFFERENCE: The LLM states the amount is 'essentially equal to' and 'nearly all' capacity was used, which is semantically equivalent to the ground truth's explicit 91.7% utilization rate. The LLM conveys the same meaning - that the facilities are highly utilized - though it doesn't explicitly state the 91.7% figure. This is a very minor omission of a calculated metric that was in the ground truth, but the core factual information and reasoning are sound. The answer demonstrates proper understanding of the relationship between outstanding amounts and borrowing capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 350,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "\nAt the end of 2021 Coca‑Cola’s pension portfolio held **$850 million** in mutual, pooled and commingled funds. By contrast, the combined holdings of hedge funds/limited partnerships (**$720 million**) and real‑estate investments (**$389 million**) totaled **$1,109 million**, which is roughly **$259 million** greater than the mutual‑fund allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. Ground truth states: mutual/pooled/commingled funds = $87 (million implied), hedge funds/limited partnerships = $9 million, real estate = $5 million, combined hedge+real estate = $14 million. The LLM provided completely different numbers: $850M, $720M, and $389M respectively. The LLM's calculation ($720M + $389M = $1,109M) is arithmetically correct, but these are wrong source numbers. The LLM also reversed the comparison conclusion - ground truth shows mutual funds ($87M) are GREATER than the combined hedge+real estate ($14M), but the LLM claims the combined hedge+real estate ($1,109M) is greater than mutual funds ($850M). This is a 180-degree reversal of the correct answer. The LLM appears to have fabricated or misread the investment values from the source documents. The question asks for a specific comparison, and the LLM provided the opposite conclusion with entirely incorrect numbers. While the LLM did address all parts of the question (mutual funds value, hedge funds/limited partnerships value, real estate value, and a comparison), every single numeric value is wrong, making this response critically flawed. The contextual relevance score reflects that the answer attempts to address the right question structure, but the execution is completely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 376,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "\nBecause LTIP units are entitled to receive a distribution equal to 10 % of the regular quarterly distribution on each Operating Partnership unit, they are treated as “participating securities” under the two‑class method.  Accordingly, a portion of net income is allocated to those units and the weighted‑average number of units (including the LTIP units) is added to the share count when earnings‑per‑share is calculated.  This splits earnings between the General Partner (common shareholders) and the Limited Partners (including LTIP holders), which reduces the earnings‑per‑share figure that is reported for common stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Strengths: (1) Correctly identifies the 10% distribution threshold as the key factor making LTIP units participating securities; (2) Accurately explains the two-class method mechanics; (3) Properly describes how earnings are allocated between common shareholders and LTIP holders; (4) Correctly notes the impact on reported EPS (reduction); (5) All quantitative references (10% distribution) are accurate with no calculation errors. The answer is more specific and mechanically detailed than the ground truth, explaining that LTIP units are added to the weighted-average share count and that earnings are split between General Partner and Limited Partners. This additional clarity enhances rather than detracts from accuracy. Minor consideration: The LLM answer uses slightly different framing (General Partner/Limited Partners terminology) compared to the ground truth's reference to 'common shares and participating securities,' but this is semantically equivalent and actually more precise in the context of partnership structures. The answer fully addresses the multi-hop synthesis required: connecting the 10% distribution feature → participating securities classification → two-class method application → EPS impact. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 365,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "\nAs of December 31 2024, NEE’s non‑controlling‑interest investment in XPLR OpCo was approximately **$3.3 billion**.  XPLR OpCo is classified as a **variable‑interest entity (VIE)** that NEE does not consolidate; the limited partners lack substantive governance rights, so the investment is presented as a non‑consolidated, equity‑method investment with a disclosed non‑controlling interest.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figure and classification of XPLR OpCo. QUANTITATIVE ACCURACY: The LLM states '$3.3 billion' while the ground truth specifies '$3,315 million' (which equals $3.315 billion). This is a minor rounding/formatting difference that is acceptable per evaluation guidelines ($3.3B ≈ $3.315B). The date (December 31, 2024) is correct. QUALITATIVE ACCURACY: The LLM correctly identifies XPLR OpCo as a variable interest entity (VIE) and correctly states that NEE does not consolidate it and uses the equity method. However, there are some nuances: (1) The ground truth explicitly states NEE is 'not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest' - the LLM mentions 'limited partners lack substantive governance rights' which is related but slightly different framing. (2) The ground truth emphasizes NEE's lack of control as the primary reason for non-consolidation; the LLM focuses on limited partners' governance rights, which is a valid but somewhat different emphasis. (3) The LLM adds the phrase 'with a disclosed non-controlling interest' which adds context not explicitly in the ground truth but is semantically reasonable. COMPLETENESS: Both parts of the multi-part question are addressed - the dollar amount and the classification/accounting treatment. MULTI-HOP REASONING: The answer correctly synthesizes the investment amount with the VIE classification and equity method accounting, showing proper understanding of the relationship between these concepts. MINOR ISSUES: The rounding from $3,315M to $3.3B is acceptable but slightly less precise than the ground truth figure. The explanation of why it's not consolidated (governance rights vs. control over significant activities) uses slightly different terminology but conveys the same essential meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 511,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "\nLinde supplies process gases through **three** distribution methods—on‑site (or tonnage), merchant (bulk liquid) and packaged (cylinder) gases. The on‑site method is distinguished by **long‑term “total‑requirement” contracts that usually run 10‑20 years and include minimum purchase‑volume requirements and price‑escalation provisions**, whereas the merchant and packaged methods are covered by shorter‑term agreements (typically 3‑7 years for merchant and 1‑3 years for packaged) that generally **do not impose minimum purchase or volume commitments**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All core facts are correct - three distribution methods identified (on-site, merchant, packaged), contract durations accurate (10-20 years for on-site, 3-7 years for merchant, 1-3 years for packaged), and the distinction regarding minimum purchase requirements is properly conveyed. (2) QUANTITATIVE ACCURACY: All numeric values are precise and match ground truth exactly. The contract duration ranges are correctly stated for all three methods. (3) QUALITATIVE ACCURACY: The LLM demonstrates strong multi-hop reasoning by synthesizing information about all three distribution methods and their comparative characteristics. The answer correctly identifies that on-site serves customers with largest volume requirements and includes minimum purchase requirements, while merchant and packaged do not. The addition of contextual details like 'total-requirement contracts' and 'price-escalation provisions' adds helpful specificity without contradicting the ground truth. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different terminology (e.g., 'on-site (or tonnage)' and 'bulk liquid' for merchant) but these are semantically equivalent and actually enhance clarity. The phrasing 'do not impose minimum purchase or volume commitments' is a clear restatement of 'do not typically include minimum purchase requirements or volume commitments.' (5) COMPLETENESS: The answer addresses all parts of the multi-part question - total number of methods, how on-site differs, contract duration differences, and customer volume requirement differences. Minor note: The LLM adds 'price-escalation provisions' which is not explicitly mentioned in the ground truth, but this is a reasonable elaboration that doesn't contradict the source material and reflects typical contract structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 500,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "\nThe February 2022 20‑for‑1 stock split was announced after the Board had already enlarged its share‑repurchase program to $50 billion of Class C stock in April 2021; the split does not alter that repurchase authorization but is a separate capital‑structure move.  To effect the split, the Board required stockholder approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation that increases the number of authorized shares of Class A, Class B and Class C stock so the split can be accommodated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key elements of the multi-hop question. QUANTITATIVE ACCURACY: All numbers are correct - the 20-for-one stock split ratio, the $50.0 billion repurchase authorization from April 2021, and the February 2022 announcement date are all accurate. COMPLETENESS: The answer addresses all three parts of the question: (1) the relationship between the stock split and prior repurchase authorization, (2) the condition required for the split to proceed, and (3) the stockholder approval requirement. ENTITY ACCURACY: All entities are correctly identified - Alphabet, Class C Capital Stock, Class A/B/C stock, and the Board of Directors. REASONING: The multi-hop synthesis is sound. The LLM correctly explains that while the stock split and repurchase authorization are separate capital-structure moves, they are related because the split required an increase in authorized shares to accommodate both the split and the ongoing repurchase program. The key condition (stockholder approval of an amendment to increase authorized shares) is clearly stated. SEMANTIC EQUIVALENCE: The LLM's phrasing 'the split does not alter that repurchase authorization but is a separate capital-structure move' effectively conveys the relationship described in the ground truth. Minor difference: The ground truth emphasizes that the increased authorized shares were necessary 'for both ongoing operations and the repurchase program,' while the LLM focuses more on accommodating the split itself. However, this is a subtle distinction and both convey the essential information. The answer is clear, accurate, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 458,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "\nGM’s equity‑method earnings from its stake in Ultium Cells Holdings LLC totaled **$293 million** for the year ended December 31 2023 【page_101】.  As of that same date, GM had **$0.8 billion** of committed capital contributions still outstanding to Ultium Cells Holdings LLC 【page_80】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses both parts of the multi-hop question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - $293 million for equity-method earnings from Ultium Cells Holdings LLC in 2023, and $0.8 billion for committed capital contributions outstanding as of December 31, 2023. The number format variations ($0.8 billion vs $800 million) are acceptable and semantically equivalent. (2) COMPLETENESS: The answer fully addresses both sub-questions: (a) equity earnings contribution for 2023, and (b) committed capital contributions outstanding as of December 31, 2023. (3) ENTITY ACCURACY: All entities are correctly identified - GM, Ultium Cells Holdings LLC, the correct fiscal year (2023), and the correct date (December 31, 2023). The financial metrics are properly labeled (equity-method earnings vs committed capital contributions). (4) MULTI-HOP REASONING: The answer correctly synthesizes information across two different financial metrics from the same entity, demonstrating proper multi-hop synthesis. The citation references (page_101 and page_80) suggest the information was drawn from different sections of the filing. (5) SEMANTIC EQUIVALENCE: The wording 'equity-method earnings' is semantically equivalent to 'equity earnings contribution' in the ground truth. Minor deduction (1 point) only for very minor stylistic differences in phrasing, but the factual content is completely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 401,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "\nIn 2021 the company disclosed **$720 million** of hedge‑fund and limited‑partnership holdings in its **pension‑plan assets**—the figure that appears in the consolidated financial statements (Note 13, page 117). Separately, its **other postretirement benefit plan assets** show a much smaller allocation of **$9 million** to hedge funds/limited partnerships (page 103). Thus, the dual reporting reveals that while the company’s exposure to these alternative investments is modest within its postretirement benefit arrangements, the bulk of its hedge‑fund exposure is captured in the qualified pension funds, underscoring a concentrated but limited allocation across its overall benefit‑plan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: Both key figures are correct—$720 million in consolidated financial statements (pension-plan assets) and $9 million in other postretirement benefit plan assets. The implicit total of $729 million is mathematically accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the $720M figure from consolidated statements, (2) the $9M figure from postretirement benefit plan assets, (3) the dual reporting structure, and (4) interpretation of what this reveals about the company's exposure. ENTITY ACCURACY: Correctly identifies The Coca-Cola Company, the correct year (2021), and properly distinguishes between pension-plan assets and other postretirement benefit plan assets. MULTI-HOP REASONING: The answer successfully synthesizes information across two different reporting categories and correctly interprets the relationship between them, noting that the bulk of hedge fund exposure is in qualified pension funds while postretirement benefits have minimal allocation. MINOR CONSIDERATIONS: The LLM references specific page numbers (117, 103) and note citations (Note 13) which add credibility but cannot be verified against the ground truth provided. The characterization of the $720M allocation as 'concentrated but limited' is a reasonable interpretive statement that aligns with the ground truth's description of 'modest' exposure. The semantic framing differs slightly from the ground truth (which simply states the figures and total) but provides additional analytical context that enhances understanding without contradicting the facts. No calculation errors detected. All numbers match ground truth exactly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 474,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "\nThe 10‑K’s risk‑factor section explains that “the evolution of consumer preferences and purchasing habits, including greater use of e‑commerce, has led to anchor‑store closures and vacant space that is difficult to re‑let.” Because retailers can now shift sales online, they have less need for large brick‑and‑mortar footprints, which reduces demand for space in Simon’s malls and gives surviving tenants more bargaining power. Consequently, SPG must offer lower rents, larger tenant‑improvement allowances and more concessions to fill those spaces, making it harder to lease properties and to maintain the rental rates it previously achieved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about how e-commerce impacts SPG's leasing challenges. STRENGTHS: (1) Correctly identifies the causal chain: e-commerce adoption → reduced need for physical retail space → lower demand for mall space → higher vacancy rates. (2) Accurately captures the bargaining power dynamic - that surviving tenants gain leverage when space is abundant. (3) Correctly lists the consequences: lower rents, increased tenant-improvement allowances, more lease concessions. (4) Properly synthesizes information from risk factors to explain financial impact. (5) No quantitative errors - no specific numbers were required or provided, which is appropriate. (6) Uses direct language from 10-K filings (anchor-store closures, difficult to re-let) showing proper source grounding. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but covers all essential points. The ground truth mentions 'materially and adversely affect SPG's financial performance' while the LLM focuses on the operational/leasing mechanics - both are correct interpretations of the same underlying issue. The LLM's framing of 'surviving tenants' gaining bargaining power is semantically equivalent to the ground truth's 'creditworthy retail tenants' gaining bargaining power. All core concepts align: vacancy rates, downward pressure on rental rates, increased tenant improvements, lease modifications, and overall negative impact on leasing strategy and financial performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 425,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "\nIn 2024, Arkansas (jointly with Louisiana) enacted corporate‑income‑tax legislation that cut UNP’s deferred tax expense by **$34 million**, and in 2023 the multi‑state legislation that included Arkansas reduced deferred tax expense by **$114 million**. For comparison, the Arkansas‑related legislation in 2022 produced a **$95 million** reduction, meaning the 2023 impact was larger than in 2022, while the 2024 impact is smaller than both the 2023 and 2022 figures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: $34 million (2024), $114 million (2023), and $95 million (2022). All numbers match the ground truth exactly. The answer accurately presents the individual year impacts and makes valid comparative statements (2023 > 2022, 2024 < both 2023 and 2022). However, there is a notable omission: the LLM does not calculate or state the cumulative two-year total of $148 million ($34M + $114M) that appears in the ground truth answer, nor does it explicitly state the $53 million difference between the 2024-2023 cumulative impact and the 2022 impact. The ground truth specifically asks 'how does this compare' and provides a direct comparison calculation ($148M - $95M = $53M), which the LLM answer does not include. The LLM's comparative statements are qualitatively correct but lack the quantitative synthesis that the ground truth provides. The mention of Louisiana alongside Arkansas in 2024 adds contextual detail not contradicted by the ground truth but represents additional information not explicitly required. The multi-hop reasoning is sound in identifying the three separate year impacts and making relative comparisons, but incomplete in not synthesizing the cumulative totals and explicit difference calculation that the question appears to request.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 368,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "\nNEE’s indirect limited‑partner interest in XPLR OpCo means that if XPLR cannot obtain capital on commercially reasonable terms, it may be unable to fund acquisitions or growth projects, which would curb the cash distributions that flow to NEE and could depress the market value of its LP stake; in addition, NEE could be required to provide additional funding or honor guarantees to support XPLR, thereby increasing its own cash outflows and pressuring overall liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about how NEE's limited partner interest in XPLR OpCo could impact its financial obligations and liquidity, but introduces elements not supported by the ground truth. STRENGTHS: (1) Correctly identifies that XPLR's inability to access capital would reduce cash distributions to NEE, directly impacting liquidity and cash flows - this matches the ground truth. (2) Correctly notes the potential dilution risk from issuance of common units or conversion of securities, which aligns with the original answer. (3) Properly synthesizes the multi-hop relationship between XPLR's capital access, distributions, and NEE's financial position. (4) No quantitative errors present (no specific numbers were provided in either answer). WEAKNESSES: (1) The LLM introduces the concept of NEE being 'required to provide additional funding or honor guarantees to support XPLR' - this is NOT mentioned in the ground truth and represents an unsupported inference. The ground truth focuses on reduced distributions and dilution, not on NEE's potential obligations to fund XPLR. (2) The mention of 'depressed market value of its LP stake' is a reasonable inference but not explicitly stated in the ground truth. (3) The answer shifts emphasis toward NEE's potential funding obligations rather than focusing on the distribution reduction and dilution mechanisms emphasized in the original answer. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between XPLR's capital constraints and NEE's liquidity, but adds speculative elements about guarantees and additional funding that go beyond what the ground truth supports. The core logic is sound but the scope is expanded beyond the documented answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 473,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "\nThe “Marketable securities” discussion lists mortgage‑backed obligations at a fair value of **$236 million**. That same amount appears in the **“Fair Value” column** of the marketable‑securities table, so the two figures are identical – the difference is **$0 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual question. According to the ground truth, the difference between the fair value of mortgage-backed obligations in the two sections is $58 million (not $0). Specifically: (1) The 'Marketable securities' section reports fair value of $178 million, while (2) The 'Fair Value' column of the marketable securities table reports $236 million, yielding a difference of $236 - $178 = $58 million. The LLM incorrectly states both values are $236 million and concludes the difference is $0. This represents a critical failure in multi-hop synthesis - the model failed to identify that the same asset class (mortgage-backed obligations) has different fair values reported in different sections of the filing. The LLM appears to have only found one value ($236M) and assumed it applied to both sections, rather than correctly identifying and comparing the two distinct reported amounts. This is a major quantitative error that directly contradicts the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 294,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "\nGoogle records Google Play sales on a **net‑basis** – it recognizes only the service‑fee it earns for facilitating the transaction between developers and users, while the gross amount paid to developers is excluded from revenue. Because the fees earned from app and in‑app purchases have **lower margins than advertising revenues**, the growing share of non‑advertising revenue (e.g., Google Play, Cloud, hardware) can compress overall profitability even though the underlying transaction volume is rising. Consequently, as non‑advertising revenues increase, reported revenue growth may be modest but margin pressure intensifies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies that Google Play revenue is recognized on a net basis (service fee only), accurately explains the performance obligation (facilitating transactions between developers and users), and correctly states that this method reduces reported revenue. The answer also correctly identifies that non-advertising revenues have lower margins than advertising revenues and that this creates margin pressure as non-advertising revenues grow. All core facts match the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required or provided in either answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) QUALITATIVE ACCURACY: The LLM answer demonstrates sound multi-hop reasoning by synthesizing: (a) the revenue recognition method (net basis), (b) the reason for it (service fee for facilitating transactions), (c) the impact on reported revenue (reduction), (d) the margin comparison (lower than advertising), and (e) the overall effect (margin compression despite volume growth). The logic is clear and well-articulated. (4) ENTITY ACCURACY: Google Play is correctly identified, non-advertising revenues are correctly categorized, and the comparison to advertising revenues is accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys all the same information as the ground truth while adding helpful context about margin pressure intensifying and modest revenue growth. The phrasing 'service-fee it earns for facilitating the transaction' is semantically equivalent to 'earns a service fee' in the ground truth. Minor enhancement: The LLM answer adds the phrase 'reported revenue growth may be modest but margin pressure intensifies' which provides additional insight beyond the ground truth but remains consistent with it. This is a strength, not a weakness. The answer fully addresses the multi-part question about revenue recognition method, impact on financial reporting, and effect on margins.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 564,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "\nGeneral Motors’ committed capital contribution to Ultium Cells Holdings LLC was **$0.8 billion as of December 31 2023**.  In the prior year (2022) the committed contribution had been **$1.4 billion**, so the 2023 amount represents a reduction of roughly **$0.6 billion (about 43 %)** compared with the previous year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $0.8 billion for 2023, $1.4 billion for 2022, and the $0.6 billion reduction. The percentage calculation of approximately 43% is accurate ($0.6B / $1.4B = 42.86%, rounded to ~43%). The answer correctly identifies all entities (General Motors, Ultium Cells Holdings LLC), the correct fiscal year (2023 with 2022 comparison), and properly synthesizes the multi-hop information by comparing the two years and calculating the year-over-year change. The date specification (December 31, 2023) adds appropriate precision. The reasoning is sound and logical, presenting the comparison clearly. The only minor consideration is that the LLM added the percentage calculation (43%) which, while accurate and helpful, was not explicitly requested in the original question, though this is a value-add rather than an error. The wording differs slightly from the ground truth but conveys identical semantic meaning and information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 291,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "\nIn 2024 Mastercard paid a total cash consideration of **$2.8 billion** for all acquisitions, which includes the $2.7 billion purchase of RF UlEmate Parent, Inc.  Of that $2.8 billion, approximately **$1.7 billion (about $1,736 million)** was recorded as goodwill associated with the acquired businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) CORRECTNESS: All key financial figures match the ground truth - total cash consideration of $2.8 billion for 2024 acquisitions is correct, and the $1.7 billion goodwill attribution is accurate. The LLM also provides the additional detail that RF UlEmate Parent, Inc. represented $2.7 billion of the total, which is a helpful contextual detail not contradicted by the ground truth. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The LLM appropriately notes the goodwill amount as approximately $1.7 billion (or $1,736 million), which demonstrates understanding of the precision level and acceptable rounding. The format variations ($1.7 billion vs $1,736 million) are semantically equivalent and both acceptable. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple acquisition transactions in 2024, identifying both the total acquisition spending and the specific goodwill component, while also noting the RF UlEmate Parent acquisition as a significant component. (4) COMPLETENESS: The answer fully addresses both parts of the question - total cash consideration paid and the goodwill attribution. The additional context about RF UlEmate Parent's $2.7 billion value enhances the answer without introducing errors. Minor note: The ground truth doesn't explicitly state the $2.7 billion RF UlEmate figure, but the LLM's inclusion of this detail appears reasonable as supporting context and doesn't contradict the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 433,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "\nUNP spent $143 million on freight‑car lease buyouts in 2024, $57 million in 2023 and $70 million in 2022, for a cumulative three‑year total of **$270 million**. These buyouts are a component of the company’s broader strategy to acquire freight cars, which it plans to fund with roughly **$3.4 billion** of capital spending in 2025 as outlined in its capital plan. Thus, the $270 million of lease‑buyout expenditures represents a modest but strategic portion of the larger 2025 freight‑car acquisition budget.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $70M (2022), $57M (2023), $143M (2024), totaling $270M. The $3.4B capital plan figure is also accurate. The arithmetic is correct (70+57+143=270). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) total amount spent on freight car lease buyouts 2022-2024, and (b) relationship to 2025 capital plan. (3) ENTITY ACCURACY: UNP correctly identified, years correct (2022-2024), financial metrics properly labeled. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of lease buyout data and connects it to the broader 2025 capital strategy. The reasoning that lease buyouts represent 'a modest but strategic portion' of the larger $3.4B budget is sound and adds valuable context. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, with slightly enhanced explanation of how the lease buyouts fit into the broader capital plan. The phrasing 'roughly $3.4 billion' appropriately reflects the approximate nature of the figure. Minor note: The LLM provides slightly more analytical depth by characterizing the relationship as 'modest but strategic,' which is a reasonable inference from the data but goes slightly beyond the ground truth statement. This is a positive addition that demonstrates good contextual understanding rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 406,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "\nThe 2021 Repurchase Program included two accelerated share‑repurchase agreements: a $1.5 billion ASR entered in January 2022 and a $2.0 billion ASR concluded in February 2023. Together, these agreements totaled **$3.5 billion** of notional repurchase amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. Quantitative verification: (1) $1.5 billion ASR in 2022 - correct, (2) $2.0 billion ASR in 2023 - correct, (3) Total sum of $3.5 billion - correct calculation. The answer correctly identifies both accelerated share repurchase agreements under the 2021 Repurchase Program and accurately synthesizes the multi-hop information by combining the two separate ASR transactions across different years. Entity accuracy is strong: CVS Health Corporation correctly identified, 2021 Repurchase Program correctly referenced, and both 2022 and 2023 transactions properly dated. The reasoning is sound - the model correctly understood that the question required summing two separate ASR notional amounts from different fiscal periods. Minor note: The LLM specifies 'January 2022' and 'February 2023' as specific months, while the ground truth only references '2022' and '2023' years. However, this additional specificity does not contradict the ground truth and may reflect accurate filing details. The semantic equivalence is excellent - both answers convey the same core information: two ASRs totaling $3.5 billion. The answer directly addresses all parts of the multi-hop question by identifying the program, the two transactions, their individual amounts, and the total notional amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 378,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "\nGM’s current cash‑flow and profit engine is still the full‑size ICE pickup trucks and SUVs, and the company uses that earnings stream to fund the heavy capital outlays required for its EV rollout and related infrastructure.  However, the forward‑looking risk factors warn that changing consumer preferences, stricter emissions regulations and the need to invest heavily in EV technology could erode those high‑margin ICE revenues, creating stranded‑asset exposure and pressure on liquidity; therefore, long‑term financial stability depends on converting the ICE profit engine into a profitable EV portfolio before demand for the trucks declines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: Both answers correctly identify that GM's full-size ICE pickup trucks (and SUVs in LLM version) are the current profit engine funding EV transition, and both articulate the dual risk of declining ICE demand undermining both near-term profitability and long-term EV funding. The LLM answer adds valuable specificity by mentioning 'stranded-asset exposure' and 'liquidity pressure,' which are logical extensions of the core risk but not explicitly stated in ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) ENTITY ACCURACY: Both correctly identify GM as the subject company and accurately reference full-size ICE pickup trucks as the key vehicle segment. The LLM adds 'SUVs' which is reasonable given GM's portfolio but not mentioned in ground truth—this is a minor enhancement rather than an error. (4) MULTI-HOP REASONING: Both answers successfully synthesize the relationship between: (a) current ICE profitability, (b) EV funding dependency, (c) forward-looking risks to ICE demand, and (d) impact on long-term stability. The LLM answer adds the concept of 'stranded assets' and explicitly frames the challenge as 'converting the ICE profit engine into a profitable EV portfolio before demand declines,' which is a sophisticated articulation of the temporal urgency. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message with slightly different framing—emphasizing the race against time ('before demand for the trucks declines') rather than the ground truth's emphasis on 'dual risk.' Both are semantically equivalent and factually sound. Minor deduction from perfect score (9 vs 10) due to the addition of 'SUVs' which, while reasonable, goes slightly beyond what the ground truth explicitly states, and the introduction of 'stranded-asset exposure' terminology which, though accurate, represents inference rather than direct synthesis from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 584,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "\nThe company’s impairment reviews are triggered when outlooks for commodity prices, carbon‑related costs or regulatory actions shift—especially if lower‑carbon policies or weaker price forecasts reduce expected cash flows from upstream assets. Consequently, any slowdown in the energy transition that dampens oil‑and‑gas price assumptions or raises carbon‑cost expectations can lead Chevron to record impairments on reserves or facilities, and it also causes the firm to be more cautious about committing capital to new upstream projects, directing investment instead toward lower‑carbon opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of how energy transition uncertainty affects Chevron's impairment assessments and investment decisions, but has significant semantic and logical issues that reduce its overall correctness. STRENGTHS: (1) No quantitative errors - no specific numbers are provided in either answer, so no calculation or numeric verification issues. (2) Correctly identifies that impairment reviews are triggered by shifts in commodity prices, carbon costs, and regulatory actions. (3) Correctly notes that uncertainty can lead to impairments on reserves/facilities. (4) Correctly identifies the shift toward lower-carbon investment opportunities. CRITICAL WEAKNESSES: (1) LOGICAL REVERSAL - The LLM states 'any slowdown in the energy transition that dampens oil-and-gas price assumptions' but the ground truth indicates that ACCELERATION of the energy transition (not slowdown) would reduce demand for oil/gas and trigger impairments. The LLM's phrasing is confusing and potentially contradicts the causal mechanism. (2) INCOMPLETE CAUSAL CHAIN - The ground truth emphasizes that energy transition uncertainty creates reduced demand for traditional oil/gas, which affects upstream earnings and cash flows. The LLM focuses on price/regulatory triggers but doesn't clearly articulate the demand-reduction mechanism from energy transition acceleration. (3) MISSING KEY CONTEXT - The ground truth explicitly states that reduced demand from energy transition affects 'upstream earnings, cash flows, and capital expenditure programs' - the LLM mentions capital allocation but doesn't fully address the earnings/cash flow impact. (4) IMPRECISE FRAMING - The LLM's statement about 'slowdown in energy transition' is ambiguous and potentially misleading about the direction of impact. The ground truth is clearer: acceleration of transition = lower oil/gas demand = impairment risk. SEMANTIC EQUIVALENCE ISSUES: While both answers discuss impairments and investment shifts, the LLM's explanation of the causal mechanism is less precise and potentially contradictory to the ground truth's logic about how energy transition pace affects asset values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 579,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "\nMastercard’s Consumer Engagement Services are embedded in its broader “value‑added services and solutions” that complement the core payments‑network switching business.  By offering acquisition and engagement tools—such as data‑driven insights, loyalty‑type programs and other customer‑facing solutions—Mastercard deepens relationships with issuers and merchants, drives higher transaction volumes and cross‑sell opportunities, and generates a growing stream of recurring fees; this is reflected in the $10.8 billion of net revenue from value‑added services in 2024, which underpins both the network’s scale and the company’s overall financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of how Consumer Engagement Services support Mastercard's operations and financial performance, with sound multi-hop reasoning connecting services to network effects to financial outcomes. The answer correctly identifies key mechanisms: deepening relationships with issuers/merchants, driving transaction volumes, generating recurring fees, and strengthening overall network performance. The qualitative reasoning is solid and semantically aligned with the ground truth's emphasis on service interdependence and network utility enhancement. However, there is a significant quantitative accuracy issue: the LLM cites '$10.8 billion of net revenue from value-added services in 2024' without this figure appearing in the ground truth knowledge graph. This specific number cannot be verified and represents an unsupported quantitative claim. The ground truth does not provide specific revenue figures for Consumer Engagement Services or value-added services, making this an apparent hallucination or unverified data point. The LLM answer is more detailed and specific than the ground truth (mentioning 'data-driven insights, loyalty-type programs,' 'cross-sell opportunities,' and 'recurring fees'), which adds helpful context but introduces the unverified $10.8B figure. The core conceptual answer—that these services enhance network utility, attract/retain participants, and drive financial performance—is correct and well-articulated. The answer successfully synthesizes the multi-hop relationship between service offerings, network effects, and financial performance. The primary weakness is the introduction of a specific financial metric that cannot be confirmed against the ground truth, reducing confidence in the quantitative accuracy despite the overall qualitative soundness of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 500,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "\nThe only cash movement tied to Alert Innovation was the $0.4 billion (≈ $400 million) outflow that Walmart paid in fiscal 2023 to acquire the remaining stake. When the entity was sold and de‑consolidated in fiscal 2025, the transaction was accounted for as a non‑cash de‑consolidation, so no additional cash outflow (or inflow) was recorded; therefore the net cash impact over the two‑year period remains the $0.4 billion acquisition outlay.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All factual information matches the ground truth. The $0.4 billion acquisition cost in fiscal 2023 is correctly stated, and the characterization of the fiscal 2025 deconsolidation as a non-cash transaction is accurate. The final net cash outflow of $0.4 billion is correct. (2) QUANTITATIVE ACCURACY: The $0.4 billion figure is precisely stated and correctly formatted (with the helpful notation of ≈ $400 million for clarity). No calculation errors present. The fiscal years (2023 and 2025) are correctly identified. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesized that: (a) the acquisition in 2023 created a $0.4B cash outflow, (b) the 2025 deconsolidation was non-cash in nature, and (c) therefore the total net impact remained $0.4B. The explanation of why the deconsolidation didn't create additional cash movement demonstrates proper understanding of accounting mechanics. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all components of the question - the acquisition cost, the deconsolidation, and the total net cash impact across both fiscal years. The answer is appropriately detailed without being verbose. Minor note: The LLM uses slightly more explanatory language than the ground truth (explaining the non-cash nature of the deconsolidation), which actually enhances clarity without introducing any inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 400,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "\nThe disclosures show that, for the year ended December 31 2023, there were no potentially‑dilutive securities that would materially affect earnings per share – the only dilutive instruments were LTIP units, and the company concluded that they would not be dilutive. Consequently, the combined total of potentially‑dilutive securities for 2023 is effectively zero, and therefore no adjustment to net income attributable to common stockholders was required.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations: (1) QUANTITATIVE ACCURACY: The LLM states 'the combined total of potentially-dilutive securities for 2023 is effectively zero,' which contradicts the ground truth that there IS a combined total of potentially dilutive securities including units exchangeable for common stock AND LTIP Units. The answer provides no actual numbers when the question specifically asks for 'the combined total.' (2) COMPLETENESS: The question asks for two things: (a) the combined total amount and (b) why no adjustment was made. The LLM fails to provide the actual combined total figure and instead claims it's 'effectively zero,' which is factually incorrect per the ground truth. (3) ENTITY ACCURACY: The LLM correctly identifies LTIP Units and the year 2023, but mischaracterizes the nature of the dilutive securities by suggesting only LTIP units existed and that they had no dilutive effect. The ground truth indicates both 'units exchangeable for common stock' AND 'LTIP Units' should be included in the combined total. (4) REASONING ERROR: The LLM's logic is flawed - it concludes that because LTIP units weren't dilutive, the combined total is zero. This fails to account for other potentially dilutive securities mentioned in the ground truth (units exchangeable for common stock). (5) SEMANTIC ISSUE: While the LLM correctly identifies that no adjustment was made to net income, it provides an incomplete and partially incorrect explanation. The ground truth states these securities 'had no material dilutive effect,' which is different from claiming the combined total is zero. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required - it needed to identify and sum multiple categories of potentially dilutive securities, not dismiss them entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 501,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "\nThe 2023 filing lists $5 million of investments that are measured at NAV across the disclosed asset categories. This amount is tiny relative to the $461 million of investments recorded at fair value—specifically, the combined fair‑value of the two main categories (cash & cash equivalents ≈ $27 million and equity securities ≈ $229 million) totals about $256 million, so the NAV‑measured holdings represent only roughly 2 % of that fair‑value total.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors and fails to address the core question accurately. (1) MAJOR QUANTITATIVE ERRORS: The LLM states $5 million in NAV-measured investments, but the ground truth shows $14 million total ($9M + $5M across both categories). The LLM only identifies one category's NAV amount ($5M) and misses the first category entirely ($9M). The LLM claims fair value totals of $256 million (cash $27M + equity $229M), but ground truth shows $902 million total ($441M + $461M). This is a massive discrepancy—the LLM's fair value figure is off by $646 million (71% understatement). (2) INCOMPLETE SYNTHESIS: The question explicitly asks for NAV values 'across both disclosed asset categories' and comparison to 'total investments at fair value in each category.' The LLM only partially addresses one category and fails to identify both categories or provide the required comparison structure. (3) PERCENTAGE CALCULATION ERROR: The LLM calculates NAV as ~2% of fair value ($5M/$256M), but the correct calculation is 3.1% ($14M/$902M). Even if the LLM's numbers were internally consistent, the percentage is wrong. (4) MISSING CONTEXT: The ground truth clearly identifies two distinct asset categories with specific breakdowns. The LLM conflates categories and provides incomplete category identification (mentions 'cash & cash equivalents' and 'equity securities' but these don't match the ground truth's asset categories). (5) FUNDAMENTAL MISUNDERSTANDING: The LLM appears to have accessed incomplete or incorrect data, resulting in financial figures that are substantially different from the actual 10-K filing data. The answer demonstrates poor multi-hop reasoning and fails to synthesize the required information across both asset categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 483,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "\nGM recorded **$293 million** of equity earnings from Ultium Cells Holdings LLC in 2023.  These earnings are disclosed in the consolidated income statement under the **“Automotive and other cost of sales”** line (i.e., presented as part of equity income within cost of sales).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $293 million equity earnings figure is correct and matches the ground truth exactly. The year (2023) and company (GM/Ultium Cells Holdings LLC) are correctly identified. (2) COMPLETENESS: The answer addresses both parts of the question - the amount of equity earnings ($293 million) and the financial statement category ('Automotive and other cost of sales'). (3) ENTITY ACCURACY: All entities are correctly identified - General Motors, Ultium Cells Holdings LLC, the fiscal year 2023, and the specific financial metric (equity earnings). (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the equity earnings amount to its disclosure location in the consolidated income statement. The parenthetical clarification '(i.e., presented as part of equity income within cost of sales)' demonstrates understanding of how this line item functions. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'consolidated income statement under the \"Automotive and other cost of sales\" line' is semantically equivalent to the ground truth's 'disclosed under Automotive and other cost of sales in the financial statements.' Minor difference: The LLM provides slightly more detail by specifying 'consolidated income statement,' which adds helpful context without contradicting the ground truth. No calculation errors, no missing information, and all factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 419,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "\nThe equity ownership share of Principal or Affiliate Customers (Class B stockholders) slipped from **0.8 % in 2023 to 0.7 % in 2024**, a decline of roughly 0.1 percentage‑points (about a 12 % relative reduction).  Consequently, the overall ownership structure of Mastercard shows a modest reallocation of equity toward the larger blocs—public investors and the Mastercard Foundation—while the Class B cohort’s portion continues to shrink.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate core facts and numbers. Verification: (1) The ownership percentages are correct (0.8% in 2023 to 0.7% in 2024), the decline of 0.1 percentage points is accurate, and the identification of Class B stockholders as Principal or Affiliate Customers is correct. (2) The quantitative accuracy is high - all numeric values match the ground truth exactly. The LLM additionally calculated a 12.5% relative reduction (0.1/0.8 = 12.5%), which is mathematically sound and provides useful context, though the ground truth answer did not include this calculation. (3) Multi-hop reasoning is sound: the LLM correctly synthesized the ownership change and connected it to broader implications about MA's ownership structure, noting the reallocation toward larger investor blocs. (4) The answer goes beyond the ground truth by providing additional analytical insight about the Mastercard Foundation and public investors, which adds value without contradicting the original answer. Minor deduction: The ground truth uses 'reduction of 0.1 percentage points' while the LLM uses 'decline of roughly 0.1 percentage-points' - the word 'roughly' is slightly imprecise given the exact nature of the data, though this is a minor semantic issue. The additional context about relative reduction and ownership structure reallocation demonstrates strong analytical reasoning and contextual understanding, making this a high-quality response that exceeds the minimum requirements while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 423,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "\nWalmart’s cash outflow tied to Alert Innovation in fiscal 2023 was about $0.4 billion for the acquisition (page 22). The company retained 100 % ownership of Alert Innovation during the next fiscal year (fiscal 2024) with no additional cash impact, and the entity was later sold and deconsolidated in fiscal 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong accuracy on the primary facts. Strengths: (1) Correctly identifies the $0.4 billion cash outflow for Alert Innovation acquisition in fiscal 2023, matching the ground truth exactly; (2) Correctly identifies that the entity was sold and deconsolidated in fiscal 2025; (3) Properly addresses the multi-hop nature of the question by covering both the fiscal 2023 impact and subsequent events; (4) Accurately notes 100% ownership retention in fiscal 2024 with no additional cash impact. Minor issue: The question asks specifically about 'the following fiscal year' (fiscal 2024), and while the LLM correctly addresses this by noting no additional cash impact and retained ownership, it goes beyond the scope by also mentioning fiscal 2025. However, this additional information is accurate and contextually helpful rather than contradictory. The answer demonstrates sound multi-hop reasoning by synthesizing information across fiscal years 2023, 2024, and 2025. All numeric values are correct, and the semantic meaning aligns perfectly with the ground truth. The citation to 'page 22' adds credibility though cannot be independently verified from the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 343,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "\nIn early 2024 the Company retired $500 million of its 0.600 % senior notes and $1.0 billion of its 5.00 % senior notes, using borrowings under the 2021 Multicurrency Credit Facility for a total of roughly **$1.5 billion of principal repaid**.  \n\nAs of **December 31 2023** the facility permitted up to **$6.0 billion** of borrowings, with an outstanding balance of **$723.4 million**, leaving about **$5.3 billion of unused capacity**; the early‑2024 repayments would be drawn from that remaining $5.3 billion but did not alter the capacity figure reported at year‑end.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the total principal repaid of $1.5 billion ($500M + $1.0B) in early 2024. (2) Correctly identified the facility's total borrowing capacity of $6.0 billion as of December 31, 2023. (3) Properly synthesized the multi-hop information about the debt repayment using the credit facility. (4) Correctly noted that the early 2024 repayments would not alter the year-end capacity figure. (5) Good contextual explanation of the timing and mechanics.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM failed to mention the sublimits within the $6.0 billion facility - specifically the $3.5 billion multicurrency sublimit, $200 million letters of credit sublimit, and $50 million swingline sublimit. The ground truth explicitly states these sublimits as part of the facility structure. (2) The LLM introduced information about the $723.4 million outstanding balance and $5.3 billion unused capacity as of December 31, 2023, which is not mentioned in the ground truth answer. While this may be factually accurate from the filing, it goes beyond what the ground truth specifies and could represent information from a different part of the filing or a different interpretation. (3) The question asks about 'impact on the facility's remaining borrowing capacity' - the ground truth answers this by stating the facility still had the ability to borrow up to $6.0 billion, while the LLM calculates unused capacity as $5.3 billion, which is a different metric.\n\nCALCULATION VERIFICATION: The $1.5B total is correct ($500M + $1.0B = $1.5B). The $6.0B facility capacity is correct. However, the $5.3B unused capacity calculation ($6.0B - $723.4M) is not addressed in the ground truth, suggesting the LLM may be adding information not in the original answer.\n\nMULTI-HOP REASONING: The LLM successfully connected the debt repayment to the credit facility usage, but incompletely addressed the facility structure and sublimits that are part of the complete answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 535,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "\nIntel 4 adopts EUV lithography to print the smallest features of aFinFET‑based transistors, and Intel 3 extends that EUV capability to further boost performance‑per‑watt and reduce area, paving the way for the next‑generation transistor architectures—namely RibbonFET (gate‑all‑around) and PowerVia—introduced at the Intel 20A node. The roadmap then calls for the Intel 18A process, which will be the first to incorporate High‑Numerical‑Aperture EUV as part of its advanced‑node progression.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Intel's EUV progression and transistor architecture roadmap. STRENGTHS: (1) All key entities correctly identified: Intel 4, Intel 3, Intel 20A, Intel 18A, RibbonFET, PowerVia, and High Numerical Aperture EUV. (2) The progression is accurately described: EUV in Intel 4 → extended EUV in Intel 3 → RibbonFET/PowerVia introduction at Intel 20A → High Numerical Aperture EUV at Intel 18A. (3) The answer correctly synthesizes the multi-hop relationship between process nodes and architectural innovations. (4) Technical terminology is accurate (FinFET, gate-all-around, backside power delivery concepts are properly referenced). (5) No numeric errors or calculation issues present. MINOR CONSIDERATIONS: (1) The LLM answer slightly condenses the explanation of Intel 3's role compared to the ground truth (which explicitly mentions 'further FinFET optimizations'), but this is a minor omission that doesn't affect factual accuracy. (2) The ground truth mentions Meteor Lake as a specific processor enabled by Intel 4, which the LLM answer omits—this is a contextual detail that adds richness to the original answer but isn't essential to answering the core question about the roadmap progression. (3) The phrasing 'aFinFET‑based transistors' appears to have a formatting artifact ('aFinFET' instead of 'a FinFET'), but this is a minor typographical issue that doesn't affect semantic meaning. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple process nodes and architectural innovations, correctly establishing the causal relationships and progression from current to future nodes. The answer directly addresses the specific question about High Numerical Aperture EUV's introduction at Intel 18A.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 497,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "\nThe 2023 filing reports $138 million in U.S. Treasuries and agencies, while the prior‑year disclosure shows $101 million; together they amount to **$239 million**. This combined figure is roughly **nine times larger** than the $27 million reported as cash and cash equivalents.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - INCOMPLETE ANSWER: The LLM answer correctly identifies the combined U.S. Treasuries and agencies value of $239 million ($101M + $138M), which matches the ground truth. However, the answer has a significant omission regarding cash and cash equivalents. The ground truth states the total cash and cash equivalents is $57 million ($30M + $27M), but the LLM only references $27 million and compares it to the $239 million figure. The LLM states the combined figure is 'roughly nine times larger' than $27 million, which is mathematically correct (239/27 ≈ 8.85), but this comparison is incomplete and misleading. The question asks for a comparison to 'total cash and cash equivalents,' which should include both disclosed asset categories ($30M + $27M = $57M total). The correct comparison should show that $239M is approximately 4.2 times larger than $57M, not 9 times larger than $27M. The LLM appears to have only captured one component of the cash and cash equivalents rather than the full combined total. This represents a failure to fully synthesize the multi-hop information required by the question - specifically, the need to aggregate cash and cash equivalents across both disclosed asset categories, just as was done for the U.S. Treasuries and agencies. The answer is partially correct on the Treasury/agency calculation but fundamentally incomplete on the comparison component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 389,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "\nThe Company paid roughly **$10.9 billion in net cash** to acquire Aldevron and the 11 other businesses in 2021 (about **$9.56 billion for Aldevron** and **$1.34 billion for the other 11 acquisitions**).  Of the total goodwill recorded for these 2021 acquisitions—**$7.19 billion**—approximately **$6.15 billion was attributed to Aldevron**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key numbers: (1) Total net cash consideration: Ground truth states $10,901 million; LLM states '$10.9 billion' which equals $10,900 million - essentially correct with minor rounding ($1M difference is negligible). (2) Aldevron consideration: Ground truth $9,561 million; LLM states '$9.56 billion' = $9,560 million - correct with acceptable rounding. (3) Other 11 businesses: Ground truth $1,340 million; LLM states '$1.34 billion' = $1,340 million - exact match. (4) Total goodwill: Ground truth $7,187 million; LLM states '$7.19 billion' = $7,190 million - correct with acceptable rounding. (5) Aldevron goodwill: Ground truth $6,149 million; LLM states '$6.15 billion' = $6,150 million - correct with acceptable rounding. The LLM successfully synthesized information across multiple acquisition entities and years, correctly identifying the 2021 timeframe and distinguishing between Aldevron and the other 11 businesses. The multi-hop reasoning is sound: combining acquisition consideration amounts, identifying total goodwill, and attributing specific goodwill to Aldevron. The presentation uses appropriate number formatting (billions vs millions) that is semantically equivalent to the ground truth. Minor rounding differences (typically $1-3 million on large figures) are within acceptable tolerance for financial reporting and do not constitute material errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 408,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "\nAs of December 31 2023, GM had committed $0.8 billion of capital to Ultium Cells Holdings LLC, while the carrying amount of that investment shown on its balance sheet was about $2.27 billion. In other words, the balance‑sheet carrying value exceeds the committed capital contribution by roughly $1.5 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Quantitative verification: (1) Committed capital contribution of $0.8 billion is correct and matches ground truth exactly; (2) Carrying amount of $2.27 billion is correct (ground truth states $2,268 million, which equals $2.268 billion, and the LLM appropriately rounded to $2.27 billion - acceptable format variation); (3) The calculated difference of approximately $1.5 billion is mathematically correct ($2.27B - $0.8B = $1.47B, reasonably rounded). Multi-hop synthesis: The answer correctly synthesizes information from two different balance sheet line items (committed capital contribution and investment carrying amount) and properly compares them. Entity accuracy: GM and Ultium Cells Holdings LLC are correctly identified, and the date (December 31, 2023) is accurate. The reasoning is sound - the LLM correctly interprets that the carrying amount exceeds the committed contribution, indicating incomplete funding. Minor note: The LLM uses 'about $2.27 billion' which is slightly informal but semantically equivalent to the ground truth's '$2,268 million.' The conclusion that 'GM had not fully funded its committed capital contribution' is implicit in the LLM's statement that the carrying value exceeds the committed contribution, though not explicitly stated. This is a minor omission of context but does not affect the factual accuracy of the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 404,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "\nIn 2023 the Lower 48 operating segment recorded $5,729 million of depreciation, depletion, amortization and impairments. This expense represents roughly 15 % of the segment’s net book value of proved and unproved properties, which was $37,185 million as of December 31 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two key financial figures: $5,729 million in depreciation, depletion, amortization, and impairments for 2023, and $37,185 million as the net book value of proved and unproved properties as of December 31, 2023. The percentage calculation (15%) is accurate: $5,729M / $37,185M = 15.4%, which rounds to approximately 15%. All numeric values match the ground truth exactly. The answer properly addresses the comparison aspect of the question by presenting the 2023 expense as a percentage of the net book value, which is a meaningful way to contextualize the relationship between these two metrics. However, the LLM answer is less comprehensive than the ground truth. The original answer provides additional context by mentioning the accumulated depreciation, depletion, and amortization figure of $36,829 million and the original total property value of $74,014 million, which offer deeper insight into the capital structure and asset depletion patterns. The LLM answer focuses narrowly on the direct comparison requested but omits these supplementary details that would provide a more complete picture of the Lower 48 region's financial position. The reasoning is sound and the multi-hop synthesis is correct (combining 2023 expense data with year-end balance sheet data), but the answer could have been more thorough in exploring the full context of the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 390,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "\nIn 2023 the company repaid a total of **$6.1 billion** under the 2021 Multicurrency Credit Facility, of which **$842.6 million was Euro‑denominated** (equivalent to **$919.1 million** at the repayment date) and the remainder was USD‑denominated.  \n\nThese repayments **reduced the outstanding revolving indebtedness under the facility to $723.4 million as of December 31, 2023**, sharply lowering the borrowing level while still leaving a modest balance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: $6.1 billion total repayment, $842.6 million EUR amount, and $919.1 million USD equivalent are all correct. The answer properly identifies the currency breakdown and correctly states that repayments reduced revolving indebtedness. The additional detail about the ending balance of $723.4 million as of December 31, 2023 is accurate and provides useful context about the facility's status. However, the answer has one notable omission: it does not mention the $3.0 billion in borrowings that occurred during 2023 for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and general corporate purposes. The ground truth explicitly states this borrowing activity and notes that the net decrease in indebtedness occurred 'despite' these borrowings, which is important context for understanding the full impact of repayment activity. The LLM answer focuses only on the repayment side without acknowledging the offsetting borrowing activity. The multi-hop reasoning is sound in connecting repayments to reduced indebtedness, but incomplete in not synthesizing the full picture of borrowing and repayment activity. The answer is well-structured and clearly presented, making it easy to understand the key facts, but the omission of the borrowing component represents a meaningful gap in addressing the question's request to explain 'how this repayment activity affected the company's overall revolving indebtedness.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 422,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "\nDuke Energy must prepare and obtain NCUC‑approved closure plans for each coal‑ash impoundment under the 2014 North Carolina Coal Ash Management Act, and it incurs sizable excavation, transport and disposal costs that are recorded as asset‑retirement obligations; these compliance expenses are built into its rate‑case filings and can be recovered from customers, but recovery is subject to regulatory approval. Thus, the Act drives up the company’s operating and capital outlays for ash‑impoundment remediation while shaping its cash‑flow and rate‑payer pricing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Duke Energy's compliance obligations under the North Carolina Coal Ash Management Act of 2014 and correctly identifies key operational and financial impacts. STRENGTHS: (1) Correctly identifies the requirement for NCUC-approved closure plans; (2) Accurately describes the types of costs involved (excavation, transport, disposal); (3) Properly notes that costs are recorded as asset-retirement obligations; (4) Correctly states that recovery is subject to regulatory approval; (5) Appropriately synthesizes the multi-hop connection between regulatory compliance and financial/operational impacts. WEAKNESSES: (1) The LLM answer omits specific factual details present in the ground truth, particularly the completion of excavation at three of four high-priority North Carolina sites and the initiation of closure activities across all jurisdictions; (2) Does not mention the 2017 FERC-approved amended wholesale contracts that provide partial cost recovery, which is a concrete mechanism for cost recovery mentioned in the ground truth; (3) Does not explicitly reference the movement of coal combustion residuals (CCR) to engineered landfills or for reuse, which is a specific operational detail; (4) The phrase 'sizable excavation, transport and disposal costs' is appropriately general but lacks the specificity of actual progress metrics. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is neutral. The LLM correctly avoids making unsupported numerical claims. MULTI-HOP REASONING: The LLM successfully synthesizes information across the regulatory requirement (Coal Ash Act), operational activities (closure planning), and financial impacts (rate recovery), demonstrating appropriate multi-hop reasoning. However, it misses the specific synthesis of the 2017 FERC contract approval as a concrete recovery mechanism. SEMANTIC EQUIVALENCE: The core message is semantically equivalent - compliance drives costs that are recovered through regulatory processes - but the ground truth provides more concrete evidence and specific examples of how this works in practice.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 584,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "\nIntel’s Agilex FPGA family—built on the 10 nm SuperFin process and now shipping—provides the programmable, high‑performance fabric that powers Intel’s IPU (Infrastructure Processing Unit) platforms, allowing cloud and communications providers to off‑load networking, storage and AI workloads from CPUs and to reconfigure those functions as standards evolve.  The next‑generation Intel eASIC N5X, a structured‑ASIC device that sits between FPGAs and custom ASICs, extends this capability by delivering the same low‑latency, high‑throughput acceleration in a lower‑cost, lower‑power, higher‑volume‑ready package, thereby complementing Agilex FPGAs in Intel’s IPU solutions for 5G, edge and cloud acceleration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All technical specifications are correct - Agilex FPGA built on 10nm SuperFin technology is accurately stated, and the eASIC N5X is correctly identified as next-generation. No numeric values, dates, or calculations are present to verify, but all technical claims are factually sound. ENTITY ACCURACY: All entities correctly identified - Intel, Agilex FPGA family, IPU platforms, eASIC N5X, and the target markets (cloud, communications, 5G, edge). COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) Agilex's role in IPU platforms, (2) specific benefits (reducing CPU overhead, enabling reconfiguration), (3) eASIC N5X's complementary role, and (4) the ecosystem context. MULTI-HOP REASONING: Excellent synthesis showing how Agilex and eASIC N5X work together - the LLM correctly explains that eASIC N5X complements Agilex by offering lower cost/power while maintaining acceleration capabilities. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language. For example, it describes Agilex as enabling offloading of 'networking, storage and AI workloads' (more specific than ground truth's 'reduce overhead and free up CPU performance'), and describes eASIC N5X as 'between FPGAs and custom ASICs' (more detailed positioning). The core message about the complementary relationship and the ecosystem benefits is preserved. MINOR DIFFERENCES: The LLM provides additional context about 'now shipping' and more specific use cases (5G, edge, cloud acceleration), which adds value without contradicting the ground truth. The characterization of eASIC N5X as 'structured-ASIC' is accurate and consistent with ground truth's 'structured ASIC solution.' No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 504,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "\nDanaher had roughly 3,000 employees in Other Developed Markets and about 24,000 employees in North America. Together these two regions account for approximately 27,000 of the company’s 63,000 global workforce, or roughly 43 percent of the total.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all parts of the multi-hop question. Verification of key facts: (1) Other Developed Markets employees: 3,000 ✓ (2) North America employees: 24,000 ✓ (3) Combined total: 27,000 ✓ (4) Global workforce: 63,000 ✓ (5) Percentage calculation: 27,000/63,000 = 0.4286 = 42.86%, LLM states 'roughly 43 percent' ✓. The LLM correctly synthesized information across multiple geographic regions and calculated the combined workforce percentage. The slight wording difference ('roughly 43 percent' vs 'approximately 42.86%') is acceptable and represents appropriate rounding. The answer demonstrates sound multi-hop reasoning by: identifying employee counts for two regions, summing them, comparing to global total, and calculating the percentage. All numeric values are factually correct, calculations are accurate, and the answer fully addresses the question's requirements regarding regional comparison and global workforce percentage representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 286,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "\nThe foreign exchange forwards and options had a fair value of $557 million as of May 31, 2023. This amount is essentially identical to the total derivative assets reported on the balance sheet for that date, showing that the company’s derivative assets were comprised solely of these foreign‑exchange instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $557 million figure for foreign exchange forwards and options as of May 31, 2023 is correct and matches the ground truth exactly. The number format is appropriate and consistent. (2) COMPLETENESS: The answer addresses both parts of the question - it identifies the fair value of FX forwards/options ($557M) and compares this to total derivative assets on the balance sheet, correctly noting they are identical. (3) ENTITY ACCURACY: Nike is correctly identified, the date (May 31, 2023) is correct, and the financial metrics (foreign exchange forwards and options, derivative assets) are properly identified. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly synthesized that the FX forwards/options fair value matches the total derivative assets, and logically concluded this means derivative assets were comprised solely of these instruments. This matches the ground truth conclusion. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially identical' and 'comprised solely of these foreign-exchange instruments' conveys the same meaning as the ground truth's 'matches' and 'all derivative assets were composed of.' Minor difference: The LLM uses 'foreign‑exchange instruments' (with a different hyphen character) versus the ground truth's 'foreign exchange forwards and options,' but this is a negligible stylistic variation that doesn't affect accuracy. The answer is comprehensive, factually correct, and demonstrates proper multi-hop reasoning across the balance sheet data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 444,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "\nThe depreciation, depletion, amortization and impairment expense for the Lower 48 segment rose from **$4,067 million in 2021 to $5,729 million in 2023**, an increase of **$1,662 million** over the two‑year span.  \n\nDuring the same period the number of productive wells in the Lower 48 fell from **87 wells in 2021 to 38 wells in 2023**, a net decrease of **49 productive wells**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Depreciation, depletion, amortization, and impairments expense increased from $4,067 million in 2021 to $5,729 million in 2023, a difference of $1,662 million - all numbers correct. (2) Productive wells decreased from 87 in 2021 to 38 in 2023, a net decrease of 49 wells - all numbers correct. The calculations are accurate: $5,729M - $4,067M = $1,662M and 87 - 38 = 49. The multi-hop reasoning is sound, correctly synthesizing two distinct metrics (depreciation/depletion/amortization/impairments and productive well count) across the same time period (2021-2023) for the same geographic segment (Lower 48 region). Entity identification is precise (Lower 48 region, correct metrics, correct years). The presentation is clear and well-organized, presenting both the absolute values and the calculated changes. No omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 279,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "\nThe 2023 table reports $1,412 million in U.S. Treasuries and agencies, while the 2022 table reports $1,541 million; together they total **$2.953 billion**. This holding made up about **15.5 %** of the $9.104 billion of total fair‑value pension assets in 2023, compared with roughly **19.3 %** of the $8.001 billion in 2022, indicating a modest decline in the proportion of the portfolio allocated to U.S. Treasuries and agencies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR NUMBER REVERSAL: The LLM states 2023 = $1,412M and 2022 = $1,541M, but the ground truth indicates the opposite allocation between the two tables. The ground truth explicitly states 'first table' has $1,412M and 'second table' has $1,541M, with the second table showing the increase. The LLM incorrectly assigned these to 2023/2022 without verification. (2) CALCULATION ERROR: The LLM correctly calculates $1,412M + $1,541M = $2,953M (formatted as $2.953 billion), which matches ground truth total. However, this is the only correct calculation. (3) MISSING CRITICAL INFORMATION: The ground truth specifies the Level 1/Level 2 breakdown for both tables ($1,274M Level 1 + $138M Level 2 for first table; $1,312M Level 1 + $229M Level 2 for second table). The LLM completely omits this required categorization detail, which is explicitly mentioned in the question asking about 'different categorizations of investments at fair value.' (4) UNSUPPORTED PERCENTAGES: The LLM introduces percentage calculations (15.5% and 19.3%) and total fair-value pension asset figures ($9.104B and $8.001B) that are NOT mentioned in the ground truth answer and cannot be verified against it. These appear to be fabricated or from different sections not relevant to the specific question. (5) YEAR CONFUSION: The LLM assumes 2023/2022 distinction, but the ground truth refers to 'first table' and 'second table' without explicitly labeling them as specific years. The LLM made an assumption about year assignment that may be incorrect. (6) INCOMPLETE SYNTHESIS: The question specifically asks about 'how this allocation compares between the two different categorizations' - the ground truth addresses this by comparing Level 1/Level 2 distributions. The LLM instead compares year-over-year percentages of total portfolio, which is a different comparison entirely and not what was asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 514,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "\nNike’s timed‑deposit balances that are classified as cash and cash equivalents fell from **$502 million in fiscal 2023** to **$347 million in fiscal 2024**, a reduction of **$155 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) All factual information is correct: Nike's timed deposits classified as cash and equivalents were $502 million in fiscal 2023 and $347 million in fiscal 2024. (2) The calculation is accurate: $502M - $347M = $155M decrease, which matches the ground truth exactly. (3) Multi-hop reasoning is sound: the model correctly identified the specific metric (timed deposits classified as cash and equivalents), retrieved values from two different fiscal years (2023 and 2024), and performed the correct subtraction to determine the change. (4) The answer goes beyond the minimum requirement by providing both the individual year values and the calculated decrease, giving complete context. All numbers are presented in standard financial notation ($XXX million) which is appropriate and clear. The answer directly addresses the question asked with no extraneous information or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1067,
        "completion_tokens": 274,
        "total_tokens": 1341
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "\nThe combined depreciation, depletion, amortization and impairments for the Alaska and Lower 48 operating segments were **$6,790 million in 2023**, versus **$5,795 million in 2022**. This represents an increase of about **$995 million** (roughly a 17 % rise) from the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $6,790 million for 2023, $5,795 million for 2022, and the calculated increase of $995 million. The percentage calculation (17% rise) is also accurate: ($995M / $5,795M) × 100 = 17.16%, which rounds appropriately to 'about 17%'. The answer correctly identifies both operating segments (Alaska and Lower 48), the correct metric (depreciation, depletion, amortization, and impairments), and the correct fiscal years. The multi-hop synthesis is sound - the model successfully combined data from both segments for both years and performed the year-over-year comparison. The wording is clear and professional, with appropriate use of formatting (bold) for emphasis. The only minor consideration is the addition of the percentage calculation, which while accurate and helpful, goes slightly beyond the ground truth answer's explicit content. However, this addition is mathematically correct and enhances the answer's value without introducing any errors. All quantitative elements match the ground truth precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 314,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "\nAs of December 31 2022, PayPal reported a crypto‑asset safeguarding liability of **$604 million** and a corresponding safeguarding asset of **$604 million** (a combined total of $1.208 billion). These figures are presented in the recurring fair‑value hierarchy tables (pages 93‑94) as Level 2 measurements, shown under “Crypto asset safeguarding liability” in financial liabilities and “Crypto asset safeguarding asset” in financial assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN INTERPRETATION: The LLM fundamentally misunderstood the nature of the crypto asset safeguarding liability and asset. The ground truth states there is a TOTAL fair value of $604 million for BOTH the liability and asset combined (meaning each is $604 million, representing the same underlying position). The LLM incorrectly calculated this as $604 million + $604 million = $1.208 billion total, treating them as separate additive values rather than offsetting positions. This is a major conceptual and mathematical error. The correct interpretation is that the safeguarding liability of $604 million and the safeguarding asset of $604 million are two sides of the same transaction/position, not separate amounts to be summed. The LLM's statement 'a combined total of $1.208 billion' is factually incorrect. The correct total fair value is $604 million. While the LLM correctly identified: (1) the individual amounts ($604 million each), (2) the Level 2 classification, (3) the proper categorization in financial liabilities and assets, and (4) the page references - the fundamental misinterpretation of what 'total fair value' means in this context represents a significant failure in understanding the question and synthesizing the information correctly. The LLM added two offsetting positions together rather than recognizing they represent the same $604 million position from different perspectives.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 393,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "\nWalmart spent about **$3.5 billion** to purchase additional PhonePe shares and settle related liabilities, but it also received roughly **$0.7 billion** from new equity funding in PhonePe.  The two transactions resulted in a **net cash outflow of approximately $2.8 billion** for fiscal 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains major factual errors across all key financial figures. (1) QUANTITATIVE ERRORS - The LLM states Walmart paid $3.5 billion to increase PhonePe ownership, but the ground truth shows $0.9 billion. This is a 289% overstatement of the cash outflow. The equity funding figure of $0.7 billion is correct. The calculated net cash outflow of $2.8 billion is incorrect; the ground truth shows $0.2 billion net outflow. The LLM's calculation ($3.5B - $0.7B = $2.8B) is arithmetically correct given its input numbers, but the input numbers themselves are fundamentally wrong. (2) MULTI-HOP REASONING - While the LLM correctly identifies the structure of the transaction (cash outflow for ownership increase minus cash inflow from equity funding), it fails at the critical step of obtaining accurate source figures. The model appears to have synthesized information incorrectly or from unreliable sources. (3) ENTITY ACCURACY - The company (Walmart/PhonePe) and fiscal period (fiscal 2024) are correctly identified, but the financial metrics are severely misstated. (4) IMPACT - The error magnitude is substantial: the net cash outflow is overstated by 1,300% ($2.8B vs $0.2B ground truth), which would significantly misrepresent Walmart's financial position and capital allocation decisions. The answer demonstrates the correct conceptual framework but fails catastrophically on the numerical execution, which is the primary requirement for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 409,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "\nSouthern Company’s total wholesale revenues (affiliate + non‑affiliate) rose by **$77 million**, or about **41 %**, in 2024 versus 2023.  The gain was driven mainly by higher volumes and added wholesale capacity, while the IIC‑approved affiliate‑sales mechanism—under which affiliate transactions are priced at marginal cost—meant that fluctuations in affiliate sales affected the reported wholesale‑revenue figure but did not have a material impact on earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states total wholesale revenue increase was $77 million, but the ground truth clearly states the net change was $69 million. This is a $8 million discrepancy (11.6% error). The LLM appears to have cited only one segment's increase ($77M) rather than the combined net change across both segments ($77M + $79M - $87M = $69M). The 41% percentage cited is also not verifiable from the ground truth data provided. (2) INCOMPLETE SYNTHESIS - The LLM failed to properly synthesize the multi-hop calculation: it should have combined the $77M increase from one segment with the net effect from the other segment ($79M affiliate increase minus $87M non-affiliate decrease = -$8M net), yielding $69M total. Instead, it appears to have stopped at the first segment's number. (3) MISSING CRITICAL DETAIL - The ground truth emphasizes the 165.5% rise in KWH sales volume as a key driver of the $79M affiliate sales increase, which the LLM completely omits. This is a material detail explaining HOW the IIC-approved mechanism influenced the outcome. (4) VAGUE MECHANISM EXPLANATION - While the LLM correctly identifies that the IIC-approved mechanism prices affiliate transactions at marginal cost, it provides only a generic statement that this 'did not have a material impact on earnings' rather than explaining the specific volume-driven increase and its relationship to the revenue change. (5) ENTITY/METRIC ACCURACY - Company (Southern Company) and mechanism (IIC-approved FERC pricing) are correctly identified, but the financial metric calculation is fundamentally wrong. The answer demonstrates partial understanding of the IIC mechanism but fails on the core quantitative requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 477,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "\nIntel’s IDM 2.0 manufacturing expansion calls for roughly **$50 billion in total capital spending** – about **$20 billion to build two new fabs in Arizona**, **more than $20 billion for two new leading‑edge fabs in Ohio**, and **≈ $10.5 billion to equip its Rio Rancho (New Mexico) and Malaysia sites for advanced packaging**. These investments together represent the bulk of the company’s announced manufacturing expansion under the IDM 2.0 strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) Total investment stated as 'roughly $50 billion' vs. ground truth '$50.5 billion' - this is acceptable as the LLM uses 'roughly' to indicate approximation, and $50B is a reasonable rounding of $50.5B; (2) Arizona investment: '$20 billion' matches exactly; (3) Ohio investment: 'more than $20 billion' matches exactly; (4) Advanced packaging sites (Rio Rancho and Malaysia): '$10.5 billion' matches exactly. The sum calculation is correct: $20B + $20B+ + $10.5B ≈ $50.5B. Multi-hop synthesis: The answer correctly synthesizes information across three geographic locations (Arizona, Ohio, and the global packaging sites in New Mexico and Malaysia) and properly attributes them to the IDM 2.0 strategy. Entity accuracy: All locations are correctly identified (Arizona, Ohio, Rio Rancho New Mexico, Malaysia), and the strategy name (IDM 2.0) is correct. The only minor difference from ground truth is the use of 'roughly $50 billion' instead of the precise '$50.5 billion,' but this is a reasonable approximation and the LLM explicitly notes the breakdown adds up to approximately that amount. The answer is well-structured, complete, and addresses all components of the question with accurate financial data and proper contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 369,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "\nDanaher recorded approximately **$3.9 billion of goodwill** in connection with its acquisition of Abcam (as noted in the preliminary purchase‑price allocation on page 73).  \n\nThe Veralto separation generated about **$2.6 billion of net cash to Danaher before the distribution date**, which the company used to retire roughly $1 billion of commercial paper and to fund ongoing dividend and bond‑maturity obligations, thereby strengthening its cash position prior to the distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All key numbers are correct - $3.9 billion in goodwill from Abcam acquisition matches ground truth exactly, and $2.6 billion in net cash distributions from Veralto prior to distribution date is accurate. The $1 billion commercial paper redemption is also correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) Abcam goodwill amount, and (b) Veralto separation's cash impact. (3) ENTITY ACCURACY: All entities correctly identified - Danaher, Abcam, and Veralto are properly named and contextualized. The timeframe (prior to distribution date) is correctly specified. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple sources - connecting the Abcam acquisition to goodwill recording, and the Veralto separation to cash distributions and their use. The logic is sound: cash received was used for specific purposes (commercial paper redemption, dividends, bond maturities). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'net cash distributions' and 'retire roughly $1 billion' are semantically equivalent to the ground truth's 'received net cash distributions' and 'redeem $1.0 billion.' The additional context about dividend and bond-maturity obligations, while not explicitly in the ground truth statement, is reasonable elaboration that strengthens the answer without contradicting it. Minor note: The LLM uses 'roughly' for the $1 billion figure, which is appropriate given the preliminary nature of such allocations, though the ground truth states it more definitively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 444,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "\nThe company recognized a **$24 million net gain in income** from foreign‑exchange forwards and options during fiscal 2024.  This gain is small relative to the **fair‑value amounts reported at year‑end** – the foreign‑exchange derivatives were recorded at **$343 million in assets** and **$120 million in liabilities** (gross), so the $24 million gain represents roughly 7 % of the asset fair value and about 20 % of the liability fair value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN FINANCIAL DATA: The LLM answer contains significant factual errors in the fair value amounts reported at year-end. Ground truth shows $557 million in assets and $180 million in liabilities, but the LLM reports $343 million in assets and $120 million in liabilities. These are material discrepancies (approximately 38% understatement of assets and 33% understatement of liabilities). The net gain figure of $24 million is correct. However, the percentage calculations provided by the LLM are based on the incorrect fair value figures: the LLM calculates the gain as ~7% of asset fair value and ~20% of liability fair value, but these percentages are mathematically incorrect even for the wrong numbers provided (24/343 = 7%, 24/120 = 20% are approximately correct for those figures, but the underlying asset and liability values are wrong). Using the correct ground truth figures, the gain would represent approximately 4.3% of asset fair value and 13.3% of liability fair value. The LLM correctly identifies the fiscal year (2024) and the type of instruments (foreign exchange forwards and options), and appropriately addresses the comparison aspect of the question. However, the fundamental error in reporting the fair value of derivatives assets and liabilities is a critical failure that undermines the entire answer's reliability. The reasoning structure is sound, but it is built on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 394,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "\nThe combined 2022 discounted future net cash flows for the Lower 48 region are $55,912 million (consolidated $55,912 million plus $0 from equity affiliates). This amount is roughly $51,058 million greater than the 2022 depreciation, depletion, amortization and impairments for the Lower 48 region, which were $4,854 million—about an 11.5‑fold difference.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key numbers: (1) Combined 2022 discounted future net cash flows for Lower 48: $55,912 million - CORRECT (consolidated $55,912M + equity affiliates $0M); (2) 2022 depreciation, depletion, amortization, and impairments for Lower 48: $4,854 million - CORRECT; (3) Difference calculation: $55,912M - $4,854M = $51,058M - CORRECT; (4) Ratio calculation: $55,912M / $4,854M ≈ 11.52x (LLM states 11.5-fold) - CORRECT. The LLM successfully synthesized information across multiple data points (consolidated operations, equity affiliates, two different financial metrics) and provided accurate comparative analysis. The answer correctly identifies that equity affiliates contributed $0 to the Lower 48 discounted future net cash flows. The only minor distinction from the ground truth is that the LLM provides a more quantitative comparison (specific dollar difference and ratio) rather than the qualitative assessment in the original answer, but this is actually more informative and equally valid. All entities (Lower 48 region, 2022 fiscal year, consolidated operations, equity affiliates) are correctly identified. The reasoning is sound and the multi-hop synthesis is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 359,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "\nIn December 2023 PayPal reported **$563 million** of Loans and Interest Receivable — held for sale.  This balance is classified as fair‑value measured on a non‑recurring basis using **Level 3 inputs** (significant unobservable inputs), so its fair‑value estimate of $563 million is derived from those unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $563 million figure is correct and properly formatted. The date (December 2023) is correctly identified. All numeric values match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the question - the total value of Loans and Interest Receivable, Held for Sale ($563 million) and the comparison to fair value based on unobservable inputs (Level 3). The multi-hop synthesis is correct: the LLM properly identified that the entire $563 million balance is measured using Level 3 inputs. (3) ENTITY ACCURACY: PayPal is correctly identified, December 31, 2023 is the correct date, and the financial metric (Loans and Interest Receivable, Held for Sale) is accurately named. (4) REASONING: The multi-hop reasoning is sound. The LLM correctly synthesized that: (a) the total value is $563 million, (b) this is measured on a non-recurring basis, (c) Level 3 inputs (significant unobservable inputs) are used, and (d) therefore the fair value estimate is entirely derived from unobservable inputs. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'fair-value measured on a non-recurring basis using Level 3 inputs' is semantically equivalent to the ground truth's statement that the amount 'was measured using significant unobservable inputs (Level 3).' Minor note: The LLM uses slightly more technical language ('non-recurring basis') which adds appropriate context without detracting from accuracy. The answer is comprehensive, factually correct, and properly synthesizes the multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 448,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "\nIn 2023 the company borrowed **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the 2021 Multicurrency Credit Facility, whereas under the 2021 Credit Facility it borrowed **$3.1 billion** and repaid **$2.6 billion**. Thus, borrowing was slightly lower and repayments were substantially higher under the Multicurrency facility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with all key financial figures accurately stated. Verification of numbers: (1) 2021 Multicurrency Credit Facility: $3.0B borrowed ✓, $6.1B repaid ✓; (2) 2021 Credit Facility: $3.1B borrowed ✓, $2.6B repaid ✓. All quantitative data matches the ground truth exactly. The multi-hop synthesis is sound - the model correctly identified and compared the two credit facilities across the same time period (year ended December 31, 2023). The comparative analysis is accurate: borrowing was indeed slightly lower ($3.0B vs $3.1B) and repayments were substantially higher ($6.1B vs $2.6B) under the Multicurrency facility. Minor deduction: The LLM answer omits the explicit net borrowing/repayment calculations ($3.1B net repayment for Multicurrency and $0.5B net borrowing for the 2021 Credit Facility) that were included in the ground truth. While these calculations can be derived from the stated figures, their explicit inclusion would have made the answer more complete. The answer is well-structured, clear, and directly addresses the comparison requested in the question. The wording is appropriately concise while maintaining accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 332,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "\nThe auditors tested management’s controls over the likelihood of cost recovery and potential refunds, read and evaluated the relevant regulatory orders and other public filings, examined the completeness of costs recorded as regulatory assets or liabilities, and obtained management representations on recoverability and future rate impacts; they also assessed the disclosures for any high‑subjectivity surrounding future regulatory decisions. These steps highlight the inherent subjectivity because they depend on management’s judgments and assumptions about how future commission orders will treat incurred costs, which cannot be known with certainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core audit procedures and their relationship to regulatory subjectivity. STRENGTHS: (1) Correctly identifies key audit procedures: testing management controls over cost recovery likelihood, reviewing regulatory orders and public information, examining regulatory assets/liabilities, and obtaining management representations. (2) Accurately captures the subjectivity element - that future regulatory orders cannot be known with certainty and depend on management judgments. (3) No quantitative errors present (no numbers to verify). (4) Properly synthesizes information about both Georgia Power and Mississippi Power (implied through 'both' companies context). (5) Semantic equivalence is strong - 'testing effectiveness of management's controls' matches 'tested management's controls over likelihood of cost recovery.' MINOR WEAKNESSES: (1) The LLM answer adds some procedural details not explicitly mentioned in ground truth ('examined the completeness of costs recorded as regulatory assets or liabilities' and 'assessed the disclosures for any high-subjectivity') - while these are reasonable audit procedures and not contradictory, they represent minor elaboration beyond the stated ground truth. (2) The ground truth emphasizes 'reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments' - the LLM answer mentions reviewing regulatory orders but doesn't explicitly emphasize the precedent assessment aspect. (3) The ground truth uses the phrase 'refunds, or future reductions in rates' while LLM uses 'refunds' and 'future rate impacts' - slightly different framing but semantically equivalent. Overall, the answer correctly addresses both parts of the question (specific procedures and how they reflect subjectivity) with accurate information and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 513,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "\nThe 2023 drop in Comirnaty revenue—down about 70 % to roughly $11.2 bn—was driven by the transition from government‑procured doses to commercial sales and weaker international demand, which produced a $3.5 bn non‑cash revenue reversal and pressured Pfizer’s operating results.  Under the 2020‑2021 collaboration with BioNTech, Pfizer shares R&D costs (paying a $75 m upfront cash and $150 m equity investment), is obligated to make milestone and royalty payments, and must honor the vaccine‑purchase commitments that have prompted formal proceedings against several countries, creating ongoing financial and contractual obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the ~70% revenue decline for Comirnaty and the approximate $11.2 billion 2023 revenue figure. It accurately captures the transition from government procurement to commercial sales and weaker international demand as drivers. The answer correctly notes ongoing financial obligations to BioNTech including royalties and milestone payments. The mention of vaccine-purchase commitments and formal proceedings adds relevant context.\n\nCRITICAL ERRORS: (1) The LLM introduces a '$3.5 bn non-cash revenue reversal' that is NOT mentioned in the ground truth and cannot be verified from the provided information. This is a significant factual addition without support. (2) The LLM cites specific upfront payments ($75M cash, $150M equity investment) from the 2020-2021 collaboration that are not in the ground truth answer and appear to be unsupported details. (3) The LLM fails to mention the specific 2022 revenue figure ($37,806 million) that is critical for understanding the magnitude of decline.\n\nMISSING ELEMENTS: The ground truth emphasizes that Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech. The LLM mentions profit-sharing generally but doesn't specify the geographic carve-outs or the profit-sharing structure as clearly. The ground truth's emphasis on 'tiered royalties' is mentioned but not detailed.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the revenue decline with collaboration obligations, but introduces unsupported financial details that undermine credibility. The connection between declining revenue and ongoing obligations is made, but the specific mechanisms (tiered royalties, profit-sharing structure) are less clearly articulated than in the ground truth.\n\nQUANTITATIVE ISSUES: While the 70% decline and $11.2B figure are correct, the introduction of the $3.5B revenue reversal and specific collaboration payment amounts ($75M, $150M) without ground truth support represents a significant quantitative accuracy problem. The 2022 baseline ($37,806M) is omitted, which weakens the quantitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 593,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "\nThe Company held $35 million of U.S. Agency securities in short‑term investments as of May 31 2024, down from $46 million on May 31 2023. This represents a year‑over‑year decrease of $11 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Verification of key elements: (1) All numeric values are correct - $35 million for May 31, 2024, $46 million for May 31, 2023, and the calculated year-over-year decrease of $11 million ($46M - $35M = $11M). (2) Dates are accurate - both May 31, 2024 and May 31, 2023 are correctly cited. (3) The entity is correctly identified as NKE (Nike) and the metric is correctly specified as U.S. Agency securities held as short-term investments. (4) The multi-hop reasoning is sound - the answer correctly synthesizes the two data points from different fiscal years and accurately calculates the year-over-year change. (5) The calculation is verified: $46 million - $35 million = $11 million decrease, which is correct. The only minor difference from the ground truth is stylistic - the LLM uses 'down from' rather than 'decreased by' in the opening clause, but this is semantically equivalent and does not affect accuracy. The answer is complete, clear, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 299,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "\nThe Japanese subsidiary issued roughly $500 million of Guaranteed Senior Notes during 2024, and subsequently repaid about $77 million of that debt.  As a result, the total principal amount of those notes rose by approximately $423 million over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key elements: (1) Net change amount: The LLM correctly identifies the net increase as approximately $423 million, matching the ground truth exactly. (2) Issuance amount: The LLM states roughly $500 million in new issuances, which is reasonable and consistent with the net change calculation. (3) Repayment amount: The LLM states about $77 million in repayments, which is also consistent ($500M - $77M ≈ $423M). (4) Calculation verification: The arithmetic is sound - the LLM correctly synthesizes that new issuances minus repayments equals the net change. (5) Entity accuracy: Correctly identifies Costco's Japanese subsidiary and Guaranteed Senior Notes. (6) Multi-hop reasoning: The answer properly synthesizes information about both issuances and repayments to arrive at the net change, demonstrating correct multi-hop reasoning. The use of 'roughly' and 'approximately' and 'about' is appropriate given the context of financial reporting. The answer directly addresses the question and provides clear explanation of the calculation logic. Minor note: The numbers provided ($500M and $77M) appear to be illustrative/derived figures rather than directly stated, but they are mathematically consistent with the ground truth net change of $423M.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 369,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "\n3M had $0.5 billion of stand‑alone letters of credit, bank guarantees and similar instruments outstanding at December 31 2024. This amount is roughly 12 % of the $4.2 billion of cash, cash equivalents and marketable securities that the company held in the United States at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key facts: (1) Stand-alone letters of credit, bank guarantees, and similar instruments: $0.5 billion - CORRECT; (2) U.S. cash, cash equivalents, and marketable securities: $4.2 billion - CORRECT; (3) Date: December 31, 2024 - CORRECT; (4) Percentage calculation: $0.5B / $4.2B = 11.9%, rounded to 12% in LLM answer - CORRECT (minor rounding difference from ground truth's 11.9% to LLM's 12% is acceptable and mathematically sound). The LLM successfully synthesized information across multiple financial metrics and correctly identified the comparative relationship. The answer is complete, addressing both the absolute values and the comparison requested. The only minor difference is the rounding of the percentage (12% vs 11.9%), which is a negligible variation and represents standard rounding practice. The wording differs slightly from the ground truth ('roughly 12%' vs 'approximately 11.9%') but conveys the same information with semantic equivalence. All entities are correctly identified (3M, the specific financial metrics, the U.S. location, and the date). Multi-hop reasoning is sound: the model correctly identified two separate data points and calculated their relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 363,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that duplicate accounts accounted for roughly 10 % of its worldwide MAUs, while false accounts made up about 4 % of worldwide MAUs. Thus, the estimated share of duplicate accounts was more than double that of false accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-part question. (1) CORRECTNESS: All factual information matches the ground truth - duplicate accounts at 10% of worldwide MAUs, false accounts at 4% of worldwide MAUs, and the comparative statement that duplicate accounts were more than double false accounts. (2) QUANTITATIVE ACCURACY: Both percentages (10% and 4%) are correct, and the comparison logic is sound (10% is 2.5x greater than 4%, which is indeed 'more than double'). The time period (Q4 2023) is correctly identified. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across the required entities (Meta, duplicate accounts, false accounts, worldwide MAUs) and correctly establishes the comparative relationship between the two account types. (4) WORDING: The LLM uses slightly different phrasing ('roughly 10%' vs 'approximately 10%', 'made up about 4%' vs 'estimated at approximately 4%', 'more than double' vs 'more than twice as prevalent') but these are semantically equivalent and represent acceptable variations. The core message is identical to the ground truth. Minor deduction (1 point) only for very slight stylistic differences in phrasing, though the substance is completely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 356,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "\nPfizer paid **$75 million in upfront cash** to BioNTech under the shingles mRNA‑vaccine collaboration (the agreement also included a $150 million equity investment). By contrast, the upfront cash paid to Biohaven for exclusive migraine‑treatment rights outside the United States was **$150 million**, which is **twice** the amount paid to BioNTech.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) BioNTech upfront payment: $75 million - CORRECT; (2) Biohaven upfront payment: $150 million - CORRECT; (3) Comparison: $150M is twice $75M - CORRECT CALCULATION. The LLM correctly identifies both upfront cash amounts and accurately synthesizes the comparison across two separate Pfizer deals. The answer goes slightly beyond the ground truth by noting the additional $150 million equity investment in BioNTech, which provides useful context without contradicting the core facts. The ground truth states a '$75 million difference in favor of the Biohaven deal' while the LLM states Biohaven's payment is 'twice' the BioNTech amount - both are mathematically equivalent and correct ($150M - $75M = $75M difference; $150M / $75M = 2x). The multi-hop reasoning is sound: the model correctly synthesized information about two separate Pfizer partnerships and made an accurate comparative analysis. All entities are correctly identified (Pfizer, BioNTech, Biohaven), and the financial metrics are precise. Minor note: The LLM uses 'twice' as the comparison metric while ground truth uses absolute difference, but both convey the same relationship accurately. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 364,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "\nThe company’s foreign‑exchange forward and option liabilities total **$120 million** as of May 31 2024 – $115 million related to derivatives designated as hedging instruments ( $110 million in accrued liabilities plus $5 million in deferred tax and other liabilities) plus $5 million for non‑hedging derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TOTAL AMOUNT INCORRECT: LLM states $120 million total, but ground truth is $115 million. This is a fundamental factual error on the primary metric requested. (2) COMPONENT BREAKDOWN CONTRADICTORY: LLM claims $115 million from hedging instruments ($110M + $5M) plus $5 million for non-hedging = $120M total. However, ground truth clearly states: $110M hedging + $5M non-hedging = $115M total. The LLM appears to have double-counted the $5M figure or misallocated the components. (3) ALLOCATION ERROR: Ground truth shows $110M hedging and $5M non-hedging. LLM incorrectly breaks down the $115M hedging amount into subcategories ($110M accrued liabilities + $5M deferred tax) which is not supported by the ground truth and creates confusion about the actual hedging vs non-hedging split. (4) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing hedging and non-hedging instrument amounts. LLM failed to correctly combine these two components, arriving at $120M instead of $115M. This represents a $5M calculation error. The core answer to the question is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 317,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "\nPayPal records a **crypto‑asset safeguarding liability** (with a matching safeguarding asset) to show its custodial obligation for crypto that customers hold on the platform.  This liability is disclosed together with the broader risk‑concentration discussion that notes PayPal places cash, cash‑equivalents and customer balances with a limited set of high‑credit‑quality financial institutions.  Because the safeguarding asset is typically held with external custodians, any credit deterioration or concentration of crypto balances with those custodians creates a **credit‑risk exposure**—if a custodian were to fail or be unable to return the crypto, PayPal would be liable for the safeguarding liability and could incur losses.  Thus, while crypto assets are not shown as assets on the balance sheet, the safeguarding liability reveals that PayPal’s exposure to credit risk is tied to the credit quality and concentration of the custodial partners that hold customer‑held crypto.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the connection between PayPal's crypto asset safeguarding liability and credit risk disclosure. STRENGTHS: (1) Correctly identifies that PayPal records a safeguarding liability with matching safeguarding asset to reflect custodial obligations; (2) Accurately explains that crypto assets are not shown as balance sheet assets but create credit risk exposure through the liability mechanism; (3) Properly synthesizes the multi-hop connection: safeguarding liability → custodial partners → credit risk concentration; (4) Correctly notes that credit risk arises from the financial institutions/custodians holding the funds, not from the crypto assets themselves; (5) Appropriately emphasizes that custodian failure or inability to return crypto would trigger PayPal's liability. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer emphasizes custodial partners and external custodians more prominently, while the ground truth focuses more on the general placement of funds in high-quality financial institutions and FDIC insurance limits; (2) The LLM mentions 'credit deterioration' of custodians as a specific risk, which is a reasonable inference but not explicitly stated in the ground truth; (3) The ground truth specifically mentions FDIC insurance limits as a factor creating concentration risk, which the LLM answer does not explicitly address. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension scores perfectly. MULTI-HOP REASONING: The LLM correctly synthesizes the three-part connection: (1) safeguarding liability recognition, (2) risk concentration disclosure, (3) credit risk exposure implications. The logic is sound and follows the causal chain appropriately. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis on custodial partners versus general financial institution placement. Both answers correctly identify that the credit risk is not from the crypto itself but from where it's held.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 564,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "\nDuring 2024 the company issued **689,202 LTIP units (net of forfeitures) under the 2019 Stock Incentive Plan**. These LTIP units are exchangeable into Simon Property Group common stock and therefore could dilute earnings per share, but the SEC filings note that **no potentially dilutive securities—including the LTIP units—had a material dilutive effect for the year ended December 31, 2024**, so they did not materially increase dilution in that reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The key number of 689,202 LTIP units issued net of forfeitures under the 2019 Plan is correct and matches the ground truth exactly. The year (2024) and plan reference (2019 Stock Incentive Plan) are also accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the number of LTIP units issued net of forfeitures, and (b) the impact on potential stock dilution for 2024. (3) ENTITY ACCURACY: All entities are correctly identified - Simon Property Group, LTIP units, 2019 Stock Incentive Plan, and the fiscal year ended December 31, 2024. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes that while LTIP units are potentially dilutive securities (being exchangeable into common stock), they did not have a material dilutive effect on EPS for 2024. This multi-hop reasoning correctly combines the quantitative fact (689,202 units) with the qualitative assessment (no material dilution). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'did not materially increase dilution' is semantically equivalent to the ground truth's 'did not have a material dilutive effect.' The additional context about exchangeability into common stock enhances understanding without introducing inaccuracy. Minor note: The LLM provides slightly more detail about the nature of LTIP units (exchangeable into common stock) which adds value and is consistent with SEC filing disclosures, though not explicitly required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 421,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "\nIn 2024 the manufactured PFAS products contributed **$0.28 per diluted share** to earnings, which is far smaller than the **$0.90 per diluted share** impact recorded in 2022 – a reduction of roughly 70 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL ERROR - 2024 Impact: The LLM states $0.28 per diluted share positive contribution, while ground truth shows $0.20 reduction (negative impact). This is a directional and magnitude error. (2) CRITICAL ERROR - 2022 Impact: The LLM correctly identifies $0.90 but fails to specify this was a reduction/negative impact, creating inconsistency with how 2024 is presented. (3) CALCULATION ERROR - The LLM calculates a 70% reduction from $0.90 to $0.28, but this math is irrelevant since the 2024 figure is wrong. The correct comparison should show 2024 impact of -$0.20 vs 2022 impact of -$0.90, representing a $0.70 improvement (78% reduction in negative impact). (4) INCOMPLETENESS - The LLM fails to provide the combined total impact of $1.10 over both years that was requested. (5) SEMANTIC CONFUSION - The LLM presents 2024 as a positive contribution ($0.28) when it should be a negative impact (-$0.20), fundamentally misrepresenting the financial impact direction. The answer demonstrates poor multi-hop synthesis, as it fails to correctly identify and compare the impacts across both years, and provides an incorrect percentage calculation based on wrong numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 357,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "\nIn 2024 the Intercompany Interchange Contract‑governed KWH volume to non‑affiliates dropped about 30 percent, which cut wholesale revenue from external sales by roughly $87 million, while the volume of sales to affiliates surged roughly 165 percent, adding about $79 million in wholesale revenue. These opposite volume changes produced only a modest net decline in total wholesale revenue for the Southern Company system.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data. All key numbers are accurate: the 30% (30.8% in ground truth) drop in non-affiliate KWH volume, the $87 million revenue decrease, the 165% (165.5% in ground truth) surge in affiliate KWH volume, and the $79 million revenue increase. The minor percentage rounding (30% vs 30.8%, 165% vs 165.5%) is acceptable and within normal reporting conventions. The answer correctly identifies the IIC as the governing contract and accurately synthesizes the multi-hop relationship between volume changes and revenue impacts. The reasoning is sound: the LLM properly explains how opposite volume trends (decline in non-affiliates, surge in affiliates) resulted in a net modest decline overall. One minor omission is the lack of explicit mention that the non-affiliate decline was due to power agreements ending in May 2023, though this contextual detail is not strictly necessary to answer the core question about 2024 impacts. The answer also doesn't explicitly state the percentage revenue changes (20.5% and 131.7%) that appear in the ground truth, but focuses instead on absolute dollar amounts and volume percentages, which is a valid alternative presentation. The semantic meaning is preserved: the answer conveys that internal IIC transfers helped mitigate external market losses. Overall, this is a well-synthesized multi-hop answer that correctly combines volume data with revenue impacts across affiliate and non-affiliate categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 417,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "\nThe Irish Data Protection Commission imposed an administrative fine of **€1.2 billion** and issued corrective orders that require Meta Ireland to suspend the unlawful transfers and bring its data‑processing into GDPR compliance.  Bringing the company into compliance will likely increase its European operating costs—through additional legal, technical and compliance measures needed to meet the orders and to redesign data‑transfer mechanisms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the €1.2 billion financial penalty and the corrective orders requiring Meta to suspend unlawful data transfers. The quantitative accuracy is perfect—the penalty amount matches exactly. The multi-hop reasoning is sound: the answer correctly synthesizes (1) the penalty amount, (2) the nature of corrective orders, and (3) the operational cost implications for Meta in Europe. The answer appropriately identifies that compliance will increase costs through legal, technical, and compliance measures. Minor differences from ground truth: (1) The LLM uses 'administrative fine' instead of 'financial penalty' (semantically equivalent), (2) The LLM mentions 'redesign data-transfer mechanisms' which is a reasonable inference about compliance costs but is slightly more specific than the ground truth's reference to 'Chapter V of the GDPR' alignment. (3) The LLM answer is slightly less explicit about the specific GDPR regulatory framework (Chapter V) but captures the essence of the compliance requirement. The answer successfully addresses both parts of the multi-part question: the penalty amount and the operational cost implications. No calculation errors present. The reasoning connecting the corrective orders to increased European operating costs is logically sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 382,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "\nThe Home Depot’s focus on offering a deep assortment and the ability to sell large “job‑lot” quantities gives professional customers the breadth and volume they need for complex, project‑level purchases—something the company cites as a key differentiator in its competition for Pros.  If the retailer cannot consistently provide that depth and lot‑size capability—due to supply‑chain breakdowns, inventory shortages, or inadequate sourcing—it risks losing professional buyers, which would depress demand and margins, erode market share, and damage its reputation as the go‑to source for pros‑focused product availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the core strategy—that Home Depot uses product depth and job-lot quantities to serve professional customers' complex needs. It correctly identifies the risks: loss of professional buyers, depressed demand and margins, market share erosion, and reputational damage. The ground truth mentions 'negatively impact demand for products and services and reduce profit margins,' while the LLM expands this to include market share loss and reputational damage, which are logical extensions of the stated risks and are consistent with the filing's emphasis on competitive positioning. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension scores perfectly. (3) ENTITY ACCURACY: Both answers correctly identify The Home Depot and the 'Pros' (professional customers) segment. The LLM uses the term 'job-lot' (with hyphen) while ground truth uses 'job lot' (two words)—both are acceptable variations of the same concept. (4) REASONING & SYNTHESIS: The LLM demonstrates superior multi-hop reasoning by explicitly connecting the strategic offering (product depth + job-lot quantities) → customer benefit (breadth and volume for complex purchases) → competitive advantage → risks if not maintained (supply-chain issues, inventory shortages, sourcing problems leading to loss of professional buyers). The ground truth is more concise but less detailed in explaining the causal chain. (5) SEMANTIC EQUIVALENCE: The LLM answer is semantically equivalent to and more comprehensive than the ground truth. It maintains all core facts while providing additional context about failure modes (supply-chain breakdowns, inventory shortages) that support the stated risks. The only minor difference is that the LLM provides more granular detail about potential causes of failure, which enhances rather than detracts from accuracy. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 541,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "\nThe two disclosures exclude a combined participating interest of **$177 million** ($94 million noted on page 131 and $83 million noted on page 130).  \nBecause these annuity contracts involve complex, contract‑specific cash‑flow and mortality assumptions and are often measured using unobservable inputs, they do not fit cleanly into the standard fair‑value hierarchy, highlighting the significant estimation and actuarial judgment required to value them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All numbers are correct - the total of $177 million is accurately calculated from the two components ($94 million + $83 million), and the page references (131 and 130) are appropriately cited. The arithmetic is precise. QUALITATIVE ACCURACY: The answer correctly identifies the key issue - that these investments don't fit cleanly into the standard fair value hierarchy due to their complexity. The explanation about contract-specific cash flow and mortality assumptions, combined with reliance on unobservable inputs, accurately captures why these interests are excluded. This reasoning is sound and demonstrates understanding of fair value measurement principles. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the total value ($177 million), and (2) what the exclusion indicates about valuation complexity. The synthesis across the two disclosures is correct. SEMANTIC EQUIVALENCE: While the LLM uses slightly different wording than the ground truth (emphasizing 'contract-specific cash-flow and mortality assumptions' and 'actuarial judgment' rather than 'lack of observable market data' and 'redemption restrictions'), both explanations are semantically equivalent and convey the same fundamental insight - that these investments are complex and difficult to value using standard hierarchy methods. The LLM's explanation is actually more specific about the nature of the complexity. MINOR CONSIDERATION: The ground truth mentions 'lack of observable market data or restrictions limiting redemption ability' while the LLM emphasizes 'unobservable inputs' and 'actuarial judgment' - these are complementary perspectives on the same issue rather than contradictory, so this represents a slight variation in emphasis rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 504,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "\nPayPal estimates its allowance for credit losses by applying historical loss‑curve patterns to each portfolio and then overlaying externally‑sourced macro‑economic forecasts; the resulting loss‑rate projections drive the quantitative allowance for both merchant and consumer receivables. For merchant loans the forecasts focus on macro trends in **unemployment rates and retail‑e‑commerce sales** (used over a ~2.5‑ to 3.5‑year horizon), while for consumer revolving and installment loans the models incorporate **household disposable‑income trends, retail‑e‑commerce sales and, through early 2023, unemployment rates** (applied over roughly 5 years for revolving and 3.5 years for installment products). These macro assumptions are fed into the loss‑curve calculations to set the respective credit‑loss allowances.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's credit loss methodology and correctly identifies the core framework: loss curves applied with macroeconomic forecasts. STRENGTHS: (1) Correctly identifies the two main receivable categories (merchant and consumer) and their respective macroeconomic factors; (2) Accurately states merchant factors as unemployment rates and retail e-commerce sales; (3) Accurately identifies consumer factors including household disposable income and retail e-commerce sales; (4) Provides additional valuable detail about time horizons (2.5-3.5 years for merchant, ~5 years for revolving, 3.5 years for installment) not explicitly in ground truth but consistent with typical CECL methodologies; (5) Notes the temporal limitation on unemployment rates for consumer products (through early 2023), showing nuanced understanding; (6) Correctly explains the mechanism: macroeconomic assumptions feed into loss-curve calculations to determine allowances. MINOR CONSIDERATIONS: (1) The ground truth mentions loss curves applied 'by geography, delinquency, and origination period' for merchant receivables - the LLM answer doesn't explicitly mention these segmentation dimensions, though this is a relatively minor omission; (2) The LLM distinguishes between revolving and installment products for consumer receivables with different time horizons, which adds specificity beyond the ground truth's simpler 'consumer revolving credit receivables' reference; (3) The phrase 'externally-sourced macro-economic forecasts' is slightly more specific than ground truth's 'macroeconomic forecasts' but semantically equivalent. QUANTITATIVE ACCURACY: The time horizons provided (2.5-3.5 years, 5 years, 3.5 years) appear reasonable and specific but cannot be verified against the ground truth which doesn't provide these numbers. However, they don't contradict the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information about how loss curves, macroeconomic factors, and allowance calculations interconnect across two different receivable categories. The logic is sound and complete. Overall, this is a comprehensive, accurate answer with minor gaps in explicitly mentioning segmentation dimensions but with added valuable specificity on time horizons.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 615,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "\nCostco’s heavy investment in developing and protecting the Kirkland Signature brand—and its reliance on its own manufacturing and distribution network for most private‑label goods—means that any decline in the brand’s reputation or a disruption at those facilities can quickly erode member loyalty; loss of member confidence reduces renewal rates and sales, while supply‑chain interruptions or quality issues lower the high‑margin private‑label sales that bolster overall gross‑margin performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Costco's risk exposure related to Kirkland Signature and its manufacturing/distribution reliance. STRENGTHS: (1) Correctly identifies the core risks: brand reputation decline, facility disruptions, and supply-chain interruptions; (2) Accurately connects these risks to the two key performance impacts: brand loyalty/member renewal and gross margin performance; (3) Properly recognizes that Kirkland Signature products carry higher margins and represent a growing portion of sales; (4) Demonstrates sound multi-hop reasoning by synthesizing how operational disruptions → quality/availability issues → member confidence loss → dual impact on loyalty and margins; (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer is more concise and doesn't explicitly mention specific types of disruptions (extreme weather, pandemics, labor issues) that the ground truth identifies; (2) Doesn't explicitly state that inconsistent product availability and quality could reduce member acceptance, though this is implied in the logic; (3) The phrase 'most private-label goods' is slightly less precise than the ground truth's focus on 'processing, packaging, and manufacturing facilities.' SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental risk narrative as the ground truth—that Kirkland Signature's importance to Costco's business model creates dual exposure (brand loyalty and margin performance) when operational disruptions occur. The reasoning chain is logically sound and factually accurate. The answer successfully addresses the multi-part question about how investment and reliance expose the company to risks affecting both brand loyalty and gross margins.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 478,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "\nThe performance‑based LTIP units awarded under the 2021 and 2022 LTI Programs had a combined grant‑date fair value of approximately **$39 million** ( $18.4 million for 2021 plus $20.6 million for 2022 ). By comparison, the time‑based restricted stock units granted in those same years had a combined grant‑date fair value of about **$11.2 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - performance-based LTIP units total $39.0 million ($18.4M in 2021 + $20.6M in 2022), and time-based RSUs total $11.2 million ($4.3M in 2021 + $6.9M in 2022). The arithmetic is accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) total grant date fair value of performance-based LTIP units for 2021-2022, (2) breakdown by year, (3) comparison to time-based RSUs, and (4) the comparative statement about relative magnitudes. ENTITY ACCURACY: All entities are correctly identified - 2021 and 2022 LTI Programs, performance-based LTIP units, and time-based restricted stock units. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points (2021 and 2022 figures for two different award types) and makes the appropriate comparison. SEMANTIC EQUIVALENCE: The phrasing 'approximately $39 million' and 'about $11.2 million' is semantically equivalent to the ground truth's exact figures, and the use of 'combined' clearly indicates summation. The concluding statement about performance-based units having 'significantly higher' fair value is a reasonable inference from the numerical comparison. MINOR OBSERVATION: The ground truth explicitly states the comparison conclusion ('significantly higher'), while the LLM answer implies it through the numbers presented without explicitly restating this conclusion, but this is a very minor stylistic difference that does not affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 429,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "\nAs of December 31 2024, 3M held U.S. municipal securities with a total fair‑value of **$20 million**. These securities are classified as **Level 3** in the fair‑value hierarchy because they are valued using a methodology that references the carrying value of the related finance‑lease obligation, which involves unobservable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM states the fair value is $20 million, but the ground truth clearly indicates it is $16 million. This is a significant factual error ($4 million discrepancy, or 25% overstatement). CORRECT ELEMENTS: (1) The classification as Level 3 in the fair value hierarchy is correct. (2) The explanation of the valuation methodology referencing the carrying value of the finance lease obligation is correct and well-articulated. (3) The mention of unobservable inputs is appropriate context for Level 3 classification. (4) The date (December 31, 2024) is correct. (5) The company (3M) is correctly identified. MULTI-HOP REASONING: The LLM correctly synthesized the relationship between the securities valuation and the finance lease obligation, demonstrating sound multi-hop reasoning. However, this reasoning quality cannot overcome the fundamental quantitative error. ASSESSMENT: While the LLM demonstrates good understanding of fair value hierarchy concepts and correctly identifies the Level 3 classification rationale, the incorrect dollar amount ($20M vs. $16M) is a material factual error that significantly undermines the answer's reliability. In financial analysis, precision of numbers is paramount, and a 25% overstatement is not a minor formatting difference but a substantive error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 371,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that roughly 3 percent of its worldwide Monthly Active Users were made up exclusively of “violating” accounts—those created primarily for spam, bots or other term‑of‑service abuses. This figure comes from an internal review of a small sample of accounts that applies significant judgment, but the process is hampered by limited data signals on encrypted services such as WhatsApp, where fewer identifiers are available and matching accounts across products is especially difficult.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The core factual claim of approximately 3% of Meta's worldwide Monthly Active Users in Q4 2023 consisting of violating accounts is correct and matches the ground truth exactly. The answer correctly identifies these as accounts created for spam, bots, or term-of-service violations. (2) QUANTITATIVE ACCURACY: The 3% figure is precise and accurate with no calculation errors. The number format is appropriate and matches the ground truth. (3) QUALITATIVE ACCURACY: The LLM successfully synthesizes the multi-hop information by: (a) correctly identifying the metric (MAP in Q4 2023), (b) explaining the estimation methodology (internal review of small sample with significant judgment), and (c) articulating the challenges specific to encrypted platforms like WhatsApp (limited data signals, fewer identifiers, difficulty matching accounts across products). The reasoning is sound and demonstrates understanding of why encrypted platforms present unique challenges. (4) ENTITY ACCURACY: Meta is correctly identified, Q4 2023 is the correct time period, and WhatsApp is correctly cited as an encrypted platform example. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys all essential information from the ground truth while using slightly different wording ('roughly 3 percent' vs 'Approximately 3%', 'exclusively of' vs 'solely of'). These variations are semantically equivalent and acceptable. The answer provides additional helpful context about the methodology (small sample, significant judgment required) that enriches understanding without contradicting the ground truth. Minor deduction only because the phrasing 'exclusively of' could be marginally clearer than 'solely of,' though both convey the same meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 485,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "\nAs of December 31 2023 Pfizer had paid a **$75 million upfront cash payment** and made a **$150 million equity investment** in its BioNTech collaboration for the shingles vaccine; no comparable upfront cash or equity outlay was disclosed for the Comirnaty (COVID‑19) program. Overall, the total upfront and equity investments Pfizer has made in its BioNTech collaborations to date amount to **approximately $225 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect on the primary quantitative metric. Ground truth states the total upfront payments and equity investments for BOTH the shingles vaccine and Comirnaty programs combined was $375 million. The LLM answer claims: (1) $75 million upfront for shingles, (2) $150 million equity for shingles, (3) nothing for Comirnaty, totaling $225 million. This is a significant discrepancy of $150 million ($375M vs $225M). The LLM's claim that 'no comparable upfront cash or equity outlay was disclosed for the Comirnaty program' directly contradicts the ground truth, which indicates both programs should be included in the $375 million total. The LLM failed to synthesize the multi-hop information correctly - it appears to have only captured partial data for the shingles program while completely missing or excluding the Comirnaty program contributions. The calculation of $75M + $150M = $225M is arithmetically correct, but the underlying data collection is incomplete and incorrect. The answer demonstrates poor multi-hop reasoning by not properly combining information across both vaccine programs as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 327,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "\nOver the 2019‑2021 period COP’s Europe‑Middle‑East‑North Africa (EMENA) operations generated a combined net income of roughly **$12.7 billion** (2019 ≈ $7.3 bn, 2020 ≈ $(2.7) bn, 2021 ≈ $8.1 bn).  In contrast, the Lower 48 region posted a **cumulative net loss of about $2.6 billion** during the same three‑year span.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all quantitative dimensions. Ground truth shows EMENA contributed a cumulative net LOSS of $17 million (1+6-24), while the LLM claims a net income of $12.7 billion - a massive discrepancy of over $12.7 billion. The LLM's year-by-year breakdown ($7.3bn, $(2.7)bn, $8.1bn) bears no resemblance to the actual figures ($1M, $6M, -$24M). For Lower 48, ground truth shows cumulative net INCOME of $1,206 million (402+804-8), but the LLM reports a net LOSS of $2.6 billion - again completely inverted and off by approximately $3.8 billion. The LLM failed to correctly identify that EMENA had negative cumulative results while Lower 48 had positive results. The comparison calculation is also wrong: the correct difference is $1,223 million ($1,206M - (-$17M)), not the implied comparison from the LLM's incorrect numbers. The LLM appears to have confused or fabricated the financial data entirely, possibly confusing revenue figures with net income, or pulling data from an entirely different company or time period. All three year-by-year figures for both regions are incorrect by orders of magnitude. This represents a complete failure to accurately retrieve and synthesize the required financial information from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 357,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "\nThe “Other noncontrolling redeemable interests” line fell from **$172,912 k in 2023 to $169,192 k in 2024**, a **$3,720 k (≈ $3.7 million) decrease**.  \n\nThat $3.7 million reduction is part of the overall **$11,220 k (≈ $11.2 million) decline** in the combined “Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties,” the remainder of which comes from the **$7.5 million drop in the 7.50 % cumulative redeemable preferred units** (reflecting redemptions during 2024). Thus, the $3.7 million fall in other noncontrolling redeemable interests directly accounts for roughly one‑third of the total decrease.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 'Other noncontrolling redeemable interests' decreased from $172,912k to $169,192k, a $3,720k decrease - CORRECT. (2) Total preferred units and noncontrolling redeemable interests decreased from $195,949k to $184,729k, a total decrease of $11,220k - CORRECT. (3) The percentage contribution calculation: $3,720k / $11,220k = 33.15%, which the LLM correctly characterizes as 'roughly one-third' and 'approximately 33.1%' - CORRECT. (4) The LLM provides additional context by identifying that the remaining $7,500k decline comes from the 7.50% cumulative redeemable preferred units, demonstrating strong multi-hop synthesis. The answer uses appropriate unit conversions (k to millions) and maintains consistency throughout. The reasoning is sound: the LLM correctly identifies that the $3.7M decrease in other noncontrolling redeemable interests is one component of the larger $11.2M total decline. All numeric values match the ground truth exactly, calculations are accurate, and the multi-hop synthesis across the related financial metrics is properly executed. Minor note: The LLM uses 'k' notation and converts to millions, which is a reasonable presentation choice and doesn't detract from accuracy. The answer fully addresses both parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 377,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "\nAs of December 31 2024, the combined fair value of foreign corporate debt ($31 million) and asset‑backed securities ($24 million) totaled **$55 million**. In the prior year (December 31 2023) the combined fair value of these two categories was **$0 million**, meaning the $55 million reported in 2024 represents a full increase from zero. (Data from the fair‑value hierarchy tables on pages 82 and 65.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The 2024 combined fair value of $55 million ($31M foreign corporate debt + $24M asset-backed securities) is correct. The 2023 comparison value of $0 million is correct. The calculation of the total ($31M + $24M = $55M) is accurate. (2) QUANTITATIVE ACCURACY: All dollar amounts are precise and correctly formatted. The breakdown of the $55 million into its two components is accurate. The year-over-year comparison showing an increase from $0M to $55M is mathematically sound. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the model correctly synthesized information about two asset categories (foreign corporate debt and asset-backed securities) across two fiscal years (2024 and 2023). The identification of MMM as the company is correct. The characterization of the change as 'a full increase from zero' is logically appropriate. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question: the total fair value as of December 31, 2024, the breakdown by asset category, and the comparison to the prior year. The citation of source pages (82 and 65) adds credibility. Minor note: The LLM uses 'asset‑backed securities' with a special hyphen character, which is a formatting variation but does not affect accuracy. The answer is complete, accurate, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 401,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "\nTechnical errors and data limitations—such as incomplete signals from encrypted WhatsApp, algorithmic or modeling flaws, and reliance on small‑sample surveys—can cause the MAP estimate to be under‑ or over‑counted, which in turn propagates into the ARPP calculation that is based on that user base. Meta acknowledges that the overall error margin for its Family metrics is roughly **3 % of worldwide MAP**, meaning that both MAP and the derived ARPP could vary by about that amount due to these inaccuracies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 3% error margin for Family metrics and acknowledges the technical errors and data limitations affecting MAP and ARPP. However, it has significant quantitative gaps: (1) The original answer provides a concrete calculation showing that 3% of 3.3 billion MAP equals approximately 99 million users—a critical quantitative detail that demonstrates the practical magnitude of the error margin. The LLM answer states the error margin is 'roughly 3%' but fails to provide this calculated example, which is essential for understanding 'by what approximate margin' the metrics could vary. (2) The LLM correctly identifies sources of error (encrypted WhatsApp, algorithmic flaws, survey sampling) and explains the propagation mechanism from MAP to ARPP, showing sound multi-hop reasoning. (3) The LLM accurately conveys that both MAP and ARPP are affected by the same error margin, which is correct. (4) However, the answer is incomplete because it doesn't quantify the absolute variation (99 million users) that would result from the 3% margin applied to the 2023 baseline of 3.3 billion MAP. The question specifically asks 'by what approximate margin could these metrics vary,' and while the LLM provides the percentage (3%), it omits the absolute number calculation that demonstrates the practical impact. The reasoning about how errors propagate is sound, but the quantitative completeness is insufficient for a full answer to a question explicitly asking for approximate margins of variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 420,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "\nThe Home Depot’s glossary defines BOPIS as **“Buy Online, Pickup In Store.”** By routing online purchases to the nearest store’s inventory, the retailer can have customers pick up those orders at a physical location instead of shipping them, which — leveraging its extensive store footprint — accounts for roughly **50 % of U.S. online orders being fulfilled through stores** in fiscal 2024. This approach speeds delivery, reduces shipping costs, and meets customer demand for convenient, in‑store pickup.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly defines BOPIS as 'Buy Online, Pickup In Store' matching the glossary definition; (2) Accurately identifies the 50% fulfillment metric for U.S. online orders through stores; (3) Properly explains the mechanism: routing online purchases to nearest store inventory for in-store pickup; (4) Correctly synthesizes the multi-hop connection between BOPIS definition and supply chain fulfillment goal; (5) Adds relevant context about benefits (speed, reduced shipping costs, customer convenience) that supports the strategic rationale. MINOR ISSUES: (1) The phrase 'in fiscal 2024' introduces a specific time period not explicitly mentioned in the ground truth answer, which only references the supply chain section without specifying a fiscal year - this is a minor addition that doesn't contradict the ground truth but adds specificity not confirmed; (2) The ground truth emphasizes BOPIS as part of 'a broader set of store-based fulfillment options' while the LLM focuses primarily on BOPIS itself, though this is more of an emphasis difference than an error. QUANTITATIVE ACCURACY: The 50% figure is correctly stated and properly contextualized. QUALITATIVE ACCURACY: The reasoning clearly connects the BOPIS mechanism to the supply chain fulfillment goal through logical cause-and-effect. MULTI-HOP SYNTHESIS: Successfully combines information from glossary definition with supply chain section metrics. Overall, this is a high-quality answer with only minor contextual nuances that prevent a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 436,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "\nMorgan Stanley records DCP expense by allocating the notional award value over the award’s vesting period and adjusting it for changes in the fair value of the referenced investments, so the expense is recognized gradually as the award vests. In contrast, carried‑interest compensation is expensed only when the firm actually allocates realized or unrealized carried interest to employees—typically at the time the underlying investments are realized or performance criteria are met—resulting in a more event‑driven, often lump‑sum recognition of expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key distinctions between DCP and carried interest compensation recognition but introduces a significant conceptual error that undermines the core accuracy. CORRECT ELEMENTS: (1) DCP expense is recognized over the vesting period - accurate; (2) DCP adjusts for changes in fair value of referenced investments - accurate; (3) Carried interest involves both realized and unrealized allocations - accurate; (4) The timing difference between the two approaches is correctly identified. CRITICAL ERROR: The LLM states that carried interest is 'expensed only when the firm actually allocates realized or unrealized carried interest to employees—typically at the time the underlying investments are realized or performance criteria are met.' This mischaracterizes the ground truth, which states carried interest is recognized IMMEDIATELY for any portion allocated (both realized and unrealized), without being tied to a vesting schedule. The LLM's phrasing suggests a delayed recognition tied to realization events or performance criteria being met, which contradicts the 'immediate' recognition stated in the ground truth. The LLM also adds language about 'event-driven, often lump-sum recognition' which is not supported by the ground truth and may mislead about the timing mechanism. MULTI-HOP REASONING: The answer correctly synthesizes the comparison between two compensation types but fails on the precise characterization of when carried interest expense is recognized. SEMANTIC ISSUES: While the answer attempts to explain the distinction, the fundamental mischaracterization of carried interest timing (immediate vs. event-driven/delayed) represents a material factual error that would affect understanding of Morgan Stanley's accounting practices. No quantitative data was required for this question, so quantitative accuracy is perfect by default.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 509,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "\nAs of December 31 2024, the combined noncontrolling redeemable interests in properties that are classified as temporary equity total **$184,729 (in thousands)**—approximately **$184.7 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity is $0, as neither Simon Property Group nor the Operating Partnership reported any such interests redeemable at amounts in excess of fair value. The LLM instead provides a specific dollar amount of $184,729 thousand ($184.7 million), which directly contradicts the ground truth answer. This is a critical factual error - the LLM has invented a number that does not match the actual filing data. The question asks for a specific quantitative value, and the LLM's answer of $184.7 million is completely wrong when the correct answer is $0. The LLM appears to have either misread the source documents or confused this metric with a different line item. While the LLM did address both entities mentioned (Simon Property Group and the Operating Partnership) and the correct date (December 31, 2024), the core numerical answer is entirely incorrect, making this response fundamentally unreliable for financial analysis purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 312,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "\nThe combined estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets as of December 31, 2021 is $9.06 billion. This exceeds the $8.92 billion carrying amount of NEE's special use funds on its consolidated balance sheet by approximately $0.14 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states the combined fair value is $9.06 billion, which is incorrect. The ground truth clearly states it is $8,922 million ($8.922 billion), not $9.06 billion. This is a $138 million error. (2) FUNDAMENTAL MISUNDERSTANDING: The LLM incorrectly compares the fair value ($9.06B claimed) to the carrying amount ($8.92B claimed), suggesting the fair value exceeds the carrying amount. However, the ground truth explicitly states the fair value is $8,922 million while the carrying amount is $2,505 million - meaning fair value is significantly HIGHER than carrying amount (by approximately $6,417 million), not by $0.14 billion. The LLM has reversed or confused which figure represents fair value vs. carrying amount. (3) INCOMPLETE ANSWER: The LLM fails to provide the carrying amount figure of $2,505 million that is central to answering the question. The question specifically asks how the combined fair value compares to the carrying amount on the consolidated balance sheet. (4) CALCULATION ERROR: The difference calculation is wrong. If fair value were $8.922B and carrying amount were $2.505B, the difference would be approximately $6.417B, not $0.14B. (5) MISSING CONTEXT: The LLM does not explain the composition of these funds (equity and available-for-sale debt securities) or the accounting treatment differences that explain the variance. The answer demonstrates a fundamental misreading of the source data and fails to correctly synthesize the multi-hop information required to answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "\nAPJC is treated as a separate geographic segment both in Cisco’s operational structure—sales are attributed to it based on the customer’s ordering location—and in its consolidated financial reporting, where APJC’s revenue and gross‑margin are shown individually in the segment‑information table. Because the CODM evaluates segment performance using only revenue and gross margin (excluding R&D, SG&A, amortization and other corporate charges), APJC’s internal performance measurement is driven by those segment‑level metrics, shaping how resources and investments are allocated within the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of APJC's dual role and provides accurate, well-reasoned information. STRENGTHS: (1) Correctly identifies APJC as a geographic segment with revenue and gross margin reporting in consolidated financials; (2) Accurately explains the CODM (Chief Operating Decision Maker) evaluation methodology using only revenue and gross margin metrics; (3) Properly identifies excluded items (R&D, SG&A, amortization, corporate charges) from segment performance measurement; (4) Clearly articulates how this measurement approach influences resource allocation decisions; (5) Correctly notes that sales attribution is based on customer ordering location; (6) No quantitative errors or incorrect numbers. MINOR GAPS: (1) The original answer explicitly mentions three segments (Americas, EMEA, APJC) while LLM focuses primarily on APJC without naming the other segments—this is a minor contextual omission but doesn't affect the core answer; (2) The original answer uses the phrase 'strategic decisions and consolidated earnings' while LLM uses 'resources and investments'—both convey similar meaning but with slightly different emphasis; (3) The LLM answer provides more technical detail about CODM methodology, which adds value but wasn't explicitly required. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between operational structure, financial reporting, and internal performance measurement, demonstrating sound multi-hop reasoning. The explanation of how segment metrics feed into consolidated reporting while excluding certain expenses is logically sound and accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth with appropriate technical precision regarding CODM evaluation practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 490,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "\nIn 2024, Business Markets and Other contributed roughly **$13.1 billion of the Business Group’s $29.5 billion total revenue – about 44 % of the segment’s sales**.  This sub‑segment incorporates FWA broadband by offering fixed‑wireless access (via 5G/4G LTE) as a business‑grade internet service, often bundled with wireless, voice and networking solutions to provide small‑ and medium‑size enterprises with a simple, all‑in‑one connectivity package.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $13.1 billion in revenues for Business Markets and Other segment, 44% of total Business Group revenues, and the implied total of $29.5 billion ($13.1B / 0.44 ≈ $29.77B, which rounds appropriately). The percentage calculation is accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the percentage contribution (44%) and revenue amount ($13.1B), and (2) how FWA broadband is incorporated into the segment's offerings. ENTITY ACCURACY: All entities are correctly identified - Verizon Business Group, Business Markets and Other segment, FWA broadband, and the 2024 fiscal year. REASONING & SYNTHESIS: The multi-hop reasoning is sound. The LLM correctly synthesized that FWA is offered as a business-grade service within the Business Markets and Other segment, and appropriately contextualized it as part of bundled connectivity solutions for SMBs. SEMANTIC EQUIVALENCE: The LLM's description of FWA as 'fixed-wireless access (via 5G/4G LTE)' and its positioning as part of bundled offerings for small and medium businesses is semantically equivalent to and slightly more detailed than the ground truth's description of 'fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.' The additional detail about bundling with wireless, voice, and networking solutions adds valuable context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM's phrasing 'roughly $13.1 billion' and 'about 44%' uses appropriate hedging language that is consistent with financial reporting conventions, though the ground truth presents these as definitive figures. This is a stylistic choice rather than an accuracy issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 490,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "\nThe interest‑rate hedge contracts had a total fair‑value of $1 million (receivable) and $51 million (payable), i.e., a net liability of roughly $50 million. By contrast, the aggregate notional amount of all foreign‑currency forward contracts was $16.2 billion, so the hedge fair‑value represents less than 0.3 % of that notional.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN NOTIONAL AMOUNT: The LLM states the foreign currency forward contracts notional amount is $16.2 billion, but the ground truth clearly states it is $23.2 billion. This is a significant factual error ($7 billion discrepancy). CORRECT ELEMENTS: (1) Interest rate hedge fair value breakdown is accurate: $1 million receivable and $51 million payable, netting to ~$50 million liability - this matches ground truth exactly. (2) The characterization of the hedge fair value as a net liability of roughly $50 million is correct. (3) The comparison structure (hedge fair value vs. notional amount) is appropriate. CALCULATION ERROR: The LLM calculates that the hedge fair value represents 'less than 0.3%' of the notional. Using the LLM's own incorrect figure: $50M / $16.2B = 0.31%, which would be 'less than 0.4%' not 'less than 0.3%'. Using the correct notional amount: $50M / $23.2B = 0.22%, which is indeed less than 0.3%. The percentage calculation appears to be based on the incorrect notional figure. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information from two different derivative categories (interest rate hedges and foreign currency forwards) and attempted a comparative analysis. However, the fundamental error in the notional amount undermines the entire comparison. The question asks for a comparison between two specific metrics, and providing the wrong notional amount makes the comparison factually incorrect and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 404,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "\nThe tables show that in Asia the equity‑company portfolio holds only ~19 k net undeveloped acres but contains about 1.5 bn boe of undeveloped reserves (≈ 80 k boe per acre), whereas the consolidated subsidiaries need roughly 33.6 m net undeveloped acres to hold ~5.8 bn boe (≈ 170 boe per acre). Thus, equity‑company assets in Asia are far more reserve‑dense and therefore exhibit a much higher development potential per unit of land, contrasting with the much lower land‑use efficiency of the broader consolidated subsidiaries. [Page 22 (acreage); Page 10 (reserve summary)]",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ERRORS: The LLM states consolidated subsidiaries have '33.6 m net undeveloped acres' and '~5.8 bn boe' of reserves. The ground truth shows 640 thousand net acres and 1,315 million barrels - a massive discrepancy (33.6M vs 640K acres is off by ~52x; 5.8B vs 1.315B barrels is off by ~4.4x). These are not minor rounding differences but fundamental data errors. (2) CALCULATION ERRORS: The LLM calculates equity companies at '~80 k boe per acre' which is incorrect. Ground truth shows 1,503 million barrels / 19 thousand acres = 79.1 million barrels per thousand acres (or ~79.1 barrels per acre when properly normalized). The LLM's '80 k boe per acre' is off by a factor of 1,000. For consolidated subsidiaries, the LLM states '~170 boe per acre' but ground truth shows 1,315M / 640K = 2.05 million barrels per thousand acres (or ~2.05 barrels per acre). The LLM's figure is off by ~83x. (3) MULTI-HOP REASONING: While the LLM correctly identifies that equity companies are more efficient than consolidated subsidiaries, the underlying numbers are so wrong that this conclusion is based on false data. The direction of the comparison is correct but the magnitude of difference is completely misrepresented. (4) ENTITY ACCURACY: The LLM correctly identifies Asia, equity companies, and consolidated subsidiaries, but fails to accurately report the financial metrics associated with each. (5) SEMANTIC ISSUES: The LLM uses 'boe' (barrels of oil equivalent) when the ground truth specifically references 'barrels' for proved undeveloped reserves - this is a minor terminology issue but adds to the overall inaccuracy. The core insight about relative efficiency is directionally correct, but the quantitative foundation is severely flawed, making this answer unreliable for decision-making.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 520,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "\nThe Parent Company’s unconditional guarantee of the securities issued by Morgan Stanley Finance LLC makes the Parent the sole, senior obligor on that debt, providing a direct credit backstop for the subsidiary’s securities.  This guarantee is a central component of the Firm’s amended and restated support agreement—under a resolution scenario the Parent (and the Funding IHC) must contribute all of its contributable assets to its supported entities, and the guaranteed securities represent a senior claim that the Parent must honor, thereby linking the guarantee to the broader obligation to supply capital and liquidity to its subsidiaries in a resolution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the interconnected financial mechanisms and correctly identifies the key elements of the guarantee and support agreement structure. STRENGTHS: (1) Accurately captures that the Parent Company provides an unconditional guarantee of Morgan Stanley Finance LLC's securities; (2) Correctly identifies the Parent as the senior obligor with direct credit backstop; (3) Properly synthesizes the multi-hop relationship between the guarantee and the amended/restated support agreement; (4) Accurately describes the resolution scenario obligations (contributing all contributable assets to supported entities and Funding IHC); (5) Correctly explains the linkage between the guarantee and broader capital/liquidity obligations; (6) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The phrase 'central component of the Firm's amended and restated support agreement' could be slightly misleading—the guarantee itself is not technically part of the support agreement, but rather a separate mechanism that operates in parallel with it during resolution scenarios. The ground truth more precisely describes them as 'interconnected' rather than one being a 'central component' of the other; (2) The answer could have been slightly more explicit about the Funding IHC's specific role in distributing capital and liquidity, though this is implied; (3) Minor semantic difference: the ground truth emphasizes these are 'interconnected mechanisms' while the LLM frames it as the guarantee being 'a central component' of the support agreement—a subtle but meaningful distinction in how the relationship is characterized. The LLM answer is substantively correct and demonstrates solid multi-hop reasoning across the guarantee, support agreement, and resolution scenario contexts, but the characterization of the relationship between these mechanisms is slightly less precise than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 526,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "\nThe Bipartisan Budget Act of 2015 lets the IRS determine any audit adjustment to a partnership’s tax items **at the partnership level**, so that if a joint‑venture entity in which SPG holds an interest—whether it is owned directly, through a third‑party manager such as Klépierre or The Taubman Realty Group, LLC, or via other platform investments—is later found to owe additional tax, interest or penalties, those liabilities are assessed to the partnership itself. Because SPG is a partner in those ventures, it may be required to bear a portion of those costs even though the REIT structure would normally avoid corporate‑level tax on the income, potentially creating unexpected financial obligations for SPG. (Page 22)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism of the Bipartisan Budget Act of 2015's partnership tax audit rules and accurately explains how they affect SPG through its joint venture investments. The explanation of partnership-level tax assessment, interest, and penalties is accurate and well-articulated. The mention of Klépierre and The Taubman Realty Group, LLC as third-party managers is correct.\n\nHowever, there is a significant quantitative omission: The original answer specifically references '84 joint venture properties and entities,' which is a concrete, verifiable number from SPG's filings. The LLM answer fails to include this specific quantitative detail, instead using vague language like 'joint-venture entity' and 'platform investments' without the numerical specificity. This is a material omission for a multi-hop financial question where precision matters.\n\nThe LLM answer also omits the explicit mention that SPG 'applies the equity method of accounting to these joint ventures,' which is an important technical accounting detail that explains why SPG bears the economic burden. The answer does convey the essence of this (SPG as a partner may bear costs), but lacks the specific accounting methodology reference.\n\nThe reasoning about REIT structure avoiding corporate-level tax is sound and well-explained. The multi-hop synthesis connecting the Act's rules → partnership-level assessment → SPG's exposure through joint ventures is logically correct. The semantic meaning is largely equivalent to the ground truth, though less comprehensive.\n\nThe citation '(Page 22)' appears to be an attempt at source attribution but cannot be verified as accurate without the original document.\n\nStrengths: Correct mechanism explanation, proper entity identification, sound logic on tax implications. Weaknesses: Missing the '84 joint venture properties' quantitative detail, omitting equity method accounting reference, less comprehensive than ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 535,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "\nThe 2020 $128 million pre‑tax impairment of the AMMROC investment produced a $96 million after‑tax charge that reduced net earnings by roughly $96 million and trimmed diluted earnings per share by about $0.34. In 2021, the $36 million pre‑tax severance and restructuring charge in RMS generated a $28 million after‑tax expense that lowered net earnings by approximately $28 million and cut diluted EPS by roughly $0.10.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) 2020 AMMROC impairment: $128M pre-tax, $96M after-tax impact on net earnings, $0.34 per share - all verified; (2) 2021 RMS restructuring: $36M pre-tax, $28M after-tax, $0.10 per share - all verified. The multi-hop synthesis is sound, correctly connecting pre-tax charges to after-tax impacts and per-share results for both years. The answer properly addresses both components of the question and their respective impacts. Minor stylistic differences from ground truth (e.g., 'roughly,' 'approximately,' 'trimmed,' 'cut') represent acceptable semantic variations that don't affect factual accuracy. The LLM correctly identified all entities (Lockheed Martin, AMMROC, RMS), years (2020, 2021), and metrics (net earnings, diluted EPS). The reasoning chain from pre-tax charges through tax effects to per-share impacts is logically sound and complete. No calculation errors detected. The answer is appropriately focused on the specific question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 302,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "\nThe balance of channel‑partner financing that Cisco guarantees fell from **$1.7 billion at the end of fiscal 2023 to $1.2 billion at the end of fiscal 2024**, a **$0.5 billion (≈ 29 %) decrease** year‑over‑year.  \n\nBecause these guarantees represent only a modest contingent cash outflow, the decline further eases the cash‑flow pressure associated with Cisco’s contractual obligations.  In the MD&A, Cisco emphasizes that its cash, cash equivalents, operating cash flow and access to capital markets are more than sufficient to meet all liquidity and capital‑resource requirements—including working‑capital needs, capital expenditures, dividends, share repurchases, debt service and pending acquisitions—so the lower guaranteed‑financing balance reinforces that confidence in its overall liquidity position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - the balance decreased from $1.7 billion (FY2023) to $1.2 billion (FY2024), representing a $0.5 billion decrease. The percentage calculation of approximately 29% is accurate (0.5/1.7 ≈ 0.294 or 29.4%). ENTITY ACCURACY: Correctly identifies Cisco, fiscal years 2023 and 2024, channel partner financing guarantees, and MD&A section. MULTI-HOP REASONING: The answer successfully synthesizes information across two sources: (1) the specific financial metric of guaranteed financing balances and their year-over-year change, and (2) Cisco's MD&A statements about liquidity and capital resources. The logical connection is sound - the decrease in guaranteed financing is correctly contextualized within Cisco's broader liquidity position. COMPLETENESS: The answer addresses both parts of the question: the YoY change in the specific metric AND how it relates to overall liquidity/capital requirements. SEMANTIC EQUIVALENCE: The LLM's explanation that the decline 'eases cash-flow pressure' and 'reinforces confidence' in liquidity position accurately conveys the relationship stated in the ground truth. The additional context about dividends, share repurchases, debt service, and acquisitions adds relevant detail consistent with typical MD&A disclosures. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail than the ground truth (e.g., characterizing guarantees as 'modest contingent cash outflow'), but this is reasonable elaboration that doesn't contradict the source material. The answer is well-structured and clearly presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 455,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "\nThe filing lists two separate “Investments measured at NAV” figures: $4,432 million in the pension‑plan assets table (page 94) and $3 million in the other investment summary (page 107). The pension‑plan category is larger, so the difference between the two is $4,429 million, and that category has the higher value.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states the two asset categories have 'Investments measured at NAV' values of $2,656 million and $3 million, with a difference of $2,653 million. The LLM instead reports $4,432 million and $3 million, with a calculated difference of $4,429 million. This represents a major factual error - the LLM's first figure ($4,432M) is completely wrong and does not match the ground truth ($2,656M). The calculation itself is arithmetically correct ($4,432M - $3M = $4,429M), but it is based on incorrect source data. The LLM correctly identifies that the first category has the higher value and correctly identifies the second category as $3 million, but the primary figure is wrong by approximately $1,776 million. The LLM also appears to have referenced different pages (94 and 107) and different table contexts (pension-plan assets vs other investment summary) than what the ground truth indicates, suggesting the LLM may have pulled data from incorrect sections of the filing. This is a critical failure in multi-hop synthesis - the model failed to identify the correct 'Investments measured at NAV' figures from the two disclosed asset categories in the 2024 VZ 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 349,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "\nAbbott’s strategic emphasis on Diabetes Care devices—particularly its continuous‑glucose‑monitoring (CGM) systems—drove the 18.1 % jump in Diabetes Care sales to $6.8 bn in 2024 (up from $5.8 bn in 2023), as shown in the 10‑K sales table.  This growth reflects the company’s focus on expanding CGM volumes and related product sales, which is explicitly highlighted in the filing’s narrative on Diabetes Care.  The revenue is recognized under Abbott’s revenue‑recognition policy (Note 1), which records product sales when control transfers (generally upon shipment) and allocates the transaction price for multiple performance obligations while estimating rebates, returns and other incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The 18.1% revenue increase is correct. The 2024 revenue of $6.8 billion matches the ground truth ($6.805 billion, with acceptable rounding). The prior year calculation of $5.8 billion is mathematically sound ($6.805B / 1.181 ≈ $5.76B, rounds to $5.8B), confirming the growth rate. ENTITY ACCURACY: Abbott is correctly identified, the Diabetes Care business segment is properly referenced, and the 2024 fiscal year is accurate. MULTI-HOP REASONING: The answer successfully synthesizes three required elements: (1) Abbott's production focus on Diabetes Care Devices (specifically CGM systems), (2) the 18.1% revenue increase with supporting numbers, and (3) the accounting policy for revenue recognition. The connection between product focus and revenue growth is logically established. ACCOUNTING POLICY: The LLM correctly identifies the revenue recognition policy as occurring upon transfer of control (shipment/delivery), matching the ground truth. The additional detail about allocating transaction prices for multiple performance obligations and estimating rebates/returns adds relevant context not contradicting the ground truth. MINOR DIFFERENCES: The LLM provides more specific product detail (CGM systems) and mentions Note 1 reference, which enhances the answer without introducing errors. The ground truth uses more general language ('Diabetes Care Devices'), while the LLM is more specific—both are accurate. COMPLETENESS: All three parts of the multi-part question are addressed: production focus, revenue increase relationship, and accounting policy support. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 471,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "\nBoth the “Competition and Seasonality” sections (pages 13 and 14) note that Pros specifically look for dedicated sales support, competitive credit and pricing, and—most importantly—project‑planning tools to manage complex purchases. By investing in and highlighting robust project‑planning tools, Home Depot meets that expectation and differentiates itself from other retailers, reinforcing its competitive positioning with professional customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual content. Both answers correctly identify that Home Depot's project planning tools address Pro customer needs for dedicated sales support, competitive pricing/credit, and complex purchase management. The LLM answer appropriately cites the specific page references (pages 13-14 of the 2024 10-K) and accurately captures the competitive positioning argument. No quantitative errors are present (no numbers to verify). The multi-hop reasoning is sound—the answer correctly synthesizes that project planning tools meet Pro expectations and thereby differentiate Home Depot competitively. Minor differences in wording exist: the ground truth emphasizes 'product depth' and 'job-lot quantities' as specific needs, while the LLM answer focuses more broadly on 'complex purchases' without explicitly mentioning product depth or job-lot quantities. The ground truth also mentions 'interconnected shopping experience' as a critical retention/attraction mechanism, which the LLM answer doesn't explicitly address. However, these are relatively minor omissions that don't fundamentally undermine the answer's correctness. The LLM answer is well-structured, directly addresses the question, and provides appropriate context about where this information appears in the filing. The reasoning connecting project planning tools to competitive positioning is logically sound and matches the ground truth's core argument.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 411,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "\nAs of the end of 2024, the remaining share authorizations were 47,088,821 under the 2003 Incentive Program, 238,700 under the 2004 Non‑Employee Director Restricted Stock Plan, and 9,362,383 under the Pioneer Natural Resources Company Amended and Restated 2006 Long‑Term Incentive Plan.  Adding these amounts gives a total of 56,689,904 shares available for award.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numeric values match the ground truth exactly: 47,088,821 shares (2003 Incentive Program), 238,700 shares (2004 Non-Employee Director Restricted Stock Plan), and 9,362,383 shares (Pioneer LTIP). The calculation is correct: 47,088,821 + 238,700 + 9,362,383 = 56,689,904 total shares. All three plans are correctly identified with proper naming conventions. The answer addresses all parts of the multi-hop question by synthesizing information across three separate equity plans and providing both the individual amounts and the total. The reasoning is sound and the presentation is clear. The LLM correctly interpreted the question as asking for shares 'available for award' (remaining authorized shares) as of end of 2024, which aligns with the ground truth interpretation. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 260,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "\nThe 2023 re‑classification of Customer receivables required an adjustment that **reduced interest income by $4.432 billion and also reduced interest expense by $4.432 billion**—with the entire impact recorded in the **Institutional Securities segment** and no net effect on net interest income. The explicit financial‑adjustment amount tied to this change is **$4,432 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that the reclassification resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment, with no net effect on net interest income. (2) QUANTITATIVE ACCURACY: The numeric value of $4,432 million is stated correctly in multiple formats ($4.432 billion and $4,432 million), demonstrating proper understanding of number equivalence. The calculation logic is sound—equal reductions to both income and expense result in zero net impact. (3) QUALITATIVE ACCURACY: The answer properly synthesizes the multi-hop information: identifies the specific event (2023 reclassification of Customer receivables), the affected segment (Institutional Securities), the dual impact (both interest income and interest expense), and the net result (no effect on net interest income). The reasoning is logically sound and complete. (4) ENTITY ACCURACY: All entities are correctly identified—the year (2023), the segment (Institutional Securities), and the financial metrics (interest income, interest expense, net interest income). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'reduced interest income by $4.432 billion and also reduced interest expense by $4.432 billion' is semantically equivalent to the ground truth's '$4,432 million decrease to both interest income and interest expense.' The only minor distinction is the format variation (billion vs. million), which is explicitly acceptable per evaluation guidelines. The answer addresses all parts of the multi-part question comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 461,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "\nThe disclosures indicate that $133 million was excluded from hedge effectiveness for net‑investment hedge derivatives in 2019 and $75 million in 2021, for a combined total of $208 million. These excluded amounts relate to the net‑investment hedge program, which includes cross‑currency interest‑rate swaps and forward contracts (and, in practice, also non‑U.S.‑dollar‑denominated debt used to hedge net investments).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - $133 million for 2019, $75 million for 2021, and the combined total of $208 million are all accurate. The calculations are correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the total amounts excluded from hedge effectiveness for 2019 and 2021 combined ($208 million), and (b) the types of contracts included in net investment hedge derivatives. (3) ENTITY ACCURACY: All entities are correctly identified - the years (2019, 2021), the metric (amounts excluded from hedge effectiveness), and the derivative type (net investment hedge derivatives) are all accurate. (4) REASONING: The multi-hop synthesis is sound - the model correctly combined the 2019 and 2021 figures to arrive at the combined total, and properly identified the contract types. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth. The LLM provides slightly more context by mentioning non-U.S.-dollar-denominated debt as an additional component of the net investment hedge program, which is supplementary information that enhances rather than contradicts the ground truth. The only minor distinction is that the ground truth lists 'cross-currency interest rate swaps and forward contracts' while the LLM answer includes these plus mentions non-U.S.-dollar-denominated debt, which represents a more complete disclosure of the program components. This additional detail does not contradict the ground truth and demonstrates thorough understanding of the disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 442,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "\nThe 2021 amendments raised the Credit Facility to a total capacity of **$5.0 billion** and the Supplemental Facility to **$4.5 billion**, for a combined borrowing capacity of **$9.5 billion**. This total capacity far exceeds the **$2.1 billion** maximum aggregate outstanding balance that was actually recorded under the Facilities during the year ended December 31, 2021, showing that the company used only a small portion of its available credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. QUANTITATIVE VERIFICATION: All dollar amounts are correct - Credit Facility at $5.0 billion, Supplemental Facility at $4.5 billion, combined total of $9.5 billion, and maximum aggregate outstanding balance of $2.1 billion. The arithmetic is accurate (5.0 + 4.5 = 9.5). COMPLETENESS: The answer addresses both parts of the question: (1) the total combined borrowing capacity after 2021 amendments, and (2) the relationship to the maximum aggregate outstanding balance. ENTITY ACCURACY: Correctly identifies Simon Property Group's facilities, the 2021 amendments, and the year ended December 31, 2021. MULTI-HOP REASONING: Successfully synthesizes information across multiple data points - the individual facility capacities, their combined total, and the actual usage metric - to provide a comprehensive answer. SEMANTIC EQUIVALENCE: The LLM's phrasing 'far exceeds' and 'used only a small portion' effectively conveys the same comparative relationship as the ground truth's 'significantly lower than the total borrowing capacity, indicating conservative leverage usage.' The only minor distinction is that the ground truth explicitly mentions the calculation breakdown (initial amounts plus increases), while the LLM presents the final amended amounts directly. This is a negligible omission that doesn't affect the core answer's accuracy or completeness. The answer demonstrates sound financial reasoning and appropriate contextualization.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 422,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "\nThe higher risk‑retirement estimates on the Black Hawk and CH‑53K helicopter programs allowed Lockheed Martin to book additional profit on those contracts, which directly added roughly **$140 million** to the Rotary and Mission Systems (RMS) operating‑profit increase in 2021. This gain was part of the $183 million (11 %) rise in RMS operating profit reported for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative verification: (1) $140 million contribution from risk retirements on Black Hawk and CH-53K programs - CORRECT, matches ground truth exactly; (2) $183 million total increase in RMS operating profit - CORRECT; (3) 11% percentage increase - CORRECT. Entity accuracy: Correctly identifies Rotary and Mission Systems (RMS) as the business segment, correctly names the helicopter programs (Black Hawk and CH-53K), and correctly identifies the year as 2021. Multi-hop reasoning: The answer properly synthesizes that risk-retirement estimates led to additional profit booking on specific contracts, which contributed to the overall segment profit increase. The answer correctly contextualizes the $140 million contribution as part of a larger $183 million increase, acknowledging other contributing factors. Semantic equivalence: The LLM uses 'higher risk-retirement estimates' and 'book additional profit' which accurately conveys the same meaning as 'increase in risk retirements' from the ground truth. Minor note: The LLM answer uses slightly more explanatory language ('allowed Lockheed Martin to book additional profit') compared to the ground truth's more direct statement, but this adds clarity without introducing inaccuracy. The answer fully addresses both parts of the multi-part question: (1) how the increase contributed (mechanism), and (2) the specific dollar amount ($140 million).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 410,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "\nIn 2021 the energy‑related derivatives reduced Southern Company’s natural‑gas revenue by $117 million and added a $27 million charge to cost of natural gas, for a combined negative impact of roughly $144 million; in 2019 they produced a $223 million gain in revenue and a $10 million gain in cost, for a combined positive $233 million. Thus the 2021 effect was opposite in sign and about $377 million smaller than the 2019 impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) 2021 impact: -$117M (revenue) + $27M (cost) = -$144M total ✓ matches ground truth; (2) 2019 impact: $223M (revenue) + $10M (cost) = $233M total ✓ matches ground truth; (3) Year-over-year difference: -$144M - $233M = -$377M ✓ correctly calculated and described as '$377 million smaller' or 'opposite in sign'. The LLM properly broke down the components (natural gas revenues vs. cost of natural gas) and showed the calculation for each year. The synthesis across multiple data points (2021 and 2019 figures) is sound. The only minor note is that the LLM used '$223 million' for 2019 revenue when ground truth shows '$233 million' combined, but the LLM correctly reconciles this by showing $223M + $10M = $233M, indicating the component breakdown is accurate. The answer directly addresses all parts of the multi-part question: the 2021 total impact, the 2019 total impact, and the comparison between years. The reasoning is clear and the conclusion about the $377 million difference is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 309,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "\nThe loss recorded on Cisco’s privately‑held investments fell from **$193 million in fiscal 2023 to $164 million in fiscal 2024**, a **$29 million improvement**.  Because this component contributed to the overall investment result, the total net gain/loss on investments narrowed from a **$177 million loss in 2023 to a $166 million loss in 2024**, improving the overall investment result by roughly **$11 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) Privately held investment losses decreased from $193 million (2023) to $164 million (2024) - correct; (2) The $29 million improvement calculation is accurate ($193M - $164M = $29M); (3) Overall net losses on investments improved from $177 million loss (2023) to $166 million loss (2024) - correct; (4) The $11 million positive shift calculation is accurate ($177M - $166M = $11M). The multi-hop reasoning is sound - the model correctly synthesized that the improvement in privately held investment losses contributed to the overall improvement in net investment results. The answer properly identifies the causal relationship between the two metrics. The wording uses 'fiscal 2023' and 'fiscal 2024' which adds appropriate context. The phrase 'narrowed from a $177 million loss...to a $166 million loss' effectively conveys the improvement. Minor note: The LLM uses 'roughly $11 million' while the ground truth states '$11 million' - this is a negligible difference and the word 'roughly' is actually reasonable given the context of discussing related but distinct metrics. All entities (Cisco, investments, years) are correctly identified. The answer fully addresses both parts of the multi-part question: the change in privately held investment losses AND the impact on overall net gains/losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 386,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "\nIn 2024 Verizon made $4.5 billion of principal repayments tied to anticipated redemptions of its ABS Notes.  By contrast, the combined outstanding balance of the 2021 and 2022 ABS Financing Facilities stood at $13.0 billion ( $8.0 billion under the 2021 facility plus $5.0 billion under the 2022 facility) as of December 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) Principal repayment amount of $4.5 billion in 2024 - CORRECT; (2) 2021 ABS Financing Facility outstanding balance of $8.0 billion as of Dec 31, 2024 - CORRECT; (3) 2022 ABS Financing Facility outstanding balance of $5.0 billion as of Dec 31, 2024 - CORRECT; (4) Combined total of $13.0 billion ($8.0B + $5.0B) - CORRECT. The LLM correctly performed the arithmetic synthesis across the two facilities. Multi-hop reasoning: The answer successfully synthesizes information from multiple data points (2024 redemptions, 2021 facility balance, 2022 facility balance) and makes the appropriate comparison showing that the combined outstanding balance ($13.0B) significantly exceeds the 2024 repayments ($4.5B). Entity accuracy: Correctly identifies VZ/Verizon, ABS Notes, and the specific financing facilities by year. The only minor distinction from the ground truth is stylistic - the LLM uses parenthetical notation to show the calculation breakdown, while the ground truth presents it more narratively. This is a semantic difference that enhances clarity rather than detracting from accuracy. All factual content matches the ground truth precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 356,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "\nThe CECL transition provisions keep the remaining $720 million CECL benefit in CET1 capital and require that certain First‑Republic assets be risk‑weighted with the Standardized approach rather than the Advanced approach; this treatment is reflected in the Tier 1 leverage ratio by adjusting the denominator (average assets) for goodwill, intangibles and the CECL‑related benefit. As a result, the Standardized approach determines the RWA for those First‑Republic exposures, influencing the capital ratios while the leverage ratio’s adjusted‑asset calculation incorporates the same CECL‑transition adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about CECL capital transition provisions and their impact on Tier 1 leverage ratio and Standardized approach application to First Republic assets. However, there are significant issues:\n\n(1) QUANTITATIVE ACCURACY - MAJOR PROBLEM: The LLM introduces a specific dollar figure ($720 million CECL benefit in CET1 capital) that is NOT present in the original answer and cannot be verified against the ground truth. This is a critical error as the evaluation criteria emphasize strictness on numbers. The original answer does not cite any specific dollar amounts, and introducing unsourced numbers significantly undermines credibility.\n\n(2) CORRECTNESS OF CORE CONCEPTS: The LLM correctly identifies that:\n- CECL transition provisions affect Tier 1 leverage ratio calculation\n- Adjustments to quarterly average assets occur\n- Goodwill and intangibles are deducted from Tier 1 capital\n- Standardized approach applies to First Republic assets\n- These provisions influence capital metrics and leverage ratio computation\n\n(3) MULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting:\n- CECL provisions → CET1 capital treatment\n- First Republic assets → Standardized approach application\n- Both effects → Tier 1 leverage ratio and RWA calculations\nThis reasoning is logically sound and addresses the interconnected nature of the question.\n\n(4) SEMANTIC EQUIVALENCE: The LLM's explanation of how adjustments to the denominator (average assets) incorporate goodwill, intangibles, and CECL-related benefits is semantically equivalent to the ground truth's description of adjusting quarterly average assets for on-balance sheet deductions.\n\n(5) COMPLETENESS: The LLM answer is more detailed than the original, explaining the mechanism more thoroughly. However, this added detail includes the unsourced $720 million figure, which is problematic.\n\n(6) ENTITY ACCURACY: JPMorgan Chase and First Republic are correctly identified; financial metrics (Tier 1 leverage ratio, RWA, CET1 capital, Standardized approach) are correctly named.\n\nThe primary issue preventing a higher score is the introduction of a specific quantitative claim ($720 million) that cannot be verified and is not in the ground truth. This violates the strict evaluation standard for numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 625,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "\nSimon maintains board independence and ethical conduct through a formal Code of Business Conduct and Ethics, a board composition that requires a majority – in fact at least three‑quarters – of its directors to qualify as independent under NYSE rules, and the mandatory use of only independent directors (who also meet the NYSE’s financial‑expert requirements) on its audit, compensation and human‑capital committees. These practices directly satisfy NYSE listing standards that require a majority‑independent board, independent audit and compensation committees, and the disclosure of independence and ethical‑conduct policies.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE INACCURACY: The LLM states that Simon requires 'at least three-quarters' of directors to be independent. The ground truth clearly states 'at least a majority of the Board are independent.' Three-quarters (75%) is significantly different from a majority (50%+), and this is a factual error that materially misrepresents Simon's governance policy. This is a major quantitative accuracy failure. CORRECT ELEMENTS: (1) Code of Business Conduct and Ethics - correctly identified; (2) Board independence requirement - correctly identified as a core policy, though the percentage is wrong; (3) Independent committee composition (Audit, Compensation, Human Capital) - correctly stated; (4) NYSE alignment - correctly noted. MISSING/INCOMPLETE ELEMENTS: (1) The ground truth mentions 'governance principles' that outline function, conduct, selection, orientation, and duties - the LLM does not mention these broader governance principles; (2) The ground truth specifies 'written charters for each of the standing committees' - the LLM does not mention written charters; (3) The ground truth notes the requirement that independent directors 'not be affiliated with the Simon family' - this specific detail is omitted by the LLM. MULTI-HOP REASONING: The LLM does attempt to synthesize the connection between Simon's policies and NYSE requirements, which is appropriate. However, the factual error regarding the percentage of independent directors undermines the credibility of this synthesis. The reasoning structure is sound but built on an incorrect foundation. SEMANTIC ISSUES: While the LLM's wording differs from the ground truth, the semantic meaning should be equivalent - except for the critical three-quarters vs. majority discrepancy. This single quantitative error is severe enough to significantly lower the overall correctness score, as it represents a material misstatement of a key governance metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 522,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "\nThe percentage‑of‑completion cost‑to‑cost method forces Lockheed Martin to continually update its “estimate‑at‑completion” for each long‑term contract; when the estimated total cost of a contract is revised, the contract’s profit‑booking rate is adjusted accordingly. If the estimate of total cost falls (e.g., risks are retired), the profit‑booking rate rises and more profit is recognized; if the estimate rises, the rate falls and profit recognized is reduced. These revisions are recorded in the accounting period in which the estimate is changed, so the change in profit booking rate directly impacts earnings in that period and can materially affect reported results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lockheed Martin's percentage-of-completion cost-to-cost method and its impact on profit booking rates. STRENGTHS: (1) Correctly explains the core mechanism: when estimated total costs decrease, profit booking rates increase, and vice versa; (2) Accurately identifies that changes are recognized in the period determined; (3) Properly explains the cause-and-effect relationship (risk retirement leading to lower estimates and higher profit rates); (4) Correctly notes the impact on reported earnings and segment results; (5) No quantitative errors or incorrect numbers/dates. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different terminology ('estimate-at-completion' vs the ground truth's more general 'estimated total costs to complete') but this is semantically equivalent and actually more precise; (2) The LLM answer emphasizes the 'inception-to-date effect' concept less explicitly than the ground truth, though it's implied in the discussion of period-by-period recognition; (3) The LLM answer adds helpful context about 'materially affect reported results' which enhances understanding without contradicting the ground truth. The answer successfully synthesizes the multi-hop relationship between: (a) the accounting method used, (b) how cost estimate changes affect it, (c) the resulting impact on profit booking rates, and (d) the financial statement effects. All core facts align with the ground truth, and the reasoning is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 417,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "\nThe APJC region’s services revenue rose by $89 million, a 4 % increase from 2023 to 2024, while the total balance (goodwill) for APJC grew by $2.826 billion; together the increase totals roughly $2.915 billion, which far exceeds the modest 4 % services‑revenue growth rate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE DISCREPANCY: The LLM states the combined increase is 'roughly $2.915 billion' ($89M + $2.826B), but the ground truth clearly states the combined increase is $8,447 million ($8.447 billion). This is a massive error - the LLM's figure is off by approximately $5.532 billion (65% understatement). (2) TOTAL BALANCE FIGURE ERROR: The LLM claims Total Balance increased by $2.826 billion, but ground truth shows $8,358 million ($8.358 billion) increase. The LLM's figure is drastically understated by $5.532 billion. (3) SERVICES REVENUE: Correctly identified as $89 million increase and 4% growth - this part is accurate. (4) MULTI-HOP REASONING: While the LLM correctly identifies the need to combine Services Revenue and Total Balance increases and compare to percentage growth, the fundamental calculation is wrong due to the incorrect Total Balance figure. (5) SEMANTIC ISSUES: The LLM characterizes the combined increase as 'far exceeding' the 4% growth rate, which is a reasonable comparative statement, but this conclusion is based on incorrect underlying numbers. The ground truth's $8,447 million combined increase is substantially larger than what the LLM calculated. The core failure is the Total Balance metric - the LLM appears to have confused or misidentified the correct figure, leading to a cascading error in the combined total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 387,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "\nAs of December 31 2024 Abbott’s interest‑rate hedge contracts had a notional amount of **≈ $2.2 billion**, while its foreign‑currency forward contracts totaled **≈ $23.2 billion** (the table on page 41 shows a total contract amount of $23,191 million). Together these derivatives represent a **combined notional exposure of roughly $25.4 billion**. By hedging both the interest‑rate risk on its debt and the foreign‑exchange risk on anticipated purchases, intercompany loans and trade payables, Abbott limits the effect of market‑price and currency movements on earnings and cash flow, illustrating its strategy of proactively managing market risk to stabilize profitability and protect its financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - interest rate hedge contracts at $2.2 billion, foreign currency forward contracts at $23.2 billion (with the LLM correctly noting the $23,191 million figure from the filing), and the combined total of $25.4 billion. The LLM appropriately uses approximation symbols (≈) given the rounding involved, which is appropriate for financial reporting. COMPLETENESS: The answer addresses both components of the question - the specific notional values and Abbott's risk management strategy. The LLM correctly identifies the breakdown of foreign currency contracts ($7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables, though not explicitly stated in the LLM answer, the total is correct). ENTITY ACCURACY: Abbott is correctly identified, December 31, 2024 is the correct date, and all financial instruments are properly named and categorized. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the specific derivative instruments to Abbott's broader risk management strategy, explaining how interest rate hedges convert fixed-rate debt to variable-rate debt and how foreign exchange contracts hedge both anticipated purchases and existing obligations. The explanation of how these instruments limit earnings and cash flow volatility demonstrates proper understanding of the strategic purpose. MINOR OBSERVATIONS: The LLM answer is slightly less explicit about the specific breakdown of the $23.2 billion foreign currency contracts (intercompany purchases vs. loans/payables), but this is a minor omission that doesn't affect the core correctness of the answer. The semantic equivalence is strong throughout, with clear and professional presentation of the financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 507,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "\nMcDonald’s consolidates only its own subsidiaries and any entities in which it holds a controlling interest; franchise‑owned restaurants, joint‑venture partners, developmental licensees and other franchisees are generally **not consolidated** because they are accounted for under the equity‑method (for 50 %‑or‑less affiliates) or qualify for the variable‑interest‑entity scope exception, and the company’s note explicitly states that “the results of operations of restaurant businesses purchased and sold in transactions with franchisees were not material either individually or in the aggregate” [page 43‑45]. Consequently, the only financial effect of franchise relationships on the consolidated statements is the recognition of rent, royalty and initial‑fee revenue (and related cost allocations) rather than the inclusion of franchisees’ assets, liabilities or operating results, making the operational impact of franchisees immaterial to the overall consolidated financial picture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that franchisees are NOT consolidated into MCD's consolidated financial statements, matching the ground truth. (2) Accurately cites the materiality threshold - 'results of operations of restaurant businesses purchased and sold in transactions with franchisees were not material either individually or in the aggregate' - which directly aligns with the original answer's core statement. (3) Properly explains the dual accounting treatment: equity method for 50%-or-less affiliates AND variable interest entity scope exception, both of which are mentioned in the ground truth. (4) Correctly identifies the financial effects that DO appear: rent, royalty, and initial-fee revenue rather than consolidated operating results. (5) Appropriately cites page references (43-45) showing source documentation. (6) Demonstrates sound multi-hop reasoning by synthesizing consolidation policy, materiality assessment, and VIE guidance into a coherent explanation. (7) Correctly identifies all relevant entity types (franchise-owned restaurants, joint-venture partners, developmental licensees). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and comprehensive than the ground truth (explaining equity method treatment and revenue recognition), but this represents added value rather than inaccuracy. The semantic meaning is fully aligned with the original answer - both convey that franchisees are not consolidated due to materiality and VIE scope exceptions. No numerical errors, calculation errors, or factual inaccuracies detected. The answer directly addresses all aspects of the question regarding operational materiality and consolidation policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 475,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "\nThe Supplementary Leverage Ratio is calculated as Tier 1 capital divided by **total leverage exposure**, which is defined as **adjusted average assets (average on‑balance‑sheet assets net of deductions such as goodwill and other intangibles) plus off‑balance‑sheet exposures** (e.g., derivatives, securities‑lending positions). Because the off‑balance‑sheet items are **added to the denominator**, they increase total leverage exposure and therefore tend to **lower the SLR**; the “adjusted average assets” figure also expands the denominator after the required deductions are applied.  \n\nIf the resulting SLR falls below the regulatory minimum (the table on page 104 shows a required SLR of **5 %**, while the firm’s reported SLR is 6.1 %), the firm becomes subject to supervisory restrictions—including limits on dividend payments, share‑repurchases, and discretionary bonus payments—and may be required to raise additional capital or reduce its leverage to restore compliance. (Pages 103, 104, 163).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies SLR formula as Tier 1 capital divided by total leverage exposure; (2) Accurately explains that adjusted average assets include deductions for goodwill and intangibles; (3) Correctly states that off-balance sheet exposures are added to the denominator, thereby lowering the SLR; (4) Accurately cites the 5% regulatory minimum threshold (3.0% minimum + 2.0% buffer = 5.0%); (5) Correctly identifies consequences including restrictions on dividends, share repurchases, and discretionary bonuses; (6) Provides specific page references (103, 104, 163) and JPMorgan Chase's actual reported SLR of 6.1%; (7) Multi-hop reasoning is sound—properly synthesizes how off-balance sheet items and adjusted assets impact the calculation and consequences. MINOR ISSUES: (1) The ground truth states the threshold as '3.0% minimum plus 2.0% leverage buffer (totaling 5.0%)' while the LLM states 'required SLR of 5%'—this is semantically equivalent but the LLM doesn't explicitly break down the components; (2) The LLM mentions 'may be required to raise additional capital or reduce its leverage' which goes slightly beyond the ground truth's focus on capital distribution restrictions, though this is a reasonable inference about supervisory actions and not incorrect. QUANTITATIVE VERIFICATION: The 5% threshold and 6.1% reported ratio are accurate. The explanation of how off-balance sheet exposures increase the denominator and thus lower the ratio is mathematically sound. COMPLETENESS: The answer addresses all parts of the question—how off-balance sheet exposures and adjusted assets impact the calculation, and what happens if SLR falls below threshold. The answer is comprehensive and well-sourced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 485,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "\nAs of December 31 2021, borrowings under the Credit Facilities totaled $125 million under the revolving Credit Facility plus $1.05 billion under the Supplemental Facility, for a combined outstanding balance of approximately $1.175 billion. The Supplemental Facility’s amended terms allow its borrowing capacity to be increased to $4.5 billion (initially $3.5 billion), so the $1.05 billion outstanding represents roughly 23 percent of that maximum capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $125 million under the Credit Facility, $1.05 billion under the Supplemental Facility, and the combined total of $1.175 billion. The maximum borrowing capacity figures are accurate ($3.5 billion base, increasable to $4.5 billion). The calculation of the percentage (23% of $4.5 billion capacity) is mathematically correct ($1.05B / $4.5B ≈ 23.3%, reasonably rounded). The answer successfully synthesizes multi-hop information by: (1) identifying borrowings across two separate facilities, (2) combining them into a total, and (3) comparing this total to the maximum capacity of the Supplemental Facility. The LLM correctly distinguishes between the initial and increased capacity of the Supplemental Facility. The only minor observation is that the LLM uses \"approximately 23 percent\" which is a reasonable rounding, though the ground truth doesn't explicitly provide this percentage calculation. The answer is well-structured, addresses all parts of the question, and provides additional context (the percentage comparison) that enhances understanding without introducing errors. All entities (Credit Facilities, Supplemental Facility, dates, amounts) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 361,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "\nThe aggregate notional amount of Lockheed Martin’s outstanding interest‑rate swaps was **$500 million at the end of 2021**, down from **$572 million at the end of 2020**. This represents a **decrease of roughly 12.6 %** over the one‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $500 million for 2021, $572 million for 2020, and the percentage decrease of 12.6% is mathematically accurate (($572M - $500M) / $572M = $72M / $572M = 0.1259 or approximately 12.6%). (2) COMPLETENESS: The answer addresses all three components of the question: the 2021 notional amount, the 2020 amount, and the percentage comparison. (3) ENTITY ACCURACY: Correctly identifies Lockheed Martin, the correct metric (interest rate swaps), and the correct time periods (end of 2021 and end of 2020). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and performs the correct calculation to derive the percentage decrease. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('aggregate notional amount' vs 'total notional amount', 'roughly 12.6%' vs 'approximately 12.6%') but these are semantically equivalent and represent acceptable variations. The answer is well-structured, clear, and provides all necessary information with proper context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 325,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "\nThe disagreement forces Georgia Power to absorb construction cost increases that are not recoverable from ratepayers.  It has already recorded a $440 million pre‑tax (≈$328 million after‑tax) charge in the fourth‑quarter 2021 earnings—reflecting the cost‑sharing and tender provisions of the Vogtle joint‑owner agreements—and may need to add up to another $460 million of similar pre‑tax charges, which would further reduce its earnings because those amounts cannot be passed on to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - $440 million pre-tax charge in Q4 2021 (matches ground truth exactly), $460 million potential additional charge (matches ground truth exactly). The after-tax calculation of approximately $328 million ($440M × ~74.5% after-tax rate) is reasonable and adds useful context not contradicting the ground truth. ENTITY ACCURACY: Georgia Power correctly identified, Vogtle joint-owner agreements properly referenced, time period (Q4 2021) accurate. COMPLETENESS: The answer addresses the core question about financial exposure and specific charges. It explains the mechanism (cost-sharing and tender provisions), identifies the recorded charge, and notes the potential future exposure. MULTI-HOP REASONING: The answer correctly synthesizes that (1) disagreement exists over cost-sharing provisions, (2) this results in unrecoverable charges, (3) specific charges are $440M recorded and $460M potential, and (4) these cannot be passed to customers. MINOR OMISSIONS: The answer does not explicitly mention the specific disagreement about the $18.38 billion threshold or the differing interpretations between Georgia Power and other owners regarding when cost-sharing thresholds were met. However, this level of detail about the nature of the disagreement is not essential to answering the core question about financial impact and specific charges. The answer focuses appropriately on the financial consequences rather than the technical dispute details. SEMANTIC EQUIVALENCE: The phrasing differs from ground truth but conveys the same essential information about unrecoverable costs and financial exposure. The addition of after-tax impact enhances rather than detracts from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 488,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "\nAdobe reported **$12.24 billion** of total Digital Media Annual Recurring Revenue (ARR) at the end of fiscal 2021. The Adobe Experience Cloud solution that is specifically designed to manage customer journeys and deliver intelligence for businesses—forming a key part of Adobe’s strategy to strengthen its competitive advantage—is **Customer Journey Analytics** (built on the Adobe Experience Platform).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The Digital Media ARR figure of $12.24 billion is correct and properly formatted. (2) The fiscal 2021 timeframe is accurate. (3) The LLM correctly identifies Adobe Experience Cloud as the relevant solution family. (4) The mention of Adobe Experience Platform is accurate and relevant. WEAKNESSES: (1) The LLM introduces 'Customer Journey Analytics' as the specific solution, which is a narrower/more specific product than what the ground truth identifies. The ground truth points to the Adobe Experience Platform itself as the solution designed to manage customer journeys and deliver intelligence. While Customer Journey Analytics is indeed built on the Adobe Experience Platform and does manage customer journeys, the ground truth answer specifically names 'Adobe Experience Platform' as the answer, not a sub-product of it. (2) This represents a slight deviation from the ground truth's direct answer, though it's not entirely incorrect since Customer Journey Analytics is a component of the Experience Platform. The LLM added specificity that wasn't in the original answer, which could be seen as either helpful detail or as not directly answering what was asked. MULTI-HOP REASONING: The model correctly synthesized information about both the ARR figure and the Experience Cloud solution, demonstrating sound multi-hop reasoning. The connection between the Experience Platform and customer journey management is accurate. OVERALL ASSESSMENT: The quantitative answer is perfect, but the qualitative answer about the specific solution is slightly off-target by naming a sub-product rather than the platform itself as stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 454,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "\nAs of December 31 2024, the interest‑rate hedge contracts had a fair‑value of **$1 million recorded as a receivable** and **$(51) million recorded as a payable** (net liability ≈ $50 million). In 2023 the fair‑value was **$0 receivable** and **$(95) million payable** (net liability ≈ $95 million). Thus the net liability fell by roughly **$45 million**—the payable decreased by about $44 million and a $1 million receivable was added.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2024 fair value components: $1 million receivable and $(51) million payable are correct, with net liability of $50 million correctly calculated; (2) 2023 fair value components: $0 receivable and $(95) million payable are correct, with net liability of $95 million correctly calculated; (3) Year-over-year comparison: The improvement of $45 million is correctly calculated ($95M - $50M = $45M improvement); (4) The LLM correctly identifies the payable decreased by approximately $44 million ($95M - $51M) and a $1 million receivable was added. The answer demonstrates sound multi-hop reasoning by synthesizing receivable and payable positions across two fiscal years and calculating the net change. The presentation is clear with proper notation using parentheses for payables. Minor note: The LLM uses \"roughly\" and \"about\" which appropriately reflects the approximate nature of the $44 million figure (exact difference is $44M), showing appropriate precision awareness. The answer fully addresses all parts of the question including both positions, both years, and the comparison. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 338,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "\nThe discounted future net cash flows from equity companies in Asia total $60.78 billion, which corresponds to roughly 1,433 % of the total proved reserves (oil‑equivalent) for those equity companies in Asia (about 4.24 billion barrels).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains critical factual errors that make it substantially incorrect: (1) CASH FLOW AMOUNT: The LLM correctly states $60.78 billion ($60,780 million), matching the ground truth of $60,780 million. (2) PROVED RESERVES - MAJOR ERROR: The LLM claims 4.24 billion barrels of proved reserves, but the ground truth shows 1,276 million barrels (1.276 billion barrels). This is a massive discrepancy - the LLM overstated reserves by approximately 3.3x. (3) PERCENTAGE CALCULATION - MAJOR ERROR: The LLM calculates 1,433% as the percentage, which is mathematically incorrect even using their own numbers. Using their stated figures: $60,780M / 4,240M barrels = $14.33/barrel, not 1,433%. The correct calculation per ground truth is: $60,780M / 1,276M barrels = $47.63/barrel. The LLM appears to have confused the calculation methodology entirely. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the two key data points (cash flows and reserves) from the filing. The question asks for cash flows 'as a percentage of' reserves, which the LLM interpreted as a percentage but calculated incorrectly. The ground truth provides the ratio as $47.63 per barrel, which is the correct interpretation. (5) ENTITY ACCURACY: Correctly identified ExxonMobil, 2024 10-K, equity companies in Asia, and the relevant metrics. The fundamental issue is the incorrect reserve volume (4.24B vs 1.276B barrels) and the resulting incorrect percentage calculation (1,433% is nonsensical for this context). These are not minor rounding differences but represent fundamental data retrieval and calculation failures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 441,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "\nJPMorgan Chase allocates capital to each Line of Business and to Corporate by measuring those units with the Basel III Standardized RWA framework and then adding the applicable GSIB surcharge; the resulting capital budget is tied to the firm‑wide leverage metrics—specifically the supplementary leverage ratio (SLR) that must be at least 3 % plus the additional 2 % leverage buffer.  Because the firm’s reported SLR is 6.1 %, the capital assigned to each LOB is calibrated to keep the overall leverage ratio well above the regulatory minimum, ensuring strict compliance with the leverage‑based capital requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of JPMorgan Chase's capital allocation framework and correctly identifies the key regulatory requirements. STRENGTHS: (1) Correctly identifies the 3.0% SLR minimum and 2.0% additional leverage buffer, totaling 5.0% combined threshold; (2) Accurately describes the Basel III Standardized RWA and GSIB surcharge as components of capital allocation; (3) Correctly states the firm's reported SLR of 6.1%, which exceeds regulatory minimums; (4) Properly explains that capital allocation to LOBs is calibrated to maintain compliance with leverage-based requirements; (5) Semantic equivalence is strong - the answer conveys the same regulatory framework and capital allocation logic as the ground truth. WEAKNESSES: (1) The LLM answer omits important details about how SLR is calculated (Tier 1 capital divided by total leverage exposure, including quarterly average assets and off-balance sheet exposures); (2) Missing reference to stress scenario simulations and capital depletion analysis, which are mentioned in the ground truth as influencing capital allocation decisions; (3) Does not explicitly mention the consequence of failing to maintain the 5.0% threshold (restrictions on dividends and share repurchases); (4) Less comprehensive in explaining the multi-hop synthesis between RWA/GSIB surcharge and leverage exposure metrics. QUANTITATIVE VERIFICATION: The 3.0% SLR minimum, 2.0% buffer, 5.0% combined threshold, and 6.1% reported SLR are all correct. No calculation errors detected. The answer correctly synthesizes the relationship between risk-weighted assets and leverage ratios, though with less technical depth than the ground truth. Overall, the answer is substantially correct on core facts and regulatory requirements but lacks some technical depth and completeness in explaining the full capital allocation methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 509,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "\nThe combined maximum revolving commitments under the amended Credit Facility and the amended Supplemental Facility total **$5.8 billion** of potential borrowing capacity. Both facilities price Daily‑SOFR loans at the **Adjusted Floating Overnight Daily SOFR Rate plus a margin that varies with the borrower’s credit rating (generally 0.65 %–1.40 %)**, so the interest‑rate structure for Daily‑SOFR borrowings is essentially the same for the two facilities (currently reflecting a spread of roughly SOFR + 72.5 bps).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states total borrowing capacity is $5.8 billion, but the ground truth clearly states $9.5 billion. This is a major factual error representing a $3.7 billion discrepancy (39% understatement). (2) INTEREST RATE STRUCTURE - The LLM provides a range of 0.65%-1.40% margin that 'varies with credit rating,' but the ground truth specifies a fixed rate of SOFR plus 72.5 basis points (0.725%) for both facilities. The LLM does mention 'roughly SOFR + 72.5 bps' parenthetically, but this contradicts the earlier statement about variable margins and creates confusion about whether the rate is fixed or variable. The ground truth indicates the rates are identical and fixed at 72.5 bps, not variable. (3) MULTI-HOP SYNTHESIS - The LLM correctly identifies that both facilities have the same interest rate structure (addressing the comparison aspect), but fails on the primary quantitative component of the question. (4) COMPLETENESS - While the LLM addresses both parts of the question (total capacity and interest rate comparison), the fundamental numbers are wrong. The $5.8 billion figure appears to be incomplete or from a different time period/context than the post-2021 amendment figures requested. The answer demonstrates partial understanding of the facilities but fails on core factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 376,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "\nThe higher production volume on Sikorsky helicopter programs contributed roughly **$540 million** to the increase in RMS’s 2021 net sales, and it added about **$560 million** to RMS’s product‑cost base for the same year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question. (1) CORRECTNESS: All factual information matches the ground truth. The two key financial metrics are correct: $540 million increase in RMS net sales and $560 million increase in product costs. (2) QUANTITATIVE ACCURACY: Both dollar amounts are precisely correct with no calculation errors. The numbers are presented in a clear, comparable format ($540M vs $560M). (3) QUALITATIVE ACCURACY: The answer correctly identifies the causal relationship between Sikorsky helicopter production volume increases and the resulting impacts on both revenue and costs. The multi-hop synthesis is sound - the model correctly connected production volume changes to their dual impacts on net sales and product costs for the RMS segment. (4) CONTEXTUAL RELEVANCE: The answer is directly relevant and appropriately scoped to the 2021 timeframe and RMS segment as specified in the question. The only minor difference from the ground truth is stylistic wording ('roughly' and 'about' vs. the more definitive ground truth phrasing), but this represents semantic equivalence rather than factual error. The LLM answer conveys identical information with appropriate hedging language that is reasonable given the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 360,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "\nMcDonald’s records the rent, royalty and initial‑fee income from franchisees in operating income and, because franchisees are not consolidated, any gain that arises when the Company sells a restaurant to a franchisee is booked directly in operating income (shown in “Other operating (income) expense, net” as gains on sales of restaurant businesses). These gains are a recurring element of earnings that lift total operating income and margin, but they are excluded from the core restaurant‑margin metrics and therefore are reported separately from the ongoing franchise‑fee revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains accurate information about how McDonald's records gains from restaurant sales to franchisees in operating income and correctly identifies that franchisees are not consolidated. However, there are significant gaps in addressing the core question about the impact on financial reporting.\n\nSTRENGTHS:\n1. Correctly identifies that gains on sales of restaurant businesses are recorded in operating income\n2. Accurately notes that franchisees are not consolidated into financial statements\n3. Correctly mentions the line item \"Other operating (income) expense, net\" for gains on sales\n4. Accurately describes these as recurring transactions that impact operating income and margins\n5. No quantitative errors or incorrect numbers\n\nWEAKNESSES:\n1. INCOMPLETE MULTI-HOP SYNTHESIS: The original answer emphasizes the consolidation policy's role in determining how financial impact is reflected (only through gains/losses at point of sale, not through ongoing consolidated operations). The LLM answer mentions non-consolidation but doesn't fully explain the causal relationship between the consolidation policy and the financial reporting approach.\n2. MISSING KEY INSIGHT: The original answer highlights that because franchisees are evaluated under variable interest entity guidelines and excluded from consolidation, the financial impact is limited to transaction-level gains/losses rather than ongoing operational consolidation. The LLM answer doesn't explain this variable interest entity evaluation framework.\n3. INCOMPLETE ANSWER TO QUESTION: The question asks how these transactions \"impact the financial reporting of gains and losses from restaurant business sales.\" The original answer explains that the consolidation policy determines that impacts are reflected only through gains/losses at point of sale. The LLM answer describes what is recorded but doesn't fully explain how the consolidation policy shapes this reporting approach.\n4. ADDITIONAL DETAIL NOT IN GROUND TRUTH: The LLM mentions that gains are \"excluded from core restaurant-margin metrics\" and \"reported separately from ongoing franchise-fee revenue.\" While this may be accurate, it goes beyond the ground truth answer and introduces information not verified against the original.\n\nMULTI-HOP REASONING: The question requires connecting (1) recurring transactions with franchisees, (2) operating income treatment, (3) consolidation policy, and (4) impact on financial reporting. The LLM addresses points 1, 2, and partially 3, but doesn't fully synthesize how the consolidation policy (point 3) determines the financial reporting approach (point 4).\n\nSCORING JUSTIFICATION:\n- Correctness: 6/10 - Core facts are correct but significant gaps in addressing the full question and the causal relationship between consolidation policy and financial reporting\n- Quantitative: 8/10 - No numeric errors, though no specific numbers were required\n- Qualitative: 5/10 - Incomplete synthesis of the consolidation policy's role in determining financial reporting approach; missing variable interest entity framework\n- Contextual: 7/10 - Relevant to the question but doesn't fully address how consolidation policy impacts financial reporting of gains/losses",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 853,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "\nIn 2023 Chevron recorded a $505 million net loss on its derivative commodity contracts, but the company’s disclosures state that this amount—and the related fair‑value fluctuations—were **not material** to its overall financial position, cash flows or results of operations.  The firm’s internal Risk Control group monitors market‑risk exposures daily, applies VaR and fair‑value measurements derived from quoted market prices, and reports these results to the Audit Committee, ensuring that derivative activities are overseen within the company’s broader risk‑management framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERROR - The LLM introduces a specific $505 million net loss figure that does NOT appear in the ground truth answer. The ground truth explicitly states the fair value of derivative commodity instruments was 'not material' with no specific dollar amount mentioned. This is a major factual error that contradicts the core finding. (2) CONTRADICTION - The LLM claims Chevron 'recorded a $505 million net loss' but then states this was 'not material' - this creates logical inconsistency. If a $505M loss occurred, the ground truth would likely mention it; the absence of this figure in the ground truth suggests it may be fabricated or misattributed. (3) MULTI-HOP REASONING - The LLM does correctly identify the Risk Control group's daily monitoring and Audit Committee oversight, which aligns with ground truth. However, this correct synthesis is undermined by the false quantitative claim. (4) COMPLETENESS - The LLM addresses the risk management framework and fair value measurements appropriately, but the introduction of an unsupported $505M figure is a fundamental error that cannot be overlooked. (5) ENTITY ACCURACY - Chevron (CVX) and 2023 are correctly identified, but the financial metrics are incorrect. The ground truth's core message is that derivative impacts were immaterial; the LLM contradicts this by citing a specific material loss amount. This is a critical factual error that significantly reduces the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 408,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "\nThe CECL transition provisions added a $5.2 billion net benefit from AOCI and a $541 million allowance for credit losses that is reflected in Tier 2 capital, for a combined effect of roughly **$5.7 billion** on JPMorgan’s Basel III CET1 capital as of 31 December 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary quantitative metric. (1) CRITICAL ERROR - AOCI Benefit: The LLM states $5.2 billion net benefit from AOCI, but the ground truth is $720 million. This is a massive discrepancy (off by a factor of ~7.2x). (2) CRITICAL ERROR - Total Impact: The LLM calculates $5.7 billion total impact ($5.2B + $541M), but the ground truth is $1.261 billion. This is completely wrong. (3) PARTIAL CREDIT - Tier 2 Capital Component: The LLM correctly identifies the $541 million allowance for credit losses in Tier 2 capital, which matches the ground truth. (4) REASONING FLAW: While the LLM correctly identifies that both components should be combined, the fundamental numbers used in the calculation are drastically incorrect. The correct calculation should be approximately $720M (AOCI benefit) + $541M (Tier 2 allowance) = $1.261 billion, not $5.7 billion. (5) ENTITY ACCURACY: JPMorgan and December 31, 2024 are correctly identified. (6) MULTI-HOP SYNTHESIS: The LLM attempted to synthesize the two components but used completely wrong source numbers for the AOCI benefit, suggesting either a data retrieval error or fundamental misunderstanding of the filing data. The answer fails on the most critical dimension - numerical accuracy - which is essential for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 369,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "\nIn 2023 GE’s AerCap‑related activities generated a net‑income contribution of **$2.525 billion** (the equity‑method share of AerCap’s earnings) and produced a **$129 million** realized/unrealized gain on the AerCap investment (shown in Note 19). Adding the two components, the total financial impact of AerCap‑related transactions in 2023 was **approximately $2.65 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key components: (1) Net income contribution: LLM states $2.525 billion, ground truth states $2,525 million - these are equivalent (same value, different format). (2) Realized/unrealized gain: LLM states $129 million, ground truth states $129 million - exact match. (3) Total calculation: LLM states approximately $2.65 billion, ground truth states $2,654 million - these are equivalent ($2.65 billion = $2,650 million, which rounds to approximately $2.654 billion). The minor difference in rounding presentation ($2.65B vs $2.654M) is acceptable and reflects appropriate use of 'approximately' language. (4) Multi-hop synthesis: The answer correctly identifies and combines both components (equity-method earnings and realized/unrealized gains) from AerCap-related transactions in 2023. (5) Entity accuracy: Correctly identifies GE, AerCap, the year 2023, and references Note 19 appropriately. (6) Reasoning quality: The logic is sound - the model correctly synthesized information across multiple financial components and explained the calculation clearly. The only minor point is the use of 'approximately' for $2.65 billion when the ground truth specifies $2,654 million more precisely, but this is a reasonable presentation choice given rounding conventions. All factual information is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 381,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "\nMerck transferred **$301 million** in cash consideration to acquire Immune Design. After recognizing the fair value of the acquired net assets ($281 million), the excess **$20 million** was recorded as goodwill.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. (1) CORRECTNESS: All factual information is correct - total consideration of $301 million, goodwill allocation of $20 million, and fair value of net assets of $281 million are all accurate. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The calculation is sound: $301M (total consideration) - $281M (fair value of net assets) = $20M (goodwill), which the LLM correctly identifies. Number formatting is appropriate and consistent. (3) QUALITATIVE ACCURACY: The LLM demonstrates proper multi-hop reasoning by synthesizing the acquisition consideration with the fair value calculation to derive the goodwill amount. The explanation clearly shows the relationship between total consideration, net assets acquired, and goodwill. Entity identification (Merck, Immune Design) is correct. (4) CONTEXTUAL RELEVANCE: The answer is directly relevant and comprehensive, addressing both parts of the question (total consideration and goodwill allocation). The LLM provides helpful context by explicitly stating the fair value of net assets ($281 million), which aids understanding of how the goodwill was derived. Minor note: The LLM uses slightly different phrasing than the ground truth ('cash consideration' vs. just 'consideration'), but this is semantically equivalent and actually adds helpful specificity. The answer is clear, well-structured, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 408,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "\nFranchisees generate revenue for McDonald’s primarily through rent and royalties based on a percentage of sales (including minimum rent payments and initial franchise fees), as well as contributions to advertising cooperatives and other system‑wide fees. When McDonald’s co‑invests with franchisees to fund restaurant improvements, the portion of the expense that is attributable to the Company is recorded as property‑and‑equipment; consequently, those added assets are depreciated over their estimated useful lives, modestly increasing the Company’s depreciation expense (the resulting adjustments are described as immaterial).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses both parts of the multi-hop question effectively. STRENGTHS: (1) Correctly identifies franchisee revenue contributions: rent, royalties based on percentage of sales, minimum rent payments, and initial franchise fees - all matching ground truth. (2) Accurately describes the co-investment mechanism: McDonald's co-invests with franchisees, manages projects, provides upfront funding, and allocates costs between Property and equipment and Accounts Receivable. (3) Correctly states that depreciation expense is impacted by these co-investments and that adjustments are immaterial. (4) Properly synthesizes the multi-hop relationship between franchisee contributions, co-investment allocation, and depreciation impact. (5) No quantitative errors or incorrect numbers. MINOR DIFFERENCES: (1) The LLM answer adds 'contributions to advertising cooperatives and other system-wide fees' which is not explicitly mentioned in the ground truth answer. While this may be factually accurate from McDonald's filings, it represents an addition beyond what the ground truth specifies. (2) The ground truth uses the phrase 'final cost allocations may result in immaterial adjustments to balances and associated depreciation expense,' while the LLM describes adjustments as 'immaterial' but phrases it slightly differently as 'modestly increasing the Company's depreciation expense.' Both convey the same essential meaning - that the impact is immaterial/modest. (3) The LLM answer is slightly more concise in explaining the depreciation impact mechanism, though it captures the essential logic. The answer demonstrates sound multi-hop reasoning by connecting franchisee contributions → co-investment allocation → depreciation expense impact. All core facts are accurate with no calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 497,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "\nThe securities‑backed‑by‑real‑estate portfolio fell from **$687 million at the end of 2023 to $562 million at the end of 2024**, a decline of **$125 million**.  \n\nIn 2023 the unrealized losses on those Level 3 investments were driven primarily by **ongoing weakness in the commercial real‑estate market**, which caused losses on the securities backed by real estate.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer addresses both parts of the multi-part question and correctly identifies the primary cause of unrealized losses (commercial real estate market weakness). However, there are significant quantitative errors that substantially impact the correctness of the response. The LLM reports December 2023 value as $687 million when the ground truth is $689 million (off by $2M), and December 2024 value as $562 million when the ground truth is $569 million (off by $7M). Most critically, the calculated decline is stated as $125 million, but the ground truth shows a $120 million decrease. These discrepancies suggest the LLM either retrieved slightly different numbers from the source documents or made calculation errors. The qualitative reasoning about commercial real estate market weakness as the primary cause is correct and well-articulated. The answer demonstrates sound multi-hop synthesis by connecting the portfolio values to the cause of unrealized losses. However, in financial analysis, precision of numbers is paramount—a $5 million variance in the final calculation and $7 million variance in the ending balance represent material errors that would be unacceptable in professional financial reporting contexts. The semantic understanding and reasoning quality are strong, but the quantitative inaccuracies prevent this from being a high-quality answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 382,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "\nAmerican Tower paid $80.1 million of prepayment consideration plus $7.8 million of accrued interest—​a total of $87.9 million above the $955.1 million of CoreSite Debt principal that was outstanding on December 31, 2021. In other words, the extra cost represented roughly 9 % of the prior‑year outstanding balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a significant factual discrepancy in the principal amount. The ground truth states the CoreSite Debt principal was $875 million as of December 31, 2021, but the LLM answer claims it was $955.1 million. This is a $80.1 million difference in a key financial figure. The LLM correctly identifies the additional costs ($80.1M prepayment consideration + $7.8M accrued interest = $87.9M total), which matches the ground truth. However, the incorrect principal amount undermines the entire answer's credibility. The LLM's calculation that the extra cost represented roughly 9% of the prior-year balance ($87.9M / $955.1M ≈ 9.2%) is mathematically consistent with their stated principal amount, but this calculation is based on the wrong principal figure. Using the correct $875M principal, the percentage would be approximately 10% ($87.9M / $875M ≈ 10.0%), which the LLM did not calculate. The LLM does address both parts of the question (additional costs and comparison to outstanding balance), and the reasoning structure is sound, but the fundamental error in the principal amount is a major factual mistake that significantly impacts the accuracy of the response. The semantic approach is reasonable, but numerical precision is critical in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 363,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "\nIn 2024, higher collections from CFM International offset roughly $0.3 billion of the $0.9 billion increase in current receivables, helping to produce the net $(0.4) billion change in cash from working‑capital movements.  This cash‑flow benefit comes from GE’s deep supplier relationship with CFM—a 50‑50 equity‑method joint venture with Safran—under long‑term parts and MRO service agreements that generate recurring revenue and support aftermarket cash inflows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states collections from CFM International offset 'roughly $0.3 billion' of the $0.9 billion increase in current receivables. The ground truth states collections 'partially offset' the $(0.9) billion impact but does NOT specify a $0.3 billion figure. This appears to be an unsupported number introduced by the LLM. The LLM also claims this produced a 'net $(0.4) billion change' - this calculation ($0.9B - $0.3B = $0.6B, not $0.4B) is mathematically inconsistent with the stated figures. (2) The ground truth does not provide a specific dollar amount for the collections contribution, only that they 'partially offset' the impact. The LLM fabricated precise numbers ($0.3B, $0.4B) not present in the source material. (3) ENTITY/RELATIONSHIP ACCURACY - The LLM correctly identifies CFM International as a 50-50 equity-method joint venture with Safran and correctly notes GE's supplier relationship with parts and MRO services. This portion aligns with ground truth. (4) COMPLETENESS - The LLM addresses both parts of the question (financial contribution and business relationship), but the financial contribution answer contains invented specificity. The ground truth answer is more cautious, stating 'partially offset' without quantifying the exact amount. (5) MULTI-HOP REASONING - The LLM attempts to synthesize working capital movements and cash flow impacts, but introduces unsupported calculations that contradict the ground truth's more measured approach. The core relationship description is sound, but the quantitative claims are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 439,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "\nThe Ohio tax‑reform deferrals and the Duke Energy Ohio electric‑rate case together added roughly $276 million to Duke Energy’s 2023 operating revenue.  This figure combines the $6 million prior‑year deferral that was recognized in 2023 with the $270 million of pricing adjustments generated by the Ohio rate case.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: The total figure of $276 million matches the ground truth exactly. The answer correctly identifies this as the combined impact from Ohio tax reform deferrals and the Duke Energy Ohio electric rate case in 2023. (2) QUANTITATIVE ACCURACY: All numbers are correct - the $276 million total, the $6 million prior-year deferral, and the $270 million in pricing adjustments from the rate case. The arithmetic is sound: $6M + $270M = $276M. The numbers are presented in a clear format that matches the ground truth. (3) QUALITATIVE ACCURACY: The LLM demonstrates strong multi-hop reasoning by correctly synthesizing information across multiple components: (a) identifying the two sources of impact (tax reform deferrals and rate case), (b) distinguishing between prior-year deferrals and current-year pricing adjustments, and (c) combining them appropriately. The answer correctly attributes the components to their respective sources. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question - it covers the total impact, the Ohio tax reform deferrals, the Duke Energy Ohio electric rate case, prior year deferrals, and current year pricing adjustments. The year (2023) is correctly identified. The only minor observation is that the LLM uses 'roughly' which is slightly informal, but this does not detract from accuracy since the numbers are precise. The answer is well-structured and provides appropriate context for understanding the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 425,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "\nIn fiscal 2021 Adobe’s Digital Media segment generated **$11.52 billion** in total revenue.  Of that amount, **Creative Cloud contributed $9.55 billion** (about **83 %** of the segment’s revenue) and **Document Cloud contributed $1.97 billion** (about **17 %** of the segment’s revenue), according to the figures disclosed in the 10‑K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Digital Media segment total revenue of $11.52 billion in fiscal 2021 is correct, (2) Creative Cloud contribution of $9.55 billion is correct, (3) Document Cloud contribution of $1.97 billion is correct, (4) percentage calculations are accurate (83% and 17% respectively). The answer properly synthesizes the multi-hop information by identifying the segment, the total revenue, and then breaking down the two sub-components with both absolute dollar amounts and percentages. The entity identification is correct (Adobe, Digital Media segment, Creative Cloud, Document Cloud, fiscal 2021). The reasoning is sound - the model correctly identified that the two components sum to the total ($9.55B + $1.97B = $11.52B) and calculated the percentages accurately. The wording is clear and directly addresses all parts of the question. Minor stylistic differences from the ground truth (e.g., 'about 83%' vs '83%') do not affect accuracy and represent acceptable semantic equivalence. The answer explicitly cites the 10-K filing as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 327,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "\nIn 2021 advertising expenses grew by about **$222 million**.  Personnel‑related costs in the **marketing** function rose roughly **$116 million**, and personnel‑related costs in **technology** increased about **$384 million**.  Adding these components together, the total increase in combined advertising and head‑count‑related personnel costs for 2021 is approximately **$722 million**.  (Pages 26 – marketing and technology expense breakdowns.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers match the ground truth exactly: (1) Advertising expenses increase: $222 million ✓, (2) Marketing personnel costs: $116 million ✓, (3) Technology personnel costs: $384 million ✓, (4) Total combined increase: $222M + $116M + $384M = $722 million ✓. The arithmetic is correct. COMPLETENESS: The answer addresses all components of the multi-part question: advertising expenses, marketing headcount growth, technology headcount growth, and the total combined figure. ENTITY ACCURACY: Correctly identifies NFLX, the year 2021, and the specific departments (marketing and technology). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple cost categories and departments, correctly combining advertising and personnel costs from different sources into a coherent total. SEMANTIC EQUIVALENCE: The wording 'advertising expenses,' 'personnel-related costs,' and 'headcount-related personnel costs' are semantically equivalent to the ground truth terminology. The answer clearly breaks down each component before summing to the total, which demonstrates sound logical reasoning. MINOR OBSERVATION: The answer includes a parenthetical reference to 'Pages 26' which adds credibility but is not part of the ground truth evaluation. This is a positive addition that doesn't detract from accuracy. No calculation errors, no missing information, and all entities correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 412,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "\nGM records the earnings (or losses) from its 50 % stake in Ultium Cells Holdings LLC directly in the “Automotive and other cost of sales” line‑item, because the joint venture supplies the battery cells that are essential to building the company’s electric‑vehicle (EV) models.  By placing this equity income there, GM treats the investment as an operational supply‑chain cost rather than a stand‑alone financial holding, highlighting that control of battery‑cell production is a core pillar of its EV‑growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies that GM records equity earnings from its 50% stake in Ultium Cells Holdings LLC in the 'Automotive and other cost of sales' line item. The core factual claims match the ground truth: the joint venture supplies battery cells essential to EV production, and the financial treatment reflects operational integration rather than standalone investment treatment. (2) QUANTITATIVE ACCURACY: The 50% ownership stake is correctly stated. No calculations are required for this question, and all numeric references are accurate. (3) QUALITATIVE ACCURACY: The reasoning is sound and demonstrates proper multi-hop synthesis. The answer correctly connects: (a) the equity earnings reporting location, (b) the operational purpose (battery cell supply), (c) the strategic implication (core EV production component), and (d) the financial treatment philosophy (supply-chain cost vs. financial holding). The explanation of why this treatment matters for EV strategy is well-articulated. (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('records the earnings (or losses)' vs. 'reports equity earnings,' 'stand‑alone financial holding' vs. 'separate investment') but conveys identical meaning. The phrase 'control of battery‑cell production is a core pillar of its EV‑growth strategy' effectively captures the strategic significance. (5) COMPLETENESS: The answer addresses all aspects of the multi-part question: how equity earnings influence cost of sales, what this indicates about financial treatment, and the connection to EV strategy. Minor: The LLM adds helpful context about 'earnings (or losses)' which slightly expands on the ground truth but remains accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 492,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "\nThe average Henry Hub natural‑gas price fell from **$6.36 /Mcf in 2022 to $2.56 /Mcf in 2023**, a **≈60 % decrease**.  By contrast, Chevron’s international natural‑gas realizations dropped from **$9.75 /Mcf in 2022 to $7.69 /Mcf in 2023**, a **≈21 % decline**.  Thus, the U.S. Henry Hub price experienced a far steeper drop than the company’s overseas gas pricing over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key metrics: (1) Henry Hub prices: $6.36/Mcf (2022) and $2.56/Mcf (2023) are correct. (2) Percentage calculation: ($6.36-$2.56)/$6.36 = 59.75%, which rounds to 59.8% in ground truth and ≈60% in LLM answer - both acceptable representations. (3) Chevron international realizations: $9.75/Mcf (2022) and $7.69/Mcf (2023) are correct. (4) Percentage calculation: ($9.75-$7.69)/$9.75 = 21.13%, which rounds to 21.1% in ground truth and ≈21% in LLM answer - both acceptable. The LLM correctly synthesized multi-hop information comparing U.S. Henry Hub prices with Chevron's international realizations across both 2022 and 2023. The reasoning is sound: the comparison correctly identifies that U.S. prices dropped significantly more steeply (≈60%) than international prices (≈21%). The LLM's use of '≈' notation for percentages is appropriate given rounding. The answer addresses all parts of the question: the percentage decrease in Henry Hub prices, Chevron's international realizations, and the comparative analysis. Minor deduction (1 point) only because the LLM didn't explicitly mention the crude oil benchmark linkage that the ground truth included, though this is contextual information rather than a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 361,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "\nGoldman Sachs values its level‑3 credit derivatives primarily with option‑pricing, correlation and discounted‑cash‑flow models that treat credit spreads, upfront credit points and recovery rates as key unobservable inputs. The firm’s sensitivity analysis shows that the fair‑value of purchased credit protection rises when credit spreads widen (the 2024 spread range is 8 – 1,328 bps, avg./median 134 / 91 bps) or when assumed recovery rates fall (20 % – 70 %, avg./median 46 % / 50 %); conversely, tighter spreads or higher recoveries depress the valuation. Because these inputs span very wide ranges, even modest shifts in market spreads or recovery assumptions can produce material changes in the reported fair value of the level‑3 credit‑derivative portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a comprehensive response to the multi-hop question about Goldman Sachs' level 3 credit derivatives valuation sensitivity. STRENGTHS: (1) Correctly identifies the directional sensitivity relationships: fair value of purchased credit protection increases with wider spreads and decreases with higher recovery rates - this matches the ground truth exactly. (2) Provides specific quantitative data (2024 spread range 8-1,328 bps with avg/median 134/91 bps; recovery rates 20%-70% with avg/median 46%/50%) that adds concrete detail beyond the ground truth. (3) Correctly names the valuation methodologies (option-pricing, correlation, discounted-cash-flow models). (4) Properly synthesizes the multi-hop relationship: identifies unobservable inputs → explains directional sensitivity → connects to portfolio impact. (5) Appropriately emphasizes the materiality of changes given wide input ranges. MINOR CONSIDERATIONS: (1) The ground truth mentions 'broad variability in underlying risk factors' (leverage, volatility, industry, borrowing costs, macroeconomic conditions) which the LLM answer does not explicitly enumerate, though it does reference 'very wide ranges' of inputs. (2) The LLM answer goes beyond ground truth by providing specific 2024 data points - while this adds value and appears accurate, it represents additional detail not in the original answer. The core semantic meaning and factual accuracy are fully aligned with ground truth. The answer correctly addresses all parts of the question: sensitivity mechanisms, impact on level 3 valuations, and the role of credit spreads and recovery rates as significant unobservable inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 466,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "\nThe January 2022 repayment eliminated the entire $955.1 million of CoreSite Debt, cutting AMT’s total long‑term obligations and thereby strengthening its leverage ratios and overall capital structure. Because the repayment amount matched the debt’s carrying value on the balance sheet, it shows that the CoreSite indebtedness had been recorded at its full outstanding (fair‑value) amount with no remaining discount or premium, confirming that the valuation reflected on AMT’s balance sheet was accurate and that the payment simply settled the liability without generating a gain or loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. QUANTITATIVE VERIFICATION: All numbers are correct - the $955.1 million repayment amount matches the carrying value exactly as stated in the ground truth. The date (January 2022) is accurate. No calculations are required, and the numeric data is presented correctly. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the impact on capital structure (elimination of long-term obligations, improved leverage ratios), and (2) the valuation implication (matching carrying value indicates fair value recording with no discount/premium). ENTITY ACCURACY: Company (AMT), debt instrument (CoreSite Debt), and time period (January 2022) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly connects the repayment amount to the balance sheet carrying value and draws the appropriate conclusion about valuation accuracy. The logic that matching amounts indicate no unamortized discounts/premiums is correct and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('full outstanding (fair-value) amount' vs 'fair value or close to its redemption value') but conveys the same meaning. The statement about 'no remaining discount or premium' is semantically equivalent to 'minimal unamortized discounts or premiums.' The mention of 'no gain or loss' on settlement is a reasonable inference that adds clarity without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM's phrasing is slightly more explicit about the settlement mechanics (no gain/loss), which is a reasonable elaboration rather than an error. The answer is comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 479,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "\nAdobe has recorded reserves for possible adjustments to its unrecognized tax benefits that stem from ongoing tax examinations of intercompany transfer‑pricing positions, estimating that any required reduction could be up to roughly $5 million over the next 12 months.  Because these reserves are already reflected in the company’s tax‑related accruals, the anticipated adjustments are not expected to materially disturb Adobe’s overall financial position, although the final outcome remains uncertain.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $5 million estimated range of potential decreases in unrecognized tax benefits over the next 12 months, matching the ground truth exactly. The company name (Adobe) and the focus on intercompany transfer pricing practices are accurate. The quantitative data is precise and properly formatted.\n\nCRITICAL WEAKNESSES: The LLM's reasoning and conclusions fundamentally contradict the ground truth. The original answer emphasizes that these adjustments 'could have an adverse effect on Adobe's financial position' and that 'actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities.' However, the LLM states the adjustments are 'not expected to materially disturb Adobe's overall financial position.' This is a significant semantic and substantive error that misrepresents the risk profile. The ground truth emphasizes uncertainty and potential for adverse impact; the LLM downplays these concerns.\n\nMISSING ELEMENTS: The LLM omits key aspects from the ground truth: (1) the explicit statement about potential adverse effects on financial position, (2) the discussion of how actual adjustments could exceed established reserves, (3) the emphasis on high uncertainty surrounding timing and outcomes, and (4) the potential for significant fluctuations in tax assets and liabilities on the balance sheet.\n\nREASONING QUALITY: While the LLM correctly notes that reserves are 'already reflected in the company's tax-related accruals,' it uses this fact to minimize impact rather than acknowledging the uncertainty and potential for exceeding reserves as the ground truth does. This represents a failure in multi-hop reasoning about the implications of tax examination risks.\n\nSCORING JUSTIFICATION: Quantitative accuracy is high (9/10) because the $5 million figure is correct. However, qualitative accuracy is low (4/10) because the reasoning about financial impact is inverted from the ground truth. Contextual relevance is moderate (6/10) because while the answer addresses the question topic, it provides misleading conclusions about the severity of potential impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 581,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "\nAlliance revenue from Lenvima grew 44 % in 2020 and 21 % in 2021—a cumulative rise of roughly 65 % over the two years (see the oncology tables on pages 5 and 59).  This rapid uptake mirrors Merck’s wider oncology strategy of pairing its flagship anti‑PD‑1 antibody Keytruda with complementary agents such as Lenvima, using combination regimens to broaden indications and generate additional sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - Lenvima alliance revenue growth of 44% in 2020 and 21% in 2021 matches the ground truth exactly. The combined growth calculation of 65% is accurate (44% + 21% = 65%). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) individual growth percentages for both years, (2) combined growth calculation, and (3) connection to Merck's broader oncology strategy. ENTITY ACCURACY: All entities are correctly identified - Lenvima, Keytruda, Merck, and the specific indications (endometrial carcinoma and RCC) are all accurate. The characterization of Keytruda as an anti-PD-1 antibody is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple sources - combining Lenvima revenue growth data with Merck's strategic approach to combination therapies and specific clinical applications. The logical connection between the revenue growth and the strategic rationale is sound. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('cumulative rise' vs 'combined growth', 'pairing' vs 'approved in combination with') but conveys identical meaning. The reference to 'oncology tables on pages 5 and 59' adds helpful sourcing detail. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information. The description of the strategic rationale is equivalent, focusing on 'broadening indications and generating additional sales growth' which captures the same concept as 'expand indications and improve patient outcomes.' No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 457,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "\nGM’s 2024 equity investment in Ultium Cells Holdings LLC generated about **$0.7 billion of additional equity earnings**, which was reported as a **$0.7 billion favorable contribution to GM’s EBIT‑adjusted profit** for the year. This increase is reflected in the EBIT‑adjusted variance tables that attribute roughly **$0.7 billion of the improvement to “increased equity earnings related to Ultium Cells Holdings LLC.”**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: All factual information is correct. The $0.7 billion equity earnings figure is accurately stated and matches the ground truth exactly. The answer correctly identifies that this contribution directly increased GM's EBIT-adjusted performance. (2) QUANTITATIVE ACCURACY: The key metric of $0.7 billion is stated consistently and correctly throughout the response. No calculation errors are present. The number format is clear and matches the ground truth ($0.7 billion). (3) MULTI-HOP REASONING: The answer successfully synthesizes the relationship between the equity investment in Ultium Cells Holdings LLC and its impact on EBIT-adjusted performance. It correctly traces the causal chain: investment → equity earnings → EBIT-adjusted improvement. The reference to EBIT-adjusted variance tables demonstrates understanding of where this information appears in financial reporting. (4) ENTITY ACCURACY: All entities are correctly identified - GM, Ultium Cells Holdings LLC, equity earnings, and EBIT-adjusted metrics. The year 2024 is correctly referenced. (5) COMPLETENESS: The answer addresses all aspects of the question: the investment, the quantified impact ($0.7 billion), and the direct effect on EBIT-adjusted performance. The only minor distinction from the ground truth is that the LLM uses slightly more detailed language ('about $0.7 billion' and references to variance tables), but this adds helpful context rather than detracting from accuracy. The semantic meaning is identical to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 439,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "\nThe SEC’s new rule that requires institutional investment managers to file monthly short‑position data for equities (effective January 2025) applies to Goldman Sachs’s asset‑management and wealth‑management businesses, which are themselves subject to the SEC’s security‑based‑swap‑dealer regime. As a registered security‑based‑swap dealer, Goldman must already report large positions in security‑based swaps to the SEC; the short‑position disclosures must therefore be incorporated into those swap‑dealer filings, prompting the firm to align its derivatives‑reporting systems so that equity‑linked swap exposures are captured, aggregated and disclosed in the same public filings that cover its short‑position activity. This convergence increases the granularity of Goldman’s derivatives reporting and subjects its security‑based‑swap positions to the same monthly, publicly‑available transparency requirements as its traditional short‑selling activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer makes several significant factual errors that contradict the ground truth: (1) The LLM claims the short-position reporting requirement 'applies to Goldman Sachs's asset-management and wealth-management businesses' and that these businesses are 'themselves subject to the SEC's security-based-swap-dealer regime.' The ground truth does not support this claim. The requirement applies to institutional investment managers meeting specified thresholds - it's a general SEC rule, not specifically targeted at Goldman Sachs's particular business units. (2) The LLM asserts that 'short-position disclosures must therefore be incorporated into those swap-dealer filings,' suggesting the two reporting regimes are merged or integrated. The ground truth indicates these are separate, complementary obligations - the short position reporting 'adds another layer' and 'complements' existing swap dealer obligations, not that they must be consolidated into single filings. (3) The LLM claims this creates 'the same public filings that cover its short-position activity' for swap positions, implying unified public disclosure. The ground truth does not support that swap dealer positions and short positions are reported in the same public filings. (4) The LLM's core premise that equity-linked swap exposures must be 'captured, aggregated and disclosed in the same public filings' appears to be an inference not supported by the ground truth. CORRECT ELEMENTS: The LLM correctly identifies the January 2025 effective date and correctly notes that Goldman Sachs is a registered security-based swap dealer with existing reporting obligations. The LLM correctly identifies that the new rule involves monthly reporting of short positions in equities. REASONING QUALITY: While the LLM attempts multi-hop synthesis, it does so incorrectly by inferring an integration of reporting systems that the ground truth does not support. The ground truth presents these as complementary but distinct obligations, while the LLM presents them as merged requirements. This represents a fundamental misunderstanding of how the two regulatory regimes interact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 578,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "\nPepsiCo recorded a **$520 million pre‑tax gain** from re‑measuring its 39 % non‑controlling equity interest in the newly created TBG joint venture at fair value as part of the juice‑brand divestiture.  The gain—reflecting that the fair‑value of the retained equity exceeded its carrying amount—was recognized in the PBNA and Europe segments and is a direct result of the transaction’s dual structure: PepsiCo received roughly **$3.5 bn in cash** for the sold brands while **retaining a 39 % equity stake** that was subsequently re‑valued, generating the non‑cash gain that boosted earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key aspects of the question. STRENGTHS: (1) All primary numbers are accurate: $520 million gain, 39% noncontrolling interest, $3.5 billion in cash proceeds are all correct. (2) The answer correctly identifies the dual structure of the transaction (cash proceeds + retained equity stake). (3) The explanation of the gain mechanism is sound—the fair value remeasurement of the retained equity interest exceeded its carrying amount, generating the non-cash gain. (4) The answer correctly notes this was a pre-tax gain and mentions segment recognition (PBNA and Europe). (5) Multi-hop synthesis is correct: connecting the juice brand sale, the creation of TBG, the cash proceeds, the retained stake, and the resulting gain. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the specific brands sold (Tropicana, Naked, and other select juice brands) that were included in the original answer, though this is a minor omission. (2) The original answer mentions the valuation methodology (transaction price, discounted cash flows, option pricing model), which the LLM answer does not include, though this level of detail may not be essential to answering the core question. (3) The LLM answer adds contextual detail about segment recognition that wasn't in the original answer, which is appropriate but represents a slight deviation. QUANTITATIVE VERIFICATION: All dollar amounts ($520M, $3.5B) and percentages (39%) match ground truth exactly. The characterization of the gain as 'non-cash' is accurate. REASONING: The multi-hop reasoning is sound—the answer correctly synthesizes that the transaction involved both immediate cash proceeds and a retained financial interest, and that the gain resulted from the fair value remeasurement of that retained interest. The answer appropriately explains why this structure created the gain.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 513,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "\nIn 2023, gains (losses) on retained and sold ownership interests—including the stake in Baker Hughes—added **$5.78 billion** to GE’s total other income. In 2024 that contribution fell sharply to **$0.518 billion**, a decline of about **$5.26 billion (roughly a 91 % reduction)** compared with the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2023 contribution of $5,778 million correctly converted to $5.78 billion format - semantically equivalent and accurate; (2) 2024 contribution of $518 million correctly converted to $0.518 billion - accurate; (3) Year-over-year decrease calculation: $5,778M - $518M = $5,260M, correctly stated as $5.26 billion - accurate; (4) Percentage reduction calculation: ($5,260M / $5,778M) × 100 = 91.0%, correctly rounded to 91% - accurate. The LLM properly synthesized multi-hop information by: identifying the specific ownership interests (retained and sold), correctly attributing the Baker Hughes stake, comparing across two fiscal years, and calculating both absolute and relative changes. Minor note: The original answer mentions '$10 million realized and unrealized gain from Baker Hughes' in 2023, which the LLM does not explicitly detail, but this is a minor omission that doesn't affect the core answer's accuracy since the $10M is already included in the $5,778M total. The LLM's presentation is clear, uses appropriate financial notation, and directly addresses all parts of the multi-part question. All entities (GE, Baker Hughes, years 2023-2024) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 355,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "\nThe company’s Mortgage‑Backed Obligations had a fair‑value of **$236 million** as of January 31, 2024 (the amount shown in the 2024 fair‑value hierarchy table). This represents **about 2 %** of the total fair‑value assets of **$12.08 billion** reported for that date.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is significantly incomplete and fails to address the core requirement of the question. CRITICAL ERRORS: (1) The LLM only reports $236 million from the first disclosure, completely omitting the second disclosure of $122 million. The ground truth explicitly states there are 'two separate disclosures' totaling $358 million. (2) The LLM calculates the percentage as 'about 2%' based on only $236M/$12.08B, which is mathematically incorrect even for that partial calculation (236/12,080 = 1.95%, not 2%). (3) The correct total should be $358 million (combining both disclosures), which represents 2.97% of total assets when properly calculated across both disclosure sources ($358M / $12,079M + $12,010M combined). (4) The LLM fails the multi-hop synthesis requirement by not identifying and combining information from the two separate disclosures mentioned in the question. The question explicitly asks for 'the two separate disclosures' and their combined total, but the LLM only references one disclosure. (5) The percentage calculation is also wrong - even using the partial $236M figure, the percentage should be closer to 1.95% of $12.08B, not 'about 2%' (though this is a minor rounding issue compared to the major omission). The answer demonstrates incomplete document review and failure to synthesize across multiple data sources as required by the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 389,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "\nNetflix’s rollout of country‑specific membership tiers let it fine‑tune pricing and plan features to local willingness‑to‑pay, and the resulting price adjustments—combined with favorable foreign‑exchange movements—lifted the average monthly revenue per paying member by about 7 % in 2021. That 7 % rise in revenue per member, together with the 11 % growth in the number of paying members, drove the company’s total streaming revenue up 19 % for the year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information. All key numbers are accurate: 7% increase in average monthly revenue per paying membership, 11% growth in paying members, and 19% total revenue growth for 2021. The mathematical relationship is correctly explained (7% per-member revenue growth + 11% membership growth = 19% total revenue growth). The answer properly identifies Netflix's strategy of country-specific membership tiers and correctly attributes the revenue increase to pricing flexibility based on regional market conditions. One minor addition in the LLM answer is the mention of 'favorable foreign-exchange movements' as a contributing factor, which is not explicitly mentioned in the ground truth but is a reasonable and accurate contextual detail that doesn't contradict the original answer. The LLM answer uses slightly different wording ('fine-tune pricing and plan features to local willingness-to-pay' vs 'pricing flexibility based on regional market conditions') but conveys semantically equivalent meaning. The answer addresses all parts of the multi-part question: how the strategy contributed to the 7% increase, and how this impacted the 19% overall revenue growth. The reasoning is sound and the synthesis across the multiple metrics is correct. The only minor distinction is that the ground truth emphasizes 'consolidated revenues' while the LLM specifies 'streaming revenue,' though this is a negligible difference in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 416,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "\nThe Lenvima‑Eisai partnership adds to Merck’s pharmaceutical segment through “alliance revenue,” which reflects Merck’s share of Lenvima sales after deducting cost‑of‑sales and commercialization expenses—$704 million in 2021 (up from $580 million in 2020).  This revenue stream is tied to the outcomes of the LEAP program; while some Phase 3 LEAP trials have been stopped (LEAP‑007, LEAP‑011) and a CRL halted accelerated HCC approval, the ongoing LEAP‑002 trial for HCC and other late‑stage studies keep the pipeline alive, meaning future alliance profits—and thus segment revenue—depend on the success of those remaining studies and any regulatory approvals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key elements of the Lenvima collaboration's impact on Merck's pharmaceutical segment revenue: (1) The alliance revenue model structure is accurately described as Merck's share of Lenvima sales after deducting costs; (2) Specific financial figures ($704M in 2021, $580M in 2020) are provided with year-over-year comparison; (3) The LEAP trial status is correctly characterized - LEAP-007 and LEAP-011 discontinuations are mentioned, LEAP-002 ongoing is noted, and the CRL for HCC is referenced; (4) The logic connecting trial outcomes to future revenue potential is sound. WEAKNESSES: (1) The answer lacks specificity on approved indications - the ground truth mentions endometrial carcinoma and RCC as approved indications where Keytruda+Lenvima combinations are already generating revenue, but the LLM only references 'approved indications' generically; (2) The answer doesn't explicitly discuss the negative impact of LEAP-007/LEAP-011 discontinuations on 'near-term revenue potential' for NSCLC and urothelial carcinoma specifically, instead focusing more on future potential; (3) The ground truth emphasizes that the pharmaceutical segment includes oncology products like Keytruda and its combinations, providing broader context that the LLM answer doesn't fully articulate. QUANTITATIVE VERIFICATION: The financial figures ($704M in 2021, $580M in 2020) cannot be verified against the ground truth provided, which does not include specific dollar amounts. However, these appear to be reasonable alliance revenue figures and are presented with appropriate context. The year-over-year comparison ($580M to $704M) shows growth logic. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) alliance revenue model mechanics, (2) trial status across LEAP program, (3) regulatory setbacks (CRL), and (4) future revenue implications. The reasoning is logically sound. COMPLETENESS: The answer addresses the core question about how the collaboration influences pharmaceutical segment revenue through the alliance revenue model and trial outcomes, but could be more comprehensive in discussing specific approved indications and near-term negative impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 599,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "\nChevron’s total cost incurred by its consolidated companies in 2023 was about **$24.6 billion**.  After subtracting the **$0.5 billion** of expensed exploration costs and the **$10.5 billion** cost of acquiring PDC Energy, the combined amount of those two items is roughly **$11.0 billion**.  Consequently, the 2023 cost incurred exceeds that combined total by **approximately $13.6 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All numerical values are correct: (1) Total cost incurred by consolidated companies in 2023: $24.6 billion ✓, (2) Expensed exploration costs: $0.5 billion ✓, (3) PDC Energy acquisition cost: $10.5 billion ✓, (4) Combined total of exploration costs and acquisition: $11.0 billion ✓, (5) Excess amount: $13.6 billion ✓. The multi-hop reasoning is sound - the model correctly identified all three required data points, performed the addition of the two cost components ($0.5B + $10.5B = $11.0B), and then calculated the difference ($24.6B - $11.0B = $13.6B). The answer addresses all parts of the question comprehensively. The only minor observation is the use of qualifiers like 'about' and 'roughly' and 'approximately' which are slightly informal but do not detract from accuracy. The semantic meaning is perfectly aligned with the ground truth. Entity identification is correct (Chevron, PDC Energy, Inc., fiscal year 2023). The presentation is clear and logical, walking through each component before arriving at the final answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 309,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "\nAmerican Tower values the market‑condition portion of its 2024 PSUs with a Monte Carlo simulation that estimates the probability of achieving the performance targets. The simulation bases the market component on **relative total shareholder return (TSR) measured against the S&P 500 REIT index**. The resulting grant‑date fair value for that component is $216.11 per PSU.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core methodology (Monte Carlo simulation) and the primary market metric (relative total shareholder return/TSR). However, there is a critical discrepancy in the specification of the index used. The ground truth states the metric is 'relative total shareholder return measured against the REIT constituents included in the S&P 500 Index,' while the LLM answer states it is measured against 'the S&P 500 REIT index.' These are not identical - the ground truth specifies REIT constituents within the S&P 500, whereas the LLM answer references what appears to be a separate S&P 500 REIT index. This is a material distinction in entity accuracy. Additionally, the LLM introduces a specific grant-date fair value of $216.11 per PSU, which is not mentioned in the ground truth answer. While this number may be factually correct from the filing, it was not part of the original question's scope and its inclusion without verification against the source document creates uncertainty. The answer demonstrates good understanding of the Monte Carlo methodology and addresses the core question about how fair value is determined and what metric is used, but the index specification error and the introduction of an unverified specific dollar amount prevent a higher score. The reasoning is sound and the answer is contextually relevant, but the quantitative accuracy is compromised by the potential index misidentification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 401,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "\nFour amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented in the filings. The fourth amendment became effective on **July 1, 2022**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-part question. (1) CORRECTNESS: Both the number of amendments (four) and the effective date of the fourth amendment (July 1, 2022) match the ground truth exactly. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the count of 4 amendments and the date of July 1, 2022 are precisely accurate with no calculation errors. (3) QUALITATIVE ACCURACY: The answer correctly identifies the entity (Caterpillar Inc. Supplemental Employees' Investment Plan), synthesizes the required information across the disclosed filings, and presents the facts clearly. The reasoning is sound and directly answers both sub-questions. (4) CONTEXTUAL RELEVANCE: The answer is highly relevant, directly addressing the specific question about amendments and their effective dates. Minor note: The LLM uses bold formatting for the date which is a stylistic choice that doesn't affect accuracy. The answer is complete, factually accurate, and demonstrates proper multi-hop synthesis of information from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 307,
        "total_tokens": 1399
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "\nIn 2024 the amortized cost of CRM’s corporate notes and obligations was **$3,014 million**, while their reported fair value was **$2,978 million**, a $36 million shortfall. This fair‑value amount is classified as **Level 2** in the hierarchy—i.e., it is derived from observable market inputs rather than quoted prices for identical securities. Consequently, the $36 million difference between amortized cost and fair value corresponds exactly to the Level 2 fair‑value figure disclosed for these securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. CORRECT ELEMENTS: The amortized cost ($3,014M), fair value ($2,978M), and the $36M difference are all correct. CRITICAL ERRORS: (1) The LLM claims the $2,978M fair value 'is classified as Level 2' and that 'the $36 million difference...corresponds exactly to the Level 2 fair-value figure.' This is factually incorrect. According to the ground truth, the Level 2 fair value is $2,557M, NOT $2,978M. (2) The LLM completely fails to address the second part of the question asking for a comparison between the total fair value ($2,978M) and the Level 2 categorized value ($2,557M). The ground truth explicitly states there is a $421M difference between these two figures. (3) The LLM's reasoning that the $36M difference 'corresponds exactly to the Level 2 fair-value figure' is logically flawed and contradicts the actual data. The question requires multi-hop synthesis: identifying the amortized cost vs. fair value difference ($36M), then separately identifying the Level 2 fair value ($2,557M), and finally comparing the total fair value to the Level 2 value ($421M difference). The LLM only partially completes the first hop and entirely misses the comparative analysis required. The answer demonstrates a fundamental misunderstanding of the fair value hierarchy and fails to synthesize the required information across multiple data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 397,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "\nDisney has secured a total of **$2.2 billion** in financing for its two upcoming cruise ships – a **$1.1 billion facility** that was used to fund the Disney Treasure (fixed‑rate 3.80%) and a second **$1.1 billion facility** that can be drawn to finance the yet‑to‑be‑delivered Disney Destiny (fixed‑rate 3.74%). Both loans are payable semi‑annually over a 12‑year term, with early repayment allowed subject to cancellation fees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: total financing of $2.2 billion, $1.1 billion for Disney Treasure at 3.80% fixed rate, and $1.1 billion facility for Disney Destiny at 3.74% fixed rate. The multi-hop synthesis is correct - the model properly identified both cruise ships, their respective financing amounts, and accurately compared the interest rates (noting the Disney Destiny rate is 'slightly lower'). The answer goes beyond the minimum requirements by providing additional relevant context about the loan terms (semi-annual payments, 12-year term, early repayment provisions), which adds value without introducing any inaccuracies. All entities are correctly identified (Disney, Disney Treasure, Disney Destiny), and the reasoning properly synthesizes information across multiple financing facilities. The only minor consideration is that the additional details about payment terms and early repayment, while accurate and helpful, were not explicitly requested in the original question - however, this represents an enhancement rather than an error. The answer demonstrates sound multi-hop reasoning by correctly connecting the two separate financing facilities to answer the comparative question about interest rates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 362,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "\nThe Tengizchevroil equity‑method investment of roughly **$27.4 billion** makes up about **59 %** of Chevron’s total equity‑method investments (which totaled **$46.6 billion** at year‑end 2024).  This large stake is reflected in Chevron’s production from the Kazakhstan joint venture, which contributed **≈45  thousand barrels of oil‑equivalent per day** (≈26  thousand barrels of crude oil) in 2024, demonstrating that the investment accounts for a substantial share of the company’s output from that JV.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Verification of key numbers: (1) Tengizchevroil investment of $27.4 billion matches the ground truth $27,368 million (formatting variation acceptable); (2) Total equity method investments of $46.6 billion matches ground truth $46,618 million; (3) Percentage calculation of 59% is accurate (27,368/46,618 = 58.7%, rounded to 59% is reasonable rounding); (4) Production volume of approximately 45 thousand barrels of oil-equivalent per day is provided with additional detail (26 thousand barrels of crude oil), which adds specificity beyond the ground truth. The multi-hop reasoning is sound: the answer correctly synthesizes the investment percentage with production volumes to demonstrate the relationship between capital allocation and operational output. The answer addresses all parts of the question - the percentage stake, the total equity method investments, and the connection to Kazakhstan production volumes. Minor strengths: the LLM provides year-end 2024 context and breaks down the production into crude oil components, adding useful detail. The only minor limitation is that the ground truth answer is somewhat more general about 'key international affiliates' while the LLM provides specific production metrics, which is actually more informative. The rounding of 58.7% to 59% is standard practice and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 396,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "\nAn increase in credit spreads or a higher upfront credit‑point amount (or a lower recovery rate) raises the fair‑value of the firm’s purchased credit‑protection within its Level 3 credit derivatives, while a tightening of spreads or lower upfront points diminishes that fair‑value.  Goldman Sachs determines the fair value of these derivatives using option‑pricing models together with correlation and discounted‑cash‑flow techniques, relying on significant unobservable inputs such as credit spreads, upfront credit points, recovery rates and correlation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The core factual claim matches the ground truth - an increase in credit spreads or upfront credit points increases fair value of purchased credit protection for Level 3 credit derivatives. The LLM correctly identifies the valuation techniques (option pricing, correlation, and discounted cash flow models). (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable but the answer contains no calculation errors. (3) QUALITATIVE ACCURACY: The LLM answer is actually more detailed and precise than the ground truth. It correctly identifies: (a) the directional relationship (increase in spreads/upfront points → increase in fair value), (b) the inverse relationship (tightening spreads/lower points → decrease in fair value), (c) the three valuation techniques explicitly mentioned in ground truth, and (d) additional relevant unobservable inputs (recovery rates, correlation) that are material to the valuation. The answer demonstrates proper understanding of credit derivative valuation mechanics. (4) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between input variables (credit spreads, upfront points, recovery rates) and their impact on fair value measurement, while also identifying the specific valuation methodologies used. (5) ENTITY ACCURACY: Goldman Sachs is correctly identified, Level 3 derivatives are correctly specified, and purchased credit protection is accurately characterized. The only minor distinction is that the LLM provides additional context about recovery rates and the inverse relationship, which enhances rather than detracts from accuracy. The answer is semantically equivalent to and more comprehensive than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 490,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "\nFailure to meet the Minimum DSCR (1.15×) in the securitization facilities would trigger an “amortization period” that locks excess cash flow into reserve accounts and requires it to be used to pay down the Series 2015‑2 Notes and other secured debt. Because the indenture expressly states that a cash‑trap condition could “prevent GTP Acquisition Partners or the AMT Asset Subs from distributing excess cash flow … which could affect our ability to fund our capital expenditures, including tower construction and acquisitions,” a breach would curtail the cash available to build new communications sites globally and could delay or scale back the company’s planned site‑construction program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism (Minimum DSCR of 1.15x triggering an amortization period) and accurately describes the consequence (cash flow being trapped and applied to debt paydown, preventing distributions for capital expenditures). The answer correctly conveys that this impacts the ability to fund communications site construction globally. However, there are notable differences from the ground truth: (1) The ground truth specifies a concrete target of '1,950 to 2,550 communications sites globally' that would be affected, while the LLM answer only generically references 'new communications sites globally' without the specific quantitative target. (2) The LLM answer introduces references to 'GTP Acquisition Partners or the AMT Asset Subs' and quotes language about 'tower construction and acquisitions,' which adds contextual detail but shifts slightly from the direct focus on the impact mechanism. (3) The LLM answer uses 'could delay or scale back' language, which is appropriately cautious but the ground truth is more direct about preventing distributions and hindering growth. The quantitative accuracy is strong (1.15x DSCR is correct), and the multi-hop reasoning is sound (DSCR failure → amortization period → cash trap → reduced distributions → inability to fund construction). The main weakness is the omission of the specific site construction target (1,950-2,550 sites), which is a material detail in the original answer. The answer is substantially correct in its core logic and mechanism but incomplete in capturing all key quantitative details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 443,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "\nCaterpillar’s product‑warranty liability is estimated by applying historical claim‑rate experience—derived from actual warranty claims by product, model, engine size and customer/dealer location—to the current field population and dealer inventory, a process that involves significant management judgment and requires auditors to subjectively assess the reasonableness of those historical rates.  This assumption is a critical audit matter because of its high subjectivity and the effort needed to evaluate the underlying claim‑rate data.  As of December 31, 2024, the liability recorded for product warranties is $1.7 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The financial estimate of $1.7 billion is correct and matches the ground truth of $1,700 million (proper format variation accepted). The date of December 31, 2024 is correctly identified. No calculation errors present. (2) COMPLETENESS: The answer addresses all parts of the multi-part question: (a) how historical claim rates are used, (b) why this is a critical audit matter per PwC, and (c) the resulting financial estimate. (3) ENTITY ACCURACY: Caterpillar is correctly identified, PricewaterhouseCoopers LLP is correctly named, and the fiscal year 2024 is correct. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop relationship between the methodology (historical claim rates applied to field population/dealer inventory), the audit implication (critical audit matter due to subjectivity and judgment), and the financial outcome ($1.7 billion liability). The reasoning is sound and logically connects all elements. (5) SEMANTIC EQUIVALENCE: The LLM provides additional helpful detail about how historical claim rates are derived (by product, model, engine size, customer/dealer location) which adds context without contradicting the ground truth. The explanation of why it's a CAM (high subjectivity, effort required to evaluate) matches the ground truth's characterization of 'high degree of auditor judgment, subjectivity, and effort.' Minor note: The LLM uses slightly different phrasing ('auditors to subjectively assess' vs ground truth's 'auditor judgment') but this is semantically equivalent and actually more precise. No material omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 458,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "\nThe Asia Theme Parks borrowings are quoted at a **stated coupon of 7.93 %** (page 102), but after applying the interest‑rate and cross‑currency swaps and other adjustments the **effective rate drops to 5.75 %** (page 102). In comparison, Disney’s senior unsecured notes carry a **stated rate of about 4.06 % and an effective rate of roughly 4.71 %** (page 99). Thus, even after hedging, the park‑specific debt is more expensive than the company’s broad, investment‑grade unsecured debt, highlighting a lower overall cost of capital for Disney’s senior notes relative to the higher‑risk Asia Theme Parks financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail beyond the ground truth but contains a critical factual discrepancy. CORRECT ELEMENTS: (1) Asia Theme Parks stated rate of 7.93% is correct; (2) Senior unsecured notes stated rate of ~4.06% is reasonable; (3) Senior unsecured notes effective rate of 4.71% matches ground truth exactly; (4) The reasoning about relative cost of capital and risk profiles is sound and well-articulated; (5) The multi-hop synthesis across debt categories is logically structured. CRITICAL ERROR: The LLM states the Asia Theme Parks effective rate is 5.75% after hedging adjustments, but the ground truth indicates the effective rate should be compared directly to 4.71% without mentioning a 5.75% intermediate figure. The ground truth answer uses 7.93% (stated) vs 4.71% (effective on senior notes), yielding a 3.22 percentage point difference. The LLM's introduction of a 5.75% effective rate for Asia parks creates confusion about which rates are being compared. QUANTITATIVE ACCURACY ISSUE: While the LLM provides page references (pages 102, 99) suggesting source documentation, the 5.75% figure either represents a different calculation or is an error not present in the ground truth. The ground truth comparison is simpler: 7.93% stated on Asia parks vs 4.71% effective on senior notes. QUALITATIVE STRENGTHS: The LLM provides better context about swaps and hedging mechanisms, and explains the risk differential more thoroughly. However, the introduction of the 5.75% figure without clear justification against the ground truth creates factual uncertainty. The answer is partially correct but introduces a discrepancy that undermines confidence in the quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 464,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "\nChevron capitalized roughly **$10.5 billion** (about **$10,487 million**) of costs for the 2023 PDC Energy acquisition, and that purchase was the source of the **2.2 trillion cubic feet (TCF) of U.S. gas purchases** recorded in 2023—primarily from the **Denver‑Julesburg (DJ) basin**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The capitalized cost of $10,487 million is correctly stated (with acceptable format variation as $10.5 billion), the 2.2 TCF figure is accurate, and the DJ Basin (Denver-Julesburg) identification is correct. (2) QUANTITATIVE ACCURACY: Both primary numbers are precisely correct - $10,487 million and 2.2 TCF. The LLM appropriately presents the dollar amount in both billions and millions format, which aids clarity without sacrificing accuracy. (3) QUALITATIVE ACCURACY: The answer correctly identifies all entities (Chevron, PDC Energy acquisition, 2023 timeframe) and synthesizes the multi-hop information properly - connecting the acquisition cost to the specific basin contribution. The reasoning is sound and the connection between the acquisition and the gas purchases is clearly established. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question: the capitalized cost amount and the basin location. The additional context about PDC Energy being the source of the 2.2 TCF purchases adds helpful clarity without introducing errors. Minor note: The LLM slightly elaborates by naming 'PDC Energy' explicitly, which is a helpful clarification not strictly required but adds value. The answer demonstrates strong multi-hop synthesis across the acquisition details and basin-specific contribution data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 405,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "\nThe adoption of the LDTI guidance required a full‑retrospective restatement of MetLife’s previously reported consolidated financial statements, affecting the **statement of operations, balance sheet, statement of cash flows and statement of comprehensive income**.  The adjustments re‑classified market‑risk‑benefit and other long‑duration contract liabilities, revised deferred acquisition costs and retained earnings (and AOCI), and consequently altered net income and equity balances, illustrating the overall impact of the new LDTI framework on MetLife’s consolidated financial reporting.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - OVERSTATEMENT OF SCOPE: The LLM answer claims that MetLife's LDTI adoption required retrospective restatement of the 'statement of operations, balance sheet, statement of cash flows and statement of comprehensive income' (4 statements). However, the ground truth specifically identifies only TWO statements as retrospectively adjusted: (1) consolidated statement of operations and (2) consolidated statements of comprehensive income. The LLM incorrectly added balance sheet and cash flows to this list, which represents a material factual error about which financial statements were actually restated. This is a significant overstatement of the scope of retrospective adjustments. CORRECT ELEMENTS: The LLM correctly identifies that LDTI adoption involved retrospective application, that it was material, and that it affected prior period financial statements. The mention of reclassifications of market-risk-benefit liabilities, deferred acquisition costs, and retained earnings adjustments appears reasonable and contextually appropriate. REASONING QUALITY: While the LLM demonstrates understanding that LDTI had broad impacts on financial reporting, it fails to accurately identify which specific statements were restated. The additional details about reclassifications and equity impacts show good contextual reasoning, but this cannot overcome the fundamental error in identifying the scope of retrospective adjustments. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information about the nature and scope of LDTI impacts, but the synthesis is inaccurate regarding which statements were affected. The core answer to 'what specific financial statements' is incorrect, which is the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 474,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "\nThe 2024 10‑K shows that two amendments have been made to the Solar Turbines Incorporated Managerial Retirement Objective Plan – a first amendment and a second amendment. The most recent amendment became effective on **January 1, 2022**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-part question. (1) CORRECTNESS: Both the number of amendments (two) and the effective date of the most recent amendment (January 1, 2022) match the ground truth exactly. The answer correctly identifies that there are two amendments (first and second) and properly specifies that the Second Amendment is the most recent one. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the count of two amendments and the date of January 1, 2022 are factually accurate with no calculation errors. (3) ENTITY ACCURACY: All entities are correctly identified - Solar Turbines Incorporated Managerial Retirement Objective Plan, Caterpillar Inc., and the 2024 10-K filing are all properly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes information from the Caterpillar 2024 10-K filing regarding the Solar Turbines plan amendments, demonstrating proper cross-document reasoning. (5) MINOR OBSERVATION: The LLM answer uses slightly different phrasing ('a first amendment and a second amendment' vs. the ground truth's 'the First Amendment' and 'the Second Amendment'), but this is a stylistic difference that does not affect factual accuracy. The semantic meaning is identical. The answer is complete, accurate, and directly responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 377,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "\nThe North Carolina Rate Case Order produced a **$13 million decrease** in the “Impairment of assets and other charges” recorded for the combined Duke Energy Carolinas and Duke Energy Progress businesses. In the consolidated statements of operations this reduction appears as a lower impairment expense, which lifted operating income (and ultimately net income) by roughly $13 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ACCURACY - CRITICAL ERROR: The LLM states a $13 million DECREASE in impairment charges, while the ground truth shows a $68 million TOTAL impact ($35M from Duke Energy Carolinas + $33M from Duke Energy Progress). This is not merely a different number—it's directionally opposite (decrease vs. charges recorded) and off by a factor of ~5x. The LLM's $13 million figure does not match any component of the correct answer. (2) COMPLETENESS - FAILED: The question explicitly asks for the impact across BOTH Duke Energy Carolinas AND Duke Energy Progress separately and combined. The ground truth provides all three data points ($35M, $33M, and $68M total). The LLM provides only a single $13M figure with no breakdown by subsidiary. (3) ENTITY ACCURACY - PARTIALLY ADDRESSED: The LLM correctly identifies Duke Energy Carolinas and Duke Energy Progress as the relevant entities, but fails to provide separate impacts for each. (4) REASONING - FLAWED: The LLM's characterization of the impact as a 'decrease' or 'reduction' in impairment expense that 'lifted operating income' contradicts the ground truth, which describes these as charges recorded (implying expenses that reduced income, not increased it). The multi-hop synthesis is fundamentally broken. (5) SEMANTIC EQUIVALENCE - NOT ACHIEVED: A $13M decrease is semantically opposite to $68M in recorded charges. These cannot be reconciled as equivalent interpretations. The answer demonstrates a complete misunderstanding of the financial impact and its direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 439,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "\nLicensed stores accounted for about 12 % of Starbucks’ total net revenue in fiscal 2024.  Under the licensed model the company earns a product margin on the coffee, food and equipment it sells to the licensee and also receives ongoing royalties and license fees based on the store’s sales; although the gross margin on these sales is lower than on company‑operated stores, the licensees absorb most operating and capital costs, giving Starbucks a higher overall operating margin on this 12 % of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The 12% revenue contribution from licensed stores in fiscal 2024 is correct. The revenue structure (product margins, royalties, license fees) is accurately described. The key insight about lower per-store gross margins but higher overall operating margins due to licensees absorbing costs is correctly conveyed. (2) QUANTITATIVE ACCURACY: The 12% figure is precise and correctly attributed to fiscal 2024. No calculations are required for this question, and the percentage is stated accurately. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes: (a) the revenue percentage contribution, (b) the payment structure from licensees (product margins, royalties, license fees), (c) the comparative margin analysis (lower gross margins on licensed vs. company-operated, but higher operating margins overall), and (d) the cost-shifting benefit to Starbucks. The logic connecting lower per-unit margins to higher overall margins through cost absorption by licensees is clear and correct. (4) ENTITY ACCURACY: Starbucks is correctly identified, fiscal 2024 is correct, and all financial metrics are properly labeled. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('about 12%' vs '12%', 'coffee, food and equipment' vs 'branded products, supplies, and equipment') but these are semantically equivalent and represent the same information. The answer is well-structured and directly addresses all components of the question. Minor deduction only for the use of 'about' which introduces slight imprecision, though this is negligible.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 472,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "\nTarget’s owned and exclusive brands account for about one‑third of sales and carry higher margins, so any inability to develop, source, or market them can sharply reduce revenue and profit. Because these products involve longer lead times and more complex, responsible‑sourcing requirements, disruptions can cause inventory shortages, higher costs, or reputational damage—jeopardizing earnings and cash flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core financial risks posed by Target's owned and exclusive brands. STRENGTHS: (1) Correctly identifies that owned/exclusive brands represent approximately one-third of sales—matches ground truth; (2) Accurately conveys that these brands carry higher margins; (3) Properly synthesizes the multi-hop connection between longer lead times, responsible sourcing risks, and financial consequences; (4) Identifies key risk factors: inventory shortages, higher costs, reputational damage, and impact on earnings/cash flow; (5) Demonstrates sound reasoning about supply chain disruptions and forecasting challenges. MINOR GAPS: (1) The LLM answer is more concise and doesn't explicitly mention the specific challenge of 'longer-term forecasting of consumer demand' or 'misjudging rapidly changing consumer preferences' as detailed in the ground truth; (2) Doesn't explicitly state that longer lead times require 'earlier ownership of products in the supply chain,' though this is implied in the discussion of lead times; (3) Uses slightly different phrasing ('inability' vs 'fails to successfully develop, source, and market') but this is semantically equivalent. QUANTITATIVE VERIFICATION: The 'one-third of sales' figure is correct and properly cited. No calculations are required in this qualitative risk assessment. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between (a) owned brand importance to revenue/profitability, (b) longer lead times and responsible sourcing complexity, and (c) resulting financial risks. The logic chain is sound and complete. OVERALL ASSESSMENT: The answer captures the essential financial risks and demonstrates proper understanding of the multi-hop relationship between brand portfolio composition, operational complexity, and financial impact. The omission of some specific operational details (demand forecasting challenges, earlier supply chain ownership) prevents a perfect score, but the core answer is substantively correct and appropriately addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 560,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "\nThree amendments to Caterpillar’s Deferred Employees’ Investment Plan have been incorporated into the 2024 10‑K by reference to earlier filings. The two most recent amendments—the Second Amendment (dated December 14, 2018) and the Third Amendment (effective January 1, 2022)—are found in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018 and the Annual Report on Form 10‑K for the year ended December 31, 2021, respectively.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERROR - The LLM states 'three amendments' were incorporated, but the ground truth clearly states there were FOUR amendments. This is a direct factual error on the primary quantitative metric. (2) INCOMPLETE IDENTIFICATION OF MOST RECENT AMENDMENTS - The LLM identifies the Second Amendment (December 14, 2018) and Third Amendment (January 1, 2022) as the two most recent, but the ground truth specifies the Third Amendment (January 1, 2022) and Fourth Amendment (July 1, 2022) as the most recent two. The LLM completely omits the Fourth Amendment, which is the most recent amendment and a critical part of the answer. (3) MISSING EXHIBIT REFERENCES - The ground truth provides specific exhibit numbers (Exhibit 10.28 for the Third Amendment and Exhibit 10.6 for the Fourth Amendment), which the LLM does not mention. (4) INCORRECT FILING REFERENCES - While the LLM correctly identifies the 2021 10-K for the Third Amendment, it fails to identify the 2022 Q3 10-Q filing that contains the Fourth Amendment. (5) MULTI-HOP REASONING FAILURE - The question explicitly asks for the 'most recent two amendments,' and the LLM failed to correctly synthesize this information across the filing documents. The answer demonstrates a fundamental misunderstanding of which amendments are most recent. The contextual relevance score reflects that the LLM at least attempted to address the question structure and identified some correct entities (Caterpillar, the plan name, some amendment dates), but the core factual content is substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 454,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "\nAs of the fiscal year ended January 31 2025, **73 million shares** remained reserved and available for future grant or issuance under the 2013 Equity Incentive Plan.  The plan’s outstanding equity awards consisted of **stock options (8 million shares)** and **restricted‑stock awards/units and performance‑based stock units (26 million shares)**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the types of equity awards outstanding (stock options, restricted stock awards/units, and performance-based stock units), which matches the ground truth. However, there is a critical quantitative error regarding the number of shares available. The ground truth states '73 shares' remain available, while the LLM answer states '73 million shares.' This is a significant discrepancy - the LLM appears to have added 'million' without verification from the source material. The ground truth answer does not specify 'million' in the share count, suggesting the actual number may be 73 shares (not millions). Additionally, the LLM provides specific numbers for outstanding awards (8 million shares in options and 26 million shares in restricted stock/PSUs), which are not mentioned in the ground truth answer. While these additional details may be accurate from the filing, they go beyond what the ground truth explicitly confirms. The LLM correctly identifies the fiscal year context (January 31, 2025 for 2024 10-K) and properly synthesizes the types of awards. The main issue is the quantitative accuracy of the available shares figure - adding 'million' without confirmation from the ground truth represents a material factual error that significantly impacts the correctness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 370,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "\nThe 10‑K notes that a large portion of the Channel Development segment operates under a licensed model of the Global Coffee Alliance with Nestlé, indicating that most of the segment’s revenue comes from that partnership. Consequently, the vast majority of Channel Development revenues are derived from the Nestlé alliance, although the filing does not disclose a precise percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and aligns well with the ground truth. Both answers correctly identify that: (1) Starbucks' Channel Development revenues are primarily derived from the Global Coffee Alliance with Nestlé, (2) the revenues come from product sales and royalties, and (3) no exact percentage is disclosed in the filing. The LLM answer uses slightly different phrasing ('vast majority' vs. 'majority' and 'greater than 50%') but conveys the same essential information. The LLM correctly notes the licensed model structure and accurately reflects that while the filing indicates most revenues come from this partnership, a precise percentage is not provided. The multi-hop reasoning is sound - the answer synthesizes information about the Channel Development segment, the Nestlé partnership, and the nature of revenues (product sales and royalties). No numerical errors are present. The only minor difference is that the ground truth explicitly states 'greater than 50%' while the LLM uses 'vast majority,' but both convey the same meaning without providing a specific percentage. The answer appropriately addresses all parts of the question and maintains semantic equivalence with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 344,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "\nThe new LDTI guidance required MetLife to **retrospectively restate its consolidated balance sheet, its consolidated statement of cash flows, and its consolidated statement of shareholders’ equity (including retained earnings and accumulated other‑comprehensive income).**  \n\nIn the 2023 10‑K, the “effects of the retrospective application” tables dated **December 31, 2022** show the adjustment amounts for each of those statements—e.g., reductions in premiums‑receivable and deferred acquisition costs, increases in market‑risk benefits and future policy‑benefit liabilities, and the resulting impacts on liabilities, equity (retained earnings, AOCI) and the corresponding cash‑flow line‑item changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer significantly diverges from the ground truth on the core factual question. Ground truth states that MetLife retrospectively adjusted TWO specific financial statements: (1) consolidated statement of operations and (2) consolidated statements of cash flows. The LLM answer claims THREE statements were adjusted: (1) consolidated balance sheet, (2) consolidated statement of cash flows, and (3) consolidated statement of shareholders' equity. This is a material factual error - the consolidated balance sheet and statement of shareholders' equity are NOT mentioned in the ground truth as being retrospectively adjusted. The LLM appears to have added information not supported by the source material. PARTIAL CREDIT: The LLM correctly identifies that the adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing, and correctly specifies December 31, 2022 as the date of the 'effects of the retrospective application' tables. The LLM also provides reasonable detail about the types of adjustments (deferred acquisition costs, market-risk benefits, future policy-benefit liabilities, etc.), though this level of detail is not present in the ground truth answer. REASONING ISSUE: The multi-hop synthesis fails because the LLM appears to have inferred or added statements beyond what the ground truth indicates were actually adjusted. This suggests either hallucination or reliance on incomplete/incorrect source material. The question specifically asks 'which specific effects are illustrated in tables' - the ground truth provides a clear, limited answer (statement of operations and cash flows), while the LLM expands this scope incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 464,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "\nIn 2022 the equity‑method investment contracts were recorded at a fair‑value of only **$3 million**, while the aggregate fair‑value of all asset‑side derivatives (the “Total fair value – Asset Derivatives” line) was **$790 million**.  Consequently, equity‑method investment contracts accounted for less than 0.5 % of the total derivative portfolio, indicating they are a negligible component relative to the company’s broader derivative holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided a significantly incorrect figure for total asset derivatives. Ground truth states total asset derivatives were $393 million in 2022, but the LLM claims $790 million - a 101% overstatement. This is a major factual error that undermines the entire answer. The equity method investment contracts value of $3 million is correct. However, the percentage calculation is also affected by the wrong denominator: the LLM calculates 3/790 = 0.38% (stated as 'less than 0.5%'), whereas the correct calculation should be 3/393 = 0.76% (less than 1%). The ground truth explicitly states 'less than 1%' while the LLM states 'less than 0.5%' - both are technically correct given their respective denominators, but the denominator itself is wrong. The qualitative reasoning about relative significance is sound (correctly identifying equity method investment contracts as negligible), and the company (MDLZ) and year (2022) are correct. The semantic intent about minimal significance is preserved, but the quantitative foundation is severely compromised. This is a multi-hop question requiring synthesis of two derivative values, and the LLM failed to accurately retrieve or synthesize the total asset derivatives figure, which is a fundamental requirement for answering the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 366,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "\nThe December 31 2019 freeze of all U.S. pension benefits eliminated the “expected rate of compensation increase” assumption from CAT’s post‑employment benefit calculations—i.e., the compensation‑growth assumption is set to 0 % (shown as “‑%” in the tables), so future benefit obligations and costs are no longer projected to grow with wages. This change is reflected in the actuarial‑assumptions tables, removing any sensitivity to salary growth for the U.S. pension component.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Key strengths: (1) Correctly identifies the December 31, 2019 freeze date and its impact on U.S. pension benefits; (2) Accurately states that the 'expected rate of compensation increase' assumption was discontinued/eliminated; (3) Provides additional helpful detail by explaining that the compensation-growth assumption is set to 0%, which is a logical and accurate elaboration on what 'discontinuation' means in practical terms; (4) Correctly explains the consequence: future benefit obligations and costs are no longer projected to grow with wages; (5) Appropriately references the actuarial assumptions tables as the source of this information. The answer demonstrates sound multi-hop reasoning by connecting the pension freeze decision to its specific impact on actuarial assumptions. The only minor distinction is that the LLM provides slightly more technical detail (0% assumption, sensitivity analysis removal) than the ground truth statement, but this is additive and accurate rather than contradictory. The semantic meaning is fully preserved and enhanced with relevant context. No numerical errors, date errors, or entity misidentifications present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 347,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "\nOracle’s decision to concentrate hardware revenue on higher‑margin Oracle Engineered Systems narrows its product mix, so any supply‑chain shock—such as component shortages, logistics delays, or the need to secure extra inventory—directly impacts a larger share of its hardware sales. While the higher profitability of Engineered Systems helps offset margin pressure and supports overall hardware earnings, the reduced breadth of lower‑margin offerings makes the business more vulnerable to disruptions, forcing Oracle to balance inventory investments and cost‑saving measures to preserve profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general strategic question but diverges significantly from the ground truth in critical ways. STRENGTHS: (1) Correctly identifies Oracle Engineered Systems as the strategic focus, (2) Acknowledges supply chain vulnerability and component shortages, (3) Recognizes inventory investment challenges, (4) Notes the tension between higher margins and vulnerability. CRITICAL WEAKNESSES: (1) The ground truth explicitly states that supply chain shortages have 'increased production costs' and 'led to higher inventory purchases to secure manufacturing capacity,' which directly negatively impacted 'operating cash flows' - the LLM answer mentions these concepts but doesn't establish the causal chain or quantify the impact. (2) The ground truth emphasizes that Oracle 'cannot always pass these increased costs on to customers' - a key constraint on profitability - which the LLM answer omits entirely. (3) The ground truth mentions 'inventory excess and obsolescence risk' as specific consequences - the LLM only vaguely references 'inventory investments.' (4) The ground truth notes 'delays in manufacturing can lead to lost sales and delayed revenue recognition' - concrete business impacts the LLM doesn't address. (5) The LLM's framing that 'higher profitability of Engineered Systems helps offset margin pressure' is somewhat contradictory to the ground truth's emphasis that supply chain disruptions directly harm profitability. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral (7/10 - both lack quantitative specificity). QUALITATIVE ACCURACY: The LLM demonstrates partial understanding but misses the core mechanism: supply chain disruptions → increased costs → inability to pass costs to customers → reduced profitability. The answer is more abstract and less grounded in the specific financial impacts documented in the 10-K. CONTEXTUAL RELEVANCE: The answer addresses the question but doesn't fully explain the impact on profitability maintenance, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 554,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "\nThe 2023 worldwide sales for UPTRAVI and OPSUMIT total **$3.555 billion** ($1.582 bn + $1.973 bn).  This combined figure grew **≈14.5 %** from 2022 (up from $3.105 bn), which outpaces the overall Pulmonary Hypertension category’s **11.6 %** growth for 2023 – about **2.9 percentage points higher** (roughly 25 % faster growth).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Combined revenue figure is correct: $3,555 million ($1.973B + $1.582B) - format variation to $3.555 billion is acceptable. (2) Overall PH category growth rate of 11.6% is correct. (3) Correctly identifies that combined growth outpaces category growth. (4) Properly synthesizes multi-hop information across products and metrics. (5) Contextually relevant to the question asked.\n\nCRITICAL ERRORS: (1) MAJOR CALCULATION ERROR: LLM calculates combined growth as ≈14.5% from 2022 ($3.105B to $3.555B), but this is mathematically incorrect. The actual calculation is ($3.555B - $3.105B) / $3.105B = 14.5%, which happens to be correct arithmetically. However, the ground truth shows individual product growth rates: OPSUMIT 10.6% and UPTRAVI 19.7%. The LLM provides a blended/weighted growth rate (14.5%) rather than the individual product growth rates that the ground truth emphasizes. (2) INCOMPLETE ANSWER: The ground truth specifically states that OPSUMIT grew 10.6% and UPTRAVI grew 19.7%, both higher than the 11.6% category growth. The LLM omits these individual product growth rates entirely, instead providing only a combined blended growth rate. (3) The LLM's statement that the combined growth is \"roughly 25% faster\" (14.5% vs 11.6% = 2.9 pp difference, which is 25% relative increase) is mathematically correct but represents a different analytical approach than the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the two products' revenues and compares to category growth, but fails to provide the individual product growth rates that are central to the ground truth answer. The question asks how the total compares in percentage growth to the category growth - the LLM answers this with a combined growth rate, but the ground truth emphasizes that BOTH individual products outpace the category.\n\nVERIFICATION: Combined revenue $3.555B ✓ | Category growth 11.6% ✓ | Individual product growth rates (10.6% OPSUMIT, 19.7% UPTRAVI) ✗ MISSING | Combined growth calculation 14.5% ✓ (arithmetically correct but not emphasized in ground truth)",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 560,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "\nThe full‑year contribution from the legacy PDC Energy assets added roughly **$2.2 billion** to Chevron’s 2024 U.S. upstream earnings, and it drove net oil‑equivalent production up by about **250  thousand barrels per day** (an ≈19 % increase).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative metrics match the ground truth exactly: (1) $2.2 billion contribution to U.S. upstream earnings - correct, (2) 250,000 barrels per day production increase - correct, (3) 19% increase percentage - correct. The answer properly synthesizes the multi-hop information by connecting the PDC Energy acquisition to both earnings impact and production impact for CVX in 2024. The formatting variations used (e.g., '250 thousand barrels per day' vs '250,000 barrels per day', '≈19%' vs '19%') are acceptable and demonstrate flexibility in presentation while maintaining accuracy. The answer correctly identifies all entities (Chevron/CVX, legacy PDC Energy assets, 2024, U.S. upstream segment) and properly contextualizes the information. The only minor observation is the use of 'roughly' and 'about' and the approximation symbol (≈) which slightly soften the precision, but this is a stylistic choice that doesn't detract from factual accuracy. The answer fully addresses both parts of the multi-part question: earnings impact and production impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 318,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "\nThe retrospective LDTI adoption required MetLife to restate its **consolidated statements of comprehensive income, equity, and cash‑flows** (and the balance‑sheet accounts that feed them).  By quantifying the “adoption adjustment” in those tables, the company shows that the new guidance reshapes key performance metrics, equity balances and cash‑flow classifications across the entire financial reporting package—not just a single line‑item.  Consequently, the impact of LDTI is broad‑ranging, affecting the entirety of MetLife’s reported financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: The answer accurately identifies that MetLife adjusted consolidated statements of comprehensive income and equity, matching the ground truth. The reasoning about broad impact and materiality is sound. INCORRECT/PROBLEMATIC: The LLM adds 'cash flows' and 'balance sheet accounts' as adjusted financial statements, which goes beyond what the ground truth specifies. The ground truth explicitly states only 'consolidated statements of equity and consolidated statements of comprehensive income' were adjusted. While cash flows and balance sheet accounts may be affected indirectly, the question asks specifically about 'financial statements adjusted,' and the LLM appears to overstate the scope by including statements not explicitly mentioned in the ground truth. The LLM's interpretation that the guidance affects 'the entirety of MetLife's reported financial statements' is somewhat speculative and broader than the ground truth's more measured statement about 'broad impact' affecting 'comprehensive income' and 'equity.' The LLM demonstrates good reasoning about the implications (showing materiality and foundational nature of changes), but the factual claim about which statements were adjusted is inaccurate. This is a significant error because the question specifically asks 'what specific financial statements were adjusted,' making precision on this point critical. The answer would have scored 8-9 if it had stuck to the two statements mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 425,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "\nAs of December 31 2022 the derivatives fair‑value table lists a **$(3 million)** fair value for equity‑method investment contracts (i.e., a $3 million liability), while net‑investment‑hedge contracts are recorded at a **$24 million** fair value (an asset). Thus, the hedge contracts exceed the equity‑method contracts by roughly **$27 million** and are on the opposite side of the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: equity method investment contracts fair value of $(3) million and net investment hedge contracts fair value of $24 million are both accurate. The calculation of the $27 million difference ($24M - (-$3M) = $27M) is mathematically correct. The LLM properly synthesized information from the derivatives fair value table and correctly identified both contract types and their respective fair values as of December 31, 2022. The answer goes beyond the ground truth by providing helpful contextual interpretation: clarifying that the $(3) million represents a liability position while the $24 million represents an asset position, and noting they are 'on the opposite side of the balance sheet.' This additional context is accurate and enhances understanding without introducing errors. The multi-hop reasoning is sound - the model correctly identified the two different derivative contract types from the fair value table and made an appropriate comparison. Minor deduction from perfect score (9 vs 10) only because the ground truth answer is more concise, though the LLM's additional explanatory detail is valuable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 342,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "\nUniversal Beijing Resort’s net assets fell by roughly **$0.3 billion** – from about **$0.6 billion** ( $7.8 B assets – $7.2 B liabilities ) at the end of 2023 to about **$0.3 billion** ( $7.3 B assets – $7.0 B liabilities ) at the end of 2024.  This decline is reflected in Comcast’s consolidated balance sheet, which shows the resort’s assets dropping by $0.5 B and its liabilities dropping by $0.2 B over the same period, leaving a smaller equity cushion in the consolidated reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical numerical error in the primary metric while correctly identifying the underlying balance sheet components. QUANTITATIVE ISSUES: (1) The LLM states net assets fell by 'roughly $0.3 billion' but the ground truth clearly shows a $0.5 billion decrease ($0.6B to $0.3B). This is a significant error in the main answer metric. (2) The LLM correctly identifies the 2023 net assets as $0.6B ($7.8B - $7.2B) and 2024 net assets as $0.3B ($7.3B - $7.0B), with correct arithmetic for these components. (3) The LLM correctly states assets dropped by $0.5B ($7.8B to $7.3B) and liabilities dropped by $0.2B ($7.2B to $7.0B), which are accurate. However, these component changes should yield a $0.3B net asset decrease, not the $0.5B stated in ground truth - this suggests a potential discrepancy in the ground truth itself, but the LLM's stated change of $0.3B is mathematically consistent with the balance sheet figures provided. QUALITATIVE ASSESSMENT: The LLM appropriately synthesizes information across Comcast's consolidated balance sheets and correctly identifies the relationship between asset/liability changes and equity position. The reasoning about 'smaller equity cushion' is sound. COMPLETENESS: The answer addresses both parts of the question (the change in net assets and how it reflects in consolidated reporting). ENTITY ACCURACY: Correctly identifies Universal Beijing Resort and Comcast. The main weakness is the discrepancy between the stated net asset change ($0.3B per LLM calculation vs $0.5B per ground truth), which appears to be a mathematical inconsistency in the ground truth itself, though the LLM's figure is arithmetically correct based on the balance sheet numbers provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 471,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "\nAs of September 29 2024, Starbucks’ two Japanese‑yen‑denominated credit facilities total ¥15 billion, which is equivalent to roughly **$34.5 million + $69.1 million = $103.6 million** in U.S. dollars.  \n\nThe 2021 Revolving Credit Agreement explicitly backs the commercial‑paper program by requiring that all commercial‑paper issuances be **fully backstopped by available commitments under this facility**, thereby providing up to **$3 billion of borrowing capacity**; the proceeds may be used for working‑capital needs, capital expenditures, dividend payments and share repurchases, among other corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - the two Japanese yen facilities (¥5.0 billion = $34.5 million and ¥10.0 billion = $69.1 million) correctly sum to $103.6 million USD as of September 29, 2024. The commercial paper program capacity of $3.0 billion is accurately stated. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the total value of Japanese yen-denominated credit facilities in USD, and (2) how the 2021 Revolving Credit Agreement supports the commercial paper program. MULTI-HOP REASONING: The LLM correctly synthesized information across multiple components - identifying the two separate facilities, converting them to USD, summing them, and then explaining the backstopping relationship between the revolving credit agreement and the commercial paper program. ENTITY ACCURACY: All entities are correctly identified (Starbucks, 2021 Revolving Credit Agreement, commercial paper program, Japanese yen facilities). MINOR OBSERVATION: The LLM answer uses slightly more concise phrasing ('roughly' before the calculation, 'among other corporate purposes') compared to the ground truth's more detailed listing of uses, but this represents appropriate summarization rather than an error. The semantic meaning is fully preserved. The answer demonstrates sound understanding of the interconnected relationship between the credit facility and the commercial paper program, correctly explaining that the facility provides the backstop for the program's $3 billion capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 432,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "\nOracle’s emphasis on Oracle Engineered Systems—high‑margin, differentiated hardware—boosts the share of its infrastructure‑technologies revenue that comes from these engineered products, while it deliberately de‑emphasizes lower‑margin commodity hardware. At the same time, this concentration relies on a limited set of specialized, often single‑source suppliers, heightening the company’s exposure to supply‑chain disruptions such as COVID‑19‑related production delays, component shortages, and the inability to pass cost increases on to customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Oracle Engineered Systems as high-margin, differentiated hardware and accurately describes the supply chain risk exposure including COVID-19 disruptions, component shortages, and single-source supplier dependencies. The reasoning about concentration risk and supply chain vulnerability is sound and relevant to the question. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth provides a specific, important metric—'Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022'—which the LLM answer completely omits. This is a concrete, verifiable number that directly addresses the revenue impact question. (2) INCOMPLETE REVENUE IMPACT ANALYSIS: While the LLM mentions that engineered systems boost infrastructure-technologies revenue share, it lacks the specific fiscal 2022 data point that grounds this claim. The ground truth explicitly quantifies the importance of infrastructure technologies to Oracle's financial performance. (3) MISSING OPERATIONAL CONSEQUENCES: The ground truth details specific negative impacts: 'manufacturing and fulfillment delays during fiscal 2022,' 'increased inventory purchases,' and 'raised inventory excess and obsolescence risk and negatively impacted operating cash flows.' The LLM answer mentions delays and shortages but omits the concrete operational consequences and their financial impact. (4) VAGUE CHARACTERIZATION: The LLM states the company cannot 'pass cost increases on to customers' but the ground truth doesn't explicitly support this claim—it focuses on inventory and cash flow impacts instead. MULTI-HOP REASONING: The LLM successfully synthesizes the two-part question (revenue impact + supply chain risk) but does so incompletely. It addresses supply chain risks adequately but underspecifies the revenue contribution with missing quantitative support. The answer reads as a reasonable summary but lacks the factual precision required for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 560,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "\nUniversal Beijing Resort’s debt fell slightly, from **$3.5 billion in 2023 to $3.4 billion in 2024** (a $0.1 billion decrease). Because this line is part of the “Debt Not Guaranteed” total, the overall “Debt Not Guaranteed” amount also declined, moving from **$5.0 billion in 2023 to $4.8 billion in 2024** (a $0.2 billion reduction).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the Universal Beijing Resort debt change ($3.5B to $3.4B, a $0.1B decrease) and the overall 'Debt Not Guaranteed' category change ($5.0B to $4.8B). However, there is a critical calculation discrepancy: The LLM states the 'Debt Not Guaranteed' reduction is $0.2 billion, but the ground truth shows it decreased by $0.2 billion ($5.0B - $4.8B = $0.2B), which the LLM correctly calculates. The issue is that the ground truth mentions the 'Other' debt also decreased from $1.5B to $1.4B (a $0.1B reduction), which accounts for the full $0.2B total decrease in 'Debt Not Guaranteed' ($0.1B from Universal Beijing + $0.1B from Other = $0.2B total). The LLM answer does not mention the 'Other' debt component, which is a significant omission from the ground truth. While the LLM correctly identifies that Universal Beijing Resort's debt decrease 'contributed to' the overall decline, it fails to provide the complete picture by omitting the parallel decrease in 'Other' debt. The multi-hop reasoning is sound in connecting the subsidiary's debt change to the category total, but the answer is incomplete in not addressing all components of the 'Debt Not Guaranteed' category change. The calculation of $0.2B reduction is correct, but the explanation of what drove that reduction is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 369,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "\nHoneywell’s long‑term contracts are accounted for using a cost‑to‑cost input method, so revenue is recognized only as costs are incurred and the overall contract progress is measured against the total estimated cost. Because the method relies on management’s judgment to estimate total contract costs—and to assess factors such as inflation, schedule risk, technical performance and subcontractor outcomes—audit procedures must rigorously test the controls over those cost estimates, evaluate the reasonableness of the underlying assumptions, and perform detailed substantive testing (e.g., analytical procedures and contract‑level sampling) to verify that revenue is recorded appropriately over the contract term.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Honeywell's cost-to-cost input method and its audit implications. STRENGTHS: (1) Correctly identifies the cost-to-cost input method as the revenue recognition approach; (2) Accurately describes how revenue is recognized based on proportion of costs incurred relative to total estimated costs; (3) Properly identifies key factors affecting cost estimates (inflation, schedule risk, technical performance, subcontractor outcomes); (4) Correctly describes audit procedures needed (testing controls, evaluating assumptions, substantive testing, analytical procedures, contract-level sampling); (5) No quantitative errors or incorrect numbers/dates; (6) Semantic equivalence with ground truth is strong. MINOR GAPS: (1) The LLM answer does not explicitly mention 'material adjustments if estimates change over time' - a specific point in the ground truth about how estimate changes can lead to material revenue adjustments; (2) Does not explicitly reference 'contracts with longer durations or significant gross margin changes' as a profiling criterion for audit focus; (3) Slightly less emphasis on the multi-year spanning nature of contract costs and how this compounds complexity. The answer is substantively correct and addresses the core question about how the cost-to-cost method increases audit complexity through estimation challenges and the need for rigorous testing. The omissions are relatively minor contextual details rather than fundamental errors. The reasoning is sound and the synthesis of how the accounting method drives audit complexity is well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 445,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "\nThe 2023 results show NEER’s non‑qualifying hedge gains of **$1,729 million** versus **$300 million** for FPL—a **$1,429 million** difference. This gap reflects the distinct accounting treatments: NEER marks its non‑qualifying derivatives to market and records the resulting gains directly in net income, while FPL’s derivative gains are deferred as regulatory assets/liabilities and recognized through the fuel‑clause mechanism, producing a much smaller and more stable impact on earnings. (Pages 37 and 50 of the 10‑K disclose the $1,729 million NEER gain and the $300 million FPL gain.)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core quantitative elements and multi-hop synthesis. STRENGTHS: (1) All numbers are correct: NEER's $1,729 million, FPL's $300 million, and the calculated difference of $1,429 million are accurate. (2) The calculation is correct ($1,729M - $300M = $1,429M). (3) Multi-hop reasoning is sound—the answer correctly synthesizes information about both business units' derivative treatment from the 10-K. (4) Entity identification is accurate (NEE, NEER, FPL, 2023 fiscal year). (5) The explanation of different accounting treatments is semantically equivalent to the ground truth: NEER's non-qualifying hedges marked to market with direct P&L impact versus FPL's regulatory deferral mechanism. (6) The reference to specific pages (37 and 50) adds credibility. MINOR WEAKNESSES: (1) The LLM uses slightly different terminology ('fuel-clause mechanism' vs. the ground truth's 'regulatory assets or liabilities until contract settlement'), though both convey the same regulatory deferral concept. (2) The answer could have been slightly more explicit about NEER's 'market-oriented operations' versus FPL's 'regulatory framework' distinction, though this is implied. (3) The ground truth emphasizes that NEER's non-qualifying hedge activity was 'a primary driver of its improved results in 2023 compared to 2022,' which the LLM answer doesn't explicitly mention, though this is a minor contextual detail. Overall, the answer correctly addresses all parts of the multi-part question with accurate numbers, sound reasoning, and appropriate synthesis of derivative treatment differences between the two business units.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 453,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "\nComcast consolidates Universal Beijing Resort (a 30 %‑owned VIE) in its 2024 balance sheet, so the resort’s $7.3 billion of assets and $7.0 billion of liabilities are recorded as part of Comcast’s consolidated totals. Because no guarantees or other financial commitments exist between the parties, Comcast’s maximum exposure is limited to its 30 % equity stake, which corresponds to roughly 30 % of the resort’s $3.4 billion debt financing (≈ $1 billion of the term‑loan). Thus, the risk represents about a 30 % share of the total debt financing of Universal Beijing Resort.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-hop question. Verification of specific claims: (1) Ownership stake: Correctly identifies 30% interest in Universal Beijing Resort - CORRECT. (2) VIE consolidation: Correctly states Comcast consolidates UBR as a VIE due to power to direct major activities - CORRECT. (3) Asset/liability figures: States $7.3 billion in assets and $7.0 billion in liabilities - CORRECT and matches ground truth exactly. (4) Debt outstanding: Identifies $3.4 billion in debt - CORRECT. (5) Maximum risk calculation: States 30% of $3.4 billion = approximately $1 billion - CORRECT (30% × $3.4B = $1.02B, and the LLM appropriately rounds to ~$1 billion). (6) Multi-hop synthesis: Successfully synthesizes information across consolidation accounting, VIE treatment, and financial exposure calculation. The answer correctly explains that consolidation includes full assets/liabilities while maximum risk is limited to equity interest. Minor observation: The LLM uses '≈ $1 billion' and 'roughly 30%' language, which is appropriate given the rounding, though the ground truth specifies $1.02 billion more precisely. The phrase 'term-loan' in parentheses is a reasonable characterization of the debt structure. The statement about 'no guarantees or other financial commitments' is a reasonable inference about why exposure is limited to equity interest, though this specific detail isn't explicitly verified in the ground truth provided. Overall, the answer demonstrates sound multi-hop reasoning, correct entity identification, accurate calculations, and appropriate contextual understanding of consolidation accounting principles.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 462,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "\nBooking Holdings recorded a cumulative goodwill impairment of $489 million (interim) plus $573 million (annual) for OpenTable in 2020, amounting to roughly $1.06 billion. In 2021, OpenTable’s restaurant‑reservation and subscription fees contributed only a modest sum—on the order of a few hundred million dollars—to the advertising and other segment, making the 2020 impairment far larger than its revenue contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two impairment charges ($489M and $573M) and their sum (~$1.06B), matching the ground truth. However, there is a critical quantitative error in the revenue comparison. The ground truth states OpenTable contributed $1.1 billion to the 'advertising and other' segment in 2021, but the LLM answer vaguely describes this as 'only a modest sum—on the order of a few hundred million dollars,' which significantly understates the actual revenue contribution. This is a major factual error that undermines the comparison. The LLM correctly synthesizes the multi-hop information (2020 impairment vs 2021 revenue) and reaches a reasonable conclusion about the impairment being 'far larger,' but this conclusion is based on an incorrect revenue figure. The reasoning quality is sound, and the answer appropriately addresses the question's structure, but the quantitative inaccuracy regarding the 2021 revenue ($1.1B vs 'a few hundred million') is a substantial error that prevents a higher score. The answer demonstrates understanding of the multi-hop synthesis required but fails on precision of the key financial metric needed for the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 333,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "\nExxonMobil adds the projected costs of meeting its greenhouse‑gas‑reduction plans to the cash‑flow forecasts used in recoverability (impairment) testing of asset groups, so that estimated emission‑control expenses are reflected in the recoverability analysis.  The specific future goal incorporated is the Company’s 2030 emission‑reduction target that includes achieving net‑zero Scope 1 and 2 GHG emissions from its unconventional operated assets in the Permian Basin (part of its broader net‑zero ambition).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that ExxonMobil incorporates estimated GHG emission costs into cash flow assessments for asset recoverability testing, includes these costs even for jurisdictions without current GHG pricing policies (implied through the broader context), and specifies the 2030 emission-reduction goal with the net-zero Scope 1 and 2 GHG emissions target for unconventional operated assets in the Permian Basin. (2) QUANTITATIVE ACCURACY: All dates and metrics are correct - the 2030 target year is accurate, and the scope definitions (Scope 1 and 2) match exactly. No calculations are required for this question. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes: (a) the mechanism of incorporation (adding projected costs to cash-flow forecasts), (b) the purpose (recoverability/impairment testing), and (c) the specific goal (2030 net-zero target for Permian Basin unconventional assets). The answer also appropriately contextualizes this as part of the broader net-zero ambition. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different but semantically equivalent phrasing - 'projected costs of meeting its greenhouse-gas-reduction plans' vs 'estimated greenhouse gas emission costs' - both convey the same meaning. The answer is well-structured and directly addresses both parts of the multi-part question. Minor: The LLM adds helpful context about 'impairment testing' in parentheses and mentions the 'broader net-zero ambition,' which enhances clarity without introducing inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 458,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "\nAs of December 31 2023, $1.2 billion of the $2.4 billion CECL‑Transition capital addition remains to be phased in ( $600 million in 2024 and $600 million in 2025 ). This amount is added to the Company’s regulatory capital and therefore raises the stress‑capital‑buffer requirement for the period October 1 2023 through September 30 2024 to 4.8%, which translates into minimum CET1, Tier 1 and total‑capital ratios of 9.3 %, 10.8 % and 12.8 % respectively for that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: $1.2 billion remaining to be phased in as of December 31, 2023, with $600 million each in 2024 and 2025. The stress capital buffer requirement of 4.8% for October 1, 2023 through September 30, 2024 is also correct. The LLM provides additional detail by translating this into minimum capital ratios (9.3% CET1, 10.8% Tier 1, 12.8% total capital), which appears mathematically sound given the 4.8% SCB requirement.\n\nHowever, there are notable omissions relative to the ground truth: (1) The LLM does not mention the 2.5% capital conservation buffer requirement for CET1, Tier 1, and total capital under Federal Reserve regulations, which is a distinct requirement from the stress capital buffer framework. (2) The LLM does not explicitly state that Capital One maintains 'well-capitalized' status or that it currently exceeds minimum capital requirements. (3) The LLM's phrasing 'raises the stress-capital-buffer requirement' could be misinterpreted as suggesting the CECL transition amount causes the 4.8% SCB, when the SCB is determined separately through stress testing.\n\nThe answer addresses the first part of the question (remaining CECL phase-in amount) well, but only partially addresses the second part regarding how this affects capital conservation buffer requirements. The ground truth distinguishes between the 2.5% conservation buffer and the 4.8% stress capital buffer, while the LLM focuses primarily on the stress capital buffer and its translated minimum ratios. The quantitative data provided is accurate, but the contextual framing and completeness of the capital buffer discussion is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 459,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "\nThe U.S. dollar notes and term‑loan balance fell from **$11,275 million in 2022 to $9,562 million in 2023**, a reduction of **$1,713 million**. In contrast, the Euro‑denominated notes increased only slightly from **$7,666 million to $7,916 million**, a gain of **$250 million**. Thus, the decline in MDLZ’s U.S. dollar debt was far larger than the modest rise in its Euro notes over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: U.S. dollar notes and term loans decreased from $11,275 million to $9,562 million (a $1,713 million reduction), and Euro notes increased from $7,666 million to $7,916 million (a $250 million increase). All calculations are accurate. The multi-hop reasoning is sound - the model correctly synthesized information about both debt instruments across the 2022-2023 period and made the appropriate comparison showing the U.S. dollar reduction was significantly larger than the Euro increase. The entity identification is correct (MDLZ, the specific debt instruments, and the time period). The wording is clear and semantically equivalent to the ground truth, with slightly more descriptive language ('far larger,' 'modest rise') that enhances clarity without introducing inaccuracy. The answer fully addresses all parts of the multi-part question. Minor deduction from perfect score only due to slightly different phrasing in the comparative conclusion, though the meaning is identical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 306,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "\nThe indemnification agreement requires the Resideo subsidiary to pay Honeywell an amount equal to **90 % of Honeywell’s annual net spending on environmental matters at the covered sites, but the payment is capped at $140 million per year**. This cap limits the maximum cash obligation to $140 million annually, regardless of the underlying level of Honeywell’s net environmental expenditures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The $140 million maximum annual payment is accurately stated, and the 90% relationship to Honeywell's net spending on environmental matters is correctly identified. (2) QUANTITATIVE ACCURACY: Both key numbers are correct - $140 million cap and 90% percentage. No calculation errors present. (3) MULTI-HOP REASONING: The answer successfully synthesizes the relationship between the two components: it explains that Resideo pays 90% of Honeywell's environmental spending, but this payment is capped at $140 million annually. This demonstrates proper understanding of how the cap functions as a limiting mechanism. (4) COMPLETENESS: The answer addresses both parts of the original question - the maximum annual payment amount AND how it relates to Honeywell's net spending. The explanation of the cap's limiting function adds valuable context. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, using slightly more detailed language to explain the mechanics of the payment structure. The phrasing 'capped at $140 million per year' is semantically equivalent to stating the maximum is $140 million. Minor deduction (1 point) only because the ground truth is more concise, though the LLM's additional explanatory detail about the cap's limiting function is actually beneficial and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 397,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "\nBetween 31 Dec 2022 and 31 Dec 2023 the VaR for Non‑Qualifying Hedges fell from $145 million to $116 million (FPL $3 → $2 million; NEER $148 → $114 million), and the VaR for Hedges in FPL Cost‑Recovery Clauses declined from $134 million to $111 million (FPL $3 → $2 million; NEER $135 → $113 million).  These lower risk‑loss estimates are reflected in a markedly improved mark‑to‑market position – the net liability for Non‑Qualifying Hedges narrowed from $1,477 million to $128 million after collateral – which together strengthened the overall financial position of both the FPL and NEER segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information, with significant issues in quantitative accuracy and focus. CORRECT ELEMENTS: (1) FPL Non-Qualifying Hedges: $3M → $2M (correct), (2) NEER Non-Qualifying Hedges: $148M → $114M (correct), (3) The $1M and $34M decreases are correctly calculated, (4) The combined $35M total decline is implicitly correct. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM introduces VaR (Value at Risk) metrics ($145M → $116M and $134M → $111M) that are NOT mentioned in the ground truth answer and appear to be from a different section of the filing or misinterpreted data. (2) The LLM discusses 'Hedges in FPL Cost Recovery Clauses' with NEER values ($135M → $113M) that don't match the ground truth, which states NEER had $148M → $114M for this category. (3) The LLM introduces mark-to-market position data ($1,477M → $128M after collateral) that is extraneous to the question and not part of the ground truth answer. (4) The answer conflates or confuses multiple hedge categories and metrics, making it unclear which numbers apply to which category. MULTI-HOP REASONING: The LLM correctly identifies FPL and NEER segments and attempts to synthesize their combined impact, but introduces unrelated metrics that muddy the analysis. The core calculation of the $35M combined decline is present but buried in confusing additional information. SEMANTIC ISSUES: The question asks specifically about 'Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses' impact on 'total financial position,' but the LLM shifts focus to VaR estimates and mark-to-market positions, which may be related but represent a different analytical lens than what the ground truth provides. The answer is partially correct on the core numbers but significantly diluted by extraneous information and metric confusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 497,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "\nUniversal Beijing Resort’s consolidated net assets declined from roughly $0.6 billion in 2023 (assets $7.8 bn – liabilities $7.2 bn) to about $0.3 billion in 2024 (assets $7.3 bn – liabilities $7.0 bn), a decrease of approximately $0.3 billion.  During the same period its debt fell from $3.5 billion to $3.4 billion, a reduction of about $0.1 billion.  Thus, the drop in net assets was roughly three times larger than the decline in its debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) NET ASSETS CALCULATION: The LLM states net assets declined from $0.6B to $0.3B (a $0.3B decrease), but the ground truth clearly states the decline was from $0.6B to -$0.3B (a $0.9B decrease). The LLM fundamentally miscalculated the 2024 net assets figure. Ground truth: 2024 net assets = $7.3B assets - $7.0B liabilities = $0.3B positive, but the original answer states it resulted in -$0.3B (negative). The LLM used $0.3B positive, which contradicts the ground truth's -$0.3B negative figure. (2) DEBT OBLIGATIONS: The LLM cites debt declining from $3.5B to $3.4B (a $0.1B reduction), but the ground truth explicitly states liabilities decreased from $7.2B to $7.0B (a $0.2B reduction). The LLM's debt figures ($3.5B and $3.4B) do not appear in the ground truth at all - these are completely incorrect numbers. (3) COMPARISON LOGIC: The LLM concludes the drop in net assets was 'roughly three times larger' than debt decline ($0.3B vs $0.1B = 3x ratio). However, using ground truth figures, the net assets decline was $0.9B while debt declined $0.2B, making it 4.5x larger - a different ratio entirely. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the asset and liability figures across both years. The fundamental error in identifying debt obligations ($3.5B-$3.4B instead of $7.2B-$7.0B) suggests the LLM either hallucinated these numbers or confused them with different financial metrics. (5) GROUND TRUTH INCONSISTENCY NOTE: The original answer itself contains an internal inconsistency (stating net assets of $0.6B in 2023 but then saying -$0.3B in 2024, yet also stating a $0.9B decrease which would be correct if 2024 was -$0.3B). However, the LLM's numbers don't match either interpretation of the ground truth. The LLM's answer is fundamentally incorrect on the primary metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 501,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "\nAccording to the 2023 10‑K, EDURANT (rilpivirine) was newly approved for **pediatric patients aged 2 – 12 years with HIV**. The company simultaneously filed for regulatory approval in both the **United States and the European Union**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth - the specific patient population (pediatric patients aged 2-12 years with HIV) is correctly identified, and the regulatory regions (US and EU) are accurately stated. (2) QUANTITATIVE ACCURACY: The age range (2-12 years) is precisely correct with no numerical errors. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across the filing by connecting the new patient population eligibility with the corresponding regulatory filing targets. (4) WORDING: The LLM uses slightly different phrasing ('newly approved' vs 'became eligible for treatment') but the semantic meaning is equivalent - both convey that this patient population newly gained access to the treatment. The phrase 'simultaneously filed' adds helpful context about the timing of regulatory submissions. (5) COMPLETENESS: Both parts of the multi-part question are fully addressed - the specific new patient population and the targeted regulatory regions. Minor note: The ground truth says 'was targeted for filing' while the LLM says 'was newly approved for' and 'filed for regulatory approval' - this is a very minor semantic distinction that doesn't affect accuracy since the filing/approval process is being described. Overall, this is an excellent answer with accurate facts, proper synthesis, and clear communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 396,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "\nBooking.com’s shift to a merchant‑based payments model adds material personnel, processing, charge‑back and other transaction‑related costs that directly compress operating margins, even though it generates incremental “merchant” revenue.  At the same time, the company faces heightened EU and Swiss regulatory scrutiny—including antitrust and consumer‑protection investigations that could force it to lower commissions, modify parity clauses or face fines—so it must reshape its business (e.g., accelerate the “Connected Trip” strategy and diversify non‑accommodation services) while shouldering higher compliance expenses, both of which weigh on profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop question. STRENGTHS: (1) Correctly identifies the merchant-based transaction model's negative impact on margins through personnel, processing, and chargeback costs; (2) Accurately references the Swiss Price Surveillance Office investigation and its potential to force commission reductions; (3) Properly mentions the EU Digital Markets Act and 'gatekeeper' classification concerns; (4) Correctly identifies Connected Trip as a strategic response; (5) Accurately synthesizes the collective impact on both short-term profitability and long-term strategy; (6) Properly characterizes regulatory uncertainties and compliance cost pressures. MINOR GAPS: (1) The LLM answer does not explicitly mention 'data usage, service bundling, and parity clauses' as specific DMA restrictions, though it does reference 'parity clauses' and 'modify parity clauses'; (2) The answer could have been slightly more explicit about the specific restrictions the DMA would impose on data usage and service bundling, though the general concept of 'additional restrictions' is captured; (3) The phrase 'accelerate the Connected Trip strategy and diversify non-accommodation services' adds interpretive language about business reshaping that goes slightly beyond the ground truth's more neutral statement about 'strategic initiatives.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dates are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid false precision. MULTI-HOP REASONING: The LLM successfully synthesizes information across three distinct domains: (1) merchant model economics, (2) Swiss regulatory environment, (3) EU regulatory environment, and (4) strategic implications. The causal chain is logically sound and matches the ground truth's reasoning structure. SEMANTIC EQUIVALENCE: The LLM's phrasing 'material personnel, processing, charge-back and other transaction-related costs' is semantically equivalent to the ground truth's 'higher expenses related to personnel, payment processing, and chargebacks.' The characterization of regulatory pressures as forcing business reshaping is consistent with the ground truth's discussion of constraints on strategic initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 619,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "\nThe PNG Oil and Gas Act allows a petroleum‑retention licence for gas to be issued for an initial five‑year term that can be extended twice, but the total period—including the initial term and any extensions—cannot exceed **15 years**. This capped yet flexible tenure gives ExxonMobil a clear, long‑term horizon for developing PNG’s gas base, enabling the company to commit capital to its 6.9 Mt/yr PNG LNG integrated development and to align that project with the multi‑decade LNG growth strategy outlined in its 2022 10‑K filing, which relies on stable, extended licence periods to justify large‑scale investments and secure long‑term export contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - the 15-year maximum total duration, 5-year initial term, and two possible extensions are accurately stated. The 6.9 Mt/yr production capacity figure is specific and appears consistent with PNG LNG project specifications. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the maximum total duration and regulatory structure, and (2) how this influences ExxonMobil's long-term strategy. ENTITY ACCURACY: Correctly identifies ExxonMobil, PNG (Papua New Guinea), the PNG Oil and Gas Act, and the PNG LNG project. The 2022 10-K filing reference is appropriate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - regulatory framework (15-year cap with extensions), specific project details (6.9 Mt/yr), and strategic implications (capital commitment, long-term contracts). The logical connection between regulatory tenure and investment justification is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with enhanced specificity (mentioning the 6.9 Mt/yr capacity and multi-decade LNG growth strategy). The explanation of how the framework 'enables the company to commit capital' and 'secure long-term export contracts' provides more strategic context than the ground truth's reference to 'commercially viable' resources. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and contextual than the ground truth, which could be viewed as either enhancement or minor deviation from the original answer structure. However, all factual claims are accurate and the additional context strengthens rather than weakens the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 487,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "\nCoca‑Cola’s Level 2 holdings in mutual, pooled and commingled funds dropped from $83 million in 2022 to $37 million in 2023, a $46 million decline. In contrast, its investments in hedge funds/limited partnerships increased modestly from $14 million to $18 million, a $4 million rise.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: Level 2 mutual/pooled/commingled funds decreased from $83M to $37M (a $46M decline), and hedge funds/limited partnerships increased from $14M to $18M (a $4M increase). All calculations are accurate and properly verified. The multi-hop synthesis is sound, correctly comparing the two investment categories across the 2022-2023 period. The answer successfully addresses both parts of the question regarding year-over-year changes and the comparative analysis between the two investment types. The only minor limitation is that the LLM answer omits the interpretive context present in the ground truth (e.g., 'significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments'). However, this is a minor semantic difference rather than a factual error. The core information is complete, accurate, and properly synthesized. The answer is concise while maintaining all essential details, making it highly effective for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 307,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "\nThe regulatory disallowances at Nicor Gas cut Southern Company Gas’ 2023 net income by about **\\$53 million** – the $29 million decline in net income at its gas‑distribution operations plus the $24 million earnings adjustment noted in the filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question. QUANTITATIVE VERIFICATION: All three key numbers are correct - $53 million total impact, $29 million decrease in net income at gas distribution operations, and $24 million earnings adjustment. The arithmetic is correct: $29M + $24M = $53M. COMPLETENESS: The answer addresses all required components of the question - it identifies the total financial impact, breaks down both components (the reduction in net income and the additional earnings adjustment), and correctly attributes these to Nicor Gas and Southern Company Gas in 2023. ENTITY ACCURACY: All entities are correctly identified - Nicor Gas, Southern Company Gas, and the year 2023. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points from the financial statements, correctly combining the two separate impacts into a single total figure. WORDING: The LLM uses slightly different phrasing than the ground truth ('cut...by about' vs 'was a...reduction', 'decline' vs 'decrease') but the semantic meaning is identical. The use of 'about' before $53 million is a minor stylistic choice that doesn't affect accuracy since the number is exact. The answer demonstrates clear understanding of the financial impact and presents it in a logical, accessible manner. No material errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 386,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "\nAT&T labeled WarnerMedia, Vrio, Xandr and Playdemic as discontinued operations.  By classifying these units as discontinued, AT&T signaled that they were being removed from its core business and either sold, merged or otherwise restructured—part of a broader strategic shift to streamline the company and focus on its core communications (wireless, wireline and Latin‑America) operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all four businesses classified as discontinued operations: WarnerMedia, Vrio, Xandr, and Playdemic. The entity accuracy is perfect with all company names correctly listed. The answer accurately conveys the significance of the classification as part of AT&T's strategic shift to focus on core communications operations. However, there are minor differences in completeness compared to the ground truth: (1) The LLM answer mentions 'wireless, wireline and Latin-America' as core operations, which adds helpful specificity not in the original question but is contextually accurate. (2) The ground truth emphasizes the key insight that these businesses were 'treated as a single strategic shift' and that some 'did not individually meet the materiality threshold for discontinued operations,' which is an important nuance about why they were grouped together. The LLM answer mentions they were 'either sold, merged or otherwise restructured' which is reasonable but less precise than the ground truth's focus on the combined divestiture treatment. (3) The LLM answer correctly captures the essence that this was part of a 'broader strategic shift to streamline the company,' which aligns with the ground truth's description of a 'comprehensive restructuring plan.' No quantitative data (numbers, dates, percentages) were required for this question, so quantitative accuracy is perfect. The multi-hop reasoning is sound—the answer correctly synthesizes that multiple business units were classified together as part of a single strategic initiative. The main weakness is the omission of the specific insight about materiality thresholds and combined treatment, which represents a moderate loss of contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 475,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "\nThe fair value of Medtronic’s auction‑rate securities was $33 million at both April 30 2021 and April 29 2022, indicating essentially no change in their valuation over the year. Consequently, the $33 million remained a constant component of the total available‑for‑sale debt securities fair value, which fell from $7,257 million to $6,893 million—a $364 million decline—so the auction‑rate securities did not contribute to that overall decrease.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) QUANTITATIVE ACCURACY: All numbers are correct - auction rate securities at $33 million for both dates (no change), total available-for-sale debt securities declining from $7,257 million to $6,893 million, and the calculated decline of $364 million. All dates are accurate (April 30, 2021 and April 29, 2022). (2) COMPLETENESS: The answer addresses both parts of the question: the change in auction rate securities and the impact on total available-for-sale debt securities. (3) ENTITY ACCURACY: Medtronic is correctly identified, the fiscal years are correct, and the financial metrics (auction rate securities, available-for-sale debt securities, fair value) are properly identified. (4) REASONING: The multi-hop synthesis is sound - the model correctly identifies that auction rate securities remained constant while other components of the portfolio declined, and logically concludes that auction rate securities did not contribute to the overall decrease. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, with slightly different wording but equivalent meaning. The phrase 'essentially no change' is semantically equivalent to 'remained unchanged.' Minor note: The LLM uses 'April 30 2021' without comma formatting, which is a trivial stylistic variation. The conclusion that auction rate securities 'did not contribute to that overall decrease' is a logical inference that adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 430,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "\nThe 2020 goodwill impairment tests cut the carrying amount of the OpenTable + KAYAK reporting unit from $1.5 billion (after the March 31 interim charge of $489 million) down to $1.0 billion as of September 30, 2020, after an additional $573 million impairment was recorded at the annual test. In total, $1.062 billion of goodwill impairment charges were recognized for OpenTable and KAYAK during 2020.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates sound multi-hop reasoning. Verification of key facts: (1) March 2020 impairment charge of $489 million - CORRECT; (2) September 2020 impairment charge of $573 million - CORRECT; (3) Final carrying value of $1.0 billion by September 30, 2020 - CORRECT; (4) Total cumulative impairment of $1,062 million ($1.062 billion) - CORRECT. The LLM correctly synthesized the multi-hop information by: identifying both impairment charges across two time periods, calculating the cumulative impact ($489M + $573M = $1,062M), and explaining the progression from an implied starting value to the final $1.0 billion carrying value. The answer properly addresses all parts of the question including the adjusted carrying value and cumulative impact. Minor note: The LLM states the carrying amount was '$1.5 billion (after the March 31 interim charge of $489 million)' which implies a pre-March value of approximately $1.989 billion ($1.5B + $489M), though this intermediate calculation is not explicitly stated in the ground truth. However, this inference is mathematically consistent with the final $1.0 billion value after the additional $573 million charge ($1.5B - $573M = $927M, which is close but not exact, suggesting the $1.5B figure may be approximate or rounded). The core facts and cumulative impact are accurate. The answer uses appropriate financial terminology and clearly explains the temporal sequence of events.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 406,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "\nNicor Gas’s regulatory disallowances shaved roughly **$29 million off Southern Company Gas’s 2023 net income** (the gas‑distribution unit’s earnings were reduced by that amount), and the disallowance—together with lower volumes—helped drive a **$1.26 billion (21.1 %) drop in operating revenue** for the gas‑distribution segment in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces a $1.26 billion (21.1%) revenue decline figure that is NOT present in the ground truth answer. The original answer only states that disallowances 'reduced revenues' without specifying a dollar amount or percentage. This is a significant factual error - the LLM appears to have fabricated or misattributed a specific number. (2) The ground truth explicitly states the disallowances reduced revenues but does NOT quantify this impact with $1.26 billion. The LLM conflates the revenue decline with the disallowances without proper attribution or verification. (3) The $29 million net income impact is correctly stated and matches the ground truth. (4) The LLM correctly identifies the dual negative impact on both net income and revenue, which aligns with the ground truth's 'dual negative financial impact' statement. STRENGTHS: The answer correctly identifies Nicor Gas, Southern Company Gas, 2023, and the gas-distribution segment. The reasoning about dual impacts (net income and revenue) is sound. WEAKNESSES: The introduction of unverified quantitative data ($1.26 billion revenue decline) is a major factual error that significantly undermines the answer's credibility. The ground truth is cautious about revenue impact specifics, while the LLM provides precise figures without justification. This represents a failure in multi-hop synthesis accuracy - the model appears to have either hallucinated the revenue figure or incorrectly synthesized information from multiple sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 421,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "\nAs of August 31 2022, 16,191,228 Class A ordinary shares were still available for issuance under the 2010 ESPP (90 million – 73,808,772 already issued). This represents roughly 18 percent of the total 90 million shares authorized for the plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor presentation issues. Verification of key facts: (1) The share count of 16,191,228 is correct. (2) The calculation shown (90,000,000 - 73,808,772 = 16,191,228) is mathematically accurate and demonstrates proper multi-hop reasoning. (3) The percentage is stated as 'roughly 18 percent' in the LLM answer versus the precise '17.99%' in the ground truth. The LLM's rounding to 18% is reasonable and mathematically sound (16,191,228 / 90,000,000 = 0.17990...), though less precise than the ground truth's 17.99%. (4) All entities are correctly identified: Accenture plc, Class A ordinary shares, 2010 ESPP, August 31, 2022, and the 90,000,000 total authorized shares. (5) The multi-hop synthesis is sound - the model correctly combined information about shares available, shares issued, and total authorized to answer both parts of the question. The main minor weakness is the use of 'roughly 18 percent' instead of the more precise '17.99%', which represents a slight loss of precision rather than an error. The answer fully addresses both parts of the multi-part question and demonstrates correct reasoning across the required information synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 338,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "\nAT&T’s Ericsson‑backed Open RAN rollout will require extra capital spending and accelerate depreciation of legacy wireless gear in 2024, pressuring short‑term expense trends.  However, the shift to a software‑defined, open‑capable radio network is meant to cut long‑term network costs and boost operational efficiency, positioning AT&T to route most traffic through open platforms by 2026 and sustain lower‑cost, more agile 5G and broadband investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core elements of AT&T's Open RAN collaboration with Ericsson and its impact on expenses and operational efficiency. STRENGTHS: (1) Correctly identifies the dual impact: near-term expense pressure from capital spending and accelerated depreciation, balanced against long-term efficiency gains; (2) Accurately conveys the software-defined, open-capable nature of Open RAN; (3) Properly synthesizes the multi-hop relationship between the 2023 10-K disclosure and 2024 expense trends; (4) Correctly emphasizes lower network costs and improved operational efficiencies as longer-term goals; (5) Mentions the ecosystem benefit of multiple suppliers, aligning with ground truth. WEAKNESSES: (1) Introduces a specific date ('by 2026') and traffic routing metric ('route most traffic through open platforms') that are not present in the ground truth answer - while this may be accurate from the 10-K, it adds specificity beyond what the ground truth validates; (2) The phrase 'Ericsson-backed' is slightly imprecise - the collaboration is with Ericsson, not necessarily 'backed by' Ericsson; (3) Minor wording differences ('software benefits of 5G wireless technology' in ground truth vs 'software-defined, open-capable radio network' in LLM) - both convey similar meaning but with different emphasis. QUANTITATIVE ASSESSMENT: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is based on the absence of errors rather than verification of numbers. The LLM does not introduce any incorrect figures. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023 10-K disclosure and projects forward to 2024 and beyond, correctly linking the collaboration announcement to expense trends and operational goals. The logic is sound and well-structured. OVERALL: The answer is substantially correct and addresses the question comprehensively, with minor additions that go slightly beyond the ground truth validation scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 540,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "\nAs of December 31 2021, XOM’s consolidated subsidiaries had **2,635 million barrels** of proved developed bitumen reserves in Canada/Other Americas.  The standardized measure of discounted future net cash flows from that region for the same date was **$28.7 billion**, which corresponds to roughly **$11 of present‑value cash flow per barrel of bitumen**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Proved developed bitumen reserves of 2,635 million barrels - CORRECT, matches ground truth exactly. (2) Discounted future net cash flows of $28,710 million ($28.7 billion) - CORRECT, matches ground truth exactly (format variation $28.7B vs $28,710M is acceptable). (3) Date of December 31, 2021 - CORRECT. (4) Company identification (XOM consolidated subsidiaries) - CORRECT. (5) Region (Canada/Other Americas) - CORRECT. The LLM additionally calculated a per-barrel metric ($11 of present-value cash flow per barrel), which is mathematically sound: $28,710M ÷ 2,635M barrels ≈ $10.90 per barrel (rounds to ~$11), demonstrating strong multi-hop reasoning. The answer directly addresses both parts of the question: the reserve quantity and the cash flow comparison. The semantic equivalence is maintained throughout. Minor deduction (1 point) only because the ground truth explicitly states 'corresponds to' while the LLM uses 'corresponds to roughly' for the per-barrel calculation, which is appropriate given rounding but slightly differs in precision framing from the original answer's more definitive statement about the correspondence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 345,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "\nThe adoption of ASU No. 2022‑02 reduced Capital One’s allowance for credit losses by about **$63 million** (the cumulative effect recorded as of January 1 2023 and reflected in the December 31 2023 allowance balances).  At the same time, the ASU eliminated the prior “troubled‑debt‑restructuring” accounting model; loan modifications that previously would have been classified as TDRs are now reported as **financial‑difficulty modifications** and are accounted for as a continuation of the existing loan, with the related allowance and disclosure requirements updated accordingly.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states ASU No. 2022-02 caused a $63 million REDUCTION in the allowance for credit losses, when the ground truth clearly indicates a $2.1 billion INCREASE. This is not a minor discrepancy—it's directionally opposite and off by approximately $2.163 billion in magnitude. The LLM also fails to mention the resulting total allowance of $15.3 billion as of December 31, 2023. (2) PARTIAL CREDIT ON QUALITATIVE ASPECTS: The LLM correctly identifies that ASU No. 2022-02 eliminated the TDR classification and replaced it with a new framework for reporting modified loans. The description of modifications being reported as 'financial-difficulty modifications' and accounted for as a continuation of the existing loan is conceptually aligned with the ground truth's statement about the new framework replacing TDRs. (3) MULTI-HOP REASONING: The LLM demonstrates understanding that the standard affected both the allowance for credit losses AND loan modification reporting practices (addressing both parts of the question), but the quantitative synthesis is completely wrong. (4) ENTITY AND DATE ACCURACY: The LLM correctly identifies Capital One, the ASU standard number (2022-02), and the relevant date (December 31, 2023, with reference to January 1, 2023 adoption). (5) OVERALL ASSESSMENT: While the LLM demonstrates some understanding of the qualitative impacts of the accounting standard, the massive error in the primary quantitative metric ($63M reduction vs. $2.1B increase) is disqualifying. This represents a fundamental failure to accurately report the core financial impact of the accounting change, which is the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 493,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "\nThe 2023 10‑K notes that “additional contingent liabilities and loss estimates for Bank BPH, in connection with the ongoing litigation in Poland related to its residential‑mortgage portfolio, may need to be recognized (or increase) and will become payable” [page 35]. If those loss estimates rise, GE would have to fund the extra cash outflows, which could erode its cash‑generation capacity and tighten the liquidity buffer it relies on to meet debt obligations and support its financing commitments [pages 33‑35]. Consequently, a worsening of the BPH litigation could materially weaken GE’s liquidity position and its ability to sustain an investment‑grade credit rating.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Bank BPH's ongoing litigation in Poland as a contingent liability concern and appropriately explains the general mechanism by which increased liabilities could impact liquidity (eroding cash-generation capacity, tightening liquidity buffer, affecting credit rating). The reasoning about potential negative impacts on GE's liquidity position is sound and logically structured. The answer correctly references the 2023 10-K filing and demonstrates understanding of the multi-hop relationship between litigation outcomes and liquidity constraints.\n\nCRITICAL WEAKNESSES: The LLM answer completely omits the specific quantitative data that forms the core of the ground truth answer. The original answer provides essential numbers: (1) total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023; (2) $14.2 billion held outside the U.S.; (3) $1.7 billion in countries with currency control restrictions. These figures are crucial for demonstrating the actual liquidity position and the constraints GE faces. The LLM's failure to include these specific amounts represents a significant gap in answering a question that explicitly asks about impact on 'liquidity position as reported in its 2023 10-K filing.' Without these numbers, the answer lacks the concrete evidence needed to substantiate the liquidity impact claim.\n\nMULTI-HOP REASONING: While the LLM demonstrates understanding of the causal chain (litigation → contingent liabilities → cash outflows → liquidity pressure), it fails to complete the full synthesis by connecting this to GE's actual reported liquidity metrics. The ground truth answer performs the critical multi-hop synthesis: it identifies the litigation issue, quantifies GE's available liquidity, notes the geographic and regulatory constraints on that liquidity, and then explains why additional liabilities would be particularly problematic given these constraints.\n\nQUANTITATIVE ACCURACY: The LLM provides no specific financial figures, making quantitative accuracy assessment difficult. The page references (33-35) appear reasonable but cannot be verified. The absence of the $17.0B, $14.2B, and $1.7B figures that are central to the ground truth answer is a major omission.\n\nSEMANTIC EQUIVALENCE: The LLM's general statements about liquidity impact are semantically aligned with the ground truth's conclusion, but the lack of supporting quantitative evidence undermines the completeness and persuasiveness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 669,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "\nThe 2022 10‑K shows that under the Amended and Restated 2010 Share Incentive Plan, 14,830,623 shares have been issued upon exercise of outstanding options (or RSUs), and an additional 27,381,461 shares remain available for future issuance. In total, 42,212,084 shares have been either issued or can still be issued under that plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all components of the multi-hop question. Verification of key facts: (1) Shares issued upon exercise of outstanding options: 14,830,623 - CORRECT, matches ground truth exactly. (2) Shares available for future issuance: 27,381,461 - CORRECT, matches ground truth exactly. (3) Total calculation: 14,830,623 + 27,381,461 = 42,212,084 - CORRECT, arithmetic is accurate and matches ground truth. (4) Plan identification: Amended and Restated 2010 Share Incentive Plan - CORRECT. (5) Filing year: 2022 10-K - CORRECT. The LLM correctly synthesized information across the multi-hop requirement (identifying both the issued shares and available shares, then summing them). Minor note: The LLM parenthetically mentions 'or RSUs' when the ground truth specifically states 'options,' but this is a reasonable clarification since share incentive plans typically include both options and RSUs, and does not contradict the stated figure. The answer is complete, accurate, and clearly presented with proper semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 311,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "\nAT&T fully repaid the $2.5 billion 2025 Term Loan during 2023, and the loan was officially terminated on **March 30, 2023**, as noted in the company’s disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: The loan amount is correctly stated as $2.5 billion, which is the equivalent format of the ground truth's $2,500 million (both represent the same value). The termination date of March 30, 2023 is exactly correct. (2) COMPLETENESS: The answer addresses both required components: the total amount of the 2025 Term Loan ($2.5 billion/$2,500 million) and the termination date (March 30, 2023). (3) ENTITY ACCURACY: AT&T is correctly identified as the company, the 2025 Term Loan is correctly named, and the year 2023 is correct. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the loan repayment action with the termination date from the disclosures. (5) SEMANTIC EQUIVALENCE: The LLM's use of '$2.5 billion' versus the ground truth's '$2,500 million' represents the same financial amount in different notation formats, which is acceptable per evaluation guidelines. The phrasing 'fully repaid' and 'officially terminated' conveys the same meaning as 'paid off in full and terminated.' All facts are accurate with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1064,
        "completion_tokens": 333,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "\nThe Company’s holdings in mutual, pooled and commingled funds fell by **$61 million** from 2022 ($304 million) to 2023 ($243 million). Of the 2023 balance, **$257 million** was classified as Level 2 in the fair‑value hierarchy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that make it substantially incorrect: (1) CHANGE CALCULATION ERROR: The LLM states the change was $61 million (from $304M to $243M), but the ground truth indicates a $47 million decrease. The LLM's own numbers ($304M - $243M = $61M) are internally consistent mathematically, but both the 2022 figure ($304M vs. correct $86M implied), 2023 figure ($243M vs. correct $39M), and resulting change ($61M vs. correct $47M) are wrong. (2) LEVEL 2 VALUATION ERROR: The LLM claims $257 million was classified as Level 2, but the ground truth states only $37 million of the $39 million total 2023 investment was Level 2. This is a massive discrepancy (257 vs. 37) and represents a fundamental misreading of the fair-value hierarchy data. (3) TOTAL INVESTMENT AMOUNT ERROR: The 2023 total investment amount is stated as $243 million when it should be $39 million - a 6x overstatement. (4) MULTI-HOP SYNTHESIS: While the LLM attempted to address both parts of the question (change and Level 2 classification), the synthesis is based on incorrect underlying data. The answer demonstrates a complete failure to accurately extract and synthesize the relevant financial data from the source documents. All three key numeric values are materially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 363,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "\nThe total pre‑tax charge related to ongoing borrower litigation for 2023 was **$1.189 billion**, and GE paid **$203 million of net cash** to AerCap in connection with its continuing involvement with the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key facts: (1) Pre-tax charge for borrower litigation in 2023: Ground truth states $1,189 million; LLM states $1.189 billion - these are numerically equivalent (1,189 million = 1.189 billion), with only a format variation that is acceptable per evaluation guidelines. (2) Net cash paid to AerCap: Ground truth states $203 million; LLM states $203 million - exact match. (3) Year and entities: Both correctly identify 2023, GE, AerCap, and the nature of the transactions (borrower litigation charge and continuing involvement cash payment). (4) Multi-hop synthesis: The LLM correctly synthesized information from what would be multiple parts of the filing (litigation charges and cash flow activities related to AerCap). The minor deduction from perfect score (9 vs 10) is solely due to the format variation in presenting the first number ($1.189 billion vs $1,189 million), though this is semantically equivalent and within acceptable variation. All factual content is accurate, calculations are correct, and the answer fully addresses both components of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 333,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "\nAccenture’s $1.1 billion investment in research and development—augmented by $3.4 billion in strategic acquisitions and $1.1 billion in learning and professional‑development spend—creates a deep portfolio of patents, industry‑specific platforms and innovation hubs that enable it to deliver advanced cloud, AI, data‑analytics and “Industry X” solutions at scale. By packaging these capabilities as 360° value—linking financial ROI, inclusion, sustainability and talent development—Accenture differentiates itself from competitors, who typically offer narrower, technology‑only or cost‑focused services, positioning the firm as a trusted, end‑to‑end partner for large‑scale enterprise transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Accenture's competitive positioning and correctly identifies the $1.1 billion R&D investment from the ground truth. However, there are significant issues with additional numbers introduced that cannot be verified against the original answer: (1) The $3.4 billion in strategic acquisitions and $1.1 billion in learning/professional development spend are not mentioned in the ground truth, raising questions about their accuracy or relevance to this specific question. (2) The ground truth does not reference 'patents,' 'industry-specific platforms,' 'innovation hubs,' 'cloud,' 'AI,' 'data-analytics,' or 'Industry X' solutions—these are LLM elaborations not grounded in the provided knowledge graph. (3) The characterization of competitors as offering 'narrower, technology-only or cost-focused services' is more specific than the ground truth's general reference to 'multinational IT providers, offshore firms, consultancies, and in-house corporate departments.' Strengths: The LLM correctly identifies the $1.1B R&D investment, accurately describes the 360° value concept (financial ROI, inclusion, sustainability, talent development), and provides sound reasoning about how this differentiates Accenture. The multi-hop synthesis connecting R&D investment to competitive positioning is logical and well-articulated. The semantic equivalence of 'end-to-end partner for large-scale enterprise transformation' aligns with the ground truth's description of delivering outcomes across strategy, execution, and transformation. Weaknesses: Introduction of unverified financial figures ($3.4B acquisitions, $1.1B learning spend) without ground truth support; elaboration on specific solution types not mentioned in original answer; more specific competitor characterization than warranted by source material. The answer goes beyond the ground truth in ways that may or may not be accurate, which creates uncertainty about factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 536,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "\nAT&T classified, besides WarnerMedia, three other businesses as discontinued operations in 2023: **Vrio, Xandr, and Playdemic**. These entities are removed from continuing‑operations results and shown separately in the financial statements (e.g., in Note 24), with their revenues, expenses, assets and liabilities presented as “discontinued operations” and prior‑period figures restated, so that only the results of AT&T’s ongoing Communications and Latin America segments remain in the main operating performance tables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) ENTITY ACCURACY: All three entities (Vrio, Xandr, and Playdemic) are correctly identified as discontinued operations in addition to WarnerMedia - this matches the ground truth exactly. (2) CLASSIFICATION EXPLANATION: The LLM correctly explains that these entities are excluded from continuing operations and reported separately as discontinued operations, which aligns with the ground truth statement about being 'excluded from ongoing operations and reported separately.' (3) FINANCIAL PRESENTATION: The LLM provides additional helpful detail about how this affects financial statement presentation (Note 24 reference, separate line items for revenues/expenses/assets/liabilities, prior-period restatement) which is consistent with standard discontinued operations accounting treatment and enhances the answer without contradicting the ground truth. (4) MULTI-HOP SYNTHESIS: The answer correctly synthesizes the multi-part question by identifying all required entities and explaining the classification impact on financial results presentation. (5) MINOR CONSIDERATION: The LLM adds contextual detail about 'Communications and Latin America segments' which, while reasonable inference about remaining operations, is not explicitly stated in the ground truth but represents reasonable financial reporting context. No factual errors detected. The answer is more detailed than the ground truth while remaining fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 409,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "\nThe 2022 10‑K reports a **$3 million unrealized loss** on the auction‑rate securities the company holds as of April 29, 2022.  This loss is recorded entirely in the “**more than 12 months**” maturity category (i.e., the long‑term bucket), with no unrealized loss shown for securities maturing in less than a year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $3 million unrealized loss figure is correct and matches the ground truth exactly. The date (April 29, 2022) and fiscal year reference (2022 10-K) are accurate. No calculation errors present. (2) COMPLETENESS: The answer addresses both parts of the question: (a) the total unrealized loss amount ($3 million), and (b) the distribution across maturity periods (entirely in the >12 months category with $0 in <12 months category). (3) ENTITY ACCURACY: Company identifier (MDT) is correctly referenced, fiscal year (2022) is correct, and the financial metric (unrealized loss on Auction Rate Securities) is properly identified. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that the loss is concentrated in one maturity bucket and explicitly noted the absence of loss in the other bucket, demonstrating proper understanding of the maturity period distribution. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('long-term bucket' vs. 'more than 12 months') but conveys identical meaning. The parenthetical clarification actually enhances clarity. Minor note: The LLM's use of 'long-term bucket' is a reasonable interpretive label that doesn't contradict the ground truth's 'more than 12 months' terminology. All factual content is accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 398,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "\nDuring the May 2024 Class B‑1 exchange, Visa issued roughly **120 million shares of Class B‑2 common stock**.  Together with the 48 million Class C shares issued, the total number of shares created in the exchange was about **168 million**, meaning the Class B‑2 shares made up **≈ 71 %** of that total.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Verification of key facts: (1) 120 million Class B-2 shares issued - CORRECT, matches ground truth exactly; (2) 48 million Class C shares issued - CORRECT, matches ground truth; (3) Total of 168 million shares - CORRECT (120 + 48 = 168); (4) Percentage calculation: 120/168 = 0.7143 or 71.43%, LLM states '≈ 71%' which is appropriately rounded and semantically equivalent to the ground truth's '71.4%'; (5) Time period (May 2024) - CORRECT; (6) Context (Class B-1 exchange offer) - CORRECT. The multi-hop reasoning is sound: the model correctly synthesized information about the two share classes issued, calculated the total, and derived the percentage. Minor note: The LLM uses '≈ 71%' while ground truth specifies '71.4%' - this is a rounding difference rather than an error, and the approximation symbol indicates awareness of precision. The answer is complete, addresses both sub-questions (number of B-2 shares and percentage), and maintains factual accuracy throughout. The company reference to Visa is contextually appropriate though not explicitly required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 332,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "\nThe company sold **8.5 GW of wind‑turbine capacity in 2023 versus 11.7 GW in 2021**, a **decrease of 3.2 GW**.  At the same time, unit shipments fell from **3,590 turbines in 2021 to 2,225 in 2023**, a reduction of **1,365 turbines**.  Thus, the lower GW figure reflects the drop of more than a thousand turbines sold over the two‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) GW capacity in 2021: 11.7 GW ✓, (2) GW capacity in 2023: 8.5 GW ✓, (3) Decrease in GW: 3.2 GW ✓, (4) Turbine units in 2021: 3,590 ✓, (5) Turbine units in 2023: 2,225 ✓, (6) Reduction in units: 1,365 ✓. The multi-hop reasoning is sound - the answer correctly synthesizes information across two metrics (GW capacity and unit shipments) and two time periods (2021 and 2023), demonstrating the correlation between declining turbine volumes and declining overall capacity. The conclusion that 'the lower GW figure reflects the drop of more than a thousand turbines sold' is logically sound and adds interpretive value. The only minor distinction from the ground truth is stylistic - the LLM uses slightly different phrasing ('unit shipments fell from...to...') versus the ground truth's more direct statement, but this is semantically equivalent and actually enhances clarity. The answer fully addresses both parts of the multi-part question and provides appropriate context about what the numbers indicate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 318,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "\nAT&T paid roughly **$27 billion in cash** for C‑Band spectrum through 2023 – the $550 million upfront deposit, the $22.86 billion purchase price, a $0.96 billion incentive payment for Phase I, a $2.11 billion payment for Phase II clearing, and about $0.86 billion of compensable relocation costs.  \n\nThis spending is reported in the **investing section** of the cash‑flow statement under the line item “**Acquisitions, net of cash acquired**,” which aggregates all cash outflows for spectrum purchases, related incentives and relocation expenses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer states approximately $27 billion total, but the ground truth is $26,477 million ($26.477 billion). More critically, the component breakdown is significantly incorrect: (1) LLM claims '$550 million upfront deposit' - not mentioned in ground truth; (2) LLM states '$22.86 billion purchase price' - ground truth shows $23,406 million ($23.406 billion) for auction deposits/payments, a $546 million discrepancy; (3) LLM shows '$0.96 billion' for Phase I incentive - ground truth is $955 million ($0.955 billion), a minor rounding difference; (4) LLM shows '$2.11 billion' for Phase II - ground truth is $2,112 million ($2.112 billion), essentially correct; (5) LLM states 'about $0.86 billion' for relocation costs - ground truth specifies $1,100 million ($1.1 billion) in compensable relocation costs with detailed annual breakdown ($650M in 2021, $98M in 2022, $109M in 2023), a $240 million understatement. The total of LLM components ($550M + $22,860M + $960M + $2,110M + $860M = $27,340M) doesn't match their stated $27 billion and exceeds the ground truth by $863 million. QUALITATIVE STRENGTHS: The LLM correctly identified the cash flow classification as 'Acquisitions, net of cash acquired' in the investing section, and correctly understood this aggregates spectrum, incentives, and relocation expenses. MULTI-HOP REASONING: The answer demonstrates understanding that multiple cost components should be synthesized, but fails in accurate aggregation and component identification. The answer is directionally correct on classification but materially incorrect on the financial amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 447,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "\nIn fiscal 2022 Medtronic recorded a $515 million non‑cash impairment charge plus an additional $366 million of restructuring and patient‑support obligations tied to its June 2021 decision to discontinue the HVAD system—charges that appear in the $617 million restructuring line and weighed on earnings.  At the same time, the company highlighted growth in its Cardiovascular portfolio (especially Cardiac Rhythm Management and Structural‑Heart/TAVR products) and in Surgical Innovations (LigaSure, Sonicision, powered stapling) as the primary drivers of the 5‑6 % rise in net sales for the year.  It also cited neuroscience pipeline products and the expanding Hugo robotic‑assisted surgery platform as additional growth engines.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the June 2021 discontinuation date, accurately reports the 5% sales growth in Medical Surgical segment, and properly identifies multiple growth drivers (Surgical Innovations products, Cardiovascular portfolio, neuroscience, Hugo robotic platform). The answer demonstrates sound multi-hop reasoning by connecting the HVAD discontinuation to financial impacts and growth strategy pivots. The contextual framing is appropriate and relevant.\n\nWEAKNESSES - QUANTITATIVE ERRORS: (1) The LLM introduces $515 million impairment charge and $366 million restructuring obligations that are NOT mentioned in the ground truth answer. These appear to be additional details from the filing but create a discrepancy: the ground truth focuses on the $141 million in lost HVAD revenue from FY2021, while the LLM cites much larger charges. Without verification these numbers are correct in the filing, this represents a significant factual divergence. (2) The LLM states 'Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5%' is NOT explicitly stated in the LLM answer - instead it says '5-6% rise in net sales for the year' without specifying the $9.1B figure or confirming it's the Medical Surgical segment.\n\nMISSING ELEMENTS: The ground truth specifically mentions several product names not in LLM answer: Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and Intrepid system for transcatheter mitral/tricuspid therapy. The LLM uses broader category language ('Structural-Heart/TAVR products') rather than specific product names.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that HVAD discontinuation impacted FY2022 performance and identifies alternative growth drivers, but the connection is made through impairment charges rather than lost revenue, which is a different analytical approach than the ground truth.\n\nCONCLUSION: The answer is directionally correct on the main narrative (discontinuation → focus on other growth drivers, 5% growth achieved) but introduces unverified large dollar figures and lacks specific product names mentioned in ground truth. The quantitative accuracy is compromised by the unexplained $515M and $366M charges.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 609,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "\nWalmart paid **$3.5 billion in cash** during fiscal 2024 to purchase additional shares from Flipkart’s non‑controlling interest holders and to settle the liability to former PhonePe non‑controlling interest holders. This transaction lifted Walmart’s ownership stake in Flipkart from **approximately 75 % (as of January 31 2023)** to **about 85 % (as of January 31 2024)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The $3.5 billion cash payment amount is correct, the ownership percentages (75% to 85%) are accurate, and the fiscal year dates (January 31, 2023 to January 31, 2024) are correct. (2) QUANTITATIVE ACCURACY: All numbers are precise and correctly stated - $3.5 billion, 75%, 85%, and the date references are all accurate with no calculation errors. (3) QUALITATIVE ACCURACY: The LLM correctly identified all entities (Walmart, Flipkart, PhonePe, noncontrolling interest holders) and properly synthesized the multi-hop information showing the connection between the cash payment and the ownership stake increase. The reasoning is sound and logically presented. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question - the total cash paid AND the impact on ownership percentage. Minor formatting variations (spaces in percentages like '75 %' vs '75%') are inconsequential and do not affect accuracy. The answer is complete, well-structured, and provides all necessary context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 324,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "\nMicrosoft records unearned revenue from its volume‑licensing and subscription programs as a liability and then recognizes it ratably over the contract term (often after invoicing customers annually at the start of each coverage period), so the timing of invoicing creates a deferred‑revenue balance that must be carefully separated from earned revenue. Because the allocation of that revenue depends on estimating standalone selling prices for bundled software, updates, and cloud services—and on assessing variable consideration and distinct performance obligations—the auditor must devote extensive testing to controls, management’s SSP estimates, and the mathematical accuracy of the revenue‑recognition calculations to ensure the financial statements are fairly presented and audit‑able.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the key accounting treatment: unearned revenue recorded as liability and recognized ratably over contract term; (2) Accurately describes the timing mechanism: annual invoicing at start of coverage period creating deferred revenue balance; (3) Properly explains the complexity around SSP estimation for bundled offerings (software, updates, cloud services); (4) Correctly identifies variable consideration and distinct performance obligations as audit concerns; (5) Appropriately emphasizes auditor focus on controls, SSP estimates, and calculation accuracy; (6) No quantitative errors or incorrect numbers/dates. MINOR GAPS: (1) The original answer specifically mentions 'Software Assurance (SA)' as a named example of volume licensing programs, while the LLM uses more generic language ('bundled software, updates, and cloud services') - this is a minor omission of specificity but not factually incorrect; (2) The original answer explicitly states this was a 'critical audit matter' for Microsoft's auditors, while the LLM describes auditor focus more generally without using the specific CAM terminology - this is a meaningful but not critical omission; (3) The original answer mentions customer size and geographic region as factors in SSP determination, which the LLM does not explicitly include. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between (a) volume licensing structure, (b) invoicing/recognition timing, (c) SSP complexity, and (d) audit implications - demonstrating sound multi-hop reasoning. The answer correctly connects the accounting treatment to both financial statement presentation and audit procedures. SEMANTIC EQUIVALENCE: The LLM's explanation of how timing mismatches create contract balances is semantically equivalent to the ground truth's discussion of receivables/unearned revenue depending on timing. The emphasis on 'fairly presented and auditable' captures the essence of the original answer's focus on presentation and auditability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 571,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "\nThe Company contributed $126 million to the 401(k) Savings and Profit Sharing Plan in fiscal 2022, $110 million in fiscal 2021 and $107 million in fiscal 2020, for a total of $343 million over the three years. No profit‑sharing contributions were included because the plan’s discretionary profit‑sharing contributions were never approved or made for any of those fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct - $126M (2022), $110M (2021), $107M (2020), totaling $343M. The calculation is accurate. (2) COMPLETENESS: The answer addresses both parts of the question: (a) total contributions over three fiscal years, and (b) explanation for why no profit sharing contributions were included. (3) ENTITY ACCURACY: Correctly identifies Nike's 401(k) Savings and Profit Sharing Plan and the correct fiscal years (2022, 2021, 2020). (4) REASONING: The multi-hop synthesis is sound - the model correctly combined contribution data across three fiscal years and provided the reason for zero profit sharing contributions. The explanation that 'discretionary profit‑sharing contributions were never approved or made' is semantically equivalent to the ground truth statement that 'the company did not make any discretionary profit sharing contributions.' (5) MINOR DIFFERENCE: The LLM uses slightly different wording ('never approved or made') versus the ground truth ('did not make'), but both convey the same factual meaning. The LLM's phrasing is actually more explicit about the approval aspect. No calculation errors, no missing data, and all entities correctly identified. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 384,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "\nThe consolidated natural‑gas reserves in the Asia Pacific/Middle East fell by **23 billion cubic feet** (from 312 BCF at the end of 2023 to 289 BCF at the end of 2024), whereas reserves in Africa rose by **285 billion cubic feet** (from 172 BCF to 457 BCF). In short, Africa’s reserves increased sharply, while the Asia Pacific/Middle East region experienced a modest decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the correct question structure and entities (Chevron, Asia Pacific/Middle East, Africa, natural gas reserves, 2023-2024 period), demonstrating good contextual relevance. However, there are critical quantitative errors that make this answer substantially incorrect: (1) Asia Pacific/Middle East change: LLM states 23 BCF decline (312 to 289), but ground truth shows 16 BCF decline (312 to 296). The LLM's ending value of 289 BCF is incorrect; should be 296 BCF. (2) Africa change: LLM states 285 BCF increase (172 to 457), but ground truth shows 297 BCF increase (172 to 468). The LLM's ending value of 457 BCF is incorrect; should be 468 BCF. Both calculations are wrong - the differences don't match the stated beginning and ending values. (3) The multi-hop reasoning structure is sound (comparing two regions' changes), but the fundamental numerical errors undermine the entire answer. The qualitative assessment that 'Africa's reserves increased sharply, while the Asia Pacific/Middle East region experienced a modest decline' is directionally correct but based on wrong numbers. These are not minor formatting differences but actual data errors of 7 BCF and 11 BCF respectively, which are material in the context of reserve reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 354,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "\nIn fiscal 2024 Walmart received roughly **$0.7 billion** of cash from new equity‑funding rounds in its majority‑owned PhonePe subsidiary, whereas it **paid about $3.5 billion** to acquire the remaining non‑controlling interest holders’ shares in PhonePe. Consequently, the cash outflow for buying those shares was more than four‑to‑five times larger than the cash inflow from the equity funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. Verification of key numbers: (1) $0.7 billion cash received from PhonePe equity funding - CORRECT, (2) $3.5 billion paid to acquire noncontrolling interest shares - CORRECT, (3) Fiscal 2024 timeframe - CORRECT. The LLM correctly identifies all entities (Walmart, PhonePe, noncontrolling interest holders) and properly synthesizes information across multiple transaction types. Quantitative accuracy is strong with all dollar amounts matching ground truth exactly. The comparison statement 'cash outflow for buying those shares was more than four-to-five times larger than the cash inflow' is mathematically sound ($3.5B / $0.7B ≈ 5x). However, the LLM answer omits the explicit net calculation that ground truth provides ($3.5B - $0.7B = $2.8B net outflow). While the LLM's ratio comparison is valid and informative, the ground truth specifically states 'Walmart spent $2.8 billion more than it received,' which is a more direct answer to the comparison question. The LLM's approach of using a ratio comparison is reasonable but represents a minor deviation from the ground truth's preferred framing. The answer demonstrates sound multi-hop reasoning by correctly connecting equity funding inflows with share acquisition outflows and properly contextualizing the relative magnitudes. All factual content is accurate with no errors in numbers, dates, or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 408,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "\nRTX recorded a **$918 million pre‑tax charge in 2024** for the settlements that included the SEC Administrative Order and the related DPAs and consent agreement. The independent compliance monitor will be required to oversee RTX’s obligations for **a three‑year term (ending three years from the monitor’s appointment).**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: Both key factual claims are correct - the $918 million pre-tax charge in 2024 and the three-year compliance monitor term match the ground truth exactly. (2) QUANTITATIVE ACCURACY: The $918 million figure is precisely correct with proper formatting. The three-year duration is accurately stated. No calculation errors present. (3) QUALITATIVE ACCURACY: The answer correctly identifies RTX as the company, 2024 as the relevant year, and properly synthesizes the multi-hop information about both the charge amount and monitor duration. The mention of 'DPAs and consent agreement' provides appropriate context about the nature of the settlements, though not explicitly required by the question. The phrasing 'ending three years from the monitor's appointment' is semantically equivalent to the ground truth's 'three years from the date on which the monitor is engaged.' (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses both parts of the two-part question. Minor note: The LLM adds contextual detail about 'DPAs and consent agreement' which, while accurate and helpful, goes slightly beyond what was explicitly in the ground truth answer, but this is a strength rather than a weakness as it demonstrates deeper understanding of the settlement structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 374,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "\nMicrosoft’s Cloud revenue in fiscal 2023 was **$111.6 billion**.  This figure reflects the combined performance of its commercial‑cloud businesses—including the Dynamics 365 cloud suite (along with Azure, Office 365 Commercial, the commercial portion of LinkedIn and other cloud services)—that are reported within the Server + cloud services, Office + cloud services, LinkedIn and Dynamics product‑and‑cloud‑services line items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $111.6 billion figure for Microsoft Cloud revenue in fiscal 2023 is correct and matches the ground truth exactly. No calculation errors present. (2) COMPLETENESS: The answer addresses both parts of the question - the total revenue amount and the specific cloud-based offerings. The LLM identifies all key contributors: Azure, Office 365 Commercial, LinkedIn (commercial portion), Dynamics 365, and other cloud services. This matches the ground truth comprehensively. (3) ENTITY ACCURACY: All entities are correctly identified - Microsoft, fiscal year 2023, and the specific product lines (Dynamics 365, Azure, Office 365 Commercial, LinkedIn). (4) REASONING & SYNTHESIS: The LLM demonstrates sound multi-hop reasoning by correctly synthesizing information across multiple product lines and explaining how they contribute to the total Microsoft Cloud revenue figure. The explanation of how these offerings are reported within specific line items (Server + cloud services, Office + cloud services, LinkedIn and Dynamics) adds helpful context. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more detailed explanation of the reporting structure, which enhances rather than detracts from the answer. The wording differs but the factual content is semantically equivalent and accurate. Minor note: The LLM provides slightly more granular detail about reporting line items, which is a value-add rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 427,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "\nUniversal Beijing Resort’s $3.5 billion term‑loan is part of the ¥29.7 billion (≈$4.2 bn) syndicated financing that was used to build the resort and is secured only by the resort’s assets and the investors’ equity (page 94).  In Comcast’s consolidated debt schedule the borrowing appears under “Debt Not Guaranteed” (page 86) and is included in the company‑wide debt total of $97.1 bn, but it is not cross‑guaranteed by Comcast or its other subsidiaries, so the $3.5 bn represents a separate, non‑recourse liability of the VIE that is nonetheless consolidated in Comcast’s overall debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $3.5 billion debt outstanding, ¥29.7 billion (~$4.2 billion) maximum facility, and the $97.1 billion consolidated debt total. The answer correctly identifies the debt as appearing under 'Debt Not Guaranteed' and accurately describes the non-recourse nature of the liability. However, the answer has notable omissions compared to the ground truth: (1) It fails to mention Comcast's 30% equity interest in the resort, which is a key component of understanding Comcast's risk exposure; (2) It does not explicitly state that Comcast has no liquidity arrangements, guarantees, or financial commitments with the resort, which is critical context for understanding why the debt is non-recourse despite consolidation; (3) It does not explain the VIE (Variable Interest Entity) consolidation rationale based on governance structure and ability to direct major economic activities; (4) It omits the $3.1 billion term loan component breakdown. The multi-hop reasoning is sound—the answer correctly synthesizes that the resort's debt is both a direct financing arrangement (syndicated facility secured by resort assets) and a consolidated liability within Comcast's structure (appearing in consolidated debt schedule but not cross-guaranteed). The page references (94, 86) add credibility. The core answer is correct but lacks the comprehensive context about Comcast's limited risk exposure and the specific governance reasons for VIE consolidation that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 428,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "\nFrom May 31 2021 to May 31 2022 Nike’s holdings of commercial paper and bonds fell from **$748 million to $660 million**, a decline of **$88 million (≈12 %)**.  This reduction shrank the share of commercial‑paper/bond securities within the overall short‑term investment portfolio, which grew from **$3.587 billion to $4.423 billion**, and the company correspondingly increased its exposure to other Level 2 assets such as money‑market funds, time deposits and Treasury securities, altering the composition of its short‑term investments toward higher‑liquidity cash‑equivalent holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core facts: commercial paper and bonds declined from $748M to $660M (a $88M decrease of ~12%). The reasoning about the shift toward higher-liquidity instruments is sound and aligns with the ground truth. The answer appropriately addresses both parts of the question (the change and its effect on composition). CRITICAL ERRORS: The LLM introduced unverified numbers for total short-term investments ($3.587B to $4.423B), which are NOT mentioned in the ground truth. The ground truth only references Level 2 short-term investments dropping from $695M to $630M. The LLM appears to have conflated or invented total portfolio figures that cannot be verified against the original answer. This is a significant factual error that undermines credibility. CALCULATION VERIFICATION: The $88M decline and ~12% percentage are correct. However, the introduction of the $3.587B-$4.423B figures without ground truth support is problematic. MULTI-HOP REASONING: The synthesis of the shift toward alternative instruments (money market funds, Treasury securities) is correct and well-reasoned, matching the ground truth's characterization. ENTITY ACCURACY: Nike and the dates (May 31, 2021 and May 31, 2022) are correct. The issue is the introduction of unsubstantiated financial metrics that go beyond what the ground truth provides. The answer demonstrates good understanding of the question's intent but introduces unsupported quantitative claims that reduce overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 415,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "\nThe Class B‑2 common‑stock shares were not issued until the May 2024 exchange offer, so they did not exist for the fiscal 2023 diluted‑EPS calculation; consequently, the 2023 diluted‑EPS denominator and income allocation were unchanged and excluded any Class B‑2 shares. As a result, the introduction of Class B‑2 has no effect on the reported 2023 diluted EPS, but will increase the diluted‑share count (and potentially lower EPS) in future periods when those shares are included.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states that Class B-2 shares were issued in May 2024 and therefore had no impact on fiscal 2023 diluted EPS. However, the ground truth explicitly states that Class B-2 shares WERE outstanding during fiscal 2023 (the question premise is 'given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer,' implying they existed after). The ground truth answer clearly indicates that Class B-2 shares DID affect the fiscal 2023 diluted EPS calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. The LLM's reasoning about future periods is reasonable, but it misses the core issue: the question asks about fiscal 2023 impact, and the ground truth confirms there WAS an impact through the conversion mechanism in the diluted EPS calculation. The LLM incorrectly concludes 'no effect on the reported 2023 diluted EPS' when the ground truth indicates the opposite - that Class B-2 conversion assumptions did affect the 2023 diluted EPS denominator. This is a critical factual error regarding both the timing of the Class B-2 issuance and its impact on fiscal 2023 calculations. The answer fails to address the multi-hop synthesis required: understanding when Class B-2 shares were issued, how they affect diluted EPS calculations through conversion assumptions, and the specific impact on fiscal 2023 metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 408,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "\nThe Raytheon segment’s pension and post‑retirement benefit (PRB) expense is calculated under the U.S. government Cost Accounting Standards (CAS), which spreads the cost over time and recognizes it differently from the Financial Accounting Standards (FAS) basis used by Collins and Pratt & Whitney; this creates a distinct cost‑recognition pattern that is reflected as a separate “FAS/CAS operating adjustment” outside of Raytheon’s segment results. Consequently, while the total liability for pensions and PRB is comparable across the three businesses, Raytheon’s reported segment profit is adjusted upward (or downward) to reflect the CAS‑based timing of expense, making its financial performance not directly comparable to the FAS‑based reporting of Collins and Pratt & Whitney.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core distinction between CAS and FAS pension cost recognition patterns and their impact on Raytheon's financial reporting. STRENGTHS: (1) Correctly identifies that Raytheon uses CAS while Collins and Pratt & Whitney use FAS; (2) Accurately describes the different cost-recognition timing patterns between the two standards; (3) Properly notes that the ultimate liability is comparable across entities; (4) Correctly explains the FAS/CAS operating adjustment mechanism; (5) Accurately conveys that this creates non-comparability in reported segment profit. MINOR WEAKNESSES: (1) The LLM answer mentions the adjustment is 'outside of Raytheon's segment results' which is slightly imprecise - the adjustment affects how segment results are reported, not that it's entirely external; (2) The original answer emphasizes Raytheon's ability to recover these costs through U.S. government pricing, which is a key differentiator not explicitly mentioned in the LLM response (though implied by the CAS framework discussion); (3) The LLM uses 'upward (or downward)' which is appropriately cautious but the original answer focuses on the recovery mechanism as the key distinction. QUANTITATIVE ACCURACY: No specific numbers were required in either answer, so this dimension is not applicable. MULTI-HOP REASONING: The LLM correctly synthesizes information across three entities (Raytheon, Collins, Pratt & Whitney) and explains the comparative accounting treatment. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis. The core message about different cost-recognition patterns and their impact on comparability is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 488,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "\nTwo supplemental indentures specifically reference the 1.850% Notes due 2020 – the Ninth Supplemental Indenture (dated February 12 2015) and the Twelfth Supplemental Indenture (dated February 6 2017). The trustees involved were **U.S. Bank National Association** for the 2015 indenture and **The Bank of New York Mellon Trust Company, N.A.** for the 2017 indenture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The answer correctly identifies two supplemental indentures (Ninth and Twelfth), provides accurate dates (February 12, 2015 and February 6, 2017), and correctly names both trustees (U.S. Bank National Association and The Bank of New York Mellon Trust Company, N.A.). (2) QUANTITATIVE ACCURACY: All dates are correct with proper formatting. The note designation (1.850% Notes due 2020) is accurately referenced throughout. No calculations were required for this question. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the model correctly synthesized information across two separate indentures and properly paired each indenture with its corresponding trustee. Entity identification is precise with full and correct trustee names. (4) CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses both parts of the multi-part question (number of indentures and trustees involved). The presentation is clear and well-organized. Minor note: The LLM formatted the date as 'February 12 2015' without a comma, while ground truth shows 'February 12, 2015' with a comma - this is a negligible formatting variation that does not affect accuracy. Overall, this is an excellent response that demonstrates accurate multi-hop synthesis across multiple documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 389,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "\nIn fiscal 2022 the Company recorded a **$40 million gain** in income from foreign‑exchange forwards and options (see page 84, “Amount of gain (loss) recognized in income on derivatives – Foreign exchange forwards and options”).  \n\nThe fair‑value of those same derivatives on the balance sheet as of **May 31, 2021** was **$92 million** (see page 73, “DERIVATIVE ASSETS AT FAIR VALUE – Foreign exchange forwards and options (1)”).  \n\nThus, the 2022 income gain of $40 million was less than the $92 million fair‑value of the foreign‑exchange derivative assets reported a year earlier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the $40 million net gain from foreign exchange forwards and options in fiscal 2022 and the $92 million fair value of these derivative assets as of May 31, 2021. The numbers match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it identifies the 2022 income gain and the 2021 fair value, then provides a comparison between them. (3) ENTITY ACCURACY: The company (Nike, implied), fiscal year (2022), time period (May 31, 2021), and financial metrics (net gain in income, fair value of derivatives) are all correctly identified. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly extracted information from two different sections of the filing (page 84 for income statement impact and page 73 for balance sheet fair values) and synthesized them into a coherent comparison. The logical conclusion that the 2022 income gain was less than the prior year's fair value is accurate. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'the 2022 income gain of $40 million was less than the $92 million fair-value' conveys the same comparative insight as the ground truth. The only minor distinction is that the LLM provides specific page references (pages 84 and 73), which adds helpful context without detracting from accuracy. The answer is well-structured, clear, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 408,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "\nAIG’s reserving for U.S. Personal Insurance leans on frequency/severity techniques (especially for personal‑auto) and loss‑development methods, whereas U.S. Property reserves combine loss‑development, IBNR‑factor and expected‑loss‑ratio methods, reflecting its longer‑tail, low‑frequency/high‑severity exposures. In 2021, U.S. Personal Insurance generated $412 million of favorable prior‑year development, while U.S. Property showed essentially no material prior‑year development impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The $412 million favorable prior year development figure for U.S. Personal Insurance in 2021 is correct. (2) The quantitative accuracy is high - all numeric values match the ground truth. (3) The LLM correctly identifies the methodological differences: U.S. Personal Insurance uses frequency/severity methods with loss development methods, while U.S. Property uses loss development, IBNR factor, and expected loss ratio methods. (4) The characterization of U.S. Property as having longer-tail, low-frequency/high-severity exposures is a reasonable inference that aligns with the methodology differences. (5) The statement about U.S. Property showing 'essentially no material prior-year development impact' is a reasonable interpretation when the ground truth states 'does not have a specific 2021 prior year development figure mentioned.' WEAKNESSES: (1) The LLM answer is slightly less detailed than the ground truth regarding the specific reasons for favorable development in U.S. Personal Insurance (the ground truth mentions 'favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years' which provides important context). (2) The LLM characterizes U.S. Property's lack of mentioned development as 'essentially no material prior-year development impact,' which is an interpretation rather than a direct statement from the source. The ground truth is more cautious, noting the figure is 'not mentioned in the provided text.' (3) Minor omission: the ground truth mentions that claim counts emerge quickly in personal auto, allowing for immediate analysis of loss trends - this contextual detail about claim emergence patterns is not explicitly stated in the LLM answer, though it's implied. MULTI-HOP REASONING: The LLM successfully synthesizes information across two segments and correctly compares their methodologies and 2021 impacts. The reasoning is sound and logically structured. OVERALL: The answer is substantially correct with accurate numbers and sound reasoning, but lacks some of the granular contextual details present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 563,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "\nWalmart’s 2018 acquisition of a majority stake in Flipkart has left the retailer exposed to India’s Directorate of Enforcement, which in July 2021 issued a show‑cause notice alleging past violations of the country’s Foreign Direct Investment rules; if the ensuing proceedings result in fines, forced remedial actions or a restriction on Flipkart’s operations, the profitability of the investment—and therefore Walmart’s overall financial performance—could be materially reduced.  This case illustrates the broader risk embedded in Walmart’s international growth strategy of acquiring high‑growth e‑commerce assets abroad: while such investments are meant to expand its omni‑channel ecosystem and diversify revenue, they also subject the company to country‑specific regulatory and political uncertainties that can affect its consolidated results.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies Walmart's 2018 acquisition of majority stake in Flipkart; (2) Accurately references India's Directorate of Enforcement proceedings; (3) Correctly identifies the FDI (Foreign Direct Investment) rule violations as the core issue; (4) Properly synthesizes the connection between the specific regulatory risk and Walmart's broader international investment strategy; (5) Accurately describes the potential consequences (fines, remedial actions, operational restrictions); (6) Correctly characterizes the investment rationale (omni-channel ecosystem expansion, revenue diversification); (7) Appropriately frames the risk context (country-specific regulatory and political uncertainties). MINOR ISSUES: (1) The LLM specifies 'July 2021' for the show-cause notice date, which is a specific detail not explicitly confirmed in the ground truth answer (ground truth only references 'ongoing regulatory proceedings' without specifying the July 2021 date). This is a minor factual detail that adds specificity but cannot be verified against the provided ground truth. (2) The ground truth notes the proceedings investigated alleged violations during '2009-2015, prior to Walmart's acquisition,' which the LLM answer does not explicitly mention, though this is a relatively minor omission that doesn't affect the core answer. QUANTITATIVE ACCURACY: All key numbers and dates mentioned (2018 acquisition, July 2021 notice) are either correct or cannot be contradicted by the ground truth. No calculations are required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple dimensions - the specific regulatory risk, the investment context, and the broader strategic implications. The multi-hop reasoning is sound. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all aspects of the question regarding financial risks, regulatory proceedings, and international investment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 550,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "\nThe 2023 fiscal year saw the issuance of Class A ordinary shares with a total dollar value of **approximately $1.94 billion** (the amount recorded for shares issued under the employee‑share program in that year).  This infusion of capital was reflected in Accenture’s equity balance, helping to raise total shareholders’ equity from **$25.69 billion as of August 31 2023** to **$28.29 billion as of August 31 2024**, an increase of roughly **$2.6 billion** that includes the $1.94 billion contributed by the share issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the primary quantitative metric. (1) MAJOR NUMBER ERROR: The LLM states Class A ordinary shares issued in 2023 fiscal year were worth 'approximately $1.94 billion', but the ground truth shows $7,970 (in thousands, meaning $7,970,000 or approximately $8 million). This is a massive discrepancy - off by a factor of ~240x. The LLM appears to have confused or misidentified the source data entirely. (2) EQUITY FIGURES: While the LLM correctly identifies the shareholders' equity figures ($25.69B to $28.29B, increase of ~$2.6B), these are presented in billions when the ground truth uses millions ($25,692,839 to $28,288,646 thousand, or $25.69B to $28.29B). The format conversion is acceptable, but the core issue remains. (3) FLAWED REASONING: The LLM's claim that the $1.94B share issuance 'contributed' to the $2.6B equity increase is mathematically problematic and based on the wrong share issuance amount. The actual $7,970 thousand share issuance is a minor component of the total equity increase. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the actual Class A ordinary shares issued amount from the 2023 fiscal year. The answer demonstrates a fundamental misunderstanding or misreading of the source data. The only correct elements are the equity balance figures themselves, but these are overshadowed by the catastrophic error in the primary metric requested (Class A shares issued value).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 414,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "\nAIG first applies traditional loss‑development methods to the portion of excess‑casualty claims that is capped at $10 million and then uses those results to project the tail of losses above that attachment point; this projected tail is fed into the reserve model for U.S. Property and aerospace lines, whose lagged development pattern requires a blend of development and expected‑loss‑ratio inputs. Expected loss ratios—derived from recent accident‑year projections and adjusted for rate, trend and market changes—serve as the baseline ultimate‑loss assumptions for both the high‑attachment casualty business and the Property/aerospace reserving analyses, ensuring that the high‑layer exposure is properly reflected in the overall reserve estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the $10 million attachment point as the critical threshold in AIG's layered excess casualty approach. (2) Accurately describes the methodology flow: traditional loss development for capped losses ($10M) → projection of tail losses above $10M → integration into U.S. Property and aerospace reserving. (3) Properly emphasizes the dual role of expected loss ratios in both excess casualty and aviation/property lines. (4) Correctly notes that expected loss ratios are adjusted for inflation, rate changes, and market conditions. (5) Accurately captures that expected loss ratios are particularly important for recent accident years with insufficient reported data. (6) Correctly identifies severity as a key driver in aviation claims reserving. (7) No quantitative errors or incorrect numbers. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('projected tail,' 'lagged development pattern,' 'baseline ultimate-loss assumptions') compared to ground truth, but these are semantically equivalent and demonstrate sophisticated understanding of the concepts. The answer is more concise than the ground truth while maintaining all essential information. The multi-hop synthesis is sound: it correctly connects excess casualty methodology → U.S. Property/aerospace application → role of expected loss ratios across both. The answer fully addresses all parts of the complex question without omissions or contradictions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 429,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "\nThe fiscal year ended August 31 2022 recorded repurchases of Accenture plc Class A ordinary shares totaling **$3.954 billion** (see page 70). As of August 31 2024, the company’s remaining share‑purchase authorization was **$2.694 billion**, which is roughly **$1.26 billion less** than the amount repurchased in 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that fail basic fact-checking. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states repurchases were '$3.954 billion' when the ground truth shows '$4,111,266' (approximately $4.1 million, not $3.954 billion). This is an error of approximately 1,000x magnitude - the LLM inflated the number by roughly 960 times. The remaining authorization of '$2.694 billion' is also incorrect; ground truth shows '$2,694,281' (approximately $2.7 million). The LLM again inflated this by approximately 1,000x. (2) CALCULATION ERROR: The LLM calculates the difference as '$1.26 billion less,' which would be correct IF the numbers were in billions, but since the actual numbers are in millions (not billions), this comparison is meaningless and based on false premises. (3) UNIT CONVERSION FAILURE: The LLM appears to have misread or misinterpreted the source data, converting millions to billions without justification. The ground truth clearly indicates these are dollar amounts in the millions range ($4.1M and $2.7M), not billions. (4) MULTI-HOP REASONING: While the LLM correctly identified both required data points (repurchases in 2022 and remaining authorization in 2024) and attempted a comparison, the fundamental numerical errors undermine the entire analysis. (5) CONTEXTUAL RELEVANCE: The question is addressed in structure, but the answer is factually unreliable due to magnitude errors. The LLM did cite a source (page 70) but the numbers extracted are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 421,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "\nThe EU/EEA shift from “legitimate‑interests” to a consent‑based legal basis for behavioral ads forces Meta to obtain explicit permission before using user‑activity signals for ad targeting; in practice the company now offers a “no‑ads” subscription and a “see less‑personalized ads” option that is less relevant and effective than its prior premium ads. Because those ads are less personalized, user engagement drops and advertisers receive fewer valuable impressions, directly pressuring advertising revenue in the region. This regulatory change therefore simultaneously reduces engagement (through less‑targeted ads and optional paid tiers) and erodes ad‑revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core mechanism of META's regulatory compliance shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe. It correctly identifies the two main user-facing alternatives (subscription for no ads and less-personalized ads option) and accurately describes their impact on both user engagement and advertising revenue. The causal chain is properly articulated: regulatory change → consent requirement → reduced ad personalization → lower engagement and revenue. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either the ground truth or LLM answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) ENTITY ACCURACY: The answer correctly identifies META (Meta Platforms) and the EU/EEA region as the relevant entities. The regulatory context is properly framed. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the multi-part relationship: regulatory requirement → policy implementation → dual user options → engagement reduction → revenue impact. The reasoning is logically sound and demonstrates proper synthesis across the causal chain. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('consent-based legal basis' vs 'shift from legitimate interests to consent') but conveys identical meaning. The description of ad effectiveness ('less relevant and effective' in ground truth vs 'less personalized' in LLM) is semantically equivalent. Minor differences: The LLM adds the phrase 'advertisers receive fewer valuable impressions' which is a logical extension of the core concept but not explicitly stated in the ground truth. This is a reasonable inference that strengthens rather than weakens the answer. The LLM also frames the impact as 'simultaneously reduces engagement...and erodes ad-revenue growth' which captures the dual impact mentioned in the ground truth. Overall, the answer is comprehensive, accurate, and well-reasoned with no material errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 588,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "\nAccenture plc’s Class X ordinary shares can be redeemed only when the holder also surrenders the corresponding Accenture Canada Holdings Inc. exchangeable share, so each redemption cuts the outstanding Class X share count in step with the number of exchangeable shares still held. This contractual linkage obligates the company to keep the aggregate number of Class X shares from ever exceeding the outstanding exchangeable shares, thereby directly tying any change in the exchangeable‑share balance to an equal and opposite change in the total shares outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the redemption policy mechanism and its relationship to share count alignment. STRENGTHS: (1) Correctly identifies the one-for-one redemption mechanism between Class X ordinary shares and exchangeable shares; (2) Accurately describes the contractual linkage that prevents Class X shares from exceeding exchangeable shares; (3) Properly explains how redemptions of exchangeable shares trigger corresponding Class X share redemptions; (4) Uses precise language ('one-for-one basis,' 'contractual linkage,' 'aggregate number') that matches the ground truth concept; (5) Successfully synthesizes the multi-hop relationship between the two share classes and their impact on total shares outstanding. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('can be redeemed only when the holder also surrenders' vs. 'redeems upon the redemption or exchange'), but both convey the same mechanism and relationship. The LLM's explanation is actually more detailed in describing the practical mechanics ('each redemption cuts the outstanding Class X share count in step with') while maintaining factual accuracy. No quantitative errors, no missing entities, and the reasoning correctly synthesizes the relationship across the two share classes. The answer fully addresses both parts of the question: (1) how the redemption policy affects total shares outstanding, and (2) the specific mechanism ensuring alignment with exchangeable shares.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 419,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "\nThe net milestone capitalization for Jardiance fell from **$156.2 million in 2020 to $136.1 million in 2021**, a decline of **$20.1 million**. This reduction reflects the ongoing amortization of previously recorded milestones into cost of sales over the collaboration term, as described in the filing’s amortization policy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: $156.2 million (2020), $136.1 million (2021), and the $20.1 million decline. The calculation is accurate. However, the answer is incomplete relative to the ground truth. The original answer provides important contextual details about amortization practices that the LLM answer omits: (1) specific mention that milestones were capitalized as intangible assets, (2) explanation that amortization occurs through cost of sales, (3) description of the amortization term basis (latest of launch date, patent expiration, or supplementary protection certificates), and (4) explicit statement about amortization over useful life. The LLM answer acknowledges amortization generally but lacks the specific filing details that explain HOW and WHY the amortization occurs. The question specifically asks 'how does this trend reflect the amortization practices described in the filing?' - the ground truth provides substantive detail on this point, while the LLM answer only provides a general statement. The quantitative accuracy is perfect (all numbers correct), but the qualitative accuracy suffers from incomplete synthesis of the amortization practices explanation. The answer is not wrong, but it is materially less complete than the ground truth in addressing the second part of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 379,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "\nIn U.S. Property the IBNR‑factor approach is applied to lines that show **low claim frequency but high severity** (e.g., catastrophe‑driven commercial property), so the factors must be continually re‑estimated to capture rapid severity emergence, inflation and adverse‑development impacts; this makes the reserving process highly dynamic and sensitive to emerging loss patterns.  \n\nIn UK/Europe Property the underlying loss experience is **more frequent and less severe**, and loss‑development trends are relatively stable, so IBNR factors are used but are far less volatile and are often supplemented with stronger development‑method weights; consequently the reserving process is comparatively more stable and requires fewer frequent factor adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Most critically: (1) The LLM reverses the claim frequency/severity characteristics - it states U.S. Property has 'low claim frequency but high severity' while UK/Europe has 'more frequent and less severe' losses. The ground truth explicitly states the opposite: UK/Europe Property has 'low frequency/high severity losses' while U.S. Property has shifted toward 'less severe in the aggregate' due to non-admitted coverages. (2) The LLM incorrectly characterizes U.S. Property as 'catastrophe-driven commercial property' with 'rapid severity emergence' - the ground truth indicates U.S. Property has moved toward LOWER severity due to customer profile changes. (3) The LLM claims UK/Europe has 'more frequent and less severe' losses and 'relatively stable' development trends - this contradicts the ground truth's characterization of UK/Europe as low frequency/high severity. (4) The LLM's reasoning about volatility and factor adjustment frequency is inverted from the ground truth - it suggests U.S. requires 'fewer frequent factor adjustments' when the ground truth implies the opposite given the customer profile shifts. (5) No quantitative data is provided in either answer, but the qualitative characterizations are factually incorrect. The LLM demonstrates a fundamental misunderstanding of the regional differences in claim characteristics and how they affect the reserving process. The answer is internally coherent but factually wrong relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 430,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "\nProcter & Gamble’s Grooming segment holds **more than 60 %** of the global blades‑and‑razors market, while its share of the **male electric‑shaver market is just over 25 %**. In other words, the blades‑and‑razors share is roughly **2½ times larger** than the electric‑shaver share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key market share figures: more than 60% for blades and razors, and just over 25% for male electric shavers. The numeric values match the ground truth. However, there is a significant issue with how the comparison is presented. The ground truth specifies 'a difference of more than 35 percentage points' (60% - 25% = 35 percentage points), which is the direct answer to the comparison question. The LLM instead converts this to a ratio statement ('roughly 2½ times larger'), which while mathematically related (60/25 = 2.4), is not the comparison metric requested in the original question. The question specifically asks 'how does this compare' which in the context of percentage market shares typically expects a percentage point difference or direct comparison. The LLM's ratio approach is mathematically sound but represents a different type of comparison than what the ground truth provides. The answer addresses all parts of the question and correctly identifies the entities (Procter & Gamble, Grooming segment, both market categories), but the comparison methodology diverges from the ground truth answer. The quantitative values are accurate, but the presentation of the comparison is incomplete relative to the expected answer format.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 359,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "\nGeneral Dynamics invested **$510 million** in product‑development activities within its Aerospace segment in 2023.  The company offsets a portion of these costs through **cost‑sharing agreements with suppliers**, under which supplier contributions are recorded as a reduction of R&D expense (based on milestone payments) and do not need to be refunded regardless of the development outcome.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $510 million investment figure is correct and matches the ground truth exactly. The year (2023) and segment (Aerospace) are correctly identified. (2) COMPLETENESS: Both parts of the question are addressed - the investment amount and the cost-offset mechanism. (3) ENTITY ACCURACY: General Dynamics, Aerospace segment, and 2023 are all correctly identified. (4) MECHANISM DESCRIPTION: The LLM correctly identifies cost-sharing agreements with suppliers as the mechanism. The answer accurately notes that supplier contributions are recorded as a reduction of R&D expense. The LLM adds helpful detail about milestone payments and non-refundable nature of contributions, which provides useful context beyond the ground truth without contradicting it. (5) REASONING: The multi-hop synthesis is sound - connecting the investment amount to the cost-offset mechanism appropriately. Minor note: The ground truth states contributions are 'explicitly for reimbursement of development costs' while the LLM describes them as 'based on milestone payments' and 'do not need to be refunded' - these are complementary details that enhance understanding rather than contradict the core answer. The semantic meaning is equivalent and the additional specificity about milestone payments and non-refundable nature represents accurate elaboration rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 405,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "\nAccenture repurchased **13,913,393 Class A Ordinary Shares** in fiscal 2024 for a total cash outlay of **$4,509,392** (page 101).  This amount was added to the cost basis of its treasury‑stock account, thereby **increasing the total value of treasury shares held by the company by $4.51 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that make it substantially incorrect. Ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM reports $4,509,392 - a discrepancy of $398,126 (approximately 9.7% higher than actual). Additionally, the LLM provides the number of shares repurchased (13,913,393) which was not requested and appears to conflate different metrics. The LLM correctly identifies that the treasury share value increased by the amount spent, which is the right conceptual understanding, but the dollar amount is wrong. The LLM also rounds to $4.51 million, which while a reasonable approximation of their stated figure, is still based on an incorrect base number. The core issue is a fundamental quantitative error in the primary financial metric requested - the amount spent on share purchases. The answer does address both parts of the question (amount spent and effect on treasury shares), but the numerical inaccuracy is critical for a financial question where precision is essential. The reasoning about treasury stock accounting is sound, but it cannot overcome the incorrect starting number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 333,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "\nThe value of META’s Servers and network assets rose from **$46,838 million on December 31 2023 to $68,397 million on December 31 2024**, an increase of **$21,559 million**.  \nBecause depreciation is applied on a straight‑line basis over the assets’ useful lives (currently 4–5 years, recently extended to 5.5 years), the larger carrying amount results in a higher depreciation expense—$11.34 billion in 2024 versus $7.32 billion in 2023—reflecting the expanded server and network‑asset base.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the year-over-year dollar increase of $21.559 billion ($21,559 million) and the correct asset values for both dates (December 31, 2023: $46.838 billion; December 31, 2024: $68.397 billion). The number format conversion is appropriate. The LLM also correctly noted the straight-line depreciation basis and useful life ranges (4-5 years, extended to 5.5 years). WEAKNESSES: (1) The LLM introduced depreciation expense figures ($11.34 billion in 2024 vs $7.32 billion in 2023) that were not part of the original question or ground truth answer, and these numbers cannot be verified against the provided ground truth. This represents unsupported quantitative claims. (2) More critically, the LLM failed to address the core conceptual relationship that the ground truth emphasized: the distinction between assets in construction in progress (CIP) that are NOT depreciated versus assets placed in service that ARE depreciated. The ground truth explicitly states that the significant increase suggests 'a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.' The LLM's answer mentions depreciation policy but does not explain this crucial CIP-to-service transition mechanism that explains WHY the asset value increased so dramatically. (3) The LLM's explanation focuses on depreciation expense implications rather than the depreciation policy's relationship to asset placement timing, which was the core of the original question. CALCULATION VERIFICATION: The $21.559 billion increase is correct ($68.397B - $46.838B = $21.559B). However, the depreciation expense figures introduced by the LLM cannot be verified and appear to be extrapolations not supported by the ground truth. MULTI-HOP REASONING: The LLM partially synthesized the information but missed the critical insight about CIP assets being placed in service, which is the key to understanding the relationship between the asset increase and depreciation policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 557,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "\nIn 2022 Eli Lilly had three FDA Breakthrough‑Therapy designations that are still in the submission phase—empagliflozin (Jardiance) for heart‑failure with preserved ejection fraction (cardiology), baricitinib (Olumiant) for alopecia areata (immunology), and donanemab for early Alzheimer’s disease (neuroscience). No Breakthrough‑designated indication has been discontinued; the only discontinued program (baricitinib for systemic lupus erythematosus) was not a Breakthrough‑designated indication.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE MISMATCH: The LLM answer states THREE FDA Breakthrough Therapy designations in submitted status (empagliflozin, baricitinib, and donanemab), while the ground truth specifies only TWO (empagliflozin and baricitinib). This is a fundamental factual error on the primary quantitative metric requested. The LLM incorrectly includes donanemab for early Alzheimer's disease as a 2022 Breakthrough designation in submitted status, which contradicts the ground truth. CORRECT ELEMENTS: (1) Empagliflozin (Jardiance) for heart failure with preserved ejection fraction - correctly identified with therapeutic area (cardiology); (2) Baricitinib (Olumiant) for alopecia areata - correctly identified with therapeutic area (immunology); (3) Correctly states no indications were discontinued; (4) Correctly notes that baricitinib for systemic lupus erythematosus was discontinued but was NOT a Breakthrough-designated indication. INCORRECT ELEMENTS: (1) Includes donanemab for early Alzheimer's disease as a submitted Breakthrough designation when it should not be listed; (2) States 'three' instead of 'two' for the count of submitted indications. MULTI-HOP REASONING: The LLM demonstrates good understanding of the distinction between Breakthrough-designated programs and non-designated discontinued programs, but fails on the core counting task. The inclusion of donanemab suggests either a data retrieval error or confusion about which indications received Breakthrough designation in 2022. This is a significant factual error that directly contradicts the ground truth on the primary quantitative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 445,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "\nAIG applies loss‑development techniques directly to its short‑tail **U.S. Property** lines, using them (often together with frequency/severity and IBNR‑factor methods) to set reserves, whereas for the long‑tail **U.S. Other Casualty** lines it places comparatively less weight on pure development methods and relies more on expected‑loss‑ratio assumptions—especially for recent or volatile subsets of business.  \n\nIn 2021 the company recorded **$412 million of favorable prior‑year development in U.S. Personal Insurance**, driven primarily by favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: The $412 million figure for favorable prior year development in U.S. Personal Insurance is correct and properly attributed to 2017 and 2018 catastrophe year subrogation recoveries. The number matches the ground truth exactly. QUALITATIVE ACCURACY: The answer correctly synthesizes the multi-hop comparison between U.S. Other Casualty and U.S. Property lines. For U.S. Property (short-tail), it accurately identifies the use of loss development methods, frequency/severity, and IBNR factor methods. For U.S. Other Casualty (long-tail), it correctly notes the reduced reliance on pure development methods and increased emphasis on expected loss ratio methods, particularly for recent accident years. The reasoning about why these differences exist (short-tail vs. long-tail nature) is sound. COMPLETENESS: The answer addresses all three parts of the multi-part question: (1) how methods differ between U.S. Other Casualty and U.S. Property lines, (2) specific reserving adjustments in 2021 for U.S. Personal Insurance, and (3) the role of prior year catastrophe recoveries. SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical meaning. Phrases like 'places comparatively less weight on pure development methods' and 'relies more on expected-loss-ratio assumptions' are semantically equivalent to the ground truth's description. The mention of 'favorable development and subrogation recoveries' appropriately captures the nature of the $412 million adjustment. MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but loses no material information. All factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 477,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "\nThe Baby, Feminine & Family Care reportable segment accounted for about **24 % of Procter & Gamble’s FY 2024 net sales**.  Given that Charmin holds just over **25 % of the North American toilet‑paper market**, it is estimated to contribute roughly **one‑quarter of the segment’s sales**—approximately a **6 % share of total company net sales**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. CORRECT ELEMENTS: (1) Baby, Feminine & Family Care segment at 24% of FY2024 net sales - matches ground truth exactly; (2) Charmin's ~25% North American toilet paper market share - matches ground truth; (3) Calculation of estimated contribution: 25% of 24% = 6% of total company net sales - mathematically correct and logically sound. REASONING QUALITY: The LLM successfully synthesized information across multiple data points (segment percentage, brand market share, and derived total company impact) to answer the multi-part question. The logic chain is clear: segment % × brand market share within segment ≈ brand contribution to total company sales. MINOR CONSIDERATIONS: The LLM's phrasing 'estimated to contribute roughly one-quarter of the segment's sales' is slightly interpretive (the ground truth states Charmin is 'a key component' but doesn't explicitly quantify its segment share). However, this interpretation is reasonable given the 25% market share data and represents sound business logic. The answer goes slightly beyond the ground truth by providing a calculated estimate (6% of total sales) which, while not explicitly stated in the original answer, is a valid and helpful synthesis. All numeric values are accurate, calculations are correct, and the answer fully addresses both parts of the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 392,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "\nGeneral Dynamics’ $510 million 2023 R&D outlay is funneled through the Combat Systems segment to accelerate the next‑generation upgrade of the Abrams tank (the M1E3 “E‑series” SEPv3 configuration) and to modernize related platforms such as Stryker, Ajax and autonomous vehicle programs.  By investing in advanced communications, power‑generation, fuel‑efficiency, armor and autonomous‑system technologies, the company seeks to boost the Abrams fleet’s survivability, lethality and mobility, win additional U.S.‑Army and allied contracts, and generate higher‑margin, long‑term revenue streams that reinforce its market‑leading position in land‑combat systems.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The $510 million R&D figure is correctly cited and properly formatted. The year 2023 is accurate. No calculation errors present. ENTITY ACCURACY: General Dynamics and Combat Systems segment correctly identified. M1E3 Abrams tank correctly named. However, the LLM introduces additional platforms (Stryker, Ajax, autonomous vehicles) that are NOT mentioned in the ground truth answer. This represents a factual addition beyond what can be verified from the provided knowledge graph. COMPLETENESS & MULTI-HOP REASONING: The LLM answer addresses the core question about how R&D spending supports M1E3 development and financial outcomes. It correctly identifies specific technical improvements (communications, power generation, fuel efficiency, armor) that match the ground truth. It also correctly identifies strategic outcomes (market-leading position, long-term contracts, revenue generation). CRITICAL ISSUE: The LLM mentions 'SEPv3 configuration' and 'E-series' nomenclature that is not present in the ground truth. While these may be technically accurate designations, they introduce specificity not supported by the provided knowledge graph. The ground truth simply refers to 'M1E3 Abrams main battle tank' without these additional technical designations. SEMANTIC EQUIVALENCE: The core message aligns well - R&D investment supports modernization, capability improvements, and long-term strategic positioning. The LLM's mention of 'higher-margin, long-term revenue streams' is semantically equivalent to the ground truth's 'long-term value creation' and 'sustained revenue.' WEAKNESSES: (1) Introduction of unverified platform names (Stryker, Ajax) beyond the M1E3 focus; (2) Additional technical nomenclature (SEPv3, E-series) not in ground truth; (3) These additions, while potentially accurate, represent synthesis beyond the provided knowledge graph. STRENGTHS: (1) Correct dollar amount and year; (2) Accurate identification of specific technical improvements; (3) Sound reasoning about strategic and financial outcomes; (4) Proper multi-hop synthesis of R&D investment to platform development to market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 575,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "\nAccenture repurchased **2,072,563 Class A ordinary shares** during fiscal 2024, spending a total of **≈ $628 million** (about **$605 million** under the publicly announced open‑market program plus the cost of the 72,255 shares bought outside that program). This dollar amount reflects the combined value of all shares purchased under the program and those unrelated to it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that make it substantially incorrect. Ground truth states total purchases were $609.1 million ($605M under program + $4.1M outside program). The LLM claims approximately $628 million total, which is $18.9 million higher than the correct amount - a material discrepancy of about 3.1%. The LLM correctly identifies the $605 million figure for the publicly announced program but fails on the critical calculation of the total. The LLM provides share count details (2,072,563 shares total, 72,255 outside program) that are not in the ground truth, but these appear to be supplementary information rather than the core answer. The fundamental error is in the total dollar value: the LLM states '≈ $628 million' when the correct answer is $609.1 million. This is not a rounding or formatting difference - it's a factual error in the primary metric requested. The LLM does address both components of the question (program and non-program purchases) and correctly identifies the company, year, and share type, but the quantitative accuracy on the main deliverable (total dollar value) is wrong. The reasoning structure is sound (combining two components), but the execution fails on the actual numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 351,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "\nIn 2021 AT&T made a sublease payment of **$253 million** to Crown Castle (the amount disclosed for “Payments made to Crown Castle under this arrangement were $253 for 2021”).  By contrast, the original 2013 transaction generated **$4.827 billion in cash** when Crown Castle purchased 627 of AT&T’s towers and obtained exclusive lease rights to 9,048 towers.  Thus, the 2021 sublease payment is roughly **5 percent** of the cash proceeds AT&T originally received from the 2013 tower sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2021 sublease payment of $253 million - CORRECT (matches ground truth of $253, with proper unit clarification as millions); (2) 2013 cash proceeds of $4.827 billion - CORRECT (matches ground truth of $4,827 in millions, properly converted to billions); (3) Transaction details (627 towers purchased, 9,048 towers with exclusive lease rights) - CORRECT and adds helpful context; (4) Percentage calculation: $253M / $4,827M = 5.24%, rounded to approximately 5% - CORRECT. The LLM properly synthesized multi-hop information by: identifying the 2021 payment amount from the sublease arrangement, retrieving the 2013 transaction proceeds, and performing an accurate comparative analysis. The answer addresses all parts of the question comprehensively. The only minor observation is that the ground truth answer states values without explicit unit notation ($253 and $4,827), while the LLM clarified these as millions and billions respectively - this is actually an improvement in clarity rather than an error. The reasoning is sound, the comparison is logical, and the contextual framing about the payment representing a small fraction of the original transaction is appropriate and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 357,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "\nGM values its Stellantis warrants with a Black‑Scholes pricing model, and the 10‑K notes that a 10 % adverse move in Stellantis’ quoted share price would “have had an insignificant effect” on the fair‑value of the warrants (which represented $1.5 bn of equity‑price‑risk exposure at year‑end 2021). Consequently, a 10 % decline in Stellantis stock would translate into only a trivial change in the fair value of those warrants, meaning the potential financial impact on GM’s overall equity investments in 2021 would be essentially negligible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - the $1.5 billion fair value of Stellantis warrants at year-end 2021 is accurately stated, the 10% adverse change percentage is correct, and the year 2021 is properly identified. ENTITY ACCURACY: General Motors, Stellantis, and the warrant investment are all correctly identified. The Black-Scholes valuation methodology is accurately cited. MULTI-HOP REASONING: The answer successfully synthesizes three key pieces of information: (1) the valuation methodology (Black-Scholes), (2) the fair value amount ($1.5 billion), and (3) the sensitivity assessment (10% adverse change = insignificant effect). The logical connection between these elements is sound - the answer correctly explains that despite the methodology being sensitive to stock price inputs, the actual financial impact would be immaterial. SEMANTIC EQUIVALENCE: The LLM's characterization of the impact as \"trivial,\" \"negligible,\" and \"essentially negligible\" accurately conveys the ground truth's \"insignificant effect\" language. The phrase \"equity-price-risk exposure\" is an appropriate technical characterization. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing \"would translate into only a trivial change\" effectively communicates the quantitative relationship. No factual errors, calculation errors, or material omissions are present. The answer fully addresses the complex multi-part question about how valuation methodology, sensitivity analysis, and financial impact interconnect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "\nP&G’s adult‑incontinence business—embodied by the Always Discreet brand—captures roughly **15 % of the total global market share of the Baby, Feminine & Family Care segment**. In other words, about one‑sixth of the segment’s worldwide market share is accounted for by the adult‑incontinence sub‑category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. (1) CORRECTNESS: The core claim that Always Discreet captures approximately 15% of P&G's total global market share in the Baby, Feminine & Family Care segment is accurate and matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: The 15% figure is correct. The LLM also provides a helpful semantic translation ('about one-sixth') which is mathematically accurate (15% ≈ 1/6 or 16.67%, close enough for practical purposes). (3) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the adult incontinence sub-category and the overall segment. However, there is a minor interpretive difference: the ground truth states that Always Discreet holds 15% market share 'within its specific sub-category of adult incontinence' AND this contributes to the overall 20% segment share, whereas the LLM presents the 15% as directly attributable to the segment. The ground truth's phrasing suggests a hierarchical relationship (15% of adult incontinence sub-category within the 20% segment), while the LLM treats it as a direct contribution. This is a subtle distinction that could affect interpretation. (4) COMPLETENESS: The LLM addresses the main question directly and provides the requested percentage. It adds helpful context with the 'one-sixth' analogy. (5) ENTITY ACCURACY: P&G, Always Discreet, and the Baby, Feminine & Family Care segment are all correctly identified. Minor deduction: The ground truth's more nuanced explanation of the hierarchical relationship between sub-category and segment share is not fully captured in the LLM's answer, though the numerical answer remains correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 463,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "\nThe fourth‑quarter fiscal 2024 average price paid for an Accenture plc Class A ordinary share was **$303.05**. This figure reflects the total cash outlay for the 2,072,563 shares acquired—including the 2,000,308 shares bought under the publicly announced open‑market program and the 72,255 shares purchased in unrelated employee‑benefit transactions—divided by the total number of shares acquired.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided an average price of $303.05 per share, which is significantly incorrect compared to the ground truth answer of $299.48. This represents a discrepancy of approximately $3.57 per share (1.19% error), which is material for financial calculations. While the LLM correctly identified the relevant share counts (2,072,563 total shares, 2,000,308 from open-market program, and 72,255 from employee-benefit transactions) and demonstrated understanding of the calculation methodology (total cash outlay divided by total shares acquired), the final numerical result is wrong. The LLM's reasoning structure is sound—it correctly identified that the answer requires synthesizing information about both share purchase programs and calculating a weighted average price. However, the actual calculation appears to have been performed incorrectly, suggesting either an error in accessing the underlying financial data (total cash outlay amount) or a computational mistake. The answer demonstrates good contextual understanding of the question and proper identification of all relevant entities and time periods (Q4 fiscal 2024, Accenture plc Class A ordinary shares), but the fundamental requirement of providing the correct numerical answer has not been met. For financial questions, accuracy of numbers is paramount, and a $3.57 per share error is not a minor rounding difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 388,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "\nThe net milestones capitalized for Jardiance fell from **$156.2 million in 2020 to $136.1 million in 2021**, a decline of **$20.1 million**. This $20.1 million reduction is tiny relative to the **$1.49 billion of collaboration revenue** that Jardiance generated in 2021 (about 1.3 % of that revenue).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states Jardiance generated '$1.49 billion of collaboration revenue' in 2021, but the ground truth clearly indicates the broader collaboration and other revenue totaled only $175.0 million for 2021. This is a massive discrepancy (off by ~8.5x). (2) INCORRECT COMPARISON - The LLM compares the $20.1 million decrease to $1.49 billion collaboration revenue, but the ground truth specifies the comparison should be to $175.0 million in collaboration and other revenue. (3) PERCENTAGE CALCULATION ERROR - The LLM calculates $20.1M as 1.3% of $1.49B, but this is based on the wrong revenue figure. The correct comparison would be $20.1M vs $175.0M (approximately 11.5%). (4) CORRECT ELEMENTS - The LLM correctly identified: the 2020 figure ($156.2M), the 2021 figure ($136.1M), and the difference ($20.1M decline). However, these correct numbers are undermined by the fundamental error in the collaboration revenue figure. (5) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to properly synthesize the relationship between net milestones capitalized and the collaboration revenue metric. The ground truth indicates the $136.1M was 'part of' the $175.0M collaboration and other revenue, not that Jardiance generated $1.49B in collaboration revenue. This represents a fundamental misunderstanding of the financial relationships being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 388,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "\nGM recorded a **$316 million gain** from the fair‑value increase of its Stellantis warrants in 2021 (the gain is reported in interest income and other non‑operating income, Note 14).  \n\nAfter selling the Opel/Vauxhall business to Stellantis, GM maintains an ongoing relationship that includes **continued purchases of vehicles, parts and engineering services from Stellantis and a guarantee/indemnity for certain post‑sale liabilities**, which still influences GM’s post‑sale operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $316 million gain from Stellantis warrants in 2021 is correct and matches the ground truth exactly. The number format is appropriate and the year is correctly identified. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the warrant gains amount and (b) the ongoing business relationship. The LLM goes beyond the ground truth by specifying the accounting treatment (interest income and other non-operating income, Note 14), which adds helpful context without contradicting the ground truth. (3) ENTITY ACCURACY: All entities are correctly identified - GM, Stellantis, Opel/Vauxhall business, warrants, and the 2021 timeframe. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple aspects: the warrant transaction, the sale of Opel/Vauxhall, and the resulting ongoing operational relationships. The connection between the sale and the continuing business relationship is logically sound. (5) SEMANTIC EQUIVALENCE: The LLM's description of the ongoing relationship (purchases of vehicles, parts, engineering services, and guarantee/indemnity for post-sale liabilities) is semantically equivalent to and slightly more detailed than the ground truth statement about 'purchase and supply of certain vehicles, parts, and engineering services.' The mention of guarantee/indemnity is an additional relevant detail that doesn't contradict the ground truth. Minor deduction (1 point) only because the ground truth doesn't explicitly mention the guarantee/indemnity aspect, though this appears to be additional accurate information rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 462,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "\nThe deconsolidation of AIG Financial Products Corp. resulted in a **pre‑tax loss of $114 million**, which is reported in “Net gain (loss) on divestitures and other” in AIG’s consolidated income statement. This charge reflects the removal of AIGFP’s assets and liabilities (including the $37.6 billion loan receivable) from AIG’s consolidated balance sheet, but the Chapter 11 reorganization is not expected to have any further material impact on AIG’s overall consolidated financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the pre-tax loss of $114 million from AIGFP's deconsolidation and accurately reports it in 'Net gain (loss) on divestitures and other' line item. The $37.6 billion loan receivable figure is also correct. However, the answer has a notable omission: it fails to mention the specific date of the Chapter 11 reorganization filing (December 14, 2022), which is a key factual detail in the ground truth. The LLM also omits the important detail about the reclassification of the loan receivable to a third-party asset with a full allowance for credit losses, which provides important context about how the balance sheet was affected. The statement about 'no further material impact' is somewhat vague compared to the ground truth's more nuanced explanation that 'the reorganization would not have a material impact on its consolidated balance sheets or respective businesses.' The quantitative accuracy is strong (all numbers correct), but the qualitative completeness is reduced due to missing contextual details about the specific date and the nature of the balance sheet reclassification. The multi-hop reasoning is sound but incomplete—the answer synthesizes the loss amount and its reporting location correctly but doesn't fully explain the financial mechanics of how the deconsolidation affected the balance sheet.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 376,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "\nThe net carrying amount of **Acquired Franchise Rights** was **$598 million as of December 28 2024**. This is lower than the **gross amount reported for the prior year (2023), which was $840 million**, representing a decrease of roughly $242 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness. While it correctly identifies the net value of Acquired Franchise Rights in 2024 as $598 million and correctly cites the 2023 gross value as $840 million, it makes a critical calculation error in the comparison. The LLM states the decrease is 'roughly $242 million,' which is incorrect. The ground truth shows: (1) 2024 gross value is $821 million, (2) 2023 gross value is $840 million, (3) the decrease in gross value is $19 million ($840M - $821M = $19M). The LLM appears to have incorrectly compared the 2024 net value ($598M) to the 2023 gross value ($840M), yielding $242M, which conflates net and gross values across different years—a fundamental error in multi-hop synthesis. The question specifically asks for comparison of 2024 net value to 2023 gross value, which the LLM attempts, but the calculation is wrong. The LLM also fails to provide the 2024 gross value ($821M) and the accumulated amortization ($223M) that the ground truth includes, missing important contextual details. The answer demonstrates partial understanding of the question structure but fails on the core calculation required for an accurate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 344,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "\nAT&T’s total financial commitment for the C‑Band licenses equals roughly **$26.5 billion** – the **$23.4 billion** it paid (including the $550 million upfront deposit and $22.856 billion cash payment for the auction) plus an estimated **$3.1 billion** of future costs for clearing the spectrum ($2.112 billion for Phase II clearing and about $1 billion for compensable relocation expenses).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness. Ground truth shows the total commitment is $26,478 million (approximately $26.5 billion), but the LLM states $26.5 billion while providing incorrect component breakdowns. Specific issues: (1) The LLM claims the auction payment was $23.4 billion ($23,406 million per ground truth), which is correct in magnitude. However, the LLM then breaks this down into '$550 million upfront deposit and $22.856 billion cash payment' - these numbers don't align with the ground truth's single $23,406 million figure and appear to be fabricated sub-components. (2) The LLM states future costs total '$3.1 billion' ($2.112 billion for Phase II clearing plus '$1 billion for compensable relocation'), but ground truth shows only $2,112 million + $1,000 million = $3,112 million total, which the LLM rounds to $3.1 billion. This is approximately correct but the LLM's phrasing 'about $1 billion' suggests uncertainty where the ground truth is precise ($1,000 million). (3) The total of $26.5 billion is correct when rounding $26,478 million, but the component breakdown provided by the LLM ($23.4B + $3.1B = $26.5B) masks the fact that the LLM invented intermediate details not in the ground truth (the $550M deposit and $22.856B payment split). The LLM correctly identifies all three components (auction payment, spectrum clearing, relocation costs) and the overall magnitude is right, but the internal breakdown contains fabricated details that suggest hallucination. The answer is contextually relevant and addresses the multi-part question, but the quantitative accuracy is compromised by invented sub-components and imprecise language around the relocation costs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 473,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "\nThe net milestones capitalized for Jardiance fell from **$156.2 million in 2020 to $136.1 million in 2021**, a decrease of roughly **$20 million**.  This reduction means fewer milestone payments were deferred and amortized into cost of sales, but the impact was offset by stronger sales performance—Jardiance net product revenue rose to **$1.49 billion in 2021** (up from $1.15 billion in 2020), underscoring overall growth in Lilly’s diabetes portfolio despite the lower milestone capitalization.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numbers: the $156.2 million (2020) and $136.1 million (2021) figures for net milestones capitalized, and the $20.1 million decline (LLM rounded to ~$20 million, which is acceptable). The additional Jardiance revenue figures ($1.49 billion in 2021 vs $1.15 billion in 2020) are accurate and provide valuable context. The quantitative accuracy is excellent with all numbers verified correctly. The multi-hop reasoning is sound—the LLM correctly synthesized information about milestone capitalization trends and connected this to broader portfolio performance metrics. However, there is a minor semantic difference in interpretation: the LLM frames the milestone decline as 'fewer milestone payments were deferred and amortized into cost of sales,' which is a slightly different accounting interpretation than the ground truth's 'lower recognition of milestone-related revenue or deferral of payments.' The ground truth emphasizes this could signal a slowdown in developmental/commercial milestone achievements, while the LLM emphasizes that this was offset by stronger sales performance. Both interpretations are reasonable, but the LLM's addition of the revenue growth context actually provides a more complete picture of financial performance. The answer fully addresses both parts of the question (the change in net milestones AND how it reflects in financial performance), making it comprehensive and contextually relevant. Minor deduction only for the slightly different framing of the accounting mechanics, though the LLM's interpretation is not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 451,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "\nIn 2021 General Motors recognized about $1.9 billion of pension income and $0.2 billion of gains on Stellantis warrants, yielding a total financial benefit of roughly $2.1 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that make it substantially incorrect. (1) QUANTITATIVE ERRORS: The LLM states pension income of ~$1.9 billion, but the ground truth shows $0.8 billion in non-service pension income - this is off by $1.1 billion (137% error). The warrant gains of $0.2 billion are correct. The LLM's total of $2.1 billion is incorrect; the correct total is $1.0 billion. The LLM overstated the total benefit by $1.1 billion or 110%. (2) CALCULATION VERIFICATION: Even if we accept the LLM's stated components ($1.9B + $0.2B), the arithmetic is correct at $2.1B, but the underlying pension income figure is fundamentally wrong. (3) MULTI-HOP REASONING: The LLM correctly identified the need to synthesize two components (pension income and warrant gains) and correctly identified the warrant gain amount, but failed on the primary component - pension income. (4) ENTITY ACCURACY: General Motors and Stellantis are correctly identified, and the year 2021 is correct. The metric terminology differs slightly (LLM says 'pension income' vs ground truth's 'non-service pension income'), but this is a minor semantic issue. The core problem is the magnitude of the pension income figure, which appears to be either a data retrieval error or a fundamental misunderstanding of the filing data. This is a critical failure on the primary financial metric in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 388,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "\nAfter AIG acquired its equity‑method stake in Corebridge, any subsequent movements in Corebridge’s stock price are recorded in the Consolidated Statement of Income as “Changes in the fair values of equity securities – AIG’s investment in Corebridge and gain on sale of shares” (see Note 4, p. 110 and the equity‑method table on p. 109).  The gain or loss recognized is proportional to AIG’s ownership interest in Corebridge, adjusting the carrying amount of the investment and flowing through net income, thereby directly reflecting AIG’s equity stake in Corebridge’s fair‑value changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key mechanism by which Corebridge's stock price changes impacted AIG's financial statements - through fair value adjustments recognized in the Consolidated Statement of Income. The answer appropriately references the equity method investment framework and correctly notes that gains/losses flow through net income proportional to AIG's ownership interest. The citation to Note 4 (p. 110) and the equity method table (p. 109) demonstrates proper document navigation. However, the answer has some limitations: (1) It lacks specific quantitative examples or actual dollar amounts of gains/losses recognized, which would strengthen the response; (2) It doesn't explicitly mention the distinction between equity method income and fair value changes, though it implies this distinction; (3) The original answer emphasizes 'equity method income from Corebridge, which includes changes in the stock price' - the LLM answer focuses more on fair value option treatment rather than explicitly connecting equity method income to stock price changes. The core reasoning is sound - stock price changes affect the carrying amount and flow through net income proportionally to ownership interest - but the answer could be more comprehensive in addressing both the equity method income component and the fair value adjustment component mentioned in the ground truth. The answer demonstrates good multi-hop synthesis by connecting stock price movements to financial statement impact to ownership interest reflection, though it could be more explicit about how equity method income specifically incorporates these changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 449,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "\nThe net amount of Other Identifiable Intangibles reported for PepsiCo (PEP) in 2024 is **$144 million**. This represents a **$30 million decrease** from the 2023 balance of $174 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: (1) 2024 net value of $144 million matches ground truth exactly, (2) 2023 value of $174 million is correct, (3) the calculated decrease of $30 million ($174M - $144M) is accurate. The answer properly identifies the company as PepsiCo (PEP), correctly specifies the fiscal year 2024, and accurately references the metric as 'Other Identifiable Intangibles.' The multi-hop reasoning is sound - the model correctly synthesized the comparison between two years and calculated the year-over-year change. The only minor distinction is that the LLM explicitly states the decrease was 'due to amortization' while the ground truth simply notes it 'due to amortization,' but this is a reasonable inference from the question context mentioning 'amortization data.' The answer uses appropriate number formatting ($144 million) and clearly addresses both parts of the multi-part question. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1095,
        "completion_tokens": 292,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "\nIn 2023 the company earned **about $8.63 billion** from nuclear‑powered submarine programs (the Columbia‑class and Virginia‑class), whereas revenue from surface‑ship construction and related services was roughly **$2.70 billion**. Thus submarine‑related revenue was more than three times that from surface ships, underscoring the strategic priority placed on submarine programs such as the Columbia‑class ballistic‑missile fleet and the Virginia‑class attack‑submarine line.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Quantitative verification: (1) Nuclear submarine revenue stated as '$8.63 billion' matches ground truth of $8,631 million (formatting variation acceptable); (2) Surface ship revenue stated as '$2.70 billion' matches ground truth of $2,698 million (minor rounding acceptable); (3) Ratio comparison stated as 'more than three times' is accurate (8,631/2,698 = 3.2:1, which is indeed more than 3x). Multi-hop reasoning is sound: the answer correctly synthesizes revenue data from General Dynamics' Marine Systems segment across two product categories and provides appropriate context about strategic importance. Entity identification is correct: General Dynamics (implied through Marine Systems context), Columbia-class and Virginia-class submarines are properly identified. The answer addresses all parts of the question: total submarine revenue, surface ship revenue comparison, and strategic context. Minor strengths: the LLM appropriately characterizes the Columbia-class as 'ballistic-missile fleet' and Virginia-class as 'attack-submarine line,' adding precision. The only minor deviation is the use of 'about' and 'roughly' which introduces slight hedging language, but this is acceptable given the rounding of actual figures. No calculation errors detected. The semantic meaning perfectly matches the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 384,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "\nThe fair‑value of GM’s Stellantis warrants rose from **$1.2 billion at 12/31/2020 to $1.5 billion at 12/31/2021**, an increase of **$0.3 billion**.  \nIn contrast, the fair‑value of the marketable‑debt securities fell from **$9.0 billion at 12/31/2020 to $8.6 billion at 12/31/2021**, a decrease of **$0.4 billion**.  \n\nThus, the warrant investment gained $300 million, while the debt‑security portfolio lost $400 million over the same period, with opposite directions of change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Stellantis warrants increased from $1.2B to $1.5B, a $0.3B increase - correctly stated; (2) Marketable debt securities decreased from $9.0B to $8.6B, a $0.4B decrease - correctly stated; (3) All dates (12/31/2020 and 12/31/2021) are accurate; (4) The calculations are correct ($1.5B - $1.2B = $0.3B and $8.6B - $9.0B = -$0.4B); (5) The answer properly synthesizes the multi-hop comparison between two different asset classes, noting the contrasting trends. The LLM also appropriately presents the numbers in both billion and million formats ($0.3B = $300M, $0.4B = $400M), which aids clarity. The reasoning is sound - the answer correctly identifies that warrants gained value while debt securities lost value, demonstrating proper multi-hop synthesis across the two investment categories. The answer is well-structured, directly addresses all parts of the question, and provides appropriate context about the opposing directional changes in these asset valuations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 310,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "\nThe net carrying amount of Acquired Franchise Rights fell from **$626 million in 2023 to $598 million in 2024**, a **$28 million decrease**. This reduction is reflected in the company’s amortization expense, which slipped only slightly from **$75 million in 2023 to $74 million in 2024**.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the net carrying amount of Acquired Franchise Rights decreased from $626 million in 2023 to $598 million in 2024, resulting in a $28 million decrease. The amortization expense figure of $74 million in 2024 is also correct. However, there is a discrepancy regarding the 2023 amortization expense. The LLM states it was $75 million in 2023, but the ground truth does not provide this comparative figure - it only mentions the $74 million in 2024. The LLM appears to have introduced an additional data point that wasn't in the original answer. The reasoning about the relationship between amortization expense and the decrease in net value is sound and logically presented. The LLM appropriately converted the numbers to millions format for clarity. The multi-hop synthesis is adequate - connecting the decrease in franchise rights value to the amortization expense. The main weakness is the introduction of the $75 million 2023 figure without verification against the ground truth, which slightly undermines the quantitative accuracy despite the core answer being correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 319,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "\nThe $775 million (≈8%) rise in Aeronautics‑segment service costs in 2023 was driven largely by higher F‑35 sustainment activity, which added about **$570 million** of the increase.  At the same time, service sales grew $788 million (≈7%), with roughly **$600 million** of that gain coming from the same F‑35 sustainment contracts.  Thus, the cost increase from those contracts was slightly smaller than the revenue increase ($570 M vs. $600 M).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates sound multi-hop reasoning. Strengths: (1) Correctly identifies the $570 million F-35 sustainment cost increase at Aeronautics, (2) Correctly identifies the $600 million corresponding sales increase, (3) Correctly calculates and notes the $30 million difference ($600M - $570M), (4) Properly synthesizes the comparison showing costs were slightly lower than revenue gains, (5) Correctly contextualizes these figures within the overall $775 million cost increase and service sales growth. Minor discrepancy: The LLM states service sales grew $788 million (≈7%), while the ground truth indicates $600 million of a larger sales increase. The ground truth doesn't explicitly state total service sales growth, but the LLM's figure of $788 million appears to be additional information not contradicted by the ground truth. The core answer about the $570M cost increase, $600M sales increase, and their $30M difference is accurate. The reasoning is sound - correctly identifying that the cost increase was less than the sales increase suggests margin improvement. The answer addresses all parts of the multi-part question: (1) the amount of cost increase ($570M), (2) its proportion of overall increase (majority of $775M), (3) the corresponding sales increase ($600M), and (4) the comparison between them. The semantic meaning matches the ground truth well, with only minor variations in presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 406,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "\nAs of September 25 2024, Accenture plc had **$6.694 billion ( $6,694 million )** of remaining share‑repurchase authority—$2.694 billion that was already authorized plus an additional $4 billion approved on that date. This large, pre‑approved reserve shows that the company is deliberately allocating capital to buy back its Class A ordinary shares, using repurchases as a core element of its financial strategy to return cash to shareholders and support the share price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $6,694 million ($6.694 billion) total authority, $2,694 million pre-existing, $4,000 million ($4 billion) newly approved on September 25, 2024. The arithmetic is sound: $2,694M + $4,000M = $6,694M. Date is correct (September 25, 2024). COMPLETENESS: The answer addresses both parts of the question - the total repurchase authority amount and how it reflects the company's financial strategy. ENTITY ACCURACY: Correctly identifies Accenture plc and Class A Ordinary Shares. REASONING: The multi-hop synthesis is sound - the model correctly connects the authorization components to the overall strategy of equity management and shareholder returns. SEMANTIC EQUIVALENCE: The LLM provides additional context about the strategic purpose (returning cash to shareholders, supporting share price) which enhances understanding without contradicting the ground truth. The only minor difference is that the LLM uses slightly different phrasing ('deliberately allocating capital,' 'core element') compared to the ground truth's 'actively manage its equity structure,' but these convey equivalent strategic intent. The presentation with both billion and million formats ($6.694 billion / $6,694 million) is helpful for clarity. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 377,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "\nA shortfall in membership growth would leave Netflix with insufficient revenue to offset the largely fixed costs of acquiring and producing the live‑programming and other content it has already committed to. Because those content expenses cannot be quickly reduced and price increases could be unpopular, the company’s margins, cash‑flow flexibility and overall profitability would be pressured, forcing it to rely on cash reserves or debt to bridge the gap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify the core issue: Netflix's fixed content costs (particularly from live programming expansion) create financial inflexibility when membership growth falls short. The LLM answer effectively synthesizes the multi-hop reasoning by: (1) identifying the fixed cost structure of content acquisition and production, (2) explaining why these costs cannot be quickly adjusted, (3) noting that price increases are constrained by market factors, and (4) concluding that this creates pressure on margins, cash flow, and profitability. The LLM answer adds valuable detail by explicitly mentioning the potential need to rely on cash reserves or debt, which represents a logical extension of the ground truth's discussion of 'financial flexibility.' No quantitative data is present in either answer (no specific dollar amounts, percentages, or dates to verify), so quantitative accuracy is perfect by default. The reasoning is sound and the semantic meaning matches the ground truth precisely. The only minor distinction is that the LLM answer provides slightly more operational detail (mentioning price increase constraints and potential financing solutions) while the ground truth is more concise, but this represents enhancement rather than deviation. All key concepts are correctly identified: fixed costs, membership growth expectations, margin pressure, liquidity concerns, and profitability impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 412,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "\nThe 5.15 % 2041 Notes carried a value of **$729 million**, which is about **2.2 %** of AMGN’s total debt carrying amount of **$33.3 billion** (as reported in 2022). In the 2020 debt‑exchange, **$245 million** of principal of these notes was tendered and cancelled.  \n\n*(Carrying value from page 130; exchange amount from page 132.)*",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Verification of key facts: (1) Carrying value of 5.15% 2041 Notes: $729 million - CORRECT (matches ground truth exactly); (2) Total debt carrying value: $33.3 billion vs. ground truth $33,309 million - CORRECT (format variation, semantically equivalent); (3) Percentage calculation: 2.2% vs. ground truth 2.19% - CORRECT (appropriate rounding, 729/33,309 = 2.187% rounds to 2.2%); (4) Principal exchanged: $245 million - CORRECT (matches ground truth exactly). Multi-hop synthesis is sound: the answer correctly combines information about the specific note's carrying value, total debt, calculates the percentage relationship, and identifies the exchange amount. The LLM properly identified all three required data points (carrying value, percentage, and exchange principal). Minor note: The LLM specifies this was a \"2020 debt-exchange\" while the ground truth doesn't specify the year of the exchange - this is a reasonable contextual addition that doesn't contradict the ground truth. The citation references (pages 130 and 132) add credibility. All entity identifications are correct (AMGN, 2022 fiscal year, 5.15% 2041 Notes). The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 358,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "\nWhen McDonald’s acquires a franchised restaurant it records the excess of cost over net tangible assets as goodwill and assigns it to the reporting unit that will benefit from the acquisition. If a Company‑operated restaurant is sold **within 24 months** of being acquired, the entire amount of goodw ill recorded for that restaurant is written off in that period. If the sale occurs **more than 24 months after acquisition**, only a portion of the goodwill is written off—specifically the amount that corresponds to the relative fair value of the sold business compared with the overall reporting unit. This treatment is disclosed in the company’s “Goodwill” accounting policy (page 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies the two distinct scenarios: (a) within 24 months = entire goodwill written off, and (b) beyond 24 months = proportional goodwill write-off based on relative fair value. The distinction between 'within 24 months' and 'beyond 24 months' (or 'more than 24 months') is semantically equivalent and correctly stated. (2) QUANTITATIVE ACCURACY: All numeric references are correct - the 24-month threshold is accurately stated in both scenarios. No calculations are required for this conceptual question, and no dollar amounts are involved. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes: (a) the acquisition process and goodwill recording, (b) the distinction between Company-operated vs franchised restaurants, (c) the time-based trigger (24 months), and (d) the different accounting treatments based on timing. The explanation of 'relative fair value of the sold business compared with the overall reporting unit' matches the ground truth's 'relative fair value of the business sold compared to the reporting unit.' (4) ENTITY ACCURACY: McDonald's is correctly identified; the accounting policy reference (page 43) adds helpful specificity. (5) SEMANTIC EQUIVALENCE: The phrasing 'more than 24 months after acquisition' is semantically equivalent to 'beyond 24 months from acquisition.' The answer maintains complete fidelity to the original while being clearly written. Minor note: The LLM adds a reference to page 43, which provides additional context not in the ground truth but does not contradict it. This is a minor enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 476,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "\nAIG recorded **$601 million of equity‑method income from Corebridge** for the period after the deconsolidation date (June 10 through December 31 2024). This amount was calculated as the sum of dividends received plus the change in the fair‑value of AIG’s retained Corebridge shares (i.e., the stock‑price movement) during that post‑deconsolidation interval.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($601 million) and correctly identifies the calculation methodology (dividends received plus change in fair value of retained shares), which aligns with the ground truth explanation. However, there is a critical date discrepancy: the LLM states the deconsolidation date as June 10, 2024, while the ground truth specifies June 9, 2024. This is a factual error on a key date. The LLM correctly identifies AIG's retained ownership stake concept and the post-deconsolidation period (through December 31, 2024). The calculation methodology is accurately described - the sum of dividends and stock price appreciation during the post-deconsolidation period. The ground truth does not provide the specific $601 million figure, only describing how the income was calculated, so the LLM's inclusion of this specific number cannot be verified against the ground truth but appears to be a reasonable addition of concrete data. The reasoning is sound and multi-hop synthesis is appropriate (combining deconsolidation event, ownership stake, and post-deconsolidation financial performance). The one-day date error (June 10 vs June 9) is a material factual mistake that reduces confidence in the answer's precision, though the overall substance and methodology explanation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 368,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "\nFranchise‑owned restaurants account for roughly 93 % of McDonald’s worldwide workforce (about two million employees versus roughly 150,000 corporate staff).  To shift this composition, the company runs a recruitment program that lowers the upfront equity hurdle and offers ongoing training for aspiring franchisees from under‑represented backgrounds, thereby increasing the share of diverse owners and the workers they employ.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All numbers are correct - the 93% franchisee workforce contribution is accurate, the ~2 million franchised restaurant employees figure is correct, and the ~150,000 company employees figure is correct. The percentages and workforce composition data match the ground truth exactly. (2) COMPLETENESS: The answer addresses both sub-questions: (a) the percentage contribution of franchisees to global workforce (93%), and (b) how the recruitment initiative aims to influence demographic composition. Both aspects are covered comprehensively. (3) ENTITY ACCURACY: McDonald's is correctly identified, the franchisee/corporate employee distinction is properly maintained, and the underrepresented groups targeting is accurately referenced. (4) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between franchisee workforce contribution and the diversity recruitment program's impact on demographic composition. The logic connecting the large franchisee workforce percentage to why diversity initiatives matter is sound. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording ('franchise-owned restaurants' vs 'franchisees,' 'upfront equity hurdle' vs 'upfront equity requirements,' 'ongoing training' vs 'ongoing learning and development') but conveys identical meaning. The phrase 'thereby increasing the share of diverse owners and the workers they employ' effectively captures the intended impact. Minor note: The LLM uses 'roughly' and 'roughly' for the percentages and numbers, which is appropriate given these are approximations in the source material. The answer is concise, accurate, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 483,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "\nThe $100 million unfavorable profit adjustment recorded on the Canadian Maritime Helicopter Program, together with the reduced Black Hawk production volume, trimmed RMS’s 2023 operating profit by roughly $41 million.  At the same time, Sikorsky programs generated the bulk of the backlog growth—higher Sikorsky orders lifted backlog to $37.7 billion—so the same Sikorsky segment that depressed current‑year profit helped increase the overall backlog.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial impacts and demonstrates sound multi-hop reasoning. STRENGTHS: (1) Accurately cites the $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program; (2) Correctly identifies the lower Black Hawk production volume as a negative factor; (3) Properly synthesizes that these factors collectively caused a $41 million decrease in RMS operating profit; (4) Makes the correct comparison showing that despite profit decline, Sikorsky programs drove backlog growth; (5) Provides specific backlog figure of $37.7 billion, demonstrating detailed knowledge. WEAKNESSES: (1) The answer omits the $65 million favorable adjustment from IWSS programs and increased Aegis volume that partially offset the negative impacts - this is a material omission from the ground truth that explains how the $100M+ negative impact resulted in only a $41M net decrease; (2) Does not explicitly mention IWSS programs' contribution to the overall RMS operating profit picture; (3) The phrasing 'trimmed RMS's 2023 operating profit by roughly $41 million' is slightly ambiguous - it could be read as the two factors alone caused $41M decline, when actually the net effect was $41M after offsets. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple dimensions (profit adjustments, production volumes, backlog impacts) and makes the appropriate comparison between current-year profit impact and future backlog contribution. The logic is sound that the same segment (Sikorsky) created both challenges and opportunities. QUANTITATIVE VERIFICATION: The $100M figure, $41M net decrease, and $37.7B backlog are all accurate. No calculation errors detected. The omission of the $65M favorable adjustment is a factual gap rather than an error in stated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 496,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "\nBroadcom completed the VMware acquisition in a cash‑and‑stock transaction valued at roughly **$53 billion** (approximately $30.8 billion in cash plus about 544 million Broadcom shares, which had a fair‑value of $53.4 billion).  The deal was pursued specifically to **expand Broadcom’s infrastructure‑software portfolio** by adding VMware’s multi‑cloud platform and related software assets, thereby advancing Broadcom’s strategic focus on delivering a comprehensive suite of infrastructure and security software that modernizes, optimizes and secures complex hybrid‑cloud environments.  (Page 58)",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Problem): The LLM states the total acquisition value as 'roughly $53 billion' which is INCORRECT. The ground truth clearly states the total value was $84,186 million ($84.186 billion). The LLM appears to have confused the stock portion ($53.398 billion) with the total deal value. While the LLM correctly identifies $30.8 billion in cash and ~$53.4 billion in stock, it fails to properly sum these to the correct total of ~$84.2 billion. This is a significant calculation error. The LLM does correctly identify the components (cash and stock portions with approximate values), but the headline total is materially wrong by approximately $31 billion. QUALITATIVE ACCURACY: The LLM correctly addresses the strategic alignment aspect of the question, explaining how the acquisition enhances Broadcom's infrastructure-software portfolio, multi-cloud capabilities, and focus on hybrid-cloud environments. The reasoning about strategic fit is sound and well-articulated. COMPLETENESS: The answer addresses both parts of the multi-part question (acquisition value and strategic alignment), though the first part contains a critical numerical error. ENTITY ACCURACY: All entities are correctly identified (Broadcom, VMware, infrastructure software). SEMANTIC EQUIVALENCE: While the qualitative discussion of strategic alignment is semantically equivalent to the ground truth, the quantitative mismatch on the total deal value is a fundamental factual error that cannot be overlooked, as financial accuracy is critical in SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 431,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "\nThe $6.99 ad‑supported tier is a lower‑priced entry point that pulls in price‑sensitive households that would otherwise stay outside Netflix’s paid base, so its rollout helped drive the 18 % year‑over‑year jump in global paid memberships reported by the company.  This growth in subscriber count (paid net additions rose to 9,497 in 2024 versus 5,832 in 2023, see p. 48) reflects Netflix’s stated strategy of expanding market penetration while keeping overall ARPU stable—using the cheaper tier to broaden the audience and then preserving higher‑margin plans for existing users.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship between the $6.99 ad-supported tier and subscriber growth, and appropriately addresses the ARPU/market penetration tradeoff strategy. However, there are significant quantitative accuracy issues that undermine the response. The LLM cites specific paid net additions figures (9,497 in 2024 vs 5,832 in 2023) with a page reference, but these numbers cannot be verified against the ground truth knowledge graph and appear to be in thousands (suggesting 9.497M vs 5.832M subscribers), which would represent a 63% increase, not the 18% year-over-year increase in global paid memberships mentioned in the question. This is a critical discrepancy. The LLM also states the strategy aims to keep 'overall ARPU stable,' which contradicts the ground truth's explicit statement that Netflix accepted 'lower ARPU' as a tradeoff for broader market penetration—these are opposite characterizations. The qualitative reasoning about price-sensitive consumers and market penetration is sound and well-articulated, and the answer appropriately synthesizes the multi-hop relationship between pricing strategy, subscriber growth, and ARPU considerations. The contextual relevance is strong as it directly addresses all components of the question. However, the quantitative errors (unverifiable/potentially incorrect net additions figures and the ARPU characterization) represent material factual problems that prevent a higher score despite good overall reasoning quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 416,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "\nMcDonald’s global workforce comprises roughly 150,000 company‑owned employees plus over 2 million people who work at franchised restaurants, for a total of **about 2.15 million individuals** worldwide. These employees bring the company’s purpose — “to feed and foster communities” — and its mission — “to make delicious, feel‑good moments easy for everyone” — to life by operating the restaurants that serve customers, uphold the brand’s core values, and drive the inclusive, community‑focused culture that underpins McDonald’s system‑wide success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 150,000 company employees, over 2 million franchised workers, and total of approximately 2.15 million (which matches 2,150,000 from ground truth). The calculation is accurate: 150,000 + 2,000,000+ = 2,150,000+. Number format variation (2.15 million vs 2,150,000) is acceptable and semantically equivalent. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total workforce numbers with breakdown by company-owned vs franchised, and (2) how this workforce contributes to purpose/mission. ENTITY ACCURACY: McDonald's is correctly identified, workforce categories are properly distinguished, and the stated purpose and mission are accurately quoted. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by connecting workforce numbers to the company's stated purpose ('feed and foster communities') and mission ('make delicious, feel-good moments easy for everyone'). The explanation of how employees 'bring to life' these statements through operations is logical and well-reasoned. MINOR CONSIDERATIONS: The LLM uses slightly more interpretive language ('bring the company's purpose to life,' 'uphold the brand's core values,' 'drive the inclusive, community-focused culture') compared to the ground truth's more direct statement that the workforce 'contributes to' the purpose/mission. However, this represents enhanced contextual relevance rather than inaccuracy. The core factual content is entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 433,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "\nThe VMware transaction was valued at roughly **$53.4 billion** in fair‑value terms (the cash‑and‑stock consideration of about $30.8 billion plus the $22.6 billion fair‑value of the shares issued).  By acquiring VMware, Broadcom adds a leading multi‑cloud and virtualization platform to its portfolio, significantly expanding and strengthening its **infrastructure‑software capabilities** and broadening its addressable market in enterprise cloud, workload‑automation and security software.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant mathematical and factual errors regarding the acquisition value. Ground truth states total fair value was $84,186 million ($84.186 billion), comprised of $30,788 million cash + $53,398 million stock. The LLM incorrectly states the value as $53.4 billion and breaks it down as '$30.8 billion plus $22.6 billion' which sums to only $53.4 billion - a major discrepancy of approximately $30.8 billion from the correct total. The LLM appears to have confused or miscalculated the stock component ($53.398B vs $22.6B stated). QUALITATIVE ASSESSMENT: The LLM correctly identifies that the acquisition enhances Broadcom's infrastructure software capabilities and mentions multi-cloud/virtualization platforms, enterprise cloud, and workload automation - these align with the ground truth's description of 'multi-cloud services enabling digital innovation with enterprise control.' However, the fundamental quantitative errors severely undermine the answer's credibility. The LLM's reasoning about strategic benefits is sound but cannot compensate for the $30+ billion valuation error. MULTI-HOP SYNTHESIS: The answer does attempt to synthesize the acquisition value components and strategic rationale, but fails on the numerical synthesis. The calculation error suggests the LLM either misread source data or performed incorrect arithmetic when combining cash and stock components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 400,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "\nNetflix’s 2024 10‑K notes that it periodically adjusts the prices of its tiered membership plans—including the newer, lower‑priced ad‑supported option—to keep pace with content costs and inflation, but it also warns that any price change can trigger cancellations when households are under macro‑economic strain. Because the filing explicitly links “adverse macroeconomic conditions, including inflation” to a heightened risk of member churn, the company’s willingness to raise fees or introduce higher‑priced tiers may conflict with its need to retain existing subscribers who are increasingly price‑sensitive. Consequently, while pricing flexibility supports revenue growth, it also creates a tension between boosting per‑membership revenue and preserving the subscriber base amid rising economic pressure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core conflict between Netflix's pricing strategy and member retention amid macroeconomic pressures. The qualitative reasoning is sound and well-articulated, correctly identifying the tension between revenue growth and subscriber preservation.\n\nSTRENGTHS:\n- Correctly identifies the fundamental conflict: pricing adjustments vs. member retention during economic strain\n- Accurately references the 2024 10-K and macroeconomic conditions (inflation, adverse conditions)\n- Properly synthesizes multi-hop information: pricing strategy + macroeconomic pressures = retention risk\n- Good contextual framing of the ad-supported tier and price sensitivity\n- Logical reasoning about fixed content costs and revenue implications\n\nWEAKNESSES:\n- The LLM states membership plans are priced \"between $1 and $32 per month\" in the original answer, but the LLM response does not cite specific price points. While the LLM mentions \"tiered membership plans\" and \"lower-priced ad-supported option,\" it lacks the concrete pricing range ($1-$32) that grounds the answer in specific 10-K data.\n- The LLM does not explicitly state the December 31, 2024 date reference, though this is a minor omission\n- The LLM adds interpretive language about \"newer, lower-priced ad-supported option\" which, while contextually relevant, goes slightly beyond what the original answer explicitly states\n\nQUANTITATIVE ACCURACY ASSESSMENT:\n- No specific dollar amounts or percentages are provided in either answer, which is appropriate for this qualitative question\n- The original answer references the $1-$32 price range; the LLM answer does not include this specific quantitative detail\n- This represents a gap in quantitative grounding (score: 6/10)\n\nQUALITATIVE ACCURACY:\n- Both answers correctly identify the core conflict\n- Both properly reference macroeconomic conditions and inflation\n- Both understand the fixed cost structure of content\n- The LLM's reasoning about per-membership revenue vs. subscriber base is sound and adds nuance\n- Multi-hop synthesis is correct in both cases (score: 8/10)\n\nCONTEXTUAL RELEVANCE:\n- Directly addresses the question about pricing strategy conflicts\n- Appropriately references the 2024 10-K filing\n- Maintains focus on the specific tension asked about\n- Well-contextualized within Netflix's business model (score: 9/10)\n\nOVERALL: The LLM answer is substantively correct and demonstrates solid reasoning, but loses points for not including the specific pricing range ($1-$32) that appears in the original answer and would strengthen the quantitative grounding of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 706,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "\nMcDonald’s goodwill for acquired restaurants is valued with a discounted‑cash‑flow (Level 3) model that assumes the franchisee’s future cash flows will cover the purchase price; if franchisee performance weakens, those cash‑flow forecasts fall and the company must test the reporting unit for impairment, potentially writing down or eliminating the goodwill. In addition, any restaurant sold within 24 months of acquisition forces a full write‑off of its goodwill (and sales thereafter remove goodwill based on relative fair value), so the financial exposure of franchisee performance directly drives the timing and amount of goodwill adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the complex multi-hop question about McDonald's goodwill accounting in relation to franchisee performance. STRENGTHS: (1) All numeric values and timeframes are correct - the 24-month threshold for full goodwill write-off is accurately stated, and the relative fair value methodology for sales after 24 months is correctly described. (2) The multi-hop reasoning is sound: the answer correctly synthesizes the connection between franchisee performance → cash flow forecasts → goodwill valuation → impairment testing → write-offs. (3) The DCF (Level 3) valuation methodology is correctly identified and explained as the basis for goodwill assignment. (4) The answer accurately captures the dual mechanisms affecting goodwill: impairment testing when performance weakens AND the mechanical write-off rules based on timing of sale. (5) Entity identification is correct (McDonald's, franchisees, restaurants, goodwill). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention that franchisees contribute through rent and royalties as a revenue driver, though this is somewhat tangential to the core goodwill accounting question. The ground truth provides slightly more context about the broader franchise business model impact, but the LLM answer focuses more directly on the goodwill mechanics themselves. The LLM's mention of impairment testing as a consequence of weakened performance is a valuable addition that enhances the answer's completeness. All key facts align: the 24-month rule, the relative fair value approach, the DCF methodology, and the causal link between franchisee performance and goodwill adjustments are all correctly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 483,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "\nLockheed Martin’s hypersonics efforts are a core part of the Space segment’s push to deliver next‑generation strike and missile‑defense capabilities that embody the company’s 21st‑Century Security vision of integrated, open‑architecture systems and advanced networking.  These programs are classified growth drivers that are slated to move into early‑production phases through 2026, expanding the Space portfolio with high‑value contracts and reinforcing the segment’s strategic priorities of technology leadership, strategic partnerships and new program awards—thereby fueling the anticipated revenue and earnings growth for the Space business up to 2026.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that hypersonics programs are part of the Space segment's strategic priorities and mentions the transition to early-production phases through 2026, which aligns with the ground truth. The timeframe (through 2026) is accurate. The answer appropriately connects hypersonics to growth objectives and mentions strategic priorities.\n\nWEAKNESSES: (1) The LLM answer introduces concepts not explicitly supported by the ground truth, such as '21st-Century Security vision,' 'integrated, open-architecture systems,' 'advanced networking,' and 'strategic partnerships' - these appear to be inferred or from different sections rather than directly tied to hypersonics programs in the Space segment. (2) The ground truth explicitly states hypersonics programs involve 'U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons' - the LLM answer generalizes this to 'strike and missile-defense capabilities' without the specific military branch context. (3) The ground truth identifies four key growth areas (hypersonics, current programs of record, classified programs, and new awards) - the LLM answer mentions only 'classified growth drivers' and 'new program awards' without the complete framework. (4) The LLM answer uses vague language like 'classified growth drivers' and 'high-value contracts' without specific program details mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between hypersonics programs and Space segment growth through 2026, but the reasoning relies on inferred strategic language rather than the explicit program details and growth framework provided in the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is based on the correct identification of the 2026 timeframe and the general accuracy of program characterization. The LLM does not contradict any specific numbers but also doesn't provide the comprehensive program context from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 561,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "\nBroadcom estimates the economic benefit of the VMware Cloud Foundation‑related developed technology by projecting the cash flows that the technology is expected to generate and then discounting those cash flows to present value—i.e., a multi‑period excess‑earnings (income‑approach) valuation that isolates the technology’s contribution after accounting for the return to other assets.  The resulting fair‑value amount ($24.2 billion) is assigned an 8‑year weighted‑average amortization period, reflecting the anticipated long‑term financial contribution of the developed technology.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-part question about Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology. (1) CORRECTNESS OF CORE METHODOLOGY: The LLM correctly identifies the 'multi-period excess earnings method' under the 'income approach' as the valuation technique used, which matches the ground truth exactly. The explanation of how this method works—projecting cash flows, discounting to present value, and isolating the technology's contribution after accounting for other assets—is semantically equivalent to and consistent with the ground truth description. (2) QUANTITATIVE ACCURACY: The LLM provides a specific fair value amount ($24.2 billion) and an 8-year weighted-average amortization period. While the ground truth does not explicitly mention these specific numbers, they represent additional factual details that enhance the answer without contradicting the ground truth. The numbers appear reasonable and specific to the filing context. (3) COMPLETENESS: The LLM answer addresses both parts of the original question: (a) how the valuation methodology reflects projected financial contribution, and (b) what specific technique was used. The answer explains the economic useful life determination concept implicitly through the 8-year amortization period, which relates to the ground truth's mention of 'economic useful life...based on the technology cycle and forecasted cash flows.' (4) MULTI-HOP REASONING: The answer successfully synthesizes the connection between the valuation method, the cash flow projections, the present value calculation, and the resulting amortization period—demonstrating proper multi-hop reasoning across the valuation framework. (5) MINOR CONSIDERATIONS: The LLM adds specific quantitative details ($24.2 billion, 8-year period) not explicitly mentioned in the ground truth, but these appear to be accurate supplementary information from the filing rather than errors. The wording differs slightly but conveys the same technical and financial concepts. No calculation errors are present, and all entities (Broadcom, VMware Cloud Foundation, developed technology) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 595,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "\nThe 2021 Corporate and Other segment recorded lower operating expenses than 2020 mainly because the company had realized pandemic‑related cost savings, but a portion of those savings was being directed toward the rollout of Sky Glass (and the related hardware sales) and the launch of XClass TV. Management explicitly expected that 2022 would bring higher expenses tied to the continued launch of Sky Glass and XClass TV as part of its strategic investment in these smart‑TV initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses both parts of the multi-part question effectively. (1) CORRECTNESS: The answer accurately identifies that Sky Glass launch contributed to increased costs in the Corporate and Other segment in 2021, and correctly notes the strategic expectation of continued costs in 2022. The semantic meaning aligns well with the ground truth. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either the original answer or the LLM response, so this dimension scores perfectly. The answer correctly references 2021 and 2022 as the relevant time periods. (3) QUALITATIVE ACCURACY: The LLM answer provides slightly more context than the ground truth by explaining that pandemic-related cost savings were being redirected toward Sky Glass and XClass TV rollout, which adds helpful context without contradicting the ground truth. The multi-hop reasoning is sound - it connects the 2021 expense impact to the 2022 strategic expectations. (4) ENTITY ACCURACY: Correctly identifies Comcast, the Corporate and Other segment, Sky Glass, and XClass TV. (5) MINOR GAPS: The ground truth uses the phrase 'costs related to Sky Glass and XClass TV' while the LLM says 'higher expenses tied to the continued launch of Sky Glass and XClass TV' - these are semantically equivalent. The LLM adds the detail about 'hardware sales' which is reasonable inference but not explicitly stated in the ground truth. Overall, the answer demonstrates solid multi-hop synthesis across the 2021-2022 period and correctly captures both the 2021 impact and 2022 expectations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 443,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "\nMcDonald’s assigns goodwill to the reporting unit based on a discounted‑cash‑flow valuation of the franchise restaurants it acquires; under its policy, any company‑operated restaurant sold ≤ 24 months after acquisition triggers a full write‑off of the goodwill recorded for that purchase, while sales > 24 months result in a goodwill write‑off limited to the portion of goodwill proportional to the relative fair value of the sold business. Consequently, quick resales generate non‑cash goodwill charges that can materially reduce earnings in the period of sale, whereas later sales only partially affect goodwill and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about McDonald's goodwill treatment. STRENGTHS: (1) All key numeric thresholds are correct - the 24-month cutoff is accurately stated with proper mathematical notation (≤ 24 months vs > 24 months), matching the ground truth exactly. (2) The valuation methodology is correctly identified as discounted cash flow (DCF), with appropriate reference to Level 3 inputs implied through the technical description. (3) The goodwill write-off policy is accurately synthesized: full write-off for sales within 24 months, proportional write-off for sales beyond 24 months based on relative fair value. (4) The financial implications are clearly articulated - the answer explains both the timing effect (quick resales vs. later sales) and the earnings impact (non-cash charges reducing earnings). (5) Multi-hop reasoning is sound: the answer correctly connects valuation methodology → goodwill assignment → write-off policy → financial consequences. (6) Entity accuracy is perfect - McDonald's is correctly identified with ticker MCD, and all financial concepts are properly named. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language ('≤' and '>' notation, 'non-cash goodwill charges') compared to the ground truth's more narrative style, but this represents enhanced clarity rather than inaccuracy. The phrase 'proportional to the relative fair value' in the LLM answer is semantically equivalent to the ground truth's 'based on the relative fair value of the business sold compared to the reporting unit.' The additional detail about 'non-cash charges that can materially reduce earnings' adds valuable context without contradicting the ground truth. No calculations are required for this question, so quantitative accuracy focuses on the correct statement of thresholds and policies, all of which are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 523,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "\nThe Boeing financing portfolio is heavily weighted toward a small group of customers and a few aircraft types—principally the 717 and 747‑8—so when the COVID‑19‑driven collapse in airline revenues produced $1.8 bn of defaults, those losses were concentrated in the same customers and airplane models that make up the bulk of the portfolio. Because the company cannot easily re‑deploy or sell those niche jets, any additional defaults or a further decline in demand would disproportionately hit earnings, force additional write‑downs of lease assets, and strain liquidity, thereby compounding the financial vulnerability created by the pandemic‑related defaults.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The $1.8 billion portfolio default figure is correctly cited and properly contextualized. No calculation errors or numeric inaccuracies are present. ENTITY ACCURACY: Boeing, 717 and 747-8 aircraft types, and COVID-19 pandemic are all correctly identified and referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three interconnected risk factors: (1) concentration risk in specific aircraft types and customer base, (2) COVID-19 pandemic impact on airline revenues/cash flows, and (3) the resulting $1.8 billion in defaults. The causal chain is logically sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys all essential information from the ground truth while using more specific and vivid language ('niche jets,' 'cannot easily re-deploy or sell,' 'force additional write-downs of lease assets'). These additions enhance clarity without contradicting the ground truth. COMPLETENESS: The answer addresses all aspects of the compound risk question, explaining both the concentration mechanism and the pandemic-driven vulnerability. The LLM goes slightly beyond the ground truth by explicitly mentioning potential consequences (write-downs, liquidity strain), which adds valuable context without introducing inaccuracy. MINOR OBSERVATION: The ground truth uses 'material adverse effects' as a concluding phrase, while the LLM uses 'compounding financial vulnerability' and specific operational impacts. Both convey equivalent meaning regarding the severity of the risk. No factual errors, omissions of critical information, or logical flaws are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 467,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "\nThe Sky Glass launch added a modest but noticeable revenue bump—its television sales helped lift the Corporate & Other segment’s revenue 86 % to $461 million in 2021—while also creating new launch‑related expenses (hardware cost of sales, marketing and other implementation costs) that appeared in the segment’s operating‑cost line.  Those added costs were largely offset by the disappearance of the prior‑year COVID‑related severance expenses, so the segment’s Adjusted EBITDA improved from a $1.785 billion loss in 2020 to a $1.358 billion loss in 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific numbers and calculations that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) The LLM cites an 86% revenue increase to $461 million for the Corporate and Other segment in 2021 - these specific figures are not provided in the ground truth and cannot be independently verified from the question context. (2) The LLM provides precise EBITDA figures ($1.785 billion loss in 2020 declining to $1.358 billion loss in 2021) that are not mentioned in the ground truth answer. (3) The ground truth explicitly states the impact was 'dual' - both revenue generation AND cost investment - but does not quantify these effects or provide the specific dollar amounts the LLM claims. (4) The LLM's reasoning about COVID-related severance expenses offsetting launch costs is not mentioned in the ground truth. (5) While the LLM correctly identifies that Sky Glass launched in Q4 2021 and affected the Corporate and Other segment with both revenue and cost impacts, it goes far beyond what the ground truth supports by inventing specific financial metrics. The answer demonstrates reasonable understanding of the question's intent (multi-hop synthesis of product launch impact on segment financials) but fails on factual accuracy by presenting unverified numbers as fact. The ground truth answer is deliberately general, acknowledging the dual impact without specific quantification, suggesting the LLM may have hallucinated these figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 414,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "\nThe Company held commercial mortgage‑backed securities with a total fair value of **$675 million** as of December 31, 2023.  The unrealized loss associated with this category was **$100 million**, which represents roughly **12 %** of the overall unrealized loss on the entire debt‑securities portfolio ($836 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Fair value of commercial mortgage-backed securities: $675 million - CORRECT; (2) Unrealized loss amount: $100 million - CORRECT; (3) Percentage calculation: 12% ($100M / $836M = 11.96%, rounds to 12%) - CORRECT; (4) Total unrealized losses across debt securities: $836 million - CORRECT. The answer addresses all parts of the multi-part question: it identifies the fair value, quantifies the unrealized loss, and provides the comparative context showing how this loss represents 12% of total debt securities portfolio losses. The multi-hop reasoning is sound - the model correctly synthesized information about CVS's commercial mortgage-backed securities holdings and their relationship to the broader debt securities portfolio. The company identification (CVS) and fiscal year (December 31, 2023) are correct. The wording is clear and professional, with appropriate use of formatting (bold for key numbers). No omissions, errors, or ambiguities detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 308,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "\nThe Deferred Compensation Plan has 1,853,363 shares remaining for future issuance, whereas the Non‑Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining. Their difference is 1,712,810 shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The answer correctly identifies the two plans (Deferred Compensation Plan and Non-Qualified Deferred Compensation Plan for Independent Contractors) at Wells Fargo for 2023. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct: Deferred Compensation Plan has 1,853,363 shares, Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares, and the difference is 1,712,810 shares. The calculation is accurate: 1,853,363 - 140,553 = 1,712,810. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two different compensation plans and correctly performs the comparative calculation required by the question. The model properly identified both plans, extracted the correct share counts, and computed the difference accurately. (4) ENTITY ACCURACY: All entities are correctly identified - Wells Fargo, the two specific compensation plans, the year 2023, and the metric (shares remaining available for future issuance). The answer directly matches the ground truth answer of 1,712,810 shares difference and provides additional supporting detail by showing the individual share counts for each plan, which enhances clarity without introducing any errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 369,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "\nPMI’s reduced‑risk product line is defined in the 2022 10‑K as comprising **heated‑tobacco (heat‑not‑burn) units, heat‑not‑burn devices and accessories, e‑vapor products and other oral‑nicotine products** (e.g., nicotine pouches). Heated‑tobacco units are explicitly counted within the “reduced‑risk products” category and contributed **about $9 billion of net revenue** in 2021, forming a core component of that classification.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the product categories in PMI's reduced-risk product line (heated-tobacco units, heat-not-burn devices and accessories, e-vapor products, and oral nicotine products), which matches the ground truth. The answer also correctly explains that heated tobacco units are a core component of this classification. However, there is a critical quantitative error: the LLM states that heated-tobacco units 'contributed about $9 billion of net revenue in 2021,' but the question specifically asks about the 2022 10-K filing. This introduces a temporal inconsistency - the LLM is citing 2021 revenue data when the filing being referenced is from 2022. The ground truth answer does not include specific revenue figures, suggesting this number may be accurate but is presented in the wrong temporal context relative to the question. The product category descriptions are semantically equivalent to the ground truth (e.g., 'heat-not-burn devices' = 'heat-not-burn devices,' 'oral-nicotine products' = 'oral nicotine products'). The multi-hop reasoning is sound in connecting heated tobacco units to the reduced-risk classification, but the inclusion of a specific revenue figure from 2021 when discussing a 2022 10-K creates ambiguity about whether this is the most current data. The answer is well-structured and addresses the core question about product categories and the role of heated tobacco units, but the quantitative element introduces uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 408,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "\nIn fiscal 2025 (year ended January 26, 2025), DirectCustomerA accounted for **12 %** of NVIDIA’s total revenue. In the prior fiscal year (fiscal 2024), the company did not list DirectCustomerA as a 10 %+ customer—its contribution was **less than 10 %** of revenue. Thus, the share rose from under 10 % to 12 % year‑over‑year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding fiscal 2024 data. Ground truth states that DirectCustomerA's contribution in FY2024 was 'not disclosed (marked as *)' - meaning the data was not available or reported. The LLM incorrectly infers that DirectCustomerA contributed 'less than 10%' in FY2024, which is a speculative interpretation not supported by the ground truth. The ground truth explicitly notes that 'a direct numerical comparison cannot be made' because FY2024 data was not disclosed. The LLM's statement that 'the share rose from under 10% to 12%' is therefore unsupported and contradicts the ground truth's finding that DirectCustomerA 'became a named top customer in 2025 after not being reported in 2024.' The FY2025 figure of 12% is correct, and the fiscal year dates are accurate. However, the core comparison requested in the question is mishandled - the LLM makes an assumption about prior year data rather than acknowledging that no prior year comparison is possible due to lack of disclosure. This represents a failure in multi-hop reasoning and semantic understanding of what 'not disclosed' means versus 'less than 10%'.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 329,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "\nThere is a single distinct Restricted Share Rights Award Agreement version that applies to grants on or after January 24, 2023, and another single distinct version that applies to grants on or after January 23, 2024. Thus, the counts are 1 for each date threshold.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The question asks for the total count of distinct versions across both date thresholds. The ground truth states there are TWO distinct versions total: (1) one for grants on or after January 24, 2023 (incorporated by reference), and (2) another for grants on or after January 23, 2024 (filed herewith). The correct answer to 'how many distinct versions' is 2. The LLM answer incorrectly states '1 for each date threshold' which, while technically identifying that there is one version per date, fails to answer the actual question being asked - the total count of distinct versions. The LLM also misses a critical distinction in the ground truth: the filing method differs between the two versions (one incorporated by reference vs. one filed herewith), which is an important contextual detail. The LLM's response demonstrates a misunderstanding of what the question is asking for - it appears to have interpreted the question as asking for counts per date threshold rather than the total number of distinct versions. This is a significant logical error in multi-hop reasoning and question interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 325,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "\nThe FAA‑approval delay left Boeing unable to predict when it could recognize revenue for undelivered 787s, so it treated a larger share of the program’s costs as cost of sales and recorded a reach‑forward loss that reflects the risk of additional customer considerations or contractual termination rights. This uncertainty drove the cost‑of‑sales ratio higher and compressed margin forecasts, with any further postponement of FAA clearance or invocation of termination rights likely to increase the loss and further erode profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core mechanism of how FAA approval uncertainty impacted Boeing's financial reporting: (1) inability to predict revenue recognition timing for undelivered 787s, (2) treatment of costs as cost of sales, (3) recording of reach-forward losses, (4) compression of margin forecasts, and (5) risks from contractual termination rights. The qualitative reasoning about the relationship between FAA delays and financial impact is sound and well-articulated. The answer demonstrates good understanding of the multi-hop synthesis required (FAA delays → revenue recognition uncertainty → cost of sales treatment → reach-forward loss → margin compression).\n\nWEAKNESSES: The LLM answer fails to include the specific quantitative data from the ground truth. The original answer explicitly states that '2021 cost of sales saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program.' This is a critical factual detail that should have been included to fully answer the question about impact on cost of sales. The LLM answer discusses the directional impact (cost-of-sales ratio higher, margins compressed) but provides no concrete numbers or year-over-year comparisons. Additionally, the LLM answer does not specify the time period (2021 vs 2020 comparison) that grounds the analysis.\n\nQUANTITATIVE ACCURACY ISSUE: The absence of the $4,574 million figure is a significant omission. While the LLM correctly describes the mechanism, it fails to provide the quantitative evidence that would substantiate the claim about impact. The answer is qualitatively correct but quantitatively incomplete.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between FAA delays and financial statement impacts, but the synthesis is incomplete without the specific financial metrics that demonstrate the magnitude of the impact.\n\nJUSTIFICATION: Score of 6 reflects that while the core reasoning and qualitative analysis are sound (7-8 range), the critical omission of specific financial figures and year-over-year comparisons prevents this from being a strong answer. A complete answer would have included the $4,574 million cost of sales decrease and the 2021 vs 2020 comparison period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 608,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "\nIn 2023, third‑party sellers were the main source of the 12 % increase in North America net sales and the 11 % increase in International net sales, supplying the additional unit volumes that drove growth alongside advertising and subscription services. Currency movements added roughly $88 million to International sales but, because of a stronger U.S. dollar, foreign‑exchange rates trimmed consolidated net sales by about $71 million, producing an overall headwind despite the tailwind in the International segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - North America sales increase of 12%, International sales increase of 11%, FX impact of -$71 million on North America, +$88 million on International, and the net positive impact of $17 million (implied by the statement about overall headwind despite International tailwind). The LLM correctly identifies the currency direction (stronger U.S. dollar causing headwind). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) third-party sellers' role in growth, (2) North America sales growth drivers, (3) International sales growth drivers, and (4) FX impact on both segments. ENTITY ACCURACY: All entities correctly identified (North America segment, International segment, third-party sellers, advertising, subscription services, foreign exchange). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - connecting third-party seller growth to segment performance, then layering in FX impacts, and finally assessing the net effect. The logic is sound: FX reduced consolidated sales by $71M but International benefited by $88M, creating a net positive of $17M. SEMANTIC EQUIVALENCE: The phrasing differs slightly from ground truth (e.g., 'produced an overall headwind despite the tailwind' vs. 'net positive impact of $17 million'), but the meaning is semantically equivalent and accurate. The LLM's characterization of the net effect as 'overall headwind' is slightly less direct than stating the $17M net positive, but this is a minor wording preference rather than a factual error. All critical financial metrics, percentages, and relationships are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 478,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "\nDeficiencies in Wells Fargo’s anti‑money‑laundering program would be scrutinized by the Federal Reserve Board (the primary regulator of bank‑holding companies) when it reviews any proposed bank‑acquisition application; the FRB must determine that the applicant is effectively combating money‑laundering before it can approve the transaction. Consequently, any perceived weakness in the AML program could delay, condition, or ultimately block the acquisition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the Federal Reserve Board (FRB) as the primary regulatory body assessing AML deficiencies during acquisition approval - this matches the ground truth. (2) Accurately conveys that AML program effectiveness is a prerequisite for acquisition approval. (3) Properly explains the constraint mechanism: deficiencies could delay, condition, or block acquisitions. (4) No quantitative errors present (no numbers to verify). (5) Multi-hop reasoning is sound: connects USA PATRIOT Act obligations → AML program requirements → FRB assessment → acquisition approval impact. MINOR WEAKNESSES: (1) The LLM answer specifies FRB as 'the primary regulator of bank-holding companies' which is accurate but slightly narrower than the ground truth's mention of 'the Federal Reserve Board (FRB), along with other federal banking regulators.' The ground truth acknowledges multiple regulators while the LLM focuses primarily on FRB. However, this is not incorrect since FRB is indeed the primary regulator for acquisition approval. (2) The ground truth explicitly mentions 'risks to financial integrity and national security under the provisions of the USA PATRIOT Act' as the rationale for potential denial, while the LLM answer doesn't explicitly reference these specific risk categories. This is a minor omission of contextual detail but doesn't affect the core correctness. (3) The LLM uses 'perceived weakness' which is slightly softer language than 'deficiencies' in the original question, though semantically equivalent. Overall, the answer demonstrates solid understanding of the regulatory framework and correctly synthesizes the multi-hop relationship between AML compliance, FRB oversight, and acquisition constraints.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 496,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "\nThe estimated international industry volume of cigarettes + heated‑tobacco units grew 2.4% in 2021 versus 2020. In PMI’s financial reporting, heated‑tobacco units are classified under the **Reduced‑risk products** category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question correctly. (1) QUANTITATIVE ACCURACY: The 2.4% increase figure is correct and matches the ground truth exactly. The percentage is properly formatted and the comparison period (2021 vs 2020) is accurate. (2) COMPLETENESS: Both sub-questions are addressed - the percentage increase is provided (2.4%) and the product category classification (Reduced-risk products) is identified. (3) ENTITY ACCURACY: PMI is correctly identified, the time periods (2021 vs 2020) are correct, and the metrics (international industry cigarette and heated tobacco unit volume) are properly referenced. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the volume growth metric with the product category classification from PMI's financial reporting structure. (5) SEMANTIC EQUIVALENCE: The LLM uses 'estimated international industry volume of cigarettes + heated-tobacco units' which is semantically equivalent to 'total international industry cigarette and heated tobacco unit volume.' The capitalization of 'Reduced-risk products' matches standard financial reporting terminology. Minor note: The LLM uses 'estimated' which adds slight nuance not explicitly in the ground truth, but this is not factually incorrect and may reflect actual filing language. Overall, the answer demonstrates accurate multi-hop reasoning across financial data and product categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 405,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "\nThe CCC‑rated portion of the portfolio is about $445 million; applying the 24.2 % default rate yields roughly $108 million of additional potential loss if all such receivables were to default. Thus, Boeing’s potential losses could increase by about $108 million under that scenario.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its correctness. (1) CRITICAL CALCULATION ERROR: The LLM states the CCC-rated portion is $445 million and applies 24.2% to get $108 million in potential losses. However, the ground truth answer indicates potential losses of $435.6 million. The correct calculation should be: $1.8 billion × 24.2% = $435.6 million (or if the CCC-rated portion is indeed $445M, then $445M × 24.2% ≈ $107.7M, which the LLM rounds to $108M). The discrepancy suggests the LLM either misidentified the CCC-rated portfolio size or misapplied the default rate. (2) MULTI-HOP REASONING FAILURE: The question asks about applying the 24.2% default rate to CCC-rated receivables within the $1.8 billion portfolio. The ground truth answer correctly synthesizes this as $1.8B × 24.2% = $435.6M. The LLM appears to have identified only a portion ($445M) of the portfolio as CCC-rated, which contradicts the ground truth interpretation that the entire $1.8B portfolio should be evaluated at the 24.2% rate for CCC-rated receivables. (3) MAGNITUDE ERROR: The LLM's answer of $108 million is off by a factor of approximately 4x compared to the ground truth of $435.6 million - this is not a minor rounding difference but a substantial quantitative error. (4) The LLM does correctly identify the 24.2% default rate and understands the basic concept of applying it, but fails in the critical execution of determining what portfolio amount to apply it to.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 413,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "\nIn fiscal year 2025 (ended January 26, 2025), DirectCustomer C accounted for **11 %** of NVIDIA’s total revenue. In the prior fiscal year (ended January 28, 2024) the same customer contributed **less than 10 %** of revenue. Thus, the share from DirectCustomer C increased from under 10 % to about 11 % year‑over‑year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a significant factual inaccuracy regarding the prior year percentage. Ground truth states DirectCustomerC represented 11% in BOTH fiscal years (FY2025 and FY2024), meaning the percentage was UNCHANGED. However, the LLM claims the prior year (FY2024) was 'less than 10%' and that there was an increase from 'under 10%' to 'about 11%' year-over-year. This is factually incorrect. The LLM correctly identified: (1) FY2025 ending date (January 26, 2025), (2) FY2024 ending date (January 28, 2024), (3) FY2025 percentage as 11%, and (4) the company as NVIDIA/NVDA. However, it fundamentally misrepresented the year-over-year comparison by stating an increase occurred when the ground truth shows no change. The LLM's conclusion that 'the share from DirectCustomer C increased from under 10% to about 11% year-over-year' directly contradicts the ground truth that the percentage remained at 11% in both years. This is a major quantitative error that undermines the core comparative analysis requested in the question. The answer addresses both parts of the multi-part question but provides incorrect data for the prior year comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 331,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "\nAs of December 31 2023, CVS Health’s Commercial Mortgage‑Backed Securities had a total fair value of **$675 million**.  The maturity‑based breakdown shows **unrealized losses of $100 million** on these CMBS, representing roughly 15 % of the portfolio’s fair‑value amount.  (Pages 150 & 149)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures: $675 million fair value and $100 million unrealized losses for CMBS as of December 31, 2023. The company (CVS Health Corporation) and date are accurate. However, there is a minor discrepancy in the percentage calculation. The ground truth states the unrealized losses represent 'approximately 14.8%' of total unrealized losses across all investment categories, while the LLM states 'roughly 15% of the portfolio's fair-value amount.' The LLM appears to have calculated the percentage differently (100/675 ≈ 14.8%, which would be 14.8% of fair value, not 15%). The stated 15% is close to 14.8% but represents a slight rounding difference. More importantly, the LLM's interpretation of what the percentage represents differs from the ground truth - the ground truth specifies it's a percentage of 'total unrealized losses across all investment categories' (a cross-category comparison), while the LLM states it's 'of the portfolio's fair-value amount' (an intra-category ratio). This represents a subtle but meaningful difference in the contextual interpretation of the comparison. The answer addresses both parts of the multi-part question (fair value and unrealized losses comparison) and correctly synthesizes the information. The citation references (Pages 150 & 149) add credibility. Overall, the core numerical facts are correct, but the contextual interpretation of the percentage comparison is not precisely aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 415,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "\nMetLife records the mark‑to‑market movements of its Unit‑linked and FVO securities directly in **net investment income** (see Note 1 – “changes in estimated fair value of Unit‑linked and FVO securities are included in net investment income”).  By contrast, **net derivative gains (losses)** capture only the fair‑value changes of the Company’s derivative contracts and embedded derivatives (and the lapse component associated with those derivatives); therefore, fluctuations in the Unit‑linked securities are excluded from that line and flow through net investment income instead.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core distinction between how Unit-linked securities are treated in net investment income versus net derivative gains (losses). The answer accurately states that: (1) mark-to-market movements of Unit-linked and FVO securities flow through net investment income, and (2) net derivative gains (losses) capture only derivative contracts and embedded derivatives. The answer provides appropriate context by referencing Note 1 and explaining the exclusion of Unit-linked securities from the derivative line item. However, there is a notable discrepancy with the ground truth: the LLM answer emphasizes that net derivative gains (losses) include 'the lapse component associated with those derivatives,' whereas the ground truth specifically states that 'lapses associated with net embedded derivatives' are included in net derivative gains (losses). The ground truth makes a more precise distinction by noting that lapses from embedded derivatives (which may arise from Unit-linked securities) are treated differently from the securities themselves. The LLM answer somewhat conflates the treatment by focusing on derivative lapses generally rather than specifically addressing how lapses from Unit-linked embedded derivatives are handled separately from the securities' fair value changes. The answer is semantically close to the ground truth but lacks the precise distinction about embedded derivative lapses that the ground truth emphasizes. No quantitative data is present in either answer, so quantitative accuracy is not applicable but scored as perfect since no numbers are involved. The multi-hop reasoning is sound in explaining the accounting treatment difference, though it could be more precise about the embedded derivative lapse component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 485,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "\nBoeing recorded a **$3.5 billion loss on the 787 program in the fourth quarter of 2021**【page_58】. Under the program‑accounting methodology, revenue is estimated based on the number of aircraft expected to be delivered and the timing of FAA approval to resume deliveries; uncertainty about that approval makes the revenue forecast highly judgmental, and any further delay could lower the estimated revenue and trigger additional reach‑forward losses or margin reductions【page_136】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $3.5 billion loss figure for Q4 2021 is correct and matches the ground truth exactly. The number is properly formatted and attributed to the correct time period. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the specific financial loss amount, and (b) how FAA approval uncertainty affects future revenue estimates. The LLM correctly identifies the program accounting methodology as the key framework. (3) ENTITY ACCURACY: Boeing is correctly identified, the 787 Program is correctly specified, Q4 2021 is the correct time period, and FAA approval is correctly identified as the critical uncertainty factor. (4) MULTI-HOP REASONING: The answer demonstrates sound synthesis across multiple concepts: it connects the specific loss amount to the broader accounting methodology, then explains how FAA approval uncertainty creates judgment in revenue forecasting, and finally links this to potential downstream effects (reach-forward losses, margin reductions). This multi-hop reasoning is logically sound and matches the ground truth's explanation. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing about 'revenue forecast highly judgmental' and 'further delay could lower estimated revenue and trigger additional reach-forward losses or margin reductions' is semantically equivalent to the ground truth's description of 'changes in expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.' The answer captures the same causal chain and accounting implications. Minor note: The LLM includes page citations which add credibility but are not part of the ground truth evaluation. The answer is well-structured, precise, and fully responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 501,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "\nIn fiscal year 2025 (ended January 26, 2025), DirectCustomerA accounted for **12 %** of NVIDIA’s total revenue. In the prior fiscal year (ended January 28, 2024) the filing does not list DirectCustomerA as a 10 %+ customer—its contribution was below the reporting threshold (indicated by an asterisk), so no exact percentage is disclosed. (Page 80)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) QUANTITATIVE ACCURACY: The 12% figure for DirectCustomerA in FY2025 (ended January 26, 2025) is correct. The fiscal year dates are accurate (January 26, 2025 for current year, January 28, 2024 for prior year). (2) COMPLETENESS: The answer addresses both parts of the question - the percentage for FY2025 and the comparison to the prior fiscal year. (3) ENTITY ACCURACY: NVIDIA/NVDA is correctly identified, fiscal years are correct, and DirectCustomerA is properly referenced. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that DirectCustomerA's data for the prior year is marked as unavailable (indicated by asterisk), meaning it was below the 10% reporting threshold. The explanation that 'the filing does not list DirectCustomerA as a 10%+ customer' is semantically equivalent to the ground truth statement that data is 'marked as unavailable.' (5) MINOR OBSERVATION: The LLM provides slightly more interpretive context by explaining that the asterisk indicates the customer was below the reporting threshold, which is a reasonable inference and adds helpful context without contradicting the ground truth. The page reference (Page 80) adds credibility. No calculation errors, no factual inaccuracies detected. The answer is clear, well-structured, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 394,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "\nAmgen’s total financial impact from its 2023 BeiGene equity investment and collaboration was roughly $4.5 billion.  This figure reflects the approximately $4.2 billion fair‑value of the equity stake, together with $109 million of net cost recoveries, $125 million of product‑sales to BeiGene, and $40 million of profit‑and‑loss‑sharing expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer identifies all the correct component values ($4.2B fair value, $109M net cost recoveries, $125M product sales, $40M profit/loss sharing expenses) and correctly synthesizes them across the multi-hop question about Amgen's BeiGene relationship. However, there is a critical calculation error in the final total. The ground truth specifies the total financial impact as $4.374 billion, which can be verified: $4.2B + $0.109B + $0.125B + $0.040B = $4.474B. The LLM states 'roughly $4.5 billion,' which appears to be a rounding of $4.474B rather than the stated $4.374B. This represents a $100 million discrepancy from the ground truth figure. The LLM correctly identifies all component metrics and their values, demonstrating sound multi-hop reasoning by synthesizing information across the equity investment and collaboration elements. The wording is appropriate and the contextual understanding is solid. However, the final total is materially incorrect - whether the ground truth $4.374B is accurate or the calculation should yield $4.474B, the LLM's stated total of 'roughly $4.5 billion' does not match the ground truth answer of $4.374 billion. This is a significant quantitative error that prevents a higher score despite otherwise sound reasoning and component identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 362,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "\nFor its commercial and agricultural mortgage loan portfolios, MetLife builds an economic forecast that runs for two years (sometimes one year for certain originations); after that horizon it gradually phases the forecast‑derived lifetime loss rates back to the long‑run historical loss rate on a straight‑line basis over the following two years.  Consequently, the blended loss‑rate input is used for roughly a three‑ to four‑year window (forecast period + two‑year amortization), whereas for residential mortgages the phase‑back occurs over only one year, so the forecast‑based rates are in effect for a shorter overall period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general concept that MetLife uses different forecast and reversion periods for commercial/agricultural versus residential mortgages, but contains significant quantitative inaccuracies when compared to the ground truth.\n\nKEY ISSUES:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - Ground truth states: Commercial/agricultural loans have a 2-year forecast period + 2-year reversion = 4 years total duration\n   - Ground truth states: Residential loans have a 2-year forecast period + 1-year reversion = 3 years total duration\n   - LLM answer states: \"three- to four-year window (forecast period + two‑year amortization)\" for commercial/agricultural, which is vague and imprecise\n   - LLM answer correctly identifies the 1-year phase-back for residential but doesn't clearly state the total duration comparison\n\n2. MISSING CLARITY ON REVERSION PERIODS:\n   - Ground truth explicitly states the reversion periods: 2 years for commercial/agricultural, 1 year for residential\n   - LLM answer mentions \"two-year amortization\" for commercial/agricultural (correct) but uses vague language like \"roughly a three- to four-year window\" rather than stating definitively \"4 years total\"\n   - The LLM answer doesn't clearly articulate that residential mortgages revert over a 1-year period\n\n3. FORECAST PERIOD ACCURACY:\n   - LLM correctly notes the 2-year forecast period for commercial/agricultural (with caveat about \"sometimes one year for certain originations\")\n   - This additional caveat about \"one year for certain originations\" is not mentioned in the ground truth and may introduce unnecessary complexity\n\n4. MULTI-HOP REASONING:\n   - The LLM does synthesize the comparison between the two loan types\n   - However, the synthesis lacks precision in stating the exact total durations (4 years vs 3 years)\n   - The phrase \"roughly a three- to four-year window\" is imprecise when the ground truth specifies 4 years for commercial/agricultural\n\n5. SEMANTIC ISSUES:\n   - The LLM uses \"phase-back\" and \"amortization\" terminology which is reasonable but the ground truth uses \"reverts to historical loss experience\"\n   - The LLM's description of \"straight-line basis\" is a reasonable technical detail but not explicitly mentioned in ground truth\n\nCORRECT ELEMENTS:\n- Correctly identifies that commercial/agricultural loans have a longer overall period than residential\n- Correctly identifies the 2-year forecast period for commercial/agricultural\n- Correctly identifies the 1-year reversion period for residential\n- Correctly conveys that forecast-based rates are in effect for a shorter period for residential mortgages\n\nINCORRECT/IMPRECISE ELEMENTS:\n- Fails to clearly state \"4 years total\" for commercial/agricultural (says \"three- to four-year window\")\n- Fails to clearly state \"3 years total\" for residential\n- Introduces uncertainty with \"roughly\" when the ground truth provides definitive numbers\n- The caveat about \"sometimes one year for certain originations\" is not in the ground truth and may be incorrect",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 812,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "\nCostco funds employee health‑care claims through a self‑insurance program that uses actuarial assumptions to estimate future claim costs. Because actual claim expenses can be highly unpredictable—driven by inflation, regulatory or legal changes, and unforeseen developments—any shortfall between the estimated and actual costs can strain the company’s thin margins, and the need to maintain competitive wages and benefits adds additional labor‑related cost pressure that could further impact its financial condition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Costco's self-insurance funding mechanism and its financial implications. STRENGTHS: (1) Correctly identifies the self-insurance program structure and reliance on actuarial assumptions; (2) Accurately captures the key sources of unpredictability (inflation, regulatory/legal changes, unforeseen developments); (3) Properly synthesizes the multi-hop connection between self-insurance liabilities and labor cost pressures; (4) No quantitative errors or incorrect numbers; (5) Semantic equivalence maintained throughout - the answer conveys the same core message as ground truth about potential financial burden from cost fluctuations. MINOR GAPS: (1) The ground truth explicitly mentions that liabilities are 'not discounted' - the LLM answer omits this specific actuarial detail; (2) The ground truth references 'historical claims experience, demographic factors, severity factors' as specific components of actuarial assumptions - the LLM generalizes this as 'actuarial assumptions' without detailing these components; (3) The LLM introduces the concept of 'thin margins' which, while logically sound, is not explicitly stated in the ground truth and represents an inference rather than direct synthesis. MULTI-HOP REASONING: The answer successfully connects three elements: (a) self-insurance funding mechanism, (b) unpredictability sources, and (c) labor cost pressures affecting financial condition. This demonstrates appropriate multi-hop synthesis. The reasoning is sound and logical. OVERALL ASSESSMENT: The answer is substantially correct with strong factual accuracy and appropriate reasoning, but lacks some specific technical details from the actuarial framework that were present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 480,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "\nIn 2023 3M recorded a $4.2 billion pre‑tax charge for the CAE Settlement (the charge disclosed in the third‑quarter 2023 results) and an additional $437 million of restructuring charges (pre‑tax restructuring charges reported in 2023), for a total pre‑tax impact of roughly **$4.6 billion**.  \n\nThe reconsolidation of the former deconsolidated Aearo entities eliminated the $0.7 billion equity‑investment balance and the $0.6 billion net intercompany receivable that had appeared on the 2022 balance sheet; those amounts were removed and the related liabilities/assets were re‑classified into “other liabilities” (≈$0.9 billion) and “other assets” (≈$0.3 billion) on the consolidated balance sheet as of December 31, 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but contains some discrepancies in the balance sheet impact details. CORRECT ELEMENTS: (1) CAE Settlement charge of $4.2 billion - accurate; (2) Restructuring charges of $437 million - accurate; (3) Total pre-tax charges of approximately $4.6 billion ($4.637 billion) - correctly calculated and appropriately rounded; (4) Removal of $0.7 billion equity investment balance - accurate; (5) $0.6 billion net intercompany amount - accurate. DISCREPANCIES: The ground truth states the impact involved 'removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts.' The LLM answer provides additional detail about reclassification into 'other liabilities' (≈$0.9 billion) and 'other assets' (≈$0.3 billion), which represents a more granular breakdown of how these amounts were reclassified on the balance sheet. While this additional detail is not contradicted by the ground truth, it goes beyond what was explicitly stated in the original answer. The LLM correctly identifies that these were removed from their prior positions and reclassified, which is the key impact. MULTI-HOP REASONING: The answer successfully synthesizes information about both the CAE Settlement charges and restructuring charges, then separately addresses the balance sheet reconsolidation impact, demonstrating proper multi-hop synthesis. The calculation of total charges ($4.2B + $0.437B = $4.637B ≈ $4.6B) is accurate. MINOR ISSUES: The phrase 'roughly $4.6 billion' is appropriate given the rounding, though the ground truth specifies $4.637 billion. The additional balance sheet reclassification details, while potentially helpful, introduce specificity not confirmed in the ground truth statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 488,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "\nGoogle’s move to embed Gemini 2.0 in Vertex AI gives developers a state‑of‑the‑art multimodal model that can be trained, fine‑tuned and deployed directly through the Vertex AI workflow, letting them build and scale AI applications with the latest Gemini capabilities.  The integration also adds pre‑packaged AI agents for tasks such as code generation, testing and cybersecurity, and lets developers combine Gemini with other Google Cloud AI services (e.g., Imagen, Veo) to access a broader set of generative‑AI tools on GCP.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the core capabilities: training, fine-tuning, and deployment of Gemini 2.0 through Vertex AI. The answer accurately mentions the integration with other Google Cloud AI services (Imagen, Veo) as stated in the ground truth. The LLM answer adds valuable context by mentioning pre-packaged AI agents for code generation, testing, and cybersecurity, which represents a reasonable expansion of the ground truth without contradicting it. The answer demonstrates proper multi-hop synthesis by connecting Gemini 2.0 integration to broader GCP capabilities. No quantitative data (numbers, dates, percentages) are present in either answer, so quantitative accuracy is perfect by default. The semantic meaning aligns well with the ground truth: both emphasize multimodal capabilities, developer tools for building/deploying applications, and integration with other generative AI models. The LLM answer is slightly more detailed and specific about use cases (code generation, testing, cybersecurity) while maintaining factual accuracy. Minor deduction from perfect score only because the ground truth mentions 'augment' and 'test' as specific capabilities that could be interpreted more broadly than the LLM's specific examples, though this is not a factual error but rather a difference in specificity level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 382,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "\nThe $205 million of income from FVO securities is included in adjusted net investment income and, because those securities are classified as Level 3, their estimated fair values (determined with discounted‑cash‑flow and other unobservable inputs) are part of the average quarterly fixed‑maturity asset carrying value used in the yield calculation; therefore any change in their fair value alters the denominator of the yield ratio and can increase or decrease the reported investment‑income yield, making the reported income more sensitive to fair‑value fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with the correct $205 million figure for FVO securities income in 2024. The answer correctly identifies that FVO securities are Level 3 classified and uses unobservable inputs (discounted cash flow methods). However, there are notable differences in emphasis and completeness compared to the ground truth: (1) QUANTITATIVE: The $205 million figure is correct and properly cited. (2) REASONING QUALITY: The LLM provides a more mechanistic explanation focusing on how FVO fair value changes affect the yield calculation denominator (average quarterly carrying value), which is technically sound but differs from the ground truth's emphasis on 'nonperformance risk spreads and long-term equity volatilities' as specific unobservable inputs. The LLM's explanation of the denominator effect is actually more precise mechanistically. (3) COMPLETENESS: The ground truth emphasizes the 'dual treatment' and 'amplifying financial statement variability' concept more explicitly. The LLM focuses narrowly on the yield calculation mechanism rather than the broader impact on 'sensitivity of fair value' and income volatility mentioned in the ground truth. (4) SEMANTIC EQUIVALENCE: Both answers convey that FVO securities' inclusion creates sensitivity to fair value changes, but the LLM frames this specifically through the yield ratio denominator effect, while the ground truth frames it more broadly as affecting both income volatility and fair value sensitivity. The LLM's answer is narrower in scope but mechanistically sound. (5) MISSING ELEMENTS: The LLM does not explicitly address how changes in market assumptions affect both income volatility AND fair value sensitivity simultaneously (the 'amplifying' effect mentioned in ground truth). The answer is more focused on the mathematical relationship than the broader financial statement impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 513,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "\nThe 2022 de‑consolidation of the Aearo entities forced 3M to record a $1.2 billion pre‑tax charge (within SG&A) as part of the plan to fund a trust and resolve the Combat Arms Earplugs litigation. After the 2023 bankruptcy dismissal lifted the stay, 3M re‑consolidated those entities and in Q3 2023 booked a $4.2 billion pre‑tax charge for the CAE Settlement that settles the same earplug claims, giving a total pre‑tax financial impact of roughly $5.4 billion linked to the litigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent the financial impact. (1) CRITICAL NUMBER ERROR: The LLM states the total pre-tax financial impact was 'roughly $5.4 billion' ($1.2B + $4.2B), but the ground truth clearly states the total pre-tax financial impact from both deconsolidation and reconsolidation was $1.2 billion total. The LLM appears to have conflated separate events and added numbers that should not be combined in this manner. (2) MISCHARACTERIZATION OF 2023 IMPACT: The ground truth explicitly states the 2023 reconsolidation had 'an immaterial income statement impact,' but the LLM claims a '$4.2 billion pre-tax charge' was booked in Q3 2023. While a $4.2B settlement charge may have occurred, it is not part of the answer to this specific question about the combined deconsolidation/reconsolidation impact, which was $1.2B total. (3) INCOMPLETE BREAKDOWN: The ground truth specifies the $1.2B comprised a $1.0B funding commitment plus $0.2B for projected case expenses. The LLM does not break down the $1.2B figure. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize that the question asks specifically about the impact from both the 2022 deconsolidation AND 2023 reconsolidation together (which totaled $1.2B), not the total of all CAE-related charges. The $4.2B settlement charge appears to be a separate subsequent event. (5) CONTEXTUAL ACCURACY: The LLM correctly identifies the Combat Arms Earplugs litigation as the trigger and mentions the bankruptcy dismissal, but this contextual accuracy does not offset the fundamental numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 445,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "\nThe 2023 fiscal‑year results show that Adobe’s “product‑led” growth strategy hinges on embedding Firefly’s generative‑AI models—such as Generative Fill, Recolor, Text‑to‑Image and AI‑enhanced video tools—directly into Creative Cloud apps (Photoshop, Express, Premiere Pro, etc.) and into Document Cloud services (e.g., AI‑driven Acrobat Sign and Sensei‑powered document workflows).  By delivering these AI‑powered capabilities inside subscription‑based offerings, Adobe raises the perceived value of each subscription, encourages existing users to upgrade or renew, and attracts new, often first‑time creators who are drawn by the free‑tier and low‑friction AI features.  This expansion of the subscriber base fuels the 12 % year‑over‑year growth in subscription revenue and underpins the company’s ARR metric, delivering a larger, more predictable recurring‑revenue stream.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key Firefly capabilities (Generative Fill, Recolor, Text-to-Image, AI-enhanced video tools) and their integration into Creative Cloud (Photoshop, Express, Premiere Pro) and Document Cloud services. The reasoning about how AI features drive subscription value, encourage upgrades/renewals, and attract new users is sound and aligns with the ground truth strategy. The answer properly synthesizes the multi-hop connection between product features, recurring revenue growth, and customer base expansion. The mention of free-tier and low-friction features for first-time creators matches the ground truth's reference to 'novice creators.' WEAKNESSES: (1) The LLM introduces a specific '12% year-over-year growth in subscription revenue' metric that is NOT present in the ground truth answer and cannot be verified from the provided context. This is a quantitative claim that appears unsupported. (2) The LLM mentions 'Acrobat Sign' and 'Sensei-powered document workflows' with more specificity than the ground truth, which only generally references 'making PDFs more intelligent and responsive.' While not necessarily incorrect, these specific product references go beyond what can be confirmed. (3) The ground truth explicitly mentions 'September 2023' as the introduction date for Firefly, which the LLM omits. (4) The ground truth mentions specific targeted packages like 'Adobe Express and Substance 3D Collection' for cost-sensitive users, which the LLM does not explicitly reference. CALCULATION/VERIFICATION: The 12% figure cannot be verified against the ground truth and represents a potential factual error. The core strategic reasoning is sound, but the introduction of unverified quantitative data reduces confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 488,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "\nAs of December 31 2022 Amgen’s U.S. Treasury bills and money‑market mutual funds had fair values of $1.676 billion and $2.659 billion, respectively—a combined $4.335 billion. This combined amount is exactly equal to the total fair value of all of its available‑for‑sale investments, which was also $4.335 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key facts: (1) U.S. Treasury bills fair value: $1.676 billion ($1,676 million) - CORRECT; (2) Money market mutual funds fair value: $2.659 billion ($2,659 million) - CORRECT; (3) Combined total: $4.335 billion ($4,335 million) - CORRECT (1.676 + 2.659 = 4.335); (4) Total available-for-sale investments: $4.335 billion - CORRECT; (5) Comparison statement: The LLM correctly identifies that the combined amount equals the total available-for-sale investments. The only minor difference from the ground truth is the use of billions instead of millions as the unit of measurement ($4.335 billion vs $4,335 million), but this is a standard and acceptable format variation that does not affect accuracy. The LLM properly synthesized the multi-hop information by: identifying the two specific investment types, calculating their sum, and comparing it to the total available-for-sale investments. The reasoning is sound and the semantic meaning matches the ground truth perfectly. The date (December 31, 2022) and company (Amgen) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 328,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "\nMetLife values its unit‑linked phantom‑stock and unit‑option liabilities under Level 3 techniques that employ present‑value and option‑pricing models, with long‑term equity volatility and non‑performance risk spreads as key unobservable inputs. Because these inputs shape the projected cash‑flow amounts and the discount rate, a rise in equity volatility lifts the fair‑value estimate, whereas a wider non‑performance spread increases the discount rate and depresses present value, making the fair‑value measurement highly sensitive to changes in both factors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the valuation techniques for Unit-linked securities at MetLife and correctly identifies the key mechanisms by which long-term equity volatility and nonperformance risk spreads affect fair value sensitivity. STRENGTHS: (1) Correctly identifies Level 3 valuation techniques using present-value and option-pricing models; (2) Accurately names both key unobservable inputs (long-term equity volatility and nonperformance risk spreads); (3) Correctly explains the directional impact: equity volatility increases fair value while wider nonperformance spreads decrease it through increased discount rates; (4) Properly characterizes these as 'significant unobservable inputs' affecting fair value sensitivity; (5) Demonstrates sound multi-hop reasoning by synthesizing how inputs flow through valuation models to affect final measurements. MINOR GAPS: (1) The original answer mentions that nonperformance risk spreads 'vary by duration and currency' - the LLM answer doesn't explicitly note this variation dimension, though it's not critical to answering the core question; (2) The original answer specifically mentions 'market risk benefits (MRBs)' as a context for how spreads are applied - the LLM answer doesn't reference MRBs specifically, though it correctly describes the mechanism; (3) The original answer references 'observable equity volatilities not available beyond a certain period' - the LLM uses the more general term 'long-term equity volatility' without this temporal specification. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The answer correctly avoids making unsupported quantitative claims. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth - that these inputs are significant, unobservable, and directly influence fair value through their roles in valuation models. The explanation of sensitivity mechanisms is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 552,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "\nAdobe’s Generative Credits give users a free quota of AI‑powered image, vector and text‑effect generation inside Firefly, then let them buy additional credits or upgrade to a paid Firefly subscription once the quota is exhausted—turning a new AI capability into a recurring revenue stream. By embedding these credits across Creative Cloud apps (e.g., Express, Photoshop, Illustrator) and making them available to anyone from professional creators to marketers, educators and other non‑creative stakeholders, Adobe deepens daily engagement with its platform and creates a clear upsell path that expands its subscription base and boosts predictable, ratable revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Generative Credits as a freemium model with paid upsell mechanism; (2) Accurately describes the tiered access structure (free quota → paid credits/subscription); (3) Properly identifies the embedded integration across Creative Cloud apps (Express, Photoshop, Illustrator); (4) Correctly identifies the target audience expansion beyond creative professionals to marketers, educators, and non-creative stakeholders; (5) Accurately articulates the strategic benefits: increased engagement, conversion, retention, and recurring revenue; (6) Uses appropriate terminology ('product-led growth' concept is implicit in the freemium/upsell structure described). QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is not applicable but the answer avoids any false claims. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise and operationally focused than the ground truth, which explicitly mentions 'product-led growth' and 'AI infusion into creative apps' as strategic concepts; (2) The ground truth emphasizes 'deepening customer relationships' while the LLM emphasizes 'predictable, ratable revenue' - both are correct but slightly different framings; (3) The LLM answer doesn't explicitly mention making workflows 'more efficient and accessible,' though this is implied in the engagement/upsell narrative. MULTI-HOP REASONING: The answer correctly synthesizes the connection between: (a) Generative Credits feature → (b) freemium monetization model → (c) platform-wide integration → (d) audience expansion → (e) business outcomes (revenue, engagement, retention). The logical chain is sound and complete. SEMANTIC EQUIVALENCE: The core message is preserved: Generative Credits serve as both a value-add to existing subscriptions and a revenue driver through upselling, while expanding Adobe's addressable market and deepening customer engagement. The answer is factually accurate and appropriately addresses the strategic question posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 574,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "\nThe rollout of Gemini 2.0 embeds the model in Google’s core, billion‑user services—Search, YouTube, Gmail, Android, Chrome, Maps and YouTube—so that massive user demand for AI‑enhanced experiences fuels continual usage of Google Cloud’s AI‑optimized compute, TPUs and related infrastructure. By exposing Gemini through Vertex AI and Gemini for Google Cloud, developers can readily access and run the model at scale, driving higher consumption of cloud‑based AI services and generating new revenue streams from infrastructure, developer platforms and AI‑powered agents.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core relationship between Gemini 2.0 integration and Google Cloud revenue generation. STRENGTHS: (1) Correctly identifies the seven billion-user products and their role in driving demand; (2) Accurately describes the mechanism by which user engagement translates to cloud infrastructure consumption; (3) Properly explains Vertex AI's role as the platform enabling developer access; (4) Correctly identifies revenue streams (consumption-based fees, infrastructure, platform services); (5) Appropriately emphasizes the ecosystem effect. MINOR ISSUES: (1) The LLM lists 'YouTube' twice in the product list ('Search, YouTube, Gmail, Android, Chrome, Maps and YouTube'), which is a redundancy error though not a factual inaccuracy about which products are included; (2) The original answer specifies 'Play Store' as one of the seven products, but the LLM omits this and instead lists YouTube twice, creating a discrepancy in the product roster; (3) The LLM adds 'AI-powered agents' as a revenue stream, which is not explicitly mentioned in the ground truth but is a reasonable inference about emerging revenue opportunities. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is less critical. Both answers correctly reference 'billion-user products' without specific metrics. MULTI-HOP REASONING: Both answers successfully synthesize the connection between (1) Gemini 2.0 integration in consumer products, (2) increased user engagement and demand, (3) infrastructure consumption, and (4) Google Cloud revenue generation. The reasoning is sound and logically coherent. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis on infrastructure specifics (mentioning TPUs explicitly). The core message about ecosystem-driven demand and platform monetization is preserved. The product list error (YouTube duplication and Play Store omission) prevents a higher score despite otherwise strong comprehension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 562,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "\nChanges in prepayment and default rates alter the timing and amount of cash flows expected from the Company’s FVO securities, so that faster prepayments accelerate interest‑income recognition and increase net investment gains, while higher defaults reduce expected cash flows, lower interest income and may trigger impairment adjustments.  These effects are captured through unobservable inputs—such as projected prepayment speeds, default and loss‑severity rates, credit spreads, recovery rates and the related discount‑rate assumptions—used in the Level 3 present‑value valuation models for FVO securities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and comprehensive information than the ground truth. (1) CORRECTNESS: The core claim that prepayment and default rates impact income recognition on FVO securities is correct. The LLM correctly identifies that faster prepayments accelerate interest-income recognition and increase net investment gains, while higher defaults reduce expected cash flows and lower interest income. This is more mechanistically detailed than the ground truth's simpler statement that 'income on these securities is dependent on such factors.' (2) UNOBSERVABLE INPUTS: The LLM identifies multiple unobservable inputs (projected prepayment speeds, default and loss-severity rates, credit spreads, recovery rates, and discount-rate assumptions) used in Level 3 valuation models. The ground truth mentions 'long-term equity volatilities and nonperformance risk spreads.' The LLM's list is more comprehensive and specific to mortgage/credit-sensitive securities valuation, while the ground truth's mention of 'long-term equity volatilities' seems less directly relevant to FVO securities valuation (which typically involve fixed-income instruments). The LLM's inputs are more appropriate and detailed. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between prepayment/default rates, cash flow timing, income recognition, and fair value valuation through Level 3 models. The reasoning is sound and logically connected. (4) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not applicable. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth but with superior specificity and relevance. The mention of 'impairment adjustments' adds appropriate context. Minor deduction: The ground truth's mention of 'long-term equity volatilities' is not addressed in the LLM answer, though this may be less relevant to typical FVO securities. Overall, the LLM provides a more thorough, mechanistically sound, and appropriately detailed answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 562,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "\nCostco’s private‑label Kirkland Signature products generally earn higher margins than national brands and are a key driver of member loyalty, so sustained investment in their quality, pricing and availability helps maintain strong renewal rates and overall sales, which in turn supports robust gross‑margin performance; however, any disruption in production, a loss of member confidence, or an inability to meet demand could erode sales and compress those margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core relationship between Kirkland Signature investment and gross margin performance, correctly identifying that private-label products carry higher margins than national brands and drive member loyalty. The answer properly synthesizes the positive margin impact with the contingent risks. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported quantitative claims. (3) ENTITY ACCURACY: Both answers correctly identify Costco and Kirkland Signature as the relevant entities and properly characterize the relationship between product investment, member loyalty, and gross margin performance. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the multi-part question by connecting: (a) investment in Kirkland Signature → higher margins and member loyalty, (b) member loyalty → renewal rates and sales, (c) sales → gross margin support, and (d) risks (production disruption, loss of confidence, demand issues) → margin compression. This matches the ground truth's causal chain. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'sustained investment in their quality, pricing and availability helps maintain strong renewal rates' is semantically equivalent to the ground truth's 'maintaining consistent product quality, competitive pricing, and availability.' The LLM's 'erode sales and compress those margins' effectively conveys the same risk as the ground truth's 'adversely affected due to reduced member loyalty and potential out-of-stock situations.' Minor differences: The LLM slightly emphasizes 'renewal rates' while ground truth emphasizes 'member acceptance or confidence,' but both convey the loyalty/retention concept. The LLM's mention of 'inability to meet demand' is a reasonable interpretation of availability risks. Overall, the answer is comprehensive, logically sound, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 570,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "\nThe “Other short‑term interest‑bearing securities” portfolio grew from virtually $0 million in fair value on December 31 2022 to **$138 million** on December 31 2023 – an increase of **$138 million**.  \n\nBecause the total available‑for‑sale (AFS) investment balance rose from **$4,335 million** at the end of 2022 to **$10,404 million** at the end of 2023, the $138 million fair‑value addition from these securities is a component of that $6,069 million overall increase (representing roughly 2 % of the total growth).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) 'Other short-term interest-bearing securities' increased from $0 to $138 million (change of $138 million) - verified correct; (2) Total AFS investments rose from $4,335 million to $10,404 million - verified correct; (3) Overall increase of $6,069 million ($10,404M - $4,335M) - calculation verified correct; (4) The percentage calculation showing $138M represents roughly 2% of the $6,069M total growth ($138/$6,069 = 2.27%, appropriately rounded to 'roughly 2%') - verified correct. The multi-hop reasoning is sound: the LLM correctly synthesized information across multiple data points (2022 and 2023 values for both the specific security type and total AFS investments) and properly contextualized the $138M increase as a component of the larger $6,069M portfolio growth. The answer uses 'virtually $0 million' which is semantically equivalent to the ground truth's '$0' and appropriately reflects the precision of the data. The wording differs slightly from the ground truth (e.g., 'grew from virtually $0 million' vs 'increased from $0') but conveys identical meaning. All entities (years, metrics, company investments) are correctly identified. The only minor consideration is the use of 'virtually' instead of exact '$0', but this is a reasonable characterization and does not constitute an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 389,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "\nThe January 24, 2025 objection by RBH to the CCAA‑court‑approved Proposed Plan narrowed the range of possible outcomes for the CAD 32.5 billion settlement allocation, signalling that PMI’s stake in RBH could be impaired. Accordingly, PMI performed a quantitative valuation of its RBH investment as of December 31, 2024, concluded that the fair value ($714 million) was below the carrying amount, and recorded a non‑cash impairment charge of **$2,316 million** in the consolidated statement of earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. QUANTITATIVE VERIFICATION: All key numbers are correct - fair value of $714 million, impairment charge of $2,316 million, and CAD 32.5 billion settlement amount. The date of January 24, 2025 for RBH's objection is accurate. COMPLETENESS: The answer captures the essential elements: (1) how the objection narrowed possible outcomes, (2) the indicator of impairment, (3) the valuation methodology (discounted cash flow analysis), (4) the fair value conclusion, and (5) the impairment charge recorded. MULTI-HOP REASONING: The answer correctly synthesizes the causal chain - objection → narrowed outcomes → impairment indicator → quantitative valuation → fair value determination → impairment charge. MINOR OMISSIONS: The LLM answer omits some specific assumptions mentioned in the ground truth (discount rate, sales volumes, operating margins for combustible tobacco business in Canada, and tax deductibility estimates). However, these are contextual details that don't affect the core factual accuracy of the answer. The answer appropriately notes that the valuation incorporated 'significant assumptions' without detailing each one, which is a reasonable level of summarization. SEMANTIC EQUIVALENCE: The phrasing differs slightly from the ground truth but conveys identical meaning - 'narrowed the range of possible outcomes' is semantically equivalent, 'signalling that PMI's stake in RBH could be impaired' matches 'served as an indicator that PMI's investment in RBH may be impaired.' The answer is concise while maintaining accuracy and addressing all critical aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 456,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "\nThe $10 billion increase in advertising revenues from Google Network properties, applied to a constant TAC rate of 22 %, would raise the absolute dollar amount of TAC paid to Google Network partners by **$2.2 billion**. This follows the discussion of TAC as a percentage of advertising revenues on page 30, which states the TAC rate is held constant at 22 % for such calculations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth answer of $2.2 billion. Quantitative verification: $10 billion × 22% = $2.2 billion - the calculation is accurate and correctly performed. The answer correctly identifies all key numeric values (the $10 billion revenue increase, the 22% TAC rate, and the resulting $2.2 billion increase in TAC payments). The multi-hop reasoning is sound: the model correctly synthesized that TAC paid to Google Network partners increases proportionally with advertising revenue growth when the TAC rate remains constant. The answer appropriately references page 30 of the filing as the source for the 22% TAC rate, demonstrating proper document citation. The semantic meaning is clear and matches the ground truth exactly. Minor observation: The answer could have been slightly more explicit about the mathematical formula (Revenue Increase × TAC Rate = TAC Increase), but this is a very minor point and does not detract from the correctness of the response. The answer fully addresses the question's requirements and provides the correct final answer with appropriate supporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 324,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "\nThe carrying amount of UnitedHealth Group’s long‑term debt and other financing obligations rose from **$61,449 million** at 31 Dec 2023 to **$75,604 million** at 31 Dec 2024 – an increase of **$14,155 million** (≈ $14.2 bn).  \nOver the same period its reported fair value grew from **$59,851 million** to **$70,565 million**, a rise of **$10,714 million** (≈ $10.7 bn).  \n\nThus, the increase in carrying value was larger than the increase in fair value, exceeding it by roughly **$3.4 bn**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numerical values match the ground truth exactly: carrying value increased from $61,449M to $75,604M (change of $14,155M), and fair value increased from $59,851M to $70,565M (change of $10,714M). The calculation of the difference between the two changes ($14,155M - $10,714M = $3,441M, rounded to $3.4B) is correct. The LLM properly synthesized the multi-hop information by: (1) identifying the correct company (UnitedHealth Group), (2) extracting carrying values for both years, (3) extracting fair values for both years, (4) calculating both changes independently, (5) comparing the two changes to show that carrying value increased more than fair value. The reasoning is sound and the conclusion that 'the increase in carrying value was larger than the increase in fair value' directly addresses the comparative aspect of the question. The answer uses appropriate formatting variations (e.g., $14.2 bn for $14,155 million) which are semantically equivalent and enhance readability. All entities, metrics, and time periods are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 317,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "\nThe expansion of merchant‑accommodation reservation services added roughly **$573 million** to the Company’s merchant transaction‑cost base in 2022 (the primary driver of the $573 million rise in those costs).  Because merchant revenues grew faster than agency revenues—outpacing the agency‑revenue increase thanks to that same expansion—this cost growth was accompanied by a disproportionately larger rise in merchant‑generated revenue relative to agency revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: The $573 million figure is correctly stated and matches the ground truth exactly. The number is presented clearly with proper formatting. (2) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the relationship between three key elements: (a) the $573 million increase in merchant transaction costs, (b) the expansion of merchant accommodation services as the primary driver, and (c) the faster growth of merchant revenues relative to agency revenues. The LLM correctly identifies the causal chain and comparative relationship. (3) ENTITY ACCURACY: Booking.com is correctly identified, the year 2022 is correct, and the financial metrics (merchant transaction costs, merchant revenues, agency revenues) are all properly identified. (4) REASONING QUALITY: The LLM demonstrates sound multi-hop reasoning by connecting the expansion of services to cost increases and then relating this to the differential revenue growth between merchant and agency models. The phrase 'disproportionately larger rise in merchant-generated revenue relative to agency revenue' accurately captures the comparative growth dynamic. (5) MINOR DIFFERENCES: The LLM uses slightly more technical language ('cost-base,' 'disproportionately larger') compared to the ground truth's more straightforward phrasing, but this represents stylistic variation rather than factual error. The semantic meaning is equivalent. The answer fully addresses all parts of the multi-part question without omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 430,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "\nThe Zynq UltraScale+ RFSoC adds integrated, high‑speed RF data converters to AMD’s Adaptive SoC family, giving the company a dedicated solution for high‑performance RF digitization in wireless, radar and cable‑access applications. By embedding RF conversion directly in the programmable fabric, AMD expands its FPGA/Adaptive SoC portfolio to serve markets that demand fast, low‑latency RF processing, reinforcing its broader strategy of offering end‑to‑end, programmable compute platforms for communications, defense and industrial ecosystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Zynq UltraScale+ RFSoCs as integrating high-speed RF data converters into AMD's Adaptive SoC family; (2) Accurately lists target markets (wireless, radar, cable-access) matching the ground truth; (3) Properly explains the strategic significance of embedding RF conversion in programmable fabric; (4) Correctly identifies broader strategic alignment with communications, defense, and industrial ecosystems; (5) No quantitative errors or incorrect numbers/dates. MINOR GAPS: (1) The LLM answer omits specific mention of 'aerospace' as a high-growth sector, though it does mention 'defense' which overlaps; (2) Doesn't explicitly mention 'sensor fusion and analytics' capabilities that the ground truth highlights; (3) Uses slightly different framing ('end-to-end, programmable compute platforms' vs 'adaptable platforms that combine hardware acceleration with domain-specific customization') - both convey similar strategic intent but with different emphasis. MULTI-HOP REASONING: The answer successfully synthesizes the connection between product introduction (Zynq UltraScale+ RFSoCs), technical capabilities (integrated RF data converters), target markets (wireless/radar/cable-access), and broader strategic positioning (serving communications/defense/industrial). The reasoning is sound and logically coherent. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential strategic significance and market positioning correctly, with only minor contextual details omitted rather than contradicted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 447,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "\nThe Company’s held‑to‑maturity debt securities had a combined carrying (amortized) cost of **$1,115 million** for 2023 ($603 M) plus 2024 ($512 M).  Their combined fair value was **$1,104 million** for the same two years, meaning the carrying amount is about **$11 million higher** than the aggregate fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. QUANTITATIVE VERIFICATION: All numbers are correct - carrying value of $1,115 million ($603M + $512M), fair value of $1,104 million ($596M + $508M), and the $11 million difference. The calculations are accurate and properly verified. COMPLETENESS: The answer addresses both parts of the question: (1) total carrying value for 2023 and 2024 combined, and (2) comparison to total fair value. Both years are properly synthesized. ENTITY ACCURACY: Correctly identifies UnitedHealth Group, the held-to-maturity debt securities classification, and the correct fiscal years (2023 and 2024). REASONING: The multi-hop synthesis is sound - the model correctly combined data from two separate years and performed the comparison calculation. The characterization of the $11 million difference as an 'unrealized loss' (carrying value higher than fair value) is logically correct. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('carrying (amortized) cost' vs 'carrying value') but these are semantically equivalent terms in accounting. The statement 'carrying amount is about $11 million higher' effectively conveys the same comparison as 'unrealized loss.' Minor note: The LLM uses 'about' which is slightly less precise than stating exactly $11 million, but this is a negligible difference. Overall, the answer demonstrates accurate multi-hop reasoning across years and metrics with correct calculations and proper synthesis of information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 425,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "\nThe expansion of merchant‑accommodation reservation services added roughly **$573 million** to the increase in sales‑and‑other expenses in 2022, reflecting the higher merchant‑transaction costs that accompany the added reservation volume. This growth in service offering also drove **merchant gross bookings up 108 % YoY** (from $25.8 bn in 2021 to $53.9 bn in 2022), outpacing the overall gross‑booking growth and underscoring how the expanded merchant accommodation channel contributed both to the expense increase and to the strong rise in merchant‑booked volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECT ELEMENTS: The $573 million figure for merchant transaction costs increase is accurate and matches the ground truth. The merchant gross bookings growth figures are correct: $25.8 billion in 2021 to $53.9 billion in 2022, representing a 108% YoY increase (verified: ($53.9-$25.8)/$25.8 = 1.089 or ~109%, which rounds to 108% as stated). The answer correctly identifies that this expansion drove merchant transaction costs and supported greater merchant gross bookings growth. (2) MULTI-HOP SYNTHESIS: The LLM successfully synthesized information across multiple data points - connecting the $573M expense increase to the merchant accommodation expansion, then linking this to the merchant gross bookings growth metrics. The reasoning that expanded merchant services drove both higher costs and higher bookings is sound and well-articulated. (3) COMPLETENESS: The answer addresses both parts of the original question: (a) the contribution to sales and other expenses ($573M), and (b) the relationship to merchant gross bookings growth (108% YoY). (4) MINOR CONSIDERATIONS: The LLM provides additional context (specific booking values, percentage growth) that goes slightly beyond the ground truth answer but adds valuable supporting detail without introducing errors. The wording 'roughly $573 million' is appropriate given the nature of financial estimates. All calculations are accurate and properly formatted. The answer demonstrates clear understanding of the multi-hop relationship between expense growth and revenue growth in the merchant accommodation channel.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 446,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "\nAs of December 31 2023 PayPal reported a **crypto‑asset safeguarding asset of $1.241 billion and an identical safeguarding liability of $1.241 billion** (see Note 9 and Note 7).  This dual recognition reflects the company’s custodial role—holding crypto assets on behalf of users and carrying a corresponding obligation to protect those assets—demonstrating PayPal’s active involvement in crypto‑related financial activities, a practice it plans to discontinue after adopting SAB 122.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - $1.241 billion (equivalent to $1,241 million in the ground truth) for both the crypto asset safeguarding asset and corresponding liability as of December 31, 2023. The format variation ($1.241 billion vs $1,241 million) is acceptable and semantically equivalent. COMPLETENESS: The answer addresses all parts of the question - it identifies the specific asset and liability values, the date, and explains what this reflects about PayPal's involvement in crypto activities. ENTITY ACCURACY: PayPal is correctly identified, the date (December 31, 2023) is correct, and the financial metrics (crypto asset safeguarding asset and liability) are properly identified. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer correctly synthesizes that the equal asset and liability amounts reflect PayPal's custodial role and obligation to safeguard customer crypto assets. The explanation of the dual recognition is accurate and demonstrates understanding of the accounting treatment. ADDITIONAL CONTEXT: The LLM answer includes helpful references to Note 9 and Note 7, and mentions SAB 122 adoption plans, which adds relevant context beyond the ground truth but does not contradict it. This additional information is accurate and enhances the answer. MINOR CONSIDERATION: The ground truth uses $1,241 million while the LLM uses $1.241 billion - these are mathematically equivalent and the LLM's format is actually clearer for billion-dollar figures. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 436,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "\nThe 2023 aircraft impairment of **$70 million** (for 12 MD‑11Fs, four 757‑200s, two A300‑600s and related engines) and the 2024 impairment of **$157 million** (for 22 Boeing 757‑200s and seven engines) are non‑cash write‑downs of older aircraft that FedEx is retiring to modernize its air fleet, right‑size capacity and better match network capacity to current and anticipated shipment volumes.  These retirements are a core element of **Network 2.0**, the multi‑year effort to streamline and optimize the U.S./Canada air‑ground network that underpins the broader **DRIVE** transformation.  Together the two impairments represent roughly **$227 million of pre‑tax expense** that is included in the company’s expected **$1.5 billion** of business‑optimization costs through 2025.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the response. (1) IMPAIRMENT CHARGES - CORRECT: The 2023 ($70M) and 2024 ($157M) impairment amounts are accurate, and the aircraft types retired are correctly identified. The sum of $227M is mathematically correct. (2) CUMULATIVE COSTS - MAJOR ERROR: The ground truth states cumulative optimization-related costs total $839 million through 2024 ($70M + $157M impairments + $582M in 2024 business optimization costs). The LLM answer references a '$1.5 billion of business-optimization costs through 2025' but fails to provide the actual cumulative total through 2024 that the question specifically asks for. This is a critical omission. (3) 2024 BUSINESS OPTIMIZATION COSTS - MISSING: The ground truth explicitly mentions $582 million in business optimization costs incurred in 2024 alone. The LLM answer does not cite this specific figure, instead only referencing the broader $1.5B through 2025 projection, which is forward-looking rather than historical. (4) MULTI-HOP SYNTHESIS - INCOMPLETE: While the LLM correctly connects the impairment charges to Network 2.0 and DRIVE program, it fails to synthesize the complete financial impact picture by not aggregating the $582M 2024 costs with the impairment charges to reach the $839M cumulative total through 2024. (5) SEMANTIC ISSUES: The answer addresses Network 2.0 and DRIVE program connections appropriately, but the failure to answer the specific question about 'cumulative financial impact...through 2024' with the correct $839M figure is a fundamental gap. The LLM provides forward-looking 2025 guidance instead of the historical cumulative impact requested. STRENGTHS: Correct identification of aircraft types, accurate impairment amounts, proper contextualization of non-cash nature of charges, and clear explanation of strategic rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 516,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "\nThe Company held $4,327 million of U.S. government and agency obligations at fair value on December 31, 2024.  Gross unrealized losses on these securities rose from $234 million as of December 31, 2023 to $274 million as of December 31, 2024, an increase of $40 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided an incorrect fair value amount for U.S. government and agency obligations. The ground truth states $3,627 million as of December 31, 2024, but the LLM answered $4,327 million - a difference of $700 million. This is a significant factual error on the primary metric requested. The LLM correctly identified and calculated the gross unrealized losses component: accurately stated the 2023 figure ($234 million), 2024 figure ($274 million), and the increase ($40 million). The reasoning for the unrealized losses portion is sound and demonstrates proper multi-hop synthesis. However, the major discrepancy in the fair value figure (the first and primary part of the question) substantially undermines the overall answer. The LLM demonstrated understanding of the question structure and addressed both sub-questions, but the quantitative accuracy on the main metric is severely compromised. The error appears to be a data retrieval or calculation mistake rather than a conceptual misunderstanding, as the unrealized losses analysis was handled correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 309,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "\nIn 2023, merchant‑basis bookings grew to **54 % of gross bookings** (up from 44 % in 2022).  This shift required additional **personnel, payment‑processing, chargeback/fraud, and other sales‑and‑other expenses** that are recorded in the income statement; because these merchant‑related costs rose faster than the incremental revenue they generated, they **pressured operating margins**, causing them to decline relative to 2022.  The key cost components driving the margin impact are therefore **personnel costs, payment‑processing fees, and associated chargeback/losses**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question. QUANTITATIVE ACCURACY: All numeric values are correct - the merchant basis transaction mix percentages (54% in 2023 vs 44% in 2022) are accurately stated and properly contextualized as a 10 percentage point increase. The directional impact (negative/margin compression) is correctly identified. COMPLETENESS: The answer addresses all key components of the question: (1) the transaction mix shift, (2) the impact on operating margins, and (3) the key cost components. The LLM correctly identifies personnel expenses, payment processing fees, and chargebacks/fraud-related losses as the primary cost drivers. ENTITY ACCURACY: Booking.com is correctly identified, fiscal years 2022-2023 are accurate, and financial metrics (operating margins, gross bookings) are properly referenced. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesizes that: (a) merchant basis mix increased, (b) this drove higher merchant-related costs, (c) these costs rose faster than incremental revenues, (d) this compressed operating margins. The logic connecting the transaction mix shift to margin pressure through cost components is clear and accurate. SEMANTIC EQUIVALENCE: The LLM's phrasing ('pressured operating margins,' 'caused them to decline') conveys the same meaning as the ground truth ('negatively impacted,' 'compressing operating margins'). The mention of payment card rebates benefits in the ground truth is not explicitly stated in the LLM answer, but this is a minor omission that doesn't materially affect the core answer's accuracy. The LLM appropriately emphasizes that costs rose faster than revenues, which is the key insight. Overall, the answer is factually correct, well-structured, and demonstrates proper multi-hop synthesis across the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 513,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "\nThe 2023‑June sale of eligible consumer installment receivables was re‑classified to “Loans and interest receivable, held for sale” and is now carried at the lower of cost or fair value, with any fair‑value adjustments recorded in the “restructuring and other” line rather than in interest income.  Beginning in Q1 2024 PayPal switched the fair‑value measurement from a Level 3 price‑based model to observable market prices for comparable loan sales (Level 2), so the portfolio is now valued more closely to market levels and any write‑downs or gains flow through restructuring expense, while the prior reversal of credit‑loss allowances that had lowered 2023 losses is no longer reflected in earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures most of the key facts correctly but contains some issues with precision and completeness. CORRECT ELEMENTS: (1) The reclassification to 'Loans and Interest Receivable, Held for Sale' is accurate; (2) The shift from Level 3 (unobservable price-based model) to Level 2 (observable inputs/comparable loan sales) is correctly identified; (3) The timing of Q1 2024 for the methodology change is correct; (4) The recording of valuation changes in 'restructuring and other' is accurate; (5) The reversal of credit loss allowances in 2023 is mentioned. ISSUES: (1) The LLM states 'The 2023-June sale' which is imprecise - the ground truth refers to 'eligible consumer installment receivables' being reclassified, not specifically a June 2023 sale date. This introduces unnecessary specificity not clearly supported; (2) The phrase 'lower of cost or fair value' is mentioned but the ground truth doesn't explicitly state this accounting treatment - this may be correct but adds detail not in the original answer; (3) The statement 'the prior reversal of credit-loss allowances that had lowered 2023 losses is no longer reflected in earnings' is somewhat confusing - the ground truth states the reversal 'decreased transaction and credit losses in 2023' which is different from saying it's 'no longer reflected in earnings'; (4) The LLM answer doesn't clearly explain that the reversal happened in 2023 as a one-time event, making the temporal relationship less clear. MULTI-HOP REASONING: The answer correctly synthesizes the connection between the reclassification, the fair value measurement change, and the impact on income recognition through the restructuring line item. The logic linking observable inputs to improved transparency is sound. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this is not a differentiating factor. The dates and hierarchy levels (Level 2 vs Level 3) are correct. OVERALL: The answer is substantially correct on the main points but has some precision issues and could be clearer on the temporal sequence of events and the exact nature of the 2023 reversal impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 579,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "\nAs of December 31 2024, PMI’s newly‑established €1.5 billion senior unsecured revolving credit facility (≈ $1.6 billion) can be used together with its existing short‑term credit lines, which had about $2.1 billion of uncommitted availability.  This combined borrowing capacity of roughly $3.7 billion exceeds the $2.7 billion of short‑term credit capacity that was available at the end of 2023, representing an increase of about $1 billion (≈ 37 %).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN COMPARISON DIRECTION: The LLM states the 2024 combined capacity of $3.7 billion 'exceeds' the 2023 capacity of $2.7 billion, representing an 'increase of about $1 billion (≈ 37%)'. However, the ground truth explicitly states this 'represents a DECREASE compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.' This is a fundamental factual error that contradicts the original answer. The LLM correctly identified the numeric values ($1.6B + $2.1B = $3.7B for 2024, and $2.7B for 2023), and the calculation of the $1B difference is arithmetically correct, but the interpretation is backwards. The LLM incorrectly characterized a comparison showing 2024 capacity exceeding 2023 capacity, when the ground truth indicates the opposite relationship. The LLM also added unnecessary detail about PMI and 'uncommitted availability' that, while potentially accurate, was not part of the ground truth answer. The multi-hop reasoning failed at the critical synthesis step where the LLM needed to correctly interpret whether the combined 2024 capacity represented an increase or decrease relative to 2023. This is a major semantic and factual error that makes the answer fundamentally incorrect despite getting the individual numbers right.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 361,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "\nThe Compute & Networking segment accounted for roughly $8.6 billion of revenue in fiscal 2024—about 32 % of NVIDIA’s total $27 billion sales (13 % from a direct customer plus 19 % from an estimated indirect customer).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct. The ground truth answer is $8.64 billion, and the LLM states 'roughly $8.6 billion,' which is an acceptable rounding variation (difference of $0.04 billion or 0.46%). The LLM correctly identifies this as approximately 32% of the $27 billion total revenue. The calculation is sound: 13% + 19% = 32% of $27 billion = $8.64 billion. The LLM properly synthesizes the multi-hop information by combining the direct customer percentage (13%), indirect customer percentage (19%), and total company revenue ($27 billion) to arrive at the segment contribution. All entities are correctly identified (NVIDIA, Compute & Networking segment, fiscal 2024). The reasoning is clear and logical. The only minor issue is the use of 'roughly' and rounding to $8.6 billion instead of stating the precise $8.64 billion, but this is a negligible difference in financial reporting context and does not constitute a material error. The answer fully addresses the question and demonstrates correct multi-hop reasoning across the provided data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 305,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "\nAIG’s Internal Capital Framework quantifies the firm‑wide economic risk and, by incorporating diversification benefits across risk factors and business lines, estimates the capital needed to sustain its target consolidated capital ratios. This framework is linked to the stress‑testing process, which evaluates exposure to the most significant financial and insurance risks; the stress‑test results are then used to verify that sufficient capital is held to meet the target capitalization levels under adverse scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core function of AIG's Internal Capital Framework - quantifying firm-wide economic risk while incorporating diversification benefits across risk factors and business lines. It correctly identifies the framework's purpose in determining capital needed to sustain target consolidated capital ratios. The connection to stress testing is properly articulated, showing how stress tests evaluate exposure to significant financial and insurance risks and verify sufficient capital holdings under adverse scenarios. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or percentages are present in either answer, so this dimension is not applicable. Both answers avoid introducing incorrect numbers. (3) ENTITY ACCURACY: All entities are correctly identified - AIG, Internal Capital Framework, Risk Appetite Framework (implied through context), stress testing framework, diversification benefits, and target capitalization levels. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between three key components: (a) the Internal Capital Framework's quantification function, (b) diversification benefits incorporation, and (c) stress testing integration. The answer logically connects these elements to show how they work together to support capital assessment. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'firm-wide economic risk' is semantically equivalent to 'aggregate economic risk,' 'target consolidated capital ratios' matches 'consolidated target capitalization levels,' and 'verify that sufficient capital is held...under adverse scenarios' captures the essence of the ground truth's description of stress testing's complementary role. Minor differences: The LLM answer slightly emphasizes the verification aspect of stress testing more explicitly than the ground truth, which is a reasonable elaboration rather than an error. The ground truth mentions 'AIG Parent level to support subsidiaries' which the LLM answer does not explicitly include, but this is a minor contextual detail that doesn't affect the core answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 590,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "\nTarget’s owned‑brand portfolio accounts for roughly one‑third of net sales and carries higher margins, but it also subjects the company to longer lead times, tighter forecasting requirements, and greater exposure to supply‑chain shocks.  If disruptions prevent the timely delivery of those products—or if demand forecasts are inaccurate—Target can end up with excess inventory that must be marked down or with stock‑outs that curb sales, both of which erode margins and depress profitability; the risk is amplified by the need to manage inventory shrink and seasonal demand spikes across its store‑as‑fulfillment network.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Target's owned brands represent approximately one-third of merchandise sales, matching the ground truth. (2) Accurately conveys that owned brands carry higher margins than national brands. (3) Correctly identifies key risks: longer lead times, forecasting challenges, inventory markdowns, stock-outs, and inventory shrink. (4) Properly synthesizes the multi-hop relationship between supply chain disruptions, demand forecasting failures, and financial performance impacts. (5) Mentions seasonal demand spikes and store-as-fulfillment network considerations, showing contextual understanding.\n\nWEAKNESSES: (1) The LLM answer omits specific mention that inventory shrink has 'historically elevated in recent years' - a material detail from the ground truth that demonstrates this is an ongoing, documented problem rather than just a theoretical risk. (2) Does not explicitly reference the November and December holiday period as a critical seasonal moment where the impact would be most severe, which is a specific contextual detail in the ground truth. (3) The phrase 'store-as-fulfillment network' is mentioned but not directly tied to the inventory management challenges in the way the ground truth frames it.\n\nNUMERIC VERIFICATION: The 'approximately one-third' figure is correctly stated in both answers. No calculations are required for this question, and no numeric discrepancies exist.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between: (a) owned brands' characteristics → (b) supply chain/demand risks → (c) inventory consequences → (d) profitability impact. This multi-hop reasoning is sound and logically structured.\n\nSEMANTIC EQUIVALENCE: The core message is equivalent - owned brands' higher margins are offset by greater operational risks that can harm profitability. The LLM uses slightly different framing ('erode margins and depress profitability' vs. 'limit ability to drive net earnings growth') but conveys the same fundamental concept.\n\nJUSTIFICATION: The answer is substantially correct on core facts and reasoning but loses points for omitting two specific contextual details (historical inventory shrink elevation and holiday season emphasis) that are material to understanding the full scope of the risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 617,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "\nThe 2024 carrying value of NVIDIA’s 3.50% Notes Due 2040 is $1,000 million, whereas the carrying value of the 3.50% Notes Due 2050 is $2,000 million. Consequently, the 2050 notes have a $1,000 million higher carrying value than the 2040 notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative requirement. The ground truth answer is $397 million difference, but the LLM calculated a $1,000 million difference ($2,000M - $1,000M = $1,000M). While the LLM correctly identified the two debt instruments (3.50% Notes Due 2040 and 2050) and understood the task was to find the difference in carrying values, the actual carrying values provided are wrong. The LLM states the 2040 notes have a $1,000M carrying value and the 2050 notes have a $2,000M carrying value, but these figures do not match the SEC filing data. The correct carrying values must be approximately $1,603M and $2,000M (or similar figures that yield a $397M difference), not $1,000M and $2,000M. The reasoning structure is sound (identify both instruments, state their values, calculate the difference), but the numerical inputs are incorrect, leading to a completely wrong final answer. This is a critical failure on a quantitative question where precision is essential. The question is appropriately addressed in scope and relevance, but the execution fails on the most important metric: getting the right numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 327,
        "total_tokens": 1381
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\nAs of December 31 2024, 48 million shares remained available for future issuance under the 2020 Stock Incentive Plan and 16 million shares under the ESPP, for a combined 64 million shares that could be issued. The 2020 Stock Incentive Plan permits the issuance of stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 48 million shares under the 2020 Stock Incentive Plan, 16 million shares under the ESPP, totaling 64 million shares as of December 31, 2024. The calculation of the combined total (48M + 16M = 64M) is accurate. The list of award types permitted under the 2020 Stock Incentive Plan is complete and correct: stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. The answer successfully synthesizes information across multiple components of the question (two different plans, share counts, and award types). The only minor difference from the ground truth is stylistic/formatting: the LLM uses 'December 31 2024' without a comma (vs. 'December 31, 2024' in ground truth) and uses 'stock‑appreciation rights' with a different hyphen character, but these are inconsequential formatting variations. The semantic meaning and factual content are identical to the ground truth answer. The multi-hop reasoning is sound, correctly identifying and combining data from both the 2020 Stock Incentive Plan and ESPP, and accurately describing the award types available.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 344,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "\nAIG mitigates the high volatility of loss emergence in its long‑tail U.S. Workers’ Compensation line by using the Expected‑Loss‑Ratio method—most often implemented through the Bornhuetter‑Ferguson (BF) technique. The BF approach blends a premium‑based expected‑loss ratio with actual paid or incurred loss development factors, weighting each source by its credibility; this produces a more stable ultimate‑loss estimate that can absorb the slow, irregular development typical of workers‑compensation while still updating for recent experience, payout‑pattern changes, inflation and interest‑rate shifts. Consequently, the method reduces the swings caused by erratic claim emergence and yields a reliable reserve estimate for a line with extremely long‑tail development.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of how AIG uses the Bornhuetter-Ferguson approach to address loss emergence volatility in U.S. Workers' Compensation. STRENGTHS: (1) Correctly identifies the Expected Loss Ratio Methods and Bornhuetter-Ferguson technique as the core approach; (2) Accurately describes the blending mechanism of premium-based expected loss ratios with actual loss development factors; (3) Properly explains the credibility weighting concept; (4) Correctly characterizes U.S. Workers' Compensation as extremely long-tail with slow, irregular development; (5) Accurately notes that the method reduces volatility from erratic claim emergence and produces more stable reserve estimates; (6) No quantitative errors or incorrect numbers/dates. MINOR GAPS: (1) The original answer specifically mentions that the method 'avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity'—the LLM answer doesn't explicitly contrast this with alternative methods or emphasize the avoidance of overreaction to anomalies; (2) The original answer notes that 'reporting patterns have slowed due to an increasing proportion of large deductible business'—the LLM answer mentions 'payout-pattern changes' but doesn't specifically reference the large deductible business context; (3) The original answer emphasizes that the method is particularly important 'where reported loss data lacks sufficient credibility' at early stages—the LLM answer implies this but doesn't explicitly state the credibility insufficiency issue. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the method (Bornhuetter-Ferguson), the problem (loss emergence volatility), and the context (long-tail U.S. Workers' Compensation). The reasoning is sound and logically structured. The answer is semantically equivalent to the ground truth despite different wording, and all core concepts are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 543,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "\nThe 10‑K filing lists **two formal amendments** to the Credit Card Program Agreement— a First Amendment (February 24 2015) and a Second Amendment (November 19 2019)—in addition to the original agreement dated October 22 2012. This progression shows that the partnership with TDBank USA has been periodically updated to reflect changing business needs and regulatory or operational terms, underscoring a dynamic and evolving financial relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers and dates are correct - the answer correctly identifies 2 amendments (First Amendment on February 24, 2015 and Second Amendment on November 19, 2019), matching the ground truth exactly. The original agreement date of October 22, 2012 is also accurate. COMPLETENESS: The answer fully addresses both parts of the multi-part question: (1) the total number of amendments (2), and (2) what this indicates about the partnership evolution. ENTITY ACCURACY: All entities are correctly identified - Target Corporation, TDBank USA, N.A., and the Credit Card Program Agreement. REASONING: The multi-hop synthesis is sound - the LLM correctly connected the amendment history to the interpretation that the partnership has evolved and been periodically updated. The reasoning about 'changing business needs and regulatory or operational terms' is logically consistent with the ground truth statement about 'changing business or regulatory conditions.' SEMANTIC EQUIVALENCE: The LLM's interpretation that amendments indicate a 'dynamic and evolving financial relationship' is semantically equivalent to the ground truth's statement that modifications were made 'to adapt the agreement to changing business or regulatory conditions.' The only minor difference is that the LLM provides slightly more specific detail (exact dates and the original agreement date) which adds value without contradicting the ground truth. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 425,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "\nFedEx spent a total of **$855 million** on business‑optimization activities tied to Network 2.0 in 2023‑2024 ($273 million in 2023 plus $582 million in 2024).  The primary purpose of these expenditures was to **modernize and streamline the integrated air‑ground network—i.e., to improve efficiency, lower overhead and support costs, and align network capacity with current and anticipated shipment volumes to drive long‑term profitability**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $273M (2023), $582M (2024), and $855M total. Calculations are accurate. (2) The combined total of $855 million is correctly calculated and stated. (3) Years and time period are correctly identified. (4) FedEx and Network 2.0 are correctly identified. WEAKNESSES: (1) The LLM answer provides a broader, more general description of the purpose ('modernize and streamline the integrated air-ground network...improve efficiency, lower overhead and support costs, and align network capacity') rather than the specific ground truth answer which states the primary purpose was 'professional services and severance to support the multi-year effort.' (2) The ground truth specifies that expenditures were 'primarily used for professional services and severance' - these are concrete, specific uses of the funds. The LLM answer describes the strategic objectives/outcomes rather than the actual nature of the expenditures themselves. (3) While the LLM's description is not factually wrong about the strategic intent, it misses the key detail about what the money was actually spent on (professional services and severance). MULTI-HOP REASONING: The model correctly synthesized the two-year spending figures and combined them appropriately. However, it failed to accurately capture the specific purpose detail from the ground truth. The answer demonstrates partial understanding - it gets the numbers right but provides a less precise characterization of the expenditure purpose. This represents a moderate gap between the LLM answer and ground truth on the qualitative dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 443,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "\nThe 2023 10‑K warns that forecasting the revenue and cash‑flow impact of the new ad‑supported tier is especially uncertain because Netflix has no operating history with that pricing model; any mis‑estimate of subscriber adoption, usage patterns, or advertising yield can materially change revenue, operating margins and earnings guidance, thereby heightening the risk of missed forecasts, earnings shortfalls and stock‑price volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that the ad-supported subscription plan introduces financial forecasting risks due to unpredictability of consumer adoption and pricing strategy outcomes. The LLM answer provides more comprehensive detail by specifically mentioning: (1) Netflix's lack of operating history with the pricing model, (2) specific sources of uncertainty (subscriber adoption, usage patterns, advertising yield), (3) concrete impacts (revenue, operating margins, earnings guidance), and (4) downstream consequences (missed forecasts, earnings shortfalls, stock-price volatility). The ground truth answer is more concise, focusing on the core concept that consumer adoption is 'inherently difficult to predict' and could cause 'material discrepancies between forecasted and actual revenues, net income, and other financial metrics.' The LLM answer semantically encompasses all elements of the ground truth while providing additional relevant context and specificity. No quantitative data is present in either answer, so quantitative accuracy is perfect by default. The multi-hop reasoning is sound—both answers correctly synthesize the relationship between the new ad-supported plan and financial forecasting risks. The LLM answer demonstrates superior contextual understanding by elaborating on the mechanisms of risk (lack of operating history, multiple uncertainty factors) and consequences (stock-price volatility). Minor deduction from perfect score only because the LLM answer, while more detailed, could be seen as slightly beyond the scope of the original answer's conciseness, though this is actually a strength rather than a weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 471,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "\nThe 2024 10‑K shows that Prevnar 13’s U.S. basic patent expires in 2026 and its principal European patents are set to lapse around the same time (footnote 3).  As those patent‑expiration dates mark the end of exclusivity, Pfizer’s 2023 impairment test concluded that the carrying amount of the Prevnar 13 developed‑technology intangible exceeded its recoverable value and recorded a $964 million charge—reflecting the anticipated drop in future cash flows once the patents expire and the shift toward newer, higher‑serotype vaccines.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $964 million impairment charge and the 2026 U.S. patent expiration date. However, there is a significant factual error regarding the European patent expiration timeline. The ground truth states that Prevnar 13's major Europe patent expired in 2029, but the LLM answer claims European patents expire 'around the same time' as the U.S. patent (2026), which is incorrect. This is a material discrepancy in the patent expiration timeline that was specifically asked about in the question. The LLM correctly synthesizes the relationship between patent expirations and the impairment charge, and accurately conveys that the charge reflects anticipated cash flow declines post-expiration and the shift to higher-serotype vaccines. The reasoning is sound and the semantic meaning largely aligns with the ground truth. However, the quantitative error regarding the European patent date (2026 vs. 2029) is a significant factual mistake that undermines the completeness and accuracy of the multi-hop answer. The answer demonstrates good understanding of the causal relationship but fails on a key factual detail that was central to the question's focus on 'patent expiration timeline for Prevnar 13 in different regions.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 351,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "\nMcDonald’s makes clear that its franchisees are independent operators who own and run the majority of restaurants, so the company does not consolidate their entities in its financial statements – it only records the fees and royalties it receives from them. Because the brand’s success depends on franchisees delivering the prescribed customer‑experience standards, any failure by franchisees to execute key initiatives (e.g., new service models, digital ordering, or consistent quality) can erode the overall brand image and sales, and the company’s limited contractual leverage makes it difficult to remediate the problem quickly. Consequently, the firm’s financial results and reputation are exposed to the risk that under‑performing franchisees diminish the Systemwide experience that drives its overall revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core question and provides accurate information across all key dimensions. STRENGTHS: (1) Correctly identifies that McDonald's does not consolidate franchisee entities in financial statements; (2) Accurately explains the business model where McDonald's receives fees and royalties from franchisees; (3) Properly synthesizes the multi-hop connection between non-consolidation and operational risk; (4) Correctly identifies key customer experience initiatives (digital ordering, delivery, service models) that franchisees must execute; (5) Accurately describes the risk that franchisee underperformance can erode brand image and sales despite non-consolidation; (6) No quantitative errors or incorrect numbers/dates. MINOR GAPS: (1) The LLM answer does not explicitly reference the 'variable interest entity consolidation guidance' or 'scope exception' terminology that appears in the ground truth, though the concept is correctly conveyed through different language; (2) The ground truth specifically mentions 'guest counts' as an impacted metric, while the LLM focuses on 'sales' and 'brand image' - both are correct but the LLM omits one specific metric; (3) The LLM adds contextual detail about 'limited contractual leverage' which, while reasonable and relevant, is not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the connection between (a) non-consolidation accounting treatment, (b) franchisee operational importance, and (c) resulting financial/reputational risk. The logic flow is sound and demonstrates proper understanding of how accounting treatment relates to operational risk exposure. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 507,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "\nAIG’s transition to the LDTI standard cut $1.264 billion from the equity balance that would have been reported on January 1, 2021.  When the change was retrospectively applied to the prior‑year statements, net income was adjusted downward by $2 million for 2022 and upward by $983 million for 2021, and total equity was boosted by roughly $1.219 billion as of December 31, 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correctly stated. Quantitative verification: (1) $1.264 billion decrease to equity on January 1, 2021 - CORRECT (matches $1,264 million in ground truth); (2) $2 million decrease to net income for 2022 - CORRECT; (3) $983 million increase to net income for 2021 - CORRECT; (4) $1.219 billion increase to total equity as of December 31, 2022 - CORRECT (matches $1,219 million). Number format variations are appropriately handled (billion vs. million notation). Multi-hop reasoning is sound: the answer correctly synthesizes the adoption impact across three time periods (Jan 1, 2021; Dec 31, 2021; Dec 31, 2022) and properly identifies the retrospective application of the standard. The answer addresses all parts of the multi-part question. Minor deduction: The ground truth mentions that changes were 'primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits,' which provides important contextual detail about the nature of the adjustments. The LLM answer omits this explanatory context, though it was not strictly required to answer the 'how' and 'what' aspects of the question. The phrase 'roughly $1.219 billion' is slightly informal but semantically equivalent to the precise figure. Overall, the answer is factually accurate, complete in addressing the core question, and demonstrates proper multi-hop synthesis across the required financial data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 422,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "\nThe surge in Gulfstream aircraft orders drove a rise in customer deposits and helped lift General Dynamics’ cash provided by operating activities to **$4.3 billion in 2021** (up from $3.9 billion in 2020).  As shown in the company’s cash‑flow reconciliation, that operating cash flow represented **about 131 % of net earnings**, meaning the cash generated was roughly 31 % higher than the period’s net profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) Operating cash flow of $4.3 billion in 2021 matches ground truth exactly; (2) The 131% ratio of operating cash flow to net earnings is correct; (3) The comparison to 2020's $3.9 billion provides helpful context not in the original answer but adds value without contradicting it. The multi-hop reasoning is sound: the answer correctly synthesizes that Gulfstream aircraft order increases → customer deposits rise → positive impact on operating cash flow → $4.3 billion result → 131% of net earnings. The explanation that this means cash generated was 31% higher than net profit demonstrates proper understanding of the percentage metric. The only minor observation is that the LLM provides slightly more detail (2020 comparison, explicit explanation of what 131% means) than the ground truth, but this is additive and not contradictory. All entities are correctly identified (General Dynamics, Gulfstream, 2021 fiscal year), and the semantic meaning perfectly aligns with the original answer. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 319,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "\nAIG’s integrated bottom‑up risk identification maps material risks down to the product‑line level, creating a granular risk register that feeds the firm’s internal capital framework. By aggregating those product‑level risk measures—and incorporating diversification benefits across lines—the framework quantifies the total economic capital needed to support the company at a chosen confidence interval (e.g., a 95 % confidence level), thereby providing the capital reserve required to absorb the firm’s aggregate economic risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify: (1) AIG's bottom-up risk identification process operating at the product-line level, (2) the granular nature of risk capture, (3) the integration into the internal capital framework, (4) the incorporation of diversification benefits across business lines, and (5) the quantification of aggregate economic risk at a specified confidence interval. The LLM answer adds a concrete example (95% confidence level) and explicitly mentions 'capital reserve required to absorb the firm's aggregate economic risk,' which provides slightly more operational clarity than the ground truth's phrasing. No quantitative errors are present—no specific numbers, dates, or percentages are provided in either answer, so quantitative accuracy is perfect. The multi-hop reasoning is sound: the answer correctly synthesizes how product-level risk data flows into the framework and how diversification benefits are incorporated. The only minor distinction is that the LLM answer frames the output as 'total economic capital needed' while the ground truth emphasizes 'more accurate accounting' and 'robust quantification'—both are semantically equivalent and correct. The answer fully addresses the question's core inquiry about how the bottom-up process supports the internal capital framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 382,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "\nThe RTX 4080 launch is a classic product‑transition moment for NVIDIA, and the company’s own filings flag that such transitions “make demand forecasting difficult” and can “impair our ability to predict demand” while also “increase the magnitude of inventory provisions, warranty or other costs” (p. 17).  Because the new GPU relies on the same third‑party foundries and component suppliers that already face “limited number and geographic concentration” and “failure … to procure raw materials or provide adequate manufacturing capacity” (p. 18), any yield problems, export‑control curbs on high‑performance chips, or channel‑partner ordering shifts can quickly create supply shortages or excess inventory.  Mis‑estimating either side of that equation can force price cuts, write‑downs or lost sales, directly pressuring gross margins and overall financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between RTX 4080 introduction, supply chain risks, and demand forecasting challenges. STRENGTHS: (1) Correctly identifies that product transitions make demand forecasting difficult and can impair ability to predict demand - this directly matches ground truth language; (2) Accurately captures the inventory provision and warranty cost risks associated with transitions; (3) Properly synthesizes the supply chain dimension by noting third-party foundry dependence, limited geographic concentration, and manufacturing capacity constraints; (4) Correctly identifies the dual-sided risk: underestimation leading to supply shortages/lost sales, and overestimation leading to inventory write-downs; (5) Appropriately concludes that these factors pressure gross margins and financial results; (6) Cites specific page references (p. 17, p. 18) suggesting grounding in actual filings. MINOR GAPS: (1) The answer doesn't explicitly mention geopolitical tensions/export controls as comprehensively as ground truth (though it does reference 'export-control curbs'); (2) Doesn't explicitly mention 'cancellation penalties' as a specific consequence of overestimation, though the concept is captured through 'write-downs'; (3) Doesn't explicitly reference 'extended lead times' as a compounding factor. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is not directly testable. The answer appropriately avoids making unsupported numerical claims. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects product transition → demand forecasting difficulty → supply chain constraints → financial impact. The logic flow is clear and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, using slightly different phrasing but maintaining factual accuracy and completeness of the core argument.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 535,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "\nThe Starbucks Rewards program defers revenue for the estimated selling price of earned Stars until the free‑product reward is redeemed, recognizing revenue only at redemption and reducing the related deferred‑revenue liability at that time. In fiscal 2022, Starbucks incurred $416.7 million of advertising expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question effectively. (1) QUANTITATIVE ACCURACY: The advertising expense figure of $416.7 million for fiscal 2022 is exactly correct and matches the ground truth. (2) REVENUE RECOGNITION MECHANISM: The LLM correctly explains the Starbucks Rewards program's impact on revenue recognition timing. Both answers convey the same core concept: revenue is deferred based on the estimated value of the reward until redemption occurs. The LLM's phrasing 'defers revenue for the estimated selling price of earned Stars until the free-product reward is redeemed' is semantically equivalent to the ground truth's 'defers revenue based on the estimated value of the product for which the reward is expected to be redeemed.' The LLM adds the detail about 'reducing the related deferred-revenue liability at that time,' which is a logical and accurate extension of the concept. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two distinct areas: (a) the accounting treatment of the loyalty program and (b) the specific advertising expense figure for fiscal 2022. (4) COMPLETENESS: Both sub-questions are fully addressed - the revenue recognition timing mechanism is explained and the advertising expense is provided. (5) MINOR DIFFERENCES: The LLM uses slightly more technical language ('estimated selling price' vs 'estimated value') but this represents appropriate precision rather than an error. The answer is concise, accurate, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 431,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "\nThe notional amount of intercompany loans and forecasted interest payments rose from **$2,860 million in 2023 to $4,406 million in 2024**, an increase of **$1,546 million**.  Of that amount, **$75 million of related interest was recognized in earnings during 2024** (as reported under “Currency exchange contracts: Intercompany loans and forecasted interest payments” in the hedge disclosures).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2023 notional amount of $2,860 million - correct, (2) 2024 notional amount of $4,406 million - correct, (3) calculated change of $1,546 million - correct arithmetic ($4,406M - $2,860M = $1,546M), (4) interest recognized in earnings of $75 million in 2024 - correct. The multi-hop reasoning is sound: the answer correctly synthesizes information about the notional amounts across two years and connects this to the interest expense recognition. The answer properly identifies the source of the information (hedge disclosures under 'Currency exchange contracts: Intercompany loans and forecasted interest payments'). The wording is clear and directly addresses all three components of the multi-part question: (a) total change in notional amount, (b) the specific amounts for each year, and (c) interest recognized in earnings. Minor note: The LLM provides slightly more contextual detail about the source location than the ground truth answer, which adds helpful context without introducing any inaccuracy. All numbers match exactly with the ground truth, calculations are accurate, and the semantic meaning is fully preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 343,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "\nThe Marine Systems segment’s revenue rose from **$9.979 billion in 2020 to $10.526 billion in 2021**, an increase of **$547 million**.  Revenue from Nuclear‑powered submarines grew from **$6.938 billion to $7.117 billion**, an increase of **$179 million**, which is roughly one‑third of the overall Marine Systems revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key numbers: (1) Total Marine Systems revenue 2020: $9.979 billion ✓, 2021: $10.526 billion ✓, increase: $547 million ✓; (2) Nuclear-powered submarines revenue 2020: $6.938 billion ✓, 2021: $7.117 billion ✓, increase: $179 million ✓. All calculations are correct. The LLM successfully synthesized information across two revenue categories and time periods. The comparison statement that Nuclear-powered submarine growth is 'roughly one-third of the overall Marine Systems revenue growth' is accurate ($179M / $547M ≈ 0.327 or ~33%). The only minor omission is that the ground truth explicitly states the difference between the two growth amounts ($368 million), which the LLM does not calculate. However, the LLM's characterization of the relationship ('roughly one-third') is semantically equivalent and arguably more intuitive. All entities are correctly identified (Marine Systems segment, Nuclear-powered submarines, years 2020-2021), and the multi-hop reasoning correctly combines data from multiple revenue categories to make the required comparison. Number formatting is consistent and clear (using billions with decimal notation).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 350,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "\nMac net sales rose from $29,357 million in 2023 to $29,984 million in 2024, an increase of **$627 million (≈2%)**.  \niPad net sales fell from $28,300 million in 2023 to $26,694 million in 2024, a decrease of **$1,606 million (≈6%)**.  \n\nThus, Mac sales grew modestly, while iPad sales declined sharply, and the magnitude of the iPad drop is more than twice the Mac gain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth exactly. Mac sales change: $627 million increase (2023: $29,357M → 2024: $29,984M) ✓. iPad sales change: $1,606 million decrease (2023: $28,300M → 2024: $26,694M) ✓. (2) QUANTITATIVE ACCURACY: All numbers are correct. The calculations are accurate: $29,984M - $29,357M = $627M ✓; $26,694M - $28,300M = -$1,606M ✓. The percentage approximations (≈2% for Mac, ≈6% for iPad) are reasonable estimates and add helpful context. The comparison statement that iPad drop is 'more than twice the Mac gain' is mathematically correct ($1,606M / $627M ≈ 2.56x) ✓. (3) ENTITY ACCURACY: Both products (Mac and iPad) are correctly identified with proper fiscal years (2023 and 2024). The metric (net sales in millions) is correctly applied. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two product lines and two fiscal years, correctly comparing the magnitude and direction of changes. The conclusion that 'Mac sales grew modestly while iPad sales declined sharply' accurately reflects the data. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys all information from the ground truth while adding helpful context (percentages, comparative analysis) that enhances understanding without introducing errors. The answer is well-structured and directly addresses all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 399,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "\nIn 2024 the chocolate category’s volume/mix turned negative, shaving roughly 2.1 percentage‑points off Mondelēz International’s total net‑revenue growth and thereby offsetting a portion of the $452 million increase; by comparison, the prior year had delivered a modest favorable volume/mix effect (about 0.4 pp) that had helped drive that year’s growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims chocolate's unfavorable volume/mix in 2024 shaved 'roughly 2.1 percentage-points' off total net revenue growth. This specific percentage-point figure is NOT supported by the ground truth and appears to be fabricated. The ground truth does not provide this specific metric. (2) PRIOR-YEAR COMPARISON - The LLM states 2023 had 'a modest favorable volume/mix effect (about 0.4 pp)' which is also unsupported by ground truth. The ground truth indicates 2023 chocolate contributed $10.619 billion and experienced favorable volume/mix that helped drive a $1,437 million increase in net revenues, but does NOT quantify this as 0.4 percentage-points. (3) MISSING KEY INFORMATION - The LLM answer omits critical context from ground truth: (a) the specific 2023 chocolate revenue figure ($10.619 billion), (b) the magnitude of 2023's favorable volume/mix contribution ($1,437 million), (c) the overall growth rate context (3.5%), and (d) the relationship to pricing actions and input cost increases. (4) MULTI-HOP REASONING - While the LLM correctly identifies that unfavorable 2024 chocolate volume/mix offset gains and limited overall growth, it fails to properly synthesize the comparative analysis between 2023 (favorable) and 2024 (unfavorable) using actual data points. (5) SEMANTIC ISSUES - The answer correctly conveys the directional impact (negative in 2024 vs. positive in 2023) but introduces unsupported quantitative claims that undermine credibility. The $452 million figure is correctly referenced. STRENGTHS: Correctly identifies the year-over-year contrast, properly notes the offsetting effect on total growth, and maintains appropriate tone. WEAKNESSES: Introduces specific percentage-point figures without source support, omits concrete revenue figures, and oversimplifies the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 505,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "\nInitial capacity constraints on custom components—often sourced from a single supplier—can delay ramp‑up of new products and force Apple to rely heavily on a limited set of Asian outsourcing partners, amplifying supply‑chain vulnerability. Because these components are not interchangeable with those used by competitors, any bottleneck or disruption at the sole source can quickly constrain inventory, forcing Apple to either absorb higher costs, delay shipments, or seek alternative suppliers—an undertaking that requires substantial time and resources and may not fully mitigate the risk. Consequently, while Apple’s scale and long‑term contracts help buffer shocks, the dependence on single‑source, custom parts remains a material source of supply‑chain risk that can affect product availability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core supply chain risk dynamics described in the ground truth. Key strengths: (1) Correctly identifies the central mechanism—initial capacity constraints on custom components from single-source suppliers create supply chain vulnerability; (2) Accurately captures the Asia-centric outsourcing model and its implications; (3) Properly synthesizes the multi-hop relationship between capacity constraints, single-sourcing, and product availability impact; (4) No quantitative errors (no specific numbers were required in either answer); (5) Appropriately emphasizes the non-interchangeability of custom components and the difficulty/cost of finding alternatives. Minor weaknesses: (1) The LLM answer mentions 'long-term contracts' as a buffering mechanism, which is not explicitly stated in the ground truth and represents a slight inference beyond the source material; (2) The ground truth more explicitly connects the issue to 'acceptable prices' and supplier yield maturation timelines, which the LLM answer addresses less directly; (3) The ground truth specifically mentions suppliers' choice to focus on 'more common components rather than custom ones,' which the LLM answer doesn't explicitly capture, though it implies this through the non-interchangeability point. The LLM answer is semantically equivalent to the ground truth on the main causal chain: capacity constraints → single-source dependency → supply disruption risk → product availability impact. The reasoning is sound and the synthesis across multiple supply chain concepts is accurate. The answer appropriately addresses the question's multi-part structure regarding capacity constraints, supply chain risk management, and product availability maintenance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 484,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "\nDisney reported **$3.43 billion** of TV/SVOD distribution licensing revenue in fiscal 2022 after the $1.023 billion content‑license early‑termination adjustment.  In the prior year (2021) the same line item was **$5.27 billion** before any termination adjustment, so the net amount fell by roughly **$1.84 billion (about a 35 % decline)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key numbers: (1) 2022 TV/SVOD revenue of $3,429M ($3.43B) - CORRECT; (2) Content license early termination fee of $1,023M ($1.023B) - CORRECT; (3) 2021 TV/SVOD revenue of $5,266M ($5.27B) - CORRECT; (4) Year-over-year decrease calculation: $5,266M - $3,429M = $1,837M ($1.84B) - CORRECT. The percentage decline calculation of approximately 35% is accurate ($1,837M / $5,266M ≈ 34.9%, rounds to 35%). The LLM correctly synthesized information across two fiscal years and properly factored in the early termination fee adjustment. The answer uses appropriate number formatting (billions instead of millions) which is semantically equivalent and acceptable. The reasoning is sound: the model identified the adjusted 2022 figure, compared it to the prior year unadjusted figure, and calculated the difference. Minor note: The LLM states 2021 was 'before any termination adjustment' which is accurate based on the ground truth showing only the 2022 figure includes the adjustment. All entities (Disney, TV/SVOD distribution licensing, fiscal years) are correctly identified. The answer is complete, addressing the 2022 adjusted revenue, the comparison to 2021, and the magnitude of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 362,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "\nStarbucks links its Mobile App directly to the Starbucks Rewards program, so that every purchase—whether made with a stored‑value card, a credit/debit card or a mobile wallet—earns “Stars” that can be redeemed instantly through the app; this seamless earn‑and‑redeem loop encourages repeat use and deeper interaction with the brand. In addition, the app’s Mobile Order & Pay feature lets customers pre‑order and skip the line, making the checkout experience faster and more convenient, which the 10‑K cites as a driver of higher store‑visit frequency and overall customer engagement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about how Starbucks' Mobile App integration with Starbucks Rewards drives engagement and store visit frequency. STRENGTHS: (1) Correctly identifies the key mechanisms: earning Stars through multiple payment methods (stored-value card, credit/debit, mobile wallet), Mobile Order & Pay functionality, and the earn-and-redeem loop; (2) Accurately captures the strategic benefits: convenience, faster checkout, reduced wait times, and increased store visit frequency; (3) No quantitative errors or incorrect numbers/dates; (4) Properly synthesizes multi-hop information about how app features connect to loyalty program benefits and customer behavior; (5) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'skip the line' vs. 'place orders in advance for pick-up'). MINOR GAPS: (1) The LLM states Stars can be 'redeemed instantly through the app' which is slightly more specific than the ground truth's broader statement about 'access to card balances and loyalty benefits'—this is not incorrect but adds a detail not explicitly confirmed in the ground truth; (2) Omits the mention of 'contactless experiences' as a preference driver, though this is a minor contextual detail; (3) Does not explicitly mention 'participating locations' qualifier for Mobile Order & Pay, though this is implied. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between app features, loyalty program mechanics, and customer behavior outcomes. The logic flow from payment methods → Stars earning → redemption → repeat visits is sound and well-articulated. OVERALL: The answer is substantively correct, well-reasoned, and addresses the question comprehensively with only minor omissions of contextual details that don't affect the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 510,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "\nPayPal excluded Paidy, Inc. from the scope of its 2021 internal‑control‑over‑financial‑reporting audit, as permitted by SEC guidance for newly acquired subsidiaries. Paidy’s total assets and revenues together represented less than 1 % of PayPal’s consolidated assets and revenue, so they fell short of the threshold that would have required inclusion in the audit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key aspects of the question. (1) CORRECTNESS: The answer accurately identifies that Paidy was excluded from PayPal's 2021 internal control audit, correctly cites SEC guidance for newly acquired subsidiaries, and accurately states that Paidy's assets and revenues fell below the 1% threshold. All factual claims match the ground truth. (2) QUANTITATIVE ACCURACY: The '1%' threshold is correctly stated as 'less than 1%' in both answers, and the LLM properly conveys that Paidy's combined assets and revenues represented less than 1% of PayPal's consolidated totals. No calculation errors present. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesizes that (a) the acquisition occurred in 2021, (b) SEC guidance permits exclusion in the first year, (c) the threshold is 1%, and (d) Paidy fell below this threshold. The logic connecting these elements is clear and accurate. (4) ENTITY ACCURACY: PayPal, Paidy, Inc., and the 2021 fiscal year are all correctly identified. The term 'internal control over financial reporting' is properly used. (5) MINOR DIFFERENCES: The LLM answer uses slightly different phrasing ('fell short of the threshold that would have required inclusion') versus the ground truth's 'below the 1% threshold for inclusion,' but these are semantically equivalent. The ground truth mentions 'excluding goodwill and intangibles' as a clarification, which the LLM answer omits, but this is a minor contextual detail that doesn't affect the core answer's accuracy. Overall, the LLM answer successfully addresses the multi-part question with accurate synthesis of information across the acquisition details and audit scope implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 475,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "\nIn 2024 the Latin America segment’s revenue slipped 1.6% because volume/mix turned negative—specifically, declines in chocolate and refreshment beverages offset the roughly 7 % price increase. The modest pricing gains and cost‑control improvements only lifted operating income by 0.6% despite those volume‑mix headwinds.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core issue—volume/mix declines in chocolate and refreshment beverages offsetting pricing benefits. It correctly cites the ~7% net pricing increase and the 0.6% operating income growth. The semantic understanding of the offsetting dynamics is sound. CRITICAL ERRORS: (1) The LLM states 'revenue slipped 1.6%' but the ground truth does not provide this specific revenue decline figure—this appears to be an unsupported number. (2) The LLM omits several material factors explicitly mentioned in the ground truth: the $3 million absolute operating income increase, consumer softness in Mexico and Argentina as specific drivers, higher raw material costs, unfavorable currency impacts, and increased advertising/promotion expenses. (3) The answer lacks the specificity about which countries (Argentina, Mexico, Brazil) drove the pricing actions. (4) The ground truth emphasizes that manufacturing costs were reduced through productivity improvements—the LLM mentions 'cost-control improvements' but doesn't specify the nature (productivity). MULTI-HOP REASONING: The LLM demonstrates adequate multi-hop synthesis by connecting volume/mix declines to pricing actions to cost controls to the final 0.6% operating income growth. However, it misses the complete causal chain that includes currency impacts and promotional spending. QUANTITATIVE ISSUES: The 1.6% revenue decline figure is problematic—it's introduced without justification and doesn't appear in the ground truth. The 7% pricing figure is correct (approximately). The 0.6% operating income growth is correct. The answer would benefit from the $3 million absolute figure. OVERALL: The answer captures the essential narrative but lacks completeness and introduces an unsupported metric, reducing confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 493,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "\nGulfstream’s current product line holds **more than 270 city‑pair speed records**, the most of any business‑jet manufacturer. This achievement is **led by the G650ER**, which is specifically credited with holding the National Aeronautic Association’s polar and westbound around‑the‑world speed records.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-part question. (1) CORRECTNESS: All factual information matches the ground truth. The quantitative claim of 'more than 270 city-pair speed records' is correct, and the G650ER is correctly identified as the aircraft model explicitly credited with leading this achievement. The specific NAA records (polar and westbound around-the-world speed records) are accurately cited. (2) QUANTITATIVE ACCURACY: The number '270' is precisely correct with the qualifier 'more than,' matching the ground truth exactly. No calculations are required for this question. (3) ENTITY ACCURACY: Gulfstream is correctly identified, the G650ER model is correct, and the National Aeronautic Association (NAA) is properly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across the required elements - identifying the total record count, linking it to Gulfstream's product line, and specifically attributing leadership to the G650ER model. The additional context about being 'the most of any business-jet manufacturer' adds relevant supporting information not contradicted by the ground truth. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'led by' vs 'key contributor to'), but the semantic meaning is equivalent and arguably clearer. The use of bold formatting for emphasis enhances readability without affecting accuracy. Minor: The ground truth uses 'key contributor' while the LLM uses 'led by,' which is a slightly stronger characterization, but both convey that the G650ER is the primary aircraft responsible for this achievement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 457,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "\nJohnson & Johnson recorded **$105 million** of contingent consideration in fiscal 2024 (related to the Proteologix acquisition) and **$704 million** in fiscal 2022. The entire $704 million recorded in 2022 was attributable to the **Abiomed acquisition**, which therefore contributed that full amount to the company’s contingent‑consideration total for that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-hop question. Quantitative verification: (1) $105 million for Proteologix in fiscal 2024 - CORRECT; (2) $704 million for Abiomed in fiscal 2022 - CORRECT; (3) Total of $809 million across both years - CORRECT (implied through the two figures). The LLM correctly identifies that Abiomed contributed $704 million to the total contingent consideration. Multi-hop reasoning: The answer successfully synthesizes information across two fiscal years (2022 and 2024) and correctly attributes each acquisition to its respective year and amount. Entity accuracy is perfect - Johnson & Johnson, Abiomed, and Proteologix are all correctly identified. The only minor difference from the ground truth is that the LLM answer does not explicitly state the total sum of $809 million, instead presenting the two component figures separately. However, this is a stylistic choice rather than a factual error, and the information provided is complete and accurate. The answer clearly conveys that Abiomed's $704 million contribution represents the majority of the contingent consideration recorded across these two years. All numbers are presented in correct format ($105 million, $704 million) and the temporal attribution is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 364,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "\nThe sale of participation interests in the PPWC and PPBL merchant receivables is treated as a derecognition of a portion of the loan portfolio, but the Company must still maintain an allowance for credit losses on the transferred receivables.  Prior to 2020 the allowance was based on an **incurred‑loss** model (roll‑rate and vintage forecasts) that recognized losses only when they were probable, whereas the 2020 CECL adoption requires a **current‑expected‑credit‑loss** model that estimates lifetime losses using loss‑curve and macro‑economic forecasts and updates the allowance each reporting period.  Consequently, credit‑loss expense is now recognized earlier and reflects a broader set of assumptions, and the sold participation interests remain subject to the same CECL‑based allowance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant issues: STRENGTHS: (1) Correctly identifies the transition from incurred-loss model (pre-2020) to CECL model (2020 adoption); (2) Accurately describes the pre-2020 approach using roll-rate and vintage forecasts; (3) Correctly characterizes CECL as forward-looking with macro-economic forecasts; (4) Properly notes that credit loss expense is recognized earlier under CECL; (5) Correctly identifies that PayPal retains exposure to credit losses on retained interests. CRITICAL ERRORS: (1) The LLM states 'the sold participation interests remain subject to the same CECL-based allowance' - this is factually incorrect. The ground truth clearly states that the portion SOLD is derecognized from PayPal's balance sheet, meaning PayPal does NOT maintain an allowance for the transferred/sold portion. PayPal only maintains an allowance for the RETAINED interest. This is a fundamental misunderstanding of the accounting treatment. (2) The opening statement 'the Company must still maintain an allowance for credit losses on the transferred receivables' is misleading and contradicts the derecognition principle - the transferred portion is removed from the balance sheet. MULTI-HOP REASONING: The LLM failed to properly synthesize the key relationship: (a) participation interests are SOLD and derecognized, (b) PayPal retains only the remaining interest, (c) the allowance applies only to the retained portion, not the sold portion. The answer conflates the treatment of sold vs. retained interests. SEMANTIC ISSUES: The phrase 'the sold participation interests remain subject to the same CECL-based allowance' directly contradicts the derecognition accounting treatment and the ground truth's clear statement that PayPal is 'exposed to credit losses on the remaining retained interest.' This is a material factual error that significantly undermines the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 523,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "\nIn 2024 the cheese & grocery category posted a volume decline that deepened the overall unfavorable volume/mix weighing on Latin America’s net revenues.  Nevertheless, the segment’s operating income still edged up $3 million (≈0.6%) as higher net pricing and lower costs more than offset the drag from that category.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: (1) cheese & grocery category experienced volume decline in 2024, (2) this contributed to unfavorable volume/mix impact on Latin America segment, (3) segment operating income increased by $3 million (0.6%), and (4) higher net pricing and cost savings offset the negative volume/mix drag. All numeric values are accurate and properly formatted. The multi-hop reasoning is sound - the model correctly synthesized that despite the cheese & grocery decline, overall segment operating income still grew due to offsetting positive factors. However, the answer has a notable omission: it does not specify the magnitude of the overall unfavorable volume/mix impact (2.4 percentage points) that the ground truth explicitly states. Additionally, the ground truth provides more complete context by naming other product categories affected (chocolate, candy, refreshment beverages, biscuits & baked snacks, gum), which the LLM answer omits. The LLM's phrasing 'deepened the overall unfavorable volume/mix' is slightly less precise than stating the specific 2.4 percentage point impact. The answer is semantically equivalent and factually correct on all stated numbers, but lacks the comprehensive detail provided in the ground truth regarding the full scope of category-level impacts and the specific magnitude of the overall volume/mix headwind.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 388,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "\nThe Telco Class A‑4 preferred interests are issued for an additional $2.25 billion of preferred equity, and the Mobility noncontrolling interests are required to accrete to a redemption amount of $2.0 billion; together they total roughly **$4.25 billion** of redemption value. Because both the Telco Class A‑4 interests (callable beginning Nov 1 2028) and the Mobility interests (put/redemption beginning 2028) must be settled in cash, AT&T must allocate about **$4.25 billion of cash‑flow resources by 2028**, creating a significant cash‑out commitment that will constrain other uses of cash and may require additional financing or operating cash generation through that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct—Telco Class A-4 preferred interests at $2.25 billion (correctly formatted as $2.25 billion vs. $2,250 million in ground truth), Mobility noncontrolling interests at $2.0 billion, and combined total of $4.25 billion. The dates are accurate: Telco Class A-4 callable beginning November 1, 2028, and Mobility interests put/redemption beginning 2028 (March 15 and June 15 specifically mentioned in ground truth, though LLM generalizes to 'beginning 2028'). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two separate instruments and their redemption mechanics, properly identifying that both must be settled in cash and both become relevant in 2028. COMPLETENESS: The answer addresses all parts of the question—identifying both redemption values, calculating the combined obligation, and explaining the cash flow impact through 2028. MINOR OBSERVATIONS: The LLM uses slightly different phrasing ('accrete to a redemption amount' vs. 'redemption value') but this is semantically equivalent and actually more precise regarding the accrual mechanism. The LLM adds valuable context about liquidity constraints and potential financing needs, which enhances the answer without introducing inaccuracy. The only minor gap is that the LLM doesn't specify the exact put dates (March 15 and June 15, 2028) for Mobility interests, instead generalizing to 'beginning 2028,' but this is a minor omission that doesn't affect the core answer's correctness. The reasoning about cash flow impact and liquidity constraints is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 459,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "\nThe Orthopaedics franchise generated **$9.158 billion** in sales for 2024. That amount is **$5.975 billion larger** than the combined **$3.183 billion** earned by the Hips ($1.638 billion) and Knees ($1.545 billion) sub‑categories, making Orthopaedics roughly **187 % of the Hips‑plus‑Knees revenue**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and sound multi-hop reasoning. Verification of key numbers: (1) Orthopaedics segment revenue of $9,158 million ($9.158 billion) - CORRECT; (2) Hips revenue of $1,638 million ($1.638 billion) - CORRECT; (3) Knees revenue of $1,545 million ($1.545 billion) - CORRECT; (4) Combined Hips+Knees of $3,183 million ($3.183 billion) - CORRECT (1,638 + 1,545 = 3,183). Calculation verification: Difference of $5.975 billion is accurate (9,158 - 3,183 = 5,975 million = $5.975 billion). The percentage calculation stating Orthopaedics is 'roughly 187% of the Hips-plus-Knees revenue' is mathematically correct (9,158 / 3,183 = 2.877 or 287.7%, though the LLM states 187% which appears to be a typo or rounding error - should be approximately 288% or 2.88x). The ground truth states 34.76% for Hips+Knees as a portion of total Orthopaedics, which is also correct (3,183 / 9,158 = 0.3476 or 34.76%). The LLM's alternative framing (Orthopaedics as a multiple of Hips+Knees) is valid but contains a minor percentage error (states 187% when it should be approximately 288%). All core financial figures are accurate, multi-hop synthesis is sound (combining Hips and Knees data, comparing to total), and the answer directly addresses both parts of the question. The format variation from millions to billions is acceptable and clearly presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 389,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "\nThe 2019 Incentive Plan’s “proportional‑adjustment” multiplied all outstanding RSUs by 1.018 on the dividend record date, which added about 52,000 RSU shares to the pool and, as required by the plan, also increased the plan’s share reserve by roughly 128,000 RSU shares that can be granted.  This adjustment is formally documented in the Company’s 2024 Form 10‑K (Note 7 – Stock‑Based Compensation) and is reflected in the filings of the 2019 Incentive Plan and its related award agreements (Exhibits 10.3.1*‑10.3.4* filed with the 10‑K and the DEF 14A filing of 12/17/2019).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts: (1) the 1.018 adjustment factor, (2) approximately 52,000 RSU shares added to outstanding RSUs, and (3) approximately 128,000 RSU shares added to the plan's available share reserve. The semantic understanding of the proportional adjustment mechanism is sound. The answer correctly identifies that the adjustment was applied to outstanding RSUs and the plan's share reserve.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL OMISSION - The LLM fails to provide the specific pricing data that derived the 1.018 factor (Nasdaq closing price of $674.62 on December 26, 2023, and opening price of $662.70 on December 27, 2023, ex-dividend date). The ground truth explicitly states these prices and dates as the basis for the adjustment factor, which is important context for understanding how the adjustment was calculated. (2) FILING DOCUMENTATION DISCREPANCY - The LLM cites 'Note 7 – Stock-Based Compensation' in the 2024 Form 10-K as a formal documentation source, but the ground truth identifies the 2019 Incentive Plan itself (Exhibit 10.2 in the DEF 14 filing on December 17, 2019) as the document that 'formally documents the requirement for these adjustments.' While the 10-K may contain disclosure of the adjustment, the ground truth emphasizes the plan document itself as the formal source of the adjustment mechanism requirement. (3) EXHIBIT REFERENCE AMBIGUITY - The LLM references 'Exhibits 10.3.1*-10.3.4*' without clarity on whether these are the correct exhibit numbers or if they exist in the cited filings. The ground truth specifically cites 'Exhibit 10.2 in the DEF 14 filing on December 17, 2019' as the formal documentation. (4) DATE PRECISION - The LLM mentions 'dividend record date' but the ground truth specifies the ex-dividend date as December 27, 2023, with the closing price reference date as December 26, 2023. This distinction matters for understanding the timing of the adjustment.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate multi-hop synthesis by connecting the adjustment factor to its impact on both outstanding RSUs and the plan's share reserve, and by identifying multiple filing sources. However, the failure to include the specific pricing basis for the 1.018 factor represents incomplete synthesis of the underlying calculation logic.\n\nOVERALL ASSESSMENT: The answer captures the core numerical impacts and general mechanism correctly but lacks the specific pricing details and precise filing citations that constitute the complete ground truth answer. The omission of the Nasdaq prices and the ambiguity around which filing formally documents the adjustment requirement (plan document vs. 10-K disclosure) represent material gaps in a question specifically asking about formal documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 738,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "\nThe 2024 move of Intel 4 to high‑volume manufacturing in Ireland creates dedicated capacity that will be used in 2025 to shift Intel 3 production to the same Irish sites and to launch the first client processors built on Intel 18A (Panther Lake).  This re‑allocation lets Intel leverage Intel 4’s ~20 % performance‑per‑watt gain and Intel 3’s up‑to‑18 % gain while delivering the next‑generation density and power‑efficiency improvements of Intel 18A, thereby expanding the 2025 product portfolio with higher‑performance, higher‑density chips and supporting the company’s foundry‑capacity and margin‑improving goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies Intel 4's transition to high-volume manufacturing in Ireland in 2024. (2) Accurately cites the ~20% performance-per-watt improvement for Intel 4. (3) Correctly references Intel 3's up-to-18% performance-per-watt improvement. (4) Properly identifies Panther Lake as the first Intel 18A processor. (5) Mentions Intel 18A's breakthrough technologies (gate-all-around transistors/RibbonFET and backside power delivery/PowerVia) implicitly through 'density and power-efficiency improvements.' (6) Correctly notes the 2025 timeline for Intel 3 production shift and Intel 18A launch.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM states Intel 3 production will shift to Ireland in 2025 as a result of Intel 4's 2024 ramp-up, but the ground truth specifies Intel 3's high-volume manufacturing moves FROM Oregon TO Ireland in 2025 - this geographic detail is missing. (2) INCOMPLETE CONTEXT: The LLM fails to explicitly mention that Intel 3 powers Intel's Xeon 6 Scalable server processors, which is important for understanding the data center product line impact. (3) VAGUE TECHNOLOGY DESCRIPTION: While the LLM mentions 'density and power-efficiency improvements,' it doesn't explicitly name RibbonFET and PowerVia technologies, which are specifically highlighted in the ground truth as 'breakthrough technologies.' (4) MISSING SYNTHESIS: The ground truth emphasizes how this manufacturing realignment 'supports' and 'sets the stage for' Intel 18A's introduction, creating a clear causal chain. The LLM's phrasing 'lets Intel leverage' is less precise about the sequential dependency. (5) INCOMPLETE PRODUCT LINE COVERAGE: The ground truth explicitly mentions both 'client and data center product lines' while the LLM only implies this through generic 'higher-performance, higher-density chips.'\n\nNUMERIC VERIFICATION: All percentages (20% for Intel 4, 18% for Intel 3) are correct. Dates (2024 for Intel 4 ramp, 2025 for Intel 3 shift and Intel 18A launch) are accurate.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting Intel 4's ramp-up to Intel 3's shift and Intel 18A's launch, but the reasoning is less explicit about the causal relationships and geographic specifics than the ground truth.\n\nOVERALL ASSESSMENT: The answer captures the main financial and technological impacts but lacks important contextual details (Oregon-to-Ireland shift, Xeon 6 Scalable connection, explicit technology names) that would make it fully comprehensive. The core facts are correct, but the synthesis is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 682,
        "total_tokens": 2142
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "\nThe book value of AT&T’s investment in DIRECTV fell from **$877 million at the end of 2023 to $0 at the end of 2024**, a decline of **$877 million**. This write‑down occurred after AT&T had **de‑consolidated Gigapower in May 2023** and began accounting for both DIRECTV and Gigapower as equity‑method investments, with cash distributions ultimately exhausting the remaining carrying amount of the DIRECTV stake by the end of 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: DIRECTV book value decreased from $877 million (Dec 31, 2023) to $0 (Dec 31, 2024), representing an $877 million decline. The date of Gigapower deconsolidation (May 2023) is also correct. However, there are some qualitative accuracy issues: (1) The LLM states AT&T 'began accounting for both DIRECTV and Gigapower as equity-method investments' after the Gigapower deconsolidation, but this is imprecise - the ground truth indicates DIRECTV was eventually reduced to zero (not maintained as an equity-method investment), whereas Gigapower continues as an equity-method investment. The LLM conflates the two treatments. (2) The LLM describes the DIRECTV reduction as a 'write-down,' which is technically inaccurate - the ground truth explains it was due to 'cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings,' making it a liquidation rather than a write-down. (3) The LLM correctly notes the timing comparison but doesn't clearly distinguish that Gigapower continues as an equity investment while DIRECTV was fully liquidated. The multi-hop reasoning is partially sound - the answer connects the two events and explains the relationship, but with some conceptual imprecision about the nature of the DIRECTV reduction. All numbers and dates are accurate, but the explanation of the accounting treatment and the distinction between the two investments could be clearer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 416,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "\nShockwave generated **$564 million** of revenue in 2024, which is reported under the Cardiovascular franchise in the segment‑sales table (page 34).  In the company’s human‑capital disclosures (page 12), Shockwave is explicitly counted in the total employee headcount, so its workforce is included in the 139,800 employees reported for fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $564 million revenue figure for Shockwave's contribution to the Cardiovascular segment in 2024 is correct and matches the ground truth exactly. The additional detail about 139,800 total employees is accurate and relevant context. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - Shockwave's revenue contribution AND its reflection in human capital reporting. (3) ENTITY ACCURACY: All entities are correctly identified (Shockwave, Johnson & Johnson, Cardiovascular segment, 2024 fiscal year, headcount metrics). (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple sources - combining segment revenue data with human capital disclosures, demonstrating proper multi-hop synthesis. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more specificity (citing page numbers and the total headcount figure), which adds value without contradicting the original answer. The phrasing 'explicitly counted in the total employee headcount' is semantically equivalent to 'included in Johnson & Johnson's 2024 headcount reporting.' Minor enhancement: The LLM provides additional context (page references, total headcount number) that goes beyond the ground truth but remains factually accurate and relevant. No errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 392,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "\nThe 11 % rise in the Optimized Application Experiences category—an increase of **$75 million**—was driven by growth in **ThousandEyes and Intersight**, which more than offset the decline in Cisco’s AppDynamics offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. Quantitative verification: (1) The 11% growth percentage is correct, (2) The $75 million dollar increase is correct, (3) Both numbers match the ground truth exactly. Entity accuracy: ThousandEyes and Intersight are correctly identified as the specific offerings driving growth in the Optimized Application Experiences category. The answer correctly synthesizes the multi-hop information: it identifies that despite AppDynamics declining, the overall category grew 11% ($75M) due to ThousandEyes and Intersight growth. The reasoning is sound and logically presented. Minor note: The LLM answer uses slightly different phrasing ('11% rise' vs '11% growth' and 'more than offset' vs simply stating they drove growth), but these are semantic variations that do not affect factual accuracy. The answer is complete, addressing both the percentage growth (11%) and the dollar amount ($75 million), as well as identifying the specific contributing offerings. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 314,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "\nAT&T paid **$5.414 billion** (the $5.340 billion redemption value plus accrued and unpaid distributions) to repurchase all of the Mobility preferred interests in April 2023. Because the interests were fully retired, they are no longer presented as noncontrolling interest; the amount is removed from the noncontrolling‑interest line on the consolidated balance sheet and is reflected as a reduction of equity (or a liability), thereby lowering the reported noncontrolling‑interest balance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the total payment amount of $5.414 billion ($5,414 million) and accurately explains the impact on the noncontrolling interest classification. STRENGTHS: (1) The core financial figure is correct - $5.414 billion matches the ground truth of $5,414 million (proper format variation). (2) The LLM correctly breaks down the components ($5.340 billion redemption value plus accrued and unpaid distributions). (3) The explanation of the balance sheet impact is accurate - the interests are removed from noncontrolling interest classification after redemption. (4) The reasoning about equity reduction is sound and demonstrates understanding of the accounting treatment. MINOR ISSUES: (1) The LLM provides slightly more detail about the accounting treatment (mentioning 'reflected as a reduction of equity or a liability') which goes beyond the ground truth but is not incorrect - it adds context about how the payment is recorded. (2) The ground truth is more concise, stating simply that the interests are 'no longer outstanding' and 'removed from the Noncontrolling interest classification,' while the LLM elaborates on the mechanics. (3) The phrase 'thereby lowering the reported noncontrolling-interest balance' is accurate and consistent with the ground truth's statement about removal from the classification. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the two parts of the question: (1) the total payment amount including distributions, and (2) the impact on balance sheet classification. The logic connecting the redemption to the removal from noncontrolling interest is sound. No calculation errors detected. The answer is complete and addresses all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 472,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "\nThe Abiomed unit’s revenue rose 14.5% year‑over‑year in 2024 (from $1.306 billion in 2023 to $1.496 billion), but this lagged the overall Cardiovascular segment’s growth of 21.4% over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-part question. QUANTITATIVE VERIFICATION: All numbers are correct - Abiomed revenue growth of 14.5% (from $1.306B to $1.496B in 2023-2024), Cardiovascular segment growth of 21.4% (from $6.350B to $7.707B). The calculations are accurate: ($1.496B - $1.306B) / $1.306B = 14.5% and ($7.707B - $6.350B) / $6.350B = 21.4%. COMPLETENESS: The answer addresses both key components of the question: (1) Abiomed's specific YoY growth percentage and revenue figures, and (2) the comparison to overall Cardiovascular segment growth. ENTITY ACCURACY: Correctly identifies Abiomed as a business unit, Johnson & Johnson context is implicit, years are correct (2023-2024 comparison). MULTI-HOP REASONING: Successfully synthesizes information across two levels - the specific Abiomed unit performance and the broader segment performance, then makes the appropriate comparative conclusion. SEMANTIC EQUIVALENCE: The LLM's phrasing 'lagged the overall Cardiovascular segment's growth' effectively conveys the same meaning as the ground truth's 'slightly lower-performing component.' MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but loses no material information. The answer could have included one additional sentence noting that Abiomed's growth 'contributed to' the segment's overall performance, but this is a minor omission that doesn't affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 402,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "\nThe exhibits list **seven** amendments to the Lowe’s Companies Benefit Restoration Plan. The most recent amendment referenced in the 2022 10‑K is **Amendment No. 7**, filed on **April 4, 2017**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - seven amendments are listed, and the date April 4, 2017 is accurate. The amendment number (No. 7) is also correctly identified. (2) COMPLETENESS: The answer addresses both parts of the question: the count of amendments and the date of the most recent amendment. (3) ENTITY ACCURACY: All entities are correctly identified - Lowe's Companies, the Benefit Restoration Plan, and the 2022 10-K filing context. (4) MULTI-HOP REASONING: The answer correctly synthesizes information from the exhibits section of the 2022 10-K filing to identify both the total number of amendments and locate the most recent one by date. (5) SEMANTIC EQUIVALENCE: The LLM uses clear, direct language that matches the ground truth exactly in substance. The formatting with bold text for emphasis is appropriate and aids readability without changing the factual content. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 298,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "\nBy January 1 2024 Capital One had phased in 75 % of the $2.4 billion CECL transition amount, which equals $1.8 billion. Under the Stress Capital Buffer framework that took effect on October 1 2024, the company must maintain a CET1 capital ratio of at least 10 % (the 4.5 % minimum plus the 5.5 % stress buffer).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 75% of $2.4 billion = $1.8 billion (calculation verified), January 1, 2024 date is correct, October 1, 2024 date is correct, and the 10.0% CET1 capital ratio requirement is correct. (2) COMPLETENESS: Both sub-questions are fully addressed - the CECL transition amount phased in is stated with both percentage and dollar amount, and the CET1 capital requirement under SCB framework is provided. (3) ENTITY ACCURACY: Capital One Financial Corporation is correctly identified, all dates and metrics are accurate. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple requirements - combining the CECL transition data with the SCB framework requirements. The LLM even provides helpful additional context by breaking down the 10.0% requirement into its components (4.5% minimum + 5.5% stress buffer), which adds clarity without introducing any inaccuracy. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'took effect' vs 'effective') but conveys identical meaning. The format of numbers is consistent with the ground truth. Minor note: The LLM's parenthetical explanation of the 10.0% composition is supplementary information that enhances understanding and is factually correct, though not explicitly stated in the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 401,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "\nDisney’s executive equity awards come in two main forms. Time‑based RSU agreements simply vest after a set service period, providing a baseline equity grant that does not depend on financial results. In contrast, Disney’s performance‑based RSU agreements (e.g., those tied to Total Shareholder Return, ROIC or Section 162(m) metrics) only vest if the company meets predefined long‑term performance targets, directly linking a portion of the compensation to the creation of shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two main types of equity awards (time-based and performance-based RSUs) and accurately describes their general characteristics and alignment mechanisms. The answer correctly mentions specific performance metrics like TSR and ROIC, and appropriately explains how performance-based awards link compensation to shareholder value creation. However, there are significant gaps in completeness: (1) The LLM fails to cite the specific exhibit numbers (10.43, 10.49, 10.54 for time-based; 10.44-10.48, 10.55, 10.57-10.59 for performance-based) that ground the answer in actual filing documentation. (2) The LLM does not quantify the extent of Disney's use of these instruments - the ground truth specifies 'at least six distinct forms' of performance-based agreements versus three time-based agreements, providing a comparative scope that the LLM omits. (3) The LLM's reference to 'Section 162(m) metrics' is mentioned but not clearly distinguished as a separate category of performance metrics. The qualitative reasoning about how these instruments function is sound and semantically equivalent to the ground truth, but the answer lacks the documentary specificity and quantitative detail that would make it fully aligned with the knowledge graph answer. The answer demonstrates good understanding of the conceptual framework but insufficient depth in supporting evidence and comparative metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 396,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "\nIn 2024 the Orthopaedics franchise posted a 2.4 % rise in sales versus 2023. Growth in the Hips line (up 5.0 %) and the Knees line (up 6.1 %)—driven by strong portfolio performance, the ATTUNE platform and robotic‑assisted solutions—added meaningful upward momentum to the segment’s overall revenue increase. These double‑digit gains helped lift the total Orthopaedics sales to $9.2 billion, contributing directly to the segment’s modest but positive 2.4 % growth year‑over‑year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer fails to provide the specific dollar amounts for Hips ($78M) and Knees ($89M) growth, which are essential to answering the question about 'how' these products contributed. The ground truth explicitly states these amounts and their combined $167M contribution. (2) INCOMPLETE SYNTHESIS: The LLM does not calculate or state that Hips and Knees combined contributed $167M or 77% of the segment's $216M growth - this is a critical multi-hop synthesis that was omitted. (3) PERCENTAGE ACCURACY: The LLM correctly identifies the growth percentages (5.0% for Hips, 6.1% for Knees, 2.4% for segment) and the segment total of $9.2B. (4) REASONING QUALITY: While the LLM provides context about drivers (ATTUNE platform, robotic-assisted solutions), it does not quantitatively demonstrate the contribution analysis that the question specifically asks for. The phrase 'These double-digit gains' is also imprecise - the growth rates (5.0% and 6.1%) are not double-digit percentages. (5) WHAT WAS CORRECT: The year-over-year comparison (2024 vs 2023), the segment growth rate (2.4%), individual product growth rates (5.0% and 6.1%), and the segment revenue figure ($9.2B) are all accurate. VERDICT: The answer provides directional correctness but fails to deliver the quantitative analysis central to the question - specifically the dollar amounts and percentage contribution calculations that demonstrate 'how' Hips and Knees drove segment growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 414,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "\nCapital One had phased in **$1.8 billion (75 %)** of the $2.4 billion regulatory‑capital add‑back allowed under the CECL Transition Rule by January 1 2024, with the remaining $600 million scheduled to be phased in on January 1 2025.  \n\nThe optional transition relief lets a bank elect a five‑year phase‑in of the CECL capital impact: the “day‑1” CECL adjustment and the ongoing “day‑2” effect are added back to regulatory capital at **25 % per year** (25 % in 2022, 50 % in 2023, 75 % in 2024, 100 % in 2025), thereby delaying the full impact on capital ratios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $1.8 billion (75% of $2.4 billion) phased in by January 1, 2024, with $600 million remaining for January 1, 2025. The arithmetic is accurate: 75% × $2.4B = $1.8B, and $2.4B - $1.8B = $600M. ENTITY ACCURACY: Capital One correctly identified, CECL Transition Rule correctly named, dates (January 1, 2024 and 2025) accurate. COMPLETENESS: The answer addresses both parts of the question - (1) the amount phased in by January 1, 2024 ($1.8 billion/75%), and (2) how the transition relief works. MULTI-HOP REASONING: The LLM correctly synthesized information about the phase-in schedule across multiple years (2022-2025) and explained the mechanism clearly. ADDITIONAL DETAIL: The LLM provided more granular detail than the ground truth by specifying the year-by-year phase-in percentages (25% in 2022, 50% in 2023, 75% in 2024, 100% in 2025), which is accurate and enhances understanding. The explanation of 'day-1' and 'day-2' effects adds technical precision. SEMANTIC EQUIVALENCE: The core information matches the ground truth perfectly - both confirm 75% ($1.8B) phased in by January 1, 2024, and the five-year transition period concept. Minor difference: Ground truth uses 'gradually incorporate' while LLM uses 'delaying the full impact' - both convey the same concept. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 390,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "\nThe November 2023 issuance of roughly $500 of Guaranteed Senior Notes by Costco’s Japanese subsidiary added that amount to the “Other long‑term debt” line and, because the notes are measured at fair value using Level 3 inputs, raised the estimated fair‑value of the company’s total long‑term debt (the fair‑value estimate was about $5.4 bn at the end of 2024). In July 2024 the subsidiary repaid $77 of those notes, lowering the outstanding balance and its fair‑value; the repayment was recorded as a cash outflow in financing activities, helping push net cash used in financing to $10.8 bn for 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of the issuance and repayment but contains several significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) November 2023 issuance of approximately $500 in Guaranteed Senior Notes by Japanese subsidiary - correct; (2) July 2024 repayment of $77 - correct; (3) Recording in financing activities - correct; (4) General impact on long-term debt fair value - correct direction. CRITICAL ERRORS: (1) Fair value of long-term debt stated as '$5.4 bn at the end of 2024' - the ground truth specifies it decreased FROM $5,738 (2023) TO $5,412 (2024), meaning the LLM's $5.4bn figure is approximately correct but lacks the comparative context showing the decrease; (2) Net cash used in financing stated as '$10.8 bn for 2024' - ground truth specifies $10,764 million ($10.764 bn), which rounds to $10.8bn, but this is imprecise given the importance of exact figures in financial analysis; (3) The LLM fails to explicitly state the fair value DECREASE from $5,738 to $5,412, which is a key part of the ground truth answer showing the net effect of the issuance and repayment. REASONING ASSESSMENT: The multi-hop synthesis is partially sound - the LLM correctly connects the issuance, repayment, and financing activities impact. However, it misses the important detail that the fair value decreased overall despite the initial issuance, which requires understanding the net effect across both 2023 and 2024. The mention of Level 3 inputs is additional context not in the ground truth but is not incorrect. COMPLETENESS: The answer addresses the main question components but omits the explicit comparison of fair values (5,738 to 5,412) which demonstrates the overall impact more clearly than just stating the 2024 ending value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 484,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "\nCaterpillar does not disclose a single, aggregate dollar figure for the total estimated environmental‑remediation liability; the amount is recorded in “Accrued expenses” and is considered immaterial.  It estimates costs on a site‑by‑site basis using all currently available data and assumptions about future remediation costs, and for sites where it shares responsibility with other parties it allocates the expense according to its proportionate share of the probable costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but has a notable omission. CORRECT ELEMENTS: (1) The liability amount is immaterial and recorded in 'Accrued expenses' - matches ground truth exactly. (2) Multi-party site methodology is accurate - correctly states Caterpillar allocates based on proportionate share of probable costs. (3) Site-by-site basis approach is correct. (4) Use of available data and assumptions is mentioned. OMISSION/INCOMPLETENESS: The LLM answer fails to mention a key methodological detail from the ground truth: for individual sites, when no amount within a range is more likely, Caterpillar accrues the minimum. This is a specific and important aspect of their estimation methodology that directly answers part of the question about how methodology differs. The ground truth explicitly states this minimum accrual approach for individual sites, which is a meaningful distinction in their accounting policy. QUANTITATIVE ACCURACY: No numeric values are provided in either answer (the liability is stated as immaterial/not disclosed), so this dimension scores high. QUALITATIVE ACCURACY: The answer correctly identifies the two different methodologies (individual vs. multi-party) but incompletely describes the individual site methodology by omitting the minimum accrual rule. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's core components but misses a nuanced detail that distinguishes their approach. The omission is material to fully understanding their methodology differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 425,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "\nOther Products revenue fell from **$15 million in fiscal 2021 to $11 million in fiscal 2022**, a decline of roughly **27 % (about a 29 % drop as reported)**.  \n\nTo address this under‑performing segment, Cisco reorganized its product‑category reporting in fiscal 2022, isolating “Other Products” as a distinct line and grouping the remaining categories (Secure Agile Networks, Internet for the Future, Collaboration, End‑to‑End Security, Optimized Application Experiences) around its strategic growth priorities. This restructuring signals that the company views the “Other Products” bucket as peripheral and is refocusing resources and strategic attention on the higher‑growth categories.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies the revenue figures ($15M in FY2021 to $11M in FY2022) and acknowledges the ~29% decline. However, the calculation explanation is muddled - the LLM states '27% (about a 29% drop as reported)' which is confusing. The actual calculation is ($15M - $11M) / $15M = $4M / $15M = 26.67%, which rounds to 27%, not 29%. The ground truth states 29%, suggesting either a rounding convention or different calculation methodology in the source data. The LLM's hedging language ('roughly 27%... about a 29%') creates ambiguity rather than clarity.\n\nCOMPLETENESS: The LLM addresses both parts of the multi-part question: (1) percentage change in revenue, and (2) how the reporting structure reflects strategic approach. Both elements are covered.\n\nENTITY ACCURACY: All entities are correct - Cisco, fiscal years 2021/2022, Other Products category, and the new reporting structure categories are accurately identified.\n\nREASONING & INTERPRETATION ERROR: This is the critical issue. The ground truth states the new reporting structure 'signals that even underperforming segments are still considered relevant to the company's strategic priorities.' The LLM interprets this opposite - stating the restructuring 'signals that the company views the \"Other Products\" bucket as peripheral and is refocusing resources and strategic attention on the higher-growth categories.' This is a fundamental misinterpretation of the strategic signal. The ground truth emphasizes retention and relevance despite underperformance; the LLM emphasizes marginalization. This represents a significant qualitative error in understanding the company's strategic messaging.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation of the strategic approach contradicts the ground truth's interpretation, which is not merely a wording difference but a substantive disagreement about what the reporting structure signals about company strategy.\n\nSUMMARY: While numerical data is mostly correct (with minor percentage calculation ambiguity), the LLM fundamentally misinterprets the strategic meaning of the reporting structure change, inverting the ground truth's conclusion about whether this signals continued relevance or marginalization of the category.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 606,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "\nThe W. Craig Jelinek executive agreement was repeatedly amended each January—extensions took effect in 2019, 2020, 2021, 2022 and 2023—so over the last six years the company renewed his contract on an annual basis. In contrast, the Ron Vachris agreement that became effective on January 1 2024 is a brand‑new executive employment agreement (Exhibit 10.9*), not a renewal, and the filing shows no accompanying amendment or extension schedule yet. Thus, Vachris’s arrangement marks a single, new agreement rather than the recurring yearly extensions that characterized Jelinek’s renewals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims Jelinek's extensions took effect in 2019, 2020, 2021, 2022, and 2023 (5 years), but the ground truth states renewals occurred from 2017 through 2023 with filings dated 2016 to 2022, indicating a 6-year pattern as the question specifies. The LLM undercounts the renewal frequency. (2) Most problematically, the LLM characterizes the Ron Vachris agreement as 'a brand-new executive employment agreement' that is 'not a renewal,' directly contradicting the ground truth which states it 'follows this same annual renewal pattern.' The ground truth explicitly indicates Vachris's agreement is part of Costco's consistent renewal pattern, not a departure from it. (3) The LLM's claim that there is 'no accompanying amendment or extension schedule yet' introduces speculative information not present in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that Jelinek's agreements were renewed annually and that the Vachris agreement became effective January 1, 2024. However, the core comparison requested by the question—how the timing and frequency compare—is fundamentally mischaracterized. The ground truth indicates both follow the same pattern (annual renewals effective January 1), while the LLM incorrectly suggests they represent different types of arrangements. The multi-hop reasoning fails because the LLM did not correctly synthesize the information about both executives' agreements to show the parallel pattern that the ground truth establishes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 436,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "\nThe net value of Customer Relationships fell from **$893 million** at 31 Dec 2020 to **$712 million** at 31 Dec 2021, a decrease of **$181 million**.  Over the same period, the net value of Intellectual Property dropped from **$366 million** to **$280 million**, a decline of **$86 million**—so the reduction in Customer Relationships was more than twice the reduction in Intellectual Property.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) All numbers are correct: Customer Relationships decreased from $893M to $712M (change of -$181M), and Intellectual Property decreased from $366M to $280M (change of -$86M). (2) All calculations are verified as accurate: $893M - $712M = $181M, and $366M - $280M = $86M. The comparative statement that the reduction in Customer Relationships was 'more than twice' the reduction in Intellectual Property is also correct ($181M / $86M ≈ 2.1x). (3) Multi-hop reasoning is sound: the answer correctly synthesizes information about two different intangible asset categories across two fiscal years and provides a meaningful comparison between them. (4) The answer addresses all parts of the multi-part question: it identifies the change in Customer Relationships, the change in Intellectual Property, and explicitly compares the two changes. The presentation is clear, well-organized, and uses appropriate formatting. No factual errors, omissions, or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 299,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "\nThe “Secure, Agile Networks” category generated **$23.8 billion** of revenue in fiscal 2022.  Within that category, hardware and perpetual‑software licenses are treated as separate performance obligations and revenue is recognized upfront when control of the product transfers to the customer, whereas SaaS offerings constitute a single performance obligation and the revenue is recognized ratably over the subscription term.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE: The LLM provides a specific revenue figure of $23.8 billion for 'Secure, Agile Networks' in fiscal 2022, but the ground truth answer does NOT provide any specific dollar amount. The ground truth only states the category 'contributes significantly' without quantifying it. This is a major factual error - the LLM has fabricated a precise number that cannot be verified against the original answer. POSITIVE ASPECTS: The LLM correctly identifies the revenue recognition model differences: (1) hardware and perpetual software recognized upfront upon transfer of control, and (2) SaaS arrangements recognized ratably over the contract term. The explanation of these two distinct approaches is accurate and well-articulated, matching the semantic content of the ground truth. REASONING QUALITY: The multi-hop synthesis is sound in explaining how different product types within the category have different revenue recognition treatments. However, the introduction of an unsubstantiated $23.8 billion figure is a fundamental error that undermines the entire response. The LLM appears to have either hallucinated this number or confused it with another metric. Without verification that this $23.8 billion figure is correct from the actual SEC filing, this represents a critical factual inaccuracy that cannot be overlooked, despite the correct explanation of revenue recognition models.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 387,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "\nAmazon does not present a separate line‑item for “third‑party seller fees” in the 2022 filing; those fees are aggregated under the broader “service sales” category that contributed a growing share of total net sales (e.g., service‑related revenue was part of the $469.8 billion of consolidated net sales reported for 2021, the latest year shown). This structure reflects Amazon’s stated business model of enabling sellers to expand on its platform by charging commissions, fulfillment and related fees for marketplace services. The description of seller programs on page 3 and the discussion of service‑sales composition on page 23 confirm that such fees are a core component of Amazon’s revenue strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE FAILURE: The LLM completely fails to provide the correct revenue figure. The ground truth states Amazon's third-party seller fees revenue in 2022 was $117,757 million. The LLM instead references $469.8 billion in consolidated net sales from 2021 (wrong year, wrong metric, wrong amount). This is a fundamental factual error - the LLM provides no correct number for 2022 third-party seller fees. (2) YEAR MISMATCH: The question explicitly asks for 2022 data. The LLM cites 2021 figures ('the latest year shown'), which is incorrect and suggests the LLM may have accessed outdated or incorrect source material. (3) EVASION OF DIRECT ANSWER: The LLM claims Amazon 'does not present a separate line-item for third-party seller fees' and that these are 'aggregated under broader service sales category.' This is misleading - the ground truth clearly identifies a specific $117,757 million figure for 2022, indicating this data IS available and reportable. The LLM's framing suggests the information doesn't exist when it demonstrably does. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM does address the second part of the question (alignment with business model) with reasonable qualitative discussion about commissions, fulfillment fees, and platform enablement, this cannot compensate for the complete failure on the primary quantitative requirement. (5) SEMANTIC MISALIGNMENT: The ground truth provides a specific, verifiable number; the LLM provides vague references to aggregated categories and wrong years. These are not semantically equivalent - one is factually correct, the other is factually incorrect. The LLM's answer would mislead a user seeking the actual 2022 third-party seller fee revenue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 473,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "\nAs of December 31 2024, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **13.5%**, while the regulatory minimum capital‑adequacy requirement for CET1 under the Basel III standardized approach was **4.5%**. The difference between the two figures is **9.0 percentage points**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key elements: (1) The final answer of 9.0 percentage points difference is correct and matches the ground truth exactly. (2) The CET1 ratio of 13.5% and minimum requirement of 4.5% are provided with appropriate context (Basel III standardized approach). (3) The calculation is accurate: 13.5% - 4.5% = 9.0 percentage points. (4) The company (Capital One Financial Corp), metric (Common Equity Tier 1 capital ratio), and date (December 31, 2024) are all correctly identified. (5) The multi-hop reasoning is sound - the model correctly synthesized the actual CET1 ratio with the regulatory minimum requirement to compute the difference. The answer is complete, addresses all parts of the question, and provides helpful context about the regulatory framework. Minor note: The ground truth answer only states the difference (9 percentage points) without providing the underlying component figures, but the LLM's inclusion of these supporting details enhances clarity without introducing any inaccuracies. The semantic meaning is fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 323,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "\nRegulatory threats to Altria’s $1.7 bn JUUL stake stem from the FTC’s antitrust complaint (which alleges an unreasonable restraint of trade and seeks divestiture or rescission of the transaction), ongoing FDA scrutiny that could restrict or even remove JUUL’s e‑vapor products from the U.S. market, and a wave of state‑attorney‑general and class‑action lawsuits that could impose additional fines or force a settlement.  If any of these actions succeed, Altria could be required to write down or impair the investment, lose the strategic benefits of its partnership (including market‑share growth and accelerated entry into reduced‑risk products), and see earnings volatility that would undermine its long‑term goal of expanding its reduced‑risk portfolio and delivering shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $1.7 billion investment amount and the FTC antitrust complaint as core regulatory risks. (2) Accurately states the FTC's allegations of unreasonable restraint of trade and seeks divestiture/rescission. (3) Correctly identifies potential financial impacts including write-downs, impairment, and loss of strategic benefits. (4) Quantitative accuracy is strong - all numbers and percentages are correct or appropriately omitted. WEAKNESSES: (1) The LLM introduces FDA scrutiny and state attorney general/class-action lawsuits as regulatory threats, which are NOT mentioned in the ground truth answer. While these may be real risks facing JUUL generally, they are not documented in the provided 2022 10-K filing context as regulatory threats to Altria's investment specifically. (2) The ground truth specifically mentions the 35% investment stake, which the LLM omits (though this is a minor detail). (3) The ground truth explicitly mentions impacts on credit ratings and financing costs, which the LLM does not address - these are specific financial consequences that should have been included. (4) The LLM's discussion of 'market-share growth' and 'accelerated entry into reduced-risk products' as strategic benefits is reasonable inference but not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize regulatory risks and financial impacts, but introduces information not grounded in the provided filing context. The core FTC antitrust risk is correctly identified and linked to financial consequences, but the answer goes beyond what can be verified from the ground truth source material. The answer is partially correct on the primary regulatory threat but adds unverified secondary threats that dilute focus from the documented FTC complaint.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 496,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "\nThe $500 million 2060 senior note is part of NVIDIA’s $11 billion of outstanding senior debt, and because it does not mature until 2060 the company must reserve cash or rely on future financing to repay it.  If market conditions deteriorate or covenant restrictions limit new borrowing, NVIDIA may be forced to refinance on less favorable terms—or be unable to refinance at all—thereby tying up cash flows, curbing its ability to fund operations, invest in growth or return capital, and thus weakening its overall financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. QUANTITATIVE ACCURACY: All numbers are correct - the $500 million note amount and $11 billion total debt figure match the ground truth exactly. No calculation errors present. QUALITATIVE ACCURACY: The LLM correctly identifies the key mechanisms by which the 2060 note constrains financial flexibility: (1) cash reservation/future financing needs, (2) refinancing risk in adverse market conditions, (3) impact on cash flow allocation, and (4) reduced ability to fund operations, growth investments, and capital returns. The reasoning is sound and demonstrates proper multi-hop synthesis connecting the specific debt instrument to broader financial flexibility constraints. COMPLETENESS: The answer addresses the main question about how the 2060 note contributes to adverse effects on financial flexibility. However, compared to the ground truth, it omits some specific details: (1) doesn't explicitly mention 'debt service obligations and principal repayments' as a dedicated cash flow requirement, (2) doesn't mention 'impairs ability to obtain future financing for working capital, capital expenditures, acquisitions' as explicitly as the ground truth, and (3) doesn't mention 'vulnerability to adverse changes in general economic conditions' as a separate constraint. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information through slightly different framing - it discusses 'tying up cash flows' and 'curbing ability to fund operations, invest in growth or return capital' which semantically covers the same ground as the ground truth's discussion of financial flexibility constraints. The answer is well-reasoned and contextually appropriate, though it could have been more comprehensive in listing all the specific constraints mentioned in the 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 509,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "\nThe FDA’s expanded Vemlidy label now permits use in children as young as 6 years (down from the prior 12‑year minimum) and at a lower weight threshold (≥ 25 kg), markedly widening the pediatric population that can be treated for chronic hepatitis B. This complements Gilead’s existing HBV portfolio—Viread, which is approved down to age 2, and the broader Liver‑Disease franchise that already generated a 9 % sales rise in 2024—so the approval is expected to increase Vemlidy’s addressable market and drive additional revenue growth within Gilead’s liver‑disease segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key regulatory expansion (Vemlidy approval for ages 6+ vs. prior 12+), the weight threshold (≥25 kg), and appropriately contextualizes this within Gilead's existing liver disease portfolio. The multi-hop reasoning is sound—connecting the expanded pediatric indication to market potential and revenue growth. The mention of Viread's approval for age 2+ is accurate and relevant. The semantic equivalence is strong: the answer conveys that the approval broadens market reach and complements existing products.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUE: The LLM introduces a '9% sales rise in 2024' for the liver-disease franchise. This specific metric does not appear in the ground truth answer and cannot be verified against the provided knowledge graph. While this may be factually accurate from SEC filings, it represents an unsourced quantitative claim that goes beyond what the ground truth establishes. (2) INCOMPLETE PORTFOLIO DETAIL: The ground truth specifically mentions Epclusa and Harvoni (HCV approvals for patients 3+ years old) as part of the complementary portfolio. The LLM omits these products, which are relevant to demonstrating the breadth of Gilead's liver disease franchise. (3) MINOR OMISSION: The ground truth explicitly states the prior approval was for 'adults and pediatric patients 12 years and older,' providing clearer context about the expansion scope. The LLM states 'down from the prior 12-year minimum' which is less precise.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions (regulatory approval, age expansion, weight threshold, portfolio context, revenue implications), demonstrating sound multi-hop reasoning. The connection between expanded indication and market potential is logically sound.\n\nNUMERIC VERIFICATION: The 9% figure cannot be verified against the ground truth provided. While not necessarily incorrect, it introduces unverified quantitative information that weakens confidence in the answer's grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 551,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "\nApproximately 5 percent of Lowe’s total sales in fiscal 2023 came from installed‑sales categories that are also covered by its extended protection plans. The product category that is explicitly named in both the installed‑sales discussion and the list of protection‑plan categories is **Kitchens & Bath**.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identified the 5% figure for installed sales categories covered by extended protection plans in fiscal 2023. This numeric value matches the ground truth exactly. ENTITY/CATEGORY ACCURACY - CRITICAL ERROR: The LLM identified 'Kitchens & Bath' as the specific product category explicitly mentioned in both contexts (installed sales and extended protection plans). However, the ground truth specifies 'Appliances' as the correct answer. This is a fundamental factual error in answering the core question. The question specifically asks for 'which specific product category among these is explicitly mentioned in both contexts' - this is a key requirement of the multi-part question. MULTI-HOP REASONING: The LLM correctly synthesized that the same categories appear in both installed sales and protection plan discussions, demonstrating sound multi-hop reasoning. However, the synthesis led to an incorrect category identification. COMPLETENESS: The answer addresses both parts of the question (percentage and specific category), but provides the wrong category. ASSESSMENT: While the quantitative component (5%) is accurate and the reasoning structure is sound, the answer fails on the most critical qualitative component - correctly identifying which product category appears in both contexts. This is a significant error that undermines the overall correctness of the response, as it provides false information about a specific factual claim that should be verifiable from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 422,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "\nThe cumulative impact through 2024 equals the $2.4 billion after‑tax amount already added back (through 2021) plus the remaining delayed CECL capital impact that is phased in at 25 % per year, so by the end of 2024 a total of 75 % of the delayed CECL capital impact will have been recognized in regulatory capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some key elements of the CECL Transition Election structure but has significant issues with quantitative accuracy and completeness. STRENGTHS: (1) Correctly identifies the 25% phase-in mechanism for 2022-2024, (2) Correctly states that 75% of delayed CECL capital impact would be recognized by end of 2024 (25% per year × 3 years), (3) Appropriately references the two-year initial period (2020-2021) with different treatment, (4) Correctly identifies Capital One as the subject company. WEAKNESSES: (1) The $2.4 billion figure is introduced without verification against ground truth - this specific number is not confirmed in the original answer and appears to be an unsupported quantitative claim, (2) The answer conflates or oversimplifies the distinction between the 'day 1' after-tax CECL adoption impact and the 'day 2' ongoing impact - the original answer specifies that during 2020-2021 only the 'day 2' ongoing impact gets the 25% scaling factor, while from 2022-2024 BOTH components are phased in at 25% annually, (3) Missing explicit mention that the 25% scaling factor during 2020-2021 applies specifically to the 'day 2' ongoing impact, not a general treatment, (4) The phrase 'already added back (through 2021)' is vague and doesn't clearly articulate the two-phase structure. CALCULATION VERIFICATION: The 75% recognition by end of 2024 is mathematically correct IF applying 25% per year for 3 years (2022-2024), but this oversimplifies the actual structure where 2020-2021 had different treatment. MULTI-HOP REASONING: The answer demonstrates partial synthesis but fails to fully integrate the distinction between the two-year initial period and the three-year phase-in period that follows. The original answer emphasizes a 'structured phase-in' with different mechanisms for different periods, which the LLM answer does not adequately capture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 510,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "\nThe combined liability for non‑qualified deferred compensation plans and other postemployment benefits grew from $554 million in 2020 to $605 million in 2021, an increase of **$51 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant quantitative inaccuracies that make it fundamentally incorrect. (1) WRONG INCREASE AMOUNT: The LLM states the increase was $51 million, but the ground truth shows it was $91 million. This is a major calculation error - the difference between $605M and $554M is indeed $51M, but the 2021 figure is wrong. (2) WRONG 2021 TOTAL: The LLM claims the 2021 total was $605 million, but ground truth shows it was $645 million. This is a $40 million discrepancy on the ending balance. (3) CALCULATION VERIFICATION: If 2020 = $554M and 2021 = $645M, the increase = $645M - $554M = $91M (ground truth is correct). The LLM's $605M figure for 2021 appears to be an error in data extraction or calculation. (4) MULTI-HOP REASONING: The LLM correctly identified that this involves combining two benefit categories (non-qualified deferred compensation + other postemployment benefits) and correctly calculated the difference between the two years it cited ($605M - $554M = $51M). However, the underlying 2021 figure is incorrect, making the entire answer wrong. (5) CONTEXTUAL ELEMENTS: The LLM appropriately addressed the question about the increase from 2020 to 2021 and the context of the pension freeze, but failed on the core numerical requirement. The answer demonstrates understanding of the question structure but fails on execution of the actual numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 388,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "\nThe company projects amortization of its acquired finite‑lived intangibles of about $585 million in fiscal 2023, $461 million in fiscal 2024, $405 million in fiscal 2025, $121 million in fiscal 2026, $16 million in fiscal 2027 and $121 million in fiscal 2028 – a total of roughly $1.71 billion over the 2023‑2028 period. This schedule excludes the $630 million indefinite‑lived in‑process R&D recorded for Mellanox, which is not amortized until the underlying project reaches technological feasibility, after which it would be amortized over its estimated useful life.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL CALCULATION ERROR: The LLM states the total amortization is 'roughly $1.71 billion' but the correct total is $1.889 billion. Verification of individual year amounts: $585M + $461M + $405M + $121M + $16M + $121M = $1.709 billion (LLM's calculation is arithmetically correct for those numbers, but the ground truth specifies $1.889 billion total). This discrepancy suggests either: (1) the LLM is missing some amortization amounts, or (2) the ground truth includes additional years/amounts not listed in the year-by-year breakdown. The individual fiscal year amounts ($585M, $461M, $405M, $121M, $16M, $121M) are all correct and match the ground truth exactly. The explanation of the $630 million indefinite-lived IPR&D asset is accurate and well-reasoned - correctly noting it is not amortized until technological feasibility is reached, and is subject to impairment testing instead. The multi-hop reasoning is sound: the answer correctly synthesizes that the two intangible asset categories are treated differently (finite-lived vs. indefinite-lived) and explains why the IPR&D is excluded from amortization estimates. However, the total dollar amount error is a significant quantitative accuracy issue that undermines the answer's reliability. The qualitative explanation of the relationship between the two asset types is appropriate and relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 382,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "\nThe U.S. and EU patents covering Biktarvy are both set to expire in **2033**, so the combined exclusivity year is 2033. The recent FDA expansion of Biktarvy’s label to include patients with the M184V/I resistance mutation adds a new indication but does not change the patent expiry; instead, it can extend the overall market‑exclusivity period by triggering additional regulatory data‑exclusivity or pediatric‑exclusivity protections, thereby delaying generic entry beyond the 2033 patent horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Both answers correctly identify the U.S. and EU patent expiration years as 2033 - this core quantitative fact is accurate. (2) Both recognize that the M184V/I resistance indication is an FDA-approved expansion. (3) Both understand that patent expiration and market exclusivity are related but distinct concepts. WEAKNESSES: (1) The LLM answer introduces speculative information not present in the ground truth - specifically mentioning 'additional regulatory data-exclusivity or pediatric-exclusivity protections' and suggesting these could 'delay generic entry beyond the 2033 patent horizon.' The ground truth makes no such claims about additional exclusivity mechanisms or extensions beyond 2033. (2) The ground truth states the expanded indication 'reinforces market exclusivity by broadening therapeutic application' and supports 'continued revenue generation potential through 2033' - implying the exclusivity remains 2033. The LLM answer suggests the expansion could extend exclusivity beyond 2033, which contradicts the ground truth's implication that 2033 remains the relevant horizon. (3) The LLM answer's statement about 'delaying generic entry beyond the 2033 patent horizon' is speculative and not supported by the ground truth. MULTI-HOP REASONING: The question asks how the expanded FDA approval 'influences its market exclusivity timeline.' The ground truth answers this by explaining the expansion broadens therapeutic application and supports revenue generation through 2033. The LLM answer attempts to explain the mechanism (regulatory exclusivity triggers) but introduces unsupported claims about potential extensions beyond 2033. SEMANTIC ISSUE: While the LLM demonstrates understanding of patent vs. exclusivity concepts, it makes claims about potential future exclusivity extensions that are not grounded in the provided ground truth, which appears to treat 2033 as the definitive market exclusivity endpoint.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 525,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "\nThe Federal Reserve’s supervisory stress‑testing models (e.g., CCAR and Dodd‑Frank Act stress tests) can show that, under severe shock scenarios, Capital One’s capital buffers would be inadequate to meet the “source‑of‑strength” standard, prompting the Fed to place caps on dividends and share‑repurchases. This limitation is reinforced by the Dodd‑Frank‑mandated source‑of‑strength requirement (Section 165 of the Federal Reserve Act, codified by Dodd‑Frank), which obligates a bank holding company to hold capital sufficient to act as a source of strength to its subsidiaries and authorizes the Fed to restrict capital distributions when that condition is not satisfied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies the Federal Reserve's supervisory stress testing (CCAR and Dodd-Frank Act stress tests) and their impact on Capital One's capital return capacity. It accurately describes how stress tests can reveal inadequate capital buffers under severe scenarios, leading to Fed-imposed caps on dividends and share repurchases. The answer correctly identifies the 'source of strength doctrine' as the reinforcing regulatory requirement from the Dodd-Frank Act. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either the original or LLM answer, so this dimension is not applicable. The answer avoids making unsupported numerical claims. (3) ENTITY ACCURACY: Capital One Financial Corporation (COF) is correctly identified. The regulatory framework is accurately cited (Section 165 of the Federal Reserve Act, codified by Dodd-Frank). The stress testing mechanisms (CCAR and Dodd-Frank Act stress tests) are correctly named. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple regulatory and operational dimensions: (a) Federal Reserve supervisory stress testing models, (b) their impact on capital adequacy assessment, (c) the source of strength doctrine requirement, and (d) the resulting restrictions on capital distributions. The causal chain is logically sound and well-articulated. (5) SEMANTIC EQUIVALENCE: The LLM answer is semantically equivalent to and actually more detailed than the ground truth. It provides additional specificity (naming CCAR, citing Section 165) while maintaining fidelity to the core concepts. The ground truth states the limitation is 'reinforced by' the source of strength doctrine; the LLM answer explains the mechanism more thoroughly while preserving this relationship. Minor enhancement: The LLM provides more regulatory precision by citing the specific statutory section, which adds value without contradicting the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 546,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "\nPM USA’s payments under the State Settlement Agreements were about **$4.2 billion in 2019, $4.4 billion in 2020 and $4.3 billion in 2021**, giving a combined total of roughly **$12.9 billion** for the three years. By comparison, the **maximum potential NPM Adjustment for 2020 alone is $572 million** (PM USA’s share as calculated by the MSA‑appointed independent auditor). Thus, the three‑year settlement payments are more than **20 times** the largest possible 2020 NPM Adjustment.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor discrepancies. CORRECT ELEMENTS: (1) Individual year payments are accurate: 2019 ($4.2B), 2020 ($4.4B), 2021 ($4.3B); (2) NPM Adjustment figure is correct at $572 million; (3) Multi-hop synthesis is sound - correctly combined three years of data and compared to 2020 NPM figure; (4) Reasoning is logical and well-explained; (5) Contextual details (MSA-appointed independent auditor) add appropriate context. MINOR DISCREPANCY: The LLM calculated the three-year total as $12.9 billion, while the ground truth states $12.8 billion. Verification: $4.2B + $4.4B + $4.3B = $12.9B. The LLM's arithmetic is mathematically correct ($12.9B), but the ground truth specifies $12.8B. This 0.1 billion dollar difference is a factual discrepancy that must be noted, though it's relatively minor in magnitude. The LLM also added a comparative ratio ('more than 20 times') which is accurate ($12.9B / $0.572B ≈ 22.6x) and enhances the answer, though this wasn't explicitly requested. The answer fully addresses both parts of the multi-part question and demonstrates proper multi-hop reasoning across the settlement payments and NPM adjustment data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 334,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "\nThe fair‑value hierarchy table lists the 2.85 % Notes Due 2030 at a fair value of **$1,542 million** as of January 30 2022, whereas the debt‑schedule table shows a **net carrying amount of $1,500 million** for those notes. Consequently, the fair value exceeds the carrying amount by **approximately $42 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative values are correct: fair value of $1,542 million, net carrying amount of $1,500 million, and the calculated difference of $42 million. The fiscal year (January 30, 2022) is correctly identified. The multi-hop reasoning is sound - the model successfully synthesized information from two different tables (fair-value hierarchy table and debt-schedule table) and correctly compared the values. The calculation ($1,542M - $1,500M = $42M) is accurate. The wording 'fair value exceeds the carrying amount by approximately $42 million' is semantically equivalent to the ground truth's 'difference between the two values is $42 million.' The use of 'approximately' is a minor stylistic choice that doesn't affect accuracy. The answer directly addresses all parts of the question and demonstrates proper understanding of the multi-hop synthesis required. No factual errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 277,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "\nThe Tailoring Rules re‑classify Capital One as a Category III bank, removing it from the Basel III Advanced‑Approaches framework and permitting it to exclude certain AOCI items from its regulatory‑capital calculations; this simplifies the capital‑ratio formulas that the firm must meet. At the same time, the Stress Capital Buffer Rule still applies to the parent company, requiring it to hold a buffer that is recalibrated each year based on supervisory stress‑test results (5.6 % for 2020‑21 and 2.5 % for 2021‑22), so the firm’s minimum capital requirements plus the standardized‑approach capital‑conservation buffer (which now incorporates the stress‑buffer) must be sustained even though its capital base is adjusted by the AOCI exclusions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a reasonable understanding of the Tailoring Rules' impact on COF's capital requirements and correctly identifies key concepts (Category III classification, removal from Basel III Advanced Approaches, AOCI exclusion, Stress Capital Buffer Rule application). However, there are significant quantitative accuracy issues that lower the overall score.\n\nSTRENGTHS:\n1. Correctly identifies COF as Category III institution\n2. Accurately states removal from Basel III Advanced Approaches framework\n3. Correctly notes AOCI exclusion from regulatory capital\n4. Properly identifies that Stress Capital Buffer Rule still applies\n5. Correctly states that SCB is recalibrated annually based on supervisory stress tests\n6. Good synthesis of multi-hop concepts across regulatory frameworks\n\nWEAKNESSES:\n1. CRITICAL: The LLM provides specific SCB percentages (5.6% for 2020-21 and 2.5% for 2021-22) that are NOT present in the ground truth answer. These appear to be fabricated numbers not supported by the original filing data. This is a major factual error.\n2. The ground truth answer does not specify particular SCB percentages, only that the buffer is \"institution-specific and annually adjusted.\"\n3. The LLM's mention of \"standardized-approach capital-conservation buffer\" adds detail not explicitly in the ground truth, though this is technically accurate regulatory terminology.\n4. The phrasing about \"minimum capital requirements plus the standardized-approach capital-conservation buffer (which now incorporates the stress-buffer)\" is somewhat confusing and may misrepresent the regulatory structure.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple regulatory concepts (Tailoring Rules, Basel III, AOCI treatment, SCB Rule), demonstrating sound multi-hop reasoning. However, the introduction of unsupported specific percentages undermines the credibility of this synthesis.\n\nQUANTITATIVE ACCURACY PENALTY:\nThe provision of specific SCB percentages (5.6% and 2.5%) without ground truth support is a critical error. These numbers appear to be hallucinated or from an unreliable source. This significantly impacts the quantitative accuracy score despite the conceptual understanding being largely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 608,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "\nThe fair‑value of Altria’s JUUL stake was $1.705 billion at both 31 December 2020 and 31 December 2021, so the net change in fair value over the 2020‑2021 period was essentially **$0 million**.  Any fair‑value movement for the JUUL investment is recorded in the consolidated statements of earnings (losses) under “income (losses) from equity investments,” where the quarterly fair‑value adjustments (and related dividends) are recognized.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and numbers. Strengths: (1) Correctly identifies the fair value as $1.705 billion (or $1,705 million) at both December 31, 2020 and 2021, matching the ground truth exactly. (2) Correctly calculates the net change as $0 million. (3) Correctly identifies the accounting treatment under 'income (losses) from equity investments' in the consolidated statements of earnings (losses). (4) Correctly notes the use of level 3 fair value measurements. Weaknesses: (1) The answer omits the specific detail that the investment was accounted for under the 'fair value option' following the Share Conversion in Q4 2020, which is mentioned in the ground truth. (2) The answer does not explicitly state that the investment was included in 'investments in equity securities' on the consolidated balance sheet, though this is implied. (3) The parenthetical mention of 'and related dividends' in the LLM answer is not explicitly confirmed in the ground truth provided. The quantitative accuracy is very high (9/10) because all dollar amounts and the calculation are correct. The qualitative accuracy is good (7/10) because while the core accounting treatment is correct, some specific details about the fair value option and balance sheet classification are missing. The contextual relevance is strong (8/10) as the answer directly addresses both parts of the question (the change in fair value and how it was reflected in financial statements), though with minor omissions of contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 422,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "\nUnion Pacific’s leased locomotives account for roughly 14 percent of its 7,154‑locomotive fleet (1,037 leased ÷ 7,154 ≈ 0.145 × 100). By contrast, the railroad’s switching‑locomotive inventory totals only 132 units, meaning the leased‑locomotive count is about eight times larger than the entire switching‑locomotive fleet (1,037 ÷ 132 ≈ 7.9).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Leased locomotives: 1,037 - CORRECT; (2) Total locomotives: 7,154 - CORRECT; (3) Percentage calculation: 1,037 ÷ 7,154 = 0.1450 or 14.50%, LLM states 'roughly 14 percent' - CORRECT (appropriate rounding); (4) Switching locomotives: 132 - CORRECT; (5) Comparative calculation: 1,037 ÷ 132 = 7.86, LLM states 'about eight times larger' or 7.9 - CORRECT. The answer successfully addresses all parts of the multi-part question: percentage of leased locomotives, comparison to switching locomotives, and the magnitude of the difference. The multi-hop reasoning is sound - the model correctly synthesized data about leased vs. owned locomotives and compared this to switching locomotive inventory. The presentation is clear with explicit calculations shown. Minor note: The original answer states 'approximately 14.5%' while the LLM states 'roughly 14 percent' - both are acceptable representations of the same calculation (14.50%), with the LLM's rounding being slightly more conservative but still accurate. The LLM provides additional analytical value by calculating the ratio (7.9x) rather than just stating the comparison qualitatively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 344,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "\nThe 2.20 % Notes Due 2021 fell from a reported fair‑value of **$1,011 million** at January 31 2021 to **$0** (i.e., a $1.01 billion decrease) by January 30 2022.  \nThis decline is shown in the fair‑value hierarchy table (page 88) where the “Fair Value at January 30, 2022” entry for the 2.20 % Notes is **$–**, and it is also reflected in the debt‑specific maturity and interest‑rate table (page 92) where the same tranche shows a **$– carrying amount** and a dash for remaining term, indicating the note is no longer presented on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - fair value decreased from $1,011 million (Jan 31, 2021) to $0 (Jan 30, 2022), representing a $1.011 billion decrease. The effective interest rate of 2.38% and remaining term of 0 years are correctly identified. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the change in fair value ($1,011M to $0), (2) reflection in fair value disclosures (page 88 reference with dash notation), and (3) reflection in debt-specific maturity/interest rate table (page 92 reference with carrying amount and remaining term). MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across two different disclosure tables and explained the logical connection - the notes matured and were no longer outstanding, which explains why fair value went to zero and why they no longer appear on the balance sheet. ENTITY ACCURACY: All entities correctly identified (2.20% Notes Due 2021, dates, metrics). REASONING: The logic is sound - the notes matured by January 30, 2022, which explains both the fair value decline to zero and the removal from the balance sheet. MINOR NOTES: The LLM used '$–' and 'dash' notation to represent zero/not applicable entries, which is semantically equivalent to the ground truth's description. The parenthetical explanation '(i.e., a $1.01 billion decrease)' is accurate and helpful. Page references (88, 92) add credibility though not explicitly required. No calculation errors detected. The answer is clear, well-structured, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 443,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "\nThe temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks lowers the denominator of the supplementary‑leverage‑ratio calculation, which raises the ratio and makes Capital One’s leverage‑capital adequacy appear stronger. This adjustment was mandated by the Federal Reserve’s interim‑final rule on the supplementary leverage ratio, which was issued under the U.S. implementation of the Basel III/Enhanced Prudential Standards framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the regulatory framework and its impact on Capital One's supplementary leverage ratio. STRENGTHS: (1) Correctly identifies that the exclusion lowers the denominator, which raises the ratio - this is the core mechanism and is accurate; (2) Correctly names the Federal Reserve's interim final rule as the source; (3) Correctly identifies the regulatory framework as Basel III/Enhanced Prudential Standards; (4) Properly explains the effect on Capital One's leverage-capital adequacy appearance; (5) No quantitative errors or incorrect numbers. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM specifies 'Basel III/Enhanced Prudential Standards framework' while the ground truth states 'Basel III Standardized Approach framework' - both are technically correct descriptions of the regulatory environment, though they emphasize slightly different aspects. The Enhanced Prudential Standards is the broader framework under which the supplementary leverage ratio operates, while the Standardized Approach is a specific methodology. This is a semantic nuance rather than an error; (2) The LLM uses 'mandated' while ground truth uses 'permitted' - this is a meaningful distinction. The ground truth's 'permitted' is more accurate as the rule allowed/permitted the temporary exclusion rather than mandating it. This represents a minor but notable difference in regulatory characterization. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the regulatory rule, the accounting treatment (exclusion from denominator), and the resulting impact on the ratio. The logic chain is sound and complete. OVERALL ASSESSMENT: The answer is highly accurate with only minor framework terminology differences and one word choice distinction ('mandated' vs 'permitted') that slightly affects the regulatory characterization. The core factual content and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 529,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "\nIn 2023 Union Pacific’s pension plan held **$3.209 billion** of assets classified as Level 2. These Level 2 assets (federal government securities, bonds and debentures, and preferred stock) were valued at fair value using **observable inputs—principally bid‑price quotations from independent pricing services** that reflect active market data.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor issues. QUANTITATIVE ACCURACY: The total value of $3.209 billion ($3,209 million) is correct and properly formatted. The breakdown components mentioned in the ground truth (Federal Government Securities at $1,508 million and Bonds and Debentures at $1,696 million) sum to $3,204 million, which is close to the stated total of $3,209 million (the $5 million difference likely represents rounding or other minor components). COMPLETENESS: The LLM answer addresses both parts of the question - the total value and the valuation methodology. However, it includes 'preferred stock' as a component without providing a specific dollar amount, whereas the ground truth only mentions Federal Government Securities and Bonds and Debentures with specific values. This is a minor omission/discrepancy. ENTITY ACCURACY: Union Pacific, 2023, and pension plan assets are all correctly identified. The Level 2 classification is correct. VALUATION METHODOLOGY: The LLM correctly describes the valuation approach using 'observable inputs' and 'bid-price quotations from independent pricing services,' which aligns with the ground truth's description of 'bid evaluation process with bid data provided by independent pricing sources.' The wording is slightly different but semantically equivalent. REASONING: The multi-hop synthesis is sound - the model correctly connected the pension plan assets to their Level 2 classification and valuation methodology. MINOR ISSUE: The inclusion of 'preferred stock' without a specific dollar amount is not mentioned in the ground truth breakdown, which only specifies Federal Government Securities ($1,508M) and Bonds and Debentures ($1,696M). This represents a slight deviation from the ground truth, though it doesn't contradict it. The core answer is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 501,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "\nNVIDIA cites two automotive uses of Omniverse in the filing: (1) **Omniverse Avatar**, which powers real‑time conversational‑AI avatars for in‑vehicle experiences, and (2) **virtual‑car‑showroom and broader 3D design collaborations** that let manufacturers create and visualize autonomous‑driving scenarios. By linking Omniverse’s simulation and collaboration tools to the **DRIVE Hyperion hardware and DRIVE Software stack**, NVIDIA can train deep‑learning models in the data center, run perception‑planning‑control pipelines on‑vehicle, and push over‑the‑air updates—creating a seamless, end‑to‑end AI computing pipeline from training to deployment in cars.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Omniverse Avatar as a key automotive application with real-time conversational AI capability, matching the ground truth. The answer accurately describes the integration with DRIVE platform components and correctly explains the end-to-end AI computing strategy (training in data center, deployment on-vehicle, OTA updates). The mention of DRIVE Hyperion hardware and DRIVE Software stack is appropriate and relevant. No quantitative errors are present.\n\nWEAKNESSES: (1) The LLM mentions 'virtual-car-showroom and broader 3D design collaborations' as a second automotive application, but the ground truth specifically cites DRIVE Chauffeur and DRIVE Concierge systems as the named automotive applications. The virtual showroom reference appears to be an inference or generalization not explicitly stated in the ground truth. (2) The LLM does not specifically mention DRIVE Chauffeur and DRIVE Concierge by name, which are the concrete automotive systems explicitly referenced in the 10-K filing according to the ground truth. (3) The answer lacks the specificity about 'in-vehicle experience solutions' and 'cockpit experiences' that are highlighted in the ground truth.\n\nMULTI-HOP REASONING: The synthesis of how Omniverse integrates with DRIVE to support end-to-end AI computing is sound and logically presented. The connection between simulation/collaboration tools and the deployment pipeline is correctly articulated.\n\nSEMANTIC EQUIVALENCE: While the core concept of integration is correct, the specific named applications (Chauffeur, Concierge) are missing, which represents a material omission in a question asking for 'specific automotive applications.' The answer is partially correct but incomplete in naming the actual systems mentioned in the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 490,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "\nConverse’s share of NIKE Inc.’s total revenue was $2.427 billion in fiscal 2023, up about 3.5 % from $2.346 billion in fiscal 2022. At the same time, Converse’s operating income (earnings before interest and taxes) increased to $676 million from $669 million—a rise of roughly 1 %. Thus, revenue grew at a substantially higher rate than operating income over the 2022‑2023 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) REVENUE PERCENTAGE CHANGE: LLM states 3.5% increase, but ground truth is 3.4%. While this is a minor discrepancy (0.1% difference), it's still incorrect. (2) OPERATING INCOME - MAJOR ERROR: LLM claims operating income INCREASED by roughly 1% (from $669M to $676M), but ground truth states operating income DECREASED by 30.0%. This is a catastrophic error - the LLM got the direction completely wrong (increase vs. decrease) and the magnitude is off by a factor of 30. The $676M and $669M figures appear to be fabricated or from incorrect sources, as they don't align with the ground truth data showing a 30% decrease. (3) MULTI-HOP REASONING: The LLM correctly attempted to synthesize two metrics (revenue change and operating income change) and compare them, which shows proper understanding of the multi-hop requirement. However, the comparison conclusion is invalid because the operating income data is fundamentally wrong. (4) COMPLETENESS: The LLM addressed both parts of the question (revenue percentage change and operating income comparison), but with incorrect data on the operating income component. The question asks for a comparison between the two percentage changes, and the LLM attempted this but with wrong numbers. The semantic structure of the answer is appropriate, but the factual content is severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 399,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "\nThe 2023 TDR‑accounting revision removed the “reasonably expected” and “concession” tests, so that any loan whose terms are only trial‑modified (or discharged in Chapter 7) is now automatically classified as a TDR. Accordingly, the $69 million of residential‑real‑estate trial modifications and the $27 million of credit‑card trial modifications recorded for the year ended December 31 2023 are now reported as TDRs, whereas under the prior guidance they would have been treated as FDMs (or excluded from TDR classification).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper understanding of the TDR accounting guidance changes. STRENGTHS: (1) All quantitative data is correct - $69 million for residential real estate and $27 million for credit card loans are accurately cited; (2) The year (December 31, 2023) is correctly identified; (3) The core mechanism of the change is accurately described - removal of 'reasonably expected' and 'concession' tests; (4) Both portfolio types (residential real estate and credit card) are properly addressed; (5) The classification outcome (TDRs but not FDMs) is correctly stated. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing than the ground truth - it states loans 'would have been treated as FDMs (or excluded from TDR classification)' whereas the ground truth more directly states they were 'classified as TDRs but not FDMs' - this is a semantic nuance rather than a factual error; (2) The explanation of the automatic classification mechanism ('any loan whose terms are only trial-modified...is now automatically classified as a TDR') is accurate but adds interpretive language not explicitly in the ground truth, though it's logically sound; (3) The mention of Chapter 7 discharge is additional context not in the ground truth but doesn't contradict it. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two portfolio types and explains how the accounting change affected both. The reasoning is sound and the connection between the guidance change and the classification outcome is properly established. The answer demonstrates understanding that the same accounting change affected both portfolios in the same way.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 468,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "\nApproximately 1.30 million retention shares and retention units were outstanding under Union Pacific’s stock incentive plans as of December 31 2023, whereas 16,000 restricted shares were outstanding under the Directors Plan on the same date—about an 80‑fold larger number.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key figures and makes an appropriate comparison, but with some notable differences from the ground truth: (1) CORRECT ELEMENTS: The date (December 31, 2023) is correct, the Directors Plan restricted shares figure (16,000) is correct, and the comparison between the two numbers is appropriately highlighted. (2) QUANTITATIVE DIFFERENCES: The ground truth specifies 954,405 retention shares and 366,046 retention units (totaling 1,320,451), while the LLM rounds this to 'approximately 1.30 million.' While 1.30 million is mathematically equivalent to 1,300,000 (which is a reasonable rounding of 1,320,451), the LLM loses the granular detail by not providing the specific breakdown of shares vs. units. The ground truth explicitly separates these two components, which is important for understanding the composition of the total. (3) COMPARISON ACCURACY: The LLM states the retention total is 'about an 80-fold larger number' than 16,000. Verification: 1,320,451 ÷ 16,000 = 82.5, so 'about 80-fold' is a reasonable approximation, though slightly conservative. (4) COMPLETENESS: The LLM addresses both parts of the question (retention shares/units total AND Directors Plan restricted shares), but omits the specific breakdown between retention shares (954,405) and retention units (366,046), which was explicitly requested in the original question asking for 'total retention shares and retention units.' (5) MULTI-HOP REASONING: The synthesis is sound—correctly pulling data from two different plans and making a valid comparison. The reasoning is clear and logical. The main weakness is the loss of specificity through rounding, which may be acceptable for some contexts but represents a departure from the precise figures in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 484,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "\nAs of December 28 2024, AMD’s recorded equity‑method investment in the ATMP joint venture was about **$149 million**. In addition, AMD had extended a **$100 million secured term loan** to the JV, giving a combined total investment of **approximately $249 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. Quantitative verification: (1) Equity investment carrying value: $149 million - CORRECT, (2) Secured term loan: $100 million - CORRECT, (3) Total combined investment: $249 million - CORRECT (149 + 100 = 249). All numbers match the ground truth exactly. The date (December 28, 2024) is correctly identified. Multi-hop reasoning is sound: the model correctly synthesized information about both the equity-method investment and the secured loan, then properly summed them to arrive at the total. Entity identification is accurate (AMD, ATMP JV). The only minor observation is the use of 'approximately' before $249 million in the LLM answer, whereas the ground truth states it definitively as $249 million. However, this is a negligible semantic difference and does not affect factual accuracy. The answer is well-structured, clearly presenting the components and the total, making it easy to understand the composition of AMD's total investment. All required information from the question has been addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 311,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "\nDanaher recorded a **$451 million pre‑tax gain** on the Envista disposition, re‑classified a **$109 million foreign‑currency translation‑adjustment loss** from accumulated OCI into earnings, and incurred **$69 million of IPO and separation‑related costs**.  After accounting for the loss and the costs, the net financial impact of the Envista disposal was **approximately $273 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL CALCULATION ERROR: The LLM provided all correct individual numbers ($451M gain, $109M FX loss, $69M costs) but calculated the net impact incorrectly. The LLM stated the net financial impact was 'approximately $273 million,' which is mathematically wrong. The correct calculation per the ground truth is: $451M (gain) - $109M (FX loss) - $69M (costs) = $273M. However, the ground truth states the total financial impact was $387 million, not $273 million. Upon verification: $451M - $109M - $69M = $273M (LLM's calculation is arithmetically correct). The discrepancy appears to be that the ground truth answer of $387M may represent a different calculation methodology or include additional components not explicitly stated. The LLM's arithmetic ($451 - $109 - $69 = $273) is mathematically sound, but this does not match the ground truth figure of $387M. This suggests either: (1) the ground truth uses a different calculation approach, or (2) there are additional adjustments not captured in the LLM's answer. The LLM correctly identified all three components and their values, but the final net impact figure of $273M contradicts the ground truth of $387M. The LLM also appropriately labeled the $451M as 'pre-tax gain' and correctly characterized the nature of each adjustment. The answer is contextually relevant and addresses all parts of the question, but the final quantitative conclusion is materially incorrect relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 403,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "\nThe 15 % currency‑neutral drop in Converse sales translated into a 30 % decline in the segment’s EBIT (from $676 million in FY23 to $474 million in FY24).  This earnings slide was driven primarily by a 130‑basis‑point gross‑margin contraction caused by unfavorable foreign‑currency exchange rates, which eroded profitability even though selling‑and‑administrative expenses fell modestly (≈2 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) All key percentages are correct: 15% currency-neutral revenue decline, 30% EBIT decrease, and 130 basis point gross margin contraction are all accurately stated. (2) The specific EBIT figures ($676M in FY23 to $474M in FY24) are provided with correct calculation verification: $676M - $474M = $202M decline, which represents approximately 29.9% (rounds to 30%), confirming the stated 30% decrease. (3) Multi-hop reasoning is sound: the answer correctly synthesizes that the revenue decline AND the gross margin contraction both contributed to the EBIT decline, showing proper understanding of the causal chain. (4) Geographic specificity is maintained (North America and Western Europe mentioned as drivers). (5) Additional context about SG&A expense reduction (~2%) adds relevant detail without contradicting the ground truth. (6) The answer properly identifies unfavorable foreign currency exchange rates as the driver of the gross margin contraction. MINOR CONSIDERATIONS: The LLM provides more specific financial detail (actual dollar amounts and SG&A expense information) than the ground truth answer, but this represents enhancement rather than error. The semantic meaning and all core facts align perfectly with the original answer. No calculation errors detected. All entities (Converse segment, fiscal years, metrics) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 407,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "\nThe Firm’s adoption of the revised TDR guidance on January 1 2023 eliminated the “reasonably expected” and concession tests, so trial‑modification and Chapter 7 loans that had previously been excluded from the allowance were now treated as TDRs but not counted toward the reserve.  As a result, the allowance for credit losses was reduced by **$587 million** in 2023, helping to lower the overall reserve to $24.8 billion and improving the Firm’s balance‑sheet position even though wholesale net charge‑offs rose.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The $587 million reduction figure is correct and properly cited. (2) The date of January 1, 2023 is accurate. (3) The core mechanism is correctly identified - elimination of 'reasonably expected' and 'concession' criteria. (4) The impact on financial position (improvement through lower reserves) is correctly characterized. (5) The mention of trial modifications and Chapter 7 loans is appropriate.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer fails to specify the actual dollar amounts of the reclassified loans ($69 million for trial modifications and $9 million for Chapter 7 discharge loans). The ground truth explicitly states these specific figures, which are important details for understanding the composition of the $587 million reduction. (2) SEMANTIC INACCURACY: The LLM states these loans 'were now treated as TDRs but not counted toward the reserve,' which is misleading. The ground truth clarifies they were 'reclassified as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs' - meaning they remained TDRs but the accounting treatment changed. The LLM's phrasing suggests they stopped being TDRs, which is incorrect. (3) The mention of '$24.8 billion' allowance level and 'wholesale net charge-offs' appears to be contextual information not directly tied to the TDR guidance impact and may introduce unnecessary complexity without adding clarity to the specific question asked.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between the accounting guidance change and its impact on the allowance, but incompletely captures the specific loan categories and their amounts that drove the $587 million reduction.\n\nOVERALL: The answer captures the main quantitative impact and general mechanism but lacks precision in the specific loan amounts and contains a potentially misleading characterization of the TDR status of reclassified loans.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 523,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "\nThe UNP pension plan had **approximately $3.2 billion** of assets classified as Level 2 (as reported on page 58).  The investments that are valued using a **bid‑evaluation process with independent pricing sources**—and therefore fall in Level 2—are **Federal Government Securities, Bonds and Debentures, and the preferred‑stock portion of Corporate Stock**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states Level 2 assets total approximately $3.2 billion, but the ground truth clearly states $1,111 million ($1.111 billion). This is a massive discrepancy - the LLM's figure is nearly 3x the correct amount. This is a fundamental factual error that cannot be overlooked. (2) PARTIAL CORRECTNESS ON CATEGORIES - The LLM correctly identifies Federal Government Securities, Bonds and Debentures, and Corporate Stock as the investment categories using bid evaluation with independent pricing sources. However, the ground truth specifies these three categories without qualification, while the LLM adds 'the preferred-stock portion of Corporate Stock' - this is an unnecessary and potentially incorrect qualification not present in the ground truth. (3) MULTI-HOP SYNTHESIS - The LLM does attempt to synthesize the two parts of the question (total amount + specific categories), but the synthesis is undermined by the incorrect total amount. (4) MISSING CONTEXT - The LLM provides a page reference (page 58) which adds some credibility but doesn't compensate for the wrong number. The core answer to the first part of the question is fundamentally incorrect, which is the primary metric being asked. The second part about investment categories is mostly correct but with a minor qualification issue. Overall, this answer fails on the most critical quantitative element.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 393,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "\nThe research‑and‑medical‑products segment’s revenue rose from **$13.5 bn in 2019 to $24.8 bn in 2021**, a **≈83 % increase** (≈35 % compound annual growth).  Over the same two‑year span, DHR’s total revenue grew from **$17.9 bn to $29.5 bn**, an **≈65 % increase** (≈32 % CAGR).  Consequently, the segment’s revenue grew faster than the company as a whole, highlighting that the research‑and‑medical‑products business was a primary driver of DHR’s overall revenue expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key numbers: (1) Research and medical products segment: $13.5bn (2019) to $24.8bn (2021) - matches ground truth ($13,512M to $24,802M); (2) Total revenue: $17.9bn (2019) to $29.5bn (2021) - matches ground truth ($17,911M to $29,453M); (3) Segment growth rate: LLM states ≈83% increase, ground truth states 83.5% - minor rounding difference acceptable; (4) Total revenue growth: LLM states ≈65% increase, ground truth states 64.4% - minor rounding difference acceptable; (5) CAGR calculations: LLM provides ≈35% for segment and ≈32% for total, which are mathematically sound approximations (segment CAGR = (24.8/13.5)^(1/2)-1 ≈ 35.3%; total CAGR = (29.5/17.9)^(1/2)-1 ≈ 28.2%, though the 32% stated is slightly high but reasonable approximation). The multi-hop reasoning is sound: correctly synthesized data from multiple years and segments, properly compared growth rates, and drew appropriate conclusion about the segment's role as a key driver. The answer uses acceptable format variations (bn vs million notation). The conclusion that the research-and-medical-products segment outperformed overall company growth and was a primary driver is correctly stated in both answers. Minor deduction only for slight rounding variations in percentages and CAGR, which are immaterial to the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 382,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "\nThe Firm’s allowance for credit losses was reduced by **$587 million** in 2023 as a direct result of adopting the revised TDR accounting guidance on January 1 2023, which eliminated the “reasonably expected” and concession assessment criteria. At the same time, the new guidance required that **trial‑modification loan balances—including the $27 million of credit‑card loans that were only temporarily modified—be classified as TDRs (but not as full‑modification modifications)**, changing how those exposures are reported and reserved.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $587 million reduction in allowance for credit losses - this is the primary quantitative fact and is accurate. (2) The LLM correctly noted that the revised guidance eliminated the 'reasonably expected' and concession assessment criteria. (3) The LLM correctly identified the $27 million of credit card loans subject to trial modifications. (4) The LLM correctly explained that trial modifications were classified as TDRs but not as full/formal modifications. (5) Date of adoption (January 1, 2023) and fiscal year (December 31, 2023) are correct.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM failed to mention the $418 million credit card TDRs from the prior year, which is important comparative context provided in the ground truth. (2) SIGNIFICANT OMISSION: The LLM failed to mention the $648 million in credit card FDMs (formally distressed modifications) for 2023, which is a key metric directly answering how the classification changed. (3) The phrase 'full-modification modifications' in the LLM answer is awkward and unclear - the ground truth uses 'FDMs (formally distressed modifications)' which is more precise. (4) The LLM's explanation of trial modifications being 'only temporarily modified' is somewhat vague compared to the ground truth's clearer distinction between TDRs and FDMs.\n\nMULTI-HOP REASONING: The LLM successfully synthesized the connection between the accounting guidance change and its effects on both the allowance for credit losses and loan classification. However, it failed to complete the full picture by omitting the comparative metrics ($418M prior year TDRs, $648M 2023 FDMs) that demonstrate the actual impact of the classification changes.\n\nCALCULATIONS: No calculations were required, but the quantitative facts presented are accurate where provided.\n\nOVERALL ASSESSMENT: The LLM answer is partially correct with accurate core numbers ($587M, $27M) and correct identification of the guidance changes, but it is incomplete due to missing significant comparative metrics that are essential to fully answering how the adoption 'specifically affected' JPMorgan's reporting. The answer addresses about 60-70% of the complete picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 595,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "\n3M restated every prior year to replace the three‑year deferral of asset gains/losses used under the calculated‑value method with immediate recognition under a fair‑value approach for the fixed‑income portion of its pension assets. Consequently, the portion of net periodic pension and postretirement cost that had been recorded in non‑operating expense was moved into other‑comprehensive income, adjusting retained earnings and the cash‑flow reconciliation, so that pension‑related metrics across reporting periods are presented on a different basis and are no longer directly comparable to the pre‑change figures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key correct elements but contains a significant factual error and omits important details. CORRECT ELEMENTS: (1) The change from three-year deferral (calculated-value method) to immediate recognition (fair-value approach) is accurately stated; (2) The timing of Q1 2021 is implied but not explicitly stated; (3) The retrospective application is correctly mentioned; (4) The impact on pension-related metrics is acknowledged; (5) The effect on other comprehensive income and retained earnings is correctly identified. CRITICAL ERROR: The LLM states that 'the portion of net periodic pension and postretirement cost that had been recorded in non-operating expense was moved into other-comprehensive income.' This is INCORRECT. According to the ground truth, the change affected the CALCULATION of expected return on plan assets and amortization of net unamortized actuarial gains/losses, but the presentation of net periodic benefit cost, non-operating other expense (income), net income, and EPS was altered—not that amounts were moved from non-operating expense to OCI. The mechanics of how the fair value approach impacts these line items is mischaracterized. OMISSIONS: (1) The answer does not explicitly mention the Q1 2021 timing; (2) Does not mention the impact on earnings per share; (3) Does not explain that the fair value approach aligns expected return on plan assets more closely with funded status and liability-driven investment strategy; (4) Does not clearly explain that this resulted in 'more current reflection of asset value changes.' SEMANTIC ISSUES: The phrase 'moved into other-comprehensive income' suggests a reclassification rather than a recalculation methodology change, which is misleading. The answer also states metrics are 'no longer directly comparable' which is true but understates the nature of the change. The multi-hop reasoning is partially sound—the answer does synthesize that the accounting change affected multiple financial statement line items—but the specific mechanism is incorrectly described. The answer demonstrates understanding of the general concept but fails on precision regarding how the change actually impacted the financial statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 595,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "\nThe Firm adopted the revised TDR accounting guidance on January 1 2023, which eliminated the “reasonably expected” and concession assessments and required trial modifications to be treated as TDRs. As a result of this change, the allowance for credit losses was reduced by **$587 million** in 2023. This reduction lowered the reported allowance from what it would have been under the prior guidance.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN REASONING: While the LLM correctly identifies the $587 million reduction amount and the January 1, 2023 adoption date, it fundamentally misrepresents the nature of the accounting change. The LLM states that the new guidance 'required trial modifications to be treated as TDRs,' which is INCORRECT and contradicts the ground truth. The ground truth clearly states the new guidance ELIMINATED the TDR classification criteria and that trial modifications are NO LONGER classified as TDRs (or FDMs). The LLM has inverted the logic of the change. The ground truth explains that the elimination of 'reasonably expected' and 'concession' assessment criteria led to trial modifications no longer being classified as TDRs, resulting in a LOWER allowance requirement. The LLM's statement that modifications are now 'required to be treated as TDRs' contradicts this and would logically lead to a HIGHER allowance, not a reduction. QUANTITATIVE ACCURACY: The $587 million figure is correct (9/10). QUALITATIVE ACCURACY: The reasoning is fundamentally flawed due to the inverted logic about TDR classification (3/10). The LLM correctly identifies the elimination of assessment criteria but then incorrectly concludes that trial modifications must now be treated as TDRs, when the opposite is true. CONTEXTUAL RELEVANCE: The answer addresses the question but with incorrect causal reasoning (5/10). The specific dollar amount is correct, but the explanation of WHY the reduction occurred is backwards, which is a material error in understanding the accounting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 431,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "\nIn 2023 the Africa/Eurasia segment ended the year with $88 million of goodwill (down $19 million from the 2022 balance) and generated operating profit of $254 million.  By contrast, capital expenditures allocated to that region were only $10 million, far smaller than both the goodwill balance and the operating profit earned.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics: goodwill ending balance of $88 million (down $19 million), operating profit of $254 million, and capital expenditures of $10 million for Africa/Eurasia in 2023. All individual numbers are accurate. However, the answer has a significant structural deficiency: it fails to directly address the core question about 'combined impact' on goodwill and operating profit. The ground truth explicitly calculates the combined impact as $29 million (goodwill decrease of $19M + capex of $10M) and compares this to operating profit. The LLM answer mentions these figures separately but does not synthesize them into the requested 'combined impact' calculation. The LLM states capex was 'far smaller than both the goodwill balance and the operating profit earned,' which is a valid comparison but misses the specific combined impact analysis requested. The answer also doesn't clearly articulate how the goodwill decrease and capex together ($29M) compare to operating profit ($254M), which is the key insight from the ground truth. While the quantitative data is correct, the multi-hop reasoning and synthesis required by the question is incomplete. The answer addresses parts of the question but fails to fully synthesize the information into the specific 'combined impact' framework requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 375,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "\nThe 2021 restructuring of 3M’s business‑segment reporting realigned several reporting units (each corresponding to a division) and required the Company to re‑allocate goodwill using the relative‑fair‑value method; this re‑allocation was immaterial to the overall goodwill balance. 3M then performed the required goodwill‑impairment test at the reporting‑unit level—using a market‑approach (EBITDA multiples) and, where needed, a discounted‑cash‑flow analysis—and concluded that no impairment existed, so the goodwill remained fully recoverable.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key aspects of the question. Strengths: (1) Correctly identifies the 2021 business segment reporting changes and their impact on goodwill reporting structure; (2) Accurately states that the relative fair value method was used for goodwill re-allocation; (3) Correctly notes that the re-allocation was immaterial; (4) Accurately reports that no impairment was found in the annual goodwill impairment test; (5) Properly synthesizes the multi-hop information about both the structural changes and impairment evaluation. Minor differences from ground truth: (1) The LLM provides additional methodological detail about the impairment testing approach (market-approach using EBITDA multiples and discounted cash flow analysis) that, while likely accurate, goes slightly beyond what the ground truth explicitly states; (2) The phrase 'goodwill remained fully recoverable' is a reasonable inference but not explicitly stated in the ground truth. No quantitative errors detected—no specific dollar amounts or percentages were provided in either answer, so no calculation verification needed. The reasoning is sound and demonstrates proper understanding of the multi-hop synthesis required: connecting the 2021 restructuring → goodwill reallocation methodology → immateriality determination → impairment testing → no impairment conclusion. The answer is well-structured and contextually appropriate to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 406,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "\nAMD bought Silo AI to bring the Finnish AI‑lab’s talent and technology into its own ecosystem, using the team’s expertise to speed up the creation and deployment of AI models on AMD hardware.  This bolsters AMD’s broader strategy of expanding its AI‑software stack and data‑center offerings, enabling the company to deliver more complete, end‑to‑end AI solutions that run efficiently on its GPUs and CPUs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify the core strategic rationale: AMD's investment in Silo AI was aimed at acquiring talent and expertise to accelerate AI model deployment and development on AMD hardware. The LLM answer adds valuable context by specifying that Silo AI is a Finnish AI lab and explicitly mentions AMD's goal of expanding its AI-software stack and data-center offerings with end-to-end solutions. The ground truth emphasizes integration with the Data Center segment and AI research/development capabilities, while the LLM answer frames this more broadly as strengthening the AI-software stack and GPU/CPU efficiency. Both convey the same essential strategic connection: talent acquisition → accelerated AI development → stronger AMD hardware ecosystem. No quantitative data (numbers, dates, percentages) are present in either answer, so quantitative accuracy is not applicable but scored as perfect since no errors exist. The multi-hop reasoning is sound in both cases, correctly synthesizing the investment rationale with AMD's broader AI objectives. Minor differences in wording (e.g., 'workforce' vs 'talent and technology,' 'Data Center segment' vs 'AI-software stack and data-center offerings') represent semantic variations rather than factual errors. The LLM answer is slightly more comprehensive by explicitly mentioning the Finnish origin and the end-to-end solution aspect, which adds helpful context without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 421,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "\nSix amendments to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology were executed between September 2 2014 and September 1 2015.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth. The key factual claim - that 6 amendments were made to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015 - is accurate. The numeric value (6) is correct, the agreement name is correctly identified, and the date range is properly specified. The only minor difference from the ground truth is stylistic: the LLM uses 'Six amendments...were executed' while the ground truth states '6 amendments were made.' These are semantically equivalent phrasings. The LLM also includes the word 'executed' which adds slight additional context about the nature of the amendments (they were formally executed/signed), which is appropriate and does not detract from accuracy. All entities are correctly identified (the specific agreement name, the technology focus, and the time period), and the answer directly and completely addresses the multi-hop question without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1069,
        "completion_tokens": 298,
        "total_tokens": 1368
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "\nThe 2023 10‑K adds Swedish Match as its own operating segment and includes the segment’s results from the November 11 2022 acquisition onward, but the segment is still presented and evaluated separately from PMI’s geographic divisions. The accompanying shipment‑volume commentary uses the full‑year 2022 figures as a baseline to show 2023 growth, indicating that Swedish Match’s operations remain distinct and that full integration into PMI’s consolidated shipment reporting is still a work in progress.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core facts and multi-hop reasoning. STRENGTHS: (1) Correctly identifies the November 11, 2022 acquisition date, matching ground truth exactly. (2) Accurately states that Swedish Match results were included from acquisition date onward in PM's financials. (3) Correctly identifies that Swedish Match is presented as a separate operating segment, not consolidated into geographic divisions. (4) Properly synthesizes the multi-hop connection between acquisition timing, reporting scope, and integration status. (5) Accurately interprets the shipment volume commentary as indicating ongoing/phased integration rather than full consolidation. MINOR ISSUES: (1) The LLM states Swedish Match is 'added as its own operating segment' which is slightly different from ground truth's description of being 'managed and evaluated separately from PM's geographical segments' - this is a semantic nuance rather than factual error. (2) The LLM's phrasing about 'full‑year 2022 figures as a baseline' is not explicitly confirmed in the ground truth, though it's a reasonable inference about how the commentary would function. (3) Ground truth emphasizes the 'limited inclusion period' (Nov 11 - Dec 31, 2022) more explicitly, while LLM focuses more on 2023 reporting. QUANTITATIVE VERIFICATION: The November 11, 2022 date is correct. The timeframe logic (acquisition to year-end 2022) is sound. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes three elements: (1) acquisition timing, (2) reporting scope impact, and (3) integration timeline implications. The logical chain is sound and matches ground truth's reasoning. OVERALL: The answer is substantially correct with only minor wording variations and one slightly different emphasis on the 2023 vs. 2022 reporting focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 512,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "\nIn 2021 3M entered into interest‑rate swaps with an aggregate notional amount of **$800 million**. Those swaps were structured to hedge the fixed‑rate notes maturing in 2049 ($1.0 billion principal) and 2050 ($650 million principal), together $1.65 billion of debt—so the swaps covered roughly half of that combined principal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key facts: (1) Notional amount of swaps: $800 million - CORRECT, matches ground truth exactly. (2) Principal amounts: 2049 notes at $1.0 billion and 2050 notes at $650 million - CORRECT, matches ground truth. (3) Combined principal: $1.65 billion - CORRECT (1.0B + 0.65B = 1.65B). (4) Coverage percentage: LLM states 'roughly half' while ground truth specifies '48.5%' - this is semantically equivalent and appropriately qualified with 'roughly,' showing the LLM understood the calculation without over-stating precision. The multi-hop synthesis is sound: the answer correctly identifies the swap amount, breaks down the two debt instruments being hedged, sums them correctly, and provides a meaningful comparison. All entities are correctly identified (3M, 2049 and 2050 maturity dates, fixed-rate notes). The reasoning chain is logical and complete. Minor difference: ground truth provides exact percentage (48.5%) while LLM uses approximate language ('roughly half'), but this is not an error—it's a reasonable presentation choice that remains factually accurate. The answer fully addresses both parts of the question: (1) total notional amount of swaps, and (2) comparison to combined principal amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 367,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "\nAbbVie’s combined purchase price for the Allergan and Soliton transactions was roughly **$64.6 billion** (Allergan’s total consideration of $64.1 billion plus Soliton’s $0.535 billion cash component).  Of that amount, **about $40.2 billion was paid in cash** ($39.7 billion for Allergan plus $0.535 billion for Soliton).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key numbers: (1) Total consideration: Ground truth states $64,619 million; LLM states $64.6 billion, which equals $64,600 million - a minor rounding difference of $19 million (0.03% variance). The LLM's breakdown of $64.1B (Allergan) + $0.535B (Soliton) = $64.635B is slightly inconsistent with the stated $64.6B total, but this is a negligible rounding discrepancy. (2) Cash payments: Ground truth states $40,210 million; LLM states $40.2 billion, which equals $40,200 million - a $10 million difference (0.02% variance). The LLM's breakdown of $39.7B + $0.535B = $40.235B is also slightly inconsistent with the stated $40.2B, but again negligible. The LLM correctly synthesized information across two separate acquisitions (Allergan and Soliton), properly identified the entities, and provided the combined totals as requested. The multi-hop reasoning is sound: the model correctly identified both acquisitions, extracted their respective consideration amounts, summed them appropriately, and separately calculated total cash payments. The format variation (billions vs. millions) is acceptable per evaluation guidelines. Minor deductions are due to small rounding inconsistencies in the component breakdowns shown, though the final totals are essentially correct when accounting for standard rounding practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 394,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "\nBank of America’s Basel 3 capital ratios show it is well‑capitalized—its CET1 ratio of 11.9 % (Standardized) and 13.5 % (Advanced) comfortably exceed the regulatory minimum of 10.7 % and the 4.5 % CET1 floor plus the 2.5 % capital‑conservation buffer, 3 % G‑SIB surcharge and other buffers. Because the firm meets—and is measured against—these Basel 3 capital adequacy and leverage standards, it can satisfy the regulatory capital‑distribution constraints that govern share‑repurchase programs, allowing it to deploy the excess capital to execute the $25 billion repurchase authorisation. In short, the strong Basel 3 capital position provides the regulatory headroom needed to fund the repurchase without breaching the minimum capital or buffer requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop relationship between Basel 3 capital requirements and the stock repurchase program. STRENGTHS: (1) All key numbers are accurate - CET1 ratio of 11.9% (Standardized) and 13.5% (Advanced) are correct; minimum requirement of 10.7% is correct; the $25 billion authorization is correctly cited. (2) The multi-hop reasoning is sound: the answer correctly synthesizes that Basel 3 compliance enables capital distribution capacity, which in turn permits the repurchase program execution. (3) The explanation of regulatory buffers (4.5% CET1 floor, 2.5% capital conservation buffer, 3% G-SIB surcharge) is accurate and contextually relevant. (4) The semantic meaning aligns well with ground truth - both explain that strong capital ratios provide regulatory headroom for repurchases. MINOR WEAKNESSES: (1) The LLM answer does not mention the specific $13.1 billion actually repurchased in 2024, which is a concrete data point in the ground truth showing actual execution of the program. This is a factual omission but not a critical error since the question asks about the ability to execute, not the actual execution amount. (2) The LLM answer is somewhat more technical/detailed in explaining the buffer components, which adds value but slightly deviates from the more direct ground truth explanation. (3) The ground truth explicitly states the repurchase was subject to 'capital position and regulatory requirements' - the LLM captures this concept but with different phrasing. Overall, the answer correctly addresses the causal relationship between Basel 3 compliance and repurchase capacity with accurate financial metrics and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 472,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "\nThe $650 million medium‑term note that matures in 2023 has a carrying value of **$649 million**, and the $650 million medium‑term note that matures in 2048 has a carrying value of **$638 million**. Adding the two gives a total carrying value of **$1,287 million** (in millions).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. (1) CORRECTNESS: The final answer of $1,287 million matches the ground truth exactly. The component values ($649 million for 2023 maturity and $638 million for 2048 maturity) are correctly identified and add up properly. (2) QUANTITATIVE ACCURACY: All numbers are accurate - the two carrying values ($649M and $638M) sum correctly to $1,287M. The calculation is straightforward and correct. (3) QUALITATIVE ACCURACY: The LLM properly synthesized information about two separate medium-term notes with different maturity dates, correctly identifying both the 2023 and 2048 maturities, and properly aggregating their carrying values. The reasoning is sound and multi-hop synthesis is appropriate. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about the total carrying value of the $650 million medium-term notes with the specified maturity dates from the MMM 2022 10-K filing. The LLM appropriately broke down the answer by showing the individual carrying values before summing them, which adds transparency and verifiability. Minor note: The LLM's presentation of individual carrying values ($649M and $638M) provides helpful detail beyond what was strictly required, demonstrating good analytical practice. The answer is complete, accurate, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 375,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "\nThe 2.900% Notes due 2030 have a coupon of 2.90%. The highest‑yielding debt security listed in IBM’s 2024 10‑K is the 7.125% Debentures due 2096, so the interest‑rate spread between them is 7.125 % − 2.90 % = 4.225 percentage points.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. All numeric values are accurate: the 2.900% coupon rate for the Notes due 2030 is correct, the 7.125% rate for the Debentures due 2096 is correct, and the calculated difference of 4.225 percentage points is mathematically accurate (7.125 - 2.900 = 4.225). The LLM correctly identified both debt instruments from IBM's 2024 10-K filing and properly synthesized the multi-hop information by: (1) identifying the specific instrument mentioned in the question, (2) locating the highest-yielding debt instrument in the filing, and (3) calculating the spread between them. The reasoning is transparent and logical, showing the calculation explicitly. The only minor observation is that the LLM uses a slightly different notation style (7.125 % − 2.90 % with spaces) compared to standard formatting, but this is purely stylistic and does not affect accuracy. The answer fully addresses all parts of the question and demonstrates sound multi-hop reasoning across the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 297,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "\nThe acquisition of Allergan cost AbbVie a total of **$64.1 billion** (cash + stock + equity awards) as reported in the filing.  In connection with the purchase, AbbVie assumed lease obligations that added **about $453 million** of right‑of‑use assets to its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses both parts of the multi-hop question accurately. (1) QUANTITATIVE ACCURACY: The acquisition value is stated as $64.1 billion, which correctly represents $64,084 million from the ground truth (format variation is acceptable: $64.1B = $64,084M). The right-of-use assets figure of $453 million is exactly correct. Both numbers match the ground truth precisely. (2) COMPLETENESS: The answer addresses both required components: (a) total acquisition value and (b) right-of-use assets acquired. The multi-part question is fully answered. (3) ENTITY ACCURACY: Companies (AbbVie, Allergan), transaction type (acquisition), and the specific metric (right-of-use assets from lease obligations) are all correctly identified. The date context (December 31, 2020) is implicit in the filing reference. (4) REASONING: The LLM correctly synthesized that the right-of-use assets were part of the lease obligations assumed during the acquisition, demonstrating proper multi-hop reasoning across the transaction details. (5) SEMANTIC EQUIVALENCE: The phrasing 'about $453 million' vs. '$453 million' is a minor stylistic difference that doesn't affect accuracy. The explanation of how ROU assets relate to assumed lease obligations is clear and correct. Minor deduction (1 point) only for the use of 'about' before the $453M figure, which introduces slight imprecision where the ground truth provides an exact figure, though this is a very minor issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 411,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "\nThe 2024 10‑K states that **391 shares of common stock** remain issuable upon distribution under the Norwest Corporation Directors’ Formula Stock Award Plan. No future awards or deferrals can be made because the plan has been closed—no additional grants or deferral elections are permitted, and the 391 shares represent the only shares left to be distributed under that plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The specific number of 391 shares is correctly stated and matches the ground truth exactly. No calculations were required, and the numeric value is precise. (2) COMPLETENESS: The answer addresses both parts of the question - it identifies the number of shares (391) and explains why no future awards or deferrals are possible (the plan has been closed). (3) ENTITY ACCURACY: The Norwest Corporation Directors' Formula Stock Award Plan is correctly identified, and the 2024 10-K filing reference is accurate. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly connects the specific share count to the plan closure status, explaining that the 391 shares represent the remaining distribution amount under a closed plan. (5) SEMANTIC EQUIVALENCE: The LLM's explanation that 'the plan has been closed—no additional grants or deferral elections are permitted' is semantically equivalent to the ground truth statement that 'it has been closed to new deferrals and awards.' The additional detail that '391 shares represent the only shares left to be distributed' adds helpful context without contradicting the ground truth. Minor variation in wording (e.g., 'remain issuable' vs. 'were issuable') does not affect accuracy. The answer is clear, complete, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 390,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "\nThe extra amortization of the intangibles acquired in the Allergan transaction was recorded in cost of products sold, which pulled down AbbVie’s gross margin in 2021 (it offset the margin gains from product‑mix improvements and lower inventory‑fair‑value step‑up amortization).  In 2021 the company recognized **$7.7 billion** of amortization expense for definite‑lived intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-hop question effectively. (1) QUANTITATIVE ACCURACY: The $7.7 billion figure for total amortization expense for definite-lived intangible assets in 2021 matches the ground truth exactly. No calculation errors present. (2) COMPLETENESS: Both sub-questions are addressed: (a) impact on gross margin from Allergan acquisition intangible amortization, and (b) total amortization expense for definite-lived intangibles. (3) ENTITY ACCURACY: AbbVie is correctly identified, 2021 is the correct fiscal year, and the Allergan acquisition is properly referenced. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes multi-hop information by explaining that: (a) amortization of Allergan intangibles was recorded in COGS, (b) this negatively impacted gross margin, (c) it offset gains from product mix improvements and lower inventory fair-value step-up amortization. This multi-hop reasoning matches the ground truth's explanation of offsetting factors. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'pulled down AbbVie's gross margin' and 'offset the margin gains' conveys the same negative impact as the ground truth's 'negatively impacted' and 'partially offset these gains.' The only minor difference is that the LLM specifies the amortization was 'recorded in cost of products sold' which adds helpful specificity not explicitly stated in the ground truth but is consistent with standard accounting treatment. This is a strength, not a weakness. Overall, the answer is factually correct, complete, well-reasoned, and appropriately detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 442,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "\nThe Restoration Plans are a supplemental, non‑qualified deferred‑compensation arrangement that provides certain highly‑compensated associates with the deferred compensation they would have received under the Company’s primary Benefit Plans but are limited by IRS compensation caps. The Company funds these plans by making cash contributions to grantor trusts, which then use the cash to purchase The Home Depot’s common stock on the open market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies the purpose of Restoration Plans as supplemental, non-qualified deferred compensation for highly-compensated associates who would have received matching contributions under the Benefit Plans but are limited by IRS compensation caps (IRC maximum limits). The funding mechanism is accurately described: cash contributions to grantor trusts that purchase The Home Depot's common stock in the open market. (2) QUANTITATIVE ACCURACY: No numeric values are present in either the ground truth or LLM answer, so this dimension is not applicable but receives full marks as there are no calculation errors. (3) ENTITY ACCURACY: All entities are correctly identified - The Home Depot, Benefit Plans, Restoration Plans, grantor trusts, and common stock. The fiscal year context (2023 10-K) is appropriately referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes the relationship between three key elements: (a) the purpose of Restoration Plans relative to Benefit Plans, (b) the IRS compensation limitations that trigger their use, and (c) the specific funding mechanism through grantor trusts and open market stock purchases. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more precise terminology ('supplemental, non-qualified deferred-compensation arrangement' vs. the ground truth's simpler phrasing) and explicitly mentions 'highly-compensated associates,' which adds appropriate specificity. The core information matches the ground truth perfectly. Minor enhancement: The LLM answer provides marginally more detail by explicitly stating 'non-qualified' status, which is technically accurate and adds value. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 478,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "\nThe Variable Rate Notes remained flat at **$22 million** on both December 31 2023 and December 31 2024, producing a **0 % change** over the year. As a result, the **≈52 % increase in total borrowings** (from $20.4 bn to $31.1 bn) is driven entirely by growth in fixed‑rate notes, commercial paper and the new term‑loan, not by any movement in the variable‑rate portion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Verification of key facts: (1) Variable Rate Notes value: Both ground truth and LLM correctly state $22 million for both Dec 31, 2023 and Dec 31, 2024 - CORRECT. (2) Percentage change in Variable Rate Notes: Both correctly identify 0% change - CORRECT. (3) Total borrowings figures: LLM states $20.4 bn to $31.1 bn (ground truth: $20,443 million to $31,099 million) - these are equivalent with acceptable rounding/formatting - CORRECT. (4) Percentage increase calculation: Ground truth states 52.1%, LLM states ≈52% - both are correct with LLM using appropriate approximation symbol - CORRECT. (5) Dollar increase: Ground truth explicitly states $10,656 million increase; LLM doesn't explicitly calculate this but the figures provided are consistent - ACCEPTABLE. The LLM successfully synthesizes multi-hop information by: connecting the flat Variable Rate Notes value to the overall borrowing increase, correctly attributing the growth to other debt instruments (fixed-rate notes, commercial paper, term loans), and explaining the relationship between the two metrics. The reasoning is sound and demonstrates proper understanding that the 52% increase in total borrowings was not driven by Variable Rate Notes. Minor note: LLM uses 'bn' abbreviation while ground truth uses 'million' - this is a formatting variation and acceptable. The answer is complete, addresses all parts of the question, and provides appropriate context about what drove the overall borrowing increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 421,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "\nThe 4.95% Senior Notes due September 2026 have a carrying amount of $746 million, and the 4.95% Senior Notes due September 2052 have a carrying amount of $980 million as of January 28, 2024, for a combined total carrying amount of $1,726 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) All numbers are correct: $746 million for the September 2026 notes, $980 million for the September 2052 notes, and the total of $1,726 million matches the ground truth exactly. (2) The calculation is accurate: $746M + $980M = $1,726M, which is verified correctly. (3) Multi-hop reasoning is sound: the answer correctly identifies and synthesizes information about two separate debt instruments with the same interest rate (4.95%) but different maturity dates, then combines them appropriately. (4) All entities are correctly identified: HD (Home Depot), the specific interest rate (4.95%), both maturity dates (September 2026 and September 2052), and the reporting date (January 28, 2024). The answer goes beyond the minimum requirement by providing the individual carrying amounts for each note before presenting the total, which adds transparency and verifiability. The semantic meaning is perfectly aligned with the ground truth, and the presentation is clear and logical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 299,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "\nThe net derivative‑asset position fell from **$186 million in 2022 to $101 million in 2023**, a decline of roughly **46 %**. This shrinkage mirrors the reduction in the **total gross notional of derivative contracts**, which dropped from **$873 million to $584 million**—about a **33 % decrease**—showing that the smaller derivative portfolio directly drove the larger percentage drop in the net asset figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key metrics: (1) Net derivative asset position correctly stated as $186M (2022) to $101M (2023) - matches ground truth exactly. (2) Percentage decrease calculation: ($186M - $101M) / $186M = $85M / $186M = 45.7%, which the LLM rounds to 'roughly 46%' - this is acceptable rounding and semantically equivalent to the ground truth's 45.7%. (3) Total gross derivative contracts correctly identified as $873M (2022) to $584M (2023) - matches ground truth exactly. (4) Percentage decrease in contracts: ($873M - $584M) / $873M = $289M / $873M = 33.1%, which the LLM correctly states as 'about a 33% decrease' - accurate. The LLM successfully synthesizes the multi-hop relationship between the two metrics, correctly noting that the smaller derivative portfolio (33% reduction) drove the larger percentage drop in net asset position (46% reduction). The reasoning is sound and logically explains the alignment between the two changes. Minor note: The LLM uses 'notional' terminology which is standard financial language and appropriate. The answer is complete, addresses both parts of the question (percentage decrease AND alignment with contract changes), and provides clear quantitative support for conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 367,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "\nAs of December 31 2024 the 2016 Stock Incentive Plan had 27.1 million shares left for future grants and the 2016 Stock Plan for Non‑Employee Directors had 0.8 million shares, for a combined 27.9 million shares that may be issued in the future. This reserve is larger than the roughly 12.8 million shares that would be needed to cover all outstanding options and RSUs (the “Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants, and Rights” shown for the approved plans), leaving about 15 million of the 29.3 million shares authorized for issuance still unallocated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the total shares available for future issuance (27.9 million: 27.1 million + 0.8 million) and properly names both plans. However, there are significant quantitative errors in the comparison section. The ground truth specifies 10,221,113 shares for options and 2,005,555 RSUs under the 2016 Stock Incentive Plan, plus 129,854 shares for options under the 2016 Stock Plan for Non-Employee Directors, totaling approximately 12,356,522 shares. The LLM states 'roughly 12.8 million shares' which is reasonably close to this figure. However, the LLM then introduces information about '29.3 million shares authorized for issuance' and '15 million unallocated shares' that is not present in the ground truth answer and appears to be extraneous or incorrectly calculated information. The ground truth answer focuses on the direct comparison between available shares (27.9M) and shares to be issued for options and RSUs (approximately 12.4M), without discussing total authorized shares or unallocated portions. The LLM's introduction of the 29.3M authorized figure and subsequent calculations about unallocated shares represents a departure from the ground truth and introduces potential inaccuracy. The core answer about the 27.9M available shares is correct, and the approximation of 12.8M for options and RSUs is close enough, but the additional analysis about authorized shares and unallocated amounts is not supported by the ground truth and may be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 411,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "\nIn fiscal 2022, revenue from Dynamics 365 rose 39% year‑over‑year. That strong 39% increase was a key driver of the broader Dynamics products and cloud services segment, which posted an overall growth of 25% for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both key percentages are correct - Dynamics 365 revenue grew 39% YoY in fiscal 2022, and the overall Dynamics products and cloud services segment grew 25%. All numeric values match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the question: the specific Dynamics 365 growth rate (39%) and how it contributes to the broader segment growth (25%). The multi-hop synthesis is correct - the answer properly identifies that the 39% growth in Dynamics 365 was a significant driver of the 25% overall growth. (3) ENTITY ACCURACY: All entities are correctly identified - Dynamics 365 product, Dynamics products and cloud services segment, fiscal year 2022, and the correct financial metrics. (4) REASONING: The multi-hop reasoning is sound. The answer correctly synthesizes that a 39% growth rate in a component (Dynamics 365) contributing to a 25% overall segment growth indicates strong performance and adoption. The logic that a higher growth rate in a key product drives broader segment performance is valid. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly more concise language ('rose 39% year-over-year' vs 'grew by 39%') but maintaining identical meaning. Minor difference: The ground truth includes interpretive language about 'strong adoption and demand' while the LLM answer focuses on the factual relationship between the two growth rates. This is a stylistic difference, not a factual error. The answer is direct, accurate, and fully responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 455,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "\nTesla’s Energy Generation and Storage segment revenue rose by **$795 million (about 40 %)** in 2021 versus 2020, and this growth was driven largely by higher deployments of **Megapack**. Megapack is Tesla’s utility‑scale battery‑storage system that complements its broader storage lineup—including the residential Powerwall, the now‑phasing‑out Powerpack, and Solar Roof—providing large‑format, grid‑connected storage solutions for commercial, industrial and utility customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - $795 million increase and 40% growth rate match ground truth exactly. (2) Year-over-year comparison (2021 vs 2020) is accurate. (3) Megapack correctly identified as primary driver of growth. (4) Megapack's role in portfolio is well-described with appropriate customer segments (commercial, industrial, utility). (5) Multi-hop reasoning is sound - correctly synthesized revenue increase with Megapack deployment. (6) Number formatting is acceptable ($795 million). MINOR WEAKNESSES: (1) The LLM answer mentions Powerpack as 'now-phasing-out' which adds interpretive language not in ground truth - while potentially accurate, this is editorial commentary beyond the filing data. (2) Ground truth explicitly mentions 'solar cash and loan jobs' and 'Solar Roof' as contributing factors alongside Megapack, but LLM states growth was 'largely by higher deployments of Megapack' without explicitly acknowledging the other contributing factors (solar cash/loan jobs). This is a minor omission of context about what drove the overall 40% increase. (3) Ground truth specifies Megapack can form 'gigawatt hours or greater capacity' installations, while LLM uses more general 'large-format, grid-connected storage solutions' language - less specific but not incorrect. CALCULATION VERIFICATION: $795M increase with 40% growth rate is internally consistent and matches ground truth. MULTI-HOP SYNTHESIS: Successfully connected revenue increase to Megapack deployment and positioned it within broader portfolio context. Overall, the answer is substantially correct with minor contextual omissions regarding other contributing factors to the revenue growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 462,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "\nWalmart recorded an estimated pre‑tax loss of **$5.5 billion** in the fourth quarter of fiscal 2021 when Asda was classified as held‑for‑sale, and upon closing the divestiture in February 2021 it recognized an additional **$0.2 billion** of pre‑tax loss in the first quarter of fiscal 2022.  Together these amount to roughly **$5.7 billion** of pre‑tax loss, of which about **$2.3 billion** stemmed from the derecognition of the Asda pension plan and related indemnity obligations—highlighting that the pension‑related liabilities were a major component of the overall loss on the disposal group.  (Note 12, pp. 78‑79)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-hop question. STRENGTHS: (1) All primary financial figures are accurate: $5.5 billion Q4 FY2021 loss, $0.2 billion Q1 FY2022 loss, $5.7 billion total, and $2.3 billion pension-related component. (2) The calculation is correct ($5.5B + $0.2B = $5.7B). (3) Fiscal years are correctly identified (fiscal 2021 and 2022). (4) The pension obligation impact is properly highlighted as a major component of the loss. (5) Multi-hop synthesis is sound—the answer correctly combines the initial loss estimate, additional adjustments upon closing, and pension-related obligations into a coherent narrative. (6) The citation to Note 12, pp. 78-79 adds credibility. MINOR ISSUES: (1) The LLM states the divestiture closed \"in February 2021\" but this appears to be a minor temporal inconsistency—the $0.2 billion loss was recorded in Q1 FY2022 (which would be early 2022, not February 2021), though the exact closing date may vary by fiscal calendar. This is a very minor point that doesn't materially affect the answer's accuracy. (2) The answer could have been slightly more explicit about the nature of the pension obligations (accumulated pension components and indemnity obligations), though this is adequately conveyed. The answer demonstrates strong multi-hop reasoning by synthesizing information across two fiscal periods and connecting the pension liabilities to the overall disposal loss. The semantic meaning aligns well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 421,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "\nApproximately 54 % of the More Personal Computing segment’s FY 2022 revenue came from the combined contribution of Surface devices and Windows OEM licensing. (Windows OEM accounted for 42 % of the $56.5 billion segment, and the Devices category—including Surface—represented about 12 % of the segment, giving a combined share of roughly 54 %.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a significant factual error in the Devices percentage. Ground truth states Devices (primarily Surface) contributed 16% ($9.04 billion), but the LLM claims it represented 'about 12%' of the segment. This is a material discrepancy of 4 percentage points. CALCULATION ERROR: The LLM's combined percentage of 54% is incorrect. The correct calculation is 42% (Windows OEM) + 16% (Devices/Surface) = 58%, not 54%. This represents a fundamental arithmetic error. CORRECT ELEMENTS: The LLM correctly identified Windows OEM at 42% and correctly referenced the $56.5 billion segment revenue. The LLM also correctly identified that the question involves combining two revenue streams. MULTI-HOP REASONING: While the LLM attempted to synthesize information across multiple data points (segment total, Windows OEM percentage, Devices percentage), the execution failed due to the incorrect Devices percentage figure. The reasoning structure is sound, but the underlying data is wrong. IMPACT: The final answer of 54% is materially incorrect when the ground truth is 58%. This is not a minor rounding difference but a substantive error that would mislead stakeholders about the revenue composition. The error appears to stem from either misremembering or miscalculating the Devices contribution percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 372,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "\nThe combined financial impact of the Asda pension items was $3.3 billion – the $1.0 billion cash contribution that Asda made to its pension plan in fiscal 2020 plus the $2.3 billion of accumulated pension components that were placed in the disposal group when Asda was sold. This amount reflects the total pension‑related obligation and the associated loss recognized in connection with the sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question. QUANTITATIVE VERIFICATION: All numbers are correct - $1.0 billion cash contribution (fiscal 2020), $2.3 billion accumulated pension components, and $3.3 billion total ($1.0B + $2.3B = $3.3B). The arithmetic is accurate. COMPLETENESS: The answer addresses all components of the question: (1) the $1.0 billion Asda pension contribution in fiscal 2020, (2) the $2.3 billion accumulated pension components in the disposal group, and (3) the combined total of $3.3 billion. ENTITY ACCURACY: Correctly identifies Walmart, Asda, the pension plan, and the disposal group. Fiscal 2020 is properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct pension-related events (the contribution and the subsequent sale/disposal), correctly combining them into a single total impact figure. SEMANTIC EQUIVALENCE: The LLM's phrasing 'combined financial impact,' 'cash contribution,' 'accumulated pension components,' and 'disposal group' all align with the ground truth terminology. The explanation that this 'reflects the total pension-related obligation and the associated loss recognized in connection with the sale' is semantically equivalent to the ground truth's 'reflects the full pension-related exposure transferred as part of the divestiture.' Minor difference: The LLM adds 'associated loss recognized' which is a reasonable inference about the nature of the transaction, though the ground truth uses 'exposure transferred.' This is not a factual error but rather a slightly different characterization of the same underlying transaction. Overall, the answer demonstrates clear understanding of the multi-hop synthesis required and presents all information accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 488,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "\nThe pre‑owned aircraft inventory rose from **$15 million** on December 31 2023 to **$23 million** on December 31 2024, an increase of **$8 million**.  \nThe company values pre‑owned aircraft at the **lower of their trade‑in value or estimated net realizable value** (i.e., the lower of cost or net realizable value).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - December 31, 2023 value of $15 million, December 31, 2024 value of $23 million, and the calculated increase of $8 million ($23M - $15M = $8M). The calculation is accurate and properly verified. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the increase in value ($8 million), and (b) the specific valuation method used. (3) ENTITY ACCURACY: The fiscal years (2023 and 2024) are correctly identified, and the financial metric (pre-owned aircraft inventories) is properly specified. (4) VALUATION METHOD: The LLM correctly identifies that the company uses 'the lower of trade-in value or estimated net realizable value.' The parenthetical clarification '(i.e., the lower of cost or net realizable value)' is semantically equivalent and provides helpful context, though the ground truth uses 'trade-in value' rather than 'cost' - this is a minor semantic variation that doesn't materially affect accuracy since both refer to the lower of two valuation approaches. (5) MULTI-HOP REASONING: The answer successfully synthesizes information across two different time periods and combines quantitative data with qualitative valuation methodology information. The reasoning is sound and logical. Minor deduction (1 point) only for the slight variation in terminology ('cost' vs 'trade-in value') in the parenthetical, though this doesn't affect the core correctness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 417,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "\nThe modest 3 % increase in Xbox content and services revenue is tied to the expansion of Xbox Game Pass’s curated game library—adding a growing roster of first‑ and third‑party titles boosts subscriber engagement and justifies higher subscription fees.  Microsoft is reinforcing this trend with major investments in content acquisition (e.g., the ZeniMax purchase and the pending Activision Blizzard deal), scaling its Xbox Cloud Gaming infrastructure, and integrating gaming across Windows and its broader cloud services to broaden the addressable market and drive future growth in the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The 3% revenue increase figure is correctly cited and properly contextualized. The reference to 'over 100 first- and third-party titles' in Game Pass is accurately captured (LLM says 'growing roster of first‑ and third‑party titles' which is semantically equivalent). No calculation errors or numeric discrepancies detected. ENTITY ACCURACY: All entities are correctly identified - Xbox Game Pass, Xbox content and services revenue, ZeniMax Media acquisition, Activision Blizzard acquisition, Xbox Cloud Gaming, and Windows integration are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between Game Pass library expansion and revenue growth, then connects this to broader strategic investments. The logical flow is sound: Game Pass expansion → subscriber engagement → revenue growth, supported by strategic acquisitions and cloud infrastructure scaling. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) how Game Pass library growth relates to 3% revenue increase, (2) the strategic investments (ZeniMax, Activision Blizzard), and (3) broader strategic context (cloud services, platform integration). SEMANTIC EQUIVALENCE: The LLM's phrasing 'modest 3% increase' and 'pending Activision Blizzard deal' are appropriate characterizations. The addition of context about 'justifies higher subscription fees' and 'broaden the addressable market' adds reasonable interpretive value without contradicting ground truth. MINOR OBSERVATIONS: The LLM slightly elaborates on the mechanism (subscription fee justification, addressable market expansion) beyond the ground truth, but these are logical extensions rather than errors. The ground truth mentions 'community engagement' while LLM emphasizes 'subscriber engagement' - these are closely related concepts and the LLM's framing is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 541,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "\nIn 2023 Eli Lilly recognized **$1.45 billion** of revenue from the sale of the olanzapine (Zyprexa) portfolio rights, and this amount is included in the **$5.31 billion “collaboration and other revenue”** line that the company reported for 2023.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE: The LLM provides specific dollar amounts ($1.45 billion for olanzapine portfolio sale and $5.31 billion for collaboration and other revenue) that cannot be verified against the ground truth. The ground truth explicitly states that Eli Lilly recognized revenue from the 2023 sale of olanzapine portfolio rights and that this is part of the 'collaboration and other revenue' category, but does NOT provide the specific dollar figures cited by the LLM. The LLM appears to have fabricated precise numerical values without evidence from the source material. While the LLM correctly identifies: (1) the year as 2023, (2) the product as olanzapine/Zyprexa, (3) that this was a sale of rights, (4) that it belongs to the collaboration and other revenue category, and (5) the logical relationship between the transaction and the broader category - the introduction of unverified specific dollar amounts is a fundamental factual error that severely undermines the answer's credibility. The qualitative reasoning about how the transaction factors into the broader category is sound, but the quantitative claims are unsupported by the ground truth provided. This represents a hallucination of financial data, which is particularly problematic in financial analysis contexts where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 365,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "\nThe 2015 supplemental indentures repeatedly add new “Series 2015/Cxx‑xx” tranches of 5.45 % Solar Bonds—each filed as a separate 8‑K exhibit and each naming the same Trustee—showing that SolarCity treated the bond issue as a modular, on‑demand financing tool rather than a single, one‑time issuance. By attaching a distinct trustee agreement to each series, the company could raise additional capital incrementally as solar projects required funding, using the same legal framework to roll out new tranches without renegotiating the entire indenture. This structure demonstrates that bond‑specific trustee agreements function as repeatable, project‑linked financing vehicles that sustain Tesla’s (via SolarCity’s) ongoing capital needs for solar‑energy installations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core financing strategy—that Tesla/SolarCity used multiple tranches of 5.45% Solar Bonds in 2015 as a modular, on-demand financing tool with separate trustee agreements. The semantic understanding of the bond structure's flexibility and its role in supporting recurring capital needs is sound. The answer appropriately emphasizes the project-linked nature of the financing and the repeatable framework. WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM fails to cite the specific series designations (2015/C122-15, 2015/C127-15, 2015/C132-15, 2015/C137-15) that ground truth provides. While it uses the placeholder 'Cxx-xx' notation, this is less precise than the actual series numbers. (2) SUPPLEMENTAL INDENTURE NUMBERS - Ground truth specifies the distinct Supplemental Indenture numbers (4.72, 4.74, 4.76, 4.78), which the LLM omits entirely. This is a factual gap in the multi-hop synthesis. (3) TIMELINE SPECIFICITY - Ground truth notes the indentures were 'dated at different points in November through December 2015,' providing temporal granularity that the LLM lacks. (4) MISSING DETAIL - The LLM doesn't mention that each indenture was filed as a separate 8-K exhibit, though it does reference this implicitly. REASONING QUALITY: The multi-hop reasoning is sound—the LLM correctly synthesizes that the structure reflects a deliberate strategy for matching funding with project deployment and investor demand. The logic connecting trustee agreements to discrete funding events is valid. However, the reasoning would be stronger with the specific series and indenture numbers. ENTITY ACCURACY: Correctly identifies Tesla, SolarCity, the 5.45% interest rate, and 2015 as the issuance year. The reference to 'the same Trustee' is correct but lacks specificity. OVERALL: The answer demonstrates good conceptual understanding but lacks the precise quantitative details (series numbers, indenture numbers, specific dates) that would elevate it to a 7-8 range. The omissions are notable but not fundamental to understanding the financing strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 563,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "\nThe Energy generation and storage segment’s revenue grew by **$795 million (≈ 40 %)** in 2021 versus 2020, a rise that was **driven primarily by higher Megapack deployments** (along with solar‑cash/loan jobs, Powerwall and Solar Roof). This growth was **partially offset by a decline in Powerpack deployments**, as the company phased the product out after introducing Megapack.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-hop question. STRENGTHS: (1) All quantitative data is accurate - correctly identifies the $795 million growth and 40% increase in Energy generation and storage revenue for 2021 vs 2020. (2) Correctly identifies Megapack deployments as the primary driver of growth. (3) Correctly identifies Powerpack as the product whose decline partially offset the growth. (4) Accurately explains the context that Tesla phased out Powerpack following Megapack introduction. (5) Multi-hop reasoning is sound - synthesizes information about revenue growth, product contributions, and offsetting factors. MINOR WEAKNESSES: (1) The LLM answer includes additional products (solar-cash/loan jobs, Powerwall, Solar Roof) as contributors to growth, which adds context but goes slightly beyond what the ground truth specifies. The ground truth focuses specifically on Megapack's contribution and Powerpack's decline as the offsetting factor. While this additional detail is not incorrect, it slightly dilutes the focused answer to the specific question asked. (2) The phrasing 'driven primarily by higher Megapack deployments (along with...)' could be interpreted as suggesting multiple equal drivers, whereas the question specifically asks about Megapack's contribution. However, this is a minor semantic distinction and doesn't constitute a factual error. CALCULATION VERIFICATION: $795 million growth and 40% increase are both correct. The multi-hop synthesis correctly connects: (a) revenue growth amount, (b) Megapack as primary driver, (c) Powerpack decline as offset, and (d) the business context of product phasing. Overall, the answer demonstrates strong understanding of the multi-hop question structure and provides accurate financial data with appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 498,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "\nThe Africa/Eurasia region’s capital expenditures in 2024 were $12 million, and its depreciation and amortization expense for the same year was $8 million. Adding these amounts gives a combined total of **$20 million** for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: The final answer of $20 million matches the ground truth exactly. The component figures ($12 million for capital expenditures and $8 million for depreciation and amortization) are correctly identified and add up correctly. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The arithmetic is sound: $12M + $8M = $20M. The year (2024) and region (Africa/Eurasia) are correctly specified. (3) QUALITATIVE ACCURACY: The LLM demonstrates proper multi-hop reasoning by identifying two separate financial metrics, retrieving their values, and synthesizing them into a combined total. The explanation is clear and logical, showing the work step-by-step. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question asked, providing the combined total for the specific region and year requested. The only minor observation is that the LLM provides the component breakdown (which adds transparency) rather than just stating the final answer, but this is actually a strength as it shows the calculation. No errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 315,
        "total_tokens": 1369
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "\nTI’s retiree health‑care benefit plan is managed under a policy that forbids direct investment in TI common stock – the plan’s assets are allocated to a diversified mix of fixed‑income, equity and other securities and are not invested in the company’s own shares. By contrast, the non‑U.S. defined‑contribution plans do hold TI common stock, which was valued at **$34 million** as of 31 December 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-part question. (1) CORRECTNESS: All factual information is correct. The answer accurately states that TI's retiree health care benefit plan policy forbids direct investment in TI common stock, and correctly identifies that non-U.S. defined contribution plans do hold TI stock valued at $34 million as of December 31, 2024. The comparison between the two investment strategies is clearly articulated. (2) QUANTITATIVE ACCURACY: The $34 million figure is correct and properly formatted. The date (December 31, 2024 / 31 December 2024) is accurate. No calculations are required for this question, and all numeric data is precise. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes information about two different plan types (retiree health care benefit plan vs. non-U.S. defined contribution plans) and correctly contrasts their investment policies regarding TI common stock. The characterization of the retiree health care plan's diversified allocation strategy is accurate. (4) ENTITY ACCURACY: TI is correctly identified throughout, and the distinction between plan types is properly maintained. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording ('forbids direct investment' vs. 'none of the assets...are directly invested'), but the meaning is semantically equivalent. The answer is well-structured and provides appropriate context about the diversified nature of the retiree health care plan's investments. Minor deduction (1 point) only for very minor stylistic differences in phrasing, but the substance is entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 468,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "\nLLY’s total Baqsimi revenue collapsed from roughly **$678 million in 2023 (U.S. $645.7 M + Outside‑U.S. $31.9 M)** to only **$29 million in 2024 (U.S. $2.5 M + Outside‑U.S. $26.7 M)** – a decline of about **$650 million (≈95 %)** when both U.S. and international sales are combined.  \n\nThe “collaboration and other arrangements” note explains that LLY sold the Baqsimi rights in June 2023 and now recognizes revenue only as it manufactures and ships the product under a supply agreement with Amphastar, i.e., over time as the product is produced rather than as a one‑time upfront gain. This shift from a lump‑sum gain to incremental product‑sales recognition accounts for the sharp drop in reported Baqsimi revenue between 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All key financial numbers are correct: 2023 total of $677.6M (rounded to ~$678M in LLM answer), 2024 total of $29.2M (rounded to ~$29M), U.S. and Outside U.S. breakdowns all accurate. (2) Percentage calculation of ~95% decline is mathematically sound ($650M/$677.6M ≈ 96%, close enough to stated 95%). (3) Multi-hop synthesis is present: correctly identified the sale of Baqsimi rights in June 2023 and connected this to the shift in revenue recognition. (4) Entity identification correct (LLY, Baqsimi, Amphastar). (5) Contextual relevance high - addresses both quantitative change and qualitative explanation from disclosures.\n\nWEAKNESSES: (1) The LLM answer introduces additional detail about 'supply agreement with Amphastar' and describes revenue recognition 'over time as the product is produced' - while this may be accurate, the ground truth answer is more conservative, stating only that the shift involves 'milestone payments or profit-sharing agreements' without specifying the exact mechanism. The LLM's more specific characterization of the supply agreement mechanics goes beyond what the ground truth explicitly states. (2) The ground truth emphasizes that revenue shifted from 'product sales to collaboration and other arrangements,' while the LLM describes it as shifting from 'lump-sum gain to incremental product-sales recognition' - these are slightly different framings. The LLM's interpretation suggests the 2024 revenue still represents product sales under a supply agreement, whereas the ground truth suggests collaboration/arrangement revenue (which could include non-product components). (3) Minor: The LLM states the sale occurred in 'June 2023' while the ground truth only says '2023' - the specific month may be correct but adds detail not in ground truth.\n\nVERIFICATION: All numeric values match ground truth exactly when accounting for rounding. The $650M decline figure is accurate. The ~95% decline percentage is correct. The 2023 and 2024 breakdowns (U.S. and Outside U.S.) all match precisely.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the revenue data and the collaboration/arrangements disclosure, connecting the dots between the transaction and the revenue recognition change. However, the specific characterization of the post-sale arrangement (supply agreement vs. collaboration/milestone payments) differs slightly from ground truth framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 648,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "\nMastercard reports “Processing and Gateway” revenue as part of its **value‑added services and solutions** segment. In the 10‑K the company groups all such offerings—including processing/gateway, data & analytics, cyber‑intelligence, ACH and real‑time payments, open‑banking and digital‑identity—under the single “value‑added services and solutions” category, which together with the “payment network” category comprises its two primary revenue streams. Thus, processing‑gateway fees are classified under the broader value‑added services bucket that the company discloses alongside its core payment‑network fees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that Mastercard classifies 'Processing and Gateway' services under the broader 'value-added services and solutions' category, which aligns perfectly with the ground truth. The answer goes beyond the minimum requirement by providing additional context about what other services fall under this category (data & analytics, cyber-intelligence, ACH, real-time payments, open-banking, digital-identity), demonstrating thorough understanding of the filing structure. The answer correctly establishes the two-part revenue structure (value-added services and solutions vs. payment network) and explains how processing-gateway fees fit within this framework. The multi-hop reasoning is sound—the model successfully synthesized information about revenue classification and broader categorization. The answer accurately conveys that these services are recognized based on fixed or transaction-based fees (implied through the reference to how such services are structured), though it doesn't explicitly state the revenue recognition timing mentioned in the ground truth. This is a minor omission but doesn't significantly detract from the overall accuracy. No numerical errors or factual inaccuracies were detected. The wording differs from the ground truth but the semantic meaning is equivalent and actually more detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 386,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "\nThe pension plan’s holdings of international common stocks fell from $20 million at the end of 2023 to $15 million at the end of 2024, a $5 million (≈25 %) year‑over‑year decline. This reduction is part of the broader drop in total international plan assets, which decreased from $566 million in 2023 to $537 million in 2024—a $29 million overall reduction.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and represents a complete reversal of the ground truth. Critical errors: (1) DIRECTION OF CHANGE: The LLM states international common stocks FELL from $20M to $15M (a decline), when the ground truth shows they INCREASED from $15M to $20M (a growth). This is a directional error that inverts the entire narrative. (2) YEAR ORDERING: The LLM incorrectly assigns 2023 and 2024 to the wrong values. Ground truth shows the progression is from $15M → $20M (earlier to later period), but LLM reverses this to $20M → $15M. (3) TOTAL INTERNATIONAL INVESTMENTS: While the LLM correctly identifies the $29M change and the $537M/$566M figures, it incorrectly characterizes this as a 'drop' or 'reduction' when the ground truth shows growth from $537M to $566M. The LLM has inverted the direction here as well. (4) PERCENTAGE CALCULATION: The LLM calculates a 25% decline ($5M/$20M), which is mathematically correct for a decline scenario, but since the actual change was an increase, this percentage is directionally wrong. (5) MISSING ANALYSIS: The LLM fails to calculate or mention that the $5M increase in international common stocks represented 17.2% of the total $29M increase in international investments—a key analytical insight from the ground truth. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to connect the specific asset class change to the broader international investment trend, it does so with inverted logic, making the synthesis incorrect. The answer demonstrates a systematic reversal of the actual data rather than a minor misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 437,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "\nThe Restricted Stock/RSUs expense rose from **$59 million in 2022 to $85 million in 2024**, an increase of **$26 million**.  This gain more than offset a $11 million decline in stock‑option expense, so the **overall equity‑based compensation expense grew by $15 million** (from $130 million in 2022 to $145 million in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All key numbers are correct: RSU expense increased from $59M (2022) to $85M (2024), a $26M increase; total equity-based compensation increased from $130M to $145M, a $15M increase. The calculation that the $26M RSU increase exceeded the $15M total increase is correct. The LLM provides additional valuable context by noting that stock-option expense declined by $11M, which explains why the RSU increase ($26M) was larger than the net increase in total compensation ($15M). This demonstrates sound multi-hop reasoning: the model correctly synthesized that RSU growth was partially offset by option expense decline. The answer directly addresses both parts of the question: (1) the specific increase in RSU expense, and (2) how this trend contributed to overall equity-based compensation changes. The semantic meaning matches the ground truth perfectly - both conclude that RSU expense growth was the primary driver of overall compensation expense growth. Minor note: The LLM uses slightly different phrasing ('gain' instead of 'increase', 'offset' language) but this is semantically equivalent and actually enhances clarity by explaining the offsetting dynamics. All entities (General Dynamics, years 2022-2024, specific expense categories) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 369,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "\nAmazon’s $8 billion 364‑day unsecured term loan demonstrates a tactical use of a dedicated short‑term borrowing facility to meet immediate cash needs or market opportunities, while still keeping its larger $20 billion commercial‑paper program as the primary source of short‑term liquidity. By issuing the term loan only for a brief period and repaying it within a year, the company preserves the much‑larger CP capacity for general corporate purposes and maintains flexibility in its short‑term funding strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $8 billion term loan, $20 billion Commercial Paper Program, 364-day maturity, and repayment within the year. The answer correctly identifies the strategic nature of the borrowing decision and the relationship between the two funding sources. However, there are some qualitative differences from the ground truth: (1) The LLM characterizes the term loan as meeting 'immediate cash needs or market opportunities' which is more speculative than the ground truth's more measured 'specific funding needs with a defined maturity.' (2) The LLM describes the CP program as 'the primary source of short-term liquidity' when the ground truth indicates no borrowings had been drawn from it as of the reporting period, making this characterization potentially misleading. (3) The ground truth provides more specific detail about the CP program's flexibility (variable issuance, maturities up to 397 days) and explicitly notes that no borrowings had been drawn, which the LLM omits. (4) The LLM's reasoning about 'preserving flexibility' and 'general corporate purposes' is sound but less precise than the ground truth's explanation about preserving flexibility 'for other short-term obligations.' The multi-hop synthesis is adequate—the answer correctly connects the term loan decision to the broader liquidity management strategy and the availability of the CP program. The core insight about strategic preference for a committed facility is present in both answers. Overall, the answer is substantially correct with minor omissions in specificity and one potentially misleading characterization about the CP program being the 'primary' source when it had zero outstanding borrowings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 479,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "\nIn 2024 the Membership Rewards liability grew to **$14,752 million** (up from $13,742 million in 2023), an increase driven by higher redemption costs and new third‑party partner arrangements that raised the cost per point and shifted the mix of redemptions.  To reflect these changes, American Express updated its liability estimation by revising the **Ultimate Redemption Rate (URR) and weighted‑average cost‑per‑point assumptions**—using more granular statistical models that incorporate recent partner‑cost data and observed redemption‑pattern shifts—and now applies these revised inputs each reporting period.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific liability figures ($14,752M in 2024, $13,742M in 2023) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated. This is a major factual error. (2) CALCULATION CLAIM: The LLM states the increase was from $13,742M to $14,752M (a $1,010M increase), but this specific calculation is not supported by the ground truth. (3) PARTIAL ALIGNMENT ON METHODOLOGY: The LLM correctly identifies that American Express adjusted its methodology using URR and weighted-average cost-per-point assumptions, which matches the ground truth. The mention of 'more granular statistical models' and 'partner-cost data' aligns with the ground truth's reference to 'statistical and actuarial models' and 'developments in third-party partner arrangements.' (4) CORRECT CONCEPTUAL ELEMENTS: The LLM correctly identifies the key drivers (redemption costs, third-party partner arrangements) and the methodology adjustments (URR and WAC assumptions), which are core to the ground truth answer. (5) MISSING CONTEXT: The LLM does not mention the 12-month rolling basis for WAC calculation or the specific factors considered (card product type, enrollment tenure, card spend levels, credit attributes) that are in the ground truth. VERDICT: While the LLM demonstrates understanding of the methodology and correctly identifies the key assumptions being adjusted, the introduction of unverified specific dollar amounts significantly undermines credibility. The quantitative accuracy score is very low due to these unsupported numbers. The qualitative accuracy is moderate because the conceptual understanding of the methodology is sound, but the fabricated numbers are a critical failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 492,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "\nColgate‑Palmolive combats foreign‑currency cost pressures by raising selling prices — which lets it pass on exchange‑rate‑driven cost increases to customers — and by hedging the remaining exposure with standard foreign‑currency derivatives.  Together, this approach mitigates the earnings volatility caused by fluctuations in foreign‑exchange rates, i.e., the financial exposure to foreign‑currency translation/transaction risk that could erode net sales and profit margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about Colgate-Palmolive's combined approach to managing foreign exchange risk. STRENGTHS: (1) Correctly identifies the two-pronged strategy: selling price increases and derivative contracts (forward, swap, option contracts); (2) Accurately describes the mechanism: passing exchange-rate-driven cost increases to customers through pricing while hedging remaining exposure; (3) Correctly identifies the financial exposure being mitigated: foreign currency translation/transaction risk affecting net sales and profit margins; (4) No quantitative errors or incorrect numbers; (5) Properly synthesizes multi-hop information about how pricing strategy and hedging work together. MINOR GAPS: (1) The original answer mentions 'over 200 countries' where Colgate operates - the LLM answer doesn't include this geographic scope detail, though it's not strictly necessary to answer the core question; (2) The original answer explicitly mentions 'local currency borrowings' as part of the derivative/hedging toolkit, which the LLM answer omits by using the more general term 'standard foreign-currency derivatives'; (3) The original answer mentions 'translation of foreign subsidiary assets and liabilities into U.S. dollars' as a specific exposure mechanism, which the LLM answer addresses more implicitly through 'foreign-currency translation/transaction risk.' SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, using slightly different but semantically equivalent phrasing ('combats foreign-currency cost pressures' vs. 'manages foreign exchange risk'). The explanation of how the combined approach works is clear and accurate. The answer successfully demonstrates understanding of the multi-hop relationship between pricing strategy, derivative hedging, and earnings volatility mitigation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 520,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "\nThe rebound in business‑to‑business shipments and the surge in residential demand lifted Next Day Air’s average daily volume by roughly 5 % (to about 2,093 k pieces in 2021, a trend the company expects to hold in 2022) and pushed revenue per piece up about 12 % (to $18.83).  However, this growth was partially offset by a modest decline in average billable weight per piece—and, to a lesser extent, by relatively flat demand‑related fuel surcharges—so the net revenue increase was not fully cumulative.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) TEMPORAL CONFUSION: The LLM answer references 2021 data ('to about 2,093 k pieces in 2021') when the question explicitly asks about 2022 impact. The ground truth states impacts occurred in 2022, not 2021. This is a fundamental error in understanding the question's timeframe. (2) UNSUPPORTED SPECIFICS: The LLM provides very specific numbers (5% volume increase, $18.83 revenue per piece, 2,093k pieces) that are NOT present in the ground truth answer. These appear to be fabricated or from different contexts, as the ground truth only mentions that volume increased and revenue per piece increased without providing these specific percentages or dollar amounts. (3) FUEL SURCHARGES DISCREPANCY: The ground truth mentions 'demand-related surcharges' as a driver of revenue per piece growth, while the LLM states fuel surcharges were 'relatively flat' and partially offset growth. This contradicts the ground truth's characterization. (4) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies that (a) B2B activity and residential demand drove volume increases, (b) revenue per piece increased, and (c) reduction in average billable weight per piece partially offset growth. These core concepts align with ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship between volume growth, revenue per piece, and offsetting factors, the temporal misalignment and introduction of unsupported specific numbers undermines the reasoning quality. The answer reads as if it's mixing data from different years or sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 435,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "\nThe U.S. biologic‑product section warns that Opdivo’s market exclusivity in America is vulnerable to biosimilar challenges and the limited 12‑year data‑protection window, so its U.S. sales cannot rely on indefinite patent‑driven protection. At the same time, the multiple 2021 international approvals (EU, Japan, and other regions) grant separate regulatory exclusivity periods and generate additional revenue streams outside the United States, allowing Bristol‑Myers Squibb to diversify its oncology portfolio, sustain growth, and offset any erosion of the U.S. market share. Together, these global approvals reinforce BMY’s strategic positioning as a truly multinational leader in oncology, spreading risk while expanding the addressable patient population worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 12-year data protection window for Opdivo in the U.S., matching ground truth exactly. (2) Accurately references multiple 2021 international approvals across EU, Japan, and other regions. (3) Properly synthesizes the interaction between U.S. regulatory exclusivity risk and international approvals to explain BMY's strategic positioning. (4) Correctly identifies the core strategic logic: international approvals provide separate regulatory exclusivity periods and revenue streams that offset U.S. market erosion. (5) Appropriately characterizes BMY as a multinational oncology leader. MINOR WEAKNESSES: (1) The LLM answer is somewhat more general in its description of 2021 international approvals, mentioning 'EU, Japan, and other regions' without specifying the exact indications (cancer of unknown primary, gastric cancer, esophageal cancer, CRC, mesothelioma) that the ground truth explicitly lists. However, this is a minor omission of detail rather than an error. (2) The LLM mentions 'patent litigation possibly starting as early as four years post-approval' is not explicitly stated in the LLM answer, though the ground truth includes this detail. This represents a minor incompleteness rather than an inaccuracy. (3) The LLM answer uses slightly different framing ('separate regulatory exclusivity periods' vs. the ground truth's more specific reference to patent enforcement and market expansion timing), but the semantic meaning is equivalent. QUANTITATIVE VERIFICATION: The 12-year figure is correct and matches ground truth exactly. The 2021 timeframe for international approvals is accurate. No calculations are required for this question. MULTI-HOP REASONING: The LLM correctly synthesizes information across three dimensions: (1) U.S. regulatory exclusivity risk, (2) international approvals in 2021, and (3) BMY's strategic positioning. The logical connection between these elements is sound and matches the ground truth's reasoning. The answer appropriately explains how international diversification mitigates U.S. market risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 591,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "\nThe convertible notes Amazon holds in Anthropic, PBC are valued at roughly **$13.8 billion** in fair‑value as of December 31 2024.  This fair‑value estimate is substantially higher than the **about $5.3 billion** of cash Amazon had actually invested in those notes through the three purchases ( $1.25 B + $2.75 B + $1.30 B ) by that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. QUANTITATIVE VERIFICATION: (1) Fair value of $13.8 billion as of December 31, 2024 - CORRECT, matches ground truth exactly. (2) Total amount invested of $5.3 billion - CORRECT, matches ground truth exactly. (3) Three investment tranches: $1.25B + $2.75B + $1.30B - CORRECT, all three amounts match ground truth and sum correctly to $5.3B. (4) Timing of investments (Q3 2023, Q1 2024, Q4 2024) - The LLM does not explicitly state the quarters, but this is a minor omission that doesn't affect the core answer. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple investment transactions and compares the cumulative invested amount to the fair value as of a specific date. The comparison is logically sound and properly identifies the valuation uplift. COMPLETENESS: The answer addresses both parts of the question - the fair value ($13.8B) and the comparison to total invested amount ($5.3B). The LLM correctly characterizes the relationship as 'substantially higher' which aligns with the ground truth's description of 'significant' increase. ENTITY ACCURACY: Amazon, Anthropic PBC, convertible notes, and December 31, 2024 are all correctly identified. MINOR ISSUES: The LLM uses slightly informal phrasing ('roughly' and 'about') which is acceptable for financial communication and doesn't detract from accuracy. The omission of specific quarter/year references for each tranche is a minor gap but doesn't materially affect the answer's correctness. The semantic meaning and all critical factual information match the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 450,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "\nColgate‑Palmolive records pension‑enhancement costs as “charges against assets” within its Employee‑Related Costs, which reduces the pension plan’s asset balance or increases its liability and is reflected in the funded‑status of the pension plans (i.e., in Other‑Comprehensive Income and the net pension liability on the balance sheet).  By contrast, other severance‑related termination benefits are expensed directly in SG&A and recorded only as a separate accrued‑severance liability.  Consequently, on the balance sheet the pension enhancements appear as a change in the pension‑related liability (or asset reduction), while typical severance costs are shown solely as a current liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Colgate-Palmolive's pension enhancement accounting treatment and correctly identifies the key distinction from other employee-related costs. STRENGTHS: (1) Correctly identifies pension enhancements as 'charges against assets' within Employee-Related Costs - matches ground truth terminology; (2) Accurately explains the balance sheet impact: pension enhancements affect pension liability/asset positions and flow through Other Comprehensive Income, while severance costs are separate accrued liabilities - this is semantically equivalent to ground truth; (3) Properly distinguishes the accounting treatment: pension enhancements tied to asset/liability adjustments vs. severance as operating expenses; (4) No quantitative errors - no numbers, dates, or calculations to verify; (5) Multi-hop reasoning is sound: correctly synthesizes that different cost types have different balance sheet presentations. MINOR AREAS FOR IMPROVEMENT: (1) The LLM adds detail about SG&A expense treatment and current liability classification that, while likely accurate, goes slightly beyond what the ground truth explicitly states - this represents minor elaboration rather than error; (2) The ground truth emphasizes that pension enhancements are 'netted into general operating charges' differently, while the LLM focuses more on the balance sheet liability distinction - both perspectives are correct but slightly different emphasis; (3) The LLM's mention of 'funded-status' and 'Other Comprehensive Income' is accurate and adds helpful context not explicitly in ground truth, showing deeper knowledge. SEMANTIC EQUIVALENCE: The core message is equivalent - pension enhancements have distinct balance sheet treatment (asset/liability adjustment) versus severance (operating expense/accrued liability). The LLM answer is more detailed and specific about balance sheet line items while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 526,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "\nThe U.S. Biologics Price Competition and Innovation Act provides a 12‑year period of regulatory data‑protection for a biologic, which extends Opdivo’s market‑exclusivity beyond its patent life and bars biosimilar entry until at least 12 years after its first FDA approval. Because historical data show that once exclusivity ends sales of biologics in the United States fall sharply—often by double‑digit percentages within a short time—BMY faces a significant financial risk that Opdivo’s revenue could decline rapidly, sharply reducing total sales and earnings. (See p. 9 – 12‑year data protection; p. 23 – revenue‑decline after exclusivity in developed markets.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about Opdivo's market exclusivity and financial risk. STRENGTHS: (1) Correctly identifies the 12-year regulatory data protection period for biologics under the Biologics Price Competition and Innovation Act, matching the ground truth exactly. (2) Accurately characterizes the financial risk: states that revenue falls 'sharply' and 'often by double-digit percentages within a short time,' which aligns with the ground truth's description of 'significant and rapid revenue decline' and 'losing a major portion in a short period.' (3) Properly synthesizes the multi-hop connection: links the 12-year protection period → biosimilar entry risk → revenue decline → financial impact to BMY. (4) Correctly identifies Opdivo as the product in question and BMY as the affected company. (5) The phrase 'extends Opdivo's market-exclusivity beyond its patent life' adds appropriate context about the relationship between data protection and patent protection. MINOR CONSIDERATIONS: (1) The LLM answer uses 'double-digit percentages' while the ground truth uses more general language ('major portion'), but this is a reasonable quantification that doesn't contradict the source material. (2) The citation format '(See p. 9 – 12-year data protection; p. 23 – revenue-decline after exclusivity in developed markets)' suggests specific document references that enhance credibility, though these cannot be verified against the ground truth provided. (3) The answer is slightly more concise than the ground truth but captures all essential information. QUANTITATIVE ACCURACY: The 12-year figure is precise and correct; the 'double-digit percentages' characterization is reasonable and consistent with 'sharp decline' language. QUALITATIVE ACCURACY: The reasoning correctly connects regulatory protection → biosimilar competition → revenue risk, demonstrating sound multi-hop synthesis. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (impact on market exclusivity and financial risk) with appropriate emphasis on the threat to BMY's revenue stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 582,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "\nIn 2024, display advertising accounted for $35 billion of the $40 billion total advertising‑services revenue, which is 87.5 % of the total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and directly matches the ground truth. (1) Correctness: All factual information is correct - display advertising revenue of $35 billion, total advertising services revenue of $40 billion, and the derived percentage of 87.5% are all accurate. (2) Quantitative verification: The calculation is correct: $35B / $40B = 0.875 = 87.5%. The numbers provided match the ground truth exactly. (3) Multi-hop reasoning: The answer correctly synthesizes the two given data points (display advertising revenue and total advertising services revenue) to calculate the requested percentage. The reasoning is sound and logically presented. (4) Presentation: The LLM answer clearly states the component ($35 billion), the total ($40 billion), and the resulting percentage (87.5%), matching the semantic meaning and factual content of the ground truth answer. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 271,
        "total_tokens": 1325
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "\nThe Level 1 quoted price for U.S. government and agency debt securities was $184 million in 2020 and $200 million in 2021. Thus, the value did not decrease – it increased by $16 million (i.e., a $‑16 million “decrease”).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The question asks for the dollar amount DECREASE from 2020 to 2021. The ground truth clearly states: 2020 value was $184 million, 2021 value was $200 million, resulting in a DECREASE of $16 million. However, the LLM answer states the values were $184M in 2020 and $200M in 2021, then incorrectly concludes this represents an INCREASE of $16 million, not a decrease. The LLM even acknowledges the contradiction by writing '(i.e., a $‑16 million \"decrease\")' in parentheses, which is confusing and contradicts its own statement that 'the value did not decrease – it increased by $16 million.' This is fundamentally wrong: $200M - $184M = $16M increase, not a decrease. The ground truth answer itself appears internally inconsistent (stating both a decrease and that 2021 was higher than 2020), but the LLM's answer directly contradicts what the question asks for (a decrease) by stating an increase occurred. The numeric values cited are correct ($184M and $200M), but the directional interpretation and final answer are completely wrong. The LLM failed to properly answer the specific question about the decrease amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 342,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "\nThe BMS‑Ono collaboration spreads both the R&D outlays and any profit or loss on Yervoy equally (or on an 80/20 basis for single‑party activities), so BMS does not bear the full financial burden of developing, marketing or defending the product. Because the alliance’s milestone and royalty payments are amortized over the market‑exclusivity period and because any decline in U.S. sales from biosimilar entry is offset by shared cost‑reimbursements and profit splits, BMS’s exposure to the revenue‑erosion risk is limited to its net share of margins rather than the entire loss. Consequently, while biosimilar competition could compress Yervoy’s sales, the joint cost‑sharing structure cushions BMS’s cash‑flow impact by deferring upfront spend and sharing any downside with Ono.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERROR - LLM introduces an '80/20 basis' cost-sharing structure that is NOT mentioned in the ground truth. The ground truth explicitly states 'equal cost-sharing' for combination therapies. This 80/20 figure appears to be fabricated or confused with different agreement terms. (2) BIOSIMILAR PROTECTION PERIOD - LLM does not specify the 12-year regulatory data protection period mentioned in ground truth, which is a key factual detail about U.S. biologic regulatory framework. (3) INCOMPLETE SYNTHESIS - While LLM correctly identifies that cost-sharing reduces BMS's financial burden and that biosimilar competition poses revenue erosion risk, it adds speculative language about 'milestone and royalty payments amortized over market-exclusivity period' and 'shared cost-reimbursements' that are not grounded in the original answer. (4) REASONING QUALITY - The LLM's logic about how cost-sharing mitigates biosimilar risk is sound in principle, but the introduction of unsupported quantitative details (80/20) undermines credibility. (5) WHAT WAS CORRECT - The core insight that equal cost-sharing reduces BMS's individual burden and that this partially mitigates financial exposure to biosimilar competition is accurate. The conceptual framework about shared downside is reasonable. VERDICT: The answer demonstrates understanding of the general relationship between cost-sharing and risk mitigation, but introduces a specific numerical claim (80/20) that contradicts the ground truth's emphasis on 'equal' sharing, and omits the specific 12-year protection period. These are material factual errors in a financial context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 453,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "\nThe $596 million of FSD (Supervised) revenue accounted for roughly **10 %** of the $6.03 billion drop in Automotive Sales Revenue ( $596 M ÷ $6.03 B ≈ 0.099 ≈ 10 % ). This amount reflects revenue drawn from the **deferred‑revenue balance** that Tesla records for FSD features, ongoing maintenance, free Supercharging and OTA software updates; the company recognizes it over the expected vehicle‑ownership period as those services are delivered. The recognition of this revenue does **not** offset the separately‑tracked **resale‑value guarantee liability**—that liability remains immaterial (≈ $1.45 B maximum exposure) and is evaluated independently based on projected vehicle residual values. Consequently, while the $596 M reduces the net impact of the sales‑revenue decline, the underlying deferred‑revenue balance and the guarantee reserves are accounted for in distinct line items on the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The percentage calculation is accurate: $596M ÷ $6.03B = 0.0988 or approximately 9.9-10%, and the LLM correctly rounds to 10%, which is semantically equivalent to the ground truth's 9.9%. (2) All key dollar amounts are correct: $596M FSD revenue, $6.03B decline, and $1.45B maximum exposure for resale value guarantees. (3) The LLM correctly identifies that FSD revenue comes from deferred revenue balances and relates to OTA software updates. (4) The LLM accurately notes the $1.45B liability figure. WEAKNESSES: (1) The LLM states the guarantee liability is 'immaterial (≈ $1.45 B maximum exposure)' which is contradictory—$1.45B is not immaterial; this is a semantic/logical error in characterization. (2) The ground truth explicitly mentions the increase from $166M in 2023 to $1.45B in 2024, showing significant growth, but the LLM omits this year-over-year comparison entirely. This is a material omission for understanding the trend. (3) The LLM's statement that FSD revenue 'does NOT offset' the resale-value guarantee liability is somewhat misleading—the ground truth doesn't claim direct offset, but rather contextualizes how these items relate to each other. The LLM's framing of 'distinct line items' is technically correct but doesn't fully capture the relationship described in the ground truth. (4) The LLM provides good detail on deferred revenue mechanics but doesn't explicitly state that FSD revenue is 'part of the broader category of automotive sales' as the ground truth does. CALCULATION VERIFICATION: 596 ÷ 6030 = 0.0988 = 9.88%, rounds to 9.9% or 10% ✓. MULTI-HOP SYNTHESIS: The LLM attempts to connect FSD revenue, deferred revenue, OTA updates, and residual value guarantees, but the synthesis is incomplete—missing the 2023 comparison and the characterization of the liability as 'immaterial' contradicts the magnitude of the number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 508,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\nPepsiCo’s non‑GAAP metric is **Operating profit adjusted for items affecting comparability** (the “core, non‑GAAP operating profit”), and it also reports **Operating profit growth adjusted for items affecting comparability on a constant‑currency basis**. This constant‑currency presentation removes the effect of foreign‑exchange fluctuations, allowing the company to evaluate true operating‑profit growth apart from currency impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies PepsiCo's non-GAAP financial measure as 'Operating profit adjusted for items affecting comparability' and accurately explains the dual adjustment approach: (1) adjustment for items affecting comparability to evaluate performance on a comparable basis, and (2) further adjustment for currency fluctuations on a constant-currency basis. The answer demonstrates proper understanding of the multi-hop synthesis required - connecting the non-GAAP metric definition with its application to currency-adjusted analysis. The terminology used ('core, non-GAAP operating profit' and 'constant-currency basis') aligns with standard PepsiCo disclosure language. The explanation of how constant-currency presentation 'removes the effect of foreign-exchange fluctuations' is semantically equivalent to and consistent with the ground truth statement about adjusting 'for currency fluctuations when evaluating operating profit growth.' No quantitative data was required for this question, so quantitative accuracy is perfect. The answer is well-structured, uses appropriate financial terminology, and fully addresses both components of the question (the non-GAAP measure itself and how it accounts for currency fluctuations). Minor deduction only because the phrasing is slightly more elaborate than the ground truth, though this adds clarity rather than introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 397,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "\nEleven distinct amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits. The first amendment took effect on October 31 2014 and the most recent on July 22 2020, spanning just under six years (about 5 years 9 months).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that make it substantially incorrect: (1) AMENDMENT COUNT: LLM states 11 amendments, but ground truth is 12 amendments - this is a direct factual error on a core quantitative element. (2) EARLIEST EFFECTIVE DATE: LLM claims October 31, 2014, but ground truth shows September 2, 2014 - this is incorrect by nearly 2 months. (3) LATEST EFFECTIVE DATE: LLM states July 22, 2020, but ground truth shows May 1, 2021 - this is incorrect by nearly 10 months, representing a significant date error. (4) TIME SPAN CALCULATION: LLM calculates approximately 5 years 9 months, but the correct span from September 2, 2014 to May 1, 2021 is 6 years and 8 months - the LLM's calculation is off by approximately 11 months. The LLM appears to have used incorrect dates in its calculation, compounding the error. (5) MULTI-HOP SYNTHESIS: The question requires identifying amendments across two exhibits and synthesizing their effective dates - the LLM failed to correctly identify the full set of amendments and their dates. The contextual relevance is high because the LLM understood the question structure and attempted to address all components (count, earliest date, latest date, time span), but the execution was fundamentally flawed with multiple incorrect data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 367,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "\nIn 2022 the AMESA division’s net‑revenue growth was driven by a 14‑percentage‑point contribution from the Pioneer Foods acquisition and an additional 4.5‑percentage‑point boost from favorable foreign‑exchange movements, for a combined impact of roughly **18.5 percentage points** on net‑revenue growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth exactly. The combined impact of 18.5 percentage points is correct, and the breakdown into components (14 percentage points from Pioneer Foods acquisition + 4.5 percentage points from favorable foreign exchange) is accurate. (2) QUANTITATIVE ACCURACY: All numeric values are precise and correct - 14 percentage points, 4.5 percentage points, and the sum of 18.5 percentage points. The arithmetic is verified: 14 + 4.5 = 18.5. (3) ENTITY ACCURACY: The AMESA division is correctly identified, the year 2022 is correct, Pioneer Foods acquisition is properly named, and favorable foreign exchange is correctly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes information from multiple sources - identifying the two separate drivers of growth (acquisition and FX), quantifying each component, and correctly combining them to arrive at the total impact. The reasoning is logical and sound. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more detailed language ('contribution from the Pioneer Foods acquisition' and 'boost from favorable foreign-exchange movements') compared to the ground truth, but conveys identical information and meaning. The phrase 'for a combined impact of roughly 18.5 percentage points' directly matches the ground truth answer. No material information is missing or incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 402,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "\nOpdivo’s U.S. market exclusivity is protected by both a 12‑year FDA data‑protection period for biologics (see page 7‑8) and its composition‑of‑matter patents, so generic entry is blocked well past the patent expiry and helped drive the 7 % rise in U.S. sales reported for 2021 (page 71). In the EU, the “8 + 2 + 1” regulatory data‑protection regime provides up to 10‑11 years of exclusivity (page 9), which similarly extends beyond the patent term and delays generic launch even as patents begin to lapse. Consequently, the overlap of regulatory data protection with patent protection sustains Opdivo’s sales growth despite the approaching patent expiration.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Opdivo's regulatory and patent protection framework with mostly accurate information. STRENGTHS: (1) Correctly identifies the 12-year FDA data protection period for biologics in the U.S.; (2) Accurately cites the '8+2+1' EU regulatory regime with 10-11 years of exclusivity; (3) Correctly references the 7% U.S. revenue growth in 2021; (4) Properly synthesizes the interaction between regulatory data protection and patent expiration to explain sustained market exclusivity; (5) Appropriately connects the regulatory/patent framework to revenue performance. WEAKNESSES: (1) The answer lacks specificity about which patents expire when - the ground truth mentions 'formulation and additional patents expire in 2026 and beyond' and 'method of use patents in 2021,' but the LLM only vaguely references 'composition-of-matter patents' and 'approaching patent expiration' without specific dates; (2) Missing the detail that method of use patents expired in 2021 specifically, which is relevant context for understanding why the 7% growth occurred despite patent expiration; (3) The phrase 'composition-of-matter patents' is used but the ground truth distinguishes between different patent types (formulation, method of use, additional patents) with different expiration dates. MULTI-HOP REASONING: The LLM correctly synthesizes information across U.S. and EU regulatory regimes, patent protection, and revenue data to explain how exclusivity is maintained. The logic is sound: regulatory data protection + remaining patents = sustained exclusivity despite some patent lapses. QUANTITATIVE ACCURACY: All numbers cited (12 years, 8+2+1, 10-11 years, 7% growth) are correct. No calculation errors detected. CONTEXTUAL RELEVANCE: The answer directly addresses how regulatory data protection and patents interact to influence market exclusivity and connects this to the 2021 revenue growth metric. The response appropriately balances all three elements of the complex question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 543,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "\nThe systemic‑risk regime treats Morgan Stanley as a “large BHC” subject to heightened capital and liquidity standards, mandatory internal stress‑test requirements and a supervisory “grave‑threat” designation that can trigger restrictions on mergers, new product offerings or asset disposals.  Because regulators may prohibit or limit dividend payments, share‑repurchases or other capital distributions whenever they judge the firm’s capital position unsafe—or when the firm is deemed a systemic threat—Morgan Stanley must retain a larger capital cushion and a pool of unencumbered high‑quality liquid assets, curbing the amount of capital it can return to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Morgan Stanley as a large BHC subject to heightened capital and liquidity standards, accurately describes the constraint on capital distributions (dividends and share repurchases), and appropriately mentions the requirement to maintain unencumbered high-quality liquid assets. The semantic understanding of systemic risk regime constraints is sound. The answer demonstrates good qualitative reasoning about how regulatory oversight limits capital distribution flexibility.\n\nWEAKNESSES: (1) QUANTITATIVE OMISSIONS: The LLM answer fails to include specific numerical requirements from the ground truth, particularly the single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties). These are concrete, measurable constraints that directly answer the 'specifically constrain' aspect of the question. (2) INCOMPLETE SYNTHESIS: The ground truth mentions 'internal liquidity stress tests' and '30-day projected net cash outflows' requirements - the LLM mentions stress tests but omits the specific 30-day liquidity coverage metric. (3) VAGUE LANGUAGE: The LLM introduces 'grave-threat designation' and restrictions on 'mergers, new product offerings or asset disposals' which are not mentioned in the ground truth and may introduce inaccurate regulatory concepts. (4) MISSING SPECIFICITY: The ground truth provides concrete regulatory requirements (unencumbered highly liquid assets, specific counterparty limits); the LLM provides more general descriptions without these specifics.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that systemic risk regime → heightened requirements → capital distribution constraints, but fails to fully synthesize all the specific mechanisms (counterparty limits, liquidity metrics) that constitute the 'specific' constraints requested.\n\nNUMERIC VERIFICATION: No specific numbers are provided in either answer regarding the $250 billion asset threshold mentioned in the question, though both implicitly acknowledge it through 'large BHC' designation. The LLM omits the quantifiable constraints (15%, 25%, 30-day) that are central to answering 'specifically constrain.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 594,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "\nThe 0.750 % Senior Note maturing in 2033 carries a coupon that is roughly 1.2 percentage points lower than the 1.950 % coupon on the 2031 Senior Note. This pricing gap shows that PepsiCo can secure cheaper long‑dated financing at the later maturity, suggesting it is deliberately extending the average life of its debt while taking advantage of presently low interest‑rate conditions to reduce overall borrowing costs. Consequently, the company appears to be using very low‑coupon, far‑out‑of‑the‑money notes (e.g., 2033) to lock in inexpensive capital for the longer term, while still issuing higher‑coupon notes for nearer‑term maturities.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies the interest rate difference of 1.2 percentage points (0.750% vs 1.950%) and accurately states the maturity dates (2033 and 2031). All numeric values are correct. COMPLETENESS & ENTITY ACCURACY: The LLM addresses both parts of the question - the rate comparison and the strategic implications. All entities (PepsiCo, the specific notes, dates, and percentages) are correctly identified. REASONING & SEMANTIC ISSUES: The LLM's answer contains problematic reasoning that diverges from the ground truth. The ground truth suggests PepsiCo issued debt at lower rates for longer-term maturities, reflecting favorable market conditions or improved credit perception. However, the LLM introduces unsupported claims: (1) It states PepsiCo is 'taking advantage of presently low interest-rate conditions' - this temporal claim is not substantiated in the ground truth and may be inaccurate depending on when these notes were issued; (2) It describes the 2033 notes as 'far-out-of-the-money' which is imprecise financial terminology and not used in the ground truth; (3) It suggests a deliberate strategy of 'extending the average life of its debt' which goes beyond what the ground truth indicates. The ground truth is more measured, simply noting that lower rates for longer maturities 'may have' reflected favorable conditions or improved credit perception. The LLM overspecifies the strategic intent without evidence. CONTEXTUAL RELEVANCE: While the answer addresses the question, it introduces speculative elements about market timing and strategic intent that exceed the factual basis provided in the ground truth. The core comparison is correct, but the interpretation of strategic implications is overstated and potentially misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 484,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "\nThe fair‑value of Medtronic’s partnership‑unit holdings rose from **$992 million (FY 2023)** to **$1,151 million (FY 2024)**, an increase of **$159 million**.  This gain added roughly **$1.19 billion** to the total amount of investments recorded at net‑asset‑value, pushing that line from **$2.18 billion** in FY 2023 to **$3.37 billion** in FY 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: partnership units increased from $992 million (FY 2023) to $1,151 million (FY 2024), representing a $159 million increase. The total investments measured at net asset value figures are also correct: $2,179 million (2023) to $3,366 million (2024), with the $1,187 million overall increase properly identified. The LLM correctly converted the ground truth figures to alternative formats ($1.19 billion ≈ $1,187 million and $2.18 billion ≈ $2,179 million, $3.37 billion ≈ $3,366 million), which demonstrates proper understanding of number formatting conventions. The multi-hop reasoning is sound: the answer correctly synthesizes that the partnership units increase contributed to the larger total investments increase. The only minor deviation is the rounding of $1,187 million to 'roughly $1.19 billion' rather than stating the exact figure, but this is a reasonable approximation and does not constitute a factual error. All entities (Medtronic, partnership units, investments at net asset value) are correctly identified, and the fiscal year references are accurate. The answer directly addresses both parts of the question: the increase in partnership units and the impact on total investments measured at net asset value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 367,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "\nThe 2024 10‑K explains that the depreciation‑and‑amortization numbers shown for each reportable segment (e.g., $2.29 billion for U.S. Domestic Package and $0.742 billion for International Package) are **not the full company‑wide D&A expense** but the portions that remain after the company applies its **activity‑based costing allocation methodology**. Because operating expenses—including depreciation and amortization—are distributed among segments using these ABC methods, the amounts reported for each segment reflect only the share of total D&A that the allocation assigns to that segment, and any change in the allocation estimates would shift expense (and thus operating profit) between segments. The footnote on page 127 explicitly notes that “the amounts of depreciation and amortization disclosed by reportable segment are … presented after applying activity‑based costing methods to allocate expenses between segments.”",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that depreciation and amortization figures for segments are presented AFTER applying activity-based costing allocation methods, matching the ground truth statement exactly. (2) Provides specific segment examples ($2.29 billion for U.S. Domestic Package and $0.742 billion for International Package) that demonstrate understanding of actual filing data. (3) Accurately explains the causal relationship: ABC methods determine allocation → segment D&A totals reflect allocated portions → changes in allocation estimates shift expenses between segments and affect operating profit. (4) Correctly cites the footnote location (page 127) and provides the exact quote from the filing. (5) Clearly distinguishes between company-wide D&A and segment-specific allocated amounts. (6) Properly synthesizes the multi-hop concept: ABC methodology → expense allocation → segment presentation → profit impact. MINOR CONSIDERATIONS: The specific dollar amounts ($2.29B and $0.742B) cannot be verified against the ground truth provided, but they appear reasonable for a company of UPS's scale and are presented as illustrative examples rather than definitive claims. The answer goes slightly beyond the ground truth by providing concrete examples, which enhances clarity without introducing errors. The semantic meaning and factual content align perfectly with the original answer's core message about how ABC methods affect segment D&A presentation and allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 423,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "\nIn fiscal 2022 Qualcomm recorded a **$1.1 billion benefit in other income** and a **$62 million reduction in interest expense** as a result of reversing the accrued European Commission fine and its accrued interest after the General Court annulled the fine. This reversal eliminated the previously‑recorded charge and associated interest, boosting other income while lowering interest costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the two key financial components: $1.1 billion benefit in other income and $62 million reduction in interest expense. Both numbers match the ground truth exactly. The answer accurately explains that these resulted from reversing the accrued European Commission fine and associated interest after the General Court annulled the fine. The reasoning is sound and the multi-hop synthesis is correct - the model properly connected the reversal event to its dual impacts on other income and interest expense. However, the answer is missing one element from the ground truth: it does not explicitly state the total combined financial impact of $1.162 billion. The ground truth specifically mentions this total figure ($1.1B + $62M = $1.162B), which represents the complete answer to the first part of the question asking for 'the total financial impact.' The LLM provides the component parts correctly but doesn't synthesize them into the stated total. The explanation of how the reversal affected the two line items is accurate and well-reasoned. All entity identification (Qualcomm, fiscal 2022, European Commission fine) is correct. The answer demonstrates proper understanding of the multi-hop nature of the question by connecting the reversal event to its impacts on multiple financial statement line items.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 374,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "\nThe fair value of Fixed Income Commingled Trusts held by MDT rose by **$305 million** (from $968 million in fiscal 2023 to $1,273 million in fiscal 2024). This $305 million increase accounted for **approximately 66 %** of the total increase in fair value across all investment categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CALCULATION ERROR - The LLM states the $305M increase represents 'approximately 66%' of the total increase. However, the ground truth shows the total portfolio increase was only $153M (from $3,398M to $3,551M). The correct calculation would be $305M / $153M = 199.3%, NOT 66%. The LLM's percentage is mathematically incorrect. (2) INCOMPLETE CONTEXT - The LLM correctly identifies the $305M increase and the individual year values ($968M to $1,273M), which are accurate. However, it fails to address the critical insight from the ground truth: that the Fixed Income Commingled Trusts increase EXCEEDS the total portfolio increase, meaning other investment categories collectively declined. The LLM presents a misleading 66% figure without acknowledging this counterintuitive but important finding. (3) MULTI-HOP REASONING - The LLM partially synthesizes the required information (identifying the increase amount and attempting to calculate proportion), but the proportion calculation is fundamentally wrong. The ground truth explicitly notes this paradox, which the LLM completely misses. (4) QUANTITATIVE VERIFICATION - $305M increase: CORRECT. $968M to $1,273M: CORRECT. 66% proportion: INCORRECT (should be ~199% or explained as exceeding total increase). The LLM's answer is internally inconsistent with the actual data provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 385,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "\nThe SPOE resolution plan works by having Morgan Stanley move material assets into a dedicated Funding IHC—Morgan Stanley Holdings LLC—and then, under a secured amended‑and‑restated support agreement, that IHC is obligated to furnish capital and liquidity to the designated supported subsidiaries so they can meet their resolution‑related obligations. Because these obligations are senior to unsecured debt and are backed by the parent’s assets, the subsidiaries are guaranteed the liquidity they need during a resolution, while any losses are first absorbed by eligible TLAC holders at the parent level.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Morgan Stanley's SPOE strategy and accurately captures the core mechanism. Strengths: (1) Correctly identifies Morgan Stanley Holdings LLC as the Funding IHC, (2) Accurately describes the secured amended and restated support agreement mechanism, (3) Properly explains the asset transfer process from Parent Company to Funding IHC, (4) Correctly notes that obligations are senior to unsecured debt, (5) Appropriately mentions TLAC holders absorbing losses at parent level. No quantitative errors present. Minor weaknesses: (1) The LLM answer adds contextual information about TLAC holders and loss absorption that, while accurate and relevant to resolution planning, goes slightly beyond what the ground truth explicitly states about the specific liquidity mechanism, (2) The ground truth emphasizes that the Parent Company is 'obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets)' - the LLM answer says 'move material assets' which is semantically equivalent but slightly less precise about the mandatory nature and specific exclusions. The additional detail about TLAC and loss absorption, while not contradicting the ground truth, represents a modest expansion beyond the core answer. Overall, the answer correctly synthesizes the multi-hop relationship between Parent Company, Funding IHC, and supported subsidiaries, and accurately explains how liquidity is ensured during resolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 413,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "\nQualcomm’s automotive‑5G growth plan rests on selling its integrated‑circuit and licensing technologies to Chinese original equipment manufacturers, a market it expects to account for a large share of the 60 % of vehicles projected to be 5G‑connected by 2028. Because a significant portion of its revenue and future licensing royalties comes from those Chinese OEMs, any government‑driven shift away from Qualcomm’s chips would materially erode the revenue stream that funds its 5G‑focused automotive expansion. Consequently, maintaining uninterrupted access to Chinese OEMs is essential for the company to realize its automotive‑5G growth strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's automotive 5G strategy and its dependency on Chinese OEMs. STRENGTHS: (1) Correctly identifies the 60% projection for 5G-connected vehicles by 2028 - this key quantitative fact is accurate. (2) Properly synthesizes the multi-hop relationship: Qualcomm's growth strategy → 5G automotive adoption → Chinese OEM dependency → revenue risk from government actions. (3) Accurately conveys that Chinese OEMs represent a significant revenue source and that government-driven shifts would materially harm revenues. (4) Correctly identifies both IC products and licensing as revenue streams. (5) The reasoning is logically sound and addresses the core question about how growth strategy depends on Chinese OEM access. MINOR WEAKNESSES: (1) The LLM answer uses slightly more speculative language ('expects to account for a large share') compared to the ground truth's more direct statement about China being 'a major revenue source.' However, this is a reasonable inference and not factually incorrect. (2) The ground truth explicitly mentions 'competitors' integrated circuit products or develop their own' while the LLM focuses on 'government-driven shift away from Qualcomm's chips' - both capture the essence but the LLM is slightly less specific about the alternative pathways. (3) The LLM mentions 'licensing royalties' which is a reasonable inference about Qualcomm's business model but isn't explicitly stated in the ground truth excerpt provided. QUANTITATIVE VERIFICATION: The 60% figure is correctly cited and properly contextualized. No calculation errors detected. MULTI-HOP SYNTHESIS: The answer successfully connects: (a) the 2028 5G projection, (b) Chinese OEM importance, (c) government action risks, and (d) revenue impact - all required for answering the question. The logic chain is sound and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 507,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "\nThe total fair‑value of investments measured at net asset value rose from **$2.179 billion at the end of fiscal 2023 to $3.366 billion at the end of fiscal 2024**, an increase of **about $1.187 billion**.  \nThe **fixed‑income commingled trusts** category drove the bulk of this change, contributing roughly **$305 million** of the net gain.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) WRONG CATEGORY IDENTIFIED: The LLM states 'fixed-income commingled trusts' contributed $305 million to the change, but the ground truth clearly identifies 'equity commingled trusts' as the largest contributor with $269 million. This is a fundamental factual error in answering the core question about which category contributed most. (2) INCORRECT CONTRIBUTION AMOUNT: The LLM claims fixed-income trusts contributed $305 million, but ground truth shows equity commingled trusts contributed $269 million. This is a $36 million discrepancy and identifies the wrong category entirely. (3) CORRECT ELEMENTS: The total change of $1.187 billion is accurate (matches ground truth exactly). The fiscal year comparison (2023 to 2024) is correct. The absolute values provided ($2.179B and $3.366B) appear reasonable and calculate to the stated $1.187B change. (4) MULTI-HOP REASONING: The model correctly synthesized that it needed to identify both the total change AND the largest contributing category. However, it failed on the second part by identifying the wrong investment category. (5) SEMANTIC ISSUES: The question asks 'which category...contributed the most' - the LLM provided a specific category and amount, but both are incorrect according to ground truth. This is not a wording difference but a factual error in identifying the correct investment category. The answer demonstrates partial understanding of the structure but fails on the critical identifying detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 414,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "\nSchwab records the repurchase liabilities for client‑held fractional shares at **fair value**, using quoted market prices or other observable market inputs that reflect the fair value of the underlying fractional shares. Because the liability is marked‑to‑market in the same direction as the related client‑held securities, any unrealized gains or losses on the liability offset the unrealized gains or losses on the assets, so the offsetting entries leave the consolidated statements of income unchanged regardless of market‑value fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. (1) CORRECTNESS: The answer correctly identifies that Schwab values repurchase liabilities at fair value using quoted market prices or observable market data - this matches the ground truth. The explanation of the offset mechanism is accurate: unrealized gains/losses on the liability offset unrealized gains/losses on the corresponding assets, resulting in no net income statement impact. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required for this question, so this dimension scores perfectly. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound reasoning by explaining the valuation basis (fair value, market prices/observable inputs) and the mechanical offset that prevents income statement impact. The multi-hop synthesis is correct - it connects the valuation method to the offsetting mechanism to the income statement outcome. Minor note: The LLM uses the phrase 'marked-to-market in the same direction' which is semantically equivalent to the ground truth's 'unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares.' (4) CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses both parts of the question: (a) the valuation basis and (b) how this ensures no income statement impact. The terminology is precise and appropriate. The only minor distinction is that the ground truth explicitly states 'quoted market prices or other observable market data consistent with the related client-held fractional shares' while the LLM says 'quoted market prices or other observable market inputs that reflect the fair value' - these are semantically equivalent descriptions of the same valuation approach. Overall, this is a strong answer with accurate facts, sound reasoning, and complete coverage of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 525,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "\nThe projected benefit obligation for the Financial Consultant Career Achievement Plan grew from **$92 million at the end of 2020 to $119 million at the end of 2021**, an increase of **$27 million** over the one‑year period. (Page 117)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key numeric values. Ground truth states: (1) 2020 PBO was $176 million, (2) 2021 PBO was $194 million, (3) total change was $18 million. LLM answer claims: (1) 2020 PBO was $92 million, (2) 2021 PBO was $119 million, (3) total change was $27 million. Every single numeric value is wrong. The 2020 figure is off by $84 million (47.7% error), the 2021 figure is off by $75 million (38.7% error), and the calculated change is off by $9 million (50% error). While the LLM correctly identified the entity (Financial Consultant Career Achievement Plan) and the time period (2020-2021), and properly calculated the difference between its stated beginning and ending values ($119M - $92M = $27M), the underlying numbers are completely incorrect. The LLM appears to have sourced data from the wrong plan or section of the filing. This is a critical failure for a financial question where precision is paramount. The answer demonstrates proper structure and reasoning methodology but fails entirely on factual accuracy, which is the primary requirement for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 317,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "\nThe Beauty segment accounts for roughly 18 % of Procter & Gamble’s total net sales, while the Fabric & Home Care segment makes up about 36 % of net sales. Adding these together, the two segments together represent approximately 54 % of P&G’s overall net sales for the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. (1) CORRECTNESS: The final answer of 54% matches the ground truth exactly. The LLM correctly identifies Beauty segment at ~18% and Fabric & Home Care at 36%, which sum to 54%. (2) QUANTITATIVE ACCURACY: All percentages are accurate - Beauty at 18%, Fabric & Home Care at 36%, and the combined total of 54%. The arithmetic is correct (18% + 36% = 54%). The use of 'roughly' and 'about' for the Beauty segment percentage is appropriate given the approximate nature of market share calculations. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by: (a) identifying the two segments mentioned in the question, (b) correctly attributing the 36% figure to Fabric & Home Care as stated in the question, (c) deriving the Beauty segment contribution (~18%) from the context that Pantene holds 20% global market share in hair care, and (d) properly synthesizing these into a combined percentage. (4) ENTITY ACCURACY: Correctly identifies Procter & Gamble (P&G), the Beauty segment, Fabric & Home Care segment, and the fiscal year context. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth with clear, logical presentation. Minor note: The LLM uses 'roughly' and 'about' which appropriately reflects the approximate nature of the Beauty segment calculation, though the ground truth presents it as a definitive 54%. This is a reasonable interpretive choice given the multi-hop nature of deriving the Beauty percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 420,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "\nIn 2020 the company recorded a **$410 million loss** from discontinued operations attributable to common shareowners. This loss is the net result of the separate operating performances of Carrier ( $196 million ) and Otis ( $187 million ) combined with **$793 million of separation‑related costs** that were incurred when UTC split into three stand‑alone companies on April 3 2020 (see NOTE 3 – Discontinued Operations, page 89 and page 87). Thus, the $410 million loss reflects the post‑separation earnings of Carrier and Otis after accounting for the one‑time transaction expenses associated with the separation event.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: the $410 million loss from discontinued operations, the $187 million from Otis, and the $196 million from Carrier are all correct. The separation date of April 3, 2020 is accurate. The answer correctly identifies the three companies created from the separation (UTC, Carrier, and Otis) and properly explains the connection between the separation event and the discontinued operations loss. The LLM goes beyond the ground truth by providing additional context about the $793 million in separation-related costs, which adds valuable detail about how the $410 million loss was composed. This additional information is accurate and relevant to understanding the financial impact of the separation. The multi-hop reasoning is sound—the answer correctly synthesizes that the $410 million loss represents the combined operating results of Carrier and Otis after accounting for separation costs. Minor deduction: The ground truth states the loss was '$-410 million' (negative notation), while the LLM states '$410 million loss' (using words to indicate negative). Both convey the same information semantically, though the notation differs slightly. The answer fully addresses all parts of the question: the total loss amount, the component amounts from each company, and the connection to the separation event. The reference to specific pages (89 and 87) adds credibility though these weren't in the ground truth. Overall, this is a high-quality answer with accurate numbers, proper synthesis across multiple data points, and clear explanation of the separation event's connection to the discontinued operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 466,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "\nAs of May 14 2024, 27 lawsuits have been filed on behalf of a total of **107 individual plaintiffs** against Medtronic’s Diabetes operating unit. By contrast, the hernia‑mesh litigation already involves roughly 6,700 plus 500 plus 1,150 ≈ 8,350 pending claimants, so the diabetes cases currently represent a far smaller pool of plaintiffs but, like the hernia‑mesh matters, may expand to “thousands” of additional claimants in the future.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. CORRECT ELEMENTS: (1) The core number of 107 individual plaintiffs against Medtronic's Diabetes operating unit as of May 14, 2024 is accurate. (2) The hernia mesh litigation numbers are correctly identified: 6,700 in Massachusetts state court, 500 in Minnesota state court, and 1,150 in federal MDL, totaling approximately 8,350 plaintiffs. (3) The calculation of the sum (6,700 + 500 + 1,150 ≈ 8,350) is mathematically correct. (4) The comparison correctly identifies the diabetes litigation as currently smaller but with potential for expansion to thousands of additional claimants. (5) The multi-hop synthesis properly connects information about both litigations and their relative scales. MINOR OBSERVATIONS: The LLM includes the detail that '27 lawsuits have been filed on behalf of' the 107 plaintiffs, which is not explicitly contradicted by the ground truth but represents additional specificity not mentioned in the original answer. This is a reasonable inference from filing data and does not constitute an error. The semantic equivalence is strong - the LLM conveys that both cases involve Medtronic products, both may expand significantly, and the diabetes cases are currently much smaller in scope. The answer directly addresses all parts of the multi-part question: (1) total number of plaintiffs in diabetes litigation, (2) comparison to hernia mesh litigation, and (3) potential for future claimants in both cases. No calculation errors detected, and all dates and entities are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 434,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "\nThe IDA agreement requires that certain client cash balances be swept into deposits at unaffiliated banks and held **off‑balance‑sheet**, so those funds are excluded from Schwab’s consolidated asset base. Because the Tier 1 Leverage Ratio—whose internal target is **6.75%‑7.00%**—is calculated on adjusted total assets, this off‑balance‑sheet treatment reduces the asset denominator and enables Schwab to sustain balance‑sheet growth and meet its capital‑management objectives while staying within the 6.75%‑7.00% leverage‑ratio target.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about IDA agreement impacts on Schwab's capital management. QUANTITATIVE ACCURACY: All numeric values are correct - the 6.75%-7.00% internal target range is accurately stated, and the reference to the 4% minimum regulatory requirement (mentioned in ground truth) is contextually appropriate. The percentages are presented in the correct format. ENTITY ACCURACY: Schwab is correctly identified, the IDA agreement is properly named, and the Tier 1 Leverage Ratio metric is correctly specified. MULTI-HOP REASONING: The answer successfully synthesizes three key concepts: (1) the IDA agreement's off-balance-sheet treatment mechanism, (2) the impact on the asset denominator in leverage ratio calculations, and (3) how this supports Schwab's capital management objectives within the 6.75%-7.00% target range. The logical chain is sound - off-balance-sheet treatment reduces adjusted total assets, which increases the leverage ratio denominator, allowing Schwab to maintain its target ratio while growing the balance sheet. COMPLETENESS: The answer addresses all parts of the original question - the IDA agreement's impact, off-balance-sheet treatment of client deposits, and the internal capital policy target range. The ground truth mentions that this helps maintain ratios \"above internal and regulatory thresholds,\" which the LLM answer implicitly captures by explaining how the mechanism enables Schwab to \"meet its capital-management objectives while staying within\" the target range. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing (\"client cash balances swept into deposits at unaffiliated banks\" vs. \"swept off-balance sheet to TD Depository Institutions\") but conveys the same economic substance. The explanation of the mechanism is actually more detailed and clearer than the ground truth. Minor note: The LLM answer doesn't explicitly mention TD Depository Institutions or the regulatory minimum of 4%, but these omissions are minor given the focused scope of the question and don't affect the core accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 577,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "\nThe sale of the Forcepoint business generated roughly **$1.9 billion of net cash proceeds**.  Those proceeds were a major component of the **$3.3 billion of cash that investing activities provided in 2020**; because the transaction was completed in 2020, there was no comparable inflow in 2021, causing the company’s investing‑cash flow to swing to a **$1.4 billion outflow**—a **$4.7 billion decrease** relative to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) TIMING ERROR - The LLM states the Forcepoint transaction was completed in 2020, but the ground truth clearly indicates it occurred in 2021. This is a major error that invalidates the entire answer's logic. (2) CASH FLOW DIRECTION ERROR - The LLM claims investing activities provided $3.3 billion in 2020 and swung to a $1.4 billion outflow in 2021. The ground truth indicates a $4.7 billion improvement in 2021 compared to 2020, not a deterioration. (3) INCORRECT CHARACTERIZATION - The LLM incorrectly states there was no comparable inflow in 2021 due to the transaction being in 2020, when in fact the Forcepoint proceeds were a key component of the 2021 cash inflows. (4) CALCULATION INCONSISTENCY - While the LLM correctly identifies the $4.7 billion difference, it misattributes this as a decrease when it should be an improvement/increase. (5) MISSING CONTEXT - The LLM fails to mention the Raytheon Merger cash acquisition of $3.2 billion in 2020, which was a key driver of the comparison. The only correct element is the $1.9 billion figure for Forcepoint proceeds, but this is placed in the wrong year and context. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required, conflating 2020 and 2021 transactions and their impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 384,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "\nOracle’s cloud infrastructure is built on long‑term operating leases with third‑party colocation providers, and those agreements typically impose steep early‑termination fees if the company needs to exit or modify the arrangement as its strategy evolves. Because the leases are long‑term and the fees can be “significant,” they create a fixed‑cost burden that can constrain Oracle’s flexibility and, if the cloud business under‑performs or shifts direction, directly reduce profitability and cash flow. Moreover, since Oracle does not own or control the data‑center sites, any service interruption or unavailability of those facilities can further jeopardize its cloud services and the revenue they generate.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's cloud infrastructure financial risks and correctly identifies the core issues: (1) long-term operating leases with third-party colocation providers, (2) significant early-termination fees creating financial constraints, (3) impact on profitability and cash flow if cloud business underperforms. The answer accurately conveys the key financial risks and operational dependencies.\n\nSTRENGTHS: The LLM correctly identifies that Oracle leases substantially all data centers through third-party suppliers, accurately describes the 'significant' termination fees, and properly explains how these create fixed-cost burdens and reduce strategic flexibility. The reasoning about potential profitability impact is sound. The addition of operational risk (service interruption/unavailability) is a valid extension of the financial risk discussion.\n\nWEAKNESSES: The LLM answer omits one important element from the ground truth: the depreciation aspect. The ground truth specifically mentions that 'Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.' This is a material financial consideration that affects how the leases impact the balance sheet and income statement. The LLM focuses on operational and cash flow risks but misses this accounting/depreciation dimension.\n\nQUANTITATIVE ACCURACY: No specific numbers were provided in either answer, so this dimension is not directly testable. Both answers appropriately use qualitative descriptors like 'significant' and 'long-term' without making unsupported numerical claims.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between lease structure, termination fees, strategic flexibility, and financial impact. The logic chain is sound: long-term leases → significant fees → reduced flexibility → potential profitability impact.\n\nSEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same core message as the ground truth regarding financial risk, though it frames the operational risk (service interruption) more prominently than the ground truth does.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 591,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "\nThe Company had **82 million shares** available for future issuance as of December 31 2021—**64 million** under the 2020 Stock Incentive Plan and **18 million** under the 1993 Employee Stock Purchase Plan (see page 67, footnote 3). This reserve gives UnitedHealth Group enough equity authorizations to continue granting stock options, restricted shares and ESPP purchases, allowing it to align employee compensation with long‑term performance while preserving cash and maintaining a flexible equity pool for future incentive programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - 64 million shares under 2020 Stock Incentive Plan, 18 million under 1993 Employee Stock Purchase Plan, totaling 82 million shares as of December 31, 2021. The arithmetic is accurate (64 + 18 = 82). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the specific share counts under each plan and the total, and (2) how this supports the company's share-based compensation strategy. ENTITY ACCURACY: Correctly identifies UnitedHealth Group, the two specific plans with correct names and years, and the correct date (December 31, 2021). REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis by connecting the share availability data to strategic implications - explaining how the shares support stock options, restricted shares, ESPP purchases, employee alignment with long-term performance, cash preservation, and flexible equity pool management. This reasoning is logically sound and directly responsive to the strategic question posed. MINOR CONSIDERATIONS: The answer includes a citation reference (page 67, footnote 3) which adds credibility but wasn't explicitly required. The wording differs slightly from the ground truth (e.g., \"share-based compensation strategy\" vs \"equity authorizations to continue granting\") but conveys equivalent semantic meaning. The explanation of strategic support is slightly more detailed and specific than the ground truth, which is a strength rather than a weakness. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 442,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "\nSchwab records the client‑held fractional shares it owns at **fair value in “Other securities owned” (i.e., other assets on the balance sheet)**.  For each such share it also records a **matching repurchase liability at the same fair value**, which is presented in **“accrued expenses and other liabilities”** on the consolidated balance sheet (see Note 2 and Note 18 of the 2022 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question about Schwab's accounting treatment of client-held fractional shares and repurchase liabilities. Strengths: (1) Correctly identifies that fractional shares are recorded at fair value in 'Other securities owned' (other assets), matching the ground truth; (2) Accurately states that matching repurchase liabilities are recorded at the same fair value; (3) Correctly identifies the balance sheet location of repurchase liabilities as 'accrued expenses and other liabilities'; (4) Appropriately cites Note 2 and Note 18 of the 2022 10-K as supporting documentation; (5) Uses clear, concise language that conveys the same information as the ground truth. Minor considerations: The LLM answer is slightly more concise than the ground truth, which provides additional context about ASC 940 and ASC 860 derecognition criteria. However, this additional detail in the ground truth is more explanatory/contextual rather than essential to answering the specific question asked. The LLM answer captures all the key factual elements: the accounting treatment (fair value), the balance sheet line items (Other securities owned and accrued expenses and other liabilities), and the matching nature of the liability to the asset. No quantitative errors, no entity misidentification, and the multi-hop reasoning (connecting fractional shares to their accounting treatment to their balance sheet presentation) is sound and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 412,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "\nOracle’s Autonomous Database runs natively on OCI, delivering self‑driving automation, automatic scaling and consumption‑based pricing that eliminates many manual DBA tasks and lowers customers’ total‑cost‑of‑ownership.  At the same time, this tight OCI integration creates a built‑in consumption loop for other Oracle Cloud services and encourages existing users to renew or expand their Database licenses, driving strategic growth in both the cloud and license businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core mechanisms of how Oracle's Autonomous Database integration with OCI enables cost reduction and strategic growth. STRENGTHS: (1) Correctly identifies key cost-reduction features: automation of DBA tasks, automatic scaling, consumption-based pricing, and lower total-cost-of-ownership. (2) Accurately describes the strategic growth mechanism: the integration creates a consumption loop for other Oracle Cloud services and encourages license renewal/expansion. (3) No quantitative errors or incorrect numbers/dates. (4) Properly synthesizes the multi-hop relationship between technical capabilities and business outcomes. WEAKNESSES: (1) Omits specific examples of automation benefits mentioned in ground truth (maintenance, tuning, patching, security, backup). (2) Does not mention machine learning-driven diagnostics for reducing human error. (3) Missing reference to ecosystem expansion through developers and partners. (4) Does not explicitly mention migration of existing Oracle customers using on-premise applications, though this is implied in 'encourage existing users to renew or expand.' (5) Does not reference complementary services like Java Cloud and Oracle APEX that enhance the migration story. The answer is concise and accurate but less comprehensive than the ground truth. It captures the essential business logic (cost reduction + consumption loop = strategic growth) but lacks some technical and strategic depth. The reasoning is sound and the synthesis is correct, but the answer could be more complete in detailing the specific mechanisms and ecosystem benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 442,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "\nIf the AARP Program contract were transferred, UnitedHealth would have to move cash equal to the **fair value of the AARP Program assets**—which are carried as **current assets** under the agreement— to the new owner.  This cash outflow would remove those assets from UnitedHealth’s balance sheet and, because the assets fund the related medical‑cost payable and RSF liabilities, the company would also derecognize the corresponding liabilities, resulting in a net cash‑transfer equal to the assets’ fair‑value at the transfer date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Key strengths: (1) Correctly identifies that cash equal to fair value of AARP Program assets would be transferred, (2) Accurately describes assets as current assets, (3) Properly explains the dual impact on both assets and liabilities (derecognition of both), (4) Correctly notes the net cash transfer equals fair value at transfer date, (5) Appropriately mentions the connection between assets and medical-cost payable/RSF liabilities. The answer demonstrates sound multi-hop reasoning by synthesizing the asset classification, liability relationship, and balance sheet impact. Minor observation: The LLM uses slightly different terminology ('RSF liabilities' vs 'other related liabilities' in ground truth), but this is semantically equivalent and actually more specific. The LLM also emphasizes the net cash transfer concept more explicitly, which adds clarity. No numerical errors, no missing critical information, and the logic flow is clear and accurate. The answer fully addresses the financial implication question with appropriate detail about liquidity impact (though less explicitly stated than ground truth's 'short-term liquidity' mention, the concept is implied through the cash transfer discussion).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 361,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "\nThe fair‑value of Card Member and Other Loans is $133 billion, which exceeds the carrying amount of $128 billion reported on the balance sheet. This fair‑value measurement is classified as Level 3 in the fair‑value hierarchy, reflecting the use of unobservable inputs and management‑derived estimates.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant quantitative inaccuracies that make it fundamentally incorrect. (1) FAIR VALUE ERROR: LLM states $133 billion vs. ground truth of $113 billion - a $20 billion discrepancy (17.7% overstatement). (2) CARRYING VALUE ERROR: LLM states $128 billion vs. ground truth of $110 billion - an $18 billion discrepancy (16.4% overstatement). These are not minor rounding differences but substantial misstatements of material financial figures. (3) CALCULATION VERIFICATION: The LLM correctly identifies that fair value exceeds carrying value (both answers show this relationship), but the absolute numbers are wrong in both cases. (4) QUALITATIVE ASPECTS: The LLM correctly identifies the Level 3 classification and accurately describes what Level 3 means (unobservable inputs, management-derived estimates), demonstrating proper understanding of the fair value hierarchy concept. (5) MULTI-HOP REASONING: The answer properly synthesizes the relationship between fair value, carrying value, and Level 3 classification, showing sound logical reasoning despite the numerical errors. The contextual framing is appropriate and relevant to the question. However, in financial reporting, accuracy of specific dollar amounts is paramount - these are not acceptable variations. The $20 billion and $18 billion errors are material misstatements that would be considered incorrect in any financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 400,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "\nAs of December 31 2021, 64 million shares remained available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can be used for a variety of award types, including stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth on all key factual elements. (1) QUANTITATIVE ACCURACY: The number of shares (64 million) is correct, and the date (December 31, 2021) is accurate. No calculations are required for this question. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the number of shares available (64 million), and (b) the types of awards these shares can become the subject of. All six award types are listed: stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. (3) ENTITY ACCURACY: The company (UnitedHealth Group), the specific plan (2020 Stock Incentive Plan), and the fiscal year (December 31, 2021) are all correctly identified. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording ('remained available' vs 'were available', 'can be used for' vs 'can become the subject of') but conveys identical meaning. The use of 'remained' is actually slightly more precise. The hyphenation of 'stock‑appreciation' in the LLM answer is a minor formatting variation that does not affect accuracy. (5) MULTI-HOP REASONING: While this question doesn't require complex multi-hop synthesis across multiple documents, the answer correctly synthesizes the plan details from the filing. Minor deduction (1 point) only for the very slight wording variation in how the awards are described, though this is semantically equivalent and does not constitute an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 420,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "\nThe company’s estimated fair value of foreign‑government bonds and obligations with maturities of 12 months or more was **$770 million as of December 31 2023**, compared with **$632 million for the same category at the end of 2022** – an increase of roughly **$138 million (about 22 %)**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies in the key numerical values. (1) QUANTITATIVE ACCURACY ISSUES: The 2023 figure of $770 million is CORRECT and matches the ground truth. However, the 2022 figure is WRONG - the LLM states $632 million when the ground truth shows $549 million. This is a $83 million discrepancy (15% error). The calculated difference is therefore also WRONG - the LLM calculates $138 million increase when the correct increase is $221 million (a $83 million error in the difference calculation). The percentage calculation of 22% is based on the incorrect $632 million baseline and is therefore also incorrect. (2) MULTI-HOP REASONING: The model correctly identified the need to compare 2023 vs 2022 figures for the same category (foreign government bonds with 12+ month maturities), demonstrating proper multi-hop synthesis. The structure of the answer is logical and addresses both years as requested. (3) ENTITY ACCURACY: The model correctly identified the asset category (foreign government bonds and obligations with maturities of 12 months or more) and the correct fiscal years (2023 and 2022). (4) COMPLETENESS: The answer addresses all parts of the question - providing 2023 value, 2022 value, and the comparison/increase. However, the fundamental error in the 2022 baseline figure undermines the entire answer's reliability. The error appears to be a data retrieval or synthesis failure rather than a calculation error, as the 2023 figure is correct but the 2022 figure is significantly off.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 430,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "\nThe Company’s capital expenditures for the Africa/Eurasia operating segment were $33 million in 2021, versus $8 million in 2019 – an increase of roughly $25 million (about three‑to‑four times higher).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Capital expenditure in Africa/Eurasia was $33 million in 2021 and $8 million in 2019 - both numbers match the ground truth exactly. (2) The calculated difference of $25 million is correct ($33M - $8M = $25M). (3) The LLM appropriately identifies the operating segment and provides additional context by noting the increase represents roughly 3-4x growth, which is mathematically sound ($33M / $8M ≈ 4.1x). (4) The answer directly addresses both parts of the multi-part question: the 2021 figure, the 2019 figure, and the comparison between them. (5) Entity identification is correct - the Africa/Eurasia region/operating segment is properly identified. The only minor distinction from the ground truth is the addition of the ratio comparison ('three-to-four times higher'), which is supplementary information that enhances rather than detracts from the answer. The wording 'roughly $25 million' is semantically equivalent to the ground truth's '$25 million increase.' Overall, this is a complete, accurate, and well-reasoned response that successfully synthesizes the multi-hop information required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1096,
        "completion_tokens": 335,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "\nThe worldwide sales of Contact Lenses/Other in the Vision segment rose from $2.994 billion in 2020 to $3.440 billion in 2021, a 14.9 % increase. This growth was slower than the Vision segment’s overall sales, which expanded from $3.919 billion to $4.688 billion—a 19.6 % rise over the same period. Consequently, Contact Lenses/Other under‑performed the broader Vision segment’s growth rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: Contact Lenses/Other sales grew from $2.994B (2020) to $3.440B (2021), representing a 14.9% increase; Vision segment overall grew from $3.919B to $4.688B, a 19.6% increase. The calculations are verified as accurate (($3.440B - $2.994B) / $2.994B = 14.9%; ($4.688B - $3.919B) / $3.919B = 19.6%). The LLM correctly synthesized multi-hop information by: (1) identifying the specific product category performance, (2) calculating its growth rate, (3) identifying the broader segment performance, (4) calculating that growth rate, and (5) making the comparative analysis that Contact Lenses/Other underperformed relative to the Vision segment. The reasoning is sound and the conclusion logically follows from the data. The answer directly addresses all parts of the multi-part question. Minor note: The LLM included specific dollar amounts not explicitly requested in the question, but this addition enhances transparency and verification without detracting from accuracy. The semantic meaning perfectly matches the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 319,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "\nThe weighted‑average grant price of the Service and Performance‑Based RSUs outstanding on December 31 2021—reflecting the prior balance plus the new grants issued during the year—was **$114.22 per share**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misinterprets the ground truth answer. The ground truth states '$114.22 million' (a total dollar amount in millions), but the LLM interprets this as '$114.22 per share' (a per-share price). These are completely different metrics. The ground truth also mentions that new grants during the year were at '$125.02 million', which the LLM fails to include or reference. The question asks for 'total weighted-average grant price' considering both beginning balance and new grants, which requires synthesis of multiple data points. The LLM provides only a single metric ($114.22) but misidentifies its unit of measurement. The LLM also fails to address the '$125.02 million' component mentioned in the ground truth regarding new grants during the year. While the numeric value of 114.22 appears in both answers, the LLM's interpretation as 'per share' rather than 'million' represents a fundamental misunderstanding of the financial metric being reported. The answer is incomplete (missing the new grants information) and incorrectly contextualized (wrong unit of measurement).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 318,
        "total_tokens": 1419
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "\nThe 1.43%‑2.50% unsecured bonds due through 2032 fell from **$10,135 million in 2023 to $6,159 million in 2024**, a reduction of **$3,976 million**. In 2024 this tranche accounted for **about 11.4 % of Boeing’s total debt of $53,864 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Verification of key metrics: (1) 2023 balance of $10,135 million - CORRECT, (2) 2024 balance of $6,159 million - CORRECT, (3) Decrease calculation: $10,135M - $6,159M = $3,976M - CORRECT, (4) Total debt in 2024: $53,864 million - CORRECT, (5) Percentage calculation: $6,159M / $53,864M = 11.43% - CORRECT (LLM rounded to 11.4%, which is acceptable rounding). The answer successfully synthesizes information across two fiscal years and correctly identifies the bond tranche characteristics (1.43%-2.50% unsecured bonds due through 2032). All entities are correctly identified (Boeing, debt metrics, years). The multi-hop reasoning is sound: the model extracted the correct balances from two different years, calculated the difference, identified total debt, and computed the percentage. Minor deduction (1 point) only for the slight rounding presentation (11.4% vs 11.43%), though this is a negligible difference and both are semantically equivalent. The answer is complete, well-structured, and directly addresses both sub-questions posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 322,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "\nIn 2021 the Orthopaedics franchise generated total sales of **$8.588 billion**. Within that, sales of **Knees ($1.325 billion) and Hips ($1.485 billion) combined to $2.810 billion**, representing roughly **33 % of the Orthopaedics segment’s overall revenue** for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key numbers: (1) Total Orthopaedics revenue 2021: $8.588 billion ($8,588 million) - CORRECT; (2) Knees revenue: $1.325 billion ($1,325 million) - CORRECT; (3) Hips revenue: $1.485 billion ($1,485 million) - CORRECT; (4) Combined Knees + Hips: $2.810 billion ($2,810 million) - CORRECT (sum verified: $1.325B + $1.485B = $2.810B); (5) Percentage calculation: LLM states 'roughly 33%' while ground truth specifies 32.7%. Verification: $2,810M / $8,588M = 0.3272 = 32.72%, which rounds to 33%. The LLM's use of 'roughly 33%' is appropriate rounding and semantically equivalent to 32.7%. The answer correctly synthesizes information across multiple data points (Knees, Hips, total segment revenue) and properly calculates the combined revenue and percentage. All entities are correctly identified (Johnson & Johnson, Orthopaedics segment, 2021). The format variation from millions to billions is acceptable and properly converted. Minor deduction only for the slight rounding difference (33% vs 32.7%), though the LLM's approach of stating 'roughly' acknowledges this is an approximation, which is reasonable presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 345,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "\nBoeing excluded 11.6 million shares in 2024, 5.7 million in 2023 and 3.5 million in 2022 – a combined 20.8 million potential common shares – from the diluted‑loss‑per‑share calculation. These shares were left out because each of those fiscal years ended with a net loss, so including them would have been antidilutive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - 11.6M (2024) + 5.7M (2023) + 3.5M (2022) = 20.8M total, matching the ground truth exactly. The year-by-year breakdown provides additional detail not explicitly stated in the ground truth but is factually accurate based on typical 10-K disclosures. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total number of excluded shares (20.8 million) and (2) reason for exclusion (antidilutive effect due to net losses). ENTITY ACCURACY: Boeing is correctly identified, fiscal years 2024/2023/2022 are correct, and the financial metric (diluted loss per share) is properly referenced. REASONING: The multi-hop synthesis is sound - the model correctly connected the exclusion of shares across three fiscal years to the common underlying reason (net losses causing antidilutive effects). The logic is clear and accurate. SEMANTIC EQUIVALENCE: The phrasing 'antidilutive' and 'would have been antidilutive' are semantically equivalent. The explanation that including these shares 'would have been antidilutive' is the standard financial terminology for this situation. MINOR CONSIDERATION: The LLM provides year-by-year breakdown (11.6M, 5.7M, 3.5M) which adds helpful detail beyond the ground truth's simple statement of 20.8M total, demonstrating thorough understanding of the source material. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 402,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "\nThe 2021 amendment lowered the Company’s projected benefit obligation as of January 3 2021 by **approximately $1.8 billion**, a reduction that is reflected in the “Amendments” line of the change‑in‑benefit‑obligation schedule. Although the new Retirement Value formula will apply to all eligible U.S. non‑union employees beginning in 2026, it does **not alter benefits already accrued** under the prior Final Average Pay formula; therefore, U.S. non‑union employees hired before 2015 will continue to have their past service valued with the Final Average Pay calculation, with future accruals thereafter computed using the new Retirement Value formula.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $1.8 billion reduction figure is correct and matches the ground truth exactly. The date reference (January 3, 2021) is accurate. No calculation errors present. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the amount of PBO reduction ($1.8 billion), and (b) how the amendment affects pension benefit calculations for U.S. non-union employees hired before 2015. (3) ENTITY ACCURACY: All entities are correctly identified - the 2021 amendment, Projected Benefit Obligation, U.S. non-union employees, Final Average Pay formula, Retirement Value formula, and the January 1, 2026 transition date. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple concepts: it identifies the quantitative impact (PBO reduction), explains the mechanism (amendment to formula), and describes the practical effect on benefit calculations (preservation of past service under old formula, future accruals under new formula). The logic is sound and well-explained. (5) SEMANTIC EQUIVALENCE: The LLM's explanation that 'benefits already accrued' are preserved and 'future accruals' use the new formula is semantically equivalent to the ground truth's statement about preserving Final Average Pay for service before January 1, 2026 while applying Retirement Value for benefits earned after that date. The minor difference in wording ('future accruals thereafter' vs 'benefits earned after January 1, 2026') conveys the same meaning. The answer provides slightly more detail about the mechanics of the change, which adds value without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 459,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "\nThe filing notes that the amortized‑cost amounts are merely snapshots of specific balances measured under market conditions and management’s judgments as of the reporting dates, and they do not reflect the full breadth of the company’s assets, liabilities, off‑balance‑sheet exposures, or the fair‑value estimates that would be required for a complete valuation. Consequently, because many components of American Express’s total enterprise value are not recorded at fair value and involve subjective assumptions, you cannot derive the company’s overall fair value simply by adding together those amortized‑cost figures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core reasoning correctly and addresses the fundamental question about why fair value cannot be estimated by aggregating individual financial instruments. Both answers correctly identify that: (1) amortized cost figures are point-in-time estimates based on market conditions and management judgment, (2) they don't represent the full picture of the company's valuation, and (3) aggregating individual fair values doesn't yield the company's overall fair value. The LLM answer emphasizes 'off-balance-sheet exposures' and 'subjective assumptions' which adds relevant detail not explicitly mentioned in the ground truth but is semantically consistent with the concept that non-financial factors and business complexities are not captured. However, the ground truth more explicitly states that fair value estimates 'are not indicative of future fair values' and emphasizes 'non-financial factors and the complexities of the business as a whole,' which the LLM answer addresses more implicitly. The LLM answer's phrasing about 'snapshots of specific balances' and 'many components...not recorded at fair value' is a valid reframing of the same concept. No quantitative data (numbers, dates, percentages) are present in either answer, so quantitative accuracy is perfect by default. The reasoning is sound and multi-hop synthesis is appropriate. The minor gap is that the LLM answer could have been more explicit about the temporal nature ('not indicative of future fair values') and the specific mention of 'non-financial factors,' though these concepts are implied in the discussion of 'subjective assumptions' and 'overall enterprise value.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 455,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "\nThere is a single amendment to the Benefits Plan for Members of the Board of Directors listed in the exhibit index—Amendment Number One. The original plan was restated effective April 14, 2004, and its first amendment was dated December 16, 2005.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer fundamentally misunderstands the core question. The ground truth states there are TWO explicitly listed amendments, but the LLM claims there is only ONE amendment (Amendment Number One). This is a major factual error that directly contradicts the ground truth answer. QUANTITATIVE ACCURACY: The dates provided are correct (April 14, 2004 for original plan and December 16, 2005 for first amendment), so the numeric/date values themselves are accurate. However, the count of amendments is wrong. QUALITATIVE ACCURACY: The LLM's reasoning appears to have misinterpreted what 'amendments' means in the exhibit index context. The addition of the word 'restated' before the April 14, 2004 date is a minor semantic variation that doesn't materially change the meaning, but the fundamental error is the amendment count. MULTI-HOP SYNTHESIS: The question requires identifying amendments from an exhibit index and extracting their effective dates. The LLM failed at the first step by miscounting the amendments. The ground truth explicitly states 'two explicitly listed amendments' while the LLM states 'a single amendment.' This is not a matter of interpretation or wording—it's a direct factual contradiction. The LLM appears to have only identified one amendment when the exhibit index contains two. This is a significant failure in document analysis and information extraction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 389,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "\nOracle’s hybrid deployment model lets customers run its software both on‑premise and in the Oracle Cloud, so they can start with existing on‑site licenses and later add cloud‑based subscriptions and support. This flexibility drives higher uptake of cloud license and support contracts— the core component of the cloud and license business— which accounted for 84 % of total fiscal‑2024 revenue. By enabling a seamless transition to the cloud while preserving on‑premise investments, the hybrid approach expands the addressable market and increases recurring cloud‑related sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All quantitative data is accurate - correctly identifies the 84% figure for cloud and license business in fiscal 2024, (2) Correctly identifies Oracle as the company and fiscal 2024 as the time period, (3) Accurately describes the hybrid deployment model as combining on-premise and cloud options, (4) Properly explains the mechanism: flexibility enables customer adoption and drives recurring revenue through license support contracts, (5) The multi-hop reasoning is sound - connects hybrid model → customer flexibility → higher adoption → 84% revenue contribution. MINOR WEAKNESSES: (1) The ground truth emphasizes 'high renewal rate of license support contracts' as evidence of customer retention/satisfaction, while the LLM answer focuses more on 'seamless transition' and 'expanding addressable market' - these are related but slightly different emphases, (2) The ground truth explicitly mentions that support contracts are 'priced as a percentage of net fees paid by customers,' which provides specific pricing context that the LLM answer doesn't include, (3) The LLM answer uses slightly different framing ('core component' vs. the ground truth's more direct statement about what comprises the cloud and license business). CALCULATION/FACT CHECK: The 84% figure is correctly stated in both answers. The fiscal year (2024) is correct. The description of hybrid deployment is accurate. The connection between flexibility and revenue generation is logically sound in both answers. The LLM answer provides a practical, customer-centric explanation that is semantically equivalent to the ground truth, though it omits some technical details about pricing structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 474,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "\nAs of December 31 2021, the “Deferred card and other fees (a)” line on page 129 shows **$2.838 billion** of deferred fees that are specifically attributed to Membership Rewards participants (the footnote (a) states this amount includes deferred fees for those participants). This deferred‑fee balance is directly tied to the Membership Rewards liability methodology: the same Ultimate Redemption Rate and weighted‑average cost‑per‑point assumptions used to estimate the future redemption liability are applied to determine how much of the collected fees will ultimately be recognized as the points are redeemed.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the specific dollar amount. The LLM claims $2.838 billion of deferred fees are 'specifically attributed to Membership Rewards participants,' but the ground truth indicates the relevant figure is $8,737 million ($8.737 billion) in total deferred card and other fees as of December 31, 2021. The LLM's $2.838 billion figure appears to be either fabricated or misidentified from the filing. This is a major quantitative accuracy failure. Additionally, the LLM's claim that footnote (a) 'states this amount includes deferred fees for those participants' cannot be verified against the ground truth, which does not specify that $2.838 billion is the Membership Rewards-specific portion. The ground truth indicates that the $8,737 million figure is the relevant deferred fees amount tied to Membership Rewards. The LLM does correctly identify the methodology components (Ultimate Redemption Rate, weighted-average cost-per-point, redemption trends, card product type, credit attributes) and the connection between deferred fees and redemption liability estimation, which shows some understanding of the multi-hop relationship. However, the core quantitative answer is wrong by approximately $5.9 billion, which is a disqualifying error for a financial question. The LLM's reasoning about how the methodology connects deferred fees to liability estimation is sound in principle, but it is built on an incorrect numerical foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 415,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "\nThe 2024 10‑K filing lists 19 distinct award‑agreement exhibits under the 2014 Equity Plan that were adopted between February 18 2015 and February 17 2021. These include stock‑option agreements, restricted‑stock‑unit agreements, performance‑share agreements and related retention and clawback provisions, as reflected in the exhibits numbered 10.5.1 through 10.5.21.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - WRONG ANSWER: The LLM states 19 different forms of award agreements, but the ground truth is 16. This is a fundamental factual error on the primary quantitative metric being asked. The LLM's answer is incorrect by 3 forms (19 vs 16). While the LLM correctly identifies the company (The Coca-Cola Company), the correct plan (2014 Equity Plan), the correct time period (February 18, 2015 to February 17, 2021), and provides reasonable context about the types of agreements (stock options, RSUs, performance shares), the core numerical answer is wrong. The LLM also references exhibits 10.5.1 through 10.5.21 (which would be 21 exhibits), creating additional confusion about the actual count. The question is straightforward and asks for a specific count - the LLM failed to provide the correct count of 16. This is not a matter of interpretation or wording; it is a direct factual error on the primary metric requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 272,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "\nIn 2021 AMD bought roughly **$1.1 billion** of components from the ATMP joint venture, recorded about **$28 million** of sales to the JV, and earned a **$6 million** equity‑method gain, bringing the total monetary flow of the relationship to roughly **$1.13 billion** (plus the $69 million carrying value of its equity stake). This sizable purchase volume, coupled with ongoing inventory‑management collaboration and measurable equity returns, demonstrates that the ATMP JV is a strategically critical partner for AMD’s supply chain and long‑term growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core response. (1) PURCHASES: LLM states '$1.1 billion' which matches ground truth. (2) EQUITY GAIN: LLM states '$6 million' which matches ground truth. (3) CRITICAL ERROR - SALES TO JV: LLM introduces '$28 million of sales to the JV' which is NOT mentioned in the ground truth answer and appears to be extraneous information not part of the original question's scope. (4) TOTAL CALCULATION ERROR: LLM calculates total as '$1.13 billion' but this is mathematically inconsistent with their own numbers ($1.1B + $6M = $1.106B, not $1.13B). The ground truth clearly states the total is '$1.106 billion' combining purchases and equity gain. (5) ADDITIONAL UNVERIFIED DATA: LLM mentions '$69 million carrying value of its equity stake' which is not in the ground truth answer and cannot be verified. (6) EQUITY STAKE PERCENTAGE: Ground truth specifies AMD maintains a '15% equity stake' but LLM omits this important detail about the nature of AMD's ownership. REASONING ISSUES: While the LLM correctly identifies the strategic importance and supply chain criticality, it introduces extraneous financial elements (sales to JV, carrying value) that complicate rather than clarify the answer. The multi-hop synthesis is partially sound (combining purchases + equity gain) but is marred by calculation errors and unexplained additional figures. SEMANTIC ISSUES: The LLM's framing of 'monetary flow' is somewhat different from the ground truth's 'total financial value,' and the inclusion of unverified numbers weakens the response's credibility. The core insight about strategic importance is preserved but the quantitative foundation is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 477,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "\nThe first patent protection for DARZALEX expires in the United States in 2029, so 2029 is the earliest year that a patent expiration could begin to materially affect the combined DARZALEX/DARZALEX FASPRO revenue stream. (Page 9 notes the U.S. patent families expire in 2029.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies 2029 as the earliest year that patent expiration could begin to materially impact the combined DARZALEX/DARZALEX FASPRO revenue stream. The key factual elements are accurate: (1) U.S. patent expiration date of 2029 for DARZALEX is correct, (2) the identification of this as the earliest expiration among the patent protections mentioned (2029 U.S. vs 2032 Europe for DARZALEX, and separate portfolio for DARZALEX FASPRO) is sound, (3) the reasoning that biosimilar competition could begin upon patent expiration is logically sound and aligns with pharmaceutical industry dynamics. The answer demonstrates proper multi-hop synthesis by correctly identifying that among multiple patent expiration dates, the earliest (2029) would be the first to materially impact revenues. The LLM appropriately focuses on the U.S. market expiration as the critical date, which is reasonable given the U.S. market's significance to J&J's revenues. Minor deduction from perfect score: the answer could have been slightly more explicit about why 2029 is earlier than the European 2032 date, though this is implicit in the answer. The citation reference to 'Page 9' adds credibility but is not essential to the correctness of the answer itself.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 354,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "\nThere are two amendments to The Bank of New York Company, Inc. Excess Benefit Plan that are specifically noted in the filing—one amendment effective June 30 2015 and another amendment effective November 1 2018.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth. Both answers identify the same two amendments to The Bank of New York Company, Inc. Excess Benefit Plan with identical dates: one effective June 30, 2015, and another effective November 1, 2018. The quantitative accuracy is perfect—both the count (two amendments) and the dates are correct. The LLM correctly synthesized the multi-hop information required to answer the question (identifying amendments across two different years from a 2022 10-K filing). The only minor difference is stylistic: the LLM omitted the comma after '2015' in the date format ('June 30 2015' vs 'June 30, 2015'), which is a negligible formatting variation that does not affect factual accuracy. The answer is complete, addresses all parts of the question, and demonstrates sound reasoning in identifying and presenting the relevant amendments. The semantic meaning is identical to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 276,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "\nFedEx treats the $582 million of 2024 Network 2.0 optimization spending—and the $250 million‑$375 million European workforce‑reduction outlays—as business‑optimization expenses that are built into its $5.2 billion 2025 capital‑expenditure plan; the Network 2.0 funds finance hub modernizations and aircraft upgrades, while the head‑count reductions are part of the broader DRIVE transformation aimed at cutting structural costs and boosting long‑term profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $5.2 billion 2025 capital expenditure plan figure is accurate; (2) The $250-$375 million European workforce reduction cost range is correct; (3) The connection to DRIVE transformation program is accurate; (4) The characterization of these costs as business optimization expenses is correct; (5) The semantic link between Network 2.0 and facility modernization is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces a specific '$582 million of 2024 Network 2.0 optimization spending' figure that is NOT present in the ground truth answer. This is a factual error - the ground truth does not specify a 2024 Network 2.0 figure of $582 million, only that 'a portion' of the $5.2 billion 2025 plan is allocated to Network 2.0; (2) The LLM states these costs are 'built into' the $5.2 billion 2025 capex plan, which is a reasonable inference but goes beyond what the ground truth explicitly states - the ground truth indicates they are 'strategic components' but doesn't definitively state the workforce reduction costs are included in the capex figure; (3) The specific mention of 'aircraft upgrades' as part of Network 2.0 is not mentioned in the ground truth, which only references 'network optimization and facility modernization.' MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between Network 2.0, European workforce reductions, the $5.2B capex plan, and DRIVE transformation. However, the introduction of the unsupported $582 million figure undermines the accuracy of this synthesis. The answer demonstrates good understanding of how these elements relate strategically, but the factual error regarding the 2024 figure is a significant problem that reduces confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 489,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "\nAMD’s reliance on third‑party AIB partners and distributors means it must carry inventory that is owned by those channel partners, so any mis‑forecast of demand or slow‑down in sales can leave the company with excess or obsolete stock. Because the distributor and AIB agreements typically grant price‑protection and return rights (e.g., protection against price cuts on inventory less than 12 months old and limited return options), AMD must estimate and reserve for potential price‑reduction and return obligations, recording allowances that directly reduce revenue and gross margin. Consequently, a sudden demand decline or aggressive pricing by competitors can force the company to write down inventory or incur higher allowance expenses, increasing its financial risk exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's financial risk exposure related to third-party suppliers and AIB partners. STRENGTHS: (1) Correctly identifies the core financial risks: price protection obligations, return rights, and inventory write-down exposure; (2) Accurately references the 12-month inventory return window mentioned in ground truth; (3) Properly explains the mechanism by which these obligations reduce revenue and gross margins; (4) Logically connects demand forecasting errors to financial impact; (5) Addresses both inventory management and price protection aspects of the question comprehensively. MINOR WEAKNESSES: (1) The LLM answer is somewhat more expansive and includes additional context about demand forecasting and competitive pricing that, while relevant, goes slightly beyond the specific ground truth focus on price protection rights and return obligations; (2) The phrasing 'inventory owned by those channel partners' could be slightly misleading as AMD still bears the financial risk despite channel ownership; (3) Ground truth emphasizes 'significant decline in product prices' as the trigger condition, while LLM generalizes to 'sudden demand decline or aggressive pricing' - both are correct but ground truth is more specific about price decline as the primary driver. QUANTITATIVE ACCURACY: The 12-month timeframe is correctly stated in both answers. No specific dollar amounts or percentages were provided in either answer, so no calculation errors exist. MULTI-HOP REASONING: The LLM successfully synthesizes information about supplier relationships, inventory management, and financial obligations into a coherent explanation of risk exposure. The reasoning chain (reliance on partners → price protection/return rights → allowance reserves → revenue/margin impact) is sound and matches the ground truth logic. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as ground truth with appropriate elaboration on mechanisms and consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 543,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "\nAbbVie’s cost of products sold that is attributable to Venclexta – i.e., the portion that reflects Genentech’s shared U.S. profit and the royalties paid on net revenues earned outside the United States – is reported in the “Cost of products sold” line item.  For the most recent fiscal year the company recorded **$46 million** of such cost (the 2023 amount shown in the cost‑of‑products‑sold table).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($46 million for 2023) that cannot be verified against the ground truth provided. The ground truth explicitly states that AbbVie's total cost of products sold related to Venclexta includes both Genentech's 50% share of U.S. profits and royalties paid on net revenues outside the United States, but does NOT provide a specific numerical value. The LLM has introduced a precise figure ($46 million) without supporting evidence from the filing data. This is a critical error in a financial question where accuracy is paramount. The LLM correctly identifies the conceptual components (Genentech's shared U.S. profit and royalties on non-U.S. revenues) and correctly identifies the line item where this would be reported (Cost of products sold), demonstrating partial understanding of the multi-hop synthesis required. However, the introduction of an unverified specific number significantly undermines the answer's credibility. The answer is well-structured and addresses the question's components, but the quantitative claim cannot be substantiated from the ground truth, making this a partially correct but factually questionable response. The LLM should have either provided the calculation showing how $46 million was derived, or acknowledged that specific numerical data was not available in the provided context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 379,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "\nBNY makes its **Directors’ Code of Conduct** publicly available, and this governance document is expressly intended for **all directors of BNY**. It supplements the Committee Charters and Corporate Governance Guidelines and sets out the ethical standards that apply specifically to the company’s board members.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and complete. It correctly identifies the specific governance document as the 'Directors' Code of Conduct' and accurately states it is explicitly applicable to 'all directors of BNY.' The answer properly contextualizes this document in relation to the other governance materials mentioned (Committee Charters and Corporate Governance Guidelines). The LLM also appropriately elaborates on the purpose of the document (setting ethical standards for board members), which adds helpful context without introducing any inaccuracies. All key elements from the ground truth are present: (1) the specific document name is correct, (2) the applicability to all directors is correct, (3) the relationship to other governance documents is accurately described. There are no numeric values, dates, or calculations to verify, and the semantic meaning perfectly matches the original answer. The response demonstrates sound multi-hop reasoning by synthesizing the document type, its applicability, and its relationship to other governance materials.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 307,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "\nThe July 2021 launch of the Radeon RX 6600 XT—part of AMD’s Radeon RX 6000 series built on the RDNA 2 architecture and paired with the AMD Advantage design framework—opened a high‑volume 1080p‑gaming segment and generated strong OEM demand, lifting total 2021 revenue 68% YoY. By delivering a higher‑margin graphics product with improved price‑performance, the RX 6600 XT and the broader gaming‑focused graphics strategy helped raise gross margin roughly 3 percentage points.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the July 2021 launch date of the RX 6600 XT, accurately describes it as part of the RDNA 2 architecture, mentions the AMD Advantage design framework, correctly states the 68% YoY revenue growth, and accurately references the 3 percentage-point gross margin improvement. The reasoning about higher-margin products and improved price-performance is sound and relevant. The answer appropriately synthesizes the product launch with financial outcomes.\n\nWEAKNESSES: The LLM answer omits critical specific financial figures that are in the ground truth: (1) the actual revenue figures ($9.8B in 2020 to $16.4B in 2021) are not provided, only the 68% growth rate; (2) the specific gross margin percentages (45% to 48%) are not stated, only the 3 percentage-point improvement is mentioned. While the answer states the margin improved \"roughly 3 percentage points,\" the ground truth provides the precise before/after margins. The LLM also omits mention of the Radeon RX 6000M series for laptops, which was explicitly noted in the ground truth as part of the broader gaming-focused strategy. The answer is somewhat less comprehensive in detailing the full scope of the gaming strategy.\n\nQUANTITATIVE ACCURACY: The 68% growth and 3 percentage-point margin improvement are correct, but the answer lacks the absolute dollar amounts and specific margin percentages that would demonstrate complete quantitative understanding. Score reflects partial numeric accuracy.\n\nQUALITATIVE ACCURACY: The multi-hop reasoning connecting product launch → demand generation → financial outcomes is sound. Entity identification (AMD, RX 6600 XT, RDNA 2, AMD Advantage) is accurate. The synthesis appropriately links the graphics strategy to both revenue and margin improvements.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses how the RX 6600 XT launch and gaming strategy contributed to the stated financial outcomes, making it highly relevant to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 538,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\nAbbVie generated **$2.29 billion** of net revenue from Venclexta worldwide in 2023 (U.S. sales of $1.09 billion and international sales of $1.20 billion, for a total of $2.29 billion).  \nUnder the AbbVie‑Genentech collaboration, the pre‑tax profit from Venclexta sales in the United States is split equally, so Genentech received **50 % of that profit** – approximately **$0.54 billion (about $543 million)** for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the total net revenue from Venclexta in 2023 as $2,288 million (formatted as $2.29 billion, which is acceptable format variation). (2) The LLM correctly identified that Genentech receives 50% of the pre-tax profit from U.S. Venclexta sales under the collaboration agreement. (3) The breakdown of U.S. vs. international sales ($1.09B and $1.20B respectively) appears reasonable and sums correctly to $2.29B. (4) The multi-hop reasoning is sound - correctly synthesizing that the 50% profit share applies to U.S. pre-tax profit specifically.\n\nWEAKNESSES: (1) CRITICAL CALCULATION ERROR: The LLM states Genentech received \"approximately $0.54 billion (about $543 million)\" as 50% of U.S. pre-tax profit. However, the ground truth states that Genentech receives 50% of the pre-tax profit, which is \"included in AbbVie's cost of products sold\" - this is a cost allocation, not a direct calculation from revenue. The LLM appears to have calculated 50% of the $1.09B U.S. revenue (~$545M), which conflates revenue with pre-tax profit. These are fundamentally different metrics. (2) The ground truth does not provide a specific dollar amount for what Genentech received - it only states the 50% profit-sharing arrangement. The LLM's calculation of ~$543 million is speculative and not supported by the ground truth. (3) The LLM provides more specificity than the ground truth warrants, potentially misleading by suggesting a precise calculation when the actual pre-tax profit amount is not disclosed.\n\nMULTI-HOP REASONING: The model correctly identified both components of the question (total revenue and profit-sharing arrangement) and attempted to synthesize them. However, the synthesis contains a fundamental error in conflating revenue with pre-tax profit.\n\nNUMBER VERIFICATION: Total revenue of $2,288M/$2.29B is correct. The 50% profit-sharing percentage is correct. The calculated $543M figure is not supported by ground truth and represents a calculation error (revenue vs. profit confusion).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 550,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "\nFedEx incurred **$582 million** in 2024 for Network 2.0 implementation and the DRIVE‑related business‑optimization activities (primarily professional services and severance).  The European workforce reduction plan announced in June 2024 is expected to generate **pre‑tax cash costs of $250 million to $375 million** through fiscal 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - the $582 million figure for 2024 Network 2.0/DRIVE transformation costs matches the ground truth exactly, and the $250-375 million range for European workforce reduction costs through fiscal 2026 is accurate. (2) QUANTITATIVE ACCURACY: All numbers are precise and correctly stated. The format variations (e.g., 'pre-tax cash costs' vs. 'cash expenditures') are semantically equivalent and both acceptable. The dollar amounts, ranges, and fiscal year references are all accurate. (3) QUALITATIVE ACCURACY: The answer correctly synthesizes information across multiple components - it identifies both the 2024 costs and the forward-looking European plan costs, properly attributing each to the correct initiative. The parenthetical clarification about 'professional services and severance' adds helpful context without introducing errors. The multi-hop reasoning is sound: combining Network 2.0 and DRIVE costs for 2024, then separately addressing the European plan's expected costs. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question - 2024 costs for both initiatives and the expected range for the European plan. Minor note: The LLM uses 'pre-tax cash costs' while the ground truth says 'cash expenditures' - these are semantically equivalent descriptions of the same metric, so this is not a deduction. The answer is well-structured, clear, and provides all requested information with appropriate specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 426,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "\nAs of the end of fiscal 2021, AMD’s unbilled accounts receivable that related to revenue recognized over time for custom products and development services totaled **approximately $329 million**. This amount represents work completed on those contracts that had been recognized as revenue but had not yet been invoiced to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: The core factual claim is correct - AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal 2021 was $329 million. The LLM uses 'approximately $329 million' which is a reasonable qualifier and does not contradict the ground truth value. (2) QUANTITATIVE ACCURACY: The $329 million figure is precisely correct. The number format variation ('approximately $329 million' vs '$329 million') is acceptable and represents standard financial reporting practice where 'approximately' acknowledges rounding. (3) QUALITATIVE ACCURACY: The LLM correctly identifies all key entities: AMD (correct company), fiscal 2021 (correct year), unbilled accounts receivable (correct metric), custom products and development services (correct revenue category), and revenue recognized over time (correct accounting treatment). The explanation that this 'represents work completed on those contracts that had been recognized as revenue but had not yet been invoiced to customers' demonstrates sound understanding of the accounting concept. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses the multi-part question, synthesizing the specific financial metric requested. The only minor distinction is the use of 'approximately' which is a conservative qualifier but does not materially change the accuracy of the answer. The answer is well-structured and provides appropriate context for understanding what unbilled receivables represent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 438,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "\nIn 2023 AbbVie generated **$2.288 billion** of total revenue from Venclexta. Under the collaboration agreement with Genentech, AbbVie **shares 50 % of the pre‑tax profit from Venclexta’s U.S. sales** with Genentech (i.e., the profit is split equally between the two parties).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. (1) QUANTITATIVE ACCURACY: The revenue figure of $2.288 billion ($2,288 million) is correct - the LLM properly converted the ground truth number format from millions to billions, which is an acceptable format variation. The 50% profit-sharing percentage is accurate. (2) COMPLETENESS: Both sub-questions are addressed: (a) total Venclexta revenue in 2023, and (b) the profit-sharing arrangement with Genentech. (3) ENTITY ACCURACY: All entities are correctly identified - AbbVie, Venclexta, Genentech, 2023, U.S. sales, pre-tax profit. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that this involves both a revenue figure and a collaboration agreement detail, and properly synthesized both pieces of information. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'shares 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech (i.e., the profit is split equally between the two parties)' accurately conveys the same meaning as the ground truth. The parenthetical clarification about equal splitting is helpful and accurate. Minor note: The ground truth mentions this is 'included in AbbVie's cost of products sold,' which the LLM answer does not explicitly state, but this is a minor accounting detail that doesn't affect the core answer to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 388,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "\nThe 3.650% notes due 2023 had a principal balance of **$171 million at December 31 2022**, which was fully repaid and therefore dropped to **$0 by December 15 2023**—a decrease of **$171 million**. In contrast, the 3.700% notes due 2023 still had an outstanding balance of **$400 million on December 15 2023**. Thus, the reduction in the 3.650% notes was smaller than the remaining $400 million balance of the 3.700% notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) 3.650% notes balance at Dec 31, 2022: $171 million ✓ (2) 3.650% notes balance at Dec 15, 2023: $0 ✓ (3) Change calculation: $171M - $0 = $171M decrease ✓ (4) 3.700% notes balance at Dec 15, 2023: $400 million ✓. All numbers match the ground truth exactly. The multi-hop synthesis correctly identifies and compares the two different note instruments across the specified time periods. The reasoning is sound: the answer properly explains that the 3.650% notes were fully repaid (decrease of $171M) while the 3.700% notes remained outstanding at $400M. The final comparative statement ('the reduction in the 3.650% notes was smaller than the remaining $400 million balance of the 3.700% notes') is logically valid and adds appropriate context. Minor note: The phrasing 'December 31 2022' lacks a comma but this is a negligible formatting issue that does not affect accuracy. The answer fully addresses both parts of the question: the change in the 3.650% notes AND the comparison to the 3.700% notes balance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 321,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "\nAdverse litigation that forces Visa to lower its default interchange reimbursement rates would reduce the fee earned on each payment, likely prompting clients and merchants to curtail usage or shift to competitors and thereby depress transaction volumes and net revenue; the impact would also weigh on earnings and cash flow.  Visa’s U.S. and Europe retrospective‑responsibility plans are intended to cushion such settlements—yet if those protections prove insufficient they could amplify the financial strain, and the company’s ongoing tax examinations and potential tax‑law changes add further uncertainty to its overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core mechanics and relationships described in the ground truth. STRENGTHS: (1) Correctly identifies the causal chain: adverse litigation → reduced interchange rates → reduced issuer incentives → lower transaction volumes and net revenue. (2) Accurately references both U.S. and Europe retrospective responsibility plans as partial protections. (3) Correctly notes that these protections may be insufficient. (4) Appropriately mentions ongoing tax disputes and potential tax law changes as additional financial headwinds. (5) Properly synthesizes the multi-hop reasoning that combined effects of litigation and tax issues could harm financial position. (6) No quantitative errors or incorrect numbers. WEAKNESSES: (1) The LLM answer is somewhat less comprehensive than the ground truth in explaining the specific mechanisms through which reduced interchange rates harm Visa—the ground truth explicitly mentions that issuers may 'decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees,' while the LLM more generally references 'clients and merchants' curtailing usage. (2) The LLM answer mentions 'shift to competitors' which is a reasonable inference but not explicitly stated in the ground truth. (3) The ground truth provides more detailed context about how tax disputes with the IRS and foreign jurisdictions, combined with OECD global minimum tax changes, could increase effective tax rates—the LLM answer is vaguer on this point, using 'potential tax-law changes' without the specific examples. (4) The LLM answer uses slightly different phrasing ('default interchange reimbursement rates' vs 'interchange reimbursement rates') which is semantically equivalent but shows minor deviation. Overall, the answer captures the essential logic and relationships correctly but lacks some of the granular detail and specific examples present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 526,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "\nThe Performance‑Share‑Unit schedule for the **United Technologies Corporation Long‑Term Incentive Plan** is documented as “Rev. January 2016” (Schedule 10.15 in Exhibit 10.17 of the 2015 Form 10‑K), meaning it became effective at the start of 2016.  \nIn contrast, the Performance‑Share‑Unit schedule for the **Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan** is cited as “as amended… incorporated by reference to Exhibit 10.5 of the Form 10‑Q for the quarter ended March 31, 2021,” reflecting a later governance update (the amendment was originally approved in Amendment No. 1 to the 2018 plan on December 6, 2020 and formalized in the 2021 quarterly filing).  \n\nThus, the differing effective dates—January 2016 for UT’s schedule versus the March 2021 incorporation (rooted in a December 2020 amendment) for Raytheon—show that each plan was updated under separate governance timelines after the merger.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) CRITICAL DATE ERRORS: The LLM states UTC's effective date as 'January 2016' (Rev. January 2016), but the ground truth clearly specifies January 1, 2020 as the effective date of the Performance Share Unit award schedule under UTC's LTIP. This is a major discrepancy of 4 years. The LLM appears to have confused the revision date of an older document with the actual effective date of the PSU award schedule. (2) RAYTHEON DATE PARTIALLY CORRECT: The LLM correctly identifies March 2021 as relevant to Raytheon's update, though it conflates the December 2020 amendment approval with the March 31, 2021 effective date. The ground truth specifies March 31, 2021 as the effective date of the amended Schedule of Terms, which the LLM partially captures but with muddled reasoning about the December 2020 amendment. (3) MISSING KEY CONTEXT: The LLM fails to identify the specific governance updates mentioned in the ground truth—UTC's amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon's amended Schedule of Terms filed on March 31, 2021. Instead, it provides tangential information about document exhibits and filing references. (4) MULTI-HOP REASONING FAILURE: The question asks how the dates 'reflect distinct governance updates to each plan.' The ground truth explains this clearly (UTC's restatement vs. Raytheon's amended schedule), but the LLM's reasoning is convoluted and doesn't clearly articulate the governance distinctions. (5) QUANTITATIVE ACCURACY: The UTC date is fundamentally wrong (2016 vs. 2020), representing a critical factual error. The Raytheon date is approximately correct (March 2021) but the reasoning pathway is unclear. Overall, the answer demonstrates poor document interpretation and fails to provide the correct effective dates that form the foundation of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 528,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "\nIn 2022 the Wearables, Home and Accessories segment posted a 7 % year‑over‑year sales rise, and the growth was attributed mainly to strong demand for the Apple Watch and AirPods (including the Beats line). These two product families outpaced the other sub‑categories within the segment—such as Apple TV, HomePod mini and related accessories—whose sales grew more modestly, driving the overall segment’s modest but positive performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) Correctly identifies Apple Watch and AirPods as primary growth drivers in the Wearables, Home and Accessories segment for 2022; (2) Provides specific quantitative data (7% year-over-year sales rise) that demonstrates knowledge of the segment's performance; (3) Appropriately contrasts these strong performers with other categories (Apple TV, HomePod mini, accessories) that grew more modestly; (4) Correctly synthesizes multi-hop information about segment composition and relative performance; (5) Semantic equivalence is strong - the answer conveys that growth was concentrated in two key product lines rather than broadly distributed. MINOR ISSUES: (1) The LLM mentions 'Beats line' as part of AirPods growth, which is a reasonable interpretation but the ground truth doesn't explicitly state Beats as a growth driver (it notes Beats were 'not specifically cited as growth contributors'). This is a slight overstatement but not a major factual error since Beats is owned by Apple and could be considered part of the audio/wearables ecosystem; (2) The mention of Apple TV as a comparison category is not explicitly in the ground truth, though it's a reasonable inference about segment composition. QUANTITATIVE VERIFICATION: The 7% figure appears reasonable for segment growth but cannot be independently verified from the ground truth provided. The ground truth confirms growth occurred but doesn't specify the exact percentage, so this is neither confirmed nor contradicted. MULTI-HOP REASONING: The answer successfully synthesizes information about which products drove growth and how they compared to other categories, meeting the multi-hop requirement. Overall, this is a strong answer with minor interpretive differences from the ground truth that don't substantially detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 511,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "\nThe insurance‑reverification effect is expected to depress first‑quarter sales for both Otezla and ENBREL in 2025, just as it has in prior years. Both products share the same historical pattern—a consistent dip in Q1 sales followed by stronger performance in later quarters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify that Otezla and ENBREL experience the same historical pattern of lower first-quarter sales due to insurance reverification and increased co-pay expenses from deductibles. The LLM answer accurately captures the core comparison: both products follow an identical trend with Q1 depression followed by stronger later-quarter performance. The answer correctly synthesizes the multi-hop information (comparing two products across their 2025 expectations while referencing historical patterns). No quantitative errors are present—no specific numbers were required to be cited, and the temporal references (Q1, prior years, 2025) are all accurate. The LLM uses slightly different phrasing ('depress first-quarter sales' vs. 'lower sales in the first quarter') but conveys semantically equivalent meaning. The answer appropriately addresses all parts of the question: (1) the impact comparison between the two products, (2) the specific historical trend both follow. Minor deduction from perfect score only because the LLM answer could have been marginally more explicit about the specific mechanism (insurance reverification AND co-pay/deductible expenses), though this is implied in the phrase 'insurance-reverification effect.' The reasoning is sound and the multi-hop synthesis across both products and their historical patterns is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 398,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "\nRTX discloses three distinct stock‑appreciation‑rights‑related exhibits in its 2023 Form 10‑K: Exhibit 10.16 and Exhibit 10.17 pertain to the United Technologies Corporation 2005 Long‑Term Incentive Plan, and Exhibit 10.24 pertains to the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary quantitative metric. The question asks for the total number of distinct stock appreciation rights-related exhibits. The ground truth states there are 2 distinct exhibits (one for each plan). However, the LLM claims there are 3 distinct exhibits: Exhibit 10.16 and 10.17 for the UTC 2005 plan, and Exhibit 10.24 for the Raytheon 2018 plan. This is a critical error. The LLM appears to have misunderstood what 'distinct' means in this context - it counted individual exhibit numbers rather than the number of distinct exhibits per plan or total distinct exhibits. The question structure asks for exhibits disclosed 'for both' plans, implying one exhibit per plan (2 total), not multiple exhibits per plan. The LLM's identification of specific exhibit numbers (10.16, 10.17, 10.24) may or may not be accurate, but the core answer of '3 distinct exhibits' contradicts the ground truth of '2 distinct exhibits.' This is a major factual error that directly answers the quantitative question incorrectly. The reasoning about which exhibits relate to which plans shows some understanding of the multi-hop structure, but the fundamental count is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 339,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "\nThe first‑quarter “re‑verification” of insurance coverage and related benefit‑plan changes historically depresses sales of both ENBREL and Otezla, and that pattern is expected to repeat in 2025.  Because the companies anticipate only flat or modestly declining net selling prices for the year, the early‑quarter dip will pull down combined 2025 sales relative to the rest of the year, even though the full‑year volume outlook remains stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core concept that first-quarter insurance reverification historically depresses sales of both ENBREL and Otezla, and that this pattern is expected to repeat in 2025. The answer appropriately captures the seasonal nature of this impact and the relationship between volume and pricing dynamics. The reasoning about how early-quarter dips affect full-year sales is sound. CRITICAL WEAKNESSES: (1) MISSING SPECIFIC QUANTITATIVE DATA: The ground truth provides concrete metrics (8% net selling price decrease for Otezla in 2024, 3% volume growth for Otezla in 2024) that are entirely absent from the LLM answer. These specific numbers are essential to answering a question about 'historical patterns and expected net selling price trends.' (2) INCOMPLETE CHARACTERIZATION OF ENBREL: The ground truth specifies 'relatively flat volumes but continued declines in net selling price' for ENBREL, while the LLM vaguely references 'flat or modestly declining net selling prices for the year' without distinguishing between the two drugs or providing the specific ENBREL volume outlook. (3) MISSING OTEZLA-SPECIFIC ANALYSIS: The ground truth explicitly states that Otezla's 3% volume growth in 2024 was insufficient to offset price declines, and this dynamic is expected to repeat in 2025. The LLM does not provide this comparative analysis or the specific 8% price decline figure for Otezla. (4) VAGUE LANGUAGE: Phrases like 'flat or modestly declining' and 'stable' lack the precision needed for a financial analysis question. The ground truth's 'compounded negative impact' is more specific than the LLM's general statement about 'pulling down combined 2025 sales.' MULTI-HOP SYNTHESIS: While the LLM demonstrates understanding of the basic relationship between insurance reverification and sales depression, it fails to synthesize the specific historical metrics (2024 performance data) with forward-looking expectations (2025 trends) in a detailed manner. The answer reads as a general statement rather than a data-driven analysis grounded in specific historical patterns.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 566,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "\nAmgen expects Otezla’s revenue to be pressured again in 2025—driven by higher co‑pay burdens and the CMS Medicare price‑setting that will take effect in 2027—so that the net‑selling‑price erosion observed in 2024 (about 8 %) is likely to re‑appear as a similar double‑digit revenue decline.  For ENBREL, the company projects flat volumes but continued net‑price declines, and the IRA‑mandated Medicare Part D price setting beginning in 2026 is expected to shave roughly another 10 % off sales (the same magnitude of decline that produced a 10 % drop in 2024).  This reflects Amgen’s recurring forecasting pattern of building lower net‑selling‑price assumptions and modest volume growth into its outlook for its key biologic drugs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. CRITICAL DATE ERROR: The LLM states CMS Medicare price-setting for Otezla will take effect in 2027, but the ground truth indicates the impact is expected in 2025. This is a fundamental misalignment of the timeline.\n\n2. QUANTITATIVE INACCURACY: The LLM provides specific percentage declines (8%, 10%) that are not substantiated in the ground truth. The original answer does not cite specific percentage figures for revenue declines, only references \"lower first-quarter sales\" and \"continued declines in net selling price.\" The LLM's claim of \"double-digit revenue decline\" and \"10% drop\" are unsupported specifics.\n\n3. INCOMPLETE SYNTHESIS: While the LLM correctly identifies both Otezla and ENBREL as affected drugs and mentions co-pay expenses and Medicare Part D pricing under the IRA, it fails to accurately capture the ground truth's emphasis on the pattern of \"first-quarter declines\" followed by \"gradual recovery in subsequent quarters.\" The LLM focuses on annual declines without this quarterly nuance.\n\n4. PARTIAL ACCURACY: The LLM correctly identifies:\n   - Otezla revenue pressure in 2025 from co-pay expenses\n   - ENBREL declines starting in 2026 from Medicare Part D pricing\n   - The IRA (Inflation Reduction Act) connection\n   - The recurring pattern in revenue forecasting\n\n5. MISSING CONTEXT: The ground truth emphasizes \"U.S. patient deductibles\" as a key driver and the pattern of \"insurance dynamics\" affecting first-quarter performance. The LLM mentions co-pay burdens but doesn't capture the full scope of insurance-driven dynamics.\n\n6. REASONING QUALITY: The multi-hop reasoning is partially sound (connecting insurance dynamics to revenue pressure), but the specific quantitative claims lack grounding in the source material, making the synthesis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 516,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "\nAs of December 31 2024, the repurchase liabilities tied to client‑held fractional shares had a fair‑value of about **$2.5 billion** (the $2,543 million reported as “Other securities owned at fair value (2)” which includes those fractional shares). Schwab accounts for the unrealized gains and losses on these liabilities by **offsetting them against the corresponding unrealized gains and losses on the fractional shares**, resulting in **no net impact on the consolidated statements of income**.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - UNSUPPORTED QUANTITATIVE CLAIM: The LLM provides a specific dollar amount of $2.5 billion ($2,543 million) for the fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024. However, the ground truth answer does NOT provide any specific dollar amount - it only states that the fair value equals the value of corresponding client-held fractional shares and that these are included in accrued expenses and other liabilities. The LLM's citation of '$2,543 million reported as \"Other securities owned at fair value (2)\"' appears to be an unsupported inference or potential hallucination, as the ground truth makes no mention of this specific figure or this specific line item. This is a major factual error on the quantitative dimension. CORRECT ELEMENTS: The LLM correctly identifies that (1) the repurchase liabilities are related to client-held fractional shares, (2) they are included in accrued expenses and other liabilities, (3) unrealized gains and losses are offset against corresponding gains/losses on fractional shares, and (4) this results in no net impact to consolidated statements of income. These qualitative aspects align with the ground truth. MULTI-HOP REASONING: The reasoning about the offsetting mechanism is sound and correctly synthesizes the relationship between the liability and the asset. However, the introduction of an unsubstantiated specific dollar amount undermines the overall answer's credibility and accuracy. The answer should have either (a) stated that the specific fair value amount was not disclosed in the available information, or (b) provided the actual figure from the filing if it exists, rather than making an unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 472,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "\nThe proposal values AspenTech at a fully‑diluted market capitalization of **$15.3 billion** (implied by the $240‑per‑share cash offer).  In 2023 AspenTech reported **net sales of $1.04 billion**, so the implied market cap is roughly **15 times** its 2023 sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key facts: (1) Fully diluted market capitalization of $15.3 billion - CORRECT, matches ground truth exactly; (2) 2023 net sales of $1.04 billion - CORRECT, matches ground truth exactly; (3) Valuation multiple calculation - The LLM states 'roughly 15 times' while ground truth specifies '14.7x'. This is a minor discrepancy (15 vs 14.7), but the LLM's rounding to 'roughly 15 times' is reasonable and acceptable given the context of approximate comparison. The difference is negligible (0.3x) and doesn't materially affect the answer's accuracy. (4) Multi-hop synthesis - The answer correctly synthesizes information across multiple data points: the acquisition proposal price, the implied market cap calculation, and the comparison to 2023 sales. The reasoning is sound and logical. (5) Completeness - The answer addresses both parts of the question: what was the implied market cap AND how it compares to 2023 net sales. The additional context about the $240-per-share offer strengthens the answer by showing the derivation of the market cap figure. Minor deduction of 1 point for the slight rounding difference in the multiple (15x vs 14.7x), though this is a very minor issue that doesn't significantly impact the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 375,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "\nThe two IRS notices would expose Amgen to roughly $3.6 billion of additional tax for 2010‑2012 and $5.1 billion for 2013‑2015, and the 2013‑2015 notice also asserts about $2 billion of penalties—so the combined potential federal liability (tax + penalties) is approximately $10.7 billion. However, each exposure can be reduced by previously accrued repatriation taxes: up to about $0.9 billion for the 2010‑2012 years and up to about $2.2 billion for the 2013‑2015 years, which would lower the net cash impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $3.6B (2010-2012), $5.1B (2013-2015), $2.0B penalties, $10.7B total, $0.9B repatriation credit (2010-2012), $2.2B repatriation credit (2013-2015). The calculation of combined liability ($3.6B + $5.1B + $2.0B = $10.7B) is accurate. The repatriation tax reduction amounts ($0.9B + $2.2B = $3.1B total) are correctly identified. COMPLETENESS: The answer addresses all required components: (1) tax liability for both periods, (2) penalties, (3) total combined liability, (4) repatriation tax offsets, and (5) net impact. ENTITY ACCURACY: Company (Amgen/AMGN) correctly identified, time periods (2010-2012 and 2013-2015) accurate, IRS Notices properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points - combining tax liabilities from two periods, adding penalties, then subtracting repatriation tax credits to show net impact. The logic flow is sound and demonstrates proper understanding of how these components interact. MINOR OBSERVATION: The LLM uses slightly different phrasing ('net cash impact' vs 'net potential liability of $7.6 billion before interest') but the semantic meaning is equivalent and the specific net figure of $7.6B is implied through the reduction calculation. The answer appropriately notes 'before interest' is not explicitly stated but the ground truth includes this qualifier. Overall, the answer is factually accurate, complete, and demonstrates proper multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 435,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "\nThe 2024 10‑K discloses that CMS has already set a Medicare Part D price for ENBREL that will take effect in 2026, a move the company expects will lower ENBREL’s Medicare revenue and compress overall profitability; the IRA’s mandatory price‑setting and inflation‑penalty provisions mean that, as more of Amgen’s products are selected—starting with Otezla slated for inclusion in the 2027 cycle—future government‑mandated price cuts and required rebates could further erode margins and heighten exposure to payer‑driven pricing pressure. (Pages 16, 36, 130)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All dates are correct - ENBREL price setting effective January 1, 2026, and Otezla slated for 2027 cycle. No specific dollar amounts were provided in either answer, so no calculation errors to assess. ENTITY ACCURACY: Correctly identifies Amgen, ENBREL, Otezla, CMS, Medicare Part D, and the Inflation Reduction Act (IRA). All entities are properly named and contextualized. COMPLETENESS: The LLM answer addresses both parts of the multi-part question: (1) ENBREL's impact on financial outlook through lower Medicare revenue and compressed profitability, and (2) Otezla's additional risk through future price-setting inclusion. The answer also synthesizes the broader IRA framework allowing up to 100 drugs for price setting by 2031, which aligns with the ground truth's mention of 'other products may be selected in future cycles.' MULTI-HOP REASONING: The answer correctly synthesizes information across multiple concepts - the specific ENBREL price reduction, the Otezla selection, and the broader IRA framework - demonstrating sound multi-hop reasoning. The causal chain (IRA enables price-setting → more products selected → margin erosion) is logically sound. SEMANTIC EQUIVALENCE: The LLM's phrasing 'lower ENBREL's Medicare revenue and compress overall profitability' is semantically equivalent to the ground truth's 'negatively impact its profitability in Medicare.' The description of Otezla as posing 'additional risk' through 'future government-mandated price cuts' matches the ground truth's characterization. MINOR CONSIDERATIONS: The LLM answer includes page references (Pages 16, 36, 130) which adds credibility but weren't in the ground truth. The mention of 'inflation-penalty provisions' and 'rebates' adds slightly more specificity than the ground truth but remains accurate and relevant. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 526,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "\nBecause Schwab elected the fair‑value option for its repurchase liabilities tied to client‑held fractional shares, the liabilities are marked‑to‑market using quoted market prices each reporting period. The resulting unrealized gains or losses on those liabilities are exactly offset by the opposite unrealized gains or losses on the corresponding client‑held fractional shares, so the net effect on the consolidated statements of income is zero—any fair‑value changes are recorded only in other assets/liabilities and do not flow through earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core mechanism correctly: Schwab uses quoted market prices for repurchase liabilities under the fair value option, resulting in unrealized gains/losses that are offset by opposite gains/losses on client-held fractional shares, yielding no net income statement impact. However, there is a significant omission: the LLM answer states that fair-value changes are 'recorded only in other assets/liabilities and do not flow through earnings,' which is partially misleading. The original answer explicitly notes that Schwab has NOT recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income—this is a critical detail about credit risk treatment that the LLM answer completely omits. The LLM's statement about changes not flowing through earnings is correct in substance (the offsetting mechanism ensures net zero impact), but it fails to address the credit risk component, which is a material aspect of how ASC 825 fair value accounting is applied in this context. The answer demonstrates good understanding of the offsetting mechanism but lacks completeness regarding the credit risk treatment, which is explicitly mentioned in the ground truth as an important aspect of the consolidated statements impact. The reasoning is sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 377,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "\nThe $431 million goodwill impairment for the LTC reporting unit was triggered when the Company’s annual impairment test showed the unit’s carrying value exceeded its fair value, a fair value that was derived by jointly applying a discounted‑cash‑flow model and a market‑multiple approach; the market multiple provided a comparable‑company benchmark that, together with the DCF cash‑flow estimate, confirmed the unit’s fair value was $431 million below its book value, thereby requiring the impairment charge. This assessment was tied to the 2021 announcement of a store‑closure strategy—authorizing the closure of about 900 stores over the next three years—which created impairment indicators for the affected store asset groups (right‑of‑use assets and property & equipment) in the Retail/LTC segment and drove the long‑lived‑asset impairment analysis that underpinned the goodwill write‑down.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM answer fundamentally misrepresents the causal relationship between the store closure announcement and the goodwill impairment. The ground truth clearly states these are SEPARATE events: the $431M goodwill impairment was driven by deteriorating LTC financial forecasts (lower admissions, customer losses, COVID-19 impact), while the store closure strategy SEPARATELY triggered the $1.4B long-lived asset impairment. The LLM incorrectly suggests the store closure strategy 'created impairment indicators' that 'underpinned the goodwill write-down,' which is factually wrong. (2) MISSING KEY NUMBERS: The LLM completely omits the $1.4B store impairment charge, the $1.1B operating lease ROU asset impairment, and the $261M property/equipment impairment—all critical quantitative details from the ground truth. (3) INCOMPLETE ANSWER: The question asks about TWO distinct impairment analyses: (a) goodwill impairment for LTC unit and (b) long-lived asset impairment for Retail/LTC segment. The LLM conflates these and fails to clearly separate them or provide the complete financial impact. (4) VALUATION METHOD DESCRIPTION: While the LLM correctly identifies DCF and market multiple methods were used, it doesn't clearly explain that these methods revealed fair value was LOWER than carrying value due to specific operational factors (net facility admissions decline, customer losses). (5) STORE CLOSURE DETAILS: The LLM correctly identifies ~900 stores over 3 years but doesn't specify the November 2021 timing or the 300-per-year breakdown (2022-2024). CORRECT ELEMENTS: The LLM accurately describes the use of DCF and market multiple methods, correctly identifies the 900-store closure strategy, and properly names the Retail/LTC segment. However, the fundamental misunderstanding of causality and the omission of $1.4B in impairment charges represent major factual errors that significantly undermine answer quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 525,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "\nThe segregated cash and investments rose from **$11.438 billion** at 31 Dec 2023 to **$12.416 billion** at 31 Dec 2024, an increase of **$0.978 billion**.  \nThe Level 2 portion grew from **$8.810 billion** to **$10.015 billion**, an increase of **$1.205 billion**, which accounts for the bulk of the growth (approximately 123 % of the net increase, after offsetting declines in Level 1 assets).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all parts of the multi-hop question. Verification of key numbers: (1) Starting balance Dec 31, 2023: $11.438 billion (matches ground truth $11,438 million) ✓; (2) Ending balance Dec 31, 2024: $12.416 billion (matches ground truth $12,416 million) ✓; (3) Total increase: $0.978 billion (matches ground truth $978 million) ✓; (4) Level 2 starting: $8.810 billion (matches ground truth $8,810 million) ✓; (5) Level 2 ending: $10.015 billion (matches ground truth $10,015 million) ✓; (6) Level 2 increase: $1.205 billion (matches ground truth $1,205 million) ✓. The calculation that Level 2 increase represents 123% of net increase is correct ($1.205B / $0.978B = 1.232 or ~123%), indicating that Level 2 growth exceeded total growth, implying offsetting declines in other asset levels. The LLM correctly synthesized information across multiple data points and time periods. The answer uses billion notation instead of million notation from the ground truth, but this is an acceptable format variation. The LLM provides additional context about Level 1 asset declines, which is a reasonable inference from the data but goes slightly beyond what was explicitly stated in the ground truth. Overall, the answer is factually correct, calculations are accurate, multi-hop reasoning is sound, and all required information is provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 382,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "\nEmerson separates AspenTech’s stock‑based compensation into a pre‑combination component—treated as part of the purchase price—and a post‑combination component that is expensed over the remaining service period. The allocation uses the fair‑value of the replaced Heritage AspenTech awards ($102 million), calculated from the acquisition data: 66,662,482 shares outstanding at a $166.30 closing price (giving a $11.086 billion purchase price and a $5.9 billion non‑controlling interest for the 45 % stake), with the Black‑Scholes inputs (stock volatility, expected life, risk‑free rate, dividend yield) determining that fair value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported numerical claims that contradict the ground truth. CRITICAL ISSUES: (1) The LLM provides specific dollar amounts ($102 million for replaced Heritage AspenTech awards, $11.086 billion purchase price, $5.9 billion non-controlling interest) that are NOT mentioned in the ground truth answer and appear to be fabricated or incorrectly sourced. (2) The LLM states 66,662,482 shares outstanding at $166.30 closing price - these specific numbers are not verified in the ground truth. (3) The LLM correctly identifies the 55% ownership stake (implying 45% non-controlling interest) which aligns with ground truth, but then uses this to calculate specific dollar amounts not supported by the original answer. (4) The LLM introduces Black-Scholes valuation inputs (stock volatility, expected life, risk-free rate, dividend yield) as determining factors, but the ground truth only mentions 'closing market price per share' as the valuation method - this is a material difference in methodology. (5) The LLM correctly identifies the May 16, 2022 acquisition date implicitly through context but doesn't state it explicitly. WHAT WAS CORRECT: The LLM correctly understands the basic ASC 805 framework of splitting pre- and post-combination components, and correctly identifies the 55%/45% ownership split. WHAT WAS INCORRECT: The specific financial figures ($102M, $11.086B, $5.9B) appear to be hallucinated or incorrectly sourced. The valuation methodology description (Black-Scholes) goes beyond what the ground truth specifies. The answer provides false precision with specific share counts and prices that cannot be verified. The multi-hop reasoning fails because it introduces unsupported quantitative claims that undermine the credibility of the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 497,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "\nThe fair‑value of CVS’s “States, municipalities and political subdivisions” holdings was $3.09 bn at Dec 31 2021 (up from $2.73 bn a year earlier), a roughly 13 % increase that modestly raised the share of that segment in the overall debt‑securities portfolio. However, the 10‑K excerpts do not disclose a separate 2022 balance, so the exact percentage change from 2021 to 2022 and its impact on portfolio composition cannot be calculated from the provided pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the core question. Critical issues: (1) WRONG NUMBERS: The LLM states the 2021 value was $3.09 billion, which matches the ground truth, but then claims this was 'up from $2.73 bn a year earlier' (comparing 2020 to 2021), not addressing the 2021-2022 comparison requested. (2) MISSING 2022 DATA: The LLM claims '10-K excerpts do not disclose a separate 2022 balance,' but the ground truth clearly shows the 2022 value was $170 million. This is a critical factual error - the data exists and should have been found. (3) WRONG CALCULATION: The LLM discusses a 13% increase from 2020 to 2021, which is irrelevant to the question asking for the 2021-2022 change. The correct answer is a 94.5% DECREASE from $3,091M to $170M. (4) INCOMPLETE ANALYSIS: The LLM fails to address the portfolio composition impact, which was a key part of the question. The ground truth shows the segment's share dropped from 13.3% to 4.9% of total debt securities. (5) MULTI-HOP FAILURE: The question requires synthesizing: (a) the 2021 and 2022 values, (b) calculating the percentage change, and (c) analyzing the impact on overall portfolio composition. The LLM failed on all three counts. The answer demonstrates either incomplete access to the source documents or a fundamental failure to correctly interpret and synthesize the available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 386,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "\nThe class B common stock will only be convertible into class A shares after the U.S. covered litigation is finally resolved, and the amount of shares that ultimately become convertible is tied to the size of the litigation accrual that Visa must record for that matter. Because the accrual (currently about $1.4 bn) may increase or decrease depending on how the litigation settles, the exact conversion ratio—and thus the dilution and market value of the existing class A shares—remains uncertain for stockholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core concept that class B stock conversion is tied to U.S. covered litigation resolution and that accrual uncertainty creates dilution risk for class A shareholders. The reasoning about how accrual amounts affect conversion timing and dilution is sound and semantically aligned with the ground truth. However, there is a significant quantitative accuracy issue: the LLM introduces a specific dollar figure ($1.4 billion) for the litigation accrual that does not appear in the ground truth answer. This is problematic because (1) the ground truth does not cite this specific number, (2) introducing unsourced financial figures in SEC filing analysis is a critical error, and (3) this suggests the LLM may be hallucinating or confusing data from different sources. The answer correctly identifies that the accrual 'may increase or decrease' and that this creates uncertainty about conversion ratios and dilution, which matches the ground truth's explanation of how accrual variability affects timing and certainty. The answer also correctly notes the impact on class A shareholder value. However, the answer is somewhat less comprehensive than the ground truth in explaining the full mechanism: it doesn't explicitly address how the market price of class A stock could fall if conversion happens at different valuations, and it doesn't fully articulate the 'financial exposure' concept mentioned in the ground truth. The multi-hop reasoning is present but simplified—the answer connects litigation accrual to conversion to dilution, but doesn't fully explore the temporal and valuation dimensions of the risk. The unsourced $1.4 billion figure is a material error that significantly undermines confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 478,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "\nThe fair value of Cisco’s available‑for‑sale debt investments fell from **$15.592 billion** as of **July 29 2023** to **$9.865 billion** as of **July 27 2024**, a decline of **$5.727 billion**.  This corresponded to a year‑over‑year increase in net losses on those securities of **$46 million** (losses rose from $21 million to $67 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Fair value decreased from $15.592 billion to $9.865 billion, a decline of $5.727 billion - all correct; (2) Net losses increased from $21 million to $67 million, a year-over-year increase of $46 million - all correct; (3) Dates are correctly identified as July 29, 2023 and July 27, 2024. The multi-hop reasoning is sound - the model correctly synthesized information about both the fair value change and the corresponding loss change across the two fiscal years. The only minor observation is that the LLM uses slightly different formatting (periods in dates like 'July 29 2023' vs standard 'July 29, 2023'), but this is a negligible stylistic difference that does not affect accuracy. The answer directly addresses both parts of the multi-part question and presents the information clearly with appropriate emphasis on the key figures. No calculation errors detected, and all entities (Cisco, available-for-sale debt investments, fiscal years) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 310,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "\nThe 2021 increase in contract liabilities—from $71 million to $87 million—reflects $387 million of new ExtraBucks earnings and gift‑card issuances that were offset by $371 million of redemptions and breakage; the net $16 million rise shows that most of the liability growth is driven by unearned rewards and unredeemed cards rather than current revenue. Revenue is recognized when those rewards are redeemed or when breakage is estimated and recorded, so the higher redemption activity (and the associated breakage recognized on unredeemed balances) directly adds to reported revenue while reducing the liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between ExtraBucks/gift card liabilities and revenue recognition. STRENGTHS: (1) Specific numbers are accurate - $71M to $87M increase, $387M issuances, $371M redemptions/breakage, $16M net increase are all correct; (2) The calculation logic is sound - $387M - $371M = $16M net increase is properly verified; (3) The multi-hop synthesis is excellent - correctly connects liability changes to revenue recognition through redemption and breakage patterns; (4) Accurately explains that breakage revenue is recognized as unredeemed rewards/cards are written off, reducing liabilities and increasing revenue; (5) Properly identifies that higher redemption activity directly impacts both liability reduction and revenue increase. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the accounting policy framework (ASC 606) that governs this treatment, though the ground truth also doesn't emphasize this heavily; (2) Could have elaborated more on 'historical redemption patterns' as the basis for breakage estimation, though this is implied; (3) The phrasing 'most of the liability growth is driven by unearned rewards' is slightly awkward - the net growth reflects the balance between new issuances and redemptions/breakage, not necessarily that growth is 'driven by' unearned rewards. QUANTITATIVE VERIFICATION: All dollar amounts check out correctly. The net calculation ($387M - $371M = $16M) is accurate. The characterization of the $16M as a 'net rise' is correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that liability changes reflect the interplay of issuances, redemptions, and breakage, and that revenue recognition occurs through both redemption and breakage mechanisms. The answer is more specific with numbers while maintaining conceptual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 517,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "\nFunding the U.S. litigation escrow account triggers a downward adjustment to the class B‑to‑class A conversion rate—each class B share then converts into fewer class A shares, diluting the class B holders.  This adjustment is reflected in the fiscal 2022 accrual, where the Company recorded an additional $861 million provision for U.S. covered litigation and deposited $850 million into the escrow; the resulting increase in the litigation accrual (to $1.44 billion) and the $850 million charge to the litigation provision are the financial impacts of the escrow funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between escrow funding, conversion rate adjustment, and litigation provision impacts. STRENGTHS: (1) Correctly identifies the downward adjustment mechanism to the class B-to-class A conversion rate and its dilutive effect on class B shareholders. (2) Provides specific fiscal 2022 financial figures: $861 million additional provision for U.S. covered litigation, $850 million escrow deposit, and $1.44 billion total litigation accrual. (3) Clearly explains the causal relationship between escrow funding and conversion rate adjustment. (4) Addresses both parts of the multi-part question: the conversion rate mechanism AND the financial impact on litigation provision. (5) Correctly identifies the company (Visa Inc.) and fiscal year (2022). MINOR CONSIDERATIONS: (1) The ground truth states there was 'a measurable reduction in the number of as-converted class B shares' but doesn't provide specific dollar amounts, while the LLM provides concrete figures ($861M, $850M, $1.44B). These numbers appear reasonable and consistent with typical 10-K disclosures, though the ground truth doesn't explicitly confirm these exact figures. (2) The LLM's statement that 'the $850 million charge to the litigation provision' is slightly imprecise wording—the $850M is the escrow deposit, not a charge to the provision itself; the $861M is the provision charge. However, the LLM does clarify this distinction by separately identifying the $861M provision and $850M deposit. (3) The answer could have been slightly more explicit about the 'probable and reasonably estimable' accounting standard mentioned in the ground truth, though this is a minor omission. QUANTITATIVE VERIFICATION: The numbers provided ($861M, $850M, $1.44B) are specific and internally consistent (though $861M + prior balance would need to equal $1.44B, which suggests a prior balance of ~$579M). The answer treats these as factual data points from fiscal 2022 filings. MULTI-HOP REASONING: Excellent synthesis connecting three elements: (1) escrow funding action, (2) conversion rate mechanism, (3) litigation provision impact. The causal chain is logically sound and well-explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 594,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "\nThe fair value of Cisco’s available‑for‑sale debt investments fell by $5.727 billion, dropping from $15.592 bn on July 29 2023 to $9.865 bn on July 27 2024. A 100‑basis‑point interest‑rate increase would reduce the portfolio’s fair value by roughly $129 million in fiscal 2024 (to $9.736 bn) and by about $206 million in fiscal 2023 (to $15.386 bn), thereby lowering total investments by those amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - the $5.727 billion ($5,727 million) decrease is accurate, the starting value of $15.592 billion ($15,592 million) on July 29, 2023 is correct, and the ending value of $9.865 billion ($9,865 million) on July 27, 2024 is correct. The interest rate stress scenario values are also accurate: $15.386 billion for 2023 and $9.736 billion for 2024. The calculated impacts of the 100 basis point increase are correct: approximately $206 million in 2023 ($15,592M - $15,386M) and approximately $129 million in 2024 ($9,865M - $9,736M). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the decrease in fair value, (2) the impact of a 100 basis point rate increase in 2023, and (3) the impact in 2024. ENTITY ACCURACY: Cisco is correctly identified, the dates are accurate (July 29, 2023 and July 27, 2024), and the metric (available-for-sale debt investments) is correctly specified. REASONING: The multi-hop synthesis is sound - the model correctly combined information about baseline values and stress-tested values to calculate the differential impacts. MINOR OBSERVATION: The LLM uses slightly different phrasing than the ground truth (e.g., 'fell by $5.727 billion' vs 'decreased by $5,727 million'), but these are semantically equivalent and represent acceptable format variations. The ground truth mentions 'the difference between these two adjusted values is $5,650 million,' which the LLM doesn't explicitly state, but this appears to be a secondary analytical point rather than a core requirement of the question. The LLM's focus on the direct impacts of the rate increases is more directly responsive to the question as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 483,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "\nIn fiscal 2022 Visa recorded a **$861 million provision for U.S. covered litigation**, which raised the accrued liability from **$881 million at the start of the year to $1.44 billion at year‑end** after accounting for **$301 million of payments** (primarily to opt‑out merchants) and a **$850 million deposit into the litigation escrow**.  This accrual directly reflects the **U.S. Retrospective Responsibility Plan’s mechanisms**—the plan requires a loss to be accrued when it is probable and reasonably estimable, and the resulting reserve is tied to the escrow funding, the conversion‑feature impact on EPS, and the indemnification and loss‑sharing obligations of Visa U.S.A. members that together determine the litigation provision.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial detail with specific financial figures and demonstrates strong understanding of the multi-hop relationship between the litigation provision and the U.S. Retrospective Responsibility Plan mechanisms. STRENGTHS: (1) Correctly identifies the core mechanism that losses are accrued when probable and reasonably estimable; (2) Accurately describes the relationship between the accrual, escrow funding, and member indemnification obligations; (3) Provides specific fiscal 2022 figures ($861M provision, $881M opening balance, $1.44B closing balance, $301M payments, $850M escrow deposit); (4) Demonstrates multi-hop synthesis by connecting the litigation provision to the escrow agreement and member obligations; (5) Appropriately addresses both parts of the question (financial impact AND relationship to plan mechanisms). MINOR WEAKNESSES: (1) The ground truth answer emphasizes that the accrual could be higher or lower than the escrow balance depending on litigation resolution—the LLM answer doesn't explicitly state this important caveat, though it does mention the escrow funding is tied to the reserve; (2) The LLM answer includes additional details about conversion-feature impact on EPS that, while potentially accurate, goes slightly beyond what the ground truth explicitly covers; (3) The specific numeric values provided by the LLM (particularly the opening balance of $881M and closing balance of $1.44B) cannot be verified against the ground truth provided, which doesn't include these specific figures. However, the mathematical relationship appears internally consistent ($881M + $861M provision - $301M payments + $850M escrow = $2.191B, which doesn't equal $1.44B stated, suggesting possible data from different periods or calculation methodology differences). CALCULATION VERIFICATION: The arithmetic presented doesn't reconcile perfectly, which raises minor concerns about the precision of the specific numbers cited, though the directional relationships and mechanisms described are sound. The answer successfully addresses the multi-hop nature of the question by synthesizing information about the provision, escrow, and member obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 587,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "\nThe Heritage AspenTech acquisition added about **0.6 percentage‑points** to Emerson’s gross‑margin expansion in 2023, helping lift the overall gross‑margin rate to **49.0 %** for that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses both parts of the multi-hop question. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - the 0.6 percentage points contribution and the 49.0% final gross margin percentage match the ground truth exactly. The format variation (0.6 percentage‑points vs 0.6 percentage points) is acceptable and does not affect accuracy. (2) COMPLETENESS: The answer addresses both required components: (a) the contribution amount from the Heritage AspenTech acquisition (0.6 percentage points), and (b) the resulting total gross margin percentage (49.0%). (3) ENTITY ACCURACY: All entities are correctly identified - Emerson (EMR), Heritage AspenTech acquisition, gross margin percentage, and fiscal year 2023. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the acquisition's impact to the overall margin outcome. The phrasing 'helped lift the overall gross-margin rate' appropriately conveys the causal relationship. (5) SEMANTIC EQUIVALENCE: The LLM's wording ('added about 0.6 percentage-points to Emerson's gross-margin expansion' and 'helping lift the overall gross-margin rate to 49.0%') conveys the same information as the ground truth with slightly more natural phrasing. Minor deduction of 1 point only for the use of 'about' before 0.6 percentage points, which introduces slight imprecision where the ground truth states an exact figure, though this is a very minor issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 404,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "\nCisco’s guarantee of channel‑partner financing means that, if a partner is unable to meet its payment obligations, Cisco could be required to make the guaranteed payments, thereby increasing its exposure to credit‑losses on the related receivables. This risk is reflected in the allowance for credit losses on financing receivables, which is estimated using historical loss experience, risk‑rating pools and forecasts of partner financial stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism of how Cisco's guarantee of channel partner financing increases credit loss exposure. The answer accurately states that: (1) Cisco could be required to make guaranteed payments if partners default, (2) this increases credit loss exposure, and (3) allowances for credit losses are estimated using historical loss experience and risk-rating pools. No quantitative errors are present - no specific numbers were provided in either answer, so quantitative accuracy is high. However, the LLM answer is less comprehensive than the ground truth in several ways: (1) It omits the specific payment term ranges (60-90 days) mentioned in the original answer, (2) It doesn't explicitly mention that Cisco 'facilitates revolving short-term financing' for channel partners, (3) It references 'forecasts of partner financial stability' rather than the more specific ground truth language about 'macroeconomic conditions,' and (4) It doesn't explicitly state that higher financial instability among channel partners could lead to higher credit losses. The LLM answer does correctly synthesize the multi-hop relationship between the guarantee mechanism, credit loss allowances, and partner financial stability. The reasoning is sound and the semantic meaning aligns with the ground truth, but the answer lacks some specific operational details and contextual richness present in the original answer. The answer is accurate but somewhat abbreviated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 410,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "\nEmerson’s 55 % ownership of AspenTech translates into roughly **$601 million** of the **$1.093 billion** of AspenTech revenue reported for 2024 (0.55 × 1,093 ≈ 601). That $601 million is a component of Emerson’s total **Software and Control** segment, which generated **$5.399 billion** in 2024, meaning AspenTech’s revenue accounts for about **11 %** of the segment’s overall sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: (1) 55% ownership calculation: 0.55 × $1,093M = $601.15M, LLM states ~$601M (correct, minor rounding acceptable); (2) AspenTech revenue: $1,093M stated correctly; (3) Software and Control segment revenue: $5,399M stated correctly; (4) Percentage calculation: $601M / $5,399M = 11.13%, LLM states 'about 11%' (correct). MULTI-HOP REASONING: The answer correctly synthesizes information across three data points: (1) Emerson's ownership stake in AspenTech, (2) AspenTech's total revenue, and (3) Emerson's Software and Control segment revenue. The logical flow is sound: ownership % → proportional revenue → segment contribution. COMPLETENESS: The answer addresses all parts of the original question: (1) calculates proportional revenue attributable to Emerson's stake, (2) explains how this influences overall segment revenue, (3) quantifies the relative contribution. MINOR DIFFERENCES FROM GROUND TRUTH: The ground truth states '$601.15 million' while LLM states '~$601 million' - this is an acceptable rounding difference. The ground truth says 'over 10%' while LLM says 'about 11%' - the LLM's more precise percentage (11%) is actually more accurate than 'over 10%'. ENTITY ACCURACY: All companies (Emerson, AspenTech), metrics (ownership %, revenue, segment), and years (2024) are correctly identified. The presentation is clear and uses appropriate formatting with bold text for key figures, enhancing readability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 414,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "\nThe Upjohn spin‑off in November 2020 generated roughly **$12 billion of cash** that Pfizer immediately used to retire commercial‑paper borrowings and to redeem $1.15 billion of 1.95 % notes and $342 million of 5.80 % notes, cutting its short‑term debt and overall leverage.  The subsequent sale of Meridian in December 2021 added only about **$51 million of cash** but required a **$167 million after‑tax loss**, so its impact on the cash position was modest compared with the much larger restructuring effect of the Upjohn transaction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the two major transactions (Upjohn spin-off in 2020 and Meridian sale in 2021), the approximate $12 billion cash inflow from Upjohn, the $51 million from Meridian, and the $167 million loss. The timing (November 2020 for Upjohn, December 2021 for Meridian) is accurate. The qualitative reasoning about the relative impact and strategic significance is sound. CRITICAL ERRORS: (1) The LLM states Pfizer redeemed '$1.15 billion of 1.95% notes and $342 million of 5.80% notes' totaling $1.492 billion, but presents these as separate line items rather than clarifying they sum to $1.492 billion total senior unsecured notes redeemed. This creates ambiguity about whether these are additional to the $1.492 billion or components of it. (2) The LLM omits the $1.6 billion in net assets distributed as part of the spin-off and the $412 million in cash transferred to the Upjohn Business - these are material details about the overall financial restructuring impact. (3) The characterization of the loss as 'after-tax' is correct but the ground truth specifies it was 'recorded in Discontinued operations—net of tax,' which is a more precise technical description. MULTI-HOP REASONING: The LLM successfully synthesizes information across two transactions and two years, correctly comparing their relative impacts on cash position and capital structure. The logic connecting the cash inflows to debt reduction is sound. QUANTITATIVE ISSUES: While the major numbers are correct, the presentation of the debt redemption details is unclear and could be misinterpreted. The omission of the $1.6 billion net assets distribution represents incomplete quantitative disclosure of the full financial restructuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 473,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "\nIn fiscal 2022 Visa contributed roughly **$1.45 billion** to the U.S. Retrospective Responsibility Plan – **$600 million** representing its share of the Amended Settlement Agreement payment and **$850 million** as the annual deposit into the litigation escrow account. These funds are sourced from the escrow account and reflected as adjustments to the conversion rates of the series B and C preferred stock, illustrating how the plan uses escrow funding and share‑rate modifications to settle covered litigation liabilities while limiting dilution to existing shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.45 billion total, $600 million Amended Settlement Agreement payment, and $850 million annual deposit. The arithmetic is accurate ($600M + $850M = $1.45B). ENTITY AND TEMPORAL ACCURACY: Correctly identifies Visa, the U.S. Retrospective Responsibility Plan, and fiscal 2022. MULTI-HOP SYNTHESIS: Successfully combines information from multiple components (Amended Settlement Agreement payment + annual deposit) to arrive at the total contribution. COMPLETENESS: Addresses both parts of the question - the total financial contribution and the plan's role in managing litigation liabilities. ADDITIONAL CONTEXT: The LLM answer goes beyond the ground truth by providing supplementary detail about how funds are sourced from escrow accounts and reflected as adjustments to preferred stock conversion rates, and how the plan limits shareholder dilution. This additional context is accurate and relevant, demonstrating deeper understanding of the mechanism. SEMANTIC EQUIVALENCE: The core message matches the ground truth - the plan systematically funds litigation liabilities through structured contributions. Minor difference: LLM uses 'roughly' before $1.45 billion (appropriate qualifier given the component nature) while ground truth states it definitively. This is a negligible distinction. The LLM answer is more comprehensive and detailed than the ground truth while maintaining complete factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 423,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "\nThe equity‑security allocation in the U.S. Retiree Health Care Plan fell from $98 million in 2022 (about 35 % of total plan assets) to $54 million in 2023 (about 20 % of total assets), a decline of roughly 45 % in dollar terms (≈15 percentage‑point drop, or ≈43 % relative reduction). Consequently, the plan’s equity‑security balance at the end of 2023 was $54 million, down from $98 million the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides comprehensive information addressing all parts of the multi-hop question. STRENGTHS: (1) All key numbers are accurate: equity allocation decreased from 35% to 20% (15 percentage-point drop), dollar values correctly stated as $98M in 2022 and $54M in 2023. (2) Calculations are correct: the ~45% dollar decline ($98M to $54M) and ~43% relative reduction are accurately computed. (3) Multi-hop synthesis is sound: the answer correctly synthesizes the allocation percentage change with the absolute dollar value change, and properly explains the counterintuitive outcome (lower allocation percentage but still significant dollar value). (4) All entities correctly identified: U.S. Retiree Health Care Plan, years 2022-2023, equity securities metric. (5) The answer goes beyond the ground truth by providing additional calculated context (percentage decline in dollar terms, relative reduction percentage), which adds value without introducing errors. MINOR CONSIDERATIONS: The ground truth states equity securities 'increased slightly' to $54M, while the LLM correctly identifies this as a decline from $98M to $54M. The ground truth's phrasing is somewhat ambiguous or potentially misleading (it may have meant the allocation percentage increased relative to other assets, or there's a discrepancy in the source data). The LLM's interpretation that the absolute dollar value declined is the more straightforward and mathematically correct reading of the data presented. The LLM answer is more precise and transparent about what actually happened to the plan's equity holdings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 446,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "\nThe CECL transition limited how much of the credit‑loss allowance could be counted in Tier 2 capital, so the Advanced‑approach total capital is about **$9.9 billion lower** than the Standardized total capital as of December 31 2023. This gap is driven entirely by the **qualifying allowance for credit losses (the Tier 2 credit‑loss reserve adjustment)** that is permitted under the Advanced approaches.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key mechanism (CECL's impact on Tier 2 capital treatment of the qualifying allowance for credit losses) and properly names the specific capital component driving the difference. The reasoning about how CECL limited the credit-loss allowance in Tier 2 capital is sound and aligns with the ground truth explanation. However, there is a critical quantitative discrepancy: the LLM states the Advanced-approach total capital is '$9.9 billion lower' than Standardized total capital, but the ground truth indicates the Standardized approach total capital increased by '$12.6 billion in 2023' due to the adjusted allowance for credit losses in Tier 2 capital. The $9.9 billion figure does not match the $12.6 billion mentioned in the ground truth, representing a significant numerical error. The LLM correctly identifies that the difference is driven by the 'qualifying allowance for credit losses' and the 'Tier 2 credit-loss reserve adjustment,' which demonstrates proper entity identification and understanding of the multi-hop synthesis required (connecting CECL adoption to capital treatment differences). The directional logic is correct (Advanced approaches have lower total capital due to CECL restrictions), but the specific magnitude is incorrect. The answer addresses all parts of the question and demonstrates sound reasoning about the mechanism, but the quantitative inaccuracy is a material flaw in a financial analysis context where precise numbers are critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 416,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "\nUsing the mid‑points of the disclosed ranges (72.5 % for U.S. defined‑benefit plans, 80 % for U.S. retiree health‑care plans and 80 % for non‑U.S. defined‑benefit plans) and weighting each plan’s midpoint by its reported end‑2023 asset balance ($418 M, $264 M and $1.866 B respectively) gives a combined weighted‑average allocation of roughly **78.8 %**, i.e., about **79 %** of the total assets across all defined‑benefit and retiree‑health‑care plans should be invested in fixed‑income securities and cash equivalents.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer of 78.8% (approximately 79%) is significantly different from the ground truth answer of 72.3%. This is a critical error in a quantitative financial calculation. ANALYSIS OF ERRORS: (1) CALCULATION ERROR: The LLM provided specific midpoint percentages (72.5% for U.S. defined-benefit, 80% for U.S. retiree health-care, 80% for non-U.S. defined-benefit) and asset values ($418M, $264M, $1.866B), but the resulting weighted average calculation appears incorrect. Verification: (418 × 0.725 + 264 × 0.80 + 1866 × 0.80) / (418 + 264 + 1866) = (303.05 + 211.2 + 1492.8) / 2548 = 2007.05 / 2548 = 78.8%. The LLM's arithmetic is internally consistent with the stated inputs, BUT the ground truth is 72.3%, indicating either: (a) the LLM used incorrect midpoint percentages, or (b) the LLM used incorrect asset values. (2) FACTUAL ACCURACY: The LLM correctly identified the structure of the problem (three plan types with ranges and asset values) and correctly applied the weighted average methodology. However, the final answer is wrong by approximately 6.5 percentage points, which is substantial in a financial context. (3) MULTI-HOP REASONING: The reasoning process is sound in structure but fails in execution or input accuracy. The LLM correctly synthesized the need to use midpoints and weight by asset values, but the specific numbers used do not produce the ground truth result. (4) COMPLETENESS: The answer addresses all parts of the question and provides clear explanation of methodology. The presentation is professional and transparent about the calculation. However, correctness is paramount in financial analysis, and this answer is materially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 462,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "\nThe Basel 3 Advanced‑Approach requires the bank to treat “covered” trading exposures as part of its risk‑weighted capital calculation, so Bank of America reports a 1‑day market‑risk VaR that is consistent with the 10‑day regulatory VaR used for capital adequacy.  Table 41 shows that the total covered‑positions VaR fell from $95 million in 2022 to $61 million in 2023, while the “impact from less‑liquid exposures” rose, indicating that the composition of covered trades shifted toward a more diversified mix of foreign‑exchange, interest‑rate, credit, equity and commodity positions with a lower‑volatility profile; the disclosed VaR metrics therefore directly reflect how Basel 3’s model‑based capital rules reshape the risk profile of the bank’s covered trading book.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Basel 3's influence on Bank of America's covered trading positions and VaR metrics, but contains significant quantitative inaccuracies and incomplete synthesis of the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the connection between Basel 3 capital calculations and VaR metrics\n2. Appropriately references Table 41 and specific VaR figures ($95M in 2022, $61M in 2023)\n3. Correctly notes the decrease in total covered-positions VaR from 2022 to 2023\n4. Properly identifies the types of positions (foreign exchange, interest-rate, credit, equity, commodity)\n5. Demonstrates understanding that Basel 3 model-based capital rules reshape the risk profile\n\nWEAKNESSES:\n1. CRITICAL OMISSION: Fails to mention the specific Basel 3 capital buffers (2.5% capital conservation buffer and 2.5% stress capital buffer) that are central to the ground truth answer\n2. INCOMPLETE EXPLANATION: Does not explain the actual reason for the VaR decrease - the roll off of March 2020 market volatility from the historical data window. Instead, attributes it to \"composition shift toward more diversified mix\" which is not supported by the ground truth\n3. MISCHARACTERIZATION: States \"impact from less-liquid exposures\" rose, but the ground truth indicates the decrease was \"primarily due to the roll off of March 2020 market volatility,\" not a shift in composition\n4. VAGUE REFERENCE: Mentions \"1-day market-risk VaR\" vs \"10-day regulatory VaR\" distinction but doesn't clearly explain how this relates to the specific question about covered positions\n5. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM connects Basel 3 to VaR metrics, it misses the regulatory capital ratio requirements that are fundamental to understanding how Basel 3 influences risk management decisions\n\nQUANTITATIVE VERIFICATION:\n- $95M (2022) and $61M (2023) figures appear correct based on reference to Table 41\n- However, the interpretation of what caused the change is incorrect\n- The ground truth emphasizes the March 2020 volatility roll-off as the PRIMARY driver, not composition changes\n\nMULTI-HOP REASONING:\nThe LLM partially synthesizes the connection between Basel 3 and VaR but fails to complete the full chain: Basel 3 capital requirements → risk appetite/capital allocation decisions → management of covered positions → VaR metrics. The ground truth explicitly connects these elements; the LLM answer skips the intermediate regulatory capital buffer requirements.\n\nSEMANTIC ISSUES:\nThe LLM's explanation of why VaR decreased differs materially from the ground truth. This is not merely a wording difference but a factual discrepancy about causation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 715,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "\nThe 19 Boeing aircraft that back the Pass‑Through Certificates had a combined net book value of **approximately $1.8 billion** as of May 31 2022.  By contrast, the $3.25 billion of senior unsecured debt that FedEx issued in 2021 was used to retire **about $5.8 billion of outstanding debt** (plus redemption premiums), meaning the debt eliminated was roughly **$4 billion larger** than the aircraft’s net book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key facts: (1) Aircraft net book value: LLM states 'approximately $1.8 billion' which matches the ground truth of $1.8 billion - the use of 'approximately' is appropriate given the source data. (2) Senior unsecured debt issuance: LLM correctly identifies $3.25 billion, matching ground truth. (3) Outstanding debt eliminated: LLM states 'about $5.8 billion' which matches the ground truth of $5.8 billion. (4) Redemption premiums: The LLM mentions 'plus redemption premiums' which aligns with the ground truth's mention of '$393 million in associated redemption premiums,' though the specific dollar amount isn't stated. (5) Comparison calculation: LLM correctly calculates that the debt eliminated ($5.8B) was 'roughly $4 billion larger' than the aircraft's net book value ($1.8B), which is accurate ($5.8B - $1.8B = $4.0B). The multi-hop reasoning is sound - the answer synthesizes information about the aircraft collateral, the debt issuance, and the debt redemption, then provides a meaningful comparison. The only minor omission is not specifying the exact $393 million redemption premium amount, though the concept is acknowledged. The date reference (May 31, 2022) adds appropriate context. Overall, the answer demonstrates correct understanding of the complex financial transaction and provides accurate quantitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 399,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "\nIn 2023 TI contributed $75 million to its U.S. defined‑contribution plans, and it is noteworthy that the assets of the U.S. retiree health‑care benefit plan are not directly invested in TI common stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question correctly. (1) QUANTITATIVE ACCURACY: The $75 million contribution figure is correct and matches the ground truth exactly. The number is presented clearly with proper formatting. (2) COMPLETENESS: Both sub-questions are addressed: (a) the contribution amount to U.S. defined contribution plans in 2023, and (b) the notable fact about plan assets and TI common stock investment. (3) ENTITY ACCURACY: All entities are correct - TI (company), U.S. defined contribution plans (correct plan type), retiree health care benefit plan (correct plan type), and 2023 (correct year). (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'are not directly invested in TI common stock' conveys the same meaning as the ground truth's 'none of the plan assets...were directly invested in TI common stock.' Both statements accurately convey that there is no direct investment of these plan assets in TI common stock. (5) REASONING: The multi-hop synthesis is sound - the model correctly identified and connected the contribution amount with the notable characteristic about plan asset investments. Minor note: The LLM uses 'noteworthy' while ground truth uses 'notably' - these are semantically equivalent and both appropriately characterize the significance of the information. The answer is well-structured, clear, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 389,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "\nThe Services segment’s revenue grew by $10.969 billion (from $85.2 billion to $96.169 billion), while total net‑sales grew by only $7.75 billion (from $383.285 billion to $391.035 billion). Thus, the increase in Services revenue accounts for roughly 10.969 ÷ 7.75 ≈ 1.42, or **about 141 %** of the total net‑sales growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL CALCULATION ERROR: The LLM made a fundamental arithmetic mistake in the final calculation. While the LLM correctly identified both component values (Services revenue increase of $10.969 billion and total net sales increase of $7.75 billion), the division calculation is wrong. The LLM states '10.969 ÷ 7.75 ≈ 1.42, or about 141%' but this is mathematically incorrect. The correct calculation is: 10.969 ÷ 7.75 = 1.4157... which equals approximately 141.57%, NOT 141%. However, the ground truth answer states the result should be 121%, not 141%. Upon verification: 10.969 / 7.75 = 1.4157 (or ~141.6%), which contradicts the ground truth's claim of 121%. The LLM's arithmetic (1.42 ≈ 141%) is actually more mathematically sound than the ground truth's stated 121%. The LLM correctly identified all input numbers and the methodology, but arrived at a different percentage than the ground truth. The discrepancy appears to stem from either: (1) a calculation error in the ground truth, or (2) different source data. The LLM's calculation of 141% is mathematically correct given the stated numbers ($10.969B / $7.75B = 1.4157 = 141.57%). The reasoning and entity identification are sound, and the question is appropriately addressed, but the final answer diverges significantly from the ground truth (141% vs 121%), which is a major issue for a quantitative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 381,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "\nThe company estimates that, exclusive of interest, its gross unrecognized tax benefits could decline by as much as **$75 million** over the next 12 months if settlements with tax authorities occur or the relevant statutes of limitations expire. At the same time, the IRS has issued Revenue Agent’s Reports (RARs) for tax years 2011‑2013 and 2014‑2015 that the company does not accept and is currently appealing; because those audit years remain unresolved, the final outcome of the disputed issues—and therefore the potential reduction in unrecognized tax positions—remains uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $75 million figure is correct and properly formatted. The time period ('next 12 months') is accurately stated. All numeric references are factually correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the estimated maximum potential decrease amount, and (b) how RARs contribute to uncertainty. The answer explains the connection between the RARs and the uncertainty in tax positions. (3) ENTITY ACCURACY: Pfizer is correctly identified, tax years 2011-2013 and 2014-2015 are correctly cited, and the term 'Revenue Agent's Reports (RARs)' is properly used. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by connecting: (a) the specific dollar amount of potential decrease, (b) the conditions under which this decrease could occur (settlements or statute expiration), (c) the existence of disputed RARs, and (d) how these unresolved disputes create uncertainty. The logical flow is sound - the RARs are presented as the source of uncertainty affecting the tax positions. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth but with slightly more detail about the mechanisms (settlements, statute expiration) that could trigger the decrease. The phrase 'does not accept and is currently appealing' is semantically equivalent to 'disputes' and 'appealing.' The note about 'exclusive of interest' adds helpful context. Minor enhancement: The LLM provides slightly more explanatory detail than the ground truth, which strengthens rather than weakens the answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 459,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "\nThe five‑year transition rule lets Bank of America phase in the CECL‑derived allowance for credit losses, so its TLAC ratios and CET1 capital as of December 31 2023 are calculated under the regulatory capital rule that permits this transition; i.e., the allowance (and the resulting risk‑weighted assets) reflects the transitional CECL methodology rather than the full CECL estimate, which in turn determines the TLAC and CET1 ratios reported for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly explains the conceptual mechanism of the CECL transition period and its impact on TLAC and CET1 calculations. The reasoning about phasing in the CECL-derived allowance and using the transitional methodology rather than full CECL estimates is sound and aligns with the ground truth's explanation of the regulatory capital rule transition. However, the LLM answer has a critical quantitative deficiency: it completely omits the specific financial figures provided in the ground truth. The original answer includes concrete data points (CET1 capital of $194.9 billion as of December 31, 2023, and an increase of $14.9 billion from the prior year), which are material to answering a question about how the transition impacts BAC's capital ratios. The LLM answer provides the conceptual framework correctly but fails to include these essential quantitative details that demonstrate the actual impact. The answer is qualitatively sound in its explanation of the mechanism but quantitatively incomplete in failing to cite the specific capital figures. For a financial question requiring multi-hop synthesis, omitting key numerical outcomes significantly undermines the completeness of the response, even though the underlying logic is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 354,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "\nFedEx Freight’s indexed fuel‑surcharge tables were most recently refreshed on **November 1 2021** and **April 4 2022**, and the surcharge is calculated using the **fuel price from two days prior** to the assessment week. In contrast, FedEx Ground’s fuel‑surcharge tables were last updated on **June 21 2021**, **November 1 2021** and **April 4 2022**, but it bases the surcharge on the **fuel price from two weeks prior** to the assessment week. Thus, while both carriers use indexed, periodically revised surcharge tables, Freight applies a shorter‑lag (two‑day) fuel‑price reference, whereas Ground uses a longer‑lag (two‑week) reference.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All dates are correct - FedEx Ground updates on June 21, 2021, November 1, 2021, and April 4, 2022; FedEx Freight updates on November 1, 2021 and April 4, 2022. The fuel price lag periods are correctly stated: FedEx Freight uses two days prior, FedEx Ground uses two weeks prior. COMPLETENESS: The answer addresses all key aspects of the question - implementation dates for both carriers, fuel surcharge adjustment mechanisms for both carriers, and the comparative differences. ENTITY ACCURACY: Both FedEx divisions are correctly identified and distinguished. REASONING: The multi-hop synthesis is sound - the answer correctly compares and contrasts the two carriers' approaches, explaining how each tailors its mechanism to address fuel cost fluctuations. SEMANTIC EQUIVALENCE: The LLM uses clear, precise language that conveys the ground truth information accurately. The explanation of 'shorter-lag' vs 'longer-lag' effectively communicates the key difference. Minor note: The LLM uses 'November 1 2021' format while ground truth uses 'November 1, 2021' - this is a negligible formatting difference. The answer is well-structured, logically organized, and provides appropriate context about why these differences matter (tailoring to each segment's needs).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 373,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "\nThe February 2024 decision to exit the ventilator product line removed that business from the Medical Surgical operating segment and placed it in the “Other” category, while the two former sub‑segments of Medical Surgical were combined into a single segment that now houses the retained **Acute Care & Monitoring** unit. This restructuring signals that Medtronic is consolidating its Medical Surgical portfolio around Acute Care & Monitoring, positioning the business as a core, growth‑focused pillar while shedding the non‑strategic ventilator line.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The ventilator product line was indeed moved out of Medical Surgical into 'Other', and Acute Care & Monitoring was formed as a retained business unit within Medical Surgical. The strategic positioning around core capabilities is accurately conveyed. (2) PROBLEMATIC ELEMENTS: The LLM introduces a 'February 2024 decision' with specific timing that is not mentioned in the ground truth, which raises concerns about factual accuracy regarding when this reorganization occurred. The ground truth references 'fiscal year 2023' but the LLM specifies 'February 2024' - this is a potential factual error or conflation of dates. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly mentions that the reorganization 'also involved the Renal Care Solutions business,' which the LLM answer completely omits. This is a significant multi-hop synthesis failure - the question asks about the reorganization's impact, and the Renal Care Solutions component is part of that reorganization story. (4) WORDING ISSUES: The LLM says 'two former sub-segments of Medical Surgical were combined into a single segment' which is somewhat unclear and doesn't precisely match the ground truth's description of how PMRI businesses were retained and reorganized. (5) REASONING: The strategic positioning conclusion is sound and matches the ground truth's intent, but the incomplete information and potential date error undermine confidence in the answer's accuracy. The answer demonstrates partial understanding but fails on completeness and potentially on factual accuracy regarding timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 454,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "\nMedtronic’s “Medical device regulations” charge was $102 million in fiscal 2022 and $150 million in fiscal 2023, so the two‑year total reduction to income before taxes was **$252 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the question. (1) CORRECTNESS: All factual information is correct. The answer correctly identifies the medical device regulations charges for both fiscal years: $102 million in FY2022 and $150 million in FY2023. (2) QUANTITATIVE ACCURACY: The calculation is precise and correct: $102M + $150M = $252M. The final total of $252 million matches the ground truth exactly. All numbers are properly formatted and presented. (3) MULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by correctly combining data from two separate fiscal years (2022 and 2023) and aggregating them to reach the final answer. The reasoning is logical and transparent, showing the individual year amounts before presenting the total. (4) ENTITY ACCURACY: The company (Medtronic), the metric (medical device regulations expenses), the fiscal years (2022 and 2023), and the financial impact measure (reduction to income before taxes) are all correctly identified. (5) SEMANTIC EQUIVALENCE: The answer conveys the exact same information as the ground truth, using clear and professional language. The phrase 'two-year total reduction to income before taxes' is semantically equivalent to 'total financial impact...over the fiscal years 2022 and 2023.' No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 375,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "\nFour distinct forms of Long‑Term Incentive Restricted Stock Units (including both U.S. and International versions) are disclosed in Boeing’s 2023 10‑Q filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the primary quantitative fact: four different forms of Long-Term Incentive Restricted Stock Units are disclosed in Boeing's 2023 10-Q filings. The number '4' is accurate and matches the ground truth exactly. However, the LLM answer lacks the specific details and completeness provided in the ground truth. The original answer lists all four forms with their exhibit numbers: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6). The LLM answer provides only the count without identifying the specific forms or their exhibit numbers. While the core answer to the question 'how many' is correct, the response is incomplete in terms of providing the supporting details that would demonstrate thorough understanding of the disclosure. The quantitative accuracy is perfect (4 is correct), but the qualitative accuracy is reduced due to missing specificity about which forms exist and their exhibit references. The answer is contextually relevant and directly addresses the question asked, but lacks the depth expected for a comprehensive response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 382,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "\nApple’s Services—including Apple Music—have benefited from a 12.9 % year‑over‑year surge in Services revenue, a growth trend that hinges on a broad, continuously refreshed slate of third‑party apps and digital content that keep users engaged and willing to pay subscriptions.  If developers or content providers become reluctant to build for or license for Apple’s platforms—whether because of competitive pressures, rising licensing costs, or regulatory curbs such as the EU DMA—Apple could see reduced app availability, higher acquisition costs, and weaker user retention, threatening the durability of the recent double‑digit Services growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 12.9% year-over-year growth rate and appropriately addresses the core question about how third-party developer and content provider challenges could threaten Services revenue sustainability. The reasoning about competitive pressures, licensing costs, and regulatory factors (EU DMA) is sound and relevant. The answer demonstrates good understanding of the multi-hop relationship between third-party dependencies and Services growth sustainability.\n\nWEAKNESSES: The LLM answer fails to provide the specific revenue figures from the ground truth ($78,129 million in 2022 and $85,200 million in 2023). While the 12.9% growth rate is mentioned, the absence of the actual dollar amounts represents a significant omission of quantitative detail that was explicitly provided in the original answer. The ground truth specifically cites these figures as evidence of the growth trajectory being discussed.\n\nQUANTITATIVE ACCURACY: Score of 4 because while the 12.9% growth percentage is correct, the LLM completely omits the specific revenue figures ($78,129M and $85,200M) that ground the analysis. This is a material omission for a financial question requiring precision.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about third-party dependencies, developer incentives, content licensing, and regulatory impacts is sound and well-articulated. The multi-hop synthesis connecting third-party challenges to Services growth sustainability is logically correct.\n\nCONTEXTUAL RELEVANCE: Score of 8 because the answer directly addresses the question's core concern about sustainability of Services growth given third-party dependencies. The mention of specific challenges (EU DMA, licensing costs) adds relevant context.\n\nOVERALL: The answer demonstrates solid qualitative reasoning but falls short on quantitative completeness by omitting specific revenue figures that were central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 530,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "\nMetLife’s cash‑buffer must be large enough to absorb the potential shortfall that would occur if a reinsurer or derivative counterparty could not meet its obligations—since the company remains liable for guaranteed benefits and may have to post collateral or settle derivatives under stress.  Although it ended 2021 with a $12.4 billion short‑term liquidity position, the firm continuously monitors and adjusts that buffer, because severe market stress that triggers large collateral calls or forces rapid asset sales could quickly erode the cushion, so the buffer is a key factor in its ability to manage liquidity under adverse scenarios.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Quantitative accuracy is perfect - the $12.4 billion short-term liquidity position as of December 31, 2021 is correctly cited and properly formatted. (2) The multi-hop synthesis is logically sound: the answer correctly connects reinsurance/derivative counterparty risks → potential liquidity strain → need for cash buffer → the $12.4 billion position as a safeguard. (3) Key concepts are accurately identified: collateral calls, asset sales, hedging effectiveness, and policyholder behavior as stress factors. (4) The reasoning about how counterparty failure creates liability for MetLife and necessitates a buffer is correct. (5) The answer appropriately emphasizes that the buffer is continuously monitored and adjusted. MINOR WEAKNESSES: (1) The LLM answer omits explicit mention that agreements are 'largely collateralized and subject to netting agreements,' which the ground truth specifically notes as risk-reducing mechanisms. (2) The answer doesn't explicitly state that these collateral/netting arrangements 'reduce counterparty risk,' though it implies this through the discussion of monitoring and adjustment. (3) The ground truth frames the $12.4 billion as serving 'current and stress market conditions' while the LLM focuses more narrowly on stress scenarios. (4) The ground truth explicitly identifies the cash buffer as 'a capital risk factor' in the risk management framework, which the LLM doesn't explicitly state. OVERALL ASSESSMENT: The LLM answer is substantively correct and demonstrates proper understanding of the multi-hop relationship between counterparty risks, cash buffer needs, and liquidity management. The omissions are contextual details rather than factual errors, and the core answer accurately addresses how MetLife's cash buffer needs are influenced by reinsurance and derivative counterparty risks and how the $12.4 billion position supports liquidity management under stress.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 542,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "\nThe total fair value of Medtronic’s Level 3 auction‑rate securities as of April 26 2024 is **$33 million**.  In the 2023 10‑K filing these securities are reported in the “Other Assets” line of the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) CORRECTNESS: Both the fair value amount ($33 million) and the balance sheet classification (Other Assets) are correct and match the ground truth exactly. The date (April 26, 2024) is correctly identified. (2) QUANTITATIVE ACCURACY: The $33 million figure is precise and matches the ground truth. No calculation errors present. Number formatting is acceptable ($33 million vs 33 million - both equivalent). (3) QUALITATIVE ACCURACY: The LLM correctly identified MDT/Medtronic as the company, properly referenced the 2023 10-K filing, and accurately synthesized the multi-hop information (identifying both the fair value amount and its balance sheet classification). The reasoning is sound and the entities are correctly identified. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses the question asked, providing both required pieces of information (fair value amount and balance sheet classification). Minor note: The LLM used 'Medtronic' (full name) rather than 'MDT' (ticker), but this is semantically equivalent and actually more explicit. The slight formatting variation in the date presentation (April 26 2024 vs April 26, 2024) is inconsequential. Overall, this is a complete, accurate, and well-synthesized answer that correctly combines information from the 2023 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 389,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "\nThe January 1 2020 credit‑loss guidance replaced the prior incurred‑loss/OTTI model with an expected‑lifetime allowance for credit losses. Consequently, mortgage‑loan losses are now estimated over the loan’s contractual term using forecasted cash‑flows, prepayments and macro‑economic conditions and are recorded continuously as an ACL, while fixed‑maturity securities AFS are measured by estimating recoverable cash‑flows and recognizing a credit‑loss provision (instead of a direct write‑down); the $129 million “impairment (loss)” reported in 2019—previously recorded under OTTI—is now shown as part of the net credit‑loss provision and impairment loss line under the new ACL methodology.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer cites a $129 million figure as the total 2019 impairment loss for fixed maturity securities AFS, but the ground truth specifies individual amounts by security type: foreign government ($81M), consumer corporate ($23M), industrial corporate ($22M), RMBS ($2M), and finance corporate ($1M). These sum to $129M, which the LLM correctly aggregated, but the answer fails to provide the detailed breakdown that was explicitly mentioned in the ground truth. This is a significant omission because the question specifically asks about 'impairment losses reported for 2019' and the ground truth provides granular detail by security type. QUALITATIVE ASSESSMENT: The LLM correctly identifies the core conceptual shift from incurred-loss/OTTI model to expected-lifetime credit loss model (ACL). The description of mortgage loan ACL methodology is accurate—incorporating contractual term, prepayments, and macro-economic conditions. However, the explanation of fixed maturity securities treatment is somewhat vague and potentially misleading. The LLM states securities are 'measured by estimating recoverable cash-flows and recognizing a credit-loss provision (instead of a direct write-down)' but the ground truth indicates the post-adoption model uses 'intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses'—meaning direct write-downs are still part of the new model, not eliminated. MULTI-HOP REASONING: The answer demonstrates adequate synthesis of the transition from old to new model and connects 2019 impairment data to the new ACL framework. However, it misses the specific security-type breakdown that would strengthen the multi-hop analysis. COMPLETENESS: The answer addresses the main components (mortgage loans, fixed maturity securities, model transition) but lacks the detailed breakdown of 2019 impairment losses by security type that was central to the ground truth answer. The omission of specific security categories (foreign government, consumer corporate, industrial corporate, RMBS, finance corporate) represents incomplete addressing of the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 580,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "\nLockheed Martin includes the consulting‑support costs required by its international offset agreements in the total‑cost estimate for each contract, so those expenses are treated as part of the contract price and are only recoverable to the extent the U.S. Government funds the contract or reimburses the cost if a contract is terminated for convenience. Because recovery depends on the successful execution of the offset program and on future funding decisions, the company may not be able to fully recoup those out‑of‑pocket costs from U.S. government contracts in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general relationship between offset agreement costs and U.S. government contract recovery, but contains significant omissions and inaccuracies compared to the ground truth. CRITICAL ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifically cites $64.3 billion in purchase obligations related to U.S. government contracts in 2024. The LLM answer completely omits this material financial figure, which is essential to answering a question about impact on cost recovery ability. (2) INCOMPLETE CHARACTERIZATION OF OFFSET OBLIGATIONS: The ground truth explains that offset investments are 'often outside the company's control, such as those tied to joint ventures' and are 'only recoverable if the joint ventures operate successfully.' The LLM answer vaguely references 'successful execution of the offset program' but fails to capture the specific risk that these investments are outside management control and dependent on joint venture performance. (3) MISCHARACTERIZATION OF COST TREATMENT: The LLM states costs are 'included in the total-cost estimate for each contract,' suggesting they are contractually embedded. The ground truth indicates these are separate obligations that may not align with domestic reimbursement mechanisms—a critical distinction. (4) INCOMPLETE RECOVERY MECHANISM ANALYSIS: The ground truth clearly explains recovery is 'only guaranteed if the government terminates the contract for convenience under the FAR.' The LLM mentions termination for convenience but doesn't emphasize this as the primary recovery mechanism. (5) MISSING RISK ARTICULATION: The ground truth explicitly identifies the core risk: 'if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts.' The LLM's framing is more generic. WHAT WAS CORRECT: The LLM correctly identifies that cost recovery depends on government funding decisions and that there is financial risk in cost recovery. The mention of termination for convenience is accurate. However, these correct elements are insufficient given the omission of the $64.3 billion figure and the incomplete analysis of the misalignment between offset obligations and domestic reimbursement mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 642,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "\nIn 2021 the Laboratory Products & Biopharma Services segment posted a 21 % rise in revenue (and a 45 % jump in segment income), with the pharma‑services business accounting for the bulk of that growth as pandemic‑driven demand for viral‑vector manufacturing, clinical‑research and other contract services surged.  The upside was amplified by a $20 million credit to cost of product revenue that resulted from changing the inventory‑accounting method, which lifted the segment’s income margin even after accounting for strategic growth investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's pharma services business performance in 2021. STRENGTHS: (1) All key quantitative facts are correct: the $20 million inventory accounting credit is accurately cited, and the segment revenue/income growth percentages (21% and 45%) are factually accurate. (2) The answer correctly identifies the segment as 'Laboratory Products & Biopharma Services' and accurately attributes growth to the pharma services business. (3) Multi-hop synthesis is sound: the answer properly connects pandemic-driven demand (vaccine/therapy development, viral-vector manufacturing, clinical research services) with the inventory accounting change and strategic investments to explain overall margin performance. (4) The answer captures the nuanced impact: acknowledging that the $20 million credit 'lifted the segment's income margin even after accounting for strategic growth investments' correctly reflects that positive impacts were partially offset. (5) Semantic equivalence is maintained throughout - the LLM uses 'viral-vector manufacturing, clinical-research and other contract services' which aligns with the ground truth's reference to 'vaccine and therapy development' and 'contract services.' MINOR CONSIDERATIONS: The LLM provides additional specificity (mentioning specific service types like viral-vector manufacturing) that goes beyond the ground truth but does not contradict it. The phrasing 'The upside was amplified by' effectively conveys the multiplicative positive effect of the inventory change. All entities, metrics, and time periods are correctly identified. The answer directly addresses both components of the question (pandemic-related demand AND inventory accounting changes) and their combined impact on segment performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 499,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "\nMetLife’s involvement in U.S. and European Supervisory Colleges subjects the company to coordinated, cross‑border oversight: the New York Department of Financial Services (NYDFS) chairs the U.S. college that brings together MetLife’s key U.S. and non‑U.S. regulators, while the European Insurance and Occupational Pensions Authority (EIOPA) requires European supervisors to run a college for MetLife’s EEA operations.  This structure forces MetLife to align its risk‑management, capital and solvency practices with the expectations of both NYDFS and EIOPA, enhancing external monitoring of its risk profile but also tying its regulatory compliance and reporting to multiple jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies all key entities and structural elements. Strengths: (1) Correctly names NYDFS and EIOPA as the respective regulatory authorities; (2) Accurately describes NYDFS's role in chairing U.S. Supervisory College meetings; (3) Correctly identifies EIOPA's requirement for European supervisors to establish colleges for EEA-based insurance groups; (4) Properly synthesizes the multi-hop relationship between MetLife's participation, regulatory oversight, and risk profile; (5) No quantitative errors or incorrect numbers/dates. The answer demonstrates sound multi-hop reasoning by connecting: MetLife → U.S. Supervisory College (NYDFS) → coordinated oversight, and MetLife → European Supervisory College (EIOPA) → coordinated oversight. Minor weaknesses: (1) The LLM answer emphasizes compliance and reporting obligations more heavily than the ground truth, which focuses more on 'understanding' and 'collaboration' aspects; (2) The phrase 'forces MetLife to align' carries a slightly different tone than the ground truth's more neutral 'enhances understanding' framing; (3) The ground truth explicitly mentions 'Central Bank of Ireland' as an example European regulator, which the LLM answer omits (though this is a minor detail); (4) The ground truth emphasizes the 'comprehensive view' of operations and risk exposures more explicitly. These are semantic/emphasis differences rather than factual errors. The core multi-hop synthesis is correct: both U.S. and European regulators gain coordinated oversight through their respective colleges, which influences MetLife's regulatory environment and risk management practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 462,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "\nThe $373 million net release of the Allowance for Credit Losses tied to transfer‑risk exposures outside the United States—driven by U.S. banking safety‑and‑soundness requirements—lowered Citi’s credit‑loss provision and directly added to earnings. This reduction helped lift 2024 net income to $12.7 billion, a 37 % increase over the $9.2 billion reported in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) PROVISION EXPENSE: Ground truth states $295M in 2024 vs $406M in 2023 (difference of $111M). LLM incorrectly cites $373M as a 'net release' without proper context. (2) NET INCOME FIGURES: Ground truth shows $4.9B in 2024 with 27% increase. LLM claims $12.7B in 2024 and $9.2B in 2023 with 37% increase—these are completely different numbers. Verification: $9.2B × 1.37 = $12.6B (approximately $12.7B), so the LLM's percentage calculation is internally consistent, but the base numbers themselves are wrong. (3) IMPACT QUANTIFICATION: Ground truth clearly states the $111M decrease in provision expense positively impacted Net Income. LLM mentions $373M release but fails to properly connect this to the actual provision expense reduction or net income impact. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship between ACL reduction, provision expense change, and net income impact. The ground truth shows a clear causal chain: ACL reduction → lower provision expense ($111M decrease) → positive impact on Net Income (27% increase to $4.9B). The LLM provides disconnected figures without proper synthesis. (5) PERCENTAGE CHANGE: Ground truth: 27% increase. LLM: 37% increase. These are materially different. The LLM appears to have used entirely different financial data, possibly from a different company or year. All major quantitative elements are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 414,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "\nThe debt‑ceiling impasse could force a short‑term lapse or continuing‑resolution that delays FY 2025 appropriations for the Department of Defense, curtailing the flow of Foreign Military‑Sales (FMS) funding that supplies roughly 73 % of Lockheed’s international revenue and represents about 32 % of Aeronautics’ total sales. Because the F‑35 program involves twelve FMS customers, any pause in U.S. funding would likely postpone new jet deliveries, sustainment contracts and related revenue in the Aeronautics segment, pressuring its backlog and margins.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly synthesizes information across multiple data points. STRENGTHS: (1) All key percentages are accurate: 73% of international sales through FMS, 32% of Aeronautics sales from international customers, twelve FMS customers for F-35. (2) The reasoning correctly identifies the causal chain: debt ceiling → funding disruption → FMS delays → F-35 production impact → revenue/margin pressure. (3) The answer appropriately addresses the specific question about how disruptions would affect the Aeronautics segment. (4) Multi-hop synthesis is sound, connecting debt ceiling → FMS funding → F-35 program → Aeronautics segment impact. MINOR WEAKNESSES: (1) The LLM states FMS represents 'about 32% of Aeronautics' total sales' which is slightly imprecise - the ground truth indicates 32% of Aeronautics' net sales come from international customers (not that FMS represents 32% of Aeronautics). The LLM appears to conflate the 32% international customer metric with FMS representation, though the context suggests this may be acceptable given the question's framing. (2) The answer is somewhat more concise than the ground truth and omits the explicit mention of 'long-cycle nature of defense contracts' and 'prolonged effect on financial performance,' though these are implied. (3) The phrasing 'represents about 32% of Aeronautics' total sales' could be clearer - it's ambiguous whether this refers to FMS or international sales. QUANTITATIVE VERIFICATION: 73% ✓, 32% ✓, twelve FMS customers ✓. All numbers are correct. The answer maintains semantic equivalence with the ground truth while using slightly different phrasing. The core insight about delayed deliveries, sustainment contracts, and margin pressure is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 493,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "\nAs of December 31 2023, the 2020 Stock Incentive Plan (including its related plans) had **approximately 70 million shares remaining available for future issuance**. By contrast, only **about 191,000 shares** of common stock were underlying stock‑option awards that had been assumed in connection with acquisitions—an amount that is essentially negligible compared with the 70 million shares that can still be issued.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-part question. Verification of numbers: (1) The 70 million shares available for future issuance is accurate - this correctly combines the 53 million from the 2020 Stock Incentive Plan and 17 million from the ESPP as stated in the ground truth. (2) The 191,000 shares underlying stock options assumed through acquisitions is exactly correct. (3) The comparison between the two figures is accurate and appropriately characterized as the acquisition-related shares being 'essentially negligible' compared to the 70 million available. The multi-hop reasoning is sound: the answer correctly synthesizes information about the 2020 Plan, related plans (ESPP), and acquisition-related options, then makes the appropriate comparative analysis. The only minor difference from the ground truth is that the LLM presents the 70 million as a single combined figure rather than breaking it down into the 53 million + 17 million components, but this is a presentation choice that doesn't affect accuracy. The date (December 31, 2023) is correct. The entity identification (UnitedHealth Group, 2020 Stock Incentive Plan, ESPP) is accurate. The semantic meaning fully matches the ground truth - both convey that the available shares under the plans vastly exceed the assumed acquisition-related options.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 382,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "\nThe cumulative stock‑based compensation expense that has been recognized for the Multi‑Year Equity Awards over fiscal 2022‑2024 is **$1.746 billion** ( $794 M in 2022 + $596 M in 2023 + $356 M in 2024 )【page_85】.  As of November 3, 2024, the total unrecognized compensation cost related to all unvested stock‑based awards—including those from the Multi‑Year Equity Awards—was **$11.259 billion**【page_85】, meaning the $1.746 billion already recognized represents only about 15 % of the remaining unrecognized balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $794M (2022) + $596M (2023) + $356M (2024) = $1,746M total, correctly formatted as $1.746 billion. The unrecognized compensation cost of $11.259 billion ($11,259 million) is accurate. The calculated percentage (1,746/11,259 ≈ 15.5%, rounded to ~15%) is mathematically correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total stock-based compensation expense for 2022-2024, and (2) comparison to unrecognized compensation cost. ENTITY ACCURACY: Correctly identifies Multi-Year Equity Awards, fiscal years 2022-2024, and the date November 3, 2024. MULTI-HOP REASONING: Properly synthesizes information across multiple fiscal years and connects recognized vs. unrecognized compensation costs. The interpretation that recognized compensation represents only ~15% of the remaining unrecognized balance demonstrates sound analytical reasoning. SEMANTIC EQUIVALENCE: The LLM's statement about the weighted-average service period (3.0 years) is mentioned in the original answer but not in the LLM response; however, the LLM does provide the key insight about the remaining unrecognized balance being the majority of compensation cost. The LLM adds valuable context by calculating the percentage relationship between recognized and unrecognized costs, which enhances understanding. Minor note: The original answer explicitly mentions the 3.0-year weighted-average service period, which the LLM omits, but this is a minor contextual detail rather than a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 439,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "\nThe 2024 minimum long‑term‑debt (LTD) requirement for Citi is **9.5 % of its risk‑weighted assets (RWA)**.  This figure is derived as the larger of two possible thresholds: (i) 6 % of RWA plus the method‑2 GSIB surcharge (which is 3.5 % for Citi in 2024), giving 6 % + 3.5 % = 9.5 % of RWA; and (ii) 4.5 % of total leverage exposure.  Because the first component (9.5 % of RWA) exceeds the second, it sets the binding minimum LTD requirement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about Citi's 2024 minimum LTD requirement. STRENGTHS: (1) All numeric values are correct: 9.5% total requirement, 6% base, 3.5% GSIB surcharge, and the arithmetic (6% + 3.5% = 9.5%) is accurate. (2) The answer correctly identifies the company (Citi), year (2024), and metric (LTD as % of RWA). (3) The calculation methodology is properly explained: base minimum LTD requirement of 6% plus the method-2 GSIB surcharge of 3.5%. (4) The answer goes beyond the ground truth by providing additional context about the 'larger of' comparison framework (9.5% of RWA vs. 4.5% of total leverage exposure), which demonstrates deeper understanding of the regulatory framework, though this additional detail was not explicitly required by the question. (5) The multi-hop synthesis is sound: correctly combining the base requirement with the GSIB surcharge component. MINOR CONSIDERATIONS: The ground truth answer is more concise and direct, stating simply that the requirement is calculated by 'adding' the two components. The LLM answer frames this within a 'larger of' comparison framework, which is technically more complete from a regulatory perspective but slightly expands beyond what the ground truth explicitly states. However, this additional context is accurate and enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 400,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "\nThe company’s table of estimated future benefit payments shows that, starting in 2025, the qualified defined‑benefit pension plans require $1.80 billion, rising to $1.86 billion in 2026, $1.91 billion in 2027, $1.96 billion in 2028 and $1.99 billion in 2029; the subsequent five‑year block (2030‑2034) is aggregated at $9.99 billion. Adding these amounts gives a total projected funding requirement of roughly **$19.5 billion over the next decade**.  \n\nThe yearly increases from 2025‑2029 are positive but progressively smaller ( +$60 M, +$50 M, +$50 M, +$30 M ), indicating that pension obligations continue to grow but at a moderating pace, reflecting a stabilizing—though still upward—trend in the plan’s funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.80B (2025), $1.86B (2026), $1.91B (2027), $1.96B (2028), $1.99B (2029), and $9.99B (2030-2034). The total of $19.5 billion matches the ground truth of $19,510 million (format variation is acceptable). The year-over-year increases are correctly calculated: +$60M, +$50M, +$50M, +$30M. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total projected funding requirement over the decade, and (2) the pattern of annual increases from 2025-2029. ENTITY ACCURACY: Correctly identifies Lockheed Martin, qualified defined benefit pension plans, and the appropriate time periods. REASONING QUALITY: The LLM provides sound multi-hop synthesis by combining the individual annual amounts to derive the total, then analyzing the year-over-year progression to characterize the trend. The interpretation that increases are 'progressively smaller' and indicate a 'moderating pace' with 'stabilizing trend' is a reasonable and accurate characterization of the data pattern. MINOR DISTINCTION: The ground truth uses the phrase 'consistent upward trend' while the LLM specifies 'positive but progressively smaller' increases. Both characterizations are factually correct - the LLM's description is actually more precise in noting the decelerating magnitude of increases. The semantic meaning is equivalent and the LLM's interpretation adds nuance about the moderating pace. No calculation errors detected. All numbers verified against ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 437,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "\nThe combined market‑value of Honeywell’s Mortgage/Asset‑backed securities was **$1,151 million in 2021** ( $1,072 million in the U.S. plans + $79 million in the non‑U.S. plans) and **$1,075 million in 2020** ( $982 million + $93 million).  \n\nIn each year this asset class made up roughly **5 % of the total fixed‑income portfolio** (≈5.5 % in 2021 and ≈5.3 % in 2020), positioning it as the fourth‑largest component of fixed‑income holdings after corporate bonds, short‑term investments and government securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR NUMBER DISCREPANCIES: The LLM reports $1,151M for 2021 and $1,075M for 2020, but the ground truth states $1,072M for 2020 and $982M for 2021. The LLM has the years reversed and provides incorrect dollar amounts. The combined total should be $2,054M, not $2,226M as the LLM's numbers would suggest. (2) PERCENTAGE CALCULATIONS WRONG: The LLM claims ~5% for both years (5.5% in 2021, 5.3% in 2020), but ground truth shows 8.1% in 2020 and 8.9% in 2021. This is a substantial error - the LLM's percentages are roughly 40% lower than actual. (3) BREAKDOWN ANALYSIS ISSUE: The LLM breaks down the figures into U.S. and non-U.S. plans, which adds complexity not present in the ground truth answer. While this additional detail could be valuable if correct, it appears to be based on incorrect underlying numbers. (4) RANKING CLAIM: The LLM states this was the 'fourth-largest component' but provides no basis for this ranking in the ground truth, and given the percentage errors, this ranking is likely incorrect. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison and proportional analysis. The core task required comparing 2020 vs 2021 values and calculating their proportion to total fixed income - the LLM got both the absolute values and the percentages wrong. The answer demonstrates fundamental calculation errors and appears to have confused or misread the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 402,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "\nBroadcom now expenses the equity it grants over the full vesting horizon of the multi‑year awards—typically 4 to 7 years—rather than front‑loading the charge in a single fiscal year as it did with the prior annual awards. Consequently, the stock‑based compensation expense is recognized gradually and evenly across those multiple years, spreading the cost out and reducing the spike in expense that occurred when large annual grants were made each year. This longer‑term recognition also means that a larger pool of unvested awards (reflected in the $11.3 billion of unrecognized compensation cost) will be amortized over several future periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general concept of the shift from annual to multi-year awards with extended vesting periods, but contains significant quantitative inaccuracies and some conceptual misstatements. STRENGTHS: (1) Correctly identifies the shift extends recognition from 4 years to up to 7 years; (2) Accurately describes the gradual/even expense recognition across multiple years; (3) Correctly notes the reduction in expense spikes compared to annual grants; (4) Appropriately references the $11.3 billion unrecognized compensation cost figure. WEAKNESSES: (1) The statement about 'front-loading the charge in a single fiscal year' for prior annual awards is misleading—the ground truth indicates annual grants were recognized over 4 years, not in one year; (2) The LLM suggests the prior model involved 'large annual grants' creating spikes, but the ground truth indicates annual grants were already spread over 4 years, so the comparison is not entirely accurate; (3) The LLM doesn't clearly explain that the multi-year awards consolidate four annual grant cycles into one award, which is a key structural difference; (4) The characterization of the prior model is somewhat distorted—it wasn't front-loaded but rather had overlapping 4-year cycles. MULTI-HOP REASONING: The answer attempts to synthesize the change in expense recognition patterns but oversimplifies the prior model's mechanics. The ground truth emphasizes that the change extends from overlapping 4-year cycles to a single 7-year recognition period, whereas the LLM frames it as moving from single-year front-loading to multi-year spreading. QUANTITATIVE ISSUES: The $11.3 billion figure is cited but not verified against ground truth; while it appears in the answer, the context of how this relates to the expense recognition pattern could be clearer. The vesting period range (4-7 years) is correctly stated but the explanation of how this differs from the prior 4-year cycle per annual grant is imprecise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 535,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "\nU.S. banking law requires banks to evaluate “transfer‑risk” exposures abroad and to adjust their allowance‑for‑credit‑loss (ACL) builds accordingly, a safety‑and‑soundness driver that has led Citi to record a **smaller ACL build for exposures outside the United States** in both the Legacy Franchises (All Other) and the Markets segment.  Because the ACL build was reduced, the net credit‑loss provision ended up **higher** despite only modest increases in actual net credit losses; the combined effect was a **total 2024 credit‑loss provision of roughly $1.6 billion** (about $463 million in Markets plus roughly $1.1 billion in the Legacy/Franchise portfolios).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant errors in both quantitative accuracy and logical reasoning that undermine its correctness:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - The LLM states the total 2024 provision is \"roughly $1.6 billion\" ($463M + $1.1B), which is arithmetically correct ($1.563B rounds to ~$1.6B). However, this is presented WITHOUT the crucial comparison to 2023.\n   - Ground truth shows: 2023 total = $1.738B ($1.3B + $438M), 2024 total = $1.563B ($1.1B + $463M)\n   - The LLM fails to provide the year-over-year comparison that is essential to answering \"what is the combined impact\"\n   - The LLM omits the 2023 Markets figure ($438M vs $406M mentioned in ground truth, though there's a discrepancy in ground truth itself)\n\n2. LOGICAL REASONING ERROR (CRITICAL):\n   - The LLM states: \"Because the ACL build was reduced, the net credit-loss provision ended up HIGHER despite only modest increases in actual net credit losses\"\n   - This is BACKWARDS. The ground truth shows provisions DECREASED from $1.738B to $1.563B (a $175M reduction)\n   - The LLM's statement contradicts its own numbers and the ground truth\n   - This represents a fundamental misunderstanding of the relationship between ACL builds and total provisions\n\n3. INCOMPLETE ANSWER:\n   - The question asks for \"combined impact on Citi's total provision for credit losses in 2024\"\n   - The LLM provides only the 2024 figure, not the impact (which requires year-over-year comparison)\n   - Ground truth clearly states: \"reduction of $175 million\" - this impact metric is completely missing from LLM answer\n\n4. WHAT WAS CORRECT:\n   - Correctly identifies that U.S. banking law led to smaller ACL builds for transfer risk\n   - Correctly identifies both Legacy Franchises and Markets segments\n   - Correctly states the 2024 figures: ~$1.1B (Legacy) and ~$463M (Markets)\n   - Correctly identifies the mechanism (transfer-risk exposures abroad)\n\n5. MISSING ELEMENTS:\n   - No mention of the $175 million reduction in total provisions\n   - No 2023 comparison figures\n   - No explanation of why provisions decreased despite the ACL mechanism\n   - Contradictory statement about provisions being \"higher\" when they were actually lower",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 598,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "\nThe insurance‑buy‑in contracts held in Honeywell’s non‑U.S. pension plans were valued at **$691 million in 2021** and **$767 million in 2020**, giving a combined amount of **$1.458 billion**.  This combined figure represents roughly **8.7 %** of the total fair‑value assets of those plans ($16.85 billion) for the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the insurance buy-in contract values for both years ($767M in 2020 and $691M in 2021) and accurately calculates the combined total of $1.458 billion. The answer properly addresses the multi-hop question by synthesizing data across two years and calculating the percentage representation. However, there is a minor discrepancy in the percentage calculation and total assets figure. Ground truth shows: $1,458M ÷ ($8,450M + $8,396M) = $1,458M ÷ $16,846M = 8.66%. The LLM states 8.7%, which is a reasonable rounding of 8.66% and falls within acceptable tolerance. The LLM also states total fair-value assets as $16.85 billion, which matches the ground truth total of $16,846 million when rounded. The answer correctly identifies HON (Honeywell) and non-U.S. pension plans. All core financial figures are accurate, the calculation methodology is sound, and the multi-hop synthesis across 2020-2021 data is properly executed. The only minor issue is the slight rounding difference in the percentage (8.7% vs 8.66%), which is negligible and represents acceptable rounding practice. The answer is complete, addresses all parts of the question, and demonstrates proper multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 343,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "\nBroadcom’s strategy explicitly calls for “extensive internal research and development” to preserve technology‑market leadership, and it channels that spending into creating AI‑focused semiconductor assets such as custom ASICs, high‑speed Ethernet/optical interconnects and other AI‑networking chips. By developing these capabilities in‑house, the semiconductor segment can rapidly introduce cutting‑edge, high‑performance solutions that meet the growing demand for AI data‑center and networking products, thereby sustaining its technology leadership in AI‑related markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Broadcom's core strategy of 'extensive internal research and development' for maintaining technology leadership, which matches the ground truth. The answer accurately describes how this R&D investment supports AI-related semiconductor products and enables rapid innovation in AI data-center and networking markets. No quantitative errors are present (no specific numbers were provided in either answer to verify). The multi-hop reasoning is sound: the answer correctly synthesizes that R&D investment → semiconductor innovation → AI market leadership. However, there are some notable omissions compared to the ground truth: (1) The LLM answer does not mention specific semiconductor technologies like CMOS-based devices, gallium arsenide (GaAs), or indium phosphide (InP), which are explicitly highlighted in the ground truth as critical for high-speed RF and optoelectronic applications. (2) The ground truth emphasizes 'complex digital and mixed-signal' capabilities and 'analog III-V based products,' which provide important technical context that the LLM answer lacks. (3) The ground truth mentions 'category-leading infrastructure technology products' and service to 'major business and government customers,' which adds important market positioning context. The LLM answer is more concise and focuses on the strategic mechanism (in-house development → rapid innovation → market leadership) rather than the specific technical implementations. While the core answer is correct and addresses the question adequately, the omission of specific technical details and product categories represents a meaningful gap in completeness relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 463,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "\nQualcomm expects to pay **$9.6 billion** in the next 12 months under its purchase agreements. This amount is **significantly larger** than the **$3.0 billion** of advance payments that had been recorded for its multi‑year capacity‑purchase commitments as of September 29, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the multi-part question effectively. Verification of key numbers: (1) $9.6 billion in next 12 months under purchase agreements - CORRECT, matches ground truth exactly; (2) $3.0 billion in advance payments under multi-year capacity purchase commitments as of September 29, 2024 - CORRECT, matches ground truth exactly; (3) Date reference (September 29, 2024) - CORRECT. The LLM correctly identifies that the 12-month payment obligation ($9.6B) is significantly larger than the advance payments already made ($3.0B), demonstrating sound multi-hop reasoning by synthesizing information from two different financial metrics. The comparison is logical and accurate. Minor observation: The ground truth answer provides slightly more context by mentioning that the $9.6B is part of a total $12.8B in obligations and that these relate to 'integrated circuit product inventory obligations,' but the LLM answer focuses on the core comparison requested in the question. The LLM's omission of these contextual details is not a significant deficiency since the question specifically asks for the comparison between the two amounts, which is fully and accurately provided. All quantitative data is precise, dates are correct, and the semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 370,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "\nThe GTN‑adjustment reductions rose by **$25 million** in 2024 ( $159 million vs. $134 million in 2023 ). This increase was driven by **non‑U.S. clawback revisions stemming from updates to VAT‑recoverable estimates**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All numbers are correct - the 2024 GTN adjustment reduction of $159 million, the 2023 figure of $134 million, and the calculated difference of $25 million are all accurate. The calculation ($159M - $134M = $25M) is correct. (2) COMPLETENESS: The answer addresses both parts of the question: the quantitative difference ($25 million) and the specific non-U.S. factor (VAT recoverable estimates/clawback revisions). (3) ENTITY ACCURACY: All entities are correctly identified - GTN adjustment reductions, the years 2023 and 2024, and the specific factor (VAT-recoverable estimates driving clawback revisions). (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the GTN adjustment figures across years and identified the underlying non-U.S. factor contributing to the change. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'non-U.S. clawback revisions stemming from updates to VAT-recoverable estimates' is semantically equivalent to the ground truth's 'revisions in clawback amounts driven by VAT recoverable estimates.' The minor wording variation ('stemming from updates to' vs 'driven by') does not affect factual accuracy. The answer is well-structured, clear, and directly responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 377,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "\nMastercard Send is the engine of the company’s disbursements‑and‑remittances strategy, letting Mastercard tap new payment flows by moving money instantly within digital messaging and payment apps and across borders through a single, globally‑connected distribution network.  This capability is enabled by partner ecosystems that include digital‑messaging/payment platforms, central banks, fintechs, financial institutions, governments and nonprofit organisations—all of which provide the bank‑account, mobile‑wallet, card and cash‑payout channels that expand Mastercard’s multi‑rail reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures Mastercard Send's role as a disbursements and remittances strategy component that enables capturing new payment flows. It correctly identifies the core functionality (enabling money movement domestically and across borders through digital channels) and the strategic objective (expanding multi-rail capabilities). The answer properly synthesizes the multi-hop relationship between the product, strategy, and business objective. (2) QUANTITATIVE ACCURACY: No numeric values are present in either the ground truth or LLM answer, so this dimension is not applicable. Score of 10 reflects absence of quantitative errors. (3) QUALITATIVE ACCURACY: The LLM answer comprehensively addresses all partner ecosystems mentioned in the ground truth: central banks, fintechs, financial institutions, governments, and nonprofits. It adds valuable specificity by mentioning 'digital-messaging/payment platforms' and the specific payment channels (bank-account, mobile-wallet, card, cash-payout). The reasoning is sound and demonstrates proper multi-hop synthesis connecting the product → strategy → business objective. (4) ENTITY ACCURACY: All entities are correctly identified (Mastercard, Mastercard Send, central banks, fintechs, financial institutions, governments, nonprofits). The fiscal year context (2022 10-K) is appropriately maintained. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys equivalent information to the ground truth while using slightly different phrasing. Both emphasize the same core concepts: enabling efficient money movement, capturing new payment flows, leveraging partner ecosystems, and expanding multi-rail capabilities. The LLM's description of Send as 'the engine' of the strategy is semantically equivalent to calling it 'a key component.' Minor differences in wording (e.g., 'instantly within digital messaging' vs. 'more efficiently') represent stylistic variation rather than factual divergence. The answer is comprehensive, accurate, and directly responsive to all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 581,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "\nThe Cyber and Intelligence Solutions are reported as part of Mastercard’s “Other revenues” and are recognized as revenue in the period the security‑related service is actually delivered (or as usage‑based fees are earned).  Consequently, the launch of these solutions adds a new, currently‑recognized component to the “Other revenues” line, expanding its size and moving a portion of what would otherwise have been deferred or capitalized into the current‑period earnings.  This is reflected in the 2021‑2022 growth of the “Other revenues” category, which now includes the Cyber and Intelligence Solutions fees alongside data‑analytics, loyalty, and other value‑added services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies that Cyber and Intelligence Solutions are part of 'Other revenues' category; (2) Accurately describes revenue recognition timing as occurring when services are delivered or usage-based fees are earned; (3) Properly identifies this as a value-added service alongside data analytics and loyalty services; (4) Correctly notes the expansion of 'Other revenues' composition. WEAKNESSES: (1) QUANTITATIVE ISSUE - The LLM claims growth in 'Other revenues' from 2021-2022 but provides no specific numbers, percentages, or dollar amounts to substantiate this claim. The ground truth does not mention specific growth figures either, but the LLM's assertion about '2021-2022 growth' is unsupported by data; (2) SPECULATIVE REASONING - The statement about 'moving a portion of what would otherwise have been deferred or capitalized into the current-period earnings' is not supported by the ground truth and appears to be speculative accounting analysis not grounded in the actual filing information; (3) INCOMPLETE SYNTHESIS - While the LLM mentions the timing of recognition, it doesn't clearly explain HOW the introduction of these solutions specifically influences the composition (what percentage, what absolute amounts); (4) VAGUE QUANTIFICATION - References to 'expanding its size' and 'adds a new component' lack concrete metrics. The ground truth is more conservative, stating these revenues 'directly contribute' and are 'recognized in the period when services are performed,' without making claims about growth rates or deferred/capitalized amounts. The LLM adds interpretive layers not present in the source material, which introduces potential inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 485,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "\nThe fair‑value of Qualcomm’s corporate bonds and notes is $4.634 billion. Together, U.S. Treasury securities and government‑related securities have a fair‑value of $208 million, which is about 3.8 % of the company’s total marketable securities of $5.451 billion (so corporate bonds and notes make up roughly 85 % of that total).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and percentages. Verification of key numbers: (1) Corporate bonds and notes fair value: LLM states $4.634 billion, ground truth states $4,634 million - these are equivalent (4,634 million = 4.634 billion), so this is correct. (2) U.S. Treasury and government-related securities: Both sources state $208 million - correct. (3) Total marketable securities: Both sources state $5.451 billion/$5,451 million - equivalent and correct. (4) Percentage calculations: Corporate bonds 85% (4,634/5,451 = 84.98% ≈ 85%) - correct. Treasury/government securities 3.8% (208/5,451 = 3.81% ≈ 3.8%) - correct. The LLM successfully synthesized the multi-hop comparison across all three metrics (corporate bonds, treasury securities, and total marketable securities). The answer addresses all parts of the question comprehensively. Minor note: The LLM uses 'fair‑value' with a special hyphen character instead of standard hyphen, which is a formatting variation but not a substantive error. The semantic meaning is preserved throughout, and the reasoning connecting the three financial metrics is sound and logical. The answer demonstrates proper multi-hop synthesis by correctly relating the component values to the total and calculating appropriate percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 368,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "\nMRK leverages the six‑month pediatric market‑exclusivity grant for Keytruda (noted on page 15) to tack on additional protection beyond the compound‑patent expiry in 2028, and together with the patent‑term‑adjusted patents that expire in 2029 (see page 34) this can keep the drug under exclusivity for pediatric indications at least through 2029‑2030.  By extending the monopoly period, the company can preserve the high‑margin oncology sales that currently drive a large share of its revenue, delaying generic erosion and helping to sustain overall oncology‑segment growth and cash‑flow forecasts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the six-month pediatric market exclusivity mechanism for Keytruda and accurately describes the financial impact (preserving high-margin oncology sales, delaying generic competition, supporting revenue predictability). The reasoning about extending monopoly periods and protecting cash flows is sound and aligns with the ground truth's core message. The answer appropriately addresses both parts of the question (mechanism and financial impact). WEAKNESSES: The LLM introduces specific patent expiration dates (2028 for compound patent, 2029 for patent-term-adjusted patents, extending through 2029-2030) that are NOT present in the ground truth answer. The ground truth does not specify these dates, only mentioning that PTE could extend up to five years and that pediatric exclusivity extends six months. By adding specific dates without ground truth support, the LLM creates potential factual inaccuracies. The ground truth mentions Patent Term Extension (PTE) as a separate mechanism that could provide up to five years of additional protection, but the LLM conflates this with the pediatric exclusivity timeline without clearly distinguishing between the two regulatory pathways. QUANTITATIVE ACCURACY ISSUE: The specific dates (2028, 2029, 2029-2030) cannot be verified against the ground truth and appear to be inferred or potentially incorrect. This is a significant concern for a financial question where precision matters. MULTI-HOP REASONING: The LLM correctly synthesizes that pediatric exclusivity extends market protection and impacts oncology revenue, which matches the ground truth's synthesis across sources. However, the introduction of unverified dates undermines the reliability of the multi-hop reasoning. The answer would have been stronger by sticking to the general framework (six months pediatric exclusivity + potential PTE up to five years) without specifying dates not in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 530,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "\nMastercard Installments, launched in 2022 as an open‑loop buy‑now‑pay‑later solution, extends the company’s digital‑payment portfolio by letting lenders connect directly to merchants across Mastercard’s acceptance network and by delivering a checkout experience that works on mobile, e‑commerce and in‑store channels. Because it builds on Mastercard’s existing technology standards (e.g., EMV Secure Remote Commerce) and its broader innovation agenda—expanding multi‑rail capabilities, digital identity and contactless payments—it directly advances the strategic goal of scaling digital payment services across multiple channels. (See page 14 “Mastercard Installments… expected to launch in 2022” and page 8 “planned launch in 2022 of Mastercard Installments…”)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies Mastercard Installments as an open-loop buy-now-pay-later solution launched in 2022, matching the ground truth. (2) Accurately describes the core mechanism: lenders connecting to merchants across Mastercard's acceptance network. (3) Properly identifies the multi-channel support (mobile, e-commerce, in-store) as part of the strategic expansion. (4) Correctly synthesizes the broader innovation context including multi-rail capabilities, digital identity, and contactless payments. (5) Appropriately cites specific page references to the 2022 10-K filing, demonstrating source verification. (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer adds specific technical details (EMV Secure Remote Commerce) not explicitly mentioned in the ground truth, though this is contextually appropriate and not contradictory. (2) The ground truth mentions 'digital currency solutions' while the LLM mentions 'digital identity'—these are related but slightly different emphases. However, both are legitimate components of Mastercard's innovation strategy. (3) The LLM answer is slightly more detailed and technical than the ground truth, but this represents enhancement rather than error. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple strategic dimensions: the specific product launch (Mastercard Installments), the mechanism (lender-merchant connections), the channels (mobile/e-commerce/in-store), and the broader strategic context (multi-rail, digital solutions). The logical connection between the product introduction and strategic goals is clearly established.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 469,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "\nIn 2024 Merck recorded roughly **$277 million** of profit‑sharing payments to Ridgeback within Cost of sales – essentially 50 % of the $554 million cost‑of‑sales amount attributed to the Lagevrio collaboration, reflecting the equal‑split of profits between the partners.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dollar amounts ($277 million and $554 million) that are NOT present in the ground truth answer. The ground truth explicitly states only that 50% of profits were recorded within Cost of sales, reflecting the equal-split agreement - it does NOT provide or validate any specific dollar figures. The LLM appears to have fabricated these numbers without evidence from the filing data. While the LLM correctly identifies the 50% profit-sharing portion and the equal-split arrangement between Merck and Ridgeback, the introduction of unverified financial figures is a major factual error. The reasoning about the equal-split structure is sound, but the quantitative claims are unsupported and potentially incorrect. The answer conflates what should be stated as a percentage/proportion with invented specific dollar amounts, which violates the requirement for strict accuracy on financial numbers. This represents a fundamental failure in quantitative accuracy despite partial correctness on the conceptual understanding of the profit-sharing arrangement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 314,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "\nThe UK’s Overseas Fund Regime (OFR) lets BlackRock market non‑UK‑domiciled funds to UK retail investors by registering those funds with the FCA, but only if the fund’s home‑state consumer‑protection regime is judged “equivalent” to the UK’s standards. Consequently, BlackRock must align the governance, disclosure and investor‑protection practices of its European (EU‑domiciled) fund structures with the UK’s consumer‑duty expectations so that the home‑jurisdiction’s rules can satisfy the FCA’s equivalence test and enable seamless UK distribution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the OFR mechanism and its interaction with BlackRock's European fund structures. STRENGTHS: (1) Correctly identifies the core requirement that consumer protection regimes must be 'equivalent' to UK standards - this matches the ground truth; (2) Accurately explains that BlackRock must register non-UK-domiciled funds with the FCA; (3) Properly synthesizes the multi-hop relationship between OFR, European domicile structures, and UK marketing ability; (4) Correctly identifies that equivalence testing is the key regulatory hurdle; (5) No quantitative errors (no numbers/dates to verify). MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'aligning governance, disclosure and investor-protection practices' and 'consumer-duty expectations' that goes slightly beyond what the ground truth explicitly states - while logically sound, this represents minor elaboration beyond the core answer; (2) The phrase 'seamless UK distribution' is somewhat interpretive language not explicitly in the ground truth; (3) The ground truth emphasizes that equivalence requirements 'may necessitate adjustments to fund structures or compliance frameworks' - the LLM captures this concept but frames it more prescriptively ('must align') rather than conditionally ('may necessitate'). MULTI-HOP REASONING: The answer correctly synthesizes three elements: (1) OFR mechanism, (2) European domicile structures, and (3) UK marketing ability, showing sound logical connection. The equivalence requirement is properly identified as the linking mechanism. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both convey that equivalence of consumer protection regimes is the critical requirement for UK distribution of EU-domiciled funds. The LLM provides slightly more operational detail while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 510,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "\nBroadcom manufactures its FBAR filters in dedicated, company‑owned fabs (e.g., Fort Collins and Breinigsville), which are the sole sources for those components. This vertical integration protects the proprietary FBAR technology, guarantees high‑performance and reliable filter quality, and lets Broadcom move quickly on design‑win opportunities and rapid production ramps. As a result, the company can offer cellular handset OEMs superior RF performance and cost‑effective solutions that are difficult for competitors to match.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing substantially more detail and specificity. STRENGTHS: (1) Correctly identifies Broadcom's internal manufacturing strategy for FBAR filters as the core competitive advantage mechanism; (2) Accurately captures the key benefits: IP protection, time-to-market acceleration, and quality assurance - all explicitly mentioned in ground truth; (3) Provides concrete examples (Fort Collins and Breinigsville fabs) that support the vertical integration claim; (4) Properly synthesizes how this strategy translates to competitive advantage in cellular handset market through superior RF performance and cost-effectiveness; (5) No quantitative errors or incorrect numbers/dates; (6) Multi-hop reasoning is sound - correctly connects manufacturing strategy → IP protection + speed → competitive advantage in handset market. MINOR CONSIDERATIONS: (1) The LLM answer goes beyond the ground truth by adding specific fab locations and additional details about 'sole sources' and 'design-win opportunities' - while these appear factually reasonable and enhance the answer, they represent elaboration beyond what was explicitly in the ground truth; (2) The ground truth emphasizes 'significant market share' of FBAR technology, while the LLM answer focuses more on relative competitive positioning versus competitors - both are valid but slightly different framings. OVERALL ASSESSMENT: The LLM answer is more comprehensive and detailed than the ground truth while maintaining complete factual accuracy. It successfully addresses all aspects of the question (internal manufacturing strategy, FBAR filters, RF semiconductors, cellular handset market, competitive advantage) with sound multi-hop reasoning connecting these elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 488,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "\nMerck extends market protection for its biologics by combining a patent‑term extension (PTE) – which can restore up to 5 years of the standard 20‑year patent life (and, when applicable, adds a further 6‑month pediatric exclusivity) – with the United States’ regulatory exclusivity regime for biologics, which provides 12 years of data‑exclusivity from the date of first approval (extended to 7 years for orphan‑drug indications). This dual strategy shields the product from generic or biosimilar competition well beyond the base patent expiration.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general question structure. CRITICAL ERRORS: (1) The LLM claims orphan-drug indications receive 7 years of exclusivity for biologics - this is INCORRECT. The ground truth specifies 12 years of regulatory data exclusivity for biologic products in the U.S., with no mention of a reduced 7-year period for orphan drugs. This appears to conflate orphan drug exclusivity rules (which provide 7 years for non-biologic drugs) with biologic exclusivity rules. (2) The LLM correctly identifies the 12-year biologic exclusivity period and the 6-month pediatric extension, matching the ground truth. (3) The patent term extension (PTE) information of 'up to 5 years' is accurate and relevant, though not explicitly mentioned in the ground truth. PARTIAL CREDIT: The answer correctly synthesizes the dual strategy of combining PTEs with regulatory exclusivity and accurately conveys that these mechanisms work together to delay biosimilar competition. The semantic understanding of the question is sound. MULTI-HOP REASONING: The answer demonstrates understanding that both patent and regulatory mechanisms work together, which is appropriate. However, the introduction of the incorrect 7-year orphan drug exclusivity claim for biologics represents a fundamental factual error that would mislead someone relying on this information for regulatory or business decisions. The ground truth makes no mention of differentiated exclusivity periods based on orphan status for biologics. This error is particularly problematic because it adds information not supported by the source material and contradicts standard FDA biologic exclusivity rules.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 472,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "\nThe 2024 UK Stewardship Code reforms introduce tailored reporting obligations for proxy advisers and investment consultants, requiring BlackRock to disclose more detailed stewardship‑related information and to align its voting and engagement practices with the new standards. These heightened disclosure and governance requirements are likely to increase compliance costs in the UK and may necessitate adjustments to how BlackRock interacts with and advises its clients to meet the revised reporting expectations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of the 2024 UK Stewardship Code reforms and their impact on BlackRock's compliance costs and client engagement. The answer accurately captures that: (1) the reforms introduce tailored reporting requirements for proxy advisers and investment consultants, (2) these changes increase compliance costs, and (3) adjustments to client engagement practices are necessary. However, the LLM answer is INCOMPLETE in several important respects compared to the ground truth: (1) It fails to mention the Consumer Duty rules and their connection to the stewardship obligations, which is a critical regulatory context provided in the original answer. (2) It does not address the specific regulatory risks outlined in the ground truth, including exposure to FCA regulatory sanctions, reputational risk, and potential client asset withdrawals. (3) It does not explain how failure to meet FCA expectations could impact operational efficiency and client engagement beyond general compliance adjustments. The LLM answer focuses narrowly on disclosure requirements and compliance costs but misses the broader regulatory risk framework and consequences of non-compliance that are central to understanding the full impact on BlackRock's UK operations. No quantitative data or calculations are involved in this question, so quantitative accuracy is perfect. The qualitative accuracy is moderate because while the core facts are correct, significant contextual elements and risk implications are omitted. The answer is contextually relevant but incomplete in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 437,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "\nThe AspenTech segment’s depreciation‑and‑amortization expense rose from **$95 million in fiscal 2021 to $242 million in fiscal 2022**, an increase of **$147 million**. This jump is tied directly to the **Heritage AspenTech acquisition**—the purchase of the former AspenTech businesses added intangible assets (customer relationships, software and patents) that are now being amortized, which the company notes as the reason for the higher D&A figure (see the backlog table on page 10 and the D&A breakdown on page 77).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct—$95 million (fiscal 2021), $242 million (fiscal 2022), and the calculated increase of $147 million are all accurate. The calculation ($242M - $95M = $147M) is correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the dollar increase amount, and (2) how the Heritage AspenTech acquisition directly factors into this change. ENTITY ACCURACY: All entities are correctly identified—AspenTech segment, Heritage AspenTech acquisition, fiscal years 2021 and 2022, and the specific financial metrics (depreciation and amortization expenses). MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple sources by connecting: (a) the D&A expense figures from one section, (b) the Heritage AspenTech acquisition event, and (c) the resulting intangible assets (customer relationships, software, patents) that drive the amortization increase. The reasoning is sound and logically connects the acquisition to the increased D&A expenses. SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, with slightly more detail about the specific types of intangible assets acquired (customer relationships, software, patents), which adds helpful context without contradicting the original answer. The reference to page numbers (page 10 and page 77) demonstrates evidence-based reasoning. Minor note: The ground truth mentions 'backlog' as the connection point, while the LLM mentions both backlog and the D&A breakdown, which is actually more comprehensive. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 454,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "\nThe Asia Pacific Subscriptions‑and‑Services revenue rose from **$720 million in fiscal 2021 to $744 million in fiscal 2022**, an increase of **$24 million year‑over‑year**. This $24 million gain represented roughly **6.6 % of the total $362 million global increase** in Subscriptions‑and‑Services revenue over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial data and calculations. Verification of key numbers: (1) Asia Pacific FY2021 revenue: $720 million ✓, (2) Asia Pacific FY2022 revenue: $744 million ✓, (3) Year-over-year increase: $24 million ✓, (4) Global segment growth: $362 million ✓, (5) Percentage calculation: $24M / $362M = 6.63% ≈ 6.6% ✓. The LLM correctly identified all entities (Asia Pacific region, Subscriptions and Services segment, fiscal years 2021-2022) and performed accurate multi-hop synthesis across the data. The answer addresses both parts of the question: the absolute increase ($24 million) and the percentage contribution to global growth (6.6%). Minor note: The ground truth states the region contributed 'approximately 0.35%' while the LLM states '6.6%' - however, the LLM's calculation is mathematically correct ($24M / $362M = 6.63%), suggesting the ground truth may have used a different denominator or calculation method. The LLM's percentage is the more intuitive and standard interpretation of 'percentage of total global growth.' All financial figures are presented in correct format and the reasoning is sound. The answer is complete, accurate, and directly responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 349,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "\nThe 2023 FTC‑DOJ merger‑guideline amendments expand the information that must be disclosed in a Hart‑Scott‑Rodino filing and add new documentation requirements, which lengthens the pre‑merger waiting period and raises compliance costs. As a result, BlackRock faces higher expenses and longer delays when pursuing acquisitions or strategic investments, and any fund that participates in an HSR‑reportable transaction must also navigate the more burdensome filing process, potentially limiting the speed and attractiveness of such deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify the 2023 FTC-DOJ merger guidelines as increasing regulatory scrutiny and compliance burdens on HSR-reportable transactions. The LLM answer accurately captures the key impacts: (1) expanded information disclosure requirements, (2) additional documentation requirements, (3) lengthened pre-merger waiting periods, and (4) increased compliance costs. The answer correctly identifies BlackRock as facing higher expenses and longer delays in acquisitions/strategic investments, and properly notes that funds engaging in HSR-reportable transactions face similar burdens. No quantitative data (numbers, dates, percentages) are present in either answer, so quantitative accuracy is perfect by default. The multi-hop reasoning is sound - the answer synthesizes the regulatory changes and their cascading effects on both BlackRock and participating funds. The LLM uses slightly more specific language ('lengthens the pre-merger waiting period,' 'more burdensome filing process') compared to the ground truth's more general phrasing ('more costly, complex, and time-consuming'), but this represents appropriate elaboration rather than deviation. The semantic meaning is equivalent across both responses. Minor deduction from perfect score only because the LLM could have been slightly more explicit about the 'Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976' context, though it does reference HSR correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 416,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "\nGoldman Sachs grants Non‑Employee Director RSUs that can be settled either in its own stock or in cash. Stock‑settled RSUs are accounted for as equity‑classified awards—recognised in shareholders’ equity and not re‑measured after the grant date—while cash‑settled RSUs are treated as cash‑based compensation, recorded as a liability and re‑measured each reporting period at fair value, with any changes flowing through earnings and appearing as accrued compensation on the balance sheet. Thus the coexistence of the two award types creates a split between equity‑classified and liability‑classified RSU expense in the company’s financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Goldman Sachs' dual RSU settlement structure and its accounting implications. (1) CORRECTNESS: The answer correctly identifies that Goldman Sachs uses both stock-settled and cash-settled Non-Employee Director RSU Award Agreements, matching the ground truth. The accounting treatment distinctions are accurately stated: stock-settled RSUs are equity-classified (not remeasured after grant date) while cash-settled RSUs are liability-classified (remeasured each reporting period). (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are required for this conceptual question about accounting treatment. The answer appropriately avoids introducing unsupported quantitative claims. (3) ENTITY ACCURACY: Goldman Sachs is correctly identified, and the specific instrument type (Non-Employee Director RSU Award Agreements) is properly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes the relationship between settlement method → accounting classification → financial statement impact. It correctly traces how the two settlement types create different accounting treatments and explains the downstream effects (equity vs. liability classification, remeasurement requirements, balance sheet presentation as accrued compensation). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly more detailed explanation of the mechanics (e.g., 'changes flowing through earnings,' 'appearing as accrued compensation on the balance sheet'). The phrase 'split between equity-classified and liability-classified RSU expense' effectively summarizes the dual-classification impact. Minor strength: The LLM provides slightly more operational detail about how the liability-classified awards appear on the balance sheet, which adds helpful context without introducing inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 521,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "\nIn 2023 Abbott granted **4,981,231 restricted stock units** under the 2017 Incentive Stock Program. These units are scheduled to **vest over three years on a ratable basis**, and each vested unit entitles the holder to receive **one share of Abbott common stock**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The number of RSUs granted (4,981,231) is exact, the program name (2017 Incentive Stock Program) is correct, the year (2023) is accurate, and the vesting condition (three years) is properly stated. (2) QUANTITATIVE ACCURACY: The specific share count of 4,981,231 is precisely correct with no calculation errors. The three-year vesting period is accurately stated. (3) QUALITATIVE ACCURACY: The LLM answer provides slightly more detail than the ground truth by specifying 'ratable basis' for the vesting schedule, which is a reasonable and accurate elaboration that enhances understanding without contradicting the source material. The explanation that each vested unit entitles the holder to one share of Abbott common stock is semantically equivalent to the ground truth statement. The multi-hop synthesis is sound - correctly identifying Abbott Laboratories, the 2017 Incentive Stock Program, the 2023 timeframe, and the RSU details. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses both parts of the question: the number of shares granted and the specific vesting condition. The additional detail about 'ratable basis' adds appropriate context without introducing errors. Minor note: The LLM uses 'Abbott common stock' while ground truth says 'Abbott stock' - this is a negligible semantic difference that actually provides more precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 410,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "\nIn 2024, 35 % of the Life Sciences segment’s sales (7 % from other developed markets + 28 % from high‑growth markets) were generated outside North America and Western Europe.  This sizable share outside the traditional NA‑Europe base illustrates how the 2005 acquisition of Leica Microsystems created a globally‑distributed platform that Danaher has since expanded through further purchases, positioning the business to capture growth in emerging regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative findings: 35% of 2024 Life Sciences segment sales from regions outside North America and Western Europe, composed of 28% from high-growth markets and 7% from other developed markets. The arithmetic is accurate (28% + 7% = 35%), and the geographic breakdown (North America 44%, Western Europe 21%) is implicitly correct through the complementary percentages. The answer accurately identifies the 2005 Leica Microsystems acquisition as foundational to the geographic expansion strategy. However, the LLM answer has a notable omission: it fails to mention the subsequent strategic acquisitions (Beckman Coulter 2011, Pall 2015, Abcam 2023) that were explicitly cited in the ground truth as key enablers of the global expansion and integration of complementary technologies. While the LLM acknowledges 'further purchases' in general terms, it does not provide the specific acquisition examples that demonstrate the long-term strategic impact. The reasoning about how Leica Microsystems created a 'globally-distributed platform' is sound and semantically equivalent to the ground truth's description of it as a 'foundational platform.' The answer appropriately addresses both parts of the multi-part question (the percentage calculation and the strategic impact reflection), but with incomplete detail on the latter component. The wording is clear and the logic is sound, but the lack of specific acquisition examples represents a meaningful gap in comprehensiveness for a question explicitly asking about long-term strategic impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 435,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "\nSince 2005, Danaher has completed nine acquisitions in its Life Sciences segment. Notably, Pall was acquired in 2015 and the most recent acquisition was Abcam in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM states Danaher has made NINE acquisitions, but the ground truth clearly indicates EIGHT acquisitions. This is a fundamental factual error on the primary quantitative metric of the question. While the LLM correctly identifies Pall (2015) and Abcam (2023) as requested, it fails on the core requirement to provide the total number of acquisitions. The LLM provides partial credit for correctly identifying the two specific acquisitions mentioned (Pall in 2015 and Abcam in 2023 as the most recent), and it does address the multi-part nature of the question by attempting to answer both the total count and the specific years requested. However, the incorrect total count (9 vs 8) is a major factual error that significantly undermines the answer's reliability. The LLM does not list all eight acquisitions, which would have provided better verification of the count. The semantic relevance is moderate since the answer attempts to address the question structure, but the quantitative inaccuracy is disqualifying for a financial question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 310,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "\nThe fair‑value of Abbott’s interest‑rate hedge contracts fell by **$123 million**—from about **$210 million at Dec 31 2020** to **$87 million at Dec 31 2021**. This decline is mirrored in the contracts’ **receivable position**, which also dropped by roughly **$123 million** over the same period, indicating that the hedges were worth less (and the associated receivable decreased) as the fair‑value of the hedged fixed‑rate debt changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value decreased from $210 million (Dec 31, 2020) to $87 million (Dec 31, 2021), representing a $123 million decline. The receivable position also decreased by $123 million, matching the ground truth exactly. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in fair value of interest rate hedge contracts, and (2) how this reflects the fluctuation in receivable position. ENTITY ACCURACY: Abbott is correctly identified, the financial metrics (fair value, receivable position) are correct, and the time periods (Dec 31, 2020 and Dec 31, 2021) are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the fair value change to the receivable position change and explains the relationship between them. The interpretation that 'the hedges were worth less (and the associated receivable decreased) as the fair-value of the hedged fixed-rate debt changed' demonstrates understanding of the underlying economic relationship. MINOR OBSERVATION: The LLM uses 'about' and 'roughly' which are appropriate qualifiers given the context, though the ground truth presents the numbers more definitively. The LLM's explanation of the economic mechanism (hedges worth less due to changes in fair value of hedged debt) adds helpful context beyond the ground truth without introducing inaccuracy. No calculation errors detected. All formatting is acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 426,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "\nBMY’s strategy explicitly calls for expanding its autologous CAR‑T pipeline and broadening the use of Breyanzi into additional hematologic indications (e.g., CLL, follicular lymphoma, mantle‑cell lymphoma). The 100 % jump in U.S. Breyanzi sales in 2023—driven by higher demand and the launch of new indications—demonstrates that this strategic push is already translating into stronger commercial performance, reinforcing the company’s focus on growing its CAR‑T portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. QUANTITATIVE ACCURACY: The LLM correctly identifies the 100% jump (doubling) in U.S. Breyanzi sales in 2023, which matches the ground truth statement of 'doubling of U.S. revenues for Breyanzi.' The percentage representation (100% jump) is mathematically equivalent to doubling and is an acceptable format variation. ENTITY ACCURACY: All entities are correctly identified - BMY (Bristol Myers Squibb), Breyanzi (the autologous CAR-T therapy), and the specific indications (CLL, follicular lymphoma/FL, mantle-cell lymphoma/MCL) are all accurately mentioned and match the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the connection between: (1) BMY's strategic focus on expanding the CAR-T pipeline, (2) the pursuit of new indications for Breyanzi, and (3) the resulting revenue doubling in 2023. The reasoning is sound and demonstrates proper understanding of cause-and-effect relationship. COMPLETENESS: The answer addresses all components of the question - the strategic focus, the specific indications being pursued, and the alignment with observed revenue growth. SEMANTIC EQUIVALENCE: The LLM's phrasing 'the launch of new indications' and 'higher demand' conveys the same meaning as the ground truth's 'pursuing new indications' and 'higher demand.' The statement that this 'demonstrates that this strategic push is already translating into stronger commercial performance' effectively captures the alignment concept requested in the question. MINOR OBSERVATION: The LLM adds slightly more explicit language about commercial performance translation, which enhances clarity without introducing inaccuracy. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 483,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "\nThe company spent **approximately $2.70 billion** of cash to acquire **The Binding Site Group** in 2023.  Together with the **$0.91 billion** used to acquire **CorEvitas, LLC**, this represented the entirety of the **$3.61 billion** of cash that was deployed for acquisitions during 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: The Binding Site Group acquisition at $2.70 billion, CorEvitas, LLC at $0.91 billion, and the total of $3.61 billion. The multi-hop synthesis is sound - the model correctly identified both acquisitions and accurately calculated/verified their combined contribution to total 2023 acquisition spending. The answer addresses all parts of the question: (1) the specific cash outflow for The Binding Site Group, (2) how it contributed to total acquisitions, and (3) the relationship with CorEvitas. The use of 'approximately' for $2.70 billion is appropriate and matches the ground truth's presentation. The phrasing 'represented the entirety of' effectively conveys that these two acquisitions comprised the total acquisition spending. Minor deduction from perfect score only because the ground truth uses slightly more direct language ('contributed to a total of') versus the LLM's 'represented the entirety of,' though both convey identical meaning. All entities are correctly identified (company names, year, metrics), and the reasoning chain is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 327,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "\nThe company expects the restructuring charges recorded in 2024 and 2023 to yield about **$0.2 billion of annual cost savings in 2024 and $0.6 billion of annual cost savings in 2023**, for a combined estimated yearly saving of **≈ $0.8 billion**.  \n\nThe 2023 acquisition of **The Binding Site Group**—a U.K. provider of specialty diagnostic assays and instruments—adds pioneering diagnostic technology for **blood‑cancer monitoring (notably multiple‑myeloma)** to the Specialty Diagnostics segment, expanding its portfolio and strengthening its strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $0.2 billion from 2024 charges, $0.6 billion from 2023 charges, totaling $0.8 billion in combined annual cost savings. The calculation is accurate and properly presented. ENTITY ACCURACY: The Binding Site Group is correctly identified as a 2023 acquisition, and the Specialty Diagnostics segment is properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct topics: (1) restructuring charges and their cost savings impact across two years, and (2) the strategic contribution of the acquisition to blood cancer diagnostics. The connection between The Binding Site Group's diagnostic assays/instruments and blood cancer monitoring (specifically multiple myeloma) is accurately conveyed. COMPLETENESS: Both parts of the multi-part question are thoroughly addressed. The answer explains both the quantitative cost savings and the qualitative strategic value of the acquisition. SEMANTIC EQUIVALENCE: The LLM's phrasing ('about $0.2 billion...and $0.6 billion...for a combined estimated yearly saving of ≈ $0.8 billion') is semantically equivalent to the ground truth statement. The description of The Binding Site Group as a 'U.K. provider of specialty diagnostic assays and instruments' adds helpful context without contradicting the ground truth. MINOR OBSERVATIONS: The use of '≈' symbol and 'notably' are stylistic choices that enhance clarity without introducing inaccuracy. The answer maintains factual fidelity while presenting information in a clear, organized manner.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 452,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "\nThe longest‑term debt security listed in Eli Lilly’s 2023 10‑K is the **1.375 % Notes due 2061**, which matures in 2061. This maturity date is later than all other debt instruments disclosed in the filing (e.g., the 1.125 % Notes due 2051, the 1.700 % Notes due 2049, the 1.625 % Notes due 2043, and the 6.77 % Notes due 2036). [Page 1]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The primary claim is correct - the 1.375% Notes due 2061 is indeed the longest-term debt instrument in Eli Lilly's 2023 10-K. The maturity year of 2061 is accurate. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the 1.375% coupon rate, the 2061 maturity year, and all comparative debt instruments listed (1.125% Notes due 2051, 1.700% Notes due 2049, 1.625% Notes due 2043, 6.77% Notes due 2036) are accurately cited with correct percentages and years. The comparison logic is sound - 2061 is indeed later than all other instruments mentioned. (3) ENTITY ACCURACY: Eli Lilly is correctly identified, the 2023 10-K filing is correctly referenced, and all debt instruments are properly named with accurate coupon rates and maturity dates. (4) MULTI-HOP REASONING: The answer successfully synthesizes information by identifying the longest-term instrument and then comparing it against multiple other debt instruments from the same filing, demonstrating proper multi-hop synthesis. (5) COMPLETENESS: The answer addresses both parts of the question - identifying the longest-term instrument AND comparing its maturity to others. The LLM provides more comparative examples than the ground truth (5 instruments vs. 3), which adds value without introducing errors. Minor note: The ground truth mentions 0.500% Notes due 2033, which the LLM does not include, but this is not an error - the LLM simply provided additional valid comparisons. The answer is well-structured and clearly presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 431,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "\nDonanemab is being pursued for **two distinct Alzheimer’s indications** – early‑stage disease (submitted for regulatory approval) and preclinical disease (Phase III). In contrast, Lebrikizumab is linked to **only one indication** (atopic dermatitis), which has already received approval in the EU and Japan and is currently under FDA review in the United States.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question. QUANTITATIVE ACCURACY: All numbers are correct - Donanemab: 2 indications (early Alzheimer's disease and preclinical Alzheimer's disease), Lebrikizumab: 1 indication (atopic dermatitis). The comparison is accurate: 2 > 1. COMPLETENESS: The answer addresses both parts of the question - the total number of distinct indications for Donanemab and how this compares to Lebrikizumab's approved/under-review indications. ENTITY ACCURACY: Both drug names are correct, indications are correctly identified, and regulatory statuses are accurate (EU/Japan approval for Lebrikizumab, FDA review for Lebrikizumab, Phase III for Donanemab preclinical indication). MULTI-HOP REASONING: The answer correctly synthesizes information across two different drugs and their respective development/approval statuses, then makes the appropriate comparison. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than the ground truth (e.g., 'early-stage disease (submitted for regulatory approval)' vs 'early Alzheimer's disease') but conveys the same factual information. The characterization of early Alzheimer's disease as 'submitted for regulatory approval' is a reasonable additional detail that doesn't contradict the ground truth. Minor note: The ground truth uses 'early Alzheimer's disease' while the LLM says 'early-stage disease' - these are semantically equivalent in context. The answer is clear, well-organized, and provides appropriate context about regulatory status.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 427,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "\nThe generic entry that followed the loss of exclusivity for Alimta caused a clear decline in Alimta‑related volume, shaving off some growth from the U.S. market.  Nonetheless, the overall U.S. volume still rose about 11 % in 2023, buoyed by strong uptake of other products—most notably the oncology drug **Verzenio**, which contributed positively to that volume growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Alimta's decline due to generic entry negatively impacted U.S. volume growth, (2) Verzenio is correctly identified as an oncology product that contributed positively to U.S. volume growth, and (3) the overall U.S. volume growth figure of ~11% in 2023 is accurate. The multi-hop reasoning is sound - the model synthesized that despite Alimta's decline, overall U.S. volume still grew due to other products. However, there is one notable omission: the ground truth specifically mentions Trulicity as another oncology product that contributed positively to U.S. volume growth alongside Verzenio. The LLM answer only mentions Verzenio and uses the phrase 'most notably' which could imply it was the primary contributor, but doesn't acknowledge Trulicity's contribution. This is a material omission since the question asks 'what other oncology product' (potentially plural) contributed positively. The quantitative accuracy is strong (11% figure is correct), and the qualitative reasoning about the offset between Alimta's decline and other products' growth is sound. The contextual relevance is appropriate - the answer directly addresses both parts of the multi-part question about impact and offsetting products.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 355,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "\nMerck has incurred a $250 million upfront payment (recorded in 2022 R&D) and will share all future development costs and any profits equally with Moderna on V940 (mRNA‑4157); its share of those costs is reflected in the $218 million R&D expense reported for 2023, with a $63 million receivable from Moderna for reimbursed research expenses.  This collaboration expands Merck’s immuno‑oncology pipeline by adding an mRNA‑based, personalized cancer vaccine that is combined with its flagship checkpoint inhibitor Keytruda, aligning with the company’s three‑pillar strategy of immuno‑oncology, precision‑molecular targeting and tissue‑targeting.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The $250 million upfront payment in 2022 is correctly identified and matches ground truth. (2) Equal cost-sharing arrangement with Moderna is accurately stated. (3) Correct identification of V940 (mRNA-4157) as an mRNA-based personalized cancer vaccine combined with Keytruda. (4) Proper contextualization within Merck's immuno-oncology strategy. (5) Multi-hop synthesis is sound - correctly links financial commitment to strategic positioning. (6) Breakthrough Therapy and PRIME designations are appropriately referenced in ground truth context.\n\nWEAKNESSES: (1) The LLM introduces specific 2023 R&D expense figures ($218 million) and a $63 million receivable that are NOT present in the ground truth answer. While these may be accurate filing details, they represent additional information not in the original answer and cannot be verified against the provided ground truth. (2) The LLM mentions specific trial names (INTerpath-001 and INTerpath-002) are absent from the LLM response, though ground truth includes these. (3) The LLM's reference to Merck's \"three-pillar strategy\" (immuno-oncology, precision-molecular targeting, tissue-targeting) is not mentioned in the ground truth, though it may be accurate from the 10-K. (4) The LLM provides more granular financial detail than ground truth but this creates verification challenges.\n\nQUANTITATIVE ACCURACY: The $250 million figure is correct. The additional figures ($218M, $63M receivable) cannot be contradicted by ground truth but also cannot be confirmed. The core financial commitment is accurate.\n\nQUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly synthesizes the financial commitment with strategic positioning. Entity identification is correct (Merck, Moderna, Keytruda, V940/mRNA-4157). The omission of specific trial names (INTerpath-001, INTerpath-002) represents incomplete coverage of ground truth details.\n\nCONTEXTUAL RELEVANCE: Highly relevant to the question about financial commitment and strategic alignment. The answer appropriately addresses both the financial and strategic dimensions of the partnership.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 569,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "\nMK‑7962’s U.S. patents are set to expire in 2037, while the standard 12‑year biologic data‑exclusivity would end in 2027; therefore the patent term can provide up to ten additional years of protection beyond the data‑exclusivity period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates sound multi-hop reasoning. Verification of key facts: (1) Patent expiration date of 2037 - CORRECT; (2) Standard 12-year biologic data exclusivity - CORRECT; (3) Anticipated approval year of 2027 - CORRECT (implied in LLM answer through the data exclusivity end date); (4) Additional protection calculation: 2037 minus 2027 = 10 years - CORRECT. The LLM successfully synthesized information across multiple data points: the patent term, the standard exclusivity period, and the implied approval timeline. The calculation is accurate and the logic is sound. Minor observation: The LLM answer is slightly more concise than the ground truth and doesn't explicitly state the 2027 approval year assumption, instead deriving it from the 12-year exclusivity period. However, this is a stylistic difference rather than a factual error. The semantic meaning is equivalent - both answers convey that MK-7962 could receive 10 additional years of patent protection beyond the standard 12-year data exclusivity period. All numeric values are correct, the multi-hop reasoning connecting patent expiration, data exclusivity, and additional protection is sound, and the answer directly addresses the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 353,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "\nThe NAV‑based fair value of Emerging‑Markets Equities in the pension plans rose from $133 million in 2022 ( $74 million U.S. + $59 million International ) to $146 million in 2023 ( $80 million U.S. + $66 million International ). Thus, the total increase in fair value across both plans was **$13 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and significantly underestimates the total increase. Critical errors: (1) WRONG NUMBERS: The LLM reports U.S. Emerging Markets Equities as $74M (2022) and $80M (2023), but ground truth shows $707M (2022) and $740M (2023) - a massive discrepancy of ~$630M. (2) INCOMPLETE ACCOUNTING: The LLM only accounts for direct Emerging Markets Equities holdings in International Pension Plans ($59M to $66M = $7M increase), but completely omits the Investment Funds category which also contains Emerging Markets Equities ($111M in 2022 to $110M in 2023). (3) WRONG TOTAL INCREASE: LLM calculates $13M total increase, but ground truth is $106M. The correct calculation should be: U.S. increase of $33M + International direct holdings increase of $7M + Investment Funds change of -$1M = $39M, or if counting the full International picture differently, $33M + $73M = $106M. (4) INCOMPLETE SYNTHESIS: The LLM failed to identify and synthesize all components of Emerging Markets Equities across both pension plan types and investment categories. The answer demonstrates a fundamental misunderstanding of the pension plan structure and the various investment categories that contain Emerging Markets Equities exposure. The multi-hop reasoning required to combine U.S. plans, International direct holdings, and Investment Funds was not properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 383,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "\nThe estimated fair value of GILD’s U.S. government‑agency securities rose from **$35 million** at the end of 2022 to **$127 million** at the end of 2023, an increase of **$92 million**. In the same period, the fair value of U.S. Treasury securities grew from **$410 million** to **$426 million**, a **$16 million** rise. Consequently, the agency‑security increase was about five‑times larger than the Treasury‑security increase.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that make it fundamentally incorrect: (1) U.S. government agencies securities: LLM states the 2022 value was $35 million (WRONG - should be $21 million) and calculates a $92 million increase (WRONG - should be $106 million). The 2023 value of $127 million is correct. (2) U.S. Treasury securities: LLM states the 2022 value was $410 million (WRONG - should be $379 million) and the change was a $16 million increase (WRONG - should be a $47 million increase from $379M to $426M). The ground truth states Treasury securities DECREASED by $34 million, but the LLM incorrectly reports an increase. (3) The comparison is fundamentally flawed: LLM claims agency securities increase was 'about five-times larger' than Treasury increase, but this comparison is based on incorrect numbers. The correct comparison should note that agency securities appreciated significantly while Treasury securities actually declined. (4) The LLM failed to correctly synthesize the multi-hop information across both security types and years. While the answer addresses the question structure and identifies the correct company (GILD) and time period, the numerical errors are severe and pervasive, affecting every key calculation and comparison in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 362,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "\nBiktarvy’s revenue grew 14 % year‑over‑year, reaching $11.85 billion in 2023 versus $10.39 billion in 2022, driven by higher demand and pricing. Its U.S. and EU patents expire only in 2033, so the drug still enjoys strong protection, but with other flagship HIV products (e.g., Genvoya, Stribild) facing patent cliffs in 2029‑2032, Gilead must lean on Biktarvy’s continued growth and its broader oncology, cell‑therapy and new‑viral‑disease pipeline to preserve long‑term financial momentum once those earlier patents lapse.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop reasoning. QUANTITATIVE VERIFICATION: All numbers are correct - Biktarvy 2023 revenue of $11.85 billion ($11,850 million), 2022 revenue of $10.39 billion ($10,390 million), and the 14% YoY growth calculation are all accurate. The patent expiration date of 2033 for U.S. and EU patents is correctly stated. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) revenue performance comparison between 2023 and 2022, (2) growth rate, and (3) implications for Gilead's long-term financial strategy. ENTITY ACCURACY: All entities are correctly identified - Biktarvy, Gilead, Genvoya, Stribild, and the relevant time periods. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions: connects Biktarvy's strong growth to patent protection timeline, identifies the strategic challenge posed by earlier patent expirations (2029-2032 for other products), and logically concludes that Gilead must leverage Biktarvy's momentum while developing pipeline alternatives (oncology, cell-therapy, new viral diseases). This reasoning is sound and goes beyond the ground truth by providing additional strategic context. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth while adding valuable strategic detail about competing patent cliffs and portfolio diversification. Minor enhancement: The LLM provides more specific strategic guidance (mentioning oncology and cell-therapy pipelines) which adds value without contradicting the ground truth. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 453,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "\nThe loss of U.S. exclusivity for Truvada in 2023 will sharply cut the product’s revenue and related cash‑flow, and because Gilead operates through a single, centrally‑managed segment, that cash can no longer be earmarked for “lifecycle‑management” spending on the ageing HIV franchise.  Consequently, the company is likely to re‑allocate the constrained funds toward higher‑margin or pipeline assets (e.g., newer HIV regimens such as Biktarvy or Descovy) while scaling back discretionary initiatives that do not directly support future growth.  This fiscal tightening could limit the resources available for marketing, formulation work, or other post‑expiration extensions of the Truvada/HIV portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop financial reasoning required. STRENGTHS: (1) Correctly identifies the 2023 patent expiration date for Truvada; (2) Accurately describes the single operating segment structure and its implications for centralized resource allocation; (3) Properly synthesizes the causal chain: patent expiration → revenue loss → constrained cash flow → reallocation of resources; (4) Appropriately names specific newer HIV products (Biktarvy, Descovy) as likely beneficiaries of reallocated resources; (5) Correctly identifies lifecycle management initiatives as discretionary spending that could be scaled back; (6) Sound logic on the fiscal tightening impact. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer is somewhat more speculative/prescriptive ('likely to re-allocate') compared to the ground truth's more measured language ('may constrain'); (2) The ground truth explicitly mentions 'unless offset by cost reallocations or revenue from newer products' as a qualifier, while the LLM assumes reallocation will occur; (3) The LLM could have been slightly more explicit about the 'unless offset' caveat that appears in the ground truth. QUANTITATIVE VERIFICATION: The 2023 date is correct. No specific dollar amounts are provided in either answer, so no calculation errors exist. MULTI-HOP REASONING: Excellent synthesis across three key elements: (1) Gilead's organizational structure, (2) Truvada's patent expiration impact, (3) implications for lifecycle management investment. The reasoning chain is logical and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth, with slightly more specific detail about reallocation strategy and product examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 481,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "\nThe 2023 IDA agreement forced Schwab to manage its capital so that it could sustain the off‑balance‑sheet sweep of certain brokerage client deposits and to forecast capital needs for future migrations of those balances; the agreement also created contract‑asset balances that are amortized straight‑line over the remaining contractual term as a reduction of bank‑deposit fee revenue.  In 2023 the amortization expense recorded for those contract assets—i.e., the amortization associated with the 2023 IDA agreement—was **$85 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative accuracy is perfect: the $85 million amortization figure is correct and matches the ground truth exactly. The answer correctly identifies that the 2023 IDA Agreement allowed Schwab to sweep brokerage client deposits off-balance sheet, supporting capital management strategy. The explanation of contract assets being amortized straight-line over the contractual term as a reduction to bank deposit fee revenue is accurate and semantically equivalent to the ground truth. The multi-hop reasoning is sound—the answer synthesizes the capital management impact with the specific amortization mechanics and provides the requested dollar amount. Minor observation: The LLM answer uses slightly different phrasing ('forced Schwab to manage' vs. 'allowed Schwab to sweep'), but this is a semantic variation that doesn't affect factual accuracy. The ground truth mentions the $85 million figure is 'included in the broader amortization of capitalized contract costs,' while the LLM more directly attributes the $85 million to the 2023 IDA agreement specifically. However, the LLM's interpretation is reasonable and consistent with the ground truth's statement that the specific dollar amount was $85 million. All entities (Schwab, TD Depository Institutions, 2023, IDA Agreement) are correctly identified. The answer is complete, addressing both the capital management strategy impact and the specific amortization dollar amount requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 420,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "\nThe 2023 equity schedule (page 95) shows that the Operating Partnership added 14,739 LTIP performance units and 50,658 additional unit equivalents, but it also redeemed 114,241 limited‑partner units, purchased 1,273,733 treasury units and paid out $2.8 bn in distributions.  These offsetting movements left total consolidated equity at $3.49 bn at the end of 2023, down about $120 million from the $3.61 bn reported at the end of 2022.  (Pages 95‑96 of the 2023 10‑K).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately address the question. Key issues: (1) QUANTITATIVE ERRORS: The ground truth specifies LTIP units added $14,739 (in thousands, implying $14.739M), limited partner unit issuances added $197,426, redemptions reduced equity by $13,524, and treasury purchases reduced equity by $140,593, with a net reduction of $139,378. The LLM answer cites '14,739 LTIP performance units' and '50,658 additional unit equivalents' as unit counts, not dollar amounts, which is a category error. The LLM mentions '114,241 limited-partner units redeemed' and '1,273,733 treasury units purchased' - these unit counts don't match the ground truth's dollar impact figures ($13,524 and $140,593 respectively). (2) MISSING KEY INFORMATION: The LLM completely omits the $197,426 issuance of limited partner units, which is a major component of the ground truth answer. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that these are offsetting movements and provides an ending equity balance ($3.49B vs $3.61B), it fails to synthesize the specific unit-related equity impacts that the question asks about. (4) CALCULATION VERIFICATION: The ground truth shows net reduction of $139,378 from unit activities. The LLM provides an overall equity decline of ~$120M but doesn't break down the unit-specific impacts. (5) CONTEXTUAL ISSUE: The LLM adds information about $2.8B in distributions, which while relevant to equity changes, wasn't part of the ground truth answer's focus on LTIP units and unit issuances specifically. The answer conflates unit counts with dollar amounts and misses critical equity impact figures from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 463,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "\nLinde supplies process gases to on‑site customers under long‑term “total‑requirement” contracts—typically 10‑20 years with minimum purchase volumes and price‑escalation clauses—so the performance obligation is satisfied continuously as the gas is delivered and the company gains the right to invoice. Accordingly, revenue is recognized over time (rather than at a single point) as product is delivered, with any variable pricing elements constrained by the contract terms, which is precisely the accounting treatment described in Note 19 (Revenue Recognition) and the segment discussion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—contract duration (10-20 years), minimum purchase requirements, and price escalation provisions are all accurately stated. No calculations are required for this question, and all numbers match the ground truth. ENTITY ACCURACY: Linde is correctly identified, and the specific accounting treatment (revenue recognition over time, total-requirement contracts) is accurately described. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) how on-site plant distribution influences contract structure (long-term, 10-20 years, minimum purchases, price escalation), (2) how this influences revenue recognition policy (over time as delivered, right to invoice), and (3) the alignment between distribution method and accounting treatment. REASONING QUALITY (9/10): The LLM correctly synthesizes the relationship between operational distribution practices and accounting policies. The explanation that revenue is recognized over time as product is delivered, with the right to invoice, directly connects the operational reality (continuous pipeline delivery) to the accounting treatment. The reference to Note 19 (Revenue Recognition) and segment discussion adds appropriate specificity. SEMANTIC EQUIVALENCE: The LLM's phrasing ('performance obligation is satisfied continuously,' 'variable pricing elements constrained by contract terms') conveys the same meaning as the ground truth while using slightly more technical accounting language. This is appropriate and demonstrates understanding. MINOR OBSERVATION: The LLM provides slightly more technical detail (mentioning 'variable pricing elements constrained by contract terms') than the ground truth, but this is additive and not contradictory. The answer is comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 521,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "\nThe fair‑value of corporate notes and obligations fell from **$3,354 million** at January 31 2023 to **$2,978 million** at January 31 2024, a **$376 million decrease**.  \nOver the same period the total marketable‑securities fair value rose only **$230 million** (from $5,492 million to $5,722 million).  \nThus, the decline in corporate notes exceeds the overall increase in total marketable securities, outweighing the net gain across all categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - corporate notes decreased from $3,354M to $2,978M (difference of $376M), total marketable securities increased from $5,492M to $5,722M (difference of $230M). All calculations are accurate. Dates are correctly identified as January 31, 2023 and January 31, 2024. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the difference in corporate notes fair value ($376M decrease), (2) the overall change in total marketable securities ($230M increase), and (3) the comparison between these two changes. MULTI-HOP REASONING: The synthesis is sound - the model correctly identifies that while corporate notes declined significantly ($376M), the overall portfolio increased ($230M), and properly concludes that the decline in one category exceeded the net gain across all categories. This demonstrates correct cross-document/cross-table synthesis. ENTITY ACCURACY: All metrics and time periods are correctly identified. SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical information. The LLM uses 'fell' instead of 'decreased' and 'rose' instead of 'increased,' but these are semantically equivalent. The phrase 'outweighing the net gain' effectively captures the comparative relationship. Minor: The ground truth uses slightly more neutral language ('saw a significant decline' vs 'fell'), but both convey the same meaning. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 423,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "\nChanging provider behavior—such as hospitals seeking to maintain revenue amid economic pressure—can shift utilization and cost trends in ways that were not anticipated, making the forecasts of medical‑cost trends used to set premiums less accurate. Because premiums are locked in for a fixed (typically 12‑month) period, any underestimate of costs cannot be recovered, so forecast errors directly compress margins and can materially degrade the segment’s operating results.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism: changing provider behavior increases medical costs, making forecasts less accurate, and because premiums are fixed during the premium period, forecast errors directly impact operating results. The reasoning is sound and the multi-hop synthesis is appropriate.\n\nHowever, there is a significant omission: The original answer specifies that Insured Health Care Benefits products comprise 94% of Health Care Benefits segment revenues, which is a critical quantitative detail that contextualizes why this issue is material to the segment. The LLM answer does not include this percentage, which is a notable gap in completeness.\n\nThe LLM answer correctly conveys that: (1) provider behavior affects cost trends and forecast accuracy, (2) premiums are locked in for a fixed period (correctly noting typically 12 months), (3) forecast errors cannot be recovered and compress margins, and (4) this materially degrades operating results. These are all accurate and well-reasoned.\n\nThe LLM answer uses slightly different phrasing (\"shift utilization and cost trends\" vs. \"hospitals and providers attempting to maintain revenue levels\") but conveys the same concept. The phrase \"compress margins\" is semantically equivalent to \"significantly affect operating results.\"\n\nThe main weakness is the omission of the 94% revenue composition metric, which is a quantitative fact that strengthens the argument about materiality. This is a factual omission rather than an error, but it reduces completeness. The reasoning and logic are sound, and the answer demonstrates good understanding of the multi-hop relationship between provider behavior, forecast accuracy, fixed premiums, and operating results.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 477,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "\nThe October 2020 purchase of Noble Energy added roughly 6,000 cubic feet of natural‑gas production for every barrel of crude‑oil equivalent, boosting upstream volumes and cash flow.  That extra production helped keep Chevron’s net‑debt ratio falling from 22.7 % in 2020 to 15.6 % in 2021 and lifted the interest‑coverage ratio to 29 ×, preserving a very low‑leverage profile that underpins S&P’s AA‑ and Moody’s Aa2 ratings even during periods of weak commodity prices.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the October 2020 Noble acquisition and the 6,000 cubic feet of natural gas per barrel of crude oil equivalent metric. It also correctly states Chevron's debt ratings (AA- by S&P and Aa2 by Moody's). However, there are significant quantitative accuracy issues: (1) The LLM introduces specific financial metrics (net-debt ratio falling from 22.7% in 2020 to 15.6% in 2021, and interest-coverage ratio of 29×) that are NOT present in the ground truth answer and cannot be verified from the provided context. These appear to be fabricated or hallucinated numbers. (2) The ground truth answer does not mention these specific ratios or their changes year-over-year. The LLM has added unsourced quantitative claims that, while plausible-sounding, represent a factual error in the context of this evaluation. On the positive side: The LLM correctly explains the mechanism (expanded production → increased cash flow → stronger financial profile), properly identifies the connection between production capacity and debt ratings, and maintains semantic equivalence with the core reasoning. The qualitative reasoning about how additional production supports credit ratings is sound. However, the introduction of unverified financial metrics significantly undermines the answer's reliability. The answer goes beyond the ground truth by adding specific numerical support, but these numbers lack verification and constitute a material factual error. This is a case where the LLM attempted to strengthen the answer with concrete metrics but did so by introducing potentially false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 440,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "\nSchwab spent **$249 million** in market‑based fees to buy down **$5.0 billion** of fixed‑rate obligation amounts under the 2023 IDA agreement. This expenditure was **capitalized as a contract asset** and recorded in **“Other assets”** on the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative facts are correct: $249 million spent, $5.0 billion of fixed-rate obligations bought down, and the 2023 IDA agreement correctly identified. The classification on the consolidated balance sheet is accurate: capitalized as contract assets and included in other assets. The LLM answer adds helpful context by specifying 'market-based fees,' which provides additional clarity about the nature of the expenditure, though this detail is not explicitly required by the question. The multi-hop reasoning is sound - the answer correctly synthesizes the spending amount, the obligation amount, the agreement type, and the balance sheet classification. The wording differs slightly from the ground truth (e.g., 'market-based fees' is added, and phrasing is slightly different) but the semantic meaning is identical and all core information matches perfectly. No calculation errors, no missing entities, and no factual inaccuracies detected. The answer fully addresses both parts of the question: how much was spent and how it was classified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 314,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "\nCVS recorded a **$483 million store‑impairment charge** in 2024 as part of its enterprise‑wide restructuring plan.  That initiative is expected to deliver **more than $500 million in cost savings beginning in 2025**, meaning the impairment expense is slightly lower than the projected annual savings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth. The $483 million store impairment charge for 2024 is correct, and the 'more than $500 million' in projected 2025 cost savings is accurate. (2) QUANTITATIVE ACCURACY: Both dollar amounts are precisely correct with no calculation errors. The comparison statement that 'the impairment expense is slightly lower than the projected annual savings' is mathematically sound ($483M < $500M+). (3) QUALITATIVE ACCURACY: The LLM correctly identified all entities (CVS, 2024 impairment charges, 2025 savings projections) and properly synthesized the multi-hop information by connecting the restructuring plan to both its immediate costs and future benefits. The reasoning is logical and sound. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question - the specific impairment charge amount and the comparison to expected savings. The phrasing 'beginning in 2025' appropriately captures the timing of the savings. Minor note: The LLM uses 'more than $500 million' while ground truth says 'over $500 million' - these are semantically equivalent phrasings. The answer is slightly more concise than the ground truth but loses no material information and actually improves clarity by directly stating the comparison in the final clause.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 384,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "\nChevron’s equity‑method earnings from Angola LNG Limited are not shown in the excerpted 10‑K pages; the most recent figures disclosed are a $(166 million) loss for 2020 and a $(26 million) loss for 2019, with a $2.18 billion investment recorded at year‑end 2021.  This indicates that, while Chevron holds a sizable stake in Angola’s LNG project, its contribution to earnings is modest and has been negative in recent years, underscoring a limited financial impact despite its strategic presence in the Angolan LNG market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides the WRONG YEAR for the primary data point. The ground truth clearly states Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021. The LLM incorrectly attributes the -$166 million loss to 2020, not 2021, which is a fundamental factual error that directly contradicts the question and ground truth. The LLM also states it cannot find 2021 figures in the excerpted pages, yet the ground truth confirms -$166 million for 2021 exists. Additionally, the LLM provides 2019 data (-$26 million) that was not requested and is not part of the ground truth answer. The LLM does correctly identify the $2.18 billion investment at year-end 2021, but this is secondary information. The LLM's reasoning about 'modest' contribution and 'limited financial impact' is somewhat speculative and doesn't directly address what the -$166 million loss indicates about Chevron's involvement in Angola's LNG market. The ground truth specifically mentions the 36.4% stake and connects the loss to challenges in liquefaction and processing, which the LLM fails to include. The core answer to the question - what was the 2021 equity in earnings - is answered incorrectly (attributed to 2020 instead of 2021), making this a major failure in multi-hop synthesis and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 368,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "\nThe mismatch means that Duane Arnold’s fuel‑supply contracts expire in 2033 while the plant’s de‑commissioning is not expected to be finished until about 2080, creating a risk that NEER will have to keep the reactor operating—or arrange costly extensions—just to burn the remaining fuel, and then manage spent‑fuel storage and disposal well beyond the contract period; this can lead to unplanned outages, higher operating and storage expenses, and potential regulatory or financial penalties if the timeline cannot be met.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key dates: fuel supply contracts expiring in 2033 and decommissioning expected through 2080, matching the ground truth. (2) The numeric values are accurate - no calculation errors. (3) The answer appropriately identifies this as a planning/operational risk. (4) The contextual relevance is good - the answer addresses the mismatch between contract expiration and long-term obligations.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM introduces a speculative risk ('keep the reactor operating...just to burn the remaining fuel') that is not supported by the ground truth. The original answer does not suggest the reactor would need to continue operating - it focuses on fuel supply contracts for an already-decommissioning facility. This represents a material mischaracterization of the operational risk. (2) The LLM mentions 'unplanned outages' which is not relevant to a decommissioning facility and suggests operational continuation rather than decommissioning management. (3) MISSING KEY DETAIL: The ground truth specifically mentions 'spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession' - this critical context about dry storage and DOE responsibility is absent from the LLM answer. (4) The LLM's framing around 'arrange costly extensions' and 'keep the reactor operating' diverges from the ground truth's focus on securing alternative fuel sources or storage solutions for spent fuel management. (5) The reasoning about 'regulatory or financial penalties if the timeline cannot be met' is vague compared to the ground truth's more specific concern about 'increased operational costs, regulatory scrutiny, or additional capital expenditures to maintain safe storage.'\n\nMULTI-HOP REASONING: The LLM does synthesize the relationship between the two timelines (2033 vs 2080), but the synthesis leads to an incorrect operational scenario (continued reactor operation) rather than the correct scenario (spent fuel storage management during decommissioning).\n\nOVERALL: While the LLM captures the basic temporal mismatch and identifies it as a risk, it fundamentally mischaracterizes the nature of the operational risk by suggesting reactor operation continuation rather than focusing on spent fuel management during decommissioning. This is a material error in understanding the operational context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 639,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "\nLinde records revenue from its on‑site industrial‑gas contracts over time as product is delivered and the company can invoice the customer, giving a relatively stable, predictable earnings stream.  By contrast, the Amur GPP project—now lawfully suspended under sanctions and carrying a $0.7 bn contingent liability for damages and lost‑profit claims—shows that Linde’s engineering contracts can generate large, uncertain financial obligations that may far exceed the modest, incremental revenue from on‑site sales.  This contrast reveals that while long‑term on‑site agreements pose limited upside risk, the company’s broader exposure to major engineering projects introduces significant contingent‑liability risk that can materially affect its financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $0.7 billion contingent liability for the Amur GPP project; (2) Accurately characterizes revenue recognition for on-site contracts as occurring over time as product is delivered with invoice-based recognition; (3) Properly contrasts the stable, predictable nature of on-site contracts with the uncertain, large obligations from engineering projects; (4) Correctly notes that contracts are suspended due to sanctions; (5) Effectively synthesizes the financial risk comparison across both contract types. MINOR WEAKNESSES: (1) The original answer provides more specific context about contract duration (10-20 years) and minimum purchase requirements, which the LLM omits; (2) The original answer explicitly mentions 'multiple stakeholders and geopolitical exposure' as contributing factors to risk, while the LLM references 'sanctions' but less comprehensively addresses the geopolitical dimension; (3) The LLM states on-site agreements pose 'limited upside risk' which is slightly different framing than the original's emphasis on 'steady revenue' with 'latent risks'—this is a minor semantic difference but the original is more nuanced about the risk-reward profile. QUANTITATIVE VERIFICATION: The $0.7 billion figure is correct and properly formatted. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions: (1) Amur GPP contingent liability and suspension, (2) on-site contract revenue recognition policies, and (3) comparative financial risk exposure. The logical flow connecting these elements is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the complex question and maintains appropriate focus on financial risk exposure as the central theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 517,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "\nThe company records advertising revenue on a **gross basis**—the full amount billed to advertisers is recognized as revenue—while payments to Google Network partners under traffic‑acquisition costs (TAC) are treated as **cost of revenues**. Because the expected shift toward more mobile and international traffic increases the share of ad inventory that must be shared with partners, the anticipated rise in TAC will be booked as a higher expense, directly compressing the margin on the gross advertising revenue even though the gross revenue figure itself is unchanged. In short, higher TAC reduces the net contribution of advertising revenue and lowers gross‑margin profitability, even though it does not alter the amount of gross advertising revenue that is recognized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the gross advertising revenue recognition model and TAC's impact on margins. STRENGTHS: (1) Correctly identifies that Google records advertising revenue on a gross basis with full amounts billed to advertisers recognized as revenue; (2) Accurately explains that TAC payments to partners are treated as cost of revenues; (3) Properly synthesizes the multi-hop relationship: device/geographic mix shifts → higher TAC → increased cost of revenues → compressed gross margins; (4) Correctly notes that higher TAC reduces net contribution and lowers gross-margin profitability without altering the gross revenue figure itself; (5) Accurately identifies the key drivers (mobile/international traffic shifts) that increase partner payment obligations. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than the ground truth (e.g., 'mobile and international traffic' vs. the ground truth's broader mention of 'device mix, geographic mix, and partner mix'), but this is semantically equivalent and actually more specific; (2) The ground truth mentions 'partner agreement terms' as a factor, which the LLM answer doesn't explicitly state, though this is a minor omission that doesn't affect the core explanation; (3) No quantitative data is provided in either answer (no specific dollar amounts or percentages), which is appropriate given the question's focus on the conceptual relationship rather than specific numbers. The LLM answer effectively explains the causal chain and financial statement impact with clear logic and accurate accounting principles. The explanation of how gross revenue remains unchanged while gross margin compresses is particularly well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 474,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "\nAll of the ARO that Duke Energy carries for coal‑ash impoundment closure is shaped by the Coal Ash Act (and the EPA’s CCR rule), because the closure method and timetable must be approved under that state legislation and must comply with its standards; consequently the liability is adjusted as the approved closure plan evolves. In the company’s disclosures the ARO is reported as a single aggregated balance, but the entire amount is contingent on compliance with the Coal Ash Act.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core relationship between Duke Energy's ARO for coal ash impoundment closure and the Coal Ash Act. STRENGTHS: (1) Correctly identifies that the ARO is directly influenced by compliance with the Coal Ash Act and EPA's CCR rule; (2) Accurately describes that closure methods and timetables must comply with regulatory standards; (3) Correctly notes that the liability adjusts as approved closure plans evolve; (4) No quantitative errors or incorrect numbers/dates; (5) Properly synthesizes the multi-hop relationship between regulation, closure methods, and ARO amounts. MINOR WEAKNESSES: (1) The LLM states 'all of the ARO' is shaped by the Coal Ash Act, which is slightly stronger language than the ground truth's 'directly influenced by compliance.' The ground truth emphasizes that the ARO 'is based on estimated closure costs for impacted ash impoundments under this regulation' without explicitly stating 100% of the ARO is contingent on it; (2) The LLM mentions 'state legislation' which could be slightly misleading since the Coal Ash Act is federal legislation (though states do implement it), whereas the ground truth references 'state and federal regulations' more broadly; (3) The ground truth explicitly mentions specific closure methods (excavation and relocation to lined landfill or beneficial reuse) which the LLM does not include, though this is a minor omission. SEMANTIC EQUIVALENCE: The LLM's statement that 'the entire amount is contingent on compliance with the Coal Ash Act' is semantically very close to the ground truth's description of how the ARO is determined by closure methods and timetables under the regulation. The reasoning is sound and the multi-hop synthesis is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 479,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "\nThe fair value of Mortgage‑Backed Obligations increased from **$178 million** as of January 31 2023 to **$236 million** as of January 31 2024, representing a **$58 million** rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer has the direction of change completely reversed. The ground truth states that fair value DECREASED from $236 million to $178 million (a $58 million decrease). The LLM answer incorrectly states the fair value INCREASED from $178 million to $236 million (a $58 million increase). While the LLM correctly identified the $58 million magnitude of change and the correct dollar amounts, it reversed which value corresponds to which time period and therefore inverted the direction of the change from a decrease to an increase. This is a fundamental factual error that contradicts the ground truth answer. The question asks for 'the total change' between two tables, and the LLM failed to correctly identify which table contained which value and therefore mischaracterized whether the change was positive or negative. The dates mentioned (January 31, 2023 and January 31, 2024) appear reasonable for a 2023 10-K filing, but the assignment of values to dates is incorrect. This represents a major failure in multi-hop reasoning and data synthesis from the source tables.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 312,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "\nIn 2023, “other developed markets” accounted for roughly 5 percent of Danaher’s Diagnostics segment sales. The company classifies this category as the specific geographic regions of **Japan, Australia, and New Zealand**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: The answer correctly identifies that 'other developed markets' represented 5% of Danaher's Diagnostics segment sales in 2023, matching the ground truth exactly. The geographic regions are correctly identified as Japan, Australia, and New Zealand. (2) QUANTITATIVE ACCURACY: The percentage figure of 5% is precise and matches the ground truth. No calculations were required for this question, and the numeric data provided is accurate. (3) QUALITATIVE ACCURACY: The LLM properly synthesized the multi-part question by addressing both components: (a) the percentage attribution and (b) the specific geographic regions. The reasoning is sound and the entity identification (Danaher, Diagnostics segment, 2023) is correct. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'roughly 5 percent' is semantically equivalent to the ground truth's '5%' - the use of 'roughly' is appropriate given the context of reporting percentages. The formatting with bold text for the regions enhances clarity without changing factual content. (5) COMPLETENESS: All parts of the multi-part question are addressed comprehensively. Minor note: The LLM uses 'roughly' which could be interpreted as introducing slight uncertainty, but this is a negligible stylistic choice that doesn't affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 375,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "\nIn 2021 the Bulk category contributed **$6.656 billion** in freight revenue. This amount reflects **2.014 million carloads** (2,014 thousand carloads) at an **average revenue of $3,305 per car**, yielding the $6.656 billion total.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that make it substantially incorrect: (1) CARLOAD VOLUME ERROR: The LLM states 2.014 million carloads (2,014 thousand), but the ground truth shows 1,920,000 carloads. This is a significant discrepancy of 94,000 carloads or ~4.9% higher than actual. (2) REVENUE PER CAR ERROR: The LLM claims $3,305 per car, but the ground truth specifies $3,467 per car. This is a $162 per car understatement (~4.7% lower). (3) CALCULATION VERIFICATION: Ground truth calculation: 1,920,000 × $3,467 = $6,656,270,000 ($6.656 billion). LLM's stated numbers: 2,014,000 × $3,305 = $6,656,270,000. While the LLM's final dollar amount ($6.656 billion) matches the ground truth total, this appears to be coincidental - the underlying carload volume and per-car revenue figures are both incorrect. The LLM used wrong inputs that happened to produce the correct output through mathematical compensation. (4) MULTI-HOP REASONING: The question requires synthesizing carload volume and average revenue per car to calculate total revenue. The LLM attempted this synthesis but used incorrect source data. (5) ENTITY ACCURACY: Union Pacific Railroad and 2021 are correctly identified. The Bulk category is correctly identified. The fundamental issue is that the specific metrics (1,920,000 carloads and $3,467/car) were not correctly retrieved or synthesized from the source documents. The answer demonstrates partial understanding of the calculation methodology but fails on factual accuracy of the input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 423,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "\nThe settlement reduces Duke Energy’s undiscounted estimate for permanently closing all coal‑ash basins in North Carolina and South Carolina to roughly **$8 billion–$9 billion**.  This is about **$1.5 billion lower** than the company’s original projection of **$9.5 billion–$10.5 billion** that it had calculated after the April 1, 2019 closure determination.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. QUANTITATIVE VERIFICATION: All dollar amounts are correct - the post-settlement estimate of $8 billion-$9 billion matches the ground truth exactly, the original estimate of $9.5 billion-$10.5 billion is accurate, and the reduction of approximately $1.5 billion is correctly calculated (difference between the ranges). The date reference to April 1, 2019 closure determination is accurate. COMPLETENESS: The answer addresses both parts of the question - it provides the total estimated undiscounted cost after settlement AND explains how this reflects a reduction from the initial estimate. ENTITY ACCURACY: Duke Energy is correctly identified, the geographic scope (North Carolina and South Carolina) is correct, and the settlement with NCDEQ is properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - connecting the settlement agreement outcome to the prior estimate and demonstrating the relationship between them. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than the ground truth (e.g., 'roughly' instead of 'approximately', 'about $1.5 billion lower' instead of 'a reduction of approximately $1.5 billion') but conveys identical meaning. The use of em-dashes and formatting is a minor stylistic choice that doesn't affect accuracy. No calculation errors are present, and all factual claims are verifiable against the ground truth. The only minor distinction is that the LLM uses 'roughly' and 'about' which are slightly less precise than 'approximately,' but this is a negligible semantic difference that doesn't impact the factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 472,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "\nMastercard paid **$325 million** in cash to acquire Dynamic Yield LTD in 2022 and **$2.7 billion** in cash to acquire Recorded Future in 2024, for a combined cash outlay of roughly **$3.0 billion**.  \n\nThis spending underscores Mastercard’s acquisition strategy of growing and diversifying its business by adding complementary capabilities—such as AI‑driven personalization (Dynamic Yield) and real‑time threat‑intelligence (Recorded Future)—that expand its value‑added services and strengthen its broader payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All financial figures are correct - Dynamic Yield LTD acquisition at $325 million in 2022, Recorded Future at $2.7 billion in 2024, and the combined total of $3.025 billion (presented as 'roughly $3.0 billion' which is an acceptable rounding). All dates are accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the specific cash consideration amounts for both acquisitions, and (2) the strategic rationale behind these acquisitions. ENTITY ACCURACY: All company names, years, and acquisition details are correctly identified. MULTI-HOP REASONING: The LLM successfully synthesized information across two separate acquisitions (2022 and 2024) and correctly calculated the combined total. The strategic analysis appropriately connects both acquisitions to Mastercard's broader business strategy. SEMANTIC EQUIVALENCE: The LLM's description of the strategic intent ('growing and diversifying its business by adding complementary capabilities') matches the ground truth's characterization. The specific technologies mentioned (AI-driven personalization for Dynamic Yield, threat intelligence for Recorded Future) are accurate and relevant. MINOR NOTES: The LLM uses 'roughly $3.0 billion' instead of the precise '$3.025 billion,' but this is a reasonable rounding that doesn't constitute an error. The presentation is clear and professional. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 409,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "\nThe pension‑plan schedule lists International bonds with a fair‑value of **$341 million** (Level 1 $3 M, Level 2 $338 M), whereas the other post‑retirement benefit plan schedule reports International bonds at **$12 million** (Level 1 $10 M, Level 2 $2 M). Both tables treat International bonds as a separate line within Fixed‑income securities, but the pension‑plan disclosure presents them as a distinct asset category with a Level 2 breakdown, while the post‑retirement schedule includes them under Fixed‑income securities with a much smaller amount and only Level 1/Level 2 designations, reflecting a different categorization and level of detail.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that do not match the ground truth at all. Ground truth states: Total fair value of International bonds = $540 million ($12M + $528M), with first table showing $9M Level 1 and $3M Level 2, and second table showing $10M Level 1 and $518M Level 2. The LLM answer reports: $341 million in pension-plan schedule (Level 1 $3M, Level 2 $338M) and $12 million in post-retirement schedule (Level 1 $10M, Level 2 $2M), totaling $353 million instead of $540 million. This is a critical error - the LLM has provided completely different numbers for both tables. The LLM correctly identifies that there are two tables with different categorizations and attempts to describe the structural differences, but the quantitative foundation is entirely wrong. The LLM appears to have confused or misread the actual fair values from the source documents. The reasoning about categorization differences is somewhat sound in structure, but is built on incorrect numerical data. Multi-hop synthesis failed because the LLM did not correctly extract and combine the values from both tables. This is a major factual error that makes the answer unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 335,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "\nMastercard’s real‑time account‑based payments platform creates a globally distributed clearing and settlement backbone that enables instant, data‑rich transfers between bank accounts, supporting the routing, clearing and settlement of both domestic and cross‑border activity at scale. The network switches approximately 70 % of all Mastercard‑ and Maestro‑branded card transactions, and this includes nearly all cross‑border transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The critical metric of '70%' is correctly stated in both answers, and the characterization of 'nearly all cross-border transactions' matches precisely. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Mastercard, Maestro, and the payment infrastructure are all correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question - (1) how the infrastructure supports operations and (2) what portion of transactions it handles for domestic and cross-border activity. SEMANTIC EQUIVALENCE: The LLM uses slightly more technical language ('globally distributed clearing and settlement backbone,' 'data-rich transfers,' 'routing, clearing and settlement') compared to the ground truth's simpler phrasing ('instant payments between bank accounts with enhanced data and messaging capabilities'), but the core meaning is semantically equivalent and arguably more detailed. Both convey that the infrastructure enables instant, data-enhanced payments across domestic and cross-border channels. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the infrastructure capability and its role in handling the specified transaction volume. The logical flow from infrastructure description to transaction handling metrics is sound. MINOR CONSIDERATIONS: The LLM's use of 'approximately 70%' with a space before the percent sign is a negligible formatting variation. The additional technical detail about 'clearing and settlement backbone' and 'switches' adds value without contradicting the ground truth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 465,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "\nWalmart U.S. paid roughly **$1.9 billion in cash** to acquire VIZIO Holding Corp. The deal adds a data‑privacy risk because VIZIO’s operations collect consumer television‑viewing data that is now stored within Walmart’s digital ecosystem, heightening exposure to privacy breaches, regulatory scrutiny and potential fines or litigation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. (1) QUANTITATIVE ACCURACY: The $1.9 billion cash consideration figure is correct and matches the ground truth exactly. The number format variation ($1.9 billion vs $1.9 billion) is acceptable. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the cash consideration amount and the specific data privacy risk. (3) ENTITY ACCURACY: All entities are correctly identified (Walmart U.S., VIZIO Holding Corp., consumer television-viewing data). (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesizes that the acquisition introduces privacy risks because VIZIO collects television viewing data that is now part of Walmart's operations. (5) SEMANTIC EQUIVALENCE: The LLM's description of the privacy risk is semantically equivalent to the ground truth. Both mention: (a) television viewing data collection, (b) digital storage/ecosystem, (c) exposure to breaches/cybersecurity incidents, (d) potential for litigation and fines. The LLM uses slightly different phrasing ('heightening exposure to privacy breaches, regulatory scrutiny and potential fines or litigation' vs 'could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage'). The LLM omits explicit mention of 'reputational damage' as a consequence, which is a minor omission. The answer is well-structured, clear, and directly responsive to the question. The slight deduction from a perfect score reflects the omission of reputational damage as an explicitly stated consequence, though this is a minor detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 458,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "\nHigher fuel prices added only about **$14 million** of fuel‑cost recovery to operating income in 2022, while fuel‑related operating expenses rose by roughly **$35 million**.  The $35 million expense increase therefore exceeds the $14 million recovery, producing a **net $21 million drag on operating cash flow (or a $21 million increase in operating expenses)** for the year【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Quantitative verification: All numbers are correct - $14 million fuel cost recovery, $35 million fuel-related operating expense increase, and the calculated net impact of $21 million ($35M - $14M = $21M). The calculation is accurate and properly presented. Multi-hop reasoning: The answer correctly synthesizes information across multiple financial metrics (operating income recovery vs. operating expenses) and properly explains the net impact on cash flow. Entity accuracy: Duke Energy and 2022 are correctly identified. The answer appropriately characterizes the $21 million as a 'net drag on operating cash flow' or 'increase in operating expenses,' which is semantically equivalent to the ground truth's 'net negative cash flow impact.' The explanation clearly shows how the recovery mechanism partially offset expenses but still resulted in a net negative impact. Minor observation: The LLM answer uses slightly more concise language ('net $21 million drag') compared to the ground truth's more detailed explanation about the recovery mechanism's partial offset, but this is a stylistic difference that doesn't affect factual accuracy. The citation reference [page_55] adds credibility. Overall, the answer demonstrates sound financial reasoning and accurate synthesis of the multi-hop information required to answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 386,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "\nIn 2021 the company recorded **$565 million of additional period charges** that were “primarily associated with the ramp‑up of Intel 4.”  This charge reflects the impact of the **July 2021 announcement that the manufacturing process node would be renamed “Intel 4”** as part of a new naming structure for its process nodes, signaling the transition to the next‑generation node.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: The $565 million figure is correct and matches the ground truth exactly. The date reference to July 2021 is accurate (ground truth specifies July 26, 2021, but the LLM's reference to 'July 2021' is sufficiently precise for the context). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the specific dollar amount of additional period charges ($565 million), and (b) the relationship to the rebranding announcement (Intel 4 naming structure announced July 2021). (3) ENTITY ACCURACY: All entities are correctly identified - the year (2021), the manufacturing process node (Intel 4), the charge type (additional period charges), and the timing (July 2021 announcement). (4) MULTI-HOP REASONING: The answer correctly synthesizes the connection between the financial charge and the strategic rebranding initiative, showing that the $565 million cost was incurred as part of the transition to the newly rebranded Intel 4 process node. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'primarily associated with the ramp-up of Intel 4' and the ground truth's 'associated with the ramp up of Intel 4' are semantically equivalent. The explanation of the rebranding as 'part of a new naming structure for its process nodes' accurately conveys the same information as the ground truth. Minor note: The LLM uses quotation marks around 'primarily associated' suggesting direct citation, which adds credibility. The only minor difference is that the ground truth specifies July 26, 2021 while the LLM says July 2021, but this is not a material error given the context of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 460,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "\nIn 2023, sales of Danaher’s Diagnostics segment to “other developed markets” accounted for **5 %** of the segment’s total sales.  At the end of 2023 the company employed **about 3,000 people** in those same markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: Both key facts are correct - the 5% figure for Diagnostics segment sales attributed to Other Developed Markets in 2023, and the 3,000 employees in those markets as of end of 2023. (2) QUANTITATIVE ACCURACY: All numbers match the ground truth exactly. The percentage (5%) and employee count (3,000) are both correct. The use of 'about 3,000 people' is a minor semantic variation from '3,000 employees' but conveys the same information accurately. (3) ENTITY ACCURACY: All entities are correctly identified - Danaher (correct company), Diagnostics segment (correct segment), 2023 (correct year), Other Developed Markets (correct geographic designation). (4) MULTI-HOP REASONING: The answer successfully synthesizes information from two different data sources: (a) segment sales data by geography, and (b) employee headcount by geography. The model correctly paired these two metrics for the same geographic region and time period. (5) COMPLETENESS: The answer fully addresses both parts of the question - the percentage of sales AND the number of employees, with an implicit comparison showing both metrics for the same market. Minor deduction (1 point) only for the slight informality of 'about 3,000 people' versus the more precise '3,000 employees,' though this is semantically equivalent and not factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 395,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "\nThe 2021 revenue from Industrial chemicals & plastics can be calculated by multiplying the average revenue per car ($3,207) by the number of carloads (606 thousand). This yields roughly **$1.94 billion** in total revenue for that segment in 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the primary metric. Ground truth states the revenue was $1,943,442 (approximately $1.94 million), but the LLM claims it was $1.94 billion - an error of approximately 1,000x magnitude. This is a catastrophic quantitative error. Additionally, while the LLM correctly identifies the calculation methodology (revenue per car × number of carloads) and uses reasonable component numbers ($3,207 per car and 606 thousand carloads), the final result is wildly incorrect. The calculation itself ($3,207 × 606,000 = $1,943,442,000 or ~$1.94 billion) is mathematically correct, but this appears to represent a misunderstanding of the units involved - the ground truth answer of $1.94 million suggests the revenue per car figure may already be in thousands or the carloads figure needs different interpretation. The LLM failed to verify the reasonableness of the final answer against the ground truth magnitude. The reasoning process is sound in structure but produces an answer that is off by three orders of magnitude, making this response fundamentally incorrect despite showing work.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1089,
        "completion_tokens": 323,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "\nVerizon’s 2023 10‑K reports that the fair‑value of International bonds held in its other postretirement benefit plans is **$12 million**—$10 million classified as Level 1 and $2 million as Level 2—representing the total amount disclosed across the two reported asset categories.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the primary quantitative metric. The ground truth states the total fair value of International Bonds is $24 million (calculated as $12 million + $12 million from two asset categories). The LLM answer claims the total is only $12 million, which is incorrect. Additionally, the LLM provides a breakdown of $10 million Level 1 and $2 million Level 2 (totaling $12 million), which contradicts the ground truth's statement that each category contains $12 million. The LLM has failed the core requirement of the question: calculating the total fair value across both reported asset categories. While the LLM correctly identifies Verizon, the 2023 fiscal year, and that these are International Bonds in postretirement benefit plans, it has made a critical calculation error by reporting only half the correct total amount. The multi-hop synthesis required here is to sum values from two separate asset category tables, and the LLM has failed to do this correctly, instead reporting only a single category's value as the total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 309,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "\nCostco’s owned processing, packaging and manufacturing facilities enable it to produce a portion of its Kirkland‑Signature private‑label merchandise in‑house, giving the company tighter cost control and higher gross margins on those items.  Because these exclusive products drive traffic and boost comparable‑sales growth, the resulting increase in revenue allows Costco to spread its fixed SG&A expenses over a larger sales base, lowering SG&A as a percentage of sales and enhancing overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: The answer correctly identifies Costco's owned facilities (processing, packaging, manufacturing) and their role in producing private-label items (Kirkland Signature). It accurately describes the strategic mechanism: private-label items drive comparable sales growth, which allows SG&A leverage. The core logic matches the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either the original or LLM answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) QUALITATIVE ACCURACY: The LLM answer provides additional valuable context not explicitly in the ground truth but consistent with it: mentions 'tighter cost control and higher gross margins' and 'exclusive products drive traffic.' These details enhance understanding while remaining factually sound and aligned with Costco's business model. The explanation of how fixed SG&A expenses are spread over a larger sales base is clear and economically sound. (4) MULTI-HOP REASONING: The answer successfully synthesizes the connection between: (a) owned facilities → private-label production, (b) private-label items → comparable sales growth, (c) sales growth → SG&A leverage. This multi-hop chain is correctly constructed. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth while providing slightly more operational detail. The phrase 'spread its fixed SG&A expenses over a larger sales base' is an economically precise way to express the leverage concept. Minor difference: LLM emphasizes gross margin benefits in addition to SG&A leverage, which is a reasonable extension of the strategy but not explicitly stated in ground truth. This is a strength, not a weakness, as it demonstrates deeper understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 512,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "\nRibbonFET—Intel’s gate‑all‑around transistor introduced at the 20A node together with PowerVia backside power delivery—delivers higher drive current and lower capacitance, enabling the company to push performance‑per‑watt on CPUs, accelerators and IPU platforms while keeping power budgets tight.  This breakthrough is a focal point of Intel’s R&D investment (which funds the accelerated process‑and‑packaging roadmap) and of the IDM 2.0 strategy, which couples internal fabs, external foundry capacity and a new foundry‑services business with advanced packaging (e.g., Foveros Omni/Direct) to produce heterogeneous, high‑performance chips at scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Intel's RibbonFET technology and its strategic importance. STRENGTHS: (1) Correctly identifies RibbonFET as a gate-all-around transistor introduced at the 20A node; (2) Accurately describes technical benefits (higher drive current, lower capacitance, improved performance-per-watt); (3) Properly connects RibbonFET to R&D investment strategy; (4) Correctly links to IDM 2.0 strategy; (5) Adds valuable context about PowerVia backside power delivery and advanced packaging (Foveros Omni/Direct) that demonstrates deeper technical knowledge. QUANTITATIVE ACCURACY: The LLM answer does not include specific dollar amounts ($20 billion Arizona, $20+ billion Ohio) mentioned in the ground truth. However, the ground truth itself provides these figures as supporting context rather than core technical specifications. The LLM answer focuses on the strategic framework rather than specific investment amounts. MINOR GAPS: (1) Does not explicitly state the $20 billion Arizona and $20+ billion Ohio investment figures from IDM 2.0, though it references the strategy itself; (2) Ground truth emphasizes 'scale' deployment while LLM emphasizes 'at scale' production - semantically equivalent. MULTI-HOP REASONING: The LLM successfully synthesizes information across three dimensions: (1) RibbonFET technical specifications, (2) R&D investment strategy connection, and (3) IDM 2.0 strategic framework. The reasoning is sound and logically connects all elements. The answer actually provides more technical depth (PowerVia, Foveros Omni/Direct) than the ground truth while maintaining accuracy. SEMANTIC EQUIVALENCE: The LLM's description of RibbonFET's role in 'process leadership' and 'manufacturing leadership' aligns with ground truth's emphasis on maintaining 'leadership in semiconductor manufacturing.' The explanation of how RibbonFET enables performance improvements across 'CPUs, accelerators and IPU platforms' is consistent with the ground truth's reference to 'multiple dimensions' of performance improvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 563,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "\nIn Q4 2023 Meta estimated that roughly 3 percent of its MAP consisted solely of violating accounts, and that about 4 percent of its MAUs were false accounts. Because these accounts are extremely difficult to measure at scale and can fluctuate sharply—especially during episodic spikes—they can undermine the stability and accuracy of Meta’s reported user‑metric estimates, causing the figures to deviate substantially from the true size of the user base.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: 3% of MAP consisting of violating accounts and 4% of MAUs consisting of false accounts in Q4 2023. The numbers are accurate and properly formatted. The answer also correctly addresses how these accounts impact stability and accuracy of user metrics by noting they are difficult to measure at scale and can fluctuate sharply. However, the answer is somewhat incomplete compared to the ground truth. Specifically: (1) The ground truth mentions that limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries further impact accuracy—these contextual details are omitted from the LLM answer. (2) The ground truth explicitly notes that the company acknowledges methodologies used to identify and remove accounts could lead to fluctuations—the LLM answer focuses on the difficulty of measurement but doesn't explicitly mention the methodological component. (3) The LLM answer uses slightly different phrasing ('roughly 3 percent' vs 'approximately 3%' and 'solely of violating accounts' which adds an interpretive word not in the original) but this is semantically acceptable. The core multi-hop reasoning is sound—the answer synthesizes the percentage data with the impact analysis. The answer is contextually relevant and addresses the main question, but lacks some of the nuanced supporting details that would make it fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 412,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "\nAs of December 31 2023, the crypto‑asset safeguarding liability and the related safeguarding asset were each recorded at the same fair‑value amount—i.e., the liability and the asset offset each other and carry an equal recorded value.  This equality occurs because the Company had not incurred any safeguarding‑loss events, so the liability is measured at the quoted market price of the underlying crypto assets and the corresponding asset is recorded at that identical fair‑value.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the crypto asset safeguarding liability and corresponding safeguarding asset were recorded at the same fair value as of December 31, 2023; (2) Accurately explains the reason: PayPal had not incurred any safeguarding loss events; (3) Correctly identifies that both are measured at fair value using quoted market prices; (4) No quantitative errors or incorrect numbers/dates; (5) Properly synthesizes the multi-hop reasoning connecting the absence of loss events to the equal valuation. MINOR WEAKNESSES: (1) The LLM answer does not provide the specific dollar amount of the liability and asset, which the original answer also omits but the question asks for 'total fair value'; (2) The phrasing 'the liability and the asset offset each other' could be slightly misleading as it suggests a netting concept, though the LLM clarifies they carry equal recorded value; (3) The original answer explicitly mentions 'quoted prices for the underlying crypto assets on the active exchange identified as the principal market' which provides slightly more technical precision about the valuation methodology, though the LLM captures the essential concept. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between (a) the absence of safeguarding loss events and (b) the equal fair value recording of both the liability and asset. The reasoning is sound and logically presented. The answer would have been a 9-10 if it had included the specific dollar amounts, but since the original answer also doesn't provide these amounts, this is not a significant deficiency.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 463,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "\nThe combined amount for 2024 is **$184,729 (thousand)**, which is lower than the 2023 combined total of **$195,949 (thousand)**. This represents a decline of **$11,220 (thousand)** (about a 5.7 % reduction) from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-presented. Verification of key elements: (1) 2024 combined value of $184,729 thousand - CORRECT; (2) 2023 combined value of $195,949 thousand - CORRECT; (3) Difference calculation: $195,949 - $184,729 = $11,220 thousand - CORRECT; (4) Percentage decline: $11,220 / $195,949 = 5.73%, rounded to 5.7% - CORRECT. The LLM successfully synthesized the two financial metrics across two fiscal years and performed accurate arithmetic. The answer directly addresses all parts of the multi-part question: identifying the 2024 combined total, the 2023 combined total, and the year-over-year comparison. Minor note: The ground truth answer contains an apparent internal inconsistency (stating the 2024 total 'matches' the 2023 total while also stating it was $195,949, which is different), but the LLM correctly identified and reported the actual numerical values and the decline between years. The LLM's presentation is clear, includes the calculated percentage change (which adds useful context), and uses proper formatting for financial figures. All numbers are accurate and the multi-hop reasoning across years and metrics is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 332,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "\nSouthern Company Gas’ floating‑price natural‑gas purchases through Nicor Gas and SouthStar totaled **approximately $136 million** (about 39 million mmBtu) as of December 31 2024.  This procurement approach is consistent with the company’s regulated cost‑recovery framework, which allows the natural‑gas distribution utilities to recover all prudently incurred gas costs from customers via rate mechanisms that adjust prices to reflect wholesale (floating) price movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: The core financial figure of $136 million is correctly stated and matches the ground truth exactly. The LLM appropriately uses 'approximately' which is reasonable given the inclusion of the mmBtu conversion (39 million mmBtu), showing additional context not in the ground truth but not contradicting it. The date of December 31, 2024 is correct. (2) QUANTITATIVE ACCURACY: The $136 million figure is precise and accurate. The additional detail of 39 million mmBtu provides supplementary information that enhances rather than detracts from the answer. No calculation errors are present. (3) QUALITATIVE ACCURACY: The LLM correctly identifies the three entities (Southern Company Gas, Nicor Gas, SouthStar) and accurately explains the regulatory cost recovery framework. The explanation that utilities can recover prudently incurred gas costs through rate mechanisms that adjust for wholesale price movements is semantically equivalent to the ground truth's description of 'natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas.' The reasoning about alignment with the regulated framework is sound and demonstrates proper multi-hop synthesis. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question - the specific dollar value and the alignment with the regulated cost recovery framework. The response is appropriately focused and relevant. Minor observation: The LLM does not explicitly mention state regulatory agency approval/review as stated in the ground truth, but this is a minor omission that doesn't significantly impact the overall accuracy of the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 481,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "\nIn 2021 ConocoPhillips reported **$4.932 billion of net income attributable to the Lower 48 region**.  By contrast, the equity‑method earnings from that same region were **a $18 million loss** (i.e., equity earnings of –$18 million).  Thus, the segment’s net income was about $4.95 billion higher than the equity earnings figure for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key facts: (1) Net income from Lower 48 region in 2021: Ground truth states $4,932 million; LLM states $4.932 billion, which is equivalent and correctly formatted. (2) Equity in earnings (losses): Ground truth states $(18) million loss; LLM correctly identifies this as a $18 million loss (equity earnings of –$18 million), using semantically equivalent phrasing. (3) Comparison: The LLM correctly synthesizes the comparison, noting the net income was approximately $4.95 billion higher than equity earnings, which is accurate ($4,932M - (-$18M) = $4,950M or ~$4.95B). The multi-hop reasoning is sound—the model correctly extracted both metrics from the same region and year, then performed the appropriate comparison. The only minor observation is that the LLM's phrasing of the comparison ($4.95 billion higher) is slightly rounded compared to the precise $4,950 million difference, but this is a negligible formatting variation. The answer demonstrates proper understanding of the distinction between net income and equity in earnings, and correctly contextualizes both figures. All entities (ConocoPhillips, Lower 48 region, 2021) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 356,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "\nThe company’s 2024 filings disclose that the aggregate notional amount of open, unsettled forward‑exchange contracts was **$1.212 billion**.  It does not provide a separate notional figure for the variable‑priced commodity contracts used to hedge energy and other commodity price movements, but these contracts are described as “normal purchases and normal sales” that qualify for an exception from mark‑to‑market accounting.  Together, the FX forwards and the index‑based commodity contracts illustrate Costco’s strategy of economically hedging both currency exposure and commodity‑price volatility without resorting to speculative or leveraged positions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the key financial metric and sound reasoning about the company's hedging strategy. STRENGTHS: (1) The forward foreign-exchange contract notional value of $1.212 billion is correctly stated and properly formatted (equivalent to $1,212 million in ground truth). (2) The answer correctly identifies that variable-priced commodity contracts are used for electricity, natural gas, and fuel purchases. (3) The explanation of the company's strategy to economically hedge currency and commodity risks without speculative positions is accurate and well-articulated. (4) The reference to 'normal purchases and normal sales' exception from mark-to-market accounting aligns with the ground truth's statement that derivative hedge accounting is not applied. (5) Multi-hop synthesis is sound - the answer correctly connects FX forwards and commodity contracts as part of an integrated risk management strategy. MINOR WEAKNESSES: (1) The ground truth explicitly states the company 'does not apply derivative hedge accounting' while the LLM uses the phrase 'normal purchases and normal sales' exception - these are related concepts but the LLM's phrasing is slightly less direct than the ground truth's explicit statement. (2) The LLM notes that no separate notional figure is provided for commodity contracts, which is accurate but could have been more explicitly stated as in the ground truth. (3) The answer attributes the strategy to 'Costco' by name, which is reasonable inference but not explicitly confirmed in the provided ground truth excerpt. CALCULATION VERIFICATION: $1.212 billion = $1,212 million (correct format conversion). No calculations required beyond this conversion. MULTI-HOP REASONING: The answer successfully synthesizes information about both FX contracts and commodity contracts, explaining how they work together in the company's overall risk management framework. The reasoning is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 536,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "\nMicrosoft’s internal development model—grouping the creation of Microsoft 365 Consumer services within the **Experiences and Devices** engineering group (which also oversees Windows, Surface, and AI‑driven experiences) – is reflected in the FY 2024 financial disclosures.  To align reporting with how the business is managed, the company revised its subscriber metric to count **all Microsoft 365 Consumer and Copilot Pro users, including Microsoft 365 Basic subscribers**, and updated the methodology for Microsoft Cloud revenue growth.  This integrated structure gives investors a single, consolidated view of consumer‑subscriber growth and its contribution to the Productivity and Business Processes segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of the multi-hop relationship between Microsoft's internal development structure and financial reporting updates. STRENGTHS: (1) Correctly identifies the 'Experiences and Devices' engineering group as responsible for Microsoft 365 Consumer development, matching the ground truth. (2) Accurately captures the key financial reporting change: expansion of Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. (3) Properly explains the causal relationship—internal development structure alignment with how the business is managed drives the reporting update. (4) Adds relevant context about Copilot Pro users and Microsoft Cloud revenue methodology updates, which are consistent with FY 2024 disclosures. (5) Correctly identifies the Productivity and Business Processes segment as the relevant reporting segment. (6) No quantitative errors or incorrect dates/numbers. MINOR CONSIDERATIONS: (1) The ground truth answer is more concise and focused, while the LLM answer provides additional context (Windows, Surface, AI-driven experiences, Copilot Pro). While this additional detail is accurate and relevant, it slightly expands beyond the core question's scope. (2) The phrase 'all Microsoft 365 Consumer and Copilot Pro users' in the LLM answer is slightly more specific than the ground truth's 'Microsoft 365 Consumer subscribers' and 'Microsoft 365 Basic subscribers,' but this represents a reasonable elaboration rather than an error. (3) The mention of 'updated the methodology for Microsoft Cloud revenue growth' is contextually relevant but not explicitly addressed in the ground truth, though it doesn't contradict it. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between (1) internal organizational structure (Experiences and Devices group), (2) business management approach, and (3) financial reporting decisions. This demonstrates sound multi-hop reasoning. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 551,
        "total_tokens": 1864
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 745,
    "successful_evaluations": 745,
    "failed_evaluations": 0,
    "average_correctness_score": 7.2,
    "average_quantitative_accuracy": 7.76,
    "average_qualitative_accuracy": 7.44,
    "average_contextual_relevance": 8.49,
    "score_distribution": {
      "excellent": 369,
      "good": 152,
      "fair": 113,
      "poor": 111
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 745,
    "failed": 5,
    "elapsed_seconds": 12084.04,
    "timestamp": "2026-02-02T19:01:49.781678"
  }
}